data_2auv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2auv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.71 ' HG2' ' CE1' ' A' ' 7' ' ' TYR . 25.4 ttpt . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 110.106 -0.331 . . . . 4.9400000000000004 110.106 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.883 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.0 m-30 -108.5 82.69 1.72 Allowed Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 116.228 -0.442 . . . . 2.0 110.412 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.935 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 87.1 Cg_exo -52.72 94.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.835 2.356 . . . . 1.1200000000000001 111.972 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.74 HD13 HG21 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -85.11 127.7 39.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 1.97 112.054 -173.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 14.3 m -100.37 110.99 23.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.286 -0.87 . . . . 1.8500000000000001 110.627 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -117.21 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.409 . . . . 2.6800000000000002 110.97 -178.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 24.4 t -67.38 121.24 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.195 -0.602 . . . . 2.2400000000000002 111.611 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.0 mtm -123.82 23.11 8.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.934 -0.765 . . . . 5.4500000000000002 108.934 164.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.03 177.38 19.65 Favored Glycine 0 C--O 1.219 -0.807 0 C-N-CA 120.945 -0.645 . . . . 4.1399999999999997 112.624 -173.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.7 p -64.29 -43.89 93.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.69 0.626 . . . . 6.2599999999999998 112.69 -168.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.696 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -69.88 -55.63 9.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.43 . . . . 4.6399999999999997 111.361 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.66 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 86.6 m -66.53 -34.93 79.02 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.408 -0.36 . . . . 3.1499999999999999 111.757 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 51.3 t80 -62.16 -32.16 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.909 0.484 . . . . 4.6500000000000004 111.746 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 16' ' ' ALA . 4.2 p -70.91 -18.67 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.147 0.499 . . . . 4.0099999999999998 110.818 -172.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -80.75 8.43 8.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.501 0.667 . . . . 5.21 109.769 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.78 54.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.561 -0.745 . . . . 1.96 112.048 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.561 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -73.43 -21.08 60.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.421 -0.389 . . . . 1.9399999999999999 110.673 -172.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.612 ' O ' HG21 ' A' ' 26' ' ' VAL . 13.6 t70 -56.93 -46.55 81.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 2.4199999999999999 111.309 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -66.88 -36.99 83.57 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.067 -0.653 . . . . 3.4100000000000001 110.353 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.531 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -72.53 -38.18 58.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.797 -0.638 . . . . 2.75 111.182 177.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 23' ' ' ASP . 4.6 m -66.19 -28.43 43.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 119.546 -0.862 . . . . 2.1299999999999999 109.15 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.48 -40.47 82.82 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.577 -0.527 . . . . 1.54 109.577 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -50.96 -51.26 54.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.863 -1.062 . . . . 1.27 108.904 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.586 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 29.8 t80 -53.65 -48.77 69.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.95 -1.023 . . . . 2.5800000000000001 112.0 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -46.75 -49.48 19.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.004 -0.998 . . . . 3.23 110.494 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -77.96 -26.79 49.02 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.676 -1.147 . . . . 2.23 110.619 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.66 ' OE1' ' HA ' ' A' ' 79' ' ' LYS . 4.6 mt-30 -60.5 -29.86 69.36 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.536 -0.757 . . . . 2.54 112.393 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.759 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 1.1 tt -48.42 -55.74 10.04 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.373 -1.714 . . . . 2.5499999999999998 106.373 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.759 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.04 -18.81 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 126.513 2.383 . . . . 4.8099999999999996 112.648 173.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.711 ' HA ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 51.71 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.398 -1.728 . . . . 4.1900000000000004 113.996 165.287 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.415 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 16.0 t70 -155.51 -55.64 0.09 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.581 -1.645 . . . . 4.6200000000000001 108.076 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 36' ' ' ASP . 3.3 pt -167.53 9.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 112.728 -2.033 . . . . 5.3700000000000001 108.486 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.92 -51.81 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.585 0 N-CA-C 108.981 -1.647 . . . . 4.1299999999999999 108.981 -164.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.603 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -169.72 143.04 2.6 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.546 -0.827 . . . . 4.3099999999999996 111.772 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.811 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER 18.83 -68.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 O-C-N 127.041 2.713 . . . . 2.96 115.167 161.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 40' ' ' VAL . 23.5 m -135.32 94.64 15.42 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 104.793 -2.299 . . . . 4.1799999999999997 104.793 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD3' ' CB ' ' A' ' 36' ' ' ASP . 1.5 Cg_endo -33.06 89.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.965 3.11 . . . . 4.3700000000000001 113.608 -149.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -144.36 -65.1 0.35 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.919 -1.491 . . . . 4.2599999999999998 111.37 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 113.49 37.41 1.32 Allowed Glycine 0 C--N 1.31 -0.89 0 N-CA-C 110.32 -1.112 . . . . 2.1299999999999999 110.32 -169.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.603 ' HD3' ' OXT' ' A' ' 85' ' ' TYR . 76.5 mtt180 -61.15 -42.26 98.23 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.876 -1.162 . . . . 3.7799999999999998 109.845 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.811 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 99.3 m-85 -84.15 136.88 33.81 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.911 -1.041 . . . . 2.6099999999999999 110.969 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.935 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 19.9 t -145.01 65.25 1.27 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.813 -1.18 . . . . 2.2799999999999998 107.813 165.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.74 HG21 HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.97 129.17 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.331 -0.85 . . . . 3.5600000000000001 111.99 -170.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -154.93 138.9 16.36 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.281 1.039 . . . . 3.3100000000000001 110.784 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.7 p -43.86 -45.42 7.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.322 -1.763 . . . . 3.7000000000000002 115.488 168.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.1 tp -53.16 -41.52 65.24 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.282 1.586 . . . . 4.7999999999999998 115.282 -149.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -64.43 -57.34 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.931 0.872 . . . . 6.9100000000000001 111.053 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -66.26 170.51 5.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.835 -1.53 . . . . 3.04 111.026 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.57 HG21 ' SG ' ' A' ' 12' ' ' CYS . 5.9 t 73.14 28.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.67 1.224 . . . . 4.6799999999999997 109.175 -164.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.65 64.2 0.3 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 113.922 -1.49 . . . . 4.1900000000000004 113.371 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.49 57.49 16.31 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.319 -1.42 . . . . 4.8499999999999996 115.321 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.252 2.0 m -133.19 -33.32 1.14 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.706 1.253 . . . . 3.5600000000000001 109.747 -161.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.98 -26.38 2.49 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.397 1.999 . . . . 3.9100000000000001 116.397 -163.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.72 3.38 6.54 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.316 1.416 . . . . 5.7000000000000002 111.413 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.94 158.36 50.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.245 -1.391 . . . . 3.5800000000000001 107.245 154.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.15 118.6 5.03 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-N 121.191 1.461 . . . . 4.3600000000000003 109.648 164.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.32 131.71 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.89 -0.141 . . . . 3.0499999999999998 110.867 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.69 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 6.1 t -138.71 125.93 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.891 -1.151 . . . . 2.3300000000000001 107.891 160.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.764 ' HG3' HG23 ' A' ' 69' ' ' VAL . 49.7 ttm -112.29 136.77 51.32 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 117.703 -1.599 . . . . 2.23 109.815 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.883 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.75 114.71 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 106.649 -1.612 . . . . 1.3300000000000001 106.649 159.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.18 -145.87 1.65 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-O 122.337 0.965 . . . . 1.1000000000000001 112.596 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.53 25.88 0.31 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.379 -1.411 . . . . 3.0099999999999998 109.423 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.615 ' HB2' HG23 ' A' ' 65' ' ' VAL . 9.1 mmpt? -106.95 -40.82 5.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.298 -0.63 . . . . 3.0600000000000001 109.298 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.764 HG23 ' HG3' ' A' ' 64' ' ' MET . 80.1 t 46.26 99.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.502 0.927 . . . . 2.0699999999999998 113.502 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.733 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -117.03 -153.21 0.52 Allowed 'General case' 0 C--O 1.246 0.906 0 CA-C-O 122.07 0.938 . . . . 1.9399999999999999 113.362 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.597 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -134.51 17.1 4.27 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.202 -1.363 . . . . 1.49 112.796 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.904 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -89.53 98.52 11.81 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.945 -0.761 . . . . 1.95 108.945 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.626 HG21 HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -126.41 -90.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 122.181 0.991 . . . . 3.4399999999999999 112.652 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.852 HG22 ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -137.77 -66.6 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 113.504 -1.68 . . . . 2.9700000000000002 111.858 -170.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.852 ' HD3' HG22 ' A' ' 74' ' ' THR . 6.3 Cg_exo -76.84 70.87 6.36 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.648 2.232 . . . . 3.0899999999999999 114.019 -162.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 80.1 -19.55 6.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.105 -0.569 . . . . 1.6399999999999999 113.108 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 81' ' ' ILE . 6.2 mt-30 -73.98 -22.86 59.45 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.342 -1.725 . . . . 1.98 106.342 -170.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.585 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 13.6 m -48.7 -59.18 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 111.826 -2.443 . . . . 1.5700000000000001 111.386 -175.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.66 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 23.6 pttt -60.17 -39.49 86.62 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.783 0.801 . . . . 2.48 110.741 -165.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.639 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -82.38 -45.27 15.07 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.75 -1.113 . . . . 2.8100000000000001 109.646 -173.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 72' ' ' ASN . 39.5 mm -69.39 -15.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.211 -1.358 . . . . 1.6399999999999999 110.155 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.508 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 53.6 tp -63.04 -37.81 88.67 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.74 -0.6 . . . . 1.3600000000000001 110.256 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.7 64.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.013 -0.736 . . . . 1.3600000000000001 109.013 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 6.6 mt-10 -73.66 -34.49 64.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.871 -1.059 . . . . 2.0899999999999999 112.748 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 5.1 m-30 . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 118.951 -0.547 . . . . 1.77 112.044 -175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 3.8 tppp? . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 109.422 -0.585 . . . . 4.9400000000000004 109.422 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.049 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 22.5 m-85 -141.71 62.71 15.34 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 114.364 -1.289 . . . . 2.0 110.254 -175.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HD2' ' CA ' ' A' ' 66' ' ' GLY . 33.4 Cg_exo -61.48 92.81 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.534 1.489 . . . . 1.1200000000000001 109.949 172.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 1.018 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.03 160.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 116.409 -0.36 . . . . 1.97 110.426 -168.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.801 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m -139.86 112.84 8.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 123.644 0.59 . . . . 1.8500000000000001 111.343 -174.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.7 t -118.17 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.182 -0.917 . . . . 2.6800000000000002 109.857 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -65.39 120.38 12.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 118.775 0.716 . . . . 2.2400000000000002 110.958 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ttt -124.3 23.05 8.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.503 -0.771 . . . . 5.4500000000000002 109.654 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -68.06 177.52 23.73 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.797 . . . . 4.1399999999999997 112.417 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -67.65 -43.8 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.078 0.399 . . . . 6.2599999999999998 112.078 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.63 ' O ' HG21 ' A' ' 19' ' ' VAL . . . -71.29 -56.8 5.29 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.549 0.574 . . . . 4.6399999999999997 112.549 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 98.9 m -63.48 -30.53 71.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.506 -0.316 . . . . 3.1499999999999999 111.572 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 56.4 t80 -59.31 -29.53 67.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.286 0.635 . . . . 4.6500000000000004 112.179 -176.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.63 HG21 ' O ' ' A' ' 16' ' ' ALA . 16.9 m -69.15 -18.65 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 111.91 0.337 . . . . 4.0099999999999998 111.91 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.02 13.32 2.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.807 0.337 . . . . 5.21 110.591 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.4 28.73 23.99 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.649 -0.58 . . . . 1.96 111.649 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . . . -72.48 -19.63 61.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.253 -0.474 . . . . 1.9399999999999999 110.97 -172.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . 8.5 p-10 -55.7 -45.0 77.92 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.887 -0.325 . . . . 2.4199999999999999 110.429 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -62.61 -48.29 80.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.352 -0.539 . . . . 3.4100000000000001 110.782 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.995 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 6.6 m -65.52 -44.3 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 116.305 -0.407 . . . . 2.75 110.526 -176.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 23' ' ' ASP . 15.0 m -64.17 -36.45 77.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.149 -0.62 . . . . 2.1299999999999999 110.2 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -60.18 -42.57 95.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.107 -0.637 . . . . 1.54 109.398 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.575 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.75 -46.66 81.27 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.42 -1.264 . . . . 1.27 108.629 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.45 ' HZ ' ' CG1' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -44.59 82.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.875 . . . . 2.5800000000000001 111.425 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -54.63 -51.21 66.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.723 0.773 . . . . 3.23 110.085 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.77 -20.75 38.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.935 -1.03 . . . . 2.23 110.653 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.575 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -62.0 -30.64 71.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.781 -0.645 . . . . 2.54 110.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.058 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.8 tt -54.69 -54.24 44.41 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.259 -1.015 . . . . 2.5499999999999998 108.259 172.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 65.77 -19.52 0.09 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.357 -2.202 . . . . 4.8099999999999996 112.493 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.647 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER 54.36 -170.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.501 -1.681 . . . . 4.1900000000000004 113.12 168.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -157.38 -49.56 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.208 -1.405 . . . . 4.6200000000000001 107.208 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -164.92 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 113.069 -1.878 . . . . 5.3700000000000001 110.836 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.05 -61.98 0.07 OUTLIER Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 109.783 -1.327 . . . . 4.1299999999999999 109.783 -166.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.572 ' HB2' ' N ' ' A' ' 44' ' ' GLY . 38.2 m-20 -165.52 122.12 1.42 Allowed 'General case' 0 CA--C 1.475 -1.925 0 CA-C-N 113.051 -1.575 . . . . 4.3099999999999996 108.796 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.913 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 1.4 p 54.99 -71.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 O-C-N 126.775 2.547 . . . . 2.96 113.348 169.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.786 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 84.3 m -151.18 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.275 -2.662 0 CA-C-N 113.262 -1.79 . . . . 4.1799999999999997 110.256 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.786 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 7.1 Cg_exo -73.83 4.42 4.15 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 120.673 0.915 . . . . 4.3700000000000001 113.946 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.531 ' HA ' ' H ' ' A' ' 39' ' ' ASP . 20.2 t70 78.09 14.12 1.56 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.294 -1.373 . . . . 4.2599999999999998 107.294 169.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.572 ' N ' ' HB2' ' A' ' 39' ' ' ASP . . . 155.07 63.58 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 114.151 -1.386 . . . . 2.1299999999999999 112.278 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 10.5 ttt180 -94.7 -64.69 1.04 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.814 -1.55 . . . . 3.7799999999999998 106.814 171.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.058 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -107.23 123.99 49.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.752 -0.658 . . . . 2.6099999999999999 112.281 171.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 4.2 m -105.33 92.15 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.966 . . . . 2.2799999999999998 109.279 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.999 HG23 HD12 ' A' ' 9' ' ' ILE . 2.3 pp -60.18 123.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.774 -0.648 . . . . 3.5600000000000001 112.72 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.801 ' O ' ' HA ' ' A' ' 10' ' ' SER . 5.3 t70 -160.85 140.49 10.77 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.241 1.019 . . . . 3.3100000000000001 113.051 167.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t -47.51 -45.96 26.9 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 115.111 1.522 . . . . 3.7000000000000002 115.111 169.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.426 ' HG ' ' OD1' ' A' ' 49' ' ' ASP . 51.6 mt -53.49 -38.12 63.38 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.254 2.316 . . . . 4.7999999999999998 117.254 -152.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.4 mmt180 -61.78 -56.82 15.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.757 1.162 . . . . 6.9100000000000001 110.18 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.629 ' H ' ' HB3' ' A' ' 10' ' ' SER . 27.4 t -65.07 165.46 11.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.327 -1.76 . . . . 3.04 109.938 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.684 HG22 ' SG ' ' A' ' 12' ' ' CYS . 10.9 t 71.26 25.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 122.93 1.347 . . . . 4.6799999999999997 108.188 -156.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.51 64.11 0.35 Allowed Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 113.583 -1.644 . . . . 4.1900000000000004 113.538 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.33 57.71 14.21 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 119.11 -1.519 . . . . 4.8499999999999996 115.3 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.635 ' HB3' HG23 ' A' ' 62' ' ' ILE 0.267 1.8 m -135.7 -32.65 0.89 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.564 1.182 . . . . 3.5600000000000001 110.416 -162.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -28.64 5.66 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.477 1.658 . . . . 3.9100000000000001 115.477 -163.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.57 7.63 2.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.777 1.172 . . . . 5.7000000000000002 112.053 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.7 160.55 36.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.888 -0.782 . . . . 3.5800000000000001 108.888 164.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.89 122.18 7.09 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 N-CA-C 108.787 -1.274 . . . . 4.3600000000000003 108.787 160.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.635 HG23 ' HB3' ' A' ' 57' ' ' CYS . 1.9 pp -110.0 133.68 54.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.875 1.065 . . . . 3.0499999999999998 113.875 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.662 HG22 ' H ' ' A' ' 73' ' ' VAL . 4.0 t -138.03 119.19 17.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.022 -1.844 . . . . 2.3300000000000001 106.022 154.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.75 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 20.9 ttt -114.36 135.34 54.19 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 120.33 -1.481 . . . . 2.23 111.926 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 1.049 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -126.57 118.43 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 N-CA-C 107.635 -1.246 . . . . 1.3300000000000001 107.635 157.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.569 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 60.2 -169.78 7.53 Favored Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.886 -1.15 . . . . 1.1000000000000001 110.481 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.83 37.96 0.31 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.926 -1.138 . . . . 3.0099999999999998 107.926 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.622 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 54.6 mmtt -107.89 -31.21 8.1 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.892 -1.049 . . . . 3.0600000000000001 108.646 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.661 ' C ' ' HD1' ' A' ' 70' ' ' TYR . 75.7 t 47.54 113.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 114.472 1.286 . . . . 2.0699999999999998 114.472 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.675 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -123.53 -170.11 2.06 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 122.615 1.197 . . . . 1.9399999999999999 112.967 -172.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.71 49.9 0.82 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 113.662 -1.608 . . . . 1.49 110.178 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.888 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -77.92 -0.41 27.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.361 1.077 . . . . 1.95 110.062 175.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.662 ' H ' HG22 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 64.33 -165.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 113.749 -1.569 . . . . 3.4399999999999999 111.65 168.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.995 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 64.4 p -138.58 -46.67 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 114.22 1.193 . . . . 2.9700000000000002 114.22 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.748 ' HD2' HE21 ' A' ' 77' ' ' GLN . 7.0 Cg_endo -88.29 78.58 1.33 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.895 1.73 . . . . 3.0899999999999999 113.787 -172.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.428 ' C ' HG21 ' A' ' 78' ' ' VAL . . . 77.28 -23.17 2.33 Favored Glycine 0 N--CA 1.461 0.335 0 C-N-CA 121.01 -0.614 . . . . 1.6399999999999999 113.078 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.748 HE21 ' HD2' ' A' ' 75' ' ' PRO . 32.7 mt-30 -75.28 -21.12 58.76 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.413 -1.699 . . . . 1.98 106.413 -174.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.557 HG23 ' HG3' ' A' ' 79' ' ' LYS . 4.0 m -45.09 -61.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 111.478 -2.601 . . . . 1.5700000000000001 112.162 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.557 ' HG3' HG23 ' A' ' 78' ' ' VAL . 43.3 mtmt -58.03 -32.03 67.57 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 122.039 0.923 . . . . 2.48 110.657 -166.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.438 ' CD ' ' HA ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -81.28 -50.84 9.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.53 -1.214 . . . . 2.8100000000000001 108.837 -177.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.888 ' CG2' ' HA ' ' A' ' 72' ' ' ASN . 28.8 mm -66.14 -5.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 113.549 -1.66 . . . . 1.6399999999999999 110.601 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 47.0 tp -54.22 -21.67 9.58 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.508 -0.745 . . . . 1.3600000000000001 110.143 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.84 -19.66 6.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.687 -0.688 . . . . 1.3600000000000001 111.352 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 6.6 tp10 -69.53 -51.34 36.54 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.44 1.096 . . . . 2.0899999999999999 110.241 173.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.675 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 11.4 m-30 . . . . . 0 N--CA 1.425 -1.693 0 CA-C-N 113.673 -1.603 . . . . 1.77 112.811 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 24.2 tptp . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 108.817 -0.809 . . . . 4.9400000000000004 108.817 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.113 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -115.89 87.51 18.71 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.711 -1.132 . . . . 2.0 110.916 175.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.34 96.55 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.637 2.225 . . . . 1.1200000000000001 111.565 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 1.05 HD11 HG22 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -75.17 117.83 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.799 0.809 . . . . 1.97 110.289 -175.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 7.3 m -100.14 113.02 25.35 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.139 -1.391 . . . . 1.8500000000000001 110.528 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.64 HG13 HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -118.48 122.81 70.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.274 -0.875 . . . . 2.6800000000000002 110.328 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.727 ' SG ' HG22 ' A' ' 54' ' ' VAL . 33.7 t -66.47 122.82 18.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.279 0.561 . . . . 2.2400000000000002 111.284 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -122.69 23.87 9.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.428 -0.805 . . . . 5.4500000000000002 109.699 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.95 178.68 20.21 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.792 -0.718 . . . . 4.1399999999999997 112.778 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -65.36 -44.85 86.38 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.462 0.541 . . . . 6.2599999999999998 112.462 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 -55.05 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.271 0.558 . . . . 4.6399999999999997 111.851 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 79.4 m -64.69 -31.08 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.537 -0.756 . . . . 3.1499999999999999 111.541 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 75.6 t80 -58.35 -27.43 64.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.447 0.699 . . . . 4.6500000000000004 111.576 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.74 -20.82 26.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.058 -0.519 . . . . 4.0099999999999998 111.468 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -80.79 11.48 3.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.159 -0.338 . . . . 5.21 111.224 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.38 29.44 27.48 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.725 -0.75 . . . . 1.96 111.954 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.491 ' O ' HG11 ' A' ' 26' ' ' VAL . . . -71.93 -20.47 61.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.906 0.335 . . . . 1.9399999999999999 111.906 -168.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 26' ' ' VAL . 27.1 t70 -57.86 -45.34 86.42 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.845 -0.342 . . . . 2.4199999999999999 110.881 -176.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.516 ' HZ3' ' HB3' ' A' ' 24' ' ' LYS . 7.2 mtpm? -64.92 -42.52 94.64 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.609 . . . . 3.4100000000000001 111.134 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.83 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.9 m -68.91 -39.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.707 0.289 . . . . 2.75 111.228 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.872 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . 10.7 m -65.31 -33.35 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.817 -0.753 . . . . 2.1299999999999999 110.258 175.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.58 -39.33 87.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.253 0.549 . . . . 1.54 109.551 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 25' ' ' VAL . . . -55.08 -45.84 75.42 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.701 -1.136 . . . . 1.27 109.443 175.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.881 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 23.1 m-85 -52.15 -50.11 62.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 123.46 0.475 . . . . 2.5800000000000001 111.02 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -49.91 -50.83 44.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.53 0.681 . . . . 3.23 111.312 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.52 -30.22 37.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.296 -0.865 . . . . 2.23 111.39 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.881 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -68.01 -19.29 64.9 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.741 -0.663 . . . . 2.54 110.313 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.017 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -54.52 -56.48 18.42 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 106.153 -1.795 . . . . 2.5499999999999998 106.153 169.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.735 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 70.16 -21.86 0.17 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.775 -2.011 . . . . 4.8099999999999996 110.909 168.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 56.56 -176.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 112.508 -2.133 . . . . 4.1900000000000004 113.702 166.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.422 ' O ' HG22 ' A' ' 37' ' ' ILE . 12.9 t70 -158.68 -44.11 0.06 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.075 -1.42 . . . . 4.6200000000000001 107.748 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 36' ' ' ASP . 2.5 pt -168.3 -0.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 113.226 -1.806 . . . . 5.3700000000000001 111.416 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.77 -52.66 0.11 Allowed Glycine 0 CA--C 1.483 -1.923 0 N-CA-C 107.629 -2.188 . . . . 4.1299999999999999 107.629 -162.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.733 ' CG ' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -171.54 135.54 0.91 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.266 -1.967 . . . . 4.3099999999999996 109.732 175.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.733 HG12 ' CG ' ' A' ' 39' ' ' ASP . 7.1 p 39.06 -65.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 127.502 3.001 . . . . 2.96 114.955 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.8 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 45.0 m -150.82 -60.11 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.69 -1.595 . . . . 4.1799999999999997 110.833 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.839 ' HG2' ' HG3' ' A' ' 45' ' ' ARG . 1.1 Cg_endo -88.33 15.51 2.07 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 121.618 1.546 . . . . 4.3700000000000001 114.937 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 25.8 t70 83.38 -1.75 1.17 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.143 0.973 . . . . 4.2599999999999998 109.708 160.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.18 53.11 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.774 -1.203 . . . . 2.1299999999999999 113.566 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.839 ' HG3' ' HG2' ' A' ' 42' ' ' PRO . 20.0 mtt180 -72.26 -53.9 11.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.924 -0.769 . . . . 3.7799999999999998 108.924 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.017 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -128.08 120.3 27.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.552 1.167 . . . . 2.6099999999999999 113.768 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.9 p -114.68 106.73 14.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.818 -1.537 . . . . 2.2799999999999998 108.307 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 1.05 HG22 HD11 ' A' ' 9' ' ' ILE . 2.0 pp -72.91 121.06 22.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.378 -0.828 . . . . 3.5600000000000001 112.229 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.49 141.95 15.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 122.744 1.259 . . . . 3.3100000000000001 112.225 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 21.4 m -43.92 -46.24 8.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.614 2.079 . . . . 3.7000000000000002 116.614 174.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.44 -41.12 65.76 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.776 2.139 . . . . 4.7999999999999998 116.776 -147.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 12.7 tpt180 -63.39 -57.72 9.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.271 0.941 . . . . 6.9100000000000001 110.786 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.612 ' H ' ' HB3' ' A' ' 10' ' ' SER . 33.0 t -65.18 172.72 2.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.591 -1.64 . . . . 3.04 110.727 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.727 HG22 ' SG ' ' A' ' 12' ' ' CYS . 13.5 t 76.2 29.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 122.93 1.348 . . . . 4.6799999999999997 109.538 -160.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.2 61.65 0.31 Allowed Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 113.849 -1.523 . . . . 4.1900000000000004 112.555 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.97 54.98 32.38 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 119.892 -1.147 . . . . 4.8499999999999996 115.709 169.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.257 1.4 m -135.12 -32.49 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.202 1.501 . . . . 3.5600000000000001 109.704 -161.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.89 -25.27 1.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.921 1.823 . . . . 3.9100000000000001 115.921 -163.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.63 8.14 1.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.563 1.074 . . . . 5.7000000000000002 111.791 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.68 161.91 27.97 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.053 -1.092 . . . . 3.5800000000000001 108.053 162.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.33 119.96 6.27 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 120.704 1.287 . . . . 4.3600000000000003 109.309 166.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.47 132.74 56.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.429 0.529 . . . . 3.0499999999999998 112.429 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.668 HG21 ' H ' ' A' ' 73' ' ' VAL . 2.5 t -138.7 119.76 16.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.446 -1.687 . . . . 2.3300000000000001 106.446 154.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 20.8 ttt -112.42 136.27 52.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 120.369 -1.457 . . . . 2.23 110.0 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 1.113 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -125.26 117.15 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.413 -1.329 . . . . 1.3300000000000001 107.413 159.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 55.09 -162.3 4.72 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.146 -1.026 . . . . 1.1000000000000001 110.863 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -79.06 34.48 0.24 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.889 -0.782 . . . . 3.0099999999999998 108.889 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.666 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 70.9 mmtt -108.47 -22.18 12.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.279 -0.873 . . . . 3.0600000000000001 110.012 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 64' ' ' MET . 23.2 m 36.54 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 115.134 1.531 . . . . 2.0699999999999998 115.134 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -116.31 -178.33 3.39 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.979 1.371 . . . . 1.9399999999999999 113.598 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.05 48.67 0.91 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 113.381 -1.736 . . . . 1.49 109.603 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.892 ' HA ' HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -78.4 -0.89 30.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.902 0.858 . . . . 1.95 109.191 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.668 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 63.31 -168.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 113.909 -1.496 . . . . 3.4399999999999999 111.282 171.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.83 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 13.3 p -135.74 -46.36 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 113.946 1.091 . . . . 2.9700000000000002 113.946 -169.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.691 ' HD2' HE21 ' A' ' 77' ' ' GLN . 4.5 Cg_endo -88.73 85.45 0.58 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.185 1.923 . . . . 3.0899999999999999 113.224 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.32 -27.77 2.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.17 -0.538 . . . . 1.6399999999999999 112.774 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.875 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 36.7 mt-30 -77.31 -18.62 57.33 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.064 -1.458 . . . . 1.98 107.064 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -46.72 -58.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-N 112.444 -2.162 . . . . 1.5700000000000001 111.354 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.662 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.3 pttt -62.17 -38.06 87.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.426 0.631 . . . . 2.48 111.096 -166.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.875 ' HD2' ' HA ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.85 -34.05 15.42 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.074 0.464 . . . . 2.8100000000000001 110.873 -176.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 72' ' ' ASN . 47.9 mm -72.45 -10.79 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.909 -0.774 . . . . 1.6399999999999999 108.909 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.948 HD12 ' HB2' ' A' ' 85' ' ' TYR . 16.7 tp -57.84 -12.97 3.55 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.462 0.705 . . . . 1.3600000000000001 110.467 171.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -25.58 6.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.08 -0.648 . . . . 1.3600000000000001 110.076 163.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 5.7 mm-40 -65.49 -49.95 67.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.459 -0.791 . . . . 2.0899999999999999 110.97 169.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.948 ' HB2' HD12 ' A' ' 82' ' ' LEU . 12.6 m-30 . . . . . 0 N--CA 1.428 -1.556 0 CA-C-N 115.682 -0.69 . . . . 1.77 112.099 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 120.848 0.356 . . . . 4.9400000000000004 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.802 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.0 m-85 -111.85 98.73 42.82 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 116.094 -0.503 . . . . 2.0 111.915 -172.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.931 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 80.0 Cg_exo -50.69 96.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.882 2.388 . . . . 1.1200000000000001 112.19 171.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.995 HD13 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.24 115.37 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.79 0.805 . . . . 1.97 110.112 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 14.0 m -92.61 127.34 38.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.194 -1.366 . . . . 1.8500000000000001 109.987 -176.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 t -114.25 126.47 71.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 2.6800000000000002 112.328 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.469 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 16.3 t -64.21 115.17 4.75 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.555 0.693 . . . . 2.2400000000000002 112.138 -175.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 84.6 mtp -129.26 24.6 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 5.4500000000000002 110.737 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.79 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . -65.57 176.73 14.11 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.381 -0.914 . . . . 4.1399999999999997 114.14 -167.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 t -66.17 -45.85 79.45 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.821 0.304 . . . . 6.2599999999999998 111.821 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 25.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.744 0.783 . . . . 4.6399999999999997 110.162 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 76.9 m -61.93 -35.73 79.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.312 -1.313 . . . . 3.1499999999999999 112.237 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.525 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 54.0 t80 -61.66 -31.74 71.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.008 0.432 . . . . 4.6500000000000004 111.024 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.0 t -71.98 -21.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 4.0099999999999998 110.319 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 27.4 mtpp -82.8 12.92 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.925 -0.579 . . . . 5.21 111.803 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.56 32.06 14.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.151 -1.023 . . . . 1.96 111.906 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.527 ' O ' HG12 ' A' ' 26' ' ' VAL . . . -70.86 -20.97 62.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.635 0.235 . . . . 1.9399999999999999 111.635 -170.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.606 ' O ' HG23 ' A' ' 26' ' ' VAL . 25.0 t70 -55.82 -49.58 72.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.953 0.406 . . . . 2.4199999999999999 110.144 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 2.5 mptp? -66.94 -39.62 87.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.561 -0.456 . . . . 3.4100000000000001 111.59 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.903 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 3.3 m -68.58 -41.09 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 120.888 -0.325 . . . . 2.75 110.843 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 23' ' ' ASP . 8.0 m -64.96 -34.08 68.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.831 -0.748 . . . . 2.1299999999999999 110.003 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.466 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 62.0 t-80 -59.42 -39.4 83.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.26 0.552 . . . . 1.54 109.805 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -54.71 -50.48 68.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.868 -1.06 . . . . 1.27 108.725 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.837 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.2 m-85 -50.57 -47.27 57.91 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 123.877 0.736 . . . . 2.5800000000000001 111.68 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 25.1 tptp -49.3 -56.32 9.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 3.23 111.213 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -83.35 -19.67 35.71 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.268 -0.878 . . . . 2.23 111.513 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.837 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.82 -22.1 65.17 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.876 -0.602 . . . . 2.54 110.684 177.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.677 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -50.1 -59.63 3.72 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.55 -1.648 . . . . 2.5499999999999998 106.55 167.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' C ' HG13 ' A' ' 35' ' ' ILE . 4.4 pttm 68.09 -27.34 0.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 112.412 -2.177 . . . . 4.8099999999999996 111.674 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.65 ' HA ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 55.55 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.24 -1.8 . . . . 4.1900000000000004 113.379 172.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 37' ' ' ILE . 14.9 t70 -155.14 -53.55 0.09 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.214 -1.402 . . . . 4.6200000000000001 107.214 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 36' ' ' ASP . 2.3 pt -174.43 19.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 112.734 -2.03 . . . . 5.3700000000000001 109.385 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.02 -70.81 0.05 OUTLIER Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 109.278 -1.529 . . . . 4.1299999999999999 109.278 -168.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.598 ' HA ' HD22 ' A' ' 33' ' ' LEU . 10.5 m-20 -165.27 119.82 1.28 Allowed 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 112.996 -1.602 . . . . 4.3099999999999996 109.293 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.976 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 7.5 p 56.11 -65.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 126.636 2.46 . . . . 2.96 114.259 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.917 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 64.8 m -164.19 -59.79 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.745 0 CA-C-N 113.236 -1.802 . . . . 4.1799999999999997 110.06 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.917 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 16.3 Cg_exo -71.3 8.51 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.715 0 N-CA-C 114.493 0.92 . . . . 4.3700000000000001 114.493 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 11.5 t70 86.56 -15.67 0.44 Allowed 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.613 -0.514 . . . . 4.2599999999999998 109.613 161.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . -170.23 47.13 0.2 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.068 -1.539 . . . . 2.1299999999999999 113.819 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.52 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -72.86 -32.44 65.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.94 0.876 . . . . 3.7799999999999998 109.382 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.976 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 49.9 m-85 -96.58 153.29 17.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.194 -1.366 . . . . 2.6099999999999999 112.386 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.931 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 31.2 t -152.8 66.72 0.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.556 -1.646 . . . . 2.2799999999999998 106.556 161.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.995 HG22 HD13 ' A' ' 9' ' ' ILE . 2.2 pp -60.09 114.67 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.475 -1.239 . . . . 3.5600000000000001 112.68 -168.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -161.15 144.53 12.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.746 1.26 . . . . 3.3100000000000001 112.738 168.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 m -42.76 -43.09 3.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.917 -1.947 . . . . 3.7000000000000002 115.022 167.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.7 mt -52.21 -41.87 63.06 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 116.058 1.874 . . . . 4.7999999999999998 116.058 -147.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.543 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 24.1 mmt85 -64.71 -56.97 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.556 1.17 . . . . 6.9100000000000001 110.261 174.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.657 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 35.9 t -66.31 167.05 11.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.714 -2.039 . . . . 3.04 112.617 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.79 HG13 ' HA2' ' A' ' 14' ' ' GLY . 15.7 t 70.44 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 123.053 1.406 . . . . 4.6799999999999997 109.411 -168.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.26 64.66 0.31 Allowed Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 113.626 -1.624 . . . . 4.1900000000000004 113.129 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.08 58.02 13.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 118.719 -1.705 . . . . 4.8499999999999996 114.941 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.279 1.8 m -132.2 -31.05 1.48 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.618 1.209 . . . . 3.5600000000000001 109.083 -162.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.7 -27.06 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.554 1.687 . . . . 3.9100000000000001 115.554 -163.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.24 5.03 3.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.181 1.355 . . . . 5.7000000000000002 111.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.03 158.65 45.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.078 -1.082 . . . . 3.5800000000000001 108.078 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -76.61 121.69 6.09 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.494 1.212 . . . . 4.3600000000000003 109.319 163.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.3 tt -108.34 132.14 56.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.114 -0.635 . . . . 3.0499999999999998 112.188 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.771 HG21 ' H ' ' A' ' 73' ' ' VAL . 20.9 t -137.88 118.43 16.42 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 105.686 -1.968 . . . . 2.3300000000000001 105.686 158.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.685 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 17.1 ttt -116.87 137.83 51.94 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.442 -1.411 . . . . 2.23 110.648 -172.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.802 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -124.45 117.09 49.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 107.045 -1.465 . . . . 1.3300000000000001 107.045 155.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 51.47 -157.52 2.9 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.527 -0.629 . . . . 1.1000000000000001 111.527 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.14 39.94 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.66 -0.867 . . . . 3.0099999999999998 108.66 170.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.621 ' HB2' HG23 ' A' ' 65' ' ' VAL . 26.0 mmmt -108.33 -26.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.478 -0.783 . . . . 3.0600000000000001 109.221 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.633 HG13 ' HG3' ' A' ' 64' ' ' MET . 9.2 m 36.01 109.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 115.138 1.533 . . . . 2.0699999999999998 115.138 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.707 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.9 m-85 -118.86 -169.88 1.81 Allowed 'General case' 0 C--O 1.248 0.98 0 CA-C-O 122.86 1.314 . . . . 1.9399999999999999 113.003 -173.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -144.82 46.45 0.8 Allowed Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 113.55 -1.659 . . . . 1.49 109.955 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.9 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.78 -0.58 21.52 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.981 0.896 . . . . 1.95 110.049 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.771 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 63.22 -165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 114.12 -1.4 . . . . 3.4399999999999999 112.679 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.903 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.1 p -137.56 -45.13 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 113.604 0.965 . . . . 2.9700000000000002 113.604 -168.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.487 ' CD ' ' H ' ' A' ' 74' ' ' THR . 83.5 Cg_endo -88.68 77.56 1.34 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 121.845 1.697 . . . . 3.0899999999999999 113.705 -171.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.92 -24.26 2.87 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.171 -0.538 . . . . 1.6399999999999999 113.031 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.648 ' NE2' HG12 ' A' ' 73' ' ' VAL . 32.8 mt-30 -75.24 -20.9 58.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.565 -1.643 . . . . 1.98 106.565 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.673 ' HB ' HE21 ' A' ' 32' ' ' GLN . 2.7 m -43.58 -56.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 111.559 -2.564 . . . . 1.5700000000000001 112.025 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.742 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.2 mtmt -56.73 -42.13 78.71 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 122.181 0.991 . . . . 2.48 110.003 -167.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -42.43 13.94 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.34 -1.3 . . . . 2.8100000000000001 109.812 -172.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.9 HG22 ' HA ' ' A' ' 72' ' ' ASN . 41.3 mm -67.99 -13.78 17.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.694 -1.139 . . . . 1.6399999999999999 109.29 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.917 HD13 ' HB2' ' A' ' 85' ' ' TYR . 27.2 tp -59.56 -13.42 9.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.657 0.783 . . . . 1.3600000000000001 110.592 170.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.62 -26.27 8.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.255 -0.578 . . . . 1.3600000000000001 109.963 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.64 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 8.8 mm-40 -62.79 -51.99 64.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.0899999999999999 109.745 169.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.917 ' HB2' HD13 ' A' ' 82' ' ' LEU . 8.9 m-30 . . . . . 0 N--CA 1.424 -1.735 0 CA-C-N 114.812 -1.086 . . . . 1.77 112.259 -171.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 122.618 1.199 . . . . 4.9400000000000004 110.739 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.752 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 7.3 m-85 -55.64 113.08 5.02 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.412 -1.722 . . . . 2.0 114.365 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.791 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 72.5 Cg_exo -56.07 90.96 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.1 2.533 . . . . 1.1200000000000001 111.919 166.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.766 HD12 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.87 119.12 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.675 0.75 . . . . 1.97 110.661 -177.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.711 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 2.6 m -100.46 114.44 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.606 -1.179 . . . . 1.8500000000000001 111.291 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.8 t -117.98 122.88 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 2.6800000000000002 110.85 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 25.1 t -67.61 121.2 15.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.28 -0.568 . . . . 2.2400000000000002 111.553 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.8 mtp -124.61 23.41 8.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.63 -0.714 . . . . 5.4500000000000002 109.584 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.67 179.61 12.47 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.178 -0.534 . . . . 4.1399999999999997 112.998 -174.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -64.25 -45.42 88.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.069 0.396 . . . . 6.2599999999999998 112.069 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.603 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -70.97 -56.41 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.078 0.466 . . . . 4.6399999999999997 112.178 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.4 m -66.28 -33.79 76.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.91 -0.587 . . . . 3.1499999999999999 111.993 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -60.6 -29.86 69.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.575 0.584 . . . . 4.6500000000000004 112.575 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 16' ' ' ALA . 18.2 m -69.43 -18.95 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.771 0.32 . . . . 4.0099999999999998 111.526 -171.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -80.57 12.88 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.541 -0.299 . . . . 5.21 110.923 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.25 29.04 26.19 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 121.114 -0.565 . . . . 1.96 111.98 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -72.1 -20.67 61.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.493 -0.353 . . . . 1.9399999999999999 110.862 -172.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 26' ' ' VAL . 24.8 t70 -53.99 -50.42 66.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 2.4199999999999999 110.759 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -66.87 -40.51 87.86 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.304 -0.559 . . . . 3.4100000000000001 111.152 -172.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.831 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 1.9 m -69.45 -42.71 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.451 -0.34 . . . . 2.75 110.655 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 23' ' ' ASP . 17.6 m -66.15 -29.0 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 119.522 -0.871 . . . . 2.1299999999999999 109.99 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -58.7 -41.2 85.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.137 0.494 . . . . 1.54 109.747 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.04 74.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.848 -1.069 . . . . 1.27 109.707 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -49.86 65.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.581 . . . . 2.5800000000000001 110.411 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -51.9 -50.13 61.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 3.23 111.547 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -79.96 -25.82 40.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.553 -0.749 . . . . 2.23 110.982 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.648 ' HG3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -61.82 -34.84 76.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.411 -0.589 . . . . 2.54 109.411 175.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.76 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -45.29 -58.74 3.08 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 107.012 -1.477 . . . . 2.5499999999999998 107.012 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 66.04 -24.77 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.729 -2.032 . . . . 4.8099999999999996 112.093 171.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.726 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.95 -174.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.477 -1.692 . . . . 4.1900000000000004 113.762 168.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' O ' HG21 ' A' ' 37' ' ' ILE . 11.0 t70 -156.0 -48.51 0.08 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.077 -1.419 . . . . 4.6200000000000001 107.497 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.551 HG21 ' O ' ' A' ' 36' ' ' ASP . 1.4 pt -172.09 16.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-N 113.35 -1.75 . . . . 5.3700000000000001 110.751 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.38 -66.94 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.883 -1.287 . . . . 4.1299999999999999 109.883 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.739 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 18.8 m-20 -164.81 117.46 1.25 Allowed 'General case' 0 CA--C 1.484 -1.583 0 CA-C-N 113.268 -1.466 . . . . 4.3099999999999996 110.296 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.942 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.4 p 57.19 -64.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 126.882 2.613 . . . . 2.96 113.592 171.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.918 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 90.6 m -157.04 -60.45 0.02 OUTLIER Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 113.272 -1.785 . . . . 4.1799999999999997 110.867 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 13.8 Cg_exo -70.94 2.18 4.46 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 120.426 0.751 . . . . 4.3700000000000001 113.449 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 4.4 t70 82.55 4.29 1.08 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-O 123.404 1.574 . . . . 4.2599999999999998 107.687 167.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 168.47 63.29 0.03 OUTLIER Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 112.539 -2.119 . . . . 2.1299999999999999 110.225 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.63 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 18.7 tpp85 -93.12 -34.63 13.57 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.296 -1.742 . . . . 3.7799999999999998 106.296 166.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.942 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 25.1 m-85 -87.9 152.59 21.97 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 110.826 -2.897 . . . . 2.6099999999999999 110.567 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.791 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 54.1 m -153.55 68.67 0.79 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.618 -1.252 . . . . 2.2799999999999998 107.618 163.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.766 HG22 HD12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -69.9 122.62 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.299 -0.864 . . . . 3.5600000000000001 112.272 -168.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.711 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.0 p30 -156.24 139.11 15.28 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.345 1.069 . . . . 3.3100000000000001 111.219 164.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 19.9 p -43.61 -46.13 7.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.616 -1.629 . . . . 3.7000000000000002 115.206 169.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.91 -39.52 65.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.869 1.804 . . . . 4.7999999999999998 115.869 -151.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.1 -57.27 11.15 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.085 0.945 . . . . 6.9100000000000001 109.88 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.682 ' O ' HG23 ' A' ' 54' ' ' VAL . 34.3 t -65.6 167.44 8.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 3.04 109.731 173.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 53' ' ' CYS . 1.9 m 72.34 26.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 125.398 1.479 . . . . 4.6799999999999997 110.129 -159.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.21 65.2 0.26 Allowed Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 113.665 -1.607 . . . . 4.1900000000000004 112.995 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 57.28 15.49 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 119.492 -1.337 . . . . 4.8499999999999996 115.235 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.911 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.293 1.8 m -134.48 -32.55 1.02 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.712 1.256 . . . . 3.5600000000000001 109.943 -162.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.65 2.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.282 1.956 . . . . 3.9100000000000001 116.282 -160.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 pp -74.37 5.16 4.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.425 1.466 . . . . 5.7000000000000002 112.101 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.46 159.46 45.71 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.264 -1.013 . . . . 3.5800000000000001 108.264 159.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.54 119.66 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 120.372 1.168 . . . . 4.3600000000000003 109.869 161.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.911 HG13 ' HB3' ' A' ' 57' ' ' CYS . 42.8 mm -110.98 134.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.609 0.226 . . . . 3.0499999999999998 111.609 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.52 123.0 30.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 107.503 -1.295 . . . . 2.3300000000000001 107.503 163.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.611 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 45.5 ttm -114.49 138.0 51.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.002 -1.686 . . . . 2.23 111.313 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -125.01 115.67 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.424 -1.324 . . . . 1.3300000000000001 107.424 158.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.524 ' CA ' ' HD2' ' A' ' 8' ' ' PRO . . . 46.37 -144.35 4.14 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-O 122.598 1.11 . . . . 1.1000000000000001 112.67 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -82.8 27.69 0.52 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 113.369 -1.415 . . . . 3.0099999999999998 109.462 176.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.774 ' HB2' HG21 ' A' ' 65' ' ' VAL . 14.3 mmmm -107.26 -24.19 11.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.875 -0.602 . . . . 3.0600000000000001 110.659 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.9 m 33.95 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.281 0.988 . . . . 2.0699999999999998 113.484 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.682 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -99.53 -168.83 1.66 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.469 1.604 . . . . 1.9399999999999999 114.247 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 73' ' ' VAL . . . -134.89 57.27 0.7 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.001 -1.909 . . . . 1.49 110.093 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.595 ' HA ' HG23 ' A' ' 81' ' ' ILE . 44.5 t-20 -86.37 39.64 0.84 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 123.17 1.462 . . . . 1.95 109.053 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.868 HG23 ' HB2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER 47.78 -161.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 112.684 -2.053 . . . . 3.4399999999999999 113.634 155.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.831 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.4 p -134.71 -45.58 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 113.016 0.747 . . . . 2.9700000000000002 113.016 173.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.698 ' HA ' HG11 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -75.1 -85.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 121.87 1.714 . . . . 3.0899999999999999 114.367 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.24 0.15 5.97 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.748 -0.739 . . . . 1.6399999999999999 112.106 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.868 ' HB2' HG23 ' A' ' 73' ' ' VAL . 9.9 mt-30 -81.26 -13.47 58.45 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 106.382 -1.711 . . . . 1.98 106.382 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.624 ' HB ' ' NE2' ' A' ' 32' ' ' GLN . 2.7 m -51.71 -46.92 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 111.988 -2.369 . . . . 1.5700000000000001 109.904 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.675 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 34.2 mttm -57.28 -44.23 83.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.123 -1.399 . . . . 2.48 109.353 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.697 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -77.85 -42.49 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.599 -1.637 . . . . 2.8100000000000001 109.755 -175.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.645 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 33.5 mm -68.4 -17.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.616 -0.72 . . . . 1.6399999999999999 110.191 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.675 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 9.6 tp -57.92 -38.32 75.66 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.545 -0.722 . . . . 1.3600000000000001 110.463 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -33.5 69.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.37 0.605 . . . . 1.3600000000000001 109.483 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.645 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 3.3 mm-40 -68.24 -30.84 69.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.964 -1.017 . . . . 2.0899999999999999 111.857 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.682 ' CE1' ' HD2' ' A' ' 70' ' ' TYR . 2.9 m-30 . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 118.801 -0.619 . . . . 1.77 111.318 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 112.804 0.668 . . . . 4.9400000000000004 112.804 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.628 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 11.2 m-85 -43.0 107.75 0.58 Allowed Pre-proline 0 N--CA 1.445 -0.713 0 C-N-CA 124.604 1.162 . . . . 2.0 112.807 175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HD2' ' CA ' ' A' ' 66' ' ' GLY . 75.1 Cg_exo -56.66 93.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.813 2.342 . . . . 1.1200000000000001 111.284 171.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.914 ' HB ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -81.3 121.89 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 121.858 0.837 . . . . 1.97 110.405 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.694 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.7 m -105.38 127.11 52.8 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.541 -1.209 . . . . 1.8500000000000001 111.203 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 50' ' ' THR . 4.1 t -117.91 123.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 2.6800000000000002 112.016 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 30.0 t -67.16 124.33 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.22 0.533 . . . . 2.2400000000000002 111.315 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.9 mmm -120.5 23.1 11.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.545 -0.752 . . . . 5.4500000000000002 109.278 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.55 177.89 25.03 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.608 -0.724 . . . . 4.1399999999999997 112.528 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 19' ' ' VAL . 17.3 m -67.45 -45.41 76.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.032 0.382 . . . . 6.2599999999999998 112.032 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 -56.01 7.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 4.6399999999999997 112.267 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.655 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 74.6 m -64.59 -32.91 74.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 3.1499999999999999 111.105 -173.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 68.2 t80 -60.52 -28.63 68.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.961 -0.563 . . . . 4.6500000000000004 111.774 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 15' ' ' THR . 60.9 t -68.87 -22.11 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.131 0.491 . . . . 4.0099999999999998 110.921 -173.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -81.94 13.34 3.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.208 -0.451 . . . . 5.21 111.329 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.463 ' O ' HG21 ' A' ' 25' ' ' VAL . . . 87.07 30.29 20.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.366 -0.921 . . . . 1.96 111.766 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . . . -70.68 -21.58 62.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.463 -0.199 . . . . 1.9399999999999999 110.463 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.03 -54.6 45.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.331 -0.395 . . . . 2.4199999999999999 110.208 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 3.4100000000000001 109.621 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.92 HG13 ' H ' ' A' ' 74' ' ' THR . 54.6 t -59.21 -57.65 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 115.649 -0.705 . . . . 2.75 109.587 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.33 -30.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 120.271 -0.571 . . . . 2.1299999999999999 109.647 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -59.26 -43.5 92.48 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.128 -0.487 . . . . 1.54 110.253 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.0 74.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.134 -0.939 . . . . 1.27 109.229 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.67 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -55.31 -53.36 57.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.065 -0.97 . . . . 2.5800000000000001 110.087 175.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -48.83 -47.48 42.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.321 -0.854 . . . . 3.23 110.757 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.41 -34.37 25.53 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.521 -0.763 . . . . 2.23 111.932 -174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.721 ' NE2' ' HB2' ' A' ' 82' ' ' LEU . 1.9 pt20 -63.17 -25.73 68.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.249 -0.649 . . . . 2.54 109.249 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.74 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -57.72 -60.43 3.7 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.323 -1.362 . . . . 2.5499999999999998 107.323 173.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.646 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 68.01 -20.83 0.13 Allowed 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 125.503 1.752 . . . . 4.8099999999999996 110.578 172.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.74 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 58.18 126.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.709 -2.042 . . . . 4.1900000000000004 113.243 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 11.1 t70 -86.72 -45.94 10.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 112.284 -2.235 . . . . 4.6200000000000001 107.741 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.527 HG13 ' HB2' ' A' ' 43' ' ' ASP . 2.0 pt -168.4 -1.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 112.93 -1.941 . . . . 5.3700000000000001 110.923 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 35' ' ' ILE . . . 173.09 -32.74 0.11 Allowed Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 110.774 -0.93 . . . . 4.1299999999999999 110.774 -163.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.716 ' OD1' ' HB3' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -145.17 -162.92 1.6 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.095 -1.052 . . . . 4.3099999999999996 110.883 -169.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.667 ' HA ' HD22 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -64.61 -30.18 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-O 123.865 1.793 . . . . 2.96 107.531 177.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.72 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 65.4 m -168.45 -64.32 0.01 OUTLIER Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 110.026 -3.261 . . . . 4.1799999999999997 111.182 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.72 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 7.1 Cg_exo -73.81 -6.64 18.93 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 121.289 1.326 . . . . 4.3700000000000001 115.445 -164.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 39' ' ' ASP . 26.0 t70 74.59 16.04 3.24 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 122.759 1.266 . . . . 4.2599999999999998 107.586 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.55 66.91 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.41 -1.723 . . . . 2.1299999999999999 111.26 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.716 ' HB3' ' OD1' ' A' ' 39' ' ' ASP . 13.7 tpt180 -132.93 -55.72 0.93 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.885 -1.154 . . . . 3.7799999999999998 107.885 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.702 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.91 146.41 27.39 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.054 -1.43 . . . . 2.6099999999999999 110.364 176.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.421 ' H ' HG23 ' A' ' 9' ' ' ILE . 52.9 m -154.57 96.85 1.94 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.215 -0.661 . . . . 2.2799999999999998 109.215 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.658 HG21 HG22 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -87.11 137.3 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.071 0.767 . . . . 3.5600000000000001 113.071 -167.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.01 138.02 12.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.968 -1.014 . . . . 3.3100000000000001 110.787 158.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 56.5 m -45.9 -45.34 15.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.11 -1.405 . . . . 3.7000000000000002 114.323 165.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.69 -39.59 65.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.14 1.534 . . . . 4.7999999999999998 115.14 -154.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -62.36 -57.13 12.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.476 1.131 . . . . 6.9100000000000001 109.694 176.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.694 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 22.5 t -66.26 167.62 10.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.59 -2.095 . . . . 3.04 111.208 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 53' ' ' CYS . 1.6 m 70.27 25.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 125.883 1.673 . . . . 4.6799999999999997 109.351 -160.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.29 65.77 0.25 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 113.479 -1.692 . . . . 4.1900000000000004 112.49 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.88 56.3 17.26 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 119.681 -1.247 . . . . 4.8499999999999996 115.801 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.597 ' HB2' HG13 ' A' ' 62' ' ' ILE . 1.9 m -136.17 -31.54 0.9 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.46 -0.941 . . . . 3.5600000000000001 108.46 -170.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.09 -25.94 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.883 1.809 . . . . 3.9100000000000001 115.883 -163.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.2 7.52 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.81 1.186 . . . . 5.7000000000000002 111.841 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.45 160.46 37.8 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.229 -1.026 . . . . 3.5800000000000001 108.229 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.93 119.33 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 120.742 1.301 . . . . 4.3600000000000003 108.822 165.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.597 HG13 ' HB2' ' A' ' 57' ' ' CYS . 49.2 mm -111.51 130.94 64.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 114.265 1.209 . . . . 3.0499999999999998 114.265 -172.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.2 122.19 6.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.3 -1.37 . . . . 2.3300000000000001 107.3 147.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.732 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 65.6 ttp -111.19 137.78 48.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.759 -1.213 . . . . 2.23 109.727 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.914 HG11 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.77 114.23 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 N-CA-C 107.015 -1.476 . . . . 1.3300000000000001 107.015 167.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 48.87 -152.88 2.55 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 122.342 0.968 . . . . 1.1000000000000001 111.869 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -78.6 37.26 0.28 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.882 -1.159 . . . . 3.0099999999999998 109.266 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.752 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 29.8 mmmt -113.68 -26.29 8.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.035 -0.529 . . . . 3.0600000000000001 111.532 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.574 ' C ' ' HD1' ' A' ' 70' ' ' TYR . 30.4 m 38.22 108.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 115.205 1.557 . . . . 2.0699999999999998 115.205 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.752 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 2.8 m-85 -122.42 -170.74 2.13 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.448 1.118 . . . . 1.9399999999999999 113.352 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.08 21.85 5.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 113.832 -1.531 . . . . 1.49 111.293 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.721 ' HB2' HG22 ' A' ' 81' ' ' ILE . 2.7 t30 -74.22 92.73 2.26 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.862 -0.422 . . . . 1.95 109.862 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -172.37 -167.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 122.882 0.473 . . . . 3.4399999999999999 111.429 177.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.92 ' H ' HG13 ' A' ' 25' ' ' VAL . 41.0 p 50.54 104.08 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 C-N-CA 125.204 1.402 . . . . 2.9700000000000002 112.266 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.727 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 73.6 Cg_exo -23.47 89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 1 C-N-CA 125.456 4.104 . . . . 3.0899999999999999 113.28 -174.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 80' ' ' LYS . . . 148.11 -61.23 0.44 Allowed Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.974 -1.012 . . . . 1.6399999999999999 112.572 -171.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.61 ' HG3' ' HG1' ' A' ' 74' ' ' THR . 5.0 mt-30 -76.26 -30.54 57.89 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.193 -1.41 . . . . 1.98 107.193 -166.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.507 HG13 ' CA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -48.24 -52.05 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 112.41 -2.177 . . . . 1.5700000000000001 111.132 -175.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.424 ' N ' HG22 ' A' ' 78' ' ' VAL . 36.6 mtmt -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.647 1.213 . . . . 2.48 108.523 -166.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -78.89 -42.16 27.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.173 -1.83 . . . . 2.8100000000000001 110.922 -173.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.721 HG22 ' HB2' ' A' ' 72' ' ' ASN . 33.2 mm -72.57 -15.34 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.157 0.503 . . . . 1.6399999999999999 109.926 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.721 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 48.0 tp -60.99 -38.58 86.51 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.069 -0.395 . . . . 1.3600000000000001 110.348 169.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -31.96 67.48 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 121.779 0.799 . . . . 1.3600000000000001 108.86 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -73.39 -31.62 63.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.753 -1.112 . . . . 2.0899999999999999 111.354 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.713 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 2.2 m-30 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 119.489 -0.291 . . . . 1.77 111.162 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 15.7 tppt? . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 109.337 -0.616 . . . . 4.9400000000000004 109.337 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.609 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 15.1 m-85 -129.59 80.58 71.53 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-O 120.934 0.397 . . . . 2.0 109.974 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' SER . 82.0 Cg_exo -50.54 107.25 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.115 2.543 . . . . 1.1200000000000001 112.09 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.964 HD13 HG23 ' A' ' 48' ' ' ILE . 13.1 pt -81.59 130.55 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 112.092 0.405 . . . . 1.97 112.092 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.5 p -94.32 132.06 39.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.178 -0.675 . . . . 1.8500000000000001 109.178 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.09 117.85 56.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.167 -0.47 . . . . 2.6800000000000002 110.63 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 1.002 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -69.96 121.85 18.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 2.2400000000000002 111.9 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.8 mmm -121.64 20.3 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.968 -1.123 . . . . 5.4500000000000002 107.968 163.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 179.32 31.15 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.557 -1.201 . . . . 4.1399999999999997 113.172 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 19' ' ' VAL . 8.1 m -68.93 -44.43 73.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.079 0.4 . . . . 6.2599999999999998 112.079 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -58.16 4.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.025 0.75 . . . . 4.6399999999999997 113.025 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 1.002 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 88.8 m -65.31 -33.91 77.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 3.1499999999999999 111.012 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -60.69 -31.68 70.93 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.904 0.383 . . . . 4.6500000000000004 111.086 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 15' ' ' THR . 57.5 t -72.54 -25.09 22.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.391 0.615 . . . . 4.0099999999999998 110.054 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -85.23 9.38 15.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.613 -0.722 . . . . 5.21 110.894 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.04 32.57 17.15 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.021 -1.085 . . . . 1.96 112.466 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -71.97 -20.81 61.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.849 0.315 . . . . 1.9399999999999999 111.849 -171.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.4 p-10 -62.48 -40.84 97.96 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.053 -0.659 . . . . 2.4199999999999999 109.74 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -66.78 -36.51 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.044 -0.724 . . . . 3.4100000000000001 109.044 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.028 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 76.7 t -55.78 -54.78 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 CA-C-N 115.057 -0.974 . . . . 2.75 109.415 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 23' ' ' ASP . 15.3 m -63.16 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.115 -0.634 . . . . 2.1299999999999999 110.902 -174.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -60.66 -47.58 85.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.733 -0.787 . . . . 1.54 109.955 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.59 -46.24 80.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.236 -0.893 . . . . 1.27 108.613 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.84 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.0 t80 -54.49 -48.49 71.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 124.218 0.949 . . . . 2.5800000000000001 110.146 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -49.11 -54.93 13.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.717 -1.129 . . . . 3.23 111.297 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 -18.87 27.51 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.287 -0.87 . . . . 2.23 111.717 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.84 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.98 -21.17 65.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.573 -0.528 . . . . 2.54 109.573 173.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.797 HD23 ' HA ' ' A' ' 39' ' ' ASP . 1.2 tt -48.6 -59.88 3.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.291 -1.744 . . . . 2.5499999999999998 106.291 168.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.663 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 65.61 -25.45 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.241 2.213 . . . . 4.8099999999999996 112.186 171.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.795 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 57.78 -174.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 113.073 -1.876 . . . . 4.1900000000000004 113.74 166.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.569 ' O ' HG21 ' A' ' 37' ' ' ILE . 12.4 t70 -146.89 -53.2 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 106.166 -1.791 . . . . 4.6200000000000001 106.166 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.637 HG13 ' OD1' ' A' ' 43' ' ' ASP . 1.2 pt -171.63 21.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 113.612 -1.631 . . . . 5.3700000000000001 109.718 172.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.52 -67.07 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 109.464 -1.454 . . . . 4.1299999999999999 109.464 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.87 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 18.5 m-20 -170.39 116.72 0.51 Allowed 'General case' 0 CA--C 1.485 -1.525 0 CA-C-N 113.602 -1.299 . . . . 4.3099999999999996 110.156 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.943 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.8 p 58.0 -64.23 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 O-C-N 126.679 2.487 . . . . 2.96 113.057 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.612 ' OG1' ' HD3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -159.33 -56.15 0.02 OUTLIER Pre-proline 0 C--N 1.276 -2.621 0 CA-C-N 113.38 -1.736 . . . . 4.1799999999999997 111.966 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HD2' HG11 ' A' ' 40' ' ' VAL . 13.1 Cg_exo -72.11 -3.63 13.64 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 CA-C-N 119.48 0.85 . . . . 4.3700000000000001 112.81 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.841 ' HA ' ' H ' ' A' ' 39' ' ' ASP . 73.0 m-20 75.34 19.05 2.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 122.457 1.122 . . . . 4.2599999999999998 108.96 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 171.7 39.15 0.03 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 CA-C-N 112.508 -2.133 . . . . 2.1299999999999999 110.949 166.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 22.1 ttt180 -74.4 -34.64 63.33 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.533 -1.654 . . . . 3.7799999999999998 106.533 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.943 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 29.1 m-85 -88.82 149.75 23.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 112.241 -2.254 . . . . 2.6099999999999999 110.396 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 15.2 m -168.45 99.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.76 0.424 . . . . 2.2799999999999998 110.018 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.964 HG23 HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -66.31 136.7 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.919 1.081 . . . . 3.5600000000000001 113.919 -168.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -160.08 135.75 8.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.626 1.203 . . . . 3.3100000000000001 113.023 154.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -46.57 -41.53 14.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.026 1.73 . . . . 3.7000000000000002 114.61 160.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -50.87 -30.24 14.01 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.959 1.466 . . . . 4.7999999999999998 114.959 -158.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.546 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 8.1 mmt180 -54.91 -47.05 74.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.008 0.433 . . . . 6.9100000000000001 111.108 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.3 t -58.0 160.2 5.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.188 -0.915 . . . . 3.04 113.439 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 14.2 t 67.51 24.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.55 0 CA-C-O 123.139 1.447 . . . . 4.6799999999999997 108.353 -164.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.88 64.49 0.33 Allowed Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 113.349 -1.75 . . . . 4.1900000000000004 112.479 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.63 57.99 14.06 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 118.839 -1.648 . . . . 4.8499999999999996 115.08 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.864 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.253 5.6 m -132.27 -35.28 1.19 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 1.411 . . . . 3.5600000000000001 113.072 -162.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.72 -30.76 23.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.694 1.739 . . . . 3.9100000000000001 115.694 -164.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.0 mt -78.37 5.37 10.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.014 1.279 . . . . 5.7000000000000002 112.793 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 159.94 43.15 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 122.549 0.34 . . . . 3.5800000000000001 110.479 170.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.9 124.23 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.531 -1.373 . . . . 4.3600000000000003 108.531 153.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.864 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.5 mm -106.82 129.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.935 -1.106 . . . . 3.0499999999999998 113.054 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.532 HG12 ' HH ' ' A' ' 85' ' ' TYR . 39.4 t -140.25 119.37 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.054 -1.462 . . . . 2.3300000000000001 107.054 158.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.604 ' HG3' HG22 ' A' ' 69' ' ' VAL . 39.0 ttm -114.2 141.61 47.31 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.911 -1.118 . . . . 2.23 111.734 -170.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.892 HG22 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.06 112.85 40.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.286 -1.746 . . . . 1.3300000000000001 106.286 158.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 40.84 -141.82 0.9 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-O 122.507 1.06 . . . . 1.1000000000000001 113.363 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -79.38 28.57 0.24 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.324 -1.438 . . . . 3.0099999999999998 109.84 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.892 ' HB2' HG22 ' A' ' 65' ' ' VAL . 10.8 mmmm -100.59 -47.88 4.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.193 -0.669 . . . . 3.0600000000000001 109.193 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.604 HG22 ' HG3' ' A' ' 64' ' ' MET . 91.1 t 48.56 116.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 114.225 1.194 . . . . 2.0699999999999998 114.225 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 62.8 m-85 -138.4 -157.84 0.81 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.099 0.952 . . . . 1.9399999999999999 113.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -135.07 39.02 1.74 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.151 -1.386 . . . . 1.49 110.0 171.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.847 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 6.0 t-20 -58.42 110.5 0.98 Allowed 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.457 -0.942 . . . . 1.95 108.457 173.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.47 ' HB ' ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -100.91 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.247 -1.342 . . . . 3.4399999999999999 114.532 -157.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 1.028 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 2.2 t -143.09 -48.0 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 115.24 1.57 . . . . 2.9700000000000002 115.24 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.552 ' HD3' HG23 ' A' ' 74' ' ' THR . 2.3 Cg_endo -80.68 64.0 8.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.939 1.759 . . . . 3.0899999999999999 113.484 -168.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.547 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 75.8 -12.22 9.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.217 -0.516 . . . . 1.6399999999999999 112.976 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.676 ' HA ' ' CD ' ' A' ' 80' ' ' LYS . 30.0 mt-30 -75.11 -28.8 60.37 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 106.944 -1.502 . . . . 1.98 106.944 -174.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.589 ' HB ' HE21 ' A' ' 32' ' ' GLN . 0.0 OUTLIER -51.23 -55.08 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 112.04 -2.346 . . . . 1.5700000000000001 112.561 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.674 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 18.8 pttp -60.07 -25.67 65.57 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 121.884 0.85 . . . . 2.48 110.571 -168.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.676 ' CD ' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -80.21 -50.81 9.73 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.936 -1.029 . . . . 2.8100000000000001 109.082 178.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.769 ' HB ' HD21 ' A' ' 72' ' ' ASN . 30.0 mm -60.05 -16.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.186 -1.37 . . . . 1.6399999999999999 109.871 172.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.674 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 63.9 tp -61.36 -40.67 95.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.881 0.372 . . . . 1.3600000000000001 110.13 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.25 68.68 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.701 0.762 . . . . 1.3600000000000001 109.336 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 15.4 mt-10 -73.92 -24.4 59.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.479 -1.237 . . . . 2.0899999999999999 111.959 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.847 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.5 m-30 . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 118.485 -0.769 . . . . 1.77 112.34 -172.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 16.7 tppt? . . . . . 0 N--CA 1.437 -1.11 0 CA-C-O 121.152 0.501 . . . . 4.9400000000000004 109.75 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.522 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 4.6 m-85 -107.6 93.99 11.16 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.831 -0.622 . . . . 2.0 110.776 172.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 38.5 Cg_exo -63.84 94.45 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.304 2.003 . . . . 1.1200000000000001 110.717 168.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.942 HG12 ' HA ' ' A' ' 48' ' ' ILE . 1.2 pt -79.08 172.47 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 112.182 0.438 . . . . 1.97 112.182 -168.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.898 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 95.0 p -146.63 117.91 7.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.631 -0.713 . . . . 1.8500000000000001 111.648 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.33 124.97 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.162 -0.926 . . . . 2.6800000000000002 110.296 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.665 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 31.8 t -66.19 120.37 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.486 0.66 . . . . 2.2400000000000002 110.954 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.2 mmt -122.57 23.11 9.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.184 -1.043 . . . . 5.4500000000000002 108.184 170.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.71 179.47 17.16 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.924 -1.035 . . . . 4.1399999999999997 113.314 -173.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.0 t -65.89 -45.56 81.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.106 0.41 . . . . 6.2599999999999998 112.106 -175.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.87 -56.98 4.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.454 0.538 . . . . 4.6399999999999997 112.454 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.665 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 71.7 m -65.72 -34.16 77.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.618 -0.719 . . . . 3.1499999999999999 111.93 -170.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.29 -27.69 68.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.119 0.568 . . . . 4.6500000000000004 112.076 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 15' ' ' THR . 86.8 t -67.71 -21.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 122.78 0.432 . . . . 4.0099999999999998 111.711 -168.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -80.99 12.15 3.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.949 -0.47 . . . . 5.21 111.806 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.09 28.48 30.89 Favored Glycine 0 C--O 1.24 0.497 0 C-N-CA 120.986 -0.626 . . . . 1.96 111.552 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -72.39 -21.74 61.23 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.105 -0.548 . . . . 1.9399999999999999 111.548 -168.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.511 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 t70 -55.63 -48.1 75.51 Favored 'General case' 0 C--O 1.211 -0.937 0 C-N-CA 120.393 -0.523 . . . . 2.4199999999999999 111.057 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -67.35 -36.17 80.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.822 -0.751 . . . . 3.4100000000000001 111.459 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.615 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.97 -44.84 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 121.118 -0.233 . . . . 2.75 110.647 176.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 23' ' ' ASP . 17.9 m -68.59 -19.06 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.975 -0.69 . . . . 2.1299999999999999 109.965 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 53.9 t-80 -59.64 -42.54 92.99 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.588 0.709 . . . . 1.54 109.158 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -51.97 -46.35 64.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.085 -1.416 . . . . 1.27 109.541 173.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.845 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 1.4 t80 -57.38 -48.26 79.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.974 -0.557 . . . . 2.5800000000000001 110.549 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 27' ' ' HIS . 60.8 mttp -47.04 -51.17 18.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.319 -0.855 . . . . 3.23 110.884 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.13 -19.97 24.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.078 -0.964 . . . . 2.23 111.367 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.845 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.33 -19.42 65.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.531 -0.544 . . . . 2.54 109.531 176.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.071 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -49.39 -59.52 3.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 106.658 -1.608 . . . . 2.5499999999999998 106.658 168.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.19 -19.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 126.42 2.325 . . . . 4.8099999999999996 113.387 169.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.663 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 50.93 -171.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 126.138 1.775 . . . . 4.1900000000000004 114.132 166.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 37' ' ' ILE . 13.9 t70 -157.31 -50.52 0.07 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.623 -1.626 . . . . 4.6200000000000001 107.238 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 36' ' ' ASP . 1.9 pt -168.64 6.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 113.103 -1.862 . . . . 5.3700000000000001 110.843 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.18 -58.7 0.03 OUTLIER Glycine 0 CA--C 1.482 -1.997 0 N-CA-C 109.653 -1.379 . . . . 4.1299999999999999 109.653 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.623 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 29.9 t70 -178.26 121.01 0.1 Allowed 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 113.244 -1.478 . . . . 4.3099999999999996 111.664 -177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 1.069 HG12 ' HD2' ' A' ' 42' ' ' PRO . 7.3 p 55.33 -66.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 127.27 2.856 . . . . 2.96 113.454 173.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.607 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 38.5 m -158.22 -58.54 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.713 0 CA-C-N 113.731 -1.577 . . . . 4.1799999999999997 110.341 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 1.069 ' HD2' HG12 ' A' ' 40' ' ' VAL . 59.3 Cg_endo -74.06 7.55 2.44 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 120.418 0.746 . . . . 4.3700000000000001 113.962 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 13.7 t70 81.55 6.0 1.23 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.817 1.294 . . . . 4.2599999999999998 108.651 164.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 39' ' ' ASP . . . 165.93 67.8 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.639 0 CA-C-N 114.05 -1.432 . . . . 2.1299999999999999 112.447 172.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.641 ' HD3' ' HG3' ' A' ' 42' ' ' PRO . 16.8 tpt180 -85.09 -64.36 1.17 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.827 -1.175 . . . . 3.7799999999999998 107.827 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.071 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -114.91 124.2 51.1 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.336 -0.847 . . . . 2.6099999999999999 112.988 -174.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 27.4 t -102.86 100.59 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.652 -0.704 . . . . 2.2799999999999998 109.274 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.942 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.5 pp -65.12 118.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 113.072 0.768 . . . . 3.5600000000000001 113.072 -171.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.898 ' O ' ' HA ' ' A' ' 10' ' ' SER . 9.2 t70 -159.49 140.25 12.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.194 0.997 . . . . 3.3100000000000001 112.605 162.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -45.61 -46.67 14.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.65 1.722 . . . . 3.7000000000000002 115.65 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -52.6 -40.73 62.98 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 116.644 2.09 . . . . 4.7999999999999998 116.644 -148.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.703 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 17.4 mmm180 -63.07 -57.83 9.3 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.096 0.951 . . . . 6.9100000000000001 110.463 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.863 ' H ' ' HB2' ' A' ' 10' ' ' SER . 33.9 t -65.56 167.11 9.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.41 -1.723 . . . . 3.04 111.12 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.585 HG22 ' SG ' ' A' ' 12' ' ' CYS . 11.6 t 71.31 26.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 123.055 1.407 . . . . 4.6799999999999997 108.501 -161.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.42 64.27 0.34 Allowed Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 113.351 -1.749 . . . . 4.1900000000000004 113.708 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.89 58.31 12.51 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 118.933 -1.603 . . . . 4.8499999999999996 115.03 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.286 1.7 m -132.95 -33.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.455 1.128 . . . . 3.5600000000000001 109.262 -161.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.92 -28.54 6.84 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.685 1.735 . . . . 3.9100000000000001 115.685 -163.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.97 6.61 3.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.783 1.174 . . . . 5.7000000000000002 112.161 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.17 160.66 38.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.876 -1.157 . . . . 3.5800000000000001 107.876 159.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.58 118.23 5.25 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-N 120.849 1.339 . . . . 4.3600000000000003 108.857 163.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 tp -111.49 129.88 66.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 112.85 0.685 . . . . 3.0499999999999998 112.85 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 73' ' ' VAL . 86.9 t -141.49 119.53 9.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 107.255 -1.387 . . . . 2.3300000000000001 107.255 153.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.646 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 38.7 ttm -110.14 135.52 50.8 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 117.779 -1.568 . . . . 2.23 110.217 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.835 HG22 ' HB2' ' A' ' 68' ' ' LYS . 2.5 m -123.91 115.92 46.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.495 -1.669 . . . . 1.3300000000000001 106.495 168.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 49.07 -153.74 2.37 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-O 122.281 0.934 . . . . 1.1000000000000001 112.368 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.2 35.62 0.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.343 -0.928 . . . . 3.0099999999999998 108.583 172.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.835 ' HB2' HG22 ' A' ' 65' ' ' VAL . 28.5 mmmt -105.52 -27.46 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.125 -0.943 . . . . 3.0600000000000001 109.776 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.498 HG11 ' HG3' ' A' ' 64' ' ' MET . 12.3 m 35.61 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 124.459 1.099 . . . . 2.0699999999999998 113.591 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.771 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 5.0 m-30 -107.89 -163.48 0.9 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-O 122.306 1.051 . . . . 1.9399999999999999 113.345 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -145.06 50.28 0.65 Allowed Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 114.468 -1.242 . . . . 1.49 110.654 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.83 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -71.62 1.58 6.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.803 0.811 . . . . 1.95 109.056 173.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER 46.0 -149.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 113.749 -1.568 . . . . 3.4399999999999999 113.958 167.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.615 ' OG1' ' HB ' ' A' ' 25' ' ' VAL . 12.8 t -148.52 -40.46 0.01 OUTLIER Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.903 -0.59 . . . . 2.9700000000000002 112.528 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.58 ' CD ' ' H ' ' A' ' 74' ' ' THR . 4.5 Cg_endo -86.04 70.98 4.41 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.881 1.721 . . . . 3.0899999999999999 113.222 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.14 -38.16 3.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.551 -0.833 . . . . 1.6399999999999999 113.301 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.569 ' HB2' HG21 ' A' ' 73' ' ' VAL . 29.3 mt-30 -71.05 -10.3 59.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.64 1.21 . . . . 1.98 108.364 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 2.2 t -42.36 -64.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 112.085 -2.325 . . . . 1.5700000000000001 112.799 174.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.703 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 47.8 mtmt -60.42 -25.55 66.03 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.976 0.893 . . . . 2.48 110.785 -167.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 2.6 mptp? -77.08 -53.87 7.24 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.596 -1.183 . . . . 2.8100000000000001 109.921 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.821 ' HB ' ' HA ' ' A' ' 72' ' ' ASN . 18.9 mm -62.73 -14.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.001 -1.0 . . . . 1.6399999999999999 110.1 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.703 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.6 tp -57.22 -42.81 82.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.969 -0.457 . . . . 1.3600000000000001 110.257 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.47 -33.55 69.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.588 0.709 . . . . 1.3600000000000001 109.422 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 81' ' ' ILE . 7.4 mt-10 -73.23 -21.05 60.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.906 -1.043 . . . . 2.0899999999999999 112.693 174.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.83 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.9 m-30 . . . . . 0 N--CA 1.433 -1.302 0 CA-C-O 118.111 -0.947 . . . . 1.77 111.854 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.626 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 2.8 tppp? . . . . . 0 N--CA 1.437 -1.103 0 N-CA-C 109.527 -0.546 . . . . 4.9400000000000004 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.044 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.2 m-85 -109.02 85.24 3.1 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.106 -0.497 . . . . 2.0 111.27 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 87.2 Cg_exo -52.55 97.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.085 2.523 . . . . 1.1200000000000001 112.327 169.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -86.77 129.27 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 112.703 0.631 . . . . 1.97 112.703 -172.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.633 ' CB ' ' HB2' ' A' ' 52' ' ' ARG . 59.9 p -91.28 135.44 33.8 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.581 -0.526 . . . . 1.8500000000000001 109.581 174.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -116.01 121.73 68.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.032 -0.531 . . . . 2.6800000000000002 110.421 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.826 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 22.1 t -67.17 120.01 13.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.066 0.765 . . . . 2.2400000000000002 113.066 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.1 mmt -123.96 22.56 8.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.462 -1.245 . . . . 5.4500000000000002 107.858 160.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.28 178.58 22.1 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.892 -1.049 . . . . 4.1399999999999997 113.744 -171.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -67.95 -44.36 76.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.29 0.478 . . . . 6.2599999999999998 112.29 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.4 -58.18 3.6 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 112.607 0.595 . . . . 4.6399999999999997 112.607 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.826 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.7 m -65.29 -35.28 80.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 3.1499999999999999 111.317 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.85 -30.83 69.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 4.6500000000000004 112.317 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.83 -25.11 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.033 0.444 . . . . 4.0099999999999998 110.896 -170.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.43 8.86 17.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.377 -0.374 . . . . 5.21 111.206 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.57 44.8 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.165 -0.774 . . . . 1.96 111.165 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.526 ' O ' HG11 ' A' ' 26' ' ' VAL . . . -73.52 -20.61 60.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.353 -0.424 . . . . 1.9399999999999999 110.946 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.812 ' O ' HG22 ' A' ' 26' ' ' VAL . 8.7 p-10 -62.86 -38.62 91.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 2.4199999999999999 110.717 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -68.56 -36.37 78.69 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 121.451 -0.78 . . . . 3.4100000000000001 110.195 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.632 HG11 ' H ' ' A' ' 76' ' ' GLY . 2.5 t -72.3 -28.61 29.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.147 -0.621 . . . . 2.75 111.685 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 23' ' ' ASP . 3.6 m -61.83 -37.49 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.949 -1.13 . . . . 2.1299999999999999 107.949 172.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.09 -41.16 91.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.055 -0.52 . . . . 1.54 109.873 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 25' ' ' VAL . . . -53.65 -44.87 69.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.295 -0.866 . . . . 1.27 109.295 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.671 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 8.2 t80 -48.82 -61.52 2.0 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 123.75 0.657 . . . . 2.5800000000000001 109.781 172.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 97.9 mttt -45.43 -45.41 12.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.754 -1.112 . . . . 3.23 111.7 -176.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -77.85 -43.28 30.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.717 -0.674 . . . . 2.23 111.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.746 ' NE2' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -63.08 -24.69 68.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.879 -0.415 . . . . 2.54 109.879 177.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.76 HD23 HG22 ' A' ' 35' ' ' ILE . 10.1 tp -63.24 -55.0 28.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.136 -1.061 . . . . 2.5499999999999998 108.136 173.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' C ' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER 68.73 -14.29 0.29 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.547 1.155 . . . . 4.8099999999999996 109.465 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.76 HG22 HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER 62.38 -10.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 127.066 2.146 . . . . 4.1900000000000004 113.366 175.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 34' ' ' LYS . 16.2 t70 68.24 -62.14 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.17 0.988 . . . . 4.6200000000000001 110.436 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' ILE . 2.4 pt -166.68 4.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.178 -1.374 . . . . 5.3700000000000001 110.378 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' C ' HG23 ' A' ' 35' ' ' ILE . . . -178.79 -38.75 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.457 -1.354 . . . . 4.1299999999999999 113.884 -164.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.859 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 14.9 t70 -162.44 179.03 8.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.496 0.554 . . . . 4.3099999999999996 112.496 -155.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 46' ' ' PHE . 1.9 t -24.82 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 125.57 1.794 . . . . 2.96 111.868 174.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 6.8 m -175.42 -55.01 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 111.033 -2.803 . . . . 4.1799999999999997 108.593 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HD2' ' OD2' ' A' ' 39' ' ' ASP . 5.1 Cg_exo -81.12 -0.08 10.33 Favored 'Trans proline' 0 N--CA 1.433 -2.081 0 N-CA-C 116.381 1.646 . . . . 4.3700000000000001 116.381 -173.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.706 ' HA ' ' HB3' ' A' ' 39' ' ' ASP . 32.3 t70 77.4 16.78 1.57 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.461 -1.311 . . . . 4.2599999999999998 107.461 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.54 71.91 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.427 -1.26 . . . . 2.1299999999999999 112.805 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.555 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 12.3 tpt180 -142.18 -60.89 0.45 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.34 -0.93 . . . . 3.7799999999999998 109.488 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.027 ' HB3' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -102.53 157.75 16.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.551 -1.204 . . . . 2.6099999999999999 111.684 -173.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.481 ' H ' HG21 ' A' ' 9' ' ' ILE . 53.7 m -165.15 113.44 1.02 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.039 -1.097 . . . . 2.2799999999999998 108.039 167.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 44.3 pt -92.78 154.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 113.859 1.059 . . . . 3.5600000000000001 113.859 -162.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.1 p-10 -161.52 137.8 8.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.822 -1.081 . . . . 3.3100000000000001 111.157 162.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -47.14 -42.29 19.18 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.54 1.311 . . . . 3.7000000000000002 114.54 163.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 51' ' ' LEU . 3.0 mm? -51.79 -31.13 25.9 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.102 1.149 . . . . 4.7999999999999998 114.102 -161.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.633 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 16.8 mmt180 -54.69 -47.51 73.57 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.817 0.341 . . . . 6.9100000000000001 110.822 176.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.661 ' O ' HG12 ' A' ' 54' ' ' VAL . 50.0 t -58.45 158.1 7.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.561 0.744 . . . . 3.04 112.132 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER 66.43 22.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 123.221 1.486 . . . . 4.6799999999999997 108.723 -160.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.92 67.87 0.27 Allowed Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 112.606 -2.088 . . . . 4.1900000000000004 112.165 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.95 57.05 11.55 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.05 -1.548 . . . . 4.8499999999999996 115.177 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.541 ' HB3' HD11 ' A' ' 62' ' ' ILE . 9.5 m -133.06 -37.73 0.98 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 118.272 1.036 . . . . 3.5600000000000001 112.816 -171.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.58 -34.57 18.13 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.691 2.108 . . . . 3.9100000000000001 116.691 -150.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.47 2.43 21.99 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.615 1.552 . . . . 5.7000000000000002 113.206 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.5 160.39 48.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 C-N-CA 123.373 0.669 . . . . 3.5800000000000001 109.998 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.583 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 Cg_endo -78.97 125.08 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.722 0.948 . . . . 4.3600000000000003 109.967 156.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 57' ' ' CYS . 1.5 mp -107.81 134.2 50.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.458 0.54 . . . . 3.0499999999999998 112.458 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.765 HG11 ' HA2' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -138.27 126.18 29.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.956 0 N-CA-C 107.251 -1.389 . . . . 2.3300000000000001 107.251 160.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.689 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 48.1 ttm -112.31 144.48 41.66 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.742 -1.224 . . . . 2.23 109.618 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 1.044 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -122.26 117.12 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.526 -1.287 . . . . 1.3300000000000001 107.526 154.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 45.98 -147.9 2.28 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-O 122.369 0.983 . . . . 1.1000000000000001 111.792 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.39 28.38 0.25 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.032 -1.084 . . . . 3.0099999999999998 108.986 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.727 ' HB2' HG22 ' A' ' 65' ' ' VAL . 42.6 mmtt -107.79 -32.87 7.44 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.512 -0.551 . . . . 3.0600000000000001 109.512 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.69 ' C ' ' HD1' ' A' ' 70' ' ' TYR . 96.9 t 44.12 110.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 115.271 1.582 . . . . 2.0699999999999998 115.271 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.737 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.5 m-85 -130.37 -155.08 0.67 Allowed 'General case' 0 C--O 1.249 1.056 0 CA-C-O 122.682 1.23 . . . . 1.9399999999999999 112.968 -173.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.765 ' HA2' HG11 ' A' ' 63' ' ' VAL . . . -151.95 46.47 0.59 Allowed Glycine 0 C--O 1.218 -0.866 0 CA-C-N 114.279 -1.328 . . . . 1.49 111.878 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.763 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -96.07 1.18 52.35 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.146 0.473 . . . . 1.95 112.237 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.702 HG22 ' HB ' ' A' ' 63' ' ' VAL . 2.6 m -119.37 17.88 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 114.786 1.402 . . . . 3.4399999999999999 114.786 -166.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.815 ' OG1' ' HD2' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -151.61 175.43 2.89 Favored Pre-proline 0 CA--C 1.563 1.461 0 O-C-N 121.342 -0.849 . . . . 2.9700000000000002 110.743 -173.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.815 ' HD2' ' OG1' ' A' ' 74' ' ' THR . 65.0 Cg_exo -14.72 94.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.956 1 C-N-CA 126.476 4.784 . . . . 3.0899999999999999 117.763 -166.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.632 ' H ' HG11 ' A' ' 25' ' ' VAL . . . 74.81 -29.96 1.07 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.871 -0.604 . . . . 1.6399999999999999 114.237 165.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.83 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 11.7 pt20 -78.38 -15.34 58.79 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.344 -1.354 . . . . 1.98 107.344 -165.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 14.0 m -46.34 -58.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-N 113.135 -1.848 . . . . 1.5700000000000001 111.248 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.746 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 28.7 mtmt -57.85 -42.88 85.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.584 1.183 . . . . 2.48 109.44 -167.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.83 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -78.5 -49.47 13.34 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 112.937 -1.938 . . . . 2.8100000000000001 109.854 -172.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.805 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 47.2 mm -68.64 -10.89 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 113.696 -1.593 . . . . 1.6399999999999999 109.975 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 52.1 tp -64.17 -36.08 82.89 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.181 -0.949 . . . . 1.3600000000000001 110.315 167.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.14 67.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.814 -0.81 . . . . 1.3600000000000001 108.814 171.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.805 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 25.4 mm-40 -69.94 -37.59 75.9 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.926 -1.034 . . . . 2.0899999999999999 111.066 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.737 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.428 -1.544 0 CA-C-O 119.163 -0.446 . . . . 1.77 111.8 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 114.378 1.251 . . . . 4.9400000000000004 114.378 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.734 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -50.55 110.94 1.9 Allowed Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 113.83 1.048 . . . . 2.0 113.83 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 88.4 Cg_exo -56.29 99.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.473 0.285 0 C-N-CA 123.191 2.594 . . . . 1.1200000000000001 111.777 169.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.844 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -85.52 122.56 38.52 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.875 0.695 . . . . 1.97 112.875 -175.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 48.5 m -92.93 129.17 38.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.572 -0.74 . . . . 1.8500000000000001 110.484 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 128.41 72.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.652 0.982 . . . . 2.6800000000000002 113.652 -170.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.6 t -63.42 114.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.314 0.578 . . . . 2.2400000000000002 111.045 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.6 mtm -130.05 22.72 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 5.4500000000000002 110.449 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.05 175.64 23.63 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.2 -1.0 . . . . 4.1399999999999997 113.818 -170.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 p -67.51 -46.19 73.61 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.271 0.471 . . . . 6.2599999999999998 112.271 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' O ' HG11 ' A' ' 19' ' ' VAL . . . -69.43 -52.88 22.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 4.6399999999999997 111.083 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -64.09 -39.74 94.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.804 -0.634 . . . . 3.1499999999999999 111.678 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 25.6 t80 -65.02 -33.42 75.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.628 0.603 . . . . 4.6500000000000004 112.628 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.528 HG11 ' O ' ' A' ' 16' ' ' ALA . 7.1 p -71.75 -24.04 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.942 0.349 . . . . 4.0099999999999998 111.942 -166.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 31.2 mmtp -84.2 14.9 3.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.148 0.499 . . . . 5.21 111.57 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.99 29.26 20.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.966 -0.635 . . . . 1.96 112.195 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.528 ' O ' HG21 ' A' ' 25' ' ' VAL . . . -71.76 -19.51 62.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.485 -0.561 . . . . 1.9399999999999999 109.485 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 14.1 t70 -53.32 -51.76 61.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.396 -0.82 . . . . 2.4199999999999999 110.605 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -65.83 -38.25 88.4 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.077 -0.649 . . . . 3.4100000000000001 110.925 -175.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.074 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.67 -39.88 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 116.408 -0.36 . . . . 2.75 111.254 -179.073 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.736 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 13.6 p -67.26 -29.82 47.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.595 -0.842 . . . . 2.1299999999999999 108.92 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.504 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 66.7 t-80 -60.65 -37.85 82.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 1.54 109.897 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.76 76.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.454 -0.943 . . . . 1.27 108.454 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.736 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 36.5 t80 -51.41 -52.67 43.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.183 -0.917 . . . . 2.5800000000000001 111.186 173.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 16.9 tppt? -45.43 -47.76 13.77 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.71 -1.132 . . . . 3.23 111.171 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.59 -29.58 36.91 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.382 -0.826 . . . . 2.23 111.024 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.828 ' NE2' ' HA ' ' A' ' 79' ' ' LYS . 8.5 mm100 -59.18 -29.39 67.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.278 -0.874 . . . . 2.54 110.988 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.047 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 2.3 tt -53.16 -54.73 31.62 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.377 -0.971 . . . . 2.5499999999999998 108.377 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.843 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.1 -17.15 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.32 -2.218 . . . . 4.8099999999999996 113.241 174.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.716 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 52.62 -161.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.215 -1.357 . . . . 4.1900000000000004 113.307 167.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.877 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 17.9 t70 -157.13 -54.99 0.08 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.945 -1.872 . . . . 4.6200000000000001 105.945 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.0 pt -177.54 21.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 111.808 -2.451 . . . . 5.3700000000000001 107.443 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.97 -70.11 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 108.953 -1.659 . . . . 4.1299999999999999 108.953 -166.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.584 ' HA ' HD22 ' A' ' 33' ' ' LEU . 17.9 m-20 -178.46 125.45 0.11 Allowed 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.33 -1.435 . . . . 4.3099999999999996 110.038 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.962 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 2.6 p 57.81 -11.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 115.746 1.758 . . . . 2.96 115.746 165.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.877 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 55.2 m 112.65 -43.09 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.377 1.471 . . . . 4.1799999999999997 110.742 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.68 ' HD2' HG11 ' A' ' 40' ' ' VAL . 87.0 Cg_exo -51.43 -19.57 7.15 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.123 1.215 . . . . 4.3700000000000001 113.022 163.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 38.2 t70 84.98 12.38 0.26 Allowed 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.98 1.372 . . . . 4.2599999999999998 107.671 163.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 156.44 76.1 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 112.78 -2.009 . . . . 2.1299999999999999 110.178 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.691 ' HB3' HG13 ' A' ' 40' ' ' VAL . 3.6 ttt180 -119.54 -53.83 2.2 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 114.724 -0.738 . . . . 3.7799999999999998 109.091 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.047 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.91 110.54 19.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 113.388 0.884 . . . . 2.6099999999999999 113.388 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.0 m -117.99 108.22 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.809 -1.087 . . . . 2.2799999999999998 109.168 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.66 145.09 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 113.439 0.903 . . . . 3.5600000000000001 113.439 -168.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.685 ' O ' ' HA ' ' A' ' 10' ' ' SER . 19.4 t70 -155.05 146.04 22.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.366 -1.288 . . . . 3.3100000000000001 111.807 175.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -42.36 -44.38 3.91 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 117.009 2.226 . . . . 3.7000000000000002 117.009 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HG ' ' OD2' ' A' ' 49' ' ' ASP . 55.7 mt -49.26 -38.83 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.783 2.142 . . . . 4.7999999999999998 116.783 -148.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.65 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 8.5 tpm_? -60.5 -51.69 68.39 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.387 0.994 . . . . 6.9100000000000001 111.011 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.1 t -62.59 154.92 27.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.54 -1.209 . . . . 3.04 113.547 -168.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 10.5 t 62.93 19.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 114.659 -1.155 . . . . 4.6799999999999997 109.157 -172.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.8 61.52 0.47 Allowed Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.634 -1.166 . . . . 4.1900000000000004 113.505 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.25 58.8 12.53 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 118.524 -1.798 . . . . 4.8499999999999996 114.478 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.567 ' HB3' HG23 ' A' ' 62' ' ' ILE 0.262 2.9 m -129.26 -34.45 1.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.859 1.829 . . . . 3.5600000000000001 111.157 -154.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.45 6.25 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.535 2.05 . . . . 3.9100000000000001 116.535 -163.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 59' ' ' LEU . 16.2 mt -73.15 4.8 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.591 1.542 . . . . 5.7000000000000002 112.238 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.74 52.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.581 -0.896 . . . . 3.5800000000000001 108.581 159.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.8 122.62 6.44 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.018 -1.57 . . . . 4.3600000000000003 108.018 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 57' ' ' CYS . 44.7 pt -106.96 127.82 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.862 -1.135 . . . . 3.0499999999999998 113.085 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.648 HG23 HG12 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -144.08 120.78 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.47 -1.307 . . . . 2.3300000000000001 107.47 152.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.844 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 25.0 ttt -111.24 135.64 51.48 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.583 -1.266 . . . . 2.23 107.583 -175.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.783 ' CG1' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -119.07 114.39 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.249 0 N-CA-C 107.179 -1.415 . . . . 1.3300000000000001 107.179 169.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 51.36 -159.14 2.24 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.088 -1.205 . . . . 1.1000000000000001 110.088 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.36 38.78 0.31 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.29 0.567 . . . . 3.0099999999999998 109.967 171.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.619 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 51.5 mmtt -105.43 -37.49 6.8 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 115.651 -0.704 . . . . 3.0600000000000001 110.473 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.682 HG22 ' HG3' ' A' ' 64' ' ' MET . 85.1 t 53.33 108.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 114.07 1.137 . . . . 2.0699999999999998 114.07 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.694 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.6 m-30 -126.94 -169.83 2.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.455 1.121 . . . . 1.9399999999999999 113.222 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.05 30.18 3.75 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.061 -1.427 . . . . 1.49 112.598 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.874 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -88.59 89.03 7.82 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.573 -1.269 . . . . 1.95 107.573 172.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.648 HG12 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -116.66 -93.19 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 122.188 0.994 . . . . 3.4399999999999999 112.785 -168.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 1.074 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 43.7 p -133.83 -61.92 0.02 OUTLIER Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.585 -1.643 . . . . 2.9700000000000002 113.484 -166.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.762 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 16.4 Cg_endo -87.4 70.07 3.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.271 1.981 . . . . 3.0899999999999999 113.121 -162.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.449 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 77.99 -12.18 18.85 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.919 -0.658 . . . . 1.6399999999999999 112.689 177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.762 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 25.7 mt-30 -73.52 -25.76 60.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.183 -1.784 . . . . 1.98 106.183 -172.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.732 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 16.0 m -46.8 -61.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 111.566 -2.561 . . . . 1.5700000000000001 111.651 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.84 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 15.5 pttm -58.45 -39.56 80.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.807 0.813 . . . . 2.48 110.84 -167.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.84 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -81.08 -46.84 14.37 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-N 114.698 -1.137 . . . . 2.8100000000000001 109.449 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.665 HG23 ' HB2' ' A' ' 72' ' ' ASN . 39.9 mm -70.56 -11.62 15.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.13 -1.395 . . . . 1.6399999999999999 110.11 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 85' ' ' TYR . 31.0 tp -62.65 -34.17 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.654 -0.654 . . . . 1.3600000000000001 110.005 168.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.74 -33.03 69.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.854 -0.795 . . . . 1.3600000000000001 108.854 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -70.09 -41.35 74.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.735 -1.121 . . . . 2.0899999999999999 111.114 171.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.874 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 7.0 m-30 . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 117.898 -1.049 . . . . 1.77 111.879 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.544 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.516 0 CA-C-O 121.713 0.768 . . . . 4.9400000000000004 111.718 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.526 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 2.7 m-85 -52.72 109.56 1.51 Allowed Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 113.759 -1.564 . . . . 2.0 113.255 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.948 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 32.1 Cg_exo -61.92 104.42 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.826 1.684 . . . . 1.1200000000000001 111.029 169.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 1.086 ' HB ' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -79.43 114.3 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.773 0.797 . . . . 1.97 110.378 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.772 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 8.3 m -93.09 107.11 18.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.526 -1.216 . . . . 1.8500000000000001 110.41 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -118.17 123.21 71.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.394 -0.821 . . . . 2.6800000000000002 110.06 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.719 ' SG ' HG21 ' A' ' 54' ' ' VAL . 32.1 t -66.86 119.28 11.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.109 -0.636 . . . . 2.2400000000000002 110.884 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.7 ttp -122.96 23.29 9.38 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.2 -1.037 . . . . 5.4500000000000002 108.2 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.78 179.5 17.48 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.18 -0.918 . . . . 4.1399999999999997 112.616 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 m -62.71 -43.9 97.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.119 0.415 . . . . 6.2599999999999998 112.119 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.564 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -70.18 -56.08 7.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.048 0.452 . . . . 4.6399999999999997 111.735 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 81.8 m -68.79 -37.75 79.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.202 0.445 . . . . 3.1499999999999999 112.202 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.75 ' HE1' ' HB2' ' A' ' 23' ' ' ASP . 74.4 t80 -63.99 -31.63 72.88 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.726 0.639 . . . . 4.6500000000000004 112.726 -176.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 16' ' ' ALA . 8.0 p -68.7 -20.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.917 0.389 . . . . 4.0099999999999998 111.043 -168.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.51 14.35 3.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.005 -0.543 . . . . 5.21 111.09 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.32 23.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.065 -0.588 . . . . 1.96 111.971 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . . . -72.9 -20.93 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.316 . . . . 1.9399999999999999 111.462 -172.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.75 ' HB2' ' HE1' ' A' ' 18' ' ' PHE . 17.5 t70 -57.52 -44.44 85.09 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.47 -0.492 . . . . 2.4199999999999999 110.946 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 1.7 mptp? -64.64 -39.3 93.46 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.885 -0.726 . . . . 3.4100000000000001 111.528 -171.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.977 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.79 -46.94 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 120.557 -0.457 . . . . 2.75 110.267 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG23 ' HE3' ' A' ' 30' ' ' LYS . 17.8 m -65.98 -25.3 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.387 -0.525 . . . . 2.1299999999999999 110.546 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.611 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 66.4 t-80 -60.74 -44.8 96.22 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.214 0.53 . . . . 1.54 109.67 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.42 -40.09 74.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.598 -1.183 . . . . 1.27 109.254 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.642 ' HE2' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -61.49 -46.5 89.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 2.5800000000000001 110.458 175.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.611 ' HD2' ' HA ' ' A' ' 27' ' ' HIS . 90.5 mttt -53.65 -40.88 66.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.566 -0.743 . . . . 3.23 110.551 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.98 -29.27 29.13 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.396 -0.82 . . . . 2.23 111.448 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -66.27 -21.98 66.3 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.914 -0.584 . . . . 2.54 109.648 177.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.932 ' HG ' HG12 ' A' ' 35' ' ' ILE . 3.6 tp -51.22 -53.94 30.41 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.812 -1.551 . . . . 2.5499999999999998 106.812 170.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.633 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 63.38 -28.46 0.08 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 125.885 1.991 . . . . 4.8099999999999996 113.098 168.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.932 HG12 ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.25 -173.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 126.152 1.781 . . . . 4.1900000000000004 114.631 165.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.707 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 8.5 t70 -157.69 -41.58 0.07 Allowed 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 113.387 -1.733 . . . . 4.6200000000000001 107.396 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.635 HG13 ' HB2' ' A' ' 43' ' ' ASP . 4.1 pt -163.23 -3.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 113.643 -1.617 . . . . 5.3700000000000001 112.646 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -174.46 -58.94 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.035 -1.078 . . . . 4.1299999999999999 110.79 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.973 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 34.1 m-20 -164.5 115.62 1.24 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.821 -0.689 . . . . 4.3099999999999996 111.798 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.869 HG21 ' CD2' ' A' ' 46' ' ' PHE . 1.3 t 72.56 -62.96 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 O-C-N 125.117 1.51 . . . . 2.96 109.755 175.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.708 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 64.1 m -169.43 -61.21 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 112.215 -2.266 . . . . 4.1799999999999997 109.635 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.708 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 72.1 Cg_endo -77.11 11.3 2.09 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 120.624 0.882 . . . . 4.3700000000000001 113.737 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.635 ' HB2' HG13 ' A' ' 37' ' ' ILE . 24.2 t70 82.02 11.03 0.7 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.001 -1.111 . . . . 4.2599999999999998 108.001 169.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.63 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 169.43 77.77 0.04 OUTLIER Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 119.292 -1.432 . . . . 2.1299999999999999 112.536 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' HD3' ' OXT' ' A' ' 85' ' ' TYR . 5.1 ttm180 -116.44 1.44 12.98 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.02 -1.844 . . . . 3.7799999999999998 106.02 165.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.973 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 1.7 m-85 -134.33 169.14 17.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.276 -2.693 . . . . 2.6099999999999999 111.097 -171.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.948 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 1.4 t 178.26 73.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.493 -1.299 . . . . 2.2799999999999998 107.493 166.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 1.049 HG22 HD13 ' A' ' 9' ' ' ILE . 2.1 pp -67.07 116.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.682 -1.145 . . . . 3.5600000000000001 112.997 -167.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.772 ' O ' ' HA ' ' A' ' 10' ' ' SER . 29.3 t70 -162.27 142.24 9.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.572 1.177 . . . . 3.3100000000000001 112.711 167.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.4 m -43.76 -45.72 7.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.692 -2.049 . . . . 3.7000000000000002 116.198 172.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 tp -51.35 -41.74 60.81 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.177 1.918 . . . . 4.7999999999999998 116.177 -149.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.633 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.0 mmm180 -63.06 -55.93 21.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.156 0.979 . . . . 6.9100000000000001 110.797 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.614 ' H ' ' HB3' ' A' ' 10' ' ' SER . 34.1 t -63.15 168.72 3.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.343 -1.753 . . . . 3.04 110.252 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.719 HG21 ' SG ' ' A' ' 12' ' ' CYS . 15.7 t 74.52 28.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 123.204 1.478 . . . . 4.6799999999999997 108.508 -156.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.29 64.35 0.28 Allowed Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 113.425 -1.716 . . . . 4.1900000000000004 113.025 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 56.89 19.19 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 119.63 -1.271 . . . . 4.8499999999999996 115.567 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.293 1.1 m -135.79 -33.66 0.85 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.985 1.392 . . . . 3.5600000000000001 110.213 -162.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.06 -28.98 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 116.221 1.934 . . . . 3.9100000000000001 116.221 -160.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.03 6.81 3.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.35 1.432 . . . . 5.7000000000000002 112.244 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.14 39.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 107.807 -1.182 . . . . 3.5800000000000001 107.807 159.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.45 117.25 4.75 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 N-CA-C 108.431 -1.411 . . . . 4.3600000000000003 108.431 160.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -113.18 133.68 58.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 119.406 -0.33 . . . . 3.0499999999999998 111.771 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.642 HG21 ' HE2' ' A' ' 29' ' ' PHE . 99.4 t -139.87 121.54 15.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 108.908 -0.775 . . . . 2.3300000000000001 108.908 155.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 50.1 ttp -112.45 136.2 52.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.864 -1.135 . . . . 2.23 109.412 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 1.086 HG13 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.27 114.8 44.05 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 119.877 -0.729 . . . . 1.3300000000000001 109.485 174.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.699 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 50.76 45.81 48.52 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.808 -0.71 . . . . 1.1000000000000001 113.433 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 59.55 6.66 0.85 Allowed 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 122.952 0.501 . . . . 3.0099999999999998 111.4 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.888 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 71.2 mmtt -77.01 -8.76 57.98 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 110.234 -0.284 . . . . 3.0600000000000001 110.234 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.4 m 35.72 99.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 124.609 1.193 . . . . 2.0699999999999998 113.889 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.888 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 3.8 m-85 -110.09 165.88 11.39 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-O 122.962 1.363 . . . . 1.9399999999999999 113.675 -173.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.683 ' O ' HG23 ' A' ' 73' ' ' VAL . . . -109.75 5.96 31.14 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 112.544 -2.116 . . . . 1.49 109.009 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.738 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 26.3 t-20 -65.25 131.57 46.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.49 -1.67 . . . . 1.95 106.49 167.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.72 -145.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.466 0.913 . . . . 3.4399999999999999 113.466 -148.578 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.977 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 76.5 p -131.29 -50.9 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.018 1.118 . . . . 2.9700000000000002 114.018 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.635 ' HD3' ' OG1' ' A' ' 74' ' ' THR . 91.2 Cg_endo -87.79 73.93 2.45 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.582 1.521 . . . . 3.0899999999999999 113.474 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.54 4.41 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.75 -0.738 . . . . 1.6399999999999999 112.782 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.571 HE21 ' HD2' ' A' ' 75' ' ' PRO . 23.6 mt-30 -74.38 -19.71 60.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 106.403 -1.702 . . . . 1.98 106.403 -172.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG21 ' HG3' ' A' ' 79' ' ' LYS . 8.4 m -43.44 -60.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 111.704 -2.498 . . . . 1.5700000000000001 111.915 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.558 ' HG3' HG21 ' A' ' 78' ' ' VAL . 45.9 mtmt -59.45 -37.59 78.55 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.277 1.037 . . . . 2.48 109.998 -165.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' CD ' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -81.4 -47.7 12.89 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 114.257 -1.338 . . . . 2.8100000000000001 109.446 -175.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.756 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 42.1 mm -66.57 -10.68 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.291 -1.322 . . . . 1.6399999999999999 110.013 177.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 85' ' ' TYR . 52.7 tp -58.75 -23.95 60.82 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.521 -0.737 . . . . 1.3600000000000001 110.127 169.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.44 27.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.448 -0.501 . . . . 1.3600000000000001 110.305 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.756 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER -67.0 -36.78 82.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.983 -0.553 . . . . 2.0899999999999999 111.715 174.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.679 ' HB2' HD11 ' A' ' 82' ' ' LEU . 6.7 m-30 . . . . . 0 N--CA 1.432 -1.355 0 CA-C-O 118.523 -0.751 . . . . 1.77 111.547 -174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 14.3 tppt? . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 108.202 -1.036 . . . . 4.9400000000000004 108.202 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.565 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 4.7 m-85 -115.44 89.16 21.02 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.837 -1.074 . . . . 2.0 110.541 173.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 51.2 Cg_exo -59.67 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.111 2.541 . . . . 1.1200000000000001 111.669 171.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 1.073 HG12 ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -84.48 173.39 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 113.387 0.884 . . . . 1.97 113.387 -167.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.703 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 14.9 p -134.65 134.85 41.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.263 -0.88 . . . . 1.8500000000000001 109.005 171.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 m -115.46 124.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.785 -0.643 . . . . 2.6800000000000002 110.962 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.0 t -66.11 112.6 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.299 0.571 . . . . 2.2400000000000002 110.463 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.3 tpt -131.11 23.85 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.37 -0.832 . . . . 5.4500000000000002 109.628 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.66 177.26 13.59 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.584 -0.817 . . . . 4.1399999999999997 113.992 -166.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -66.21 -45.55 80.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 6.2599999999999998 111.676 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.2 -52.27 20.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.556 0.693 . . . . 4.6399999999999997 110.339 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.65 -34.19 76.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.626 -1.17 . . . . 3.1499999999999999 111.734 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.69 -34.31 74.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.787 0.327 . . . . 4.6500000000000004 111.346 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.82 -24.33 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.545 0.688 . . . . 4.0099999999999998 109.862 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -84.44 12.2 7.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.171 -0.922 . . . . 5.21 110.408 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 31.1 17.24 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.537 -0.84 . . . . 1.96 113.145 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -70.74 -19.81 62.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.707 0.289 . . . . 1.9399999999999999 110.789 -175.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.99 -52.88 62.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 2.4199999999999999 110.248 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -64.55 -31.36 72.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.887 -0.412 . . . . 3.4100000000000001 109.887 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.89 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 98.2 t -56.82 -62.51 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 115.557 -0.747 . . . . 2.75 109.426 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -63.98 -27.86 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.729 -0.669 . . . . 2.1299999999999999 110.793 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -58.5 -47.87 82.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 120.299 -0.56 . . . . 1.54 110.368 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.55 -45.01 81.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.15 -0.932 . . . . 1.27 109.163 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.623 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -53.5 -53.39 52.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.093 -0.958 . . . . 2.5800000000000001 110.087 177.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -51.34 -48.95 62.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.587 -0.733 . . . . 3.23 110.995 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.81 -28.55 28.0 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.123 -0.944 . . . . 2.23 111.446 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -63.97 -26.77 68.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 123.437 0.461 . . . . 2.54 110.328 176.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.022 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.5 tt -50.95 -56.21 13.46 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.612 -1.255 . . . . 2.5499999999999998 107.612 173.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.835 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 63.59 -19.47 0.06 Allowed 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.527 2.392 . . . . 4.8099999999999996 112.644 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.661 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 56.9 -173.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 113.621 -1.627 . . . . 4.1900000000000004 112.713 170.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.78 -48.7 0.07 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.944 -1.132 . . . . 4.6200000000000001 107.944 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 pt -165.58 5.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 112.898 -1.955 . . . . 5.3700000000000001 110.615 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.528 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 177.16 -54.51 0.1 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 110.103 -1.199 . . . . 4.1299999999999999 110.103 -166.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.676 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 24.4 t70 -176.53 116.88 0.12 Allowed 'General case' 0 CA--C 1.483 -1.635 0 CA-C-N 113.446 -1.377 . . . . 4.3099999999999996 111.291 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 1.05 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 6.5 p 54.9 -65.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 127.301 2.876 . . . . 2.96 113.488 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.814 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 26.2 m -154.0 -58.81 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 113.631 -1.622 . . . . 4.1799999999999997 110.565 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.814 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 2.8 Cg_exo -77.63 10.06 2.68 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 C-N-CA 120.745 0.963 . . . . 4.3700000000000001 114.235 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.528 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 6.8 t0 81.43 9.41 0.95 Allowed 'General case' 0 C--N 1.349 0.558 0 N-CA-C 107.644 -1.243 . . . . 4.2599999999999998 107.644 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.676 ' N ' ' HB3' ' A' ' 39' ' ' ASP . . . 156.92 59.36 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.237 -1.347 . . . . 2.1299999999999999 112.171 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.638 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 11.6 ttt180 -86.73 -62.0 1.61 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.029 -1.1 . . . . 3.7799999999999998 108.029 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.05 ' HE1' ' HB ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -100.95 102.42 13.43 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 122.806 1.289 . . . . 2.6099999999999999 112.738 173.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.485 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 22.6 t -92.02 91.98 8.08 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.887 -1.506 . . . . 2.2799999999999998 109.215 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 1.073 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.3 pp -56.46 124.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 3.5600000000000001 112.518 -174.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' SER . 8.5 m-20 -143.21 132.73 23.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.518 1.151 . . . . 3.3100000000000001 113.464 166.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -48.5 -43.41 35.06 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.171 -1.831 . . . . 3.7000000000000002 114.581 158.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.16 -35.13 59.44 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.558 1.318 . . . . 4.7999999999999998 114.558 -160.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.703 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 9.8 mmt85 -60.77 -49.87 75.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.806 0.812 . . . . 6.9100000000000001 110.176 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.0 t -59.22 158.58 8.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.944 -1.48 . . . . 3.04 112.895 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.7 t 66.27 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.388 0 CA-C-O 122.83 1.3 . . . . 4.6799999999999997 108.558 -167.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.77 63.6 0.37 Allowed Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 113.829 -1.532 . . . . 4.1900000000000004 113.263 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.21 59.08 10.04 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.739 -1.696 . . . . 4.8499999999999996 114.609 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.706 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.282 2.8 m -130.14 -37.13 1.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.058 1.429 . . . . 3.5600000000000001 110.765 -159.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.06 -32.65 35.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.916 1.45 . . . . 3.9100000000000001 114.916 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.611 ' H ' HD21 ' A' ' 59' ' ' LEU . 2.5 pt? -76.83 6.13 6.64 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.117 -0.989 . . . . 5.7000000000000002 112.334 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.76 160.86 38.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.305 -0.628 . . . . 3.5800000000000001 109.305 164.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.52 119.19 4.8 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 108.572 -1.357 . . . . 4.3600000000000003 108.572 155.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.706 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.0 mm -111.58 129.58 66.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.567 0.58 . . . . 3.0499999999999998 112.567 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.628 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 4.7 t -139.57 123.15 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.832 -1.544 . . . . 2.3300000000000001 106.832 153.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.726 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 22.7 ttt -112.75 136.08 52.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.954 -1.498 . . . . 2.23 110.598 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -124.81 114.91 42.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 106.545 -1.65 . . . . 1.3300000000000001 106.545 156.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.75 -149.25 1.09 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 122.165 0.87 . . . . 1.1000000000000001 112.752 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.31 31.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.842 -1.179 . . . . 3.0099999999999998 108.744 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.73 ' HB2' HG23 ' A' ' 65' ' ' VAL . 13.2 mmmm -106.61 -41.56 5.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.535 -0.757 . . . . 3.0600000000000001 109.214 -177.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.658 HG23 ' HG3' ' A' ' 64' ' ' MET . 87.8 t 46.38 101.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 124.472 1.108 . . . . 2.0699999999999998 113.523 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.691 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 9.1 m-30 -120.41 -154.77 0.6 Allowed 'General case' 0 C--O 1.248 1.024 0 CA-C-O 121.863 0.839 . . . . 1.9399999999999999 112.312 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.608 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -142.6 28.21 2.19 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.695 -1.139 . . . . 1.49 112.003 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.862 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 3.1 t30 -81.76 112.73 19.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.711 -0.477 . . . . 1.95 109.711 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.569 HG21 ' HD3' ' A' ' 75' ' ' PRO . 6.9 m -137.2 -78.78 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 116.922 2.193 . . . . 3.4399999999999999 116.922 -171.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.89 ' CB ' ' HA ' ' A' ' 25' ' ' VAL . 13.6 t -153.41 -41.68 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 115.51 1.671 . . . . 2.9700000000000002 115.51 -172.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.921 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 3.0 Cg_exo -75.31 57.22 4.68 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.09 1.86 . . . . 3.0899999999999999 112.036 -170.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.422 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 76.3 -7.54 30.23 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.58 -0.737 . . . . 1.6399999999999999 111.562 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.921 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 6.8 mt-30 -73.62 -35.75 65.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.209 -1.404 . . . . 1.98 107.209 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.606 ' HA ' ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -50.67 -55.69 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 112.802 -1.999 . . . . 1.5700000000000001 110.941 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 48.9 mtmt -54.51 -45.66 73.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.019 0.914 . . . . 2.48 109.508 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.775 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -85.56 -40.94 15.74 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.642 -1.163 . . . . 2.8100000000000001 110.987 -173.077 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.768 ' CG2' ' HB2' ' A' ' 72' ' ' ASN . 33.3 mm -69.69 -15.11 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.955 -0.566 . . . . 1.6399999999999999 109.765 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 54.7 tp -58.93 -41.57 87.65 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.989 -0.445 . . . . 1.3600000000000001 110.29 171.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.2 -32.74 66.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.544 0.688 . . . . 1.3600000000000001 109.422 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.55 -31.64 67.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.755 -1.111 . . . . 2.0899999999999999 112.125 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.862 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 2.1 m-30 . . . . . 0 N--CA 1.432 -1.369 0 CA-C-O 117.418 -1.277 . . . . 1.77 112.004 -170.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 122.248 1.023 . . . . 4.9400000000000004 110.915 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.922 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -69.31 112.59 12.35 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.075 -1.42 . . . . 2.0 112.764 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.972 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 21.0 Cg_exo -70.8 131.14 19.2 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.903 1.735 . . . . 1.1200000000000001 111.678 170.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.851 HG23 ' HA ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -77.45 156.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.376 0.608 . . . . 1.97 112.085 -175.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.806 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.6 m -141.68 100.81 3.84 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.299 -0.864 . . . . 1.8500000000000001 109.56 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -117.81 124.64 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.744 -0.662 . . . . 2.6800000000000002 110.799 -176.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.737 ' SG ' HG21 ' A' ' 54' ' ' VAL . 31.5 t -65.14 120.87 13.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 2.2400000000000002 110.876 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.4 mtt -122.01 24.8 9.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.15 -0.932 . . . . 5.4500000000000002 108.714 173.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.09 179.91 13.19 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.132 -0.94 . . . . 4.1399999999999997 112.836 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 19' ' ' VAL . 19.8 m -65.78 -45.67 81.59 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.993 0.368 . . . . 6.2599999999999998 111.993 -172.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -71.62 -56.54 5.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.465 0.543 . . . . 4.6399999999999997 112.465 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 83.3 m -66.62 -36.55 82.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.535 0.569 . . . . 3.1499999999999999 112.535 -171.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.78 -30.87 71.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.126 0.787 . . . . 4.6500000000000004 113.126 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 16' ' ' ALA . 32.6 m -69.74 -18.92 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.948 0.351 . . . . 4.0099999999999998 111.948 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.95 16.46 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 5.21 111.612 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.85 32.3 10.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.451 -0.881 . . . . 1.96 111.851 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HA ' HG23 ' A' ' 25' ' ' VAL . . . -72.05 -20.82 61.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.436 -0.382 . . . . 1.9399999999999999 110.617 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.18 -50.86 66.07 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.031 -0.359 . . . . 2.4199999999999999 110.031 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -65.02 -40.62 95.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.698 -0.401 . . . . 3.4100000000000001 110.983 -171.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.746 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 6.1 m -67.17 -49.0 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 C-N-CA 120.42 -0.512 . . . . 2.75 110.153 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.649 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 21.8 m -64.83 -28.95 46.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.182 -0.607 . . . . 2.1299999999999999 110.269 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -59.5 -43.11 93.42 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 120.72 -0.392 . . . . 1.54 110.219 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -52.96 -49.16 66.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.202 -0.908 . . . . 1.27 109.062 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.66 ' CZ ' HG13 ' A' ' 9' ' ' ILE . 39.7 t80 -47.54 -56.9 6.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.065 -0.97 . . . . 2.5800000000000001 110.488 174.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.17 -52.66 11.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.373 -1.285 . . . . 3.23 112.229 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -84.45 -30.52 25.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.84 -0.618 . . . . 2.23 111.762 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.674 ' NE2' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -64.71 -25.02 67.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.54 -0.541 . . . . 2.54 109.54 176.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.784 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.3 tt -48.59 -58.23 5.01 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.246 -1.39 . . . . 2.5499999999999998 107.246 174.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.742 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 64.09 -21.49 0.07 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 126.328 2.268 . . . . 4.8099999999999996 112.874 171.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.68 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 53.98 -173.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 C-N-CA 126.342 1.857 . . . . 4.1900000000000004 114.389 166.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 35' ' ' ILE . 14.7 t70 -157.74 -50.93 0.07 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.848 -1.524 . . . . 4.6200000000000001 107.985 -172.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pt -164.79 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 113.441 -1.709 . . . . 5.3700000000000001 110.863 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.31 -65.04 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 109.675 -1.37 . . . . 4.1299999999999999 109.675 -166.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.869 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 25.1 m-20 -164.31 119.97 1.53 Allowed 'General case' 0 CA--C 1.48 -1.742 0 CA-C-N 112.903 -1.648 . . . . 4.3099999999999996 109.107 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.961 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 4.4 p 59.01 -66.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 126.684 2.49 . . . . 2.96 112.871 171.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.928 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 50.7 m -164.71 -58.52 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.759 0 CA-C-N 112.688 -2.051 . . . . 4.1799999999999997 110.006 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 1.043 ' HG2' ' HD2' ' A' ' 45' ' ' ARG . 23.8 Cg_exo -67.69 4.26 1.47 Allowed 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 120.88 1.054 . . . . 4.3700000000000001 114.44 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 18.0 t70 86.23 -4.85 0.77 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.93 0.872 . . . . 4.2599999999999998 109.578 159.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.518 ' HA2' ' OD2' ' A' ' 39' ' ' ASP . . . 179.06 41.4 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.747 -1.115 . . . . 2.1299999999999999 112.282 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 1.043 ' HD2' ' HG2' ' A' ' 42' ' ' PRO . 2.6 ttt180 -82.74 -7.79 59.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.548 1.166 . . . . 3.7799999999999998 109.167 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.961 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -105.51 -58.98 1.83 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.608 -2.087 . . . . 2.6099999999999999 113.453 -171.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.972 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 73.9 m 30.31 -170.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.588 1.555 . . . . 2.2799999999999998 114.723 -162.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.851 ' HA ' HG23 ' A' ' 9' ' ' ILE . 8.4 tp -166.99 104.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 113.686 0.995 . . . . 3.5600000000000001 113.686 -168.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.806 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.2 m-20 -144.69 130.79 19.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.678 -0.809 . . . . 3.3100000000000001 110.272 160.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t -50.03 -45.24 51.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.972 1.101 . . . . 3.7000000000000002 113.972 160.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.3 -37.86 70.47 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.898 1.814 . . . . 4.7999999999999998 115.898 -157.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' HD2' ' OG ' ' A' ' 10' ' ' SER . 44.9 mtt180 -62.14 -56.87 14.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.229 1.014 . . . . 6.9100000000000001 110.09 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.2 t -64.77 170.7 3.94 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.374 -1.739 . . . . 3.04 109.288 171.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.737 HG21 ' SG ' ' A' ' 12' ' ' CYS . 12.2 t 75.1 30.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 123.168 1.461 . . . . 4.6799999999999997 108.492 -157.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.5 63.24 0.3 Allowed Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 113.457 -1.701 . . . . 4.1900000000000004 112.886 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.23 56.02 24.42 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 119.507 -1.33 . . . . 4.8499999999999996 115.782 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.9 m -136.35 -30.83 0.91 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.588 1.194 . . . . 3.5600000000000001 109.708 -166.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.51 -26.97 1.57 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.766 2.136 . . . . 3.9100000000000001 116.766 -160.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.83 5.14 5.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.815 1.643 . . . . 5.7000000000000002 112.045 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.67 161.15 35.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 107.876 -1.157 . . . . 3.5800000000000001 107.876 162.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.8 118.69 5.39 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.705 1.287 . . . . 4.3600000000000003 108.998 164.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.76 131.39 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.059 0.392 . . . . 3.0499999999999998 112.059 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.685 HG13 ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -142.05 124.04 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.29 -1.004 . . . . 2.3300000000000001 108.29 158.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 49.7 ttp -113.2 134.59 54.5 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 118.152 -1.419 . . . . 2.23 111.106 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.922 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.89 119.28 55.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 CA-C-O 119.207 -0.425 . . . . 1.3300000000000001 110.0 174.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.669 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 55.55 31.42 57.37 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.117 -1.039 . . . . 1.1000000000000001 112.008 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.537 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 42.7 mt-10 58.54 12.62 2.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.727 -0.737 . . . . 3.0099999999999998 111.525 -174.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 30.8 mmmt -73.77 -27.49 61.19 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 109.642 -0.503 . . . . 3.0600000000000001 109.642 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 94.6 t 60.51 100.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.047 -0.979 . . . . 2.0699999999999998 112.675 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.847 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.1 m-85 -124.98 -161.45 1.02 Allowed 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.046 0.927 . . . . 1.9399999999999999 112.15 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.685 ' HA2' HG13 ' A' ' 63' ' ' VAL . . . -137.14 18.89 3.48 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.505 -1.225 . . . . 1.49 112.091 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.837 ' HB2' HG23 ' A' ' 81' ' ' ILE . 8.2 t30 -84.62 85.89 7.37 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.083 -0.657 . . . . 1.95 109.813 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.625 HG23 ' HB ' ' A' ' 63' ' ' VAL . 59.9 t -153.36 -56.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.55 0.944 . . . . 3.4399999999999999 113.55 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 25' ' ' VAL . 8.3 p -102.15 149.98 37.08 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.559 -0.291 . . . . 2.9700000000000002 111.586 -164.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.746 ' HD2' ' HA ' ' A' ' 25' ' ' VAL . 1.1 Cg_endo -42.85 112.98 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.21 3.274 . . . . 3.0899999999999999 111.742 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.665 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 119.23 -83.75 0.36 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.216 -1.154 . . . . 1.6399999999999999 110.216 -170.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 1.9 pt20 -64.58 -38.73 92.03 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.766 0.793 . . . . 1.98 109.855 -175.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.674 HG23 ' NE2' ' A' ' 32' ' ' GLN . 9.9 p -50.99 -57.4 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.875 -1.057 . . . . 1.5700000000000001 111.609 -174.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 16.6 pttp -59.87 -42.4 93.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.604 0.716 . . . . 2.48 110.342 -164.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.665 ' HD2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -89.1 -34.95 16.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.068 -0.969 . . . . 2.8100000000000001 110.489 -172.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.837 HG23 ' HB2' ' A' ' 72' ' ' ASN . 51.1 mm -68.1 -11.54 14.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.87 -0.604 . . . . 1.6399999999999999 109.868 174.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HB2' HE22 ' A' ' 32' ' ' GLN . 57.4 tp -60.48 -37.19 80.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.32 -0.862 . . . . 1.3600000000000001 110.47 168.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.54 68.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.724 0.773 . . . . 1.3600000000000001 109.003 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.562 -1.199 . . . . 2.0899999999999999 111.365 174.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.847 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 8.0 m-30 . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 118.283 -0.865 . . . . 1.77 110.95 175.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.856 0.836 . . . . 4.9400000000000004 110.95 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.818 ' HB2' HG11 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -33.96 116.6 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.198 -1.819 . . . . 2.0 113.611 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.642 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 24.2 Cg_exo -66.34 109.54 1.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.024 1.816 . . . . 1.1200000000000001 110.582 166.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -78.52 158.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.166 -0.309 . . . . 1.97 110.166 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.862 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 25.1 m -141.88 111.46 6.58 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.041 -0.527 . . . . 1.8500000000000001 110.354 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.72 120.48 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.971 -0.559 . . . . 2.6800000000000002 110.985 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.713 ' SG ' HG22 ' A' ' 54' ' ' VAL . 35.8 t -70.2 122.98 20.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.673 -0.411 . . . . 2.2400000000000002 110.717 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.75 ' HE1' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -122.84 22.83 9.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.372 -0.377 . . . . 5.4500000000000002 111.019 174.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.611 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -66.43 177.49 16.63 Favored Glycine 0 C--O 1.22 -0.736 0 C-N-CA 120.497 -0.859 . . . . 4.1399999999999997 112.363 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.7 m -66.32 -45.14 81.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.613 0.597 . . . . 6.2599999999999998 112.613 -171.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.63 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.609 0.719 . . . . 4.6399999999999997 110.783 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 91.3 m -63.51 -28.52 70.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.131 -0.94 . . . . 3.1499999999999999 111.568 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 61.4 t80 -56.07 -27.45 53.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.302 0.641 . . . . 4.6500000000000004 110.265 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.45 -20.74 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 4.0099999999999998 110.402 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -80.92 10.45 5.05 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.661 0.267 . . . . 5.21 110.671 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.17 28.21 34.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.927 -0.654 . . . . 1.96 112.546 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -73.02 -22.7 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.575 0.226 . . . . 1.9399999999999999 111.454 -171.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.631 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 18.0 t70 -61.43 -46.35 90.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.204 0.526 . . . . 2.4199999999999999 110.29 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.546 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 9.1 mptt -67.18 -33.06 74.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.285 -0.635 . . . . 3.4100000000000001 109.285 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.017 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 99.6 t -56.12 -58.19 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 109.011 -0.737 . . . . 2.75 109.011 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 29' ' ' PHE . 28.9 m -61.58 -34.63 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.706 -0.679 . . . . 2.1299999999999999 111.566 -174.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -63.1 -48.37 78.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 119.112 -1.035 . . . . 1.54 110.189 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.62 81.87 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.846 -1.168 . . . . 1.27 107.846 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.78 ' HZ ' ' HH ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -53.35 -52.56 58.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.488 -1.233 . . . . 2.5800000000000001 110.988 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -51.67 -49.55 62.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.106 -0.952 . . . . 3.23 110.578 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.97 -31.54 34.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.442 -1.254 . . . . 2.23 110.842 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.678 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 5.7 mm100 -64.42 -21.92 66.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.632 -0.713 . . . . 2.54 111.933 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.057 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.4 tt -57.45 -55.0 40.47 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.373 -1.343 . . . . 2.5499999999999998 107.373 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.817 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 62.9 -22.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 126.576 2.422 . . . . 4.8099999999999996 112.997 171.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.21 -175.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.153 -1.385 . . . . 4.1900000000000004 112.667 170.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -156.6 -47.35 0.07 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.687 -1.227 . . . . 4.6200000000000001 107.687 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 pt -167.19 5.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 113.222 -1.808 . . . . 5.3700000000000001 111.089 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 178.65 -54.54 0.09 OUTLIER Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.06 -1.216 . . . . 4.1299999999999999 110.06 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.54 ' HA ' HG22 ' A' ' 35' ' ' ILE . 20.5 t70 -175.24 118.65 0.18 Allowed 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.187 -1.507 . . . . 4.3099999999999996 110.709 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.961 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 9.5 p 56.17 -66.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 O-C-N 127.205 2.816 . . . . 2.96 113.044 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.879 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 41.1 m -154.64 -61.62 0.02 OUTLIER Pre-proline 0 C--N 1.279 -2.495 0 CA-C-N 113.619 -1.628 . . . . 4.1799999999999997 109.99 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.879 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.1 Cg_exo -79.75 8.41 4.02 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 120.908 1.072 . . . . 4.3700000000000001 114.297 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.546 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 22.3 t70 82.77 5.85 0.91 Allowed 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.347 1.07 . . . . 4.2599999999999998 108.356 166.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.482 ' N ' ' HB3' ' A' ' 39' ' ' ASP . . . 175.76 76.2 0.05 OUTLIER Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.177 -1.374 . . . . 2.1299999999999999 112.157 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.607 ' CB ' HG11 ' A' ' 40' ' ' VAL . 5.2 tpt180 -100.45 -60.42 1.53 Allowed 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.463 -0.94 . . . . 3.7799999999999998 108.463 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.057 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.19 115.8 21.68 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 122.508 1.147 . . . . 2.6099999999999999 114.002 -176.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.44 ' C ' HG22 ' A' ' 9' ' ' ILE . 21.2 t -102.27 93.38 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.156 -1.384 . . . . 2.2799999999999998 108.56 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.757 ' HA ' HG22 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -67.52 135.28 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.861 0.689 . . . . 3.5600000000000001 112.861 -168.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.862 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.5 t70 -160.12 138.03 9.93 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.205 1.003 . . . . 3.3100000000000001 112.73 163.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.75 HG22 ' HE1' ' A' ' 13' ' ' MET . 19.3 m -48.47 -49.91 33.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 115.407 1.632 . . . . 3.7000000000000002 115.407 170.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -54.67 -40.65 69.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.915 2.191 . . . . 4.7999999999999998 116.915 -150.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.655 ' HE ' ' HA ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -63.25 -55.37 25.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.896 0.855 . . . . 6.9100000000000001 110.945 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.643 ' H ' ' HB3' ' A' ' 10' ' ' SER . 25.3 t -63.95 166.41 7.5 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.886 -1.506 . . . . 3.04 109.156 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.713 HG22 ' SG ' ' A' ' 12' ' ' CYS . 14.3 t 72.83 27.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.206 1.479 . . . . 4.6799999999999997 107.586 -153.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.34 65.74 0.32 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 113.292 -1.776 . . . . 4.1900000000000004 113.321 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.16 55.19 25.3 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 119.485 -1.341 . . . . 4.8499999999999996 116.04 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -138.82 -29.89 0.77 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.24 1.02 . . . . 3.5600000000000001 110.183 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.24 -29.51 3.87 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 116.632 2.086 . . . . 3.9100000000000001 116.632 -158.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.9 6.77 4.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.407 1.458 . . . . 5.7000000000000002 111.85 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.39 161.62 30.67 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 3.5800000000000001 108.309 163.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.24 119.13 5.45 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.326 1.152 . . . . 4.3600000000000003 109.307 163.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.09 132.78 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.973 0.731 . . . . 3.0499999999999998 112.973 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.521 HG22 ' CZ ' ' A' ' 29' ' ' PHE . 11.7 p -143.07 121.8 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.86 -0.736 . . . . 2.3300000000000001 109.133 148.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 50.1 ttp -113.44 133.99 54.9 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 119.26 -0.976 . . . . 2.23 108.778 -173.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.818 HG11 ' HB2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -126.04 117.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.222 -0.591 . . . . 1.3300000000000001 109.491 173.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.642 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 49.12 50.79 27.27 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 123.748 0.655 . . . . 1.1000000000000001 113.935 173.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 62.12 -0.67 0.45 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.111 0.412 . . . . 3.0099999999999998 112.111 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.491 ' HZ3' ' HH ' ' A' ' 70' ' ' TYR . 14.4 mmmm -75.8 -38.56 58.1 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.834 -0.432 . . . . 3.0600000000000001 109.834 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 95.3 t 61.43 113.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.042 -0.981 . . . . 2.0699999999999998 112.465 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.595 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 40.0 m-85 -131.53 -172.7 2.92 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.142 0.972 . . . . 1.9399999999999999 112.278 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -132.01 26.32 3.79 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.024 -1.444 . . . . 1.49 110.96 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.697 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 2.1 t30 -76.13 111.73 11.84 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.937 -0.764 . . . . 1.95 108.937 177.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.454 HG21 ' H ' ' A' ' 74' ' ' THR . 3.2 m -134.12 -97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 116.34 1.978 . . . . 3.4399999999999999 116.34 -164.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 1.017 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 10.2 t -143.92 -41.41 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 115.66 1.726 . . . . 2.9700000000000002 115.66 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.601 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 5.6 Cg_exo -73.65 57.84 3.76 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 122.133 1.889 . . . . 3.0899999999999999 113.193 -169.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.18 -7.34 10.95 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 116.063 -0.517 . . . . 1.6399999999999999 112.468 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' O ' HG12 ' A' ' 81' ' ' ILE . 13.8 mt-30 -75.84 -30.8 59.09 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 107.227 -1.398 . . . . 1.98 107.227 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.678 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -52.63 -46.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-N 112.554 -2.112 . . . . 1.5700000000000001 112.317 -175.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -54.76 -44.8 73.97 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.517 1.151 . . . . 2.48 108.153 -170.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.569 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -80.63 -46.75 15.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.826 -1.988 . . . . 2.8100000000000001 110.331 -173.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 77' ' ' GLN . 28.9 mm -69.02 -16.24 20.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.893 -1.049 . . . . 1.6399999999999999 110.239 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 78' ' ' VAL . 54.9 tp -61.34 -33.95 74.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.483 -0.76 . . . . 1.3600000000000001 110.107 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 -27.93 69.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.281 0.562 . . . . 1.3600000000000001 109.535 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' OE1' HG22 ' A' ' 81' ' ' ILE . 1.7 mt-10 -71.38 -27.33 63.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.403 -0.817 . . . . 2.0899999999999999 110.191 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.78 ' HH ' ' HZ ' ' A' ' 29' ' ' PHE . 3.3 m-30 . . . . . 0 N--CA 1.422 -1.864 0 CA-C-N 115.628 -0.714 . . . . 1.77 110.555 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HB3' ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 121.729 0.776 . . . . 4.9400000000000004 112.054 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.687 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 15.6 m-85 -46.79 125.98 8.27 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.054 -1.43 . . . . 2.0 112.224 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.682 ' HA ' ' O ' ' A' ' 47' ' ' SER . 61.0 Cg_exo -57.72 94.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.968 2.446 . . . . 1.1200000000000001 112.175 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.826 ' HB ' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -82.02 135.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.32 0.581 . . . . 1.97 111.909 -174.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.675 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.0 m -100.68 124.28 46.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.075 -0.966 . . . . 1.8500000000000001 110.665 -177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 m -116.83 125.01 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.844 0.683 . . . . 2.6800000000000002 112.844 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' CB ' ' A' ' 17' ' ' CYS . 15.1 t -67.71 117.38 9.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.058 0.456 . . . . 2.2400000000000002 112.057 175.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.5 ttt -129.32 23.75 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.901 -0.591 . . . . 5.4500000000000002 109.583 166.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.5 176.46 23.82 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.503 -0.856 . . . . 4.1399999999999997 114.65 -167.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -67.34 -45.33 76.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.979 0.418 . . . . 6.2599999999999998 112.091 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.63 25.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.474 0.654 . . . . 4.6399999999999997 110.1 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 88.5 m -63.76 -33.84 76.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.59 -1.186 . . . . 3.1499999999999999 112.021 -176.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 43.8 t80 -60.45 -32.62 71.55 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.984 0.421 . . . . 4.6500000000000004 111.015 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -72.68 -23.84 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.537 0.684 . . . . 4.0099999999999998 109.886 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 23.9 tptm -83.2 8.1 14.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.419 -0.809 . . . . 5.21 110.001 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.23 28.29 34.13 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.898 -0.668 . . . . 1.96 112.184 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HA ' ' CG2' ' A' ' 25' ' ' VAL . . . -71.73 -22.41 61.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 1.9399999999999999 111.15 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.416 ' O ' HG21 ' A' ' 26' ' ' VAL . 10.0 t70 -56.78 -52.86 63.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.409 -0.359 . . . . 2.4199999999999999 110.232 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -66.17 -37.88 86.71 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.44 -0.504 . . . . 3.4100000000000001 110.908 -172.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.02 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.4 m -69.31 -44.56 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 120.583 -0.447 . . . . 2.75 110.72 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 18.9 m -64.52 -31.32 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.919 -0.712 . . . . 2.1299999999999999 109.441 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -59.66 -45.85 90.78 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.932 0.396 . . . . 1.54 110.08 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . -56.1 -43.25 77.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.091 -0.958 . . . . 1.27 108.516 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.725 ' HZ ' ' HE2' ' A' ' 85' ' ' TYR . 1.3 t80 -56.17 -49.18 74.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.062 -0.972 . . . . 2.5800000000000001 110.776 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -50.92 -46.63 60.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.262 -0.881 . . . . 3.23 110.551 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -76.17 -30.18 58.0 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.97 -1.014 . . . . 2.23 110.919 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.737 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 13.5 mm100 -61.66 -27.59 68.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.218 -0.901 . . . . 2.54 111.059 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.65 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -50.86 -58.41 6.03 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.854 -1.165 . . . . 2.5499999999999998 107.854 170.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER 57.45 -2.63 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 O-C-N 125.683 1.865 . . . . 4.8099999999999996 112.61 173.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.65 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 46.05 -166.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.656 -1.611 . . . . 4.1900000000000004 112.935 174.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 6.9 t70 -159.57 -40.25 0.05 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.2 -1.407 . . . . 4.6200000000000001 107.2 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.751 HD13 ' HB2' ' A' ' 43' ' ' ASP . 1.5 pt -164.32 0.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.247 -2.252 . . . . 5.3700000000000001 110.557 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.84 -27.41 0.58 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 119.517 -1.325 . . . . 4.1299999999999999 112.944 -165.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.987 ' HA ' ' HE1' ' A' ' 46' ' ' PHE . 10.6 t70 -138.28 167.86 20.96 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 121.157 0.503 . . . . 4.3099999999999996 111.898 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.0 t -25.58 -58.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 126.877 2.611 . . . . 2.96 110.422 174.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.808 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 98.5 m -159.55 -64.69 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 111.627 -2.533 . . . . 4.1799999999999997 111.397 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.808 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.2 Cg_exo -78.62 5.93 5.22 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 121.097 1.198 . . . . 4.3700000000000001 114.561 -172.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.972 ' HA ' ' HB3' ' A' ' 39' ' ' ASP . 36.9 t70 74.27 21.38 2.45 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.252 -1.018 . . . . 4.2599999999999998 108.252 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.05 58.52 0.16 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 118.691 -1.718 . . . . 2.1299999999999999 113.882 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.487 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -122.53 -44.28 2.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.241 0.543 . . . . 3.7799999999999998 110.476 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.987 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -119.55 142.11 48.64 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 113.208 0.818 . . . . 2.6099999999999999 113.208 -170.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.682 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 23.2 t -155.64 97.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.354 -1.721 . . . . 2.2799999999999998 106.354 166.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.488 HG23 ' HD2' ' A' ' 46' ' ' PHE . 36.1 pt -87.97 149.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 114.021 1.119 . . . . 3.5600000000000001 114.021 -159.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.3 p30 -161.02 138.01 8.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.394 -1.275 . . . . 3.3100000000000001 110.333 159.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.5 m -44.06 -45.55 8.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.9 -1.5 . . . . 3.7000000000000002 114.095 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 tp -53.48 -39.5 64.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.711 1.745 . . . . 4.7999999999999998 115.711 -152.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -62.65 -57.76 9.91 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.611 1.196 . . . . 6.9100000000000001 109.62 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.675 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 38.5 t -66.99 166.45 13.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.831 -1.986 . . . . 3.04 111.208 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 54' ' ' VAL . 21.4 t 70.65 26.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 123.332 1.539 . . . . 4.6799999999999997 109.238 -169.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.17 63.58 0.3 Allowed Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 113.319 -1.764 . . . . 4.1900000000000004 112.36 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.34 58.84 10.78 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 119.044 -1.55 . . . . 4.8499999999999996 114.498 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.314 0.8 OUTLIER -131.43 -33.76 1.44 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.05 1.425 . . . . 3.5600000000000001 108.982 -157.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.36 2.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 115.311 1.597 . . . . 3.9100000000000001 115.311 -163.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.737 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -72.82 6.39 2.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.984 -1.086 . . . . 5.7000000000000002 111.746 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.1 158.2 46.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 108.027 -1.101 . . . . 3.5800000000000001 108.027 157.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.59 120.07 5.43 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 CA-C-N 120.659 1.271 . . . . 4.3600000000000003 109.507 163.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.61 ' O ' HD12 ' A' ' 62' ' ' ILE . 2.0 pp -111.46 130.31 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.048 0.758 . . . . 3.0499999999999998 113.048 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.895 HG21 ' H ' ' A' ' 73' ' ' VAL . 3.9 t -142.27 116.52 4.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 107.091 -1.448 . . . . 2.3300000000000001 107.091 157.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.606 ' HG3' HG11 ' A' ' 69' ' ' VAL . 20.5 ttt -119.11 136.47 54.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 118.434 -1.306 . . . . 2.23 111.334 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.826 HG12 ' HB ' ' A' ' 9' ' ' ILE . 1.8 m -123.46 115.94 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.533 -1.284 . . . . 1.3300000000000001 107.533 157.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.579 ' HA3' ' HB3' ' A' ' 7' ' ' TYR . . . 50.03 -155.47 2.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.648 -0.787 . . . . 1.1000000000000001 111.223 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.79 37.27 0.41 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.995 -0.603 . . . . 3.0099999999999998 109.93 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.77 ' HB2' HG23 ' A' ' 65' ' ' VAL . 14.5 mmmm -103.09 -22.76 13.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.056 -0.52 . . . . 3.0600000000000001 109.999 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.606 HG11 ' HG3' ' A' ' 64' ' ' MET . 3.5 m 29.06 101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.134 1.531 . . . . 2.0699999999999998 115.134 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.758 ' HD2' ' HE1' ' A' ' 85' ' ' TYR . 62.7 m-85 -118.09 -158.68 0.72 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.99 0.9 . . . . 1.9399999999999999 112.14 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 81' ' ' ILE . . . -147.84 40.8 0.95 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 114.38 -1.282 . . . . 1.49 110.138 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.982 ' HA ' HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -64.37 -4.99 4.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.717 0.77 . . . . 1.95 110.759 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.895 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 48.89 -160.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.91 1.684 . . . . 3.4399999999999999 114.308 169.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 1.02 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 27.1 p -139.66 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.964 1.468 . . . . 2.9700000000000002 114.964 -166.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.823 ' HD2' HE21 ' A' ' 77' ' ' GLN . 3.7 Cg_exo -77.99 76.98 4.1 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.307 2.004 . . . . 3.0899999999999999 113.811 -170.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.2 -20.75 3.03 Favored Glycine 0 N--CA 1.462 0.397 0 C-N-CA 121.405 -0.426 . . . . 1.6399999999999999 112.751 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.823 HE21 ' HD2' ' A' ' 75' ' ' PRO . 18.4 mt-30 -77.99 -18.91 55.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.824 -1.547 . . . . 1.98 106.824 -172.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.737 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -47.15 -51.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 112.069 -2.332 . . . . 1.5700000000000001 110.908 -177.51 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.697 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 44.7 mtmt -54.0 -51.61 63.41 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 122.833 1.301 . . . . 2.48 109.343 -167.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.461 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.23 -35.5 15.29 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.176 -1.829 . . . . 2.8100000000000001 110.675 -169.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.982 HG23 ' HA ' ' A' ' 72' ' ' ASN . 46.5 mm -71.98 -13.6 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.176 -0.92 . . . . 1.6399999999999999 109.126 176.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 85' ' ' TYR . 43.9 tp -56.11 -19.89 15.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.469 -0.332 . . . . 1.3600000000000001 110.343 171.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.7 -22.23 1.98 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.777 0.322 . . . . 1.3600000000000001 111.428 167.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.25 -44.37 95.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.431 0.634 . . . . 2.0899999999999999 110.251 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.758 ' HE1' ' HD2' ' A' ' 70' ' ' TYR . 10.1 m-30 . . . . . 0 N--CA 1.427 -1.586 0 CA-C-N 115.018 -0.992 . . . . 1.77 112.082 -173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.275 -0.268 . . . . 14.24 110.275 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.782 ' HB ' ' HD3' ' A' ' 3' ' ' PRO . 60.1 t -64.22 -52.23 56.18 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 108.511 -0.922 . . . . 10.970000000000001 108.511 171.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.782 ' HD3' ' HB ' ' A' ' 2' ' ' VAL . 21.1 Cg_exo -67.74 119.93 6.95 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.619 -1.339 . . . . 9.9600000000000009 108.619 158.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.659 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 13.0 tptm -42.6 -65.82 0.43 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.19 0.931 . . . . 9.3399999999999999 112.144 -171.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 1.101 ' HA2' ' HB2' ' A' ' 47' ' ' SER . . . 112.37 31.66 2.55 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 114.636 -1.166 . . . . 4.1799999999999997 111.916 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.71 ' HG2' ' CE1' ' A' ' 7' ' ' TYR . 25.4 ttpt -58.94 -54.01 51.94 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.194 -0.503 . . . . 4.9400000000000004 110.106 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.883 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.0 m-30 -108.5 82.69 1.72 Allowed Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 116.228 -0.442 . . . . 2.0 110.412 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.935 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 87.1 Cg_exo -52.72 94.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.835 2.356 . . . . 1.1200000000000001 111.972 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.74 HD13 HG21 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -85.11 127.7 39.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 1.97 112.054 -173.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 14.3 m -100.37 110.99 23.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.286 -0.87 . . . . 1.8500000000000001 110.627 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -117.21 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.409 . . . . 2.6800000000000002 110.97 -178.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 24.4 t -67.38 121.24 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.195 -0.602 . . . . 2.2400000000000002 111.611 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.0 mtm -123.82 23.11 8.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.934 -0.765 . . . . 5.4500000000000002 108.934 164.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.03 177.38 19.65 Favored Glycine 0 C--O 1.219 -0.807 0 C-N-CA 120.945 -0.645 . . . . 4.1399999999999997 112.624 -173.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.7 p -64.29 -43.89 93.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.69 0.626 . . . . 6.2599999999999998 112.69 -168.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.696 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -69.88 -55.63 9.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.43 . . . . 4.6399999999999997 111.361 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.66 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 86.6 m -66.53 -34.93 79.02 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.408 -0.36 . . . . 3.1499999999999999 111.757 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 51.3 t80 -62.16 -32.16 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.909 0.484 . . . . 4.6500000000000004 111.746 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 16' ' ' ALA . 4.2 p -70.91 -18.67 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.147 0.499 . . . . 4.0099999999999998 110.818 -172.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -80.75 8.43 8.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.501 0.667 . . . . 5.21 109.769 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.78 54.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.561 -0.745 . . . . 1.96 112.048 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.561 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -73.43 -21.08 60.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.421 -0.389 . . . . 1.9399999999999999 110.673 -172.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.612 ' O ' HG21 ' A' ' 26' ' ' VAL . 13.6 t70 -56.93 -46.55 81.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 2.4199999999999999 111.309 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -66.88 -36.99 83.57 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.067 -0.653 . . . . 3.4100000000000001 110.353 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.531 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -72.53 -38.18 58.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.797 -0.638 . . . . 2.75 111.182 177.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 23' ' ' ASP . 4.6 m -66.19 -28.43 43.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 119.546 -0.862 . . . . 2.1299999999999999 109.15 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.48 -40.47 82.82 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.577 -0.527 . . . . 1.54 109.577 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -50.96 -51.26 54.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.863 -1.062 . . . . 1.27 108.904 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.586 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 29.8 t80 -53.65 -48.77 69.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.95 -1.023 . . . . 2.5800000000000001 112.0 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -46.75 -49.48 19.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.004 -0.998 . . . . 3.23 110.494 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -77.96 -26.79 49.02 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.676 -1.147 . . . . 2.23 110.619 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.66 ' OE1' ' HA ' ' A' ' 79' ' ' LYS . 4.6 mt-30 -60.5 -29.86 69.36 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.536 -0.757 . . . . 2.54 112.393 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.759 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 1.1 tt -48.42 -55.74 10.04 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.373 -1.714 . . . . 2.5499999999999998 106.373 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.759 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.04 -18.81 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 126.513 2.383 . . . . 4.8099999999999996 112.648 173.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.711 ' HA ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 51.71 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.398 -1.728 . . . . 4.1900000000000004 113.996 165.287 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.415 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 16.0 t70 -155.51 -55.64 0.09 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.581 -1.645 . . . . 4.6200000000000001 108.076 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 36' ' ' ASP . 3.3 pt -167.53 9.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 112.728 -2.033 . . . . 5.3700000000000001 108.486 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.92 -51.81 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.585 0 N-CA-C 108.981 -1.647 . . . . 4.1299999999999999 108.981 -164.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.603 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -169.72 143.04 2.6 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.546 -0.827 . . . . 4.3099999999999996 111.772 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.811 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER 18.83 -68.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 O-C-N 127.041 2.713 . . . . 2.96 115.167 161.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 40' ' ' VAL . 23.5 m -135.32 94.64 15.42 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 104.793 -2.299 . . . . 4.1799999999999997 104.793 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD3' ' CB ' ' A' ' 36' ' ' ASP . 1.5 Cg_endo -33.06 89.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.965 3.11 . . . . 4.3700000000000001 113.608 -149.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 4' ' ' LYS . 8.8 t70 -144.36 -65.1 0.35 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.919 -1.491 . . . . 4.2599999999999998 111.37 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 4' ' ' LYS . . . 113.49 37.41 1.32 Allowed Glycine 0 C--N 1.31 -0.89 0 N-CA-C 110.32 -1.112 . . . . 2.1299999999999999 110.32 -169.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.603 ' HD3' ' OXT' ' A' ' 85' ' ' TYR . 76.5 mtt180 -61.15 -42.26 98.23 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.876 -1.162 . . . . 3.7799999999999998 109.845 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.811 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 99.3 m-85 -84.15 136.88 33.81 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.911 -1.041 . . . . 2.6099999999999999 110.969 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 1.101 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 19.9 t -145.01 65.25 1.27 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.813 -1.18 . . . . 2.2799999999999998 107.813 165.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.74 HG21 HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.97 129.17 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.331 -0.85 . . . . 3.5600000000000001 111.99 -170.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -154.93 138.9 16.36 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.281 1.039 . . . . 3.3100000000000001 110.784 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.7 p -43.86 -45.42 7.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.322 -1.763 . . . . 3.7000000000000002 115.488 168.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.1 tp -53.16 -41.52 65.24 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.282 1.586 . . . . 4.7999999999999998 115.282 -149.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -64.43 -57.34 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.931 0.872 . . . . 6.9100000000000001 111.053 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -66.26 170.51 5.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.835 -1.53 . . . . 3.04 111.026 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.909 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 5.9 t 73.14 28.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.67 1.224 . . . . 4.6799999999999997 109.175 -164.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.65 64.2 0.3 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 113.922 -1.49 . . . . 4.1900000000000004 113.371 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.49 57.49 16.31 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.319 -1.42 . . . . 4.8499999999999996 115.321 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.252 2.0 m -133.19 -33.32 1.14 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.706 1.253 . . . . 3.5600000000000001 109.747 -161.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.98 -26.38 2.49 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.397 1.999 . . . . 3.9100000000000001 116.397 -163.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.72 3.38 6.54 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.316 1.416 . . . . 5.7000000000000002 111.413 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.94 158.36 50.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.245 -1.391 . . . . 3.5800000000000001 107.245 154.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.15 118.6 5.03 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-N 121.191 1.461 . . . . 4.3600000000000003 109.648 164.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.32 131.71 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.89 -0.141 . . . . 3.0499999999999998 110.867 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.69 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 6.1 t -138.71 125.93 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.891 -1.151 . . . . 2.3300000000000001 107.891 160.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.764 ' HG3' HG23 ' A' ' 69' ' ' VAL . 49.7 ttm -112.29 136.77 51.32 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 117.703 -1.599 . . . . 2.23 109.815 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.883 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.75 114.71 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 106.649 -1.612 . . . . 1.3300000000000001 106.649 159.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.18 -145.87 1.65 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-O 122.337 0.965 . . . . 1.1000000000000001 112.596 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.53 25.88 0.31 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.379 -1.411 . . . . 3.0099999999999998 109.423 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.615 ' HB2' HG23 ' A' ' 65' ' ' VAL . 9.1 mmpt? -106.95 -40.82 5.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.298 -0.63 . . . . 3.0600000000000001 109.298 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.764 HG23 ' HG3' ' A' ' 64' ' ' MET . 80.1 t 46.26 99.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.502 0.927 . . . . 2.0699999999999998 113.502 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.733 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -117.03 -153.21 0.52 Allowed 'General case' 0 C--O 1.246 0.906 0 CA-C-O 122.07 0.938 . . . . 1.9399999999999999 113.362 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.597 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -134.51 17.1 4.27 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.202 -1.363 . . . . 1.49 112.796 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.904 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -89.53 98.52 11.81 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.945 -0.761 . . . . 1.95 108.945 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.626 HG21 HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -126.41 -90.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 122.181 0.991 . . . . 3.4399999999999999 112.652 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.852 HG22 ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -137.77 -66.6 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 113.504 -1.68 . . . . 2.9700000000000002 111.858 -170.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.852 ' HD3' HG22 ' A' ' 74' ' ' THR . 6.3 Cg_exo -76.84 70.87 6.36 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.648 2.232 . . . . 3.0899999999999999 114.019 -162.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 80.1 -19.55 6.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.105 -0.569 . . . . 1.6399999999999999 113.108 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.519 ' O ' HG12 ' A' ' 81' ' ' ILE . 6.2 mt-30 -73.98 -22.86 59.45 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.342 -1.725 . . . . 1.98 106.342 -170.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.585 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 13.6 m -48.7 -59.18 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 111.826 -2.443 . . . . 1.5700000000000001 111.386 -175.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.66 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 23.6 pttt -60.17 -39.49 86.62 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.783 0.801 . . . . 2.48 110.741 -165.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.639 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -82.38 -45.27 15.07 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.75 -1.113 . . . . 2.8100000000000001 109.646 -173.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 72' ' ' ASN . 39.5 mm -69.39 -15.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.211 -1.358 . . . . 1.6399999999999999 110.155 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.508 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 53.6 tp -63.04 -37.81 88.67 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.74 -0.6 . . . . 1.3600000000000001 110.256 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.7 64.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.013 -0.736 . . . . 1.3600000000000001 109.013 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 6.6 mt-10 -73.66 -34.49 64.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.871 -1.059 . . . . 2.0899999999999999 112.748 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 5.1 m-30 . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 118.951 -0.547 . . . . 1.77 112.044 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 0.909 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mmm . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.881 0.372 . . . . 14.24 110.478 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -125.06 101.1 32.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 10.970000000000001 110.232 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.9 100.57 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.498 2.132 . . . . 9.9600000000000009 111.223 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.834 ' HG3' ' HA3' ' A' ' 44' ' ' GLY . 25.3 mmtp -58.34 -45.22 88.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.428 0.633 . . . . 9.3399999999999999 111.421 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.92 0.35 58.86 Favored Glycine 0 C--N 1.307 -1.059 0 CA-C-N 115.165 -0.925 . . . . 4.1799999999999997 114.262 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 3.8 tppp? -64.87 -58.72 5.45 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.422 -0.585 . . . . 4.9400000000000004 109.422 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.049 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 22.5 m-85 -141.71 62.71 15.34 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 114.364 -1.289 . . . . 2.0 110.254 -175.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HD2' ' CA ' ' A' ' 66' ' ' GLY . 33.4 Cg_exo -61.48 92.81 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.534 1.489 . . . . 1.1200000000000001 109.949 172.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 1.018 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.03 160.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 116.409 -0.36 . . . . 1.97 110.426 -168.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.801 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m -139.86 112.84 8.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 123.644 0.59 . . . . 1.8500000000000001 111.343 -174.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.7 t -118.17 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.182 -0.917 . . . . 2.6800000000000002 109.857 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -65.39 120.38 12.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 118.775 0.716 . . . . 2.2400000000000002 110.958 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ttt -124.3 23.05 8.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.503 -0.771 . . . . 5.4500000000000002 109.654 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -68.06 177.52 23.73 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.797 . . . . 4.1399999999999997 112.417 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -67.65 -43.8 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.078 0.399 . . . . 6.2599999999999998 112.078 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.63 ' O ' HG21 ' A' ' 19' ' ' VAL . . . -71.29 -56.8 5.29 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.549 0.574 . . . . 4.6399999999999997 112.549 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 98.9 m -63.48 -30.53 71.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.506 -0.316 . . . . 3.1499999999999999 111.572 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 56.4 t80 -59.31 -29.53 67.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.286 0.635 . . . . 4.6500000000000004 112.179 -176.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.63 HG21 ' O ' ' A' ' 16' ' ' ALA . 16.9 m -69.15 -18.65 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 111.91 0.337 . . . . 4.0099999999999998 111.91 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.02 13.32 2.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.807 0.337 . . . . 5.21 110.591 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.4 28.73 23.99 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.649 -0.58 . . . . 1.96 111.649 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . . . -72.48 -19.63 61.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.253 -0.474 . . . . 1.9399999999999999 110.97 -172.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . 8.5 p-10 -55.7 -45.0 77.92 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.887 -0.325 . . . . 2.4199999999999999 110.429 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -62.61 -48.29 80.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.352 -0.539 . . . . 3.4100000000000001 110.782 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.995 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 6.6 m -65.52 -44.3 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 116.305 -0.407 . . . . 2.75 110.526 -176.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 23' ' ' ASP . 15.0 m -64.17 -36.45 77.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.149 -0.62 . . . . 2.1299999999999999 110.2 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -60.18 -42.57 95.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.107 -0.637 . . . . 1.54 109.398 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.575 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.75 -46.66 81.27 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.42 -1.264 . . . . 1.27 108.629 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.45 ' HZ ' ' CG1' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -44.59 82.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.875 . . . . 2.5800000000000001 111.425 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -54.63 -51.21 66.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.723 0.773 . . . . 3.23 110.085 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.77 -20.75 38.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.935 -1.03 . . . . 2.23 110.653 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.575 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -62.0 -30.64 71.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.781 -0.645 . . . . 2.54 110.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.058 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.8 tt -54.69 -54.24 44.41 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.259 -1.015 . . . . 2.5499999999999998 108.259 172.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 65.77 -19.52 0.09 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.357 -2.202 . . . . 4.8099999999999996 112.493 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.647 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER 54.36 -170.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.501 -1.681 . . . . 4.1900000000000004 113.12 168.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -157.38 -49.56 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.208 -1.405 . . . . 4.6200000000000001 107.208 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -164.92 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 113.069 -1.878 . . . . 5.3700000000000001 110.836 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.05 -61.98 0.07 OUTLIER Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 109.783 -1.327 . . . . 4.1299999999999999 109.783 -166.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.572 ' HB2' ' N ' ' A' ' 44' ' ' GLY . 38.2 m-20 -165.52 122.12 1.42 Allowed 'General case' 0 CA--C 1.475 -1.925 0 CA-C-N 113.051 -1.575 . . . . 4.3099999999999996 108.796 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.913 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 1.4 p 54.99 -71.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 O-C-N 126.775 2.547 . . . . 2.96 113.348 169.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.786 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 84.3 m -151.18 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.275 -2.662 0 CA-C-N 113.262 -1.79 . . . . 4.1799999999999997 110.256 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.786 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 7.1 Cg_exo -73.83 4.42 4.15 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 120.673 0.915 . . . . 4.3700000000000001 113.946 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.531 ' HA ' ' H ' ' A' ' 39' ' ' ASP . 20.2 t70 78.09 14.12 1.56 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.294 -1.373 . . . . 4.2599999999999998 107.294 169.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.834 ' HA3' ' HG3' ' A' ' 4' ' ' LYS . . . 155.07 63.58 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 114.151 -1.386 . . . . 2.1299999999999999 112.278 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 10.5 ttt180 -94.7 -64.69 1.04 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.814 -1.55 . . . . 3.7799999999999998 106.814 171.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.058 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -107.23 123.99 49.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.752 -0.658 . . . . 2.6099999999999999 112.281 171.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 4.2 m -105.33 92.15 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.966 . . . . 2.2799999999999998 109.279 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.999 HG23 HD12 ' A' ' 9' ' ' ILE . 2.3 pp -60.18 123.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.774 -0.648 . . . . 3.5600000000000001 112.72 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.801 ' O ' ' HA ' ' A' ' 10' ' ' SER . 5.3 t70 -160.85 140.49 10.77 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.241 1.019 . . . . 3.3100000000000001 113.051 167.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t -47.51 -45.96 26.9 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 115.111 1.522 . . . . 3.7000000000000002 115.111 169.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.426 ' HG ' ' OD1' ' A' ' 49' ' ' ASP . 51.6 mt -53.49 -38.12 63.38 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.254 2.316 . . . . 4.7999999999999998 117.254 -152.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.4 mmt180 -61.78 -56.82 15.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.757 1.162 . . . . 6.9100000000000001 110.18 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.629 ' H ' ' HB3' ' A' ' 10' ' ' SER . 27.4 t -65.07 165.46 11.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.327 -1.76 . . . . 3.04 109.938 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.05 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 10.9 t 71.26 25.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 122.93 1.347 . . . . 4.6799999999999997 108.188 -156.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.51 64.11 0.35 Allowed Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 113.583 -1.644 . . . . 4.1900000000000004 113.538 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.33 57.71 14.21 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 119.11 -1.519 . . . . 4.8499999999999996 115.3 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.635 ' HB3' HG23 ' A' ' 62' ' ' ILE 0.267 1.8 m -135.7 -32.65 0.89 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.564 1.182 . . . . 3.5600000000000001 110.416 -162.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -28.64 5.66 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.477 1.658 . . . . 3.9100000000000001 115.477 -163.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.57 7.63 2.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.777 1.172 . . . . 5.7000000000000002 112.053 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.7 160.55 36.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.888 -0.782 . . . . 3.5800000000000001 108.888 164.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.89 122.18 7.09 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 N-CA-C 108.787 -1.274 . . . . 4.3600000000000003 108.787 160.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.635 HG23 ' HB3' ' A' ' 57' ' ' CYS . 1.9 pp -110.0 133.68 54.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.875 1.065 . . . . 3.0499999999999998 113.875 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.662 HG22 ' H ' ' A' ' 73' ' ' VAL . 4.0 t -138.03 119.19 17.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.022 -1.844 . . . . 2.3300000000000001 106.022 154.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.75 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 20.9 ttt -114.36 135.34 54.19 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 120.33 -1.481 . . . . 2.23 111.926 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 1.049 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -126.57 118.43 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 N-CA-C 107.635 -1.246 . . . . 1.3300000000000001 107.635 157.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.569 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 60.2 -169.78 7.53 Favored Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.886 -1.15 . . . . 1.1000000000000001 110.481 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.83 37.96 0.31 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.926 -1.138 . . . . 3.0099999999999998 107.926 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.622 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 54.6 mmtt -107.89 -31.21 8.1 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.892 -1.049 . . . . 3.0600000000000001 108.646 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.661 ' C ' ' HD1' ' A' ' 70' ' ' TYR . 75.7 t 47.54 113.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 114.472 1.286 . . . . 2.0699999999999998 114.472 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.675 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -123.53 -170.11 2.06 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 122.615 1.197 . . . . 1.9399999999999999 112.967 -172.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.71 49.9 0.82 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 113.662 -1.608 . . . . 1.49 110.178 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.888 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -77.92 -0.41 27.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.361 1.077 . . . . 1.95 110.062 175.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.662 ' H ' HG22 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 64.33 -165.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 113.749 -1.569 . . . . 3.4399999999999999 111.65 168.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.995 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 64.4 p -138.58 -46.67 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 114.22 1.193 . . . . 2.9700000000000002 114.22 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.748 ' HD2' HE21 ' A' ' 77' ' ' GLN . 7.0 Cg_endo -88.29 78.58 1.33 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.895 1.73 . . . . 3.0899999999999999 113.787 -172.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.428 ' C ' HG21 ' A' ' 78' ' ' VAL . . . 77.28 -23.17 2.33 Favored Glycine 0 N--CA 1.461 0.335 0 C-N-CA 121.01 -0.614 . . . . 1.6399999999999999 113.078 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.748 HE21 ' HD2' ' A' ' 75' ' ' PRO . 32.7 mt-30 -75.28 -21.12 58.76 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.413 -1.699 . . . . 1.98 106.413 -174.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.557 HG23 ' HG3' ' A' ' 79' ' ' LYS . 4.0 m -45.09 -61.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 111.478 -2.601 . . . . 1.5700000000000001 112.162 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.557 ' HG3' HG23 ' A' ' 78' ' ' VAL . 43.3 mtmt -58.03 -32.03 67.57 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 122.039 0.923 . . . . 2.48 110.657 -166.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' CD ' ' HA ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -81.28 -50.84 9.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.53 -1.214 . . . . 2.8100000000000001 108.837 -177.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.888 ' CG2' ' HA ' ' A' ' 72' ' ' ASN . 28.8 mm -66.14 -5.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 113.549 -1.66 . . . . 1.6399999999999999 110.601 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 47.0 tp -54.22 -21.67 9.58 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.508 -0.745 . . . . 1.3600000000000001 110.143 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.84 -19.66 6.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.687 -0.688 . . . . 1.3600000000000001 111.352 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 6.6 tp10 -69.53 -51.34 36.54 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.44 1.096 . . . . 2.0899999999999999 110.241 173.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.675 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 11.4 m-30 . . . . . 0 N--CA 1.425 -1.693 0 CA-C-N 113.673 -1.603 . . . . 1.77 112.811 -166.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 1.05 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtm . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.757 -0.46 . . . . 14.24 109.757 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.95 113.01 26.79 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.258 -0.645 . . . . 10.970000000000001 109.258 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.707 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 17.4 Cg_exo -66.13 147.87 84.49 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.509 2.139 . . . . 9.9600000000000009 112.353 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.562 ' HB3' ' HA3' ' A' ' 44' ' ' GLY . 22.5 ttmm -50.37 -74.38 0.03 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.572 0.701 . . . . 9.3399999999999999 112.241 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.0 35.67 0.54 Allowed Glycine 0 C--N 1.31 -0.876 0 CA-C-N 114.637 -1.165 . . . . 4.1799999999999997 112.607 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 24.2 tptp -56.16 -59.44 4.92 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.817 -0.809 . . . . 4.9400000000000004 108.817 170.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.113 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -115.89 87.51 18.71 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.711 -1.132 . . . . 2.0 110.916 175.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.34 96.55 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.637 2.225 . . . . 1.1200000000000001 111.565 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 1.05 HD11 HG22 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -75.17 117.83 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.799 0.809 . . . . 1.97 110.289 -175.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 7.3 m -100.14 113.02 25.35 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.139 -1.391 . . . . 1.8500000000000001 110.528 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.64 HG13 HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -118.48 122.81 70.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.274 -0.875 . . . . 2.6800000000000002 110.328 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.727 ' SG ' HG22 ' A' ' 54' ' ' VAL . 33.7 t -66.47 122.82 18.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.279 0.561 . . . . 2.2400000000000002 111.284 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -122.69 23.87 9.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.428 -0.805 . . . . 5.4500000000000002 109.699 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.95 178.68 20.21 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.792 -0.718 . . . . 4.1399999999999997 112.778 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -65.36 -44.85 86.38 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.462 0.541 . . . . 6.2599999999999998 112.462 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 -55.05 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.271 0.558 . . . . 4.6399999999999997 111.851 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 79.4 m -64.69 -31.08 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.537 -0.756 . . . . 3.1499999999999999 111.541 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 75.6 t80 -58.35 -27.43 64.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.447 0.699 . . . . 4.6500000000000004 111.576 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.74 -20.82 26.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.058 -0.519 . . . . 4.0099999999999998 111.468 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -80.79 11.48 3.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.159 -0.338 . . . . 5.21 111.224 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.38 29.44 27.48 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.725 -0.75 . . . . 1.96 111.954 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.491 ' O ' HG11 ' A' ' 26' ' ' VAL . . . -71.93 -20.47 61.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.906 0.335 . . . . 1.9399999999999999 111.906 -168.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 26' ' ' VAL . 27.1 t70 -57.86 -45.34 86.42 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.845 -0.342 . . . . 2.4199999999999999 110.881 -176.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.516 ' HZ3' ' HB3' ' A' ' 24' ' ' LYS . 7.2 mtpm? -64.92 -42.52 94.64 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.609 . . . . 3.4100000000000001 111.134 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.83 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.9 m -68.91 -39.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.707 0.289 . . . . 2.75 111.228 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.872 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . 10.7 m -65.31 -33.35 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.817 -0.753 . . . . 2.1299999999999999 110.258 175.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.58 -39.33 87.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.253 0.549 . . . . 1.54 109.551 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 25' ' ' VAL . . . -55.08 -45.84 75.42 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.701 -1.136 . . . . 1.27 109.443 175.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.881 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 23.1 m-85 -52.15 -50.11 62.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 123.46 0.475 . . . . 2.5800000000000001 111.02 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -49.91 -50.83 44.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.53 0.681 . . . . 3.23 111.312 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.52 -30.22 37.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.296 -0.865 . . . . 2.23 111.39 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.881 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -68.01 -19.29 64.9 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.741 -0.663 . . . . 2.54 110.313 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.017 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -54.52 -56.48 18.42 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 106.153 -1.795 . . . . 2.5499999999999998 106.153 169.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.735 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 70.16 -21.86 0.17 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.775 -2.011 . . . . 4.8099999999999996 110.909 168.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 56.56 -176.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 112.508 -2.133 . . . . 4.1900000000000004 113.702 166.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.422 ' O ' HG22 ' A' ' 37' ' ' ILE . 12.9 t70 -158.68 -44.11 0.06 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.075 -1.42 . . . . 4.6200000000000001 107.748 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 36' ' ' ASP . 2.5 pt -168.3 -0.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 113.226 -1.806 . . . . 5.3700000000000001 111.416 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 176.77 -52.66 0.11 Allowed Glycine 0 CA--C 1.483 -1.923 0 N-CA-C 107.629 -2.188 . . . . 4.1299999999999999 107.629 -162.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.733 ' CG ' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -171.54 135.54 0.91 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.266 -1.967 . . . . 4.3099999999999996 109.732 175.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.733 HG12 ' CG ' ' A' ' 39' ' ' ASP . 7.1 p 39.06 -65.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 127.502 3.001 . . . . 2.96 114.955 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.8 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 45.0 m -150.82 -60.11 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.69 -1.595 . . . . 4.1799999999999997 110.833 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.839 ' HG2' ' HG3' ' A' ' 45' ' ' ARG . 1.1 Cg_endo -88.33 15.51 2.07 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 121.618 1.546 . . . . 4.3700000000000001 114.937 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 25.8 t70 83.38 -1.75 1.17 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.143 0.973 . . . . 4.2599999999999998 109.708 160.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.562 ' HA3' ' HB3' ' A' ' 4' ' ' LYS . . . 172.18 53.11 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.774 -1.203 . . . . 2.1299999999999999 113.566 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.839 ' HG3' ' HG2' ' A' ' 42' ' ' PRO . 20.0 mtt180 -72.26 -53.9 11.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.924 -0.769 . . . . 3.7799999999999998 108.924 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.017 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -128.08 120.3 27.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.552 1.167 . . . . 2.6099999999999999 113.768 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.707 ' HB3' ' HB2' ' A' ' 3' ' ' PRO . 41.9 p -114.68 106.73 14.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.818 -1.537 . . . . 2.2799999999999998 108.307 175.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 1.05 HG22 HD11 ' A' ' 9' ' ' ILE . 2.0 pp -72.91 121.06 22.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.378 -0.828 . . . . 3.5600000000000001 112.229 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.49 141.95 15.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 122.744 1.259 . . . . 3.3100000000000001 112.225 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 21.4 m -43.92 -46.24 8.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.614 2.079 . . . . 3.7000000000000002 116.614 174.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.44 -41.12 65.76 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.776 2.139 . . . . 4.7999999999999998 116.776 -147.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 12.7 tpt180 -63.39 -57.72 9.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.271 0.941 . . . . 6.9100000000000001 110.786 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.612 ' H ' ' HB3' ' A' ' 10' ' ' SER . 33.0 t -65.18 172.72 2.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.591 -1.64 . . . . 3.04 110.727 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.019 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 13.5 t 76.2 29.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 122.93 1.348 . . . . 4.6799999999999997 109.538 -160.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.2 61.65 0.31 Allowed Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 113.849 -1.523 . . . . 4.1900000000000004 112.555 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.97 54.98 32.38 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 119.892 -1.147 . . . . 4.8499999999999996 115.709 169.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.257 1.4 m -135.12 -32.49 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.202 1.501 . . . . 3.5600000000000001 109.704 -161.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.89 -25.27 1.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.921 1.823 . . . . 3.9100000000000001 115.921 -163.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.63 8.14 1.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.563 1.074 . . . . 5.7000000000000002 111.791 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.68 161.91 27.97 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.053 -1.092 . . . . 3.5800000000000001 108.053 162.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.33 119.96 6.27 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 120.704 1.287 . . . . 4.3600000000000003 109.309 166.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.47 132.74 56.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.429 0.529 . . . . 3.0499999999999998 112.429 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.668 HG21 ' H ' ' A' ' 73' ' ' VAL . 2.5 t -138.7 119.76 16.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.446 -1.687 . . . . 2.3300000000000001 106.446 154.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 20.8 ttt -112.42 136.27 52.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 120.369 -1.457 . . . . 2.23 110.0 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 1.113 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -125.26 117.15 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.413 -1.329 . . . . 1.3300000000000001 107.413 159.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 55.09 -162.3 4.72 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.146 -1.026 . . . . 1.1000000000000001 110.863 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -79.06 34.48 0.24 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.889 -0.782 . . . . 3.0099999999999998 108.889 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.666 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 70.9 mmtt -108.47 -22.18 12.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.279 -0.873 . . . . 3.0600000000000001 110.012 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 64' ' ' MET . 23.2 m 36.54 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 115.134 1.531 . . . . 2.0699999999999998 115.134 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -116.31 -178.33 3.39 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.979 1.371 . . . . 1.9399999999999999 113.598 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.05 48.67 0.91 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 113.381 -1.736 . . . . 1.49 109.603 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.892 ' HA ' HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -78.4 -0.89 30.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.902 0.858 . . . . 1.95 109.191 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.668 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 63.31 -168.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 113.909 -1.496 . . . . 3.4399999999999999 111.282 171.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.83 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 13.3 p -135.74 -46.36 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 113.946 1.091 . . . . 2.9700000000000002 113.946 -169.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.691 ' HD2' HE21 ' A' ' 77' ' ' GLN . 4.5 Cg_endo -88.73 85.45 0.58 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.185 1.923 . . . . 3.0899999999999999 113.224 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.32 -27.77 2.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.17 -0.538 . . . . 1.6399999999999999 112.774 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.875 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 36.7 mt-30 -77.31 -18.62 57.33 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.064 -1.458 . . . . 1.98 107.064 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -46.72 -58.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-N 112.444 -2.162 . . . . 1.5700000000000001 111.354 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.662 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.3 pttt -62.17 -38.06 87.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.426 0.631 . . . . 2.48 111.096 -166.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.875 ' HD2' ' HA ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.85 -34.05 15.42 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.074 0.464 . . . . 2.8100000000000001 110.873 -176.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 72' ' ' ASN . 47.9 mm -72.45 -10.79 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.909 -0.774 . . . . 1.6399999999999999 108.909 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.948 HD12 ' HB2' ' A' ' 85' ' ' TYR . 16.7 tp -57.84 -12.97 3.55 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.462 0.705 . . . . 1.3600000000000001 110.467 171.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -25.58 6.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.08 -0.648 . . . . 1.3600000000000001 110.076 163.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 5.7 mm-40 -65.49 -49.95 67.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.459 -0.791 . . . . 2.0899999999999999 110.97 169.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.948 ' HB2' HD12 ' A' ' 82' ' ' LEU . 12.6 m-30 . . . . . 0 N--CA 1.428 -1.556 0 CA-C-N 115.682 -0.69 . . . . 1.77 112.099 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 1.019 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 tpp . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.935 -0.394 . . . . 14.24 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.837 ' HB ' ' HD3' ' A' ' 3' ' ' PRO . 48.9 t -84.59 -56.39 0.41 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.529 -0.305 . . . . 10.970000000000001 110.591 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.837 ' HD3' ' HB ' ' A' ' 2' ' ' VAL . 10.4 Cg_exo -73.18 108.61 2.65 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.105 1.87 . . . . 9.9600000000000009 110.857 172.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.974 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 12.3 mptt -65.32 -53.62 41.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.575 -0.739 . . . . 9.3399999999999999 109.527 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.556 ' H ' ' HB2' ' A' ' 47' ' ' SER . . . -129.64 -137.19 4.2 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.765 -1.107 . . . . 4.1799999999999997 111.213 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -81.15 -47.51 13.37 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 122.636 0.375 . . . . 4.9400000000000004 111.928 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.802 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.0 m-85 -111.85 98.73 42.82 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 116.094 -0.503 . . . . 2.0 111.915 -172.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.931 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 80.0 Cg_exo -50.69 96.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.882 2.388 . . . . 1.1200000000000001 112.19 171.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.995 HD13 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.24 115.37 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.79 0.805 . . . . 1.97 110.112 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 14.0 m -92.61 127.34 38.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.194 -1.366 . . . . 1.8500000000000001 109.987 -176.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 t -114.25 126.47 71.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 2.6800000000000002 112.328 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.469 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 16.3 t -64.21 115.17 4.75 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.555 0.693 . . . . 2.2400000000000002 112.138 -175.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 84.6 mtp -129.26 24.6 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 5.4500000000000002 110.737 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.79 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . -65.57 176.73 14.11 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.381 -0.914 . . . . 4.1399999999999997 114.14 -167.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 t -66.17 -45.85 79.45 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.821 0.304 . . . . 6.2599999999999998 111.821 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 25.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.744 0.783 . . . . 4.6399999999999997 110.162 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 76.9 m -61.93 -35.73 79.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.312 -1.313 . . . . 3.1499999999999999 112.237 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.525 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 54.0 t80 -61.66 -31.74 71.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.008 0.432 . . . . 4.6500000000000004 111.024 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.0 t -71.98 -21.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 4.0099999999999998 110.319 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 27.4 mtpp -82.8 12.92 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.925 -0.579 . . . . 5.21 111.803 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.56 32.06 14.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.151 -1.023 . . . . 1.96 111.906 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.527 ' O ' HG12 ' A' ' 26' ' ' VAL . . . -70.86 -20.97 62.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.635 0.235 . . . . 1.9399999999999999 111.635 -170.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.606 ' O ' HG23 ' A' ' 26' ' ' VAL . 25.0 t70 -55.82 -49.58 72.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.953 0.406 . . . . 2.4199999999999999 110.144 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 2.5 mptp? -66.94 -39.62 87.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.561 -0.456 . . . . 3.4100000000000001 111.59 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.903 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 3.3 m -68.58 -41.09 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 120.888 -0.325 . . . . 2.75 110.843 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 23' ' ' ASP . 8.0 m -64.96 -34.08 68.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.831 -0.748 . . . . 2.1299999999999999 110.003 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.466 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 62.0 t-80 -59.42 -39.4 83.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.26 0.552 . . . . 1.54 109.805 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -54.71 -50.48 68.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.868 -1.06 . . . . 1.27 108.725 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.837 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.2 m-85 -50.57 -47.27 57.91 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 123.877 0.736 . . . . 2.5800000000000001 111.68 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 25.1 tptp -49.3 -56.32 9.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 3.23 111.213 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -83.35 -19.67 35.71 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.268 -0.878 . . . . 2.23 111.513 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.837 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.82 -22.1 65.17 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.876 -0.602 . . . . 2.54 110.684 177.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.677 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -50.1 -59.63 3.72 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.55 -1.648 . . . . 2.5499999999999998 106.55 167.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' C ' HG13 ' A' ' 35' ' ' ILE . 4.4 pttm 68.09 -27.34 0.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 112.412 -2.177 . . . . 4.8099999999999996 111.674 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.65 ' HA ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 55.55 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.24 -1.8 . . . . 4.1900000000000004 113.379 172.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.563 ' O ' HG22 ' A' ' 37' ' ' ILE . 14.9 t70 -155.14 -53.55 0.09 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.214 -1.402 . . . . 4.6200000000000001 107.214 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 36' ' ' ASP . 2.3 pt -174.43 19.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 112.734 -2.03 . . . . 5.3700000000000001 109.385 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.02 -70.81 0.05 OUTLIER Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 109.278 -1.529 . . . . 4.1299999999999999 109.278 -168.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.598 ' HA ' HD22 ' A' ' 33' ' ' LEU . 10.5 m-20 -165.27 119.82 1.28 Allowed 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 112.996 -1.602 . . . . 4.3099999999999996 109.293 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.976 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 7.5 p 56.11 -65.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 126.636 2.46 . . . . 2.96 114.259 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.917 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 64.8 m -164.19 -59.79 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.745 0 CA-C-N 113.236 -1.802 . . . . 4.1799999999999997 110.06 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.917 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 16.3 Cg_exo -71.3 8.51 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.715 0 N-CA-C 114.493 0.92 . . . . 4.3700000000000001 114.493 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 11.5 t70 86.56 -15.67 0.44 Allowed 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.613 -0.514 . . . . 4.2599999999999998 109.613 161.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . -170.23 47.13 0.2 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.068 -1.539 . . . . 2.1299999999999999 113.819 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.52 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -72.86 -32.44 65.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.94 0.876 . . . . 3.7799999999999998 109.382 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.976 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 49.9 m-85 -96.58 153.29 17.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.194 -1.366 . . . . 2.6099999999999999 112.386 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.974 ' HA ' ' HB2' ' A' ' 4' ' ' LYS . 31.2 t -152.8 66.72 0.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.556 -1.646 . . . . 2.2799999999999998 106.556 161.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.995 HG22 HD13 ' A' ' 9' ' ' ILE . 2.2 pp -60.09 114.67 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.475 -1.239 . . . . 3.5600000000000001 112.68 -168.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -161.15 144.53 12.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.746 1.26 . . . . 3.3100000000000001 112.738 168.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 m -42.76 -43.09 3.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.917 -1.947 . . . . 3.7000000000000002 115.022 167.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.7 mt -52.21 -41.87 63.06 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 116.058 1.874 . . . . 4.7999999999999998 116.058 -147.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.543 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 24.1 mmt85 -64.71 -56.97 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.556 1.17 . . . . 6.9100000000000001 110.261 174.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.657 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 35.9 t -66.31 167.05 11.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.714 -2.039 . . . . 3.04 112.617 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.79 HG13 ' HA2' ' A' ' 14' ' ' GLY . 15.7 t 70.44 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 123.053 1.406 . . . . 4.6799999999999997 109.411 -168.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.26 64.66 0.31 Allowed Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 113.626 -1.624 . . . . 4.1900000000000004 113.129 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.08 58.02 13.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 118.719 -1.705 . . . . 4.8499999999999996 114.941 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.279 1.8 m -132.2 -31.05 1.48 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.618 1.209 . . . . 3.5600000000000001 109.083 -162.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.734 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . . . -47.7 -27.06 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.554 1.687 . . . . 3.9100000000000001 115.554 -163.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.24 5.03 3.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.181 1.355 . . . . 5.7000000000000002 111.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.03 158.65 45.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.078 -1.082 . . . . 3.5800000000000001 108.078 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -76.61 121.69 6.09 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.494 1.212 . . . . 4.3600000000000003 109.319 163.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.428 HG22 ' S1 ' ' A' ' 86' ' ' FES . 13.3 tt -108.34 132.14 56.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.114 -0.635 . . . . 3.0499999999999998 112.188 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.771 HG21 ' H ' ' A' ' 73' ' ' VAL . 20.9 t -137.88 118.43 16.42 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 105.686 -1.968 . . . . 2.3300000000000001 105.686 158.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.685 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 17.1 ttt -116.87 137.83 51.94 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.442 -1.411 . . . . 2.23 110.648 -172.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.802 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -124.45 117.09 49.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 107.045 -1.465 . . . . 1.3300000000000001 107.045 155.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 51.47 -157.52 2.9 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.527 -0.629 . . . . 1.1000000000000001 111.527 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.14 39.94 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.66 -0.867 . . . . 3.0099999999999998 108.66 170.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.621 ' HB2' HG23 ' A' ' 65' ' ' VAL . 26.0 mmmt -108.33 -26.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.478 -0.783 . . . . 3.0600000000000001 109.221 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.633 HG13 ' HG3' ' A' ' 64' ' ' MET . 9.2 m 36.01 109.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 115.138 1.533 . . . . 2.0699999999999998 115.138 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.707 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.9 m-85 -118.86 -169.88 1.81 Allowed 'General case' 0 C--O 1.248 0.98 0 CA-C-O 122.86 1.314 . . . . 1.9399999999999999 113.003 -173.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.414 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -144.82 46.45 0.8 Allowed Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 113.55 -1.659 . . . . 1.49 109.955 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.9 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.78 -0.58 21.52 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.981 0.896 . . . . 1.95 110.049 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.771 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 63.22 -165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 114.12 -1.4 . . . . 3.4399999999999999 112.679 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.903 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.1 p -137.56 -45.13 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 113.604 0.965 . . . . 2.9700000000000002 113.604 -168.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.487 ' CD ' ' H ' ' A' ' 74' ' ' THR . 83.5 Cg_endo -88.68 77.56 1.34 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 121.845 1.697 . . . . 3.0899999999999999 113.705 -171.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.92 -24.26 2.87 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.171 -0.538 . . . . 1.6399999999999999 113.031 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.648 ' NE2' HG12 ' A' ' 73' ' ' VAL . 32.8 mt-30 -75.24 -20.9 58.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.565 -1.643 . . . . 1.98 106.565 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.673 ' HB ' HE21 ' A' ' 32' ' ' GLN . 2.7 m -43.58 -56.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 111.559 -2.564 . . . . 1.5700000000000001 112.025 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.742 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.2 mtmt -56.73 -42.13 78.71 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 122.181 0.991 . . . . 2.48 110.003 -167.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -42.43 13.94 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.34 -1.3 . . . . 2.8100000000000001 109.812 -172.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.9 HG22 ' HA ' ' A' ' 72' ' ' ASN . 41.3 mm -67.99 -13.78 17.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.694 -1.139 . . . . 1.6399999999999999 109.29 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.917 HD13 ' HB2' ' A' ' 85' ' ' TYR . 27.2 tp -59.56 -13.42 9.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.657 0.783 . . . . 1.3600000000000001 110.592 170.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.62 -26.27 8.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.255 -0.578 . . . . 1.3600000000000001 109.963 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.64 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 8.8 mm-40 -62.79 -51.99 64.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.0899999999999999 109.745 169.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.917 ' HB2' HD13 ' A' ' 82' ' ' LEU . 8.9 m-30 . . . . . 0 N--CA 1.424 -1.735 0 CA-C-N 114.812 -1.086 . . . . 1.77 112.259 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 0.734 ' S1 ' ' HA ' ' A' ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.067 -0.345 . . . . 14.24 110.067 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p -70.09 127.18 92.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.334 -0.394 . . . . 10.970000000000001 110.112 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.03 111.7 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.882 2.388 . . . . 9.9600000000000009 112.277 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.523 ' HB3' ' HE2' ' A' ' 6' ' ' LYS . 90.8 mttt -101.55 -89.43 0.36 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.833 -0.621 . . . . 9.3399999999999999 109.487 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.73 ' HA2' ' CZ ' ' A' ' 7' ' ' TYR . . . 85.62 36.07 10.98 Favored Glycine 0 CA--C 1.501 -0.826 0 C-N-CA 120.355 -0.926 . . . . 4.1799999999999997 112.738 172.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -147.68 45.93 1.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.618 1.199 . . . . 4.9400000000000004 110.739 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.752 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 7.3 m-85 -55.64 113.08 5.02 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.412 -1.722 . . . . 2.0 114.365 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.791 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 72.5 Cg_exo -56.07 90.96 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.1 2.533 . . . . 1.1200000000000001 111.919 166.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.766 HD12 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.87 119.12 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.675 0.75 . . . . 1.97 110.661 -177.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.711 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 2.6 m -100.46 114.44 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.606 -1.179 . . . . 1.8500000000000001 111.291 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.8 t -117.98 122.88 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 2.6800000000000002 110.85 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 25.1 t -67.61 121.2 15.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.28 -0.568 . . . . 2.2400000000000002 111.553 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.8 mtp -124.61 23.41 8.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.63 -0.714 . . . . 5.4500000000000002 109.584 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.67 179.61 12.47 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.178 -0.534 . . . . 4.1399999999999997 112.998 -174.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -64.25 -45.42 88.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.069 0.396 . . . . 6.2599999999999998 112.069 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.603 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -70.97 -56.41 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.078 0.466 . . . . 4.6399999999999997 112.178 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.4 m -66.28 -33.79 76.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.91 -0.587 . . . . 3.1499999999999999 111.993 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -60.6 -29.86 69.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.575 0.584 . . . . 4.6500000000000004 112.575 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 16' ' ' ALA . 18.2 m -69.43 -18.95 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.771 0.32 . . . . 4.0099999999999998 111.526 -171.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -80.57 12.88 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.541 -0.299 . . . . 5.21 110.923 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.25 29.04 26.19 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 121.114 -0.565 . . . . 1.96 111.98 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -72.1 -20.67 61.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.493 -0.353 . . . . 1.9399999999999999 110.862 -172.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 26' ' ' VAL . 24.8 t70 -53.99 -50.42 66.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 2.4199999999999999 110.759 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -66.87 -40.51 87.86 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.304 -0.559 . . . . 3.4100000000000001 111.152 -172.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.831 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 1.9 m -69.45 -42.71 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.451 -0.34 . . . . 2.75 110.655 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 23' ' ' ASP . 17.6 m -66.15 -29.0 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 119.522 -0.871 . . . . 2.1299999999999999 109.99 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -58.7 -41.2 85.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.137 0.494 . . . . 1.54 109.747 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.04 74.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.848 -1.069 . . . . 1.27 109.707 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -49.86 65.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.581 . . . . 2.5800000000000001 110.411 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -51.9 -50.13 61.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 3.23 111.547 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -79.96 -25.82 40.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.553 -0.749 . . . . 2.23 110.982 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.648 ' HG3' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -61.82 -34.84 76.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.411 -0.589 . . . . 2.54 109.411 175.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.76 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -45.29 -58.74 3.08 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 107.012 -1.477 . . . . 2.5499999999999998 107.012 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 66.04 -24.77 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.729 -2.032 . . . . 4.8099999999999996 112.093 171.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.726 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.95 -174.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.477 -1.692 . . . . 4.1900000000000004 113.762 168.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' O ' HG21 ' A' ' 37' ' ' ILE . 11.0 t70 -156.0 -48.51 0.08 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.077 -1.419 . . . . 4.6200000000000001 107.497 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.551 HG21 ' O ' ' A' ' 36' ' ' ASP . 1.4 pt -172.09 16.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-N 113.35 -1.75 . . . . 5.3700000000000001 110.751 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.38 -66.94 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.883 -1.287 . . . . 4.1299999999999999 109.883 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.739 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 18.8 m-20 -164.81 117.46 1.25 Allowed 'General case' 0 CA--C 1.484 -1.583 0 CA-C-N 113.268 -1.466 . . . . 4.3099999999999996 110.296 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.942 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.4 p 57.19 -64.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 126.882 2.613 . . . . 2.96 113.592 171.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.918 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 90.6 m -157.04 -60.45 0.02 OUTLIER Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 113.272 -1.785 . . . . 4.1799999999999997 110.867 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 13.8 Cg_exo -70.94 2.18 4.46 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 120.426 0.751 . . . . 4.3700000000000001 113.449 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.582 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 4.4 t70 82.55 4.29 1.08 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-O 123.404 1.574 . . . . 4.2599999999999998 107.687 167.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 168.47 63.29 0.03 OUTLIER Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 112.539 -2.119 . . . . 2.1299999999999999 110.225 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 18.7 tpp85 -93.12 -34.63 13.57 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.296 -1.742 . . . . 3.7799999999999998 106.296 166.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.942 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 25.1 m-85 -87.9 152.59 21.97 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 110.826 -2.897 . . . . 2.6099999999999999 110.567 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.791 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 54.1 m -153.55 68.67 0.79 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.618 -1.252 . . . . 2.2799999999999998 107.618 163.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.766 HG22 HD12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -69.9 122.62 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.299 -0.864 . . . . 3.5600000000000001 112.272 -168.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.711 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.0 p30 -156.24 139.11 15.28 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.345 1.069 . . . . 3.3100000000000001 111.219 164.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 19.9 p -43.61 -46.13 7.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.616 -1.629 . . . . 3.7000000000000002 115.206 169.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.91 -39.52 65.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.869 1.804 . . . . 4.7999999999999998 115.869 -151.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.1 -57.27 11.15 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.085 0.945 . . . . 6.9100000000000001 109.88 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.682 ' O ' HG23 ' A' ' 54' ' ' VAL . 34.3 t -65.6 167.44 8.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 3.04 109.731 173.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.182 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 1.9 m 72.34 26.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 125.398 1.479 . . . . 4.6799999999999997 110.129 -159.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.21 65.2 0.26 Allowed Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 113.665 -1.607 . . . . 4.1900000000000004 112.995 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 57.28 15.49 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 119.492 -1.337 . . . . 4.8499999999999996 115.235 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.911 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.293 1.8 m -134.48 -32.55 1.02 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.712 1.256 . . . . 3.5600000000000001 109.943 -162.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.65 2.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.282 1.956 . . . . 3.9100000000000001 116.282 -160.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 pp -74.37 5.16 4.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.425 1.466 . . . . 5.7000000000000002 112.101 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.46 159.46 45.71 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.264 -1.013 . . . . 3.5800000000000001 108.264 159.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.54 119.66 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 120.372 1.168 . . . . 4.3600000000000003 109.869 161.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.911 HG13 ' HB3' ' A' ' 57' ' ' CYS . 42.8 mm -110.98 134.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.609 0.226 . . . . 3.0499999999999998 111.609 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.52 123.0 30.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 107.503 -1.295 . . . . 2.3300000000000001 107.503 163.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.611 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 45.5 ttm -114.49 138.0 51.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.002 -1.686 . . . . 2.23 111.313 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -125.01 115.67 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.424 -1.324 . . . . 1.3300000000000001 107.424 158.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.524 ' CA ' ' HD2' ' A' ' 8' ' ' PRO . . . 46.37 -144.35 4.14 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-O 122.598 1.11 . . . . 1.1000000000000001 112.67 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -82.8 27.69 0.52 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 113.369 -1.415 . . . . 3.0099999999999998 109.462 176.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.774 ' HB2' HG21 ' A' ' 65' ' ' VAL . 14.3 mmmm -107.26 -24.19 11.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.875 -0.602 . . . . 3.0600000000000001 110.659 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.9 m 33.95 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.281 0.988 . . . . 2.0699999999999998 113.484 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.682 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -99.53 -168.83 1.66 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.469 1.604 . . . . 1.9399999999999999 114.247 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 73' ' ' VAL . . . -134.89 57.27 0.7 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.001 -1.909 . . . . 1.49 110.093 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.595 ' HA ' HG23 ' A' ' 81' ' ' ILE . 44.5 t-20 -86.37 39.64 0.84 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 123.17 1.462 . . . . 1.95 109.053 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.868 HG23 ' HB2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER 47.78 -161.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 112.684 -2.053 . . . . 3.4399999999999999 113.634 155.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.831 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.4 p -134.71 -45.58 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 113.016 0.747 . . . . 2.9700000000000002 113.016 173.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.698 ' HA ' HG11 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -75.1 -85.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 121.87 1.714 . . . . 3.0899999999999999 114.367 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.24 0.15 5.97 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.748 -0.739 . . . . 1.6399999999999999 112.106 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.868 ' HB2' HG23 ' A' ' 73' ' ' VAL . 9.9 mt-30 -81.26 -13.47 58.45 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 106.382 -1.711 . . . . 1.98 106.382 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.624 ' HB ' ' NE2' ' A' ' 32' ' ' GLN . 2.7 m -51.71 -46.92 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 111.988 -2.369 . . . . 1.5700000000000001 109.904 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.675 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 34.2 mttm -57.28 -44.23 83.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.123 -1.399 . . . . 2.48 109.353 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.697 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -77.85 -42.49 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.599 -1.637 . . . . 2.8100000000000001 109.755 -175.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.645 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 33.5 mm -68.4 -17.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.616 -0.72 . . . . 1.6399999999999999 110.191 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.675 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 9.6 tp -57.92 -38.32 75.66 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.545 -0.722 . . . . 1.3600000000000001 110.463 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -33.5 69.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.37 0.605 . . . . 1.3600000000000001 109.483 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.645 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 3.3 mm-40 -68.24 -30.84 69.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.964 -1.017 . . . . 2.0899999999999999 111.857 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.682 ' CE1' ' HD2' ' A' ' 70' ' ' TYR . 2.9 m-30 . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 118.801 -0.619 . . . . 1.77 111.318 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 1.182 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptp . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 121.604 0.716 . . . . 14.24 110.434 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 6.4 p -111.77 125.84 29.6 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.802 -0.635 . . . . 10.970000000000001 110.248 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 23.9 Cg_exo -63.9 97.38 0.23 Allowed 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.991 2.461 . . . . 9.9600000000000009 112.783 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.76 -95.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.79 -0.641 . . . . 9.3399999999999999 109.809 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.581 ' C ' ' HD2' ' A' ' 6' ' ' LYS . . . 93.21 167.48 38.61 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.617 -0.72 . . . . 4.1799999999999997 111.706 176.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.581 ' HD2' ' C ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER 36.14 46.57 0.39 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.98 0.912 . . . . 4.9400000000000004 112.804 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.628 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 11.2 m-85 -43.0 107.75 0.58 Allowed Pre-proline 0 N--CA 1.445 -0.713 0 C-N-CA 124.604 1.162 . . . . 2.0 112.807 175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HD2' ' CA ' ' A' ' 66' ' ' GLY . 75.1 Cg_exo -56.66 93.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.813 2.342 . . . . 1.1200000000000001 111.284 171.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.914 ' HB ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -81.3 121.89 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 121.858 0.837 . . . . 1.97 110.405 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.694 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.7 m -105.38 127.11 52.8 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.541 -1.209 . . . . 1.8500000000000001 111.203 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 50' ' ' THR . 4.1 t -117.91 123.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 2.6800000000000002 112.016 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 30.0 t -67.16 124.33 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.22 0.533 . . . . 2.2400000000000002 111.315 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.9 mmm -120.5 23.1 11.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.545 -0.752 . . . . 5.4500000000000002 109.278 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.55 177.89 25.03 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.608 -0.724 . . . . 4.1399999999999997 112.528 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 19' ' ' VAL . 17.3 m -67.45 -45.41 76.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.032 0.382 . . . . 6.2599999999999998 112.032 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 -56.01 7.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 4.6399999999999997 112.267 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.655 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 74.6 m -64.59 -32.91 74.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 3.1499999999999999 111.105 -173.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 68.2 t80 -60.52 -28.63 68.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.961 -0.563 . . . . 4.6500000000000004 111.774 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 15' ' ' THR . 60.9 t -68.87 -22.11 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.131 0.491 . . . . 4.0099999999999998 110.921 -173.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -81.94 13.34 3.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.208 -0.451 . . . . 5.21 111.329 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.463 ' O ' HG21 ' A' ' 25' ' ' VAL . . . 87.07 30.29 20.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.366 -0.921 . . . . 1.96 111.766 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . . . -70.68 -21.58 62.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.463 -0.199 . . . . 1.9399999999999999 110.463 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.03 -54.6 45.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.331 -0.395 . . . . 2.4199999999999999 110.208 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 3.4100000000000001 109.621 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.92 HG13 ' H ' ' A' ' 74' ' ' THR . 54.6 t -59.21 -57.65 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 115.649 -0.705 . . . . 2.75 109.587 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.33 -30.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 120.271 -0.571 . . . . 2.1299999999999999 109.647 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -59.26 -43.5 92.48 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.128 -0.487 . . . . 1.54 110.253 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.0 74.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.134 -0.939 . . . . 1.27 109.229 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.67 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -55.31 -53.36 57.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.065 -0.97 . . . . 2.5800000000000001 110.087 175.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -48.83 -47.48 42.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.321 -0.854 . . . . 3.23 110.757 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.41 -34.37 25.53 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.521 -0.763 . . . . 2.23 111.932 -174.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.721 ' NE2' ' HB2' ' A' ' 82' ' ' LEU . 1.9 pt20 -63.17 -25.73 68.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.249 -0.649 . . . . 2.54 109.249 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.74 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -57.72 -60.43 3.7 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.323 -1.362 . . . . 2.5499999999999998 107.323 173.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.646 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 68.01 -20.83 0.13 Allowed 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 125.503 1.752 . . . . 4.8099999999999996 110.578 172.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.74 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 58.18 126.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.709 -2.042 . . . . 4.1900000000000004 113.243 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.561 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 11.1 t70 -86.72 -45.94 10.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 112.284 -2.235 . . . . 4.6200000000000001 107.741 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.527 HG13 ' HB2' ' A' ' 43' ' ' ASP . 2.0 pt -168.4 -1.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 112.93 -1.941 . . . . 5.3700000000000001 110.923 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 35' ' ' ILE . . . 173.09 -32.74 0.11 Allowed Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 110.774 -0.93 . . . . 4.1299999999999999 110.774 -163.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.716 ' OD1' ' HB3' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -145.17 -162.92 1.6 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.095 -1.052 . . . . 4.3099999999999996 110.883 -169.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.667 ' HA ' HD22 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -64.61 -30.18 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-O 123.865 1.793 . . . . 2.96 107.531 177.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.72 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 65.4 m -168.45 -64.32 0.01 OUTLIER Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 110.026 -3.261 . . . . 4.1799999999999997 111.182 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.72 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 7.1 Cg_exo -73.81 -6.64 18.93 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 121.289 1.326 . . . . 4.3700000000000001 115.445 -164.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.606 ' H ' ' CB ' ' A' ' 39' ' ' ASP . 26.0 t70 74.59 16.04 3.24 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 122.759 1.266 . . . . 4.2599999999999998 107.586 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.55 66.91 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.41 -1.723 . . . . 2.1299999999999999 111.26 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.716 ' HB3' ' OD1' ' A' ' 39' ' ' ASP . 13.7 tpt180 -132.93 -55.72 0.93 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.885 -1.154 . . . . 3.7799999999999998 107.885 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.702 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.91 146.41 27.39 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.054 -1.43 . . . . 2.6099999999999999 110.364 176.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.421 ' H ' HG23 ' A' ' 9' ' ' ILE . 52.9 m -154.57 96.85 1.94 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.215 -0.661 . . . . 2.2799999999999998 109.215 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.658 HG21 HG22 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -87.11 137.3 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.071 0.767 . . . . 3.5600000000000001 113.071 -167.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.01 138.02 12.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.968 -1.014 . . . . 3.3100000000000001 110.787 158.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 56.5 m -45.9 -45.34 15.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.11 -1.405 . . . . 3.7000000000000002 114.323 165.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.69 -39.59 65.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.14 1.534 . . . . 4.7999999999999998 115.14 -154.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -62.36 -57.13 12.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.476 1.131 . . . . 6.9100000000000001 109.694 176.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.694 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 22.5 t -66.26 167.62 10.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.59 -2.095 . . . . 3.04 111.208 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.748 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 1.6 m 70.27 25.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 125.883 1.673 . . . . 4.6799999999999997 109.351 -160.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.29 65.77 0.25 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 113.479 -1.692 . . . . 4.1900000000000004 112.49 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.88 56.3 17.26 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 119.681 -1.247 . . . . 4.8499999999999996 115.801 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.597 ' HB2' HG13 ' A' ' 62' ' ' ILE . 1.9 m -136.17 -31.54 0.9 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.46 -0.941 . . . . 3.5600000000000001 108.46 -170.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.448 ' HB1' ' S1 ' ' A' ' 86' ' ' FES . . . -48.09 -25.94 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.883 1.809 . . . . 3.9100000000000001 115.883 -163.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.2 7.52 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.81 1.186 . . . . 5.7000000000000002 111.841 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.45 160.46 37.8 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.229 -1.026 . . . . 3.5800000000000001 108.229 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.93 119.33 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 120.742 1.301 . . . . 4.3600000000000003 108.822 165.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.597 HG13 ' HB2' ' A' ' 57' ' ' CYS . 49.2 mm -111.51 130.94 64.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 114.265 1.209 . . . . 3.0499999999999998 114.265 -172.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.2 122.19 6.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.3 -1.37 . . . . 2.3300000000000001 107.3 147.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.732 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 65.6 ttp -111.19 137.78 48.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.759 -1.213 . . . . 2.23 109.727 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.914 HG11 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.77 114.23 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 N-CA-C 107.015 -1.476 . . . . 1.3300000000000001 107.015 167.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 48.87 -152.88 2.55 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 122.342 0.968 . . . . 1.1000000000000001 111.869 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -78.6 37.26 0.28 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.882 -1.159 . . . . 3.0099999999999998 109.266 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.752 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 29.8 mmmt -113.68 -26.29 8.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.035 -0.529 . . . . 3.0600000000000001 111.532 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.574 ' C ' ' HD1' ' A' ' 70' ' ' TYR . 30.4 m 38.22 108.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 115.205 1.557 . . . . 2.0699999999999998 115.205 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.752 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 2.8 m-85 -122.42 -170.74 2.13 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.448 1.118 . . . . 1.9399999999999999 113.352 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.08 21.85 5.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 113.832 -1.531 . . . . 1.49 111.293 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.721 ' HB2' HG22 ' A' ' 81' ' ' ILE . 2.7 t30 -74.22 92.73 2.26 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.862 -0.422 . . . . 1.95 109.862 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -172.37 -167.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 122.882 0.473 . . . . 3.4399999999999999 111.429 177.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.92 ' H ' HG13 ' A' ' 25' ' ' VAL . 41.0 p 50.54 104.08 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 C-N-CA 125.204 1.402 . . . . 2.9700000000000002 112.266 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.727 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 73.6 Cg_exo -23.47 89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 1 C-N-CA 125.456 4.104 . . . . 3.0899999999999999 113.28 -174.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 80' ' ' LYS . . . 148.11 -61.23 0.44 Allowed Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.974 -1.012 . . . . 1.6399999999999999 112.572 -171.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.61 ' HG3' ' HG1' ' A' ' 74' ' ' THR . 5.0 mt-30 -76.26 -30.54 57.89 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.193 -1.41 . . . . 1.98 107.193 -166.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.507 HG13 ' CA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -48.24 -52.05 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 112.41 -2.177 . . . . 1.5700000000000001 111.132 -175.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.424 ' N ' HG22 ' A' ' 78' ' ' VAL . 36.6 mtmt -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.647 1.213 . . . . 2.48 108.523 -166.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -78.89 -42.16 27.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.173 -1.83 . . . . 2.8100000000000001 110.922 -173.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.721 HG22 ' HB2' ' A' ' 72' ' ' ASN . 33.2 mm -72.57 -15.34 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.157 0.503 . . . . 1.6399999999999999 109.926 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.721 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 48.0 tp -60.99 -38.58 86.51 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.069 -0.395 . . . . 1.3600000000000001 110.348 169.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -31.96 67.48 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 121.779 0.799 . . . . 1.3600000000000001 108.86 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -73.39 -31.62 63.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.753 -1.112 . . . . 2.0899999999999999 111.354 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.713 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 2.2 m-30 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 119.489 -0.291 . . . . 1.77 111.162 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 0.748 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 110.085 -0.339 . . . . 14.24 110.085 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.9 m -70.28 116.94 49.94 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.359 0.6 . . . . 10.970000000000001 112.09 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 1.5 Cg_endo -84.93 68.22 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.16 2.573 . . . . 9.9600000000000009 111.05 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.711 ' HG3' ' HB3' ' A' ' 47' ' ' SER . 38.2 tptt -50.2 -58.67 5.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.807 0.813 . . . . 9.3399999999999999 109.543 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.86 -156.97 7.09 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 109.045 -1.622 . . . . 4.1799999999999997 109.045 170.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 15.7 tppt? -66.68 -45.54 78.53 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 117.695 0.748 . . . . 4.9400000000000004 109.337 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.609 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 15.1 m-85 -129.59 80.58 71.53 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-O 120.934 0.397 . . . . 2.0 109.974 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' SER . 82.0 Cg_exo -50.54 107.25 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.115 2.543 . . . . 1.1200000000000001 112.09 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.964 HD13 HG23 ' A' ' 48' ' ' ILE . 13.1 pt -81.59 130.55 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 112.092 0.405 . . . . 1.97 112.092 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.5 p -94.32 132.06 39.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.178 -0.675 . . . . 1.8500000000000001 109.178 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.09 117.85 56.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.167 -0.47 . . . . 2.6800000000000002 110.63 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 1.002 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -69.96 121.85 18.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 2.2400000000000002 111.9 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.8 mmm -121.64 20.3 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.968 -1.123 . . . . 5.4500000000000002 107.968 163.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 179.32 31.15 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.557 -1.201 . . . . 4.1399999999999997 113.172 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 19' ' ' VAL . 8.1 m -68.93 -44.43 73.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.079 0.4 . . . . 6.2599999999999998 112.079 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -58.16 4.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.025 0.75 . . . . 4.6399999999999997 113.025 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 1.002 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 88.8 m -65.31 -33.91 77.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 3.1499999999999999 111.012 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -60.69 -31.68 70.93 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.904 0.383 . . . . 4.6500000000000004 111.086 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 15' ' ' THR . 57.5 t -72.54 -25.09 22.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.391 0.615 . . . . 4.0099999999999998 110.054 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -85.23 9.38 15.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.613 -0.722 . . . . 5.21 110.894 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.04 32.57 17.15 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.021 -1.085 . . . . 1.96 112.466 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -71.97 -20.81 61.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.849 0.315 . . . . 1.9399999999999999 111.849 -171.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.4 p-10 -62.48 -40.84 97.96 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.053 -0.659 . . . . 2.4199999999999999 109.74 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -66.78 -36.51 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.044 -0.724 . . . . 3.4100000000000001 109.044 176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.028 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 76.7 t -55.78 -54.78 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 CA-C-N 115.057 -0.974 . . . . 2.75 109.415 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 23' ' ' ASP . 15.3 m -63.16 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.115 -0.634 . . . . 2.1299999999999999 110.902 -174.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -60.66 -47.58 85.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.733 -0.787 . . . . 1.54 109.955 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.59 -46.24 80.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.236 -0.893 . . . . 1.27 108.613 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.84 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.0 t80 -54.49 -48.49 71.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 124.218 0.949 . . . . 2.5800000000000001 110.146 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -49.11 -54.93 13.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.717 -1.129 . . . . 3.23 111.297 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 -18.87 27.51 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.287 -0.87 . . . . 2.23 111.717 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.84 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.98 -21.17 65.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.573 -0.528 . . . . 2.54 109.573 173.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.797 HD23 ' HA ' ' A' ' 39' ' ' ASP . 1.2 tt -48.6 -59.88 3.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.291 -1.744 . . . . 2.5499999999999998 106.291 168.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.663 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 65.61 -25.45 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.241 2.213 . . . . 4.8099999999999996 112.186 171.183 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.795 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 57.78 -174.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 113.073 -1.876 . . . . 4.1900000000000004 113.74 166.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.569 ' O ' HG21 ' A' ' 37' ' ' ILE . 12.4 t70 -146.89 -53.2 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 106.166 -1.791 . . . . 4.6200000000000001 106.166 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.637 HG13 ' OD1' ' A' ' 43' ' ' ASP . 1.2 pt -171.63 21.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 113.612 -1.631 . . . . 5.3700000000000001 109.718 172.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.52 -67.07 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 109.464 -1.454 . . . . 4.1299999999999999 109.464 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.87 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 18.5 m-20 -170.39 116.72 0.51 Allowed 'General case' 0 CA--C 1.485 -1.525 0 CA-C-N 113.602 -1.299 . . . . 4.3099999999999996 110.156 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.943 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.8 p 58.0 -64.23 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 O-C-N 126.679 2.487 . . . . 2.96 113.057 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.612 ' OG1' ' HD3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -159.33 -56.15 0.02 OUTLIER Pre-proline 0 C--N 1.276 -2.621 0 CA-C-N 113.38 -1.736 . . . . 4.1799999999999997 111.966 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HD2' HG11 ' A' ' 40' ' ' VAL . 13.1 Cg_exo -72.11 -3.63 13.64 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 CA-C-N 119.48 0.85 . . . . 4.3700000000000001 112.81 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.841 ' HA ' ' H ' ' A' ' 39' ' ' ASP . 73.0 m-20 75.34 19.05 2.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 122.457 1.122 . . . . 4.2599999999999998 108.96 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 171.7 39.15 0.03 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 CA-C-N 112.508 -2.133 . . . . 2.1299999999999999 110.949 166.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 22.1 ttt180 -74.4 -34.64 63.33 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.533 -1.654 . . . . 3.7799999999999998 106.533 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.943 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 29.1 m-85 -88.82 149.75 23.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 112.241 -2.254 . . . . 2.6099999999999999 110.396 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.711 ' HB3' ' HG3' ' A' ' 4' ' ' LYS . 15.2 m -168.45 99.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.76 0.424 . . . . 2.2799999999999998 110.018 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.964 HG23 HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -66.31 136.7 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.919 1.081 . . . . 3.5600000000000001 113.919 -168.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -160.08 135.75 8.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.626 1.203 . . . . 3.3100000000000001 113.023 154.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -46.57 -41.53 14.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.026 1.73 . . . . 3.7000000000000002 114.61 160.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -50.87 -30.24 14.01 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.959 1.466 . . . . 4.7999999999999998 114.959 -158.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.546 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 8.1 mmt180 -54.91 -47.05 74.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.008 0.433 . . . . 6.9100000000000001 111.108 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.3 t -58.0 160.2 5.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.188 -0.915 . . . . 3.04 113.439 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 14.2 t 67.51 24.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.55 0 CA-C-O 123.139 1.447 . . . . 4.6799999999999997 108.353 -164.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.88 64.49 0.33 Allowed Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 113.349 -1.75 . . . . 4.1900000000000004 112.479 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.63 57.99 14.06 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 118.839 -1.648 . . . . 4.8499999999999996 115.08 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.864 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.253 5.6 m -132.27 -35.28 1.19 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 1.411 . . . . 3.5600000000000001 113.072 -162.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.72 -30.76 23.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.694 1.739 . . . . 3.9100000000000001 115.694 -164.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.0 mt -78.37 5.37 10.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.014 1.279 . . . . 5.7000000000000002 112.793 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 159.94 43.15 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 122.549 0.34 . . . . 3.5800000000000001 110.479 170.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.9 124.23 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.531 -1.373 . . . . 4.3600000000000003 108.531 153.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.864 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.5 mm -106.82 129.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.935 -1.106 . . . . 3.0499999999999998 113.054 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.532 HG12 ' HH ' ' A' ' 85' ' ' TYR . 39.4 t -140.25 119.37 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.054 -1.462 . . . . 2.3300000000000001 107.054 158.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.604 ' HG3' HG22 ' A' ' 69' ' ' VAL . 39.0 ttm -114.2 141.61 47.31 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.911 -1.118 . . . . 2.23 111.734 -170.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.892 HG22 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.06 112.85 40.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.286 -1.746 . . . . 1.3300000000000001 106.286 158.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 40.84 -141.82 0.9 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-O 122.507 1.06 . . . . 1.1000000000000001 113.363 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -79.38 28.57 0.24 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.324 -1.438 . . . . 3.0099999999999998 109.84 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.892 ' HB2' HG22 ' A' ' 65' ' ' VAL . 10.8 mmmm -100.59 -47.88 4.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.193 -0.669 . . . . 3.0600000000000001 109.193 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.604 HG22 ' HG3' ' A' ' 64' ' ' MET . 91.1 t 48.56 116.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 114.225 1.194 . . . . 2.0699999999999998 114.225 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 62.8 m-85 -138.4 -157.84 0.81 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.099 0.952 . . . . 1.9399999999999999 113.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -135.07 39.02 1.74 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.151 -1.386 . . . . 1.49 110.0 171.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.847 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 6.0 t-20 -58.42 110.5 0.98 Allowed 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.457 -0.942 . . . . 1.95 108.457 173.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.47 ' HB ' ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -100.91 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.247 -1.342 . . . . 3.4399999999999999 114.532 -157.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 1.028 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 2.2 t -143.09 -48.0 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 115.24 1.57 . . . . 2.9700000000000002 115.24 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.552 ' HD3' HG23 ' A' ' 74' ' ' THR . 2.3 Cg_endo -80.68 64.0 8.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.939 1.759 . . . . 3.0899999999999999 113.484 -168.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.547 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 75.8 -12.22 9.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.217 -0.516 . . . . 1.6399999999999999 112.976 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.676 ' HA ' ' CD ' ' A' ' 80' ' ' LYS . 30.0 mt-30 -75.11 -28.8 60.37 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 106.944 -1.502 . . . . 1.98 106.944 -174.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.589 ' HB ' HE21 ' A' ' 32' ' ' GLN . 0.0 OUTLIER -51.23 -55.08 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 112.04 -2.346 . . . . 1.5700000000000001 112.561 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.674 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 18.8 pttp -60.07 -25.67 65.57 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 121.884 0.85 . . . . 2.48 110.571 -168.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.676 ' CD ' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -80.21 -50.81 9.73 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.936 -1.029 . . . . 2.8100000000000001 109.082 178.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.769 ' HB ' HD21 ' A' ' 72' ' ' ASN . 30.0 mm -60.05 -16.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.186 -1.37 . . . . 1.6399999999999999 109.871 172.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.674 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 63.9 tp -61.36 -40.67 95.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.881 0.372 . . . . 1.3600000000000001 110.13 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.25 68.68 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.701 0.762 . . . . 1.3600000000000001 109.336 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 15.4 mt-10 -73.92 -24.4 59.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.479 -1.237 . . . . 2.0899999999999999 111.959 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.847 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.5 m-30 . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 118.485 -0.769 . . . . 1.77 112.34 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 0.702 ' S2 ' ' HB ' ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 26.0 mmt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.683 0.278 . . . . 14.24 110.253 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.13 79.19 51.93 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.482 -0.327 . . . . 10.970000000000001 110.388 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.23 116.75 3.69 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.705 2.27 . . . . 9.9600000000000009 111.542 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 39.0 mmtm -64.54 -49.48 71.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.635 -0.711 . . . . 9.3399999999999999 112.629 -175.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 47' ' ' SER . . . 99.62 32.98 5.49 Favored Glycine 0 CA--C 1.496 -1.121 0 C-N-CA 120.197 -1.001 . . . . 4.1799999999999997 111.883 172.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 16.7 tppt? -52.09 -52.88 48.54 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.947 -0.626 . . . . 4.9400000000000004 109.75 176.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.522 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 4.6 m-85 -107.6 93.99 11.16 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.831 -0.622 . . . . 2.0 110.776 172.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 38.5 Cg_exo -63.84 94.45 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.304 2.003 . . . . 1.1200000000000001 110.717 168.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.942 HG12 ' HA ' ' A' ' 48' ' ' ILE . 1.2 pt -79.08 172.47 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 112.182 0.438 . . . . 1.97 112.182 -168.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.898 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 95.0 p -146.63 117.91 7.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.631 -0.713 . . . . 1.8500000000000001 111.648 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.33 124.97 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.162 -0.926 . . . . 2.6800000000000002 110.296 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.665 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 31.8 t -66.19 120.37 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.486 0.66 . . . . 2.2400000000000002 110.954 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.2 mmt -122.57 23.11 9.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.184 -1.043 . . . . 5.4500000000000002 108.184 170.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.71 179.47 17.16 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.924 -1.035 . . . . 4.1399999999999997 113.314 -173.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.0 t -65.89 -45.56 81.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.106 0.41 . . . . 6.2599999999999998 112.106 -175.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.87 -56.98 4.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.454 0.538 . . . . 4.6399999999999997 112.454 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.665 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 71.7 m -65.72 -34.16 77.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.618 -0.719 . . . . 3.1499999999999999 111.93 -170.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.29 -27.69 68.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.119 0.568 . . . . 4.6500000000000004 112.076 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 15' ' ' THR . 86.8 t -67.71 -21.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 122.78 0.432 . . . . 4.0099999999999998 111.711 -168.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -80.99 12.15 3.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.949 -0.47 . . . . 5.21 111.806 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.09 28.48 30.89 Favored Glycine 0 C--O 1.24 0.497 0 C-N-CA 120.986 -0.626 . . . . 1.96 111.552 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -72.39 -21.74 61.23 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.105 -0.548 . . . . 1.9399999999999999 111.548 -168.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.511 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 t70 -55.63 -48.1 75.51 Favored 'General case' 0 C--O 1.211 -0.937 0 C-N-CA 120.393 -0.523 . . . . 2.4199999999999999 111.057 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -67.35 -36.17 80.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.822 -0.751 . . . . 3.4100000000000001 111.459 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.615 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.97 -44.84 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 121.118 -0.233 . . . . 2.75 110.647 176.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 23' ' ' ASP . 17.9 m -68.59 -19.06 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.975 -0.69 . . . . 2.1299999999999999 109.965 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 53.9 t-80 -59.64 -42.54 92.99 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.588 0.709 . . . . 1.54 109.158 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.577 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -51.97 -46.35 64.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.085 -1.416 . . . . 1.27 109.541 173.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.845 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 1.4 t80 -57.38 -48.26 79.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.974 -0.557 . . . . 2.5800000000000001 110.549 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 27' ' ' HIS . 60.8 mttp -47.04 -51.17 18.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.319 -0.855 . . . . 3.23 110.884 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.13 -19.97 24.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.078 -0.964 . . . . 2.23 111.367 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.845 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.33 -19.42 65.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.531 -0.544 . . . . 2.54 109.531 176.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.071 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -49.39 -59.52 3.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 106.658 -1.608 . . . . 2.5499999999999998 106.658 168.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.19 -19.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 126.42 2.325 . . . . 4.8099999999999996 113.387 169.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.663 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 50.93 -171.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 126.138 1.775 . . . . 4.1900000000000004 114.132 166.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 37' ' ' ILE . 13.9 t70 -157.31 -50.52 0.07 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.623 -1.626 . . . . 4.6200000000000001 107.238 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.9 pt -168.64 6.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 113.103 -1.862 . . . . 5.3700000000000001 110.843 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.18 -58.7 0.03 OUTLIER Glycine 0 CA--C 1.482 -1.997 0 N-CA-C 109.653 -1.379 . . . . 4.1299999999999999 109.653 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.623 ' HB3' ' HA2' ' A' ' 44' ' ' GLY . 29.9 t70 -178.26 121.01 0.1 Allowed 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 113.244 -1.478 . . . . 4.3099999999999996 111.664 -177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 1.069 HG12 ' HD2' ' A' ' 42' ' ' PRO . 7.3 p 55.33 -66.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 127.27 2.856 . . . . 2.96 113.454 173.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.607 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 38.5 m -158.22 -58.54 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.713 0 CA-C-N 113.731 -1.577 . . . . 4.1799999999999997 110.341 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 1.069 ' HD2' HG12 ' A' ' 40' ' ' VAL . 59.3 Cg_endo -74.06 7.55 2.44 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 120.418 0.746 . . . . 4.3700000000000001 113.962 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.533 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 13.7 t70 81.55 6.0 1.23 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.817 1.294 . . . . 4.2599999999999998 108.651 164.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 39' ' ' ASP . . . 165.93 67.8 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.639 0 CA-C-N 114.05 -1.432 . . . . 2.1299999999999999 112.447 172.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.641 ' HD3' ' HG3' ' A' ' 42' ' ' PRO . 16.8 tpt180 -85.09 -64.36 1.17 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.827 -1.175 . . . . 3.7799999999999998 107.827 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.071 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -114.91 124.2 51.1 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.336 -0.847 . . . . 2.6099999999999999 112.988 -174.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.578 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 27.4 t -102.86 100.59 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.652 -0.704 . . . . 2.2799999999999998 109.274 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.942 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.5 pp -65.12 118.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 113.072 0.768 . . . . 3.5600000000000001 113.072 -171.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.898 ' O ' ' HA ' ' A' ' 10' ' ' SER . 9.2 t70 -159.49 140.25 12.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.194 0.997 . . . . 3.3100000000000001 112.605 162.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -45.61 -46.67 14.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.65 1.722 . . . . 3.7000000000000002 115.65 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -52.6 -40.73 62.98 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 116.644 2.09 . . . . 4.7999999999999998 116.644 -148.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.703 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 17.4 mmm180 -63.07 -57.83 9.3 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.096 0.951 . . . . 6.9100000000000001 110.463 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.863 ' H ' ' HB2' ' A' ' 10' ' ' SER . 33.9 t -65.56 167.11 9.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.41 -1.723 . . . . 3.04 111.12 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.139 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 11.6 t 71.31 26.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 123.055 1.407 . . . . 4.6799999999999997 108.501 -161.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.42 64.27 0.34 Allowed Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 113.351 -1.749 . . . . 4.1900000000000004 113.708 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.89 58.31 12.51 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 118.933 -1.603 . . . . 4.8499999999999996 115.03 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.286 1.7 m -132.95 -33.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.455 1.128 . . . . 3.5600000000000001 109.262 -161.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.92 -28.54 6.84 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.685 1.735 . . . . 3.9100000000000001 115.685 -163.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.97 6.61 3.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.783 1.174 . . . . 5.7000000000000002 112.161 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.17 160.66 38.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.876 -1.157 . . . . 3.5800000000000001 107.876 159.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.58 118.23 5.25 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-N 120.849 1.339 . . . . 4.3600000000000003 108.857 163.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.739 HG22 ' S2 ' ' A' ' 86' ' ' FES . 7.3 tp -111.49 129.88 66.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 112.85 0.685 . . . . 3.0499999999999998 112.85 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 73' ' ' VAL . 86.9 t -141.49 119.53 9.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 107.255 -1.387 . . . . 2.3300000000000001 107.255 153.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.646 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 38.7 ttm -110.14 135.52 50.8 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 117.779 -1.568 . . . . 2.23 110.217 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.835 HG22 ' HB2' ' A' ' 68' ' ' LYS . 2.5 m -123.91 115.92 46.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.495 -1.669 . . . . 1.3300000000000001 106.495 168.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 49.07 -153.74 2.37 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-O 122.281 0.934 . . . . 1.1000000000000001 112.368 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.2 35.62 0.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.343 -0.928 . . . . 3.0099999999999998 108.583 172.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.835 ' HB2' HG22 ' A' ' 65' ' ' VAL . 28.5 mmmt -105.52 -27.46 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.125 -0.943 . . . . 3.0600000000000001 109.776 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.498 HG11 ' HG3' ' A' ' 64' ' ' MET . 12.3 m 35.61 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 124.459 1.099 . . . . 2.0699999999999998 113.591 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.771 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 5.0 m-30 -107.89 -163.48 0.9 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-O 122.306 1.051 . . . . 1.9399999999999999 113.345 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -145.06 50.28 0.65 Allowed Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 114.468 -1.242 . . . . 1.49 110.654 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.83 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -71.62 1.58 6.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.803 0.811 . . . . 1.95 109.056 173.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER 46.0 -149.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 113.749 -1.568 . . . . 3.4399999999999999 113.958 167.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.615 ' OG1' ' HB ' ' A' ' 25' ' ' VAL . 12.8 t -148.52 -40.46 0.01 OUTLIER Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.903 -0.59 . . . . 2.9700000000000002 112.528 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.58 ' CD ' ' H ' ' A' ' 74' ' ' THR . 4.5 Cg_endo -86.04 70.98 4.41 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.881 1.721 . . . . 3.0899999999999999 113.222 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.14 -38.16 3.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.551 -0.833 . . . . 1.6399999999999999 113.301 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.569 ' HB2' HG21 ' A' ' 73' ' ' VAL . 29.3 mt-30 -71.05 -10.3 59.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.64 1.21 . . . . 1.98 108.364 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 2.2 t -42.36 -64.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 112.085 -2.325 . . . . 1.5700000000000001 112.799 174.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.703 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 47.8 mtmt -60.42 -25.55 66.03 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.976 0.893 . . . . 2.48 110.785 -167.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 2.6 mptp? -77.08 -53.87 7.24 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.596 -1.183 . . . . 2.8100000000000001 109.921 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.821 ' HB ' ' HA ' ' A' ' 72' ' ' ASN . 18.9 mm -62.73 -14.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.001 -1.0 . . . . 1.6399999999999999 110.1 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.703 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.6 tp -57.22 -42.81 82.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.969 -0.457 . . . . 1.3600000000000001 110.257 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.47 -33.55 69.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.588 0.709 . . . . 1.3600000000000001 109.422 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 81' ' ' ILE . 7.4 mt-10 -73.23 -21.05 60.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.906 -1.043 . . . . 2.0899999999999999 112.693 174.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.83 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.9 m-30 . . . . . 0 N--CA 1.433 -1.302 0 CA-C-O 118.111 -0.947 . . . . 1.77 111.854 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 1.139 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptp . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.686 0.279 . . . . 14.24 110.806 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 81.8 t -124.35 101.45 34.38 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-O 120.975 0.417 . . . . 10.970000000000001 111.27 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -87.43 -168.85 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.067 2.511 . . . . 9.9600000000000009 111.234 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 15.9 mmtp -84.87 -63.76 1.28 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.32 -0.552 . . . . 9.3399999999999999 111.556 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.43 35.83 1.7 Allowed Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 120.591 -0.814 . . . . 4.1799999999999997 113.753 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.626 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 2.8 tppp? -64.67 -49.06 72.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.527 -0.546 . . . . 4.9400000000000004 109.527 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.044 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.2 m-85 -109.02 85.24 3.1 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.106 -0.497 . . . . 2.0 111.27 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 87.2 Cg_exo -52.55 97.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.085 2.523 . . . . 1.1200000000000001 112.327 169.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -86.77 129.27 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 112.703 0.631 . . . . 1.97 112.703 -172.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.633 ' CB ' ' HB2' ' A' ' 52' ' ' ARG . 59.9 p -91.28 135.44 33.8 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.581 -0.526 . . . . 1.8500000000000001 109.581 174.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -116.01 121.73 68.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.032 -0.531 . . . . 2.6800000000000002 110.421 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.826 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 22.1 t -67.17 120.01 13.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.066 0.765 . . . . 2.2400000000000002 113.066 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.1 mmt -123.96 22.56 8.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.462 -1.245 . . . . 5.4500000000000002 107.858 160.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.511 ' HA3' ' S1 ' ' A' ' 86' ' ' FES . . . -68.28 178.58 22.1 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.892 -1.049 . . . . 4.1399999999999997 113.744 -171.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -67.95 -44.36 76.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.29 0.478 . . . . 6.2599999999999998 112.29 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.4 -58.18 3.6 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 112.607 0.595 . . . . 4.6399999999999997 112.607 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.826 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.7 m -65.29 -35.28 80.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 3.1499999999999999 111.317 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.85 -30.83 69.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 4.6500000000000004 112.317 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.83 -25.11 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.033 0.444 . . . . 4.0099999999999998 110.896 -170.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.43 8.86 17.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.377 -0.374 . . . . 5.21 111.206 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.57 44.8 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.165 -0.774 . . . . 1.96 111.165 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' O ' HG11 ' A' ' 26' ' ' VAL . . . -73.52 -20.61 60.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.353 -0.424 . . . . 1.9399999999999999 110.946 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.812 ' O ' HG22 ' A' ' 26' ' ' VAL . 8.7 p-10 -62.86 -38.62 91.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 2.4199999999999999 110.717 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -68.56 -36.37 78.69 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 121.451 -0.78 . . . . 3.4100000000000001 110.195 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.632 HG11 ' H ' ' A' ' 76' ' ' GLY . 2.5 t -72.3 -28.61 29.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.147 -0.621 . . . . 2.75 111.685 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 23' ' ' ASP . 3.6 m -61.83 -37.49 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.949 -1.13 . . . . 2.1299999999999999 107.949 172.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -60.09 -41.16 91.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.055 -0.52 . . . . 1.54 109.873 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 25' ' ' VAL . . . -53.65 -44.87 69.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.295 -0.866 . . . . 1.27 109.295 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.671 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 8.2 t80 -48.82 -61.52 2.0 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 123.75 0.657 . . . . 2.5800000000000001 109.781 172.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 97.9 mttt -45.43 -45.41 12.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.754 -1.112 . . . . 3.23 111.7 -176.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -77.85 -43.28 30.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.717 -0.674 . . . . 2.23 111.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.746 ' NE2' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -63.08 -24.69 68.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.879 -0.415 . . . . 2.54 109.879 177.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.76 HD23 HG22 ' A' ' 35' ' ' ILE . 10.1 tp -63.24 -55.0 28.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.136 -1.061 . . . . 2.5499999999999998 108.136 173.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' C ' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER 68.73 -14.29 0.29 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.547 1.155 . . . . 4.8099999999999996 109.465 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.76 HG22 HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER 62.38 -10.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 127.066 2.146 . . . . 4.1900000000000004 113.366 175.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 34' ' ' LYS . 16.2 t70 68.24 -62.14 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.17 0.988 . . . . 4.6200000000000001 110.436 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' ILE . 2.4 pt -166.68 4.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.178 -1.374 . . . . 5.3700000000000001 110.378 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' C ' HG23 ' A' ' 35' ' ' ILE . . . -178.79 -38.75 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.457 -1.354 . . . . 4.1299999999999999 113.884 -164.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.859 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 14.9 t70 -162.44 179.03 8.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.496 0.554 . . . . 4.3099999999999996 112.496 -155.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 46' ' ' PHE . 1.9 t -24.82 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 125.57 1.794 . . . . 2.96 111.868 174.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 6.8 m -175.42 -55.01 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 111.033 -2.803 . . . . 4.1799999999999997 108.593 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HD2' ' OD2' ' A' ' 39' ' ' ASP . 5.1 Cg_exo -81.12 -0.08 10.33 Favored 'Trans proline' 0 N--CA 1.433 -2.081 0 N-CA-C 116.381 1.646 . . . . 4.3700000000000001 116.381 -173.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.706 ' HA ' ' HB3' ' A' ' 39' ' ' ASP . 32.3 t70 77.4 16.78 1.57 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.461 -1.311 . . . . 4.2599999999999998 107.461 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.54 71.91 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.427 -1.26 . . . . 2.1299999999999999 112.805 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.555 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 12.3 tpt180 -142.18 -60.89 0.45 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.34 -0.93 . . . . 3.7799999999999998 109.488 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.027 ' HB3' HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -102.53 157.75 16.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.551 -1.204 . . . . 2.6099999999999999 111.684 -173.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.481 ' H ' HG21 ' A' ' 9' ' ' ILE . 53.7 m -165.15 113.44 1.02 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.039 -1.097 . . . . 2.2799999999999998 108.039 167.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 44.3 pt -92.78 154.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 113.859 1.059 . . . . 3.5600000000000001 113.859 -162.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.569 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.1 p-10 -161.52 137.8 8.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.822 -1.081 . . . . 3.3100000000000001 111.157 162.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -47.14 -42.29 19.18 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.54 1.311 . . . . 3.7000000000000002 114.54 163.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 51' ' ' LEU . 3.0 mm? -51.79 -31.13 25.9 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.102 1.149 . . . . 4.7999999999999998 114.102 -161.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.633 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 16.8 mmt180 -54.69 -47.51 73.57 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.817 0.341 . . . . 6.9100000000000001 110.822 176.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.661 ' O ' HG12 ' A' ' 54' ' ' VAL . 50.0 t -58.45 158.1 7.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.561 0.744 . . . . 3.04 112.132 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER 66.43 22.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 123.221 1.486 . . . . 4.6799999999999997 108.723 -160.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.92 67.87 0.27 Allowed Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 112.606 -2.088 . . . . 4.1900000000000004 112.165 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.95 57.05 11.55 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.05 -1.548 . . . . 4.8499999999999996 115.177 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.541 ' HB3' HD11 ' A' ' 62' ' ' ILE . 9.5 m -133.06 -37.73 0.98 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 118.272 1.036 . . . . 3.5600000000000001 112.816 -171.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.58 -34.57 18.13 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.691 2.108 . . . . 3.9100000000000001 116.691 -150.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.47 2.43 21.99 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.615 1.552 . . . . 5.7000000000000002 113.206 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.5 160.39 48.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 C-N-CA 123.373 0.669 . . . . 3.5800000000000001 109.998 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.583 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 Cg_endo -78.97 125.08 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.722 0.948 . . . . 4.3600000000000003 109.967 156.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.838 ' HB ' ' S2 ' ' A' ' 86' ' ' FES . 1.5 mp -107.81 134.2 50.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.458 0.54 . . . . 3.0499999999999998 112.458 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.765 HG11 ' HA2' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -138.27 126.18 29.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.956 0 N-CA-C 107.251 -1.389 . . . . 2.3300000000000001 107.251 160.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.689 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 48.1 ttm -112.31 144.48 41.66 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.742 -1.224 . . . . 2.23 109.618 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 1.044 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -122.26 117.12 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.526 -1.287 . . . . 1.3300000000000001 107.526 154.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 45.98 -147.9 2.28 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-O 122.369 0.983 . . . . 1.1000000000000001 111.792 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.39 28.38 0.25 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.032 -1.084 . . . . 3.0099999999999998 108.986 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.727 ' HB2' HG22 ' A' ' 65' ' ' VAL . 42.6 mmtt -107.79 -32.87 7.44 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.512 -0.551 . . . . 3.0600000000000001 109.512 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.69 ' C ' ' HD1' ' A' ' 70' ' ' TYR . 96.9 t 44.12 110.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 115.271 1.582 . . . . 2.0699999999999998 115.271 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.737 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.5 m-85 -130.37 -155.08 0.67 Allowed 'General case' 0 C--O 1.249 1.056 0 CA-C-O 122.682 1.23 . . . . 1.9399999999999999 112.968 -173.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.765 ' HA2' HG11 ' A' ' 63' ' ' VAL . . . -151.95 46.47 0.59 Allowed Glycine 0 C--O 1.218 -0.866 0 CA-C-N 114.279 -1.328 . . . . 1.49 111.878 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.763 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -96.07 1.18 52.35 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.146 0.473 . . . . 1.95 112.237 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.702 HG22 ' HB ' ' A' ' 63' ' ' VAL . 2.6 m -119.37 17.88 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 114.786 1.402 . . . . 3.4399999999999999 114.786 -166.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.815 ' OG1' ' HD2' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -151.61 175.43 2.89 Favored Pre-proline 0 CA--C 1.563 1.461 0 O-C-N 121.342 -0.849 . . . . 2.9700000000000002 110.743 -173.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.815 ' HD2' ' OG1' ' A' ' 74' ' ' THR . 65.0 Cg_exo -14.72 94.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.956 1 C-N-CA 126.476 4.784 . . . . 3.0899999999999999 117.763 -166.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.632 ' H ' HG11 ' A' ' 25' ' ' VAL . . . 74.81 -29.96 1.07 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.871 -0.604 . . . . 1.6399999999999999 114.237 165.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.83 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 11.7 pt20 -78.38 -15.34 58.79 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.344 -1.354 . . . . 1.98 107.344 -165.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 14.0 m -46.34 -58.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-N 113.135 -1.848 . . . . 1.5700000000000001 111.248 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.746 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 28.7 mtmt -57.85 -42.88 85.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.584 1.183 . . . . 2.48 109.44 -167.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.83 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -78.5 -49.47 13.34 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 112.937 -1.938 . . . . 2.8100000000000001 109.854 -172.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.805 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 47.2 mm -68.64 -10.89 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 113.696 -1.593 . . . . 1.6399999999999999 109.975 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 52.1 tp -64.17 -36.08 82.89 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.181 -0.949 . . . . 1.3600000000000001 110.315 167.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.14 67.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.814 -0.81 . . . . 1.3600000000000001 108.814 171.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.805 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 25.4 mm-40 -69.94 -37.59 75.9 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.926 -1.034 . . . . 2.0899999999999999 111.066 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.737 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.428 -1.544 0 CA-C-O 119.163 -0.446 . . . . 1.77 111.8 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 0.838 ' S2 ' ' HB ' ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.817 -0.438 . . . . 14.24 109.817 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.19 120.13 9.56 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 120.995 0.426 . . . . 10.970000000000001 111.22 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.4 71.76 4.45 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.314 2.676 . . . . 9.9600000000000009 111.941 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -67.24 -40.09 86.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.21 0.528 . . . . 9.3399999999999999 111.206 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.803 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . 153.34 -18.58 0.7 Allowed Glycine 0 C--O 1.212 -1.224 0 C-N-CA 119.512 -1.328 . . . . 4.1799999999999997 115.731 167.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.22 45.73 0.99 Allowed 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 114.378 1.251 . . . . 4.9400000000000004 114.378 -164.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.734 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -50.55 110.94 1.9 Allowed Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 113.83 1.048 . . . . 2.0 113.83 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 88.4 Cg_exo -56.29 99.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.473 0.285 0 C-N-CA 123.191 2.594 . . . . 1.1200000000000001 111.777 169.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.844 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -85.52 122.56 38.52 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.875 0.695 . . . . 1.97 112.875 -175.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 48.5 m -92.93 129.17 38.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.572 -0.74 . . . . 1.8500000000000001 110.484 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 128.41 72.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.652 0.982 . . . . 2.6800000000000002 113.652 -170.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.6 t -63.42 114.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.314 0.578 . . . . 2.2400000000000002 111.045 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.6 mtm -130.05 22.72 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 5.4500000000000002 110.449 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.05 175.64 23.63 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.2 -1.0 . . . . 4.1399999999999997 113.818 -170.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 p -67.51 -46.19 73.61 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.271 0.471 . . . . 6.2599999999999998 112.271 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' O ' HG11 ' A' ' 19' ' ' VAL . . . -69.43 -52.88 22.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 4.6399999999999997 111.083 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -64.09 -39.74 94.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.804 -0.634 . . . . 3.1499999999999999 111.678 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 25.6 t80 -65.02 -33.42 75.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.628 0.603 . . . . 4.6500000000000004 112.628 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.528 HG11 ' O ' ' A' ' 16' ' ' ALA . 7.1 p -71.75 -24.04 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.942 0.349 . . . . 4.0099999999999998 111.942 -166.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 31.2 mmtp -84.2 14.9 3.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.148 0.499 . . . . 5.21 111.57 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.99 29.26 20.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.966 -0.635 . . . . 1.96 112.195 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' O ' HG21 ' A' ' 25' ' ' VAL . . . -71.76 -19.51 62.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.485 -0.561 . . . . 1.9399999999999999 109.485 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 14.1 t70 -53.32 -51.76 61.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.396 -0.82 . . . . 2.4199999999999999 110.605 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -65.83 -38.25 88.4 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.077 -0.649 . . . . 3.4100000000000001 110.925 -175.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.074 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.67 -39.88 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 116.408 -0.36 . . . . 2.75 111.254 -179.073 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.736 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 13.6 p -67.26 -29.82 47.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.595 -0.842 . . . . 2.1299999999999999 108.92 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.504 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 66.7 t-80 -60.65 -37.85 82.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 1.54 109.897 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.76 76.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.454 -0.943 . . . . 1.27 108.454 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.736 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 36.5 t80 -51.41 -52.67 43.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.183 -0.917 . . . . 2.5800000000000001 111.186 173.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 16.9 tppt? -45.43 -47.76 13.77 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.71 -1.132 . . . . 3.23 111.171 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.59 -29.58 36.91 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.382 -0.826 . . . . 2.23 111.024 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.828 ' NE2' ' HA ' ' A' ' 79' ' ' LYS . 8.5 mm100 -59.18 -29.39 67.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.278 -0.874 . . . . 2.54 110.988 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.047 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 2.3 tt -53.16 -54.73 31.62 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.377 -0.971 . . . . 2.5499999999999998 108.377 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.843 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.1 -17.15 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.32 -2.218 . . . . 4.8099999999999996 113.241 174.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.716 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 52.62 -161.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.215 -1.357 . . . . 4.1900000000000004 113.307 167.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.877 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 17.9 t70 -157.13 -54.99 0.08 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.945 -1.872 . . . . 4.6200000000000001 105.945 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.0 pt -177.54 21.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 111.808 -2.451 . . . . 5.3700000000000001 107.443 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.97 -70.11 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 108.953 -1.659 . . . . 4.1299999999999999 108.953 -166.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.584 ' HA ' HD22 ' A' ' 33' ' ' LEU . 17.9 m-20 -178.46 125.45 0.11 Allowed 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.33 -1.435 . . . . 4.3099999999999996 110.038 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.962 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 2.6 p 57.81 -11.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 115.746 1.758 . . . . 2.96 115.746 165.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.877 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 55.2 m 112.65 -43.09 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.377 1.471 . . . . 4.1799999999999997 110.742 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.68 ' HD2' HG11 ' A' ' 40' ' ' VAL . 87.0 Cg_exo -51.43 -19.57 7.15 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.123 1.215 . . . . 4.3700000000000001 113.022 163.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 38.2 t70 84.98 12.38 0.26 Allowed 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.98 1.372 . . . . 4.2599999999999998 107.671 163.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 156.44 76.1 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 112.78 -2.009 . . . . 2.1299999999999999 110.178 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.803 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 3.6 ttt180 -119.54 -53.83 2.2 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 114.724 -0.738 . . . . 3.7799999999999998 109.091 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.047 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.91 110.54 19.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 113.388 0.884 . . . . 2.6099999999999999 113.388 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.0 m -117.99 108.22 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.809 -1.087 . . . . 2.2799999999999998 109.168 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.66 145.09 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 113.439 0.903 . . . . 3.5600000000000001 113.439 -168.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.685 ' O ' ' HA ' ' A' ' 10' ' ' SER . 19.4 t70 -155.05 146.04 22.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.366 -1.288 . . . . 3.3100000000000001 111.807 175.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -42.36 -44.38 3.91 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 117.009 2.226 . . . . 3.7000000000000002 117.009 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HG ' ' OD2' ' A' ' 49' ' ' ASP . 55.7 mt -49.26 -38.83 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.783 2.142 . . . . 4.7999999999999998 116.783 -148.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.65 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 8.5 tpm_? -60.5 -51.69 68.39 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.387 0.994 . . . . 6.9100000000000001 111.011 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.1 t -62.59 154.92 27.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.54 -1.209 . . . . 3.04 113.547 -168.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 10.5 t 62.93 19.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 114.659 -1.155 . . . . 4.6799999999999997 109.157 -172.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.8 61.52 0.47 Allowed Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.634 -1.166 . . . . 4.1900000000000004 113.505 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.25 58.8 12.53 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 118.524 -1.798 . . . . 4.8499999999999996 114.478 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.567 ' HB3' HG23 ' A' ' 62' ' ' ILE 0.262 2.9 m -129.26 -34.45 1.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.859 1.829 . . . . 3.5600000000000001 111.157 -154.339 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.45 6.25 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.535 2.05 . . . . 3.9100000000000001 116.535 -163.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 59' ' ' LEU . 16.2 mt -73.15 4.8 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.591 1.542 . . . . 5.7000000000000002 112.238 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.74 52.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.581 -0.896 . . . . 3.5800000000000001 108.581 159.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.8 122.62 6.44 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.018 -1.57 . . . . 4.3600000000000003 108.018 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.601 HG12 ' S1 ' ' A' ' 86' ' ' FES . 44.7 pt -106.96 127.82 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.862 -1.135 . . . . 3.0499999999999998 113.085 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.648 HG23 HG12 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -144.08 120.78 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.47 -1.307 . . . . 2.3300000000000001 107.47 152.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.844 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 25.0 ttt -111.24 135.64 51.48 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.583 -1.266 . . . . 2.23 107.583 -175.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.783 ' CG1' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -119.07 114.39 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.249 0 N-CA-C 107.179 -1.415 . . . . 1.3300000000000001 107.179 169.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 51.36 -159.14 2.24 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.088 -1.205 . . . . 1.1000000000000001 110.088 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.36 38.78 0.31 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.29 0.567 . . . . 3.0099999999999998 109.967 171.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.619 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 51.5 mmtt -105.43 -37.49 6.8 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 115.651 -0.704 . . . . 3.0600000000000001 110.473 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.682 HG22 ' HG3' ' A' ' 64' ' ' MET . 85.1 t 53.33 108.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 114.07 1.137 . . . . 2.0699999999999998 114.07 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.694 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.6 m-30 -126.94 -169.83 2.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.455 1.121 . . . . 1.9399999999999999 113.222 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -129.05 30.18 3.75 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.061 -1.427 . . . . 1.49 112.598 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.874 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -88.59 89.03 7.82 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.573 -1.269 . . . . 1.95 107.573 172.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.648 HG12 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -116.66 -93.19 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 122.188 0.994 . . . . 3.4399999999999999 112.785 -168.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 1.074 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 43.7 p -133.83 -61.92 0.02 OUTLIER Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.585 -1.643 . . . . 2.9700000000000002 113.484 -166.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.762 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 16.4 Cg_endo -87.4 70.07 3.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.271 1.981 . . . . 3.0899999999999999 113.121 -162.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.449 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 77.99 -12.18 18.85 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.919 -0.658 . . . . 1.6399999999999999 112.689 177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.762 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 25.7 mt-30 -73.52 -25.76 60.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.183 -1.784 . . . . 1.98 106.183 -172.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.732 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 16.0 m -46.8 -61.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 111.566 -2.561 . . . . 1.5700000000000001 111.651 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.84 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 15.5 pttm -58.45 -39.56 80.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.807 0.813 . . . . 2.48 110.84 -167.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.84 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -81.08 -46.84 14.37 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-N 114.698 -1.137 . . . . 2.8100000000000001 109.449 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.665 HG23 ' HB2' ' A' ' 72' ' ' ASN . 39.9 mm -70.56 -11.62 15.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.13 -1.395 . . . . 1.6399999999999999 110.11 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 85' ' ' TYR . 31.0 tp -62.65 -34.17 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.654 -0.654 . . . . 1.3600000000000001 110.005 168.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.74 -33.03 69.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.854 -0.795 . . . . 1.3600000000000001 108.854 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -70.09 -41.35 74.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.735 -1.121 . . . . 2.0899999999999999 111.114 171.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.874 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 7.0 m-30 . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 117.898 -1.049 . . . . 1.77 111.879 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 0.601 ' S1 ' HG12 ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.41 -0.219 . . . . 14.24 110.41 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.559 ' HB ' ' HD3' ' A' ' 3' ' ' PRO . 93.3 t -81.29 -57.02 0.57 Allowed Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 120.923 -0.311 . . . . 10.970000000000001 110.368 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 2' ' ' VAL . 59.4 Cg_endo -75.01 78.64 2.85 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.859 1.706 . . . . 9.9600000000000009 111.109 172.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.63 ' HB3' ' HD2' ' A' ' 6' ' ' LYS . 88.1 mttt -64.3 -71.82 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.594 -0.73 . . . . 9.3399999999999999 111.617 -175.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . 110.94 -21.06 23.43 Favored Glycine 0 C--N 1.314 -0.692 0 C-N-CA 120.709 -0.758 . . . . 4.1799999999999997 113.374 173.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.63 ' HD2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -101.52 51.87 0.84 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.713 0.768 . . . . 4.9400000000000004 111.718 -170.073 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.614 ' HH ' ' HA2' ' A' ' 5' ' ' GLY . 2.7 m-85 -52.72 109.56 1.51 Allowed Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 113.759 -1.564 . . . . 2.0 113.255 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.948 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 32.1 Cg_exo -61.92 104.42 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.826 1.684 . . . . 1.1200000000000001 111.029 169.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 1.086 ' HB ' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -79.43 114.3 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.773 0.797 . . . . 1.97 110.378 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.772 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 8.3 m -93.09 107.11 18.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.526 -1.216 . . . . 1.8500000000000001 110.41 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -118.17 123.21 71.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.394 -0.821 . . . . 2.6800000000000002 110.06 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.719 ' SG ' HG21 ' A' ' 54' ' ' VAL . 32.1 t -66.86 119.28 11.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.109 -0.636 . . . . 2.2400000000000002 110.884 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.7 ttp -122.96 23.29 9.38 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.2 -1.037 . . . . 5.4500000000000002 108.2 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.78 179.5 17.48 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.18 -0.918 . . . . 4.1399999999999997 112.616 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 m -62.71 -43.9 97.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.119 0.415 . . . . 6.2599999999999998 112.119 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.564 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -70.18 -56.08 7.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.048 0.452 . . . . 4.6399999999999997 111.735 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 81.8 m -68.79 -37.75 79.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.202 0.445 . . . . 3.1499999999999999 112.202 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.75 ' HE1' ' HB2' ' A' ' 23' ' ' ASP . 74.4 t80 -63.99 -31.63 72.88 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.726 0.639 . . . . 4.6500000000000004 112.726 -176.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 16' ' ' ALA . 8.0 p -68.7 -20.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.917 0.389 . . . . 4.0099999999999998 111.043 -168.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.51 14.35 3.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.005 -0.543 . . . . 5.21 111.09 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.32 23.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.065 -0.588 . . . . 1.96 111.971 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . . . -72.9 -20.93 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.316 . . . . 1.9399999999999999 111.462 -172.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.75 ' HB2' ' HE1' ' A' ' 18' ' ' PHE . 17.5 t70 -57.52 -44.44 85.09 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.47 -0.492 . . . . 2.4199999999999999 110.946 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 1.7 mptp? -64.64 -39.3 93.46 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.885 -0.726 . . . . 3.4100000000000001 111.528 -171.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.977 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.79 -46.94 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 120.557 -0.457 . . . . 2.75 110.267 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG23 ' HE3' ' A' ' 30' ' ' LYS . 17.8 m -65.98 -25.3 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.387 -0.525 . . . . 2.1299999999999999 110.546 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.611 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 66.4 t-80 -60.74 -44.8 96.22 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.214 0.53 . . . . 1.54 109.67 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.42 -40.09 74.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.598 -1.183 . . . . 1.27 109.254 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.642 ' HE2' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -61.49 -46.5 89.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 2.5800000000000001 110.458 175.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.611 ' HD2' ' HA ' ' A' ' 27' ' ' HIS . 90.5 mttt -53.65 -40.88 66.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.566 -0.743 . . . . 3.23 110.551 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.98 -29.27 29.13 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.396 -0.82 . . . . 2.23 111.448 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -66.27 -21.98 66.3 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.914 -0.584 . . . . 2.54 109.648 177.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.932 ' HG ' HG12 ' A' ' 35' ' ' ILE . 3.6 tp -51.22 -53.94 30.41 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.812 -1.551 . . . . 2.5499999999999998 106.812 170.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 63.38 -28.46 0.08 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 125.885 1.991 . . . . 4.8099999999999996 113.098 168.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.932 HG12 ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.25 -173.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 126.152 1.781 . . . . 4.1900000000000004 114.631 165.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.707 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 8.5 t70 -157.69 -41.58 0.07 Allowed 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 113.387 -1.733 . . . . 4.6200000000000001 107.396 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.635 HG13 ' HB2' ' A' ' 43' ' ' ASP . 4.1 pt -163.23 -3.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 113.643 -1.617 . . . . 5.3700000000000001 112.646 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.432 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -174.46 -58.94 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.035 -1.078 . . . . 4.1299999999999999 110.79 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.973 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 34.1 m-20 -164.5 115.62 1.24 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.821 -0.689 . . . . 4.3099999999999996 111.798 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.869 HG21 ' CD2' ' A' ' 46' ' ' PHE . 1.3 t 72.56 -62.96 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 O-C-N 125.117 1.51 . . . . 2.96 109.755 175.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.708 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 64.1 m -169.43 -61.21 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 112.215 -2.266 . . . . 4.1799999999999997 109.635 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.708 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 72.1 Cg_endo -77.11 11.3 2.09 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 120.624 0.882 . . . . 4.3700000000000001 113.737 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.635 ' HB2' HG13 ' A' ' 37' ' ' ILE . 24.2 t70 82.02 11.03 0.7 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.001 -1.111 . . . . 4.2599999999999998 108.001 169.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.63 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 169.43 77.77 0.04 OUTLIER Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 119.292 -1.432 . . . . 2.1299999999999999 112.536 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.76 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 5.1 ttm180 -116.44 1.44 12.98 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.02 -1.844 . . . . 3.7799999999999998 106.02 165.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.973 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 1.7 m-85 -134.33 169.14 17.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.276 -2.693 . . . . 2.6099999999999999 111.097 -171.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.948 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 1.4 t 178.26 73.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.493 -1.299 . . . . 2.2799999999999998 107.493 166.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 1.049 HG22 HD13 ' A' ' 9' ' ' ILE . 2.1 pp -67.07 116.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.682 -1.145 . . . . 3.5600000000000001 112.997 -167.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.772 ' O ' ' HA ' ' A' ' 10' ' ' SER . 29.3 t70 -162.27 142.24 9.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.572 1.177 . . . . 3.3100000000000001 112.711 167.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.4 m -43.76 -45.72 7.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.692 -2.049 . . . . 3.7000000000000002 116.198 172.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 tp -51.35 -41.74 60.81 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.177 1.918 . . . . 4.7999999999999998 116.177 -149.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.633 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.0 mmm180 -63.06 -55.93 21.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.156 0.979 . . . . 6.9100000000000001 110.797 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.614 ' H ' ' HB3' ' A' ' 10' ' ' SER . 34.1 t -63.15 168.72 3.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.343 -1.753 . . . . 3.04 110.252 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.114 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 15.7 t 74.52 28.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 123.204 1.478 . . . . 4.6799999999999997 108.508 -156.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.29 64.35 0.28 Allowed Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 113.425 -1.716 . . . . 4.1900000000000004 113.025 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 56.89 19.19 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 119.63 -1.271 . . . . 4.8499999999999996 115.567 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.293 1.1 m -135.79 -33.66 0.85 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.985 1.392 . . . . 3.5600000000000001 110.213 -162.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.06 -28.98 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 116.221 1.934 . . . . 3.9100000000000001 116.221 -160.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.03 6.81 3.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.35 1.432 . . . . 5.7000000000000002 112.244 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.14 39.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 107.807 -1.182 . . . . 3.5800000000000001 107.807 159.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.45 117.25 4.75 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 N-CA-C 108.431 -1.411 . . . . 4.3600000000000003 108.431 160.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -113.18 133.68 58.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 119.406 -0.33 . . . . 3.0499999999999998 111.771 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.642 HG21 ' HE2' ' A' ' 29' ' ' PHE . 99.4 t -139.87 121.54 15.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 108.908 -0.775 . . . . 2.3300000000000001 108.908 155.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.656 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 50.1 ttp -112.45 136.2 52.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.864 -1.135 . . . . 2.23 109.412 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 1.086 HG13 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.27 114.8 44.05 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 119.877 -0.729 . . . . 1.3300000000000001 109.485 174.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.699 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 50.76 45.81 48.52 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.808 -0.71 . . . . 1.1000000000000001 113.433 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 59.55 6.66 0.85 Allowed 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 122.952 0.501 . . . . 3.0099999999999998 111.4 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.888 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 71.2 mmtt -77.01 -8.76 57.98 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 110.234 -0.284 . . . . 3.0600000000000001 110.234 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.4 m 35.72 99.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 124.609 1.193 . . . . 2.0699999999999998 113.889 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.888 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 3.8 m-85 -110.09 165.88 11.39 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-O 122.962 1.363 . . . . 1.9399999999999999 113.675 -173.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.683 ' O ' HG23 ' A' ' 73' ' ' VAL . . . -109.75 5.96 31.14 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 112.544 -2.116 . . . . 1.49 109.009 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.738 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 26.3 t-20 -65.25 131.57 46.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.49 -1.67 . . . . 1.95 106.49 167.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.72 -145.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.466 0.913 . . . . 3.4399999999999999 113.466 -148.578 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.977 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 76.5 p -131.29 -50.9 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.018 1.118 . . . . 2.9700000000000002 114.018 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.635 ' HD3' ' OG1' ' A' ' 74' ' ' THR . 91.2 Cg_endo -87.79 73.93 2.45 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.582 1.521 . . . . 3.0899999999999999 113.474 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.54 4.41 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.75 -0.738 . . . . 1.6399999999999999 112.782 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.571 HE21 ' HD2' ' A' ' 75' ' ' PRO . 23.6 mt-30 -74.38 -19.71 60.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 106.403 -1.702 . . . . 1.98 106.403 -172.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG21 ' HG3' ' A' ' 79' ' ' LYS . 8.4 m -43.44 -60.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 111.704 -2.498 . . . . 1.5700000000000001 111.915 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.558 ' HG3' HG21 ' A' ' 78' ' ' VAL . 45.9 mtmt -59.45 -37.59 78.55 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.277 1.037 . . . . 2.48 109.998 -165.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' CD ' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -81.4 -47.7 12.89 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 114.257 -1.338 . . . . 2.8100000000000001 109.446 -175.278 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.756 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 42.1 mm -66.57 -10.68 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.291 -1.322 . . . . 1.6399999999999999 110.013 177.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 85' ' ' TYR . 52.7 tp -58.75 -23.95 60.82 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.521 -0.737 . . . . 1.3600000000000001 110.127 169.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.44 27.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.448 -0.501 . . . . 1.3600000000000001 110.305 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.756 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER -67.0 -36.78 82.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.983 -0.553 . . . . 2.0899999999999999 111.715 174.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.679 ' HB2' HD11 ' A' ' 82' ' ' LEU . 6.7 m-30 . . . . . 0 N--CA 1.432 -1.355 0 CA-C-O 118.523 -0.751 . . . . 1.77 111.547 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 1.114 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' HB ' ' A' ' 2' ' ' VAL . 6.5 tmm? . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 109.347 -0.612 . . . . 14.24 109.347 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 1' ' ' MET . 99.5 t 74.17 105.72 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.278 0 O-C-N 123.598 0.561 . . . . 10.970000000000001 110.191 -175.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.05 101.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.25 2.633 . . . . 9.9600000000000009 112.51 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.738 ' H ' ' HA3' ' A' ' 44' ' ' GLY . 26.2 tptp -36.07 -67.49 0.16 Allowed 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 124.682 1.239 . . . . 9.3399999999999999 112.824 -173.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 47' ' ' SER . . . 122.4 34.49 0.81 Allowed Glycine 0 CA--C 1.495 -1.161 0 CA-C-N 114.815 -1.084 . . . . 4.1799999999999997 112.269 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 14.3 tppt? -50.66 -62.02 1.85 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.202 -1.036 . . . . 4.9400000000000004 108.202 169.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.565 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 4.7 m-85 -115.44 89.16 21.02 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.837 -1.074 . . . . 2.0 110.541 173.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 51.2 Cg_exo -59.67 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.111 2.541 . . . . 1.1200000000000001 111.669 171.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 1.073 HG12 ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -84.48 173.39 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 113.387 0.884 . . . . 1.97 113.387 -167.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.703 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 14.9 p -134.65 134.85 41.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.263 -0.88 . . . . 1.8500000000000001 109.005 171.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 m -115.46 124.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.785 -0.643 . . . . 2.6800000000000002 110.962 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.0 t -66.11 112.6 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.299 0.571 . . . . 2.2400000000000002 110.463 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.3 tpt -131.11 23.85 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.37 -0.832 . . . . 5.4500000000000002 109.628 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.66 177.26 13.59 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.584 -0.817 . . . . 4.1399999999999997 113.992 -166.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -66.21 -45.55 80.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 6.2599999999999998 111.676 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.2 -52.27 20.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.556 0.693 . . . . 4.6399999999999997 110.339 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.65 -34.19 76.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.626 -1.17 . . . . 3.1499999999999999 111.734 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.69 -34.31 74.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.787 0.327 . . . . 4.6500000000000004 111.346 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.82 -24.33 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.545 0.688 . . . . 4.0099999999999998 109.862 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -84.44 12.2 7.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.171 -0.922 . . . . 5.21 110.408 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 31.1 17.24 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.537 -0.84 . . . . 1.96 113.145 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -70.74 -19.81 62.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.707 0.289 . . . . 1.9399999999999999 110.789 -175.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.99 -52.88 62.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 2.4199999999999999 110.248 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -64.55 -31.36 72.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.887 -0.412 . . . . 3.4100000000000001 109.887 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.89 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 98.2 t -56.82 -62.51 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 115.557 -0.747 . . . . 2.75 109.426 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -63.98 -27.86 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.729 -0.669 . . . . 2.1299999999999999 110.793 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -58.5 -47.87 82.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 120.299 -0.56 . . . . 1.54 110.368 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.55 -45.01 81.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.15 -0.932 . . . . 1.27 109.163 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.623 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -53.5 -53.39 52.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.093 -0.958 . . . . 2.5800000000000001 110.087 177.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -51.34 -48.95 62.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.587 -0.733 . . . . 3.23 110.995 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.81 -28.55 28.0 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.123 -0.944 . . . . 2.23 111.446 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -63.97 -26.77 68.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 123.437 0.461 . . . . 2.54 110.328 176.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.022 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.5 tt -50.95 -56.21 13.46 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.612 -1.255 . . . . 2.5499999999999998 107.612 173.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.835 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 63.59 -19.47 0.06 Allowed 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.527 2.392 . . . . 4.8099999999999996 112.644 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.661 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 56.9 -173.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 113.621 -1.627 . . . . 4.1900000000000004 112.713 170.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.78 -48.7 0.07 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.944 -1.132 . . . . 4.6200000000000001 107.944 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 pt -165.58 5.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 112.898 -1.955 . . . . 5.3700000000000001 110.615 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.528 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 177.16 -54.51 0.1 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 110.103 -1.199 . . . . 4.1299999999999999 110.103 -166.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.676 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 24.4 t70 -176.53 116.88 0.12 Allowed 'General case' 0 CA--C 1.483 -1.635 0 CA-C-N 113.446 -1.377 . . . . 4.3099999999999996 111.291 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 1.05 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 6.5 p 54.9 -65.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 127.301 2.876 . . . . 2.96 113.488 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.814 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 26.2 m -154.0 -58.81 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 113.631 -1.622 . . . . 4.1799999999999997 110.565 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.814 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 2.8 Cg_exo -77.63 10.06 2.68 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 C-N-CA 120.745 0.963 . . . . 4.3700000000000001 114.235 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.528 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 6.8 t0 81.43 9.41 0.95 Allowed 'General case' 0 C--N 1.349 0.558 0 N-CA-C 107.644 -1.243 . . . . 4.2599999999999998 107.644 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.738 ' HA3' ' H ' ' A' ' 4' ' ' LYS . . . 156.92 59.36 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.237 -1.347 . . . . 2.1299999999999999 112.171 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.638 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 11.6 ttt180 -86.73 -62.0 1.61 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.029 -1.1 . . . . 3.7799999999999998 108.029 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.05 ' HE1' ' HB ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -100.95 102.42 13.43 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 122.806 1.289 . . . . 2.6099999999999999 112.738 173.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.485 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 22.6 t -92.02 91.98 8.08 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.887 -1.506 . . . . 2.2799999999999998 109.215 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 1.073 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.3 pp -56.46 124.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 3.5600000000000001 112.518 -174.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' SER . 8.5 m-20 -143.21 132.73 23.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.518 1.151 . . . . 3.3100000000000001 113.464 166.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -48.5 -43.41 35.06 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.171 -1.831 . . . . 3.7000000000000002 114.581 158.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.16 -35.13 59.44 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.558 1.318 . . . . 4.7999999999999998 114.558 -160.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.703 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 9.8 mmt85 -60.77 -49.87 75.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.806 0.812 . . . . 6.9100000000000001 110.176 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.0 t -59.22 158.58 8.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.944 -1.48 . . . . 3.04 112.895 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 54' ' ' VAL . 14.7 t 66.27 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.388 0 CA-C-O 122.83 1.3 . . . . 4.6799999999999997 108.558 -167.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.77 63.6 0.37 Allowed Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 113.829 -1.532 . . . . 4.1900000000000004 113.263 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.21 59.08 10.04 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.739 -1.696 . . . . 4.8499999999999996 114.609 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.706 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.282 2.8 m -130.14 -37.13 1.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.058 1.429 . . . . 3.5600000000000001 110.765 -159.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.06 -32.65 35.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.916 1.45 . . . . 3.9100000000000001 114.916 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.611 ' H ' HD21 ' A' ' 59' ' ' LEU . 2.5 pt? -76.83 6.13 6.64 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.117 -0.989 . . . . 5.7000000000000002 112.334 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.76 160.86 38.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.305 -0.628 . . . . 3.5800000000000001 109.305 164.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.52 119.19 4.8 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 108.572 -1.357 . . . . 4.3600000000000003 108.572 155.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.706 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.0 mm -111.58 129.58 66.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.567 0.58 . . . . 3.0499999999999998 112.567 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.628 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 4.7 t -139.57 123.15 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.832 -1.544 . . . . 2.3300000000000001 106.832 153.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.726 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 22.7 ttt -112.75 136.08 52.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.954 -1.498 . . . . 2.23 110.598 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -124.81 114.91 42.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 106.545 -1.65 . . . . 1.3300000000000001 106.545 156.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.75 -149.25 1.09 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 122.165 0.87 . . . . 1.1000000000000001 112.752 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.31 31.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.842 -1.179 . . . . 3.0099999999999998 108.744 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.73 ' HB2' HG23 ' A' ' 65' ' ' VAL . 13.2 mmmm -106.61 -41.56 5.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.535 -0.757 . . . . 3.0600000000000001 109.214 -177.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.658 HG23 ' HG3' ' A' ' 64' ' ' MET . 87.8 t 46.38 101.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 124.472 1.108 . . . . 2.0699999999999998 113.523 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.691 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 9.1 m-30 -120.41 -154.77 0.6 Allowed 'General case' 0 C--O 1.248 1.024 0 CA-C-O 121.863 0.839 . . . . 1.9399999999999999 112.312 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.608 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -142.6 28.21 2.19 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.695 -1.139 . . . . 1.49 112.003 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.862 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 3.1 t30 -81.76 112.73 19.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.711 -0.477 . . . . 1.95 109.711 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.569 HG21 ' HD3' ' A' ' 75' ' ' PRO . 6.9 m -137.2 -78.78 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 116.922 2.193 . . . . 3.4399999999999999 116.922 -171.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.89 ' CB ' ' HA ' ' A' ' 25' ' ' VAL . 13.6 t -153.41 -41.68 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 115.51 1.671 . . . . 2.9700000000000002 115.51 -172.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.921 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 3.0 Cg_exo -75.31 57.22 4.68 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.09 1.86 . . . . 3.0899999999999999 112.036 -170.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 76.3 -7.54 30.23 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.58 -0.737 . . . . 1.6399999999999999 111.562 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.921 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 6.8 mt-30 -73.62 -35.75 65.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.209 -1.404 . . . . 1.98 107.209 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.606 ' HA ' ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -50.67 -55.69 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 112.802 -1.999 . . . . 1.5700000000000001 110.941 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 48.9 mtmt -54.51 -45.66 73.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.019 0.914 . . . . 2.48 109.508 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.775 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -85.56 -40.94 15.74 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.642 -1.163 . . . . 2.8100000000000001 110.987 -173.077 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.768 ' CG2' ' HB2' ' A' ' 72' ' ' ASN . 33.3 mm -69.69 -15.11 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.955 -0.566 . . . . 1.6399999999999999 109.765 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 54.7 tp -58.93 -41.57 87.65 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.989 -0.445 . . . . 1.3600000000000001 110.29 171.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.2 -32.74 66.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.544 0.688 . . . . 1.3600000000000001 109.422 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.55 -31.64 67.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.755 -1.111 . . . . 2.0899999999999999 112.125 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.862 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 2.1 m-30 . . . . . 0 N--CA 1.432 -1.369 0 CA-C-O 117.418 -1.277 . . . . 1.77 112.004 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.506 ' HG2' HG22 ' A' ' 2' ' ' VAL . 25.8 ttt . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.649 0.261 . . . . 14.24 110.797 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.506 HG22 ' HG2' ' A' ' 1' ' ' MET . 68.3 t -120.57 113.51 33.42 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.756 -0.202 . . . . 10.970000000000001 110.694 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.2 Cg_exo -76.96 125.13 7.8 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.002 2.468 . . . . 9.9600000000000009 112.152 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -123.96 -79.06 0.61 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.279 0.561 . . . . 9.3399999999999999 110.947 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.02 1.52 45.26 Favored Glycine 0 C--N 1.312 -0.754 0 CA-C-N 115.338 -0.846 . . . . 4.1799999999999997 112.862 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -140.36 53.27 1.63 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.248 1.023 . . . . 4.9400000000000004 110.915 -176.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.922 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -69.31 112.59 12.35 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.075 -1.42 . . . . 2.0 112.764 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.972 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 21.0 Cg_exo -70.8 131.14 19.2 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.903 1.735 . . . . 1.1200000000000001 111.678 170.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.851 HG23 ' HA ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -77.45 156.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.376 0.608 . . . . 1.97 112.085 -175.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.806 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.6 m -141.68 100.81 3.84 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.299 -0.864 . . . . 1.8500000000000001 109.56 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -117.81 124.64 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.744 -0.662 . . . . 2.6800000000000002 110.799 -176.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.737 ' SG ' HG21 ' A' ' 54' ' ' VAL . 31.5 t -65.14 120.87 13.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 2.2400000000000002 110.876 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.4 mtt -122.01 24.8 9.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.15 -0.932 . . . . 5.4500000000000002 108.714 173.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.09 179.91 13.19 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.132 -0.94 . . . . 4.1399999999999997 112.836 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 19' ' ' VAL . 19.8 m -65.78 -45.67 81.59 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.993 0.368 . . . . 6.2599999999999998 111.993 -172.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -71.62 -56.54 5.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.465 0.543 . . . . 4.6399999999999997 112.465 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 83.3 m -66.62 -36.55 82.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.535 0.569 . . . . 3.1499999999999999 112.535 -171.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.78 -30.87 71.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.126 0.787 . . . . 4.6500000000000004 113.126 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 16' ' ' ALA . 32.6 m -69.74 -18.92 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.948 0.351 . . . . 4.0099999999999998 111.948 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.95 16.46 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 5.21 111.612 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.85 32.3 10.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.451 -0.881 . . . . 1.96 111.851 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HA ' HG23 ' A' ' 25' ' ' VAL . . . -72.05 -20.82 61.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.436 -0.382 . . . . 1.9399999999999999 110.617 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.18 -50.86 66.07 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.031 -0.359 . . . . 2.4199999999999999 110.031 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -65.02 -40.62 95.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.698 -0.401 . . . . 3.4100000000000001 110.983 -171.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.746 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 6.1 m -67.17 -49.0 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 C-N-CA 120.42 -0.512 . . . . 2.75 110.153 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.649 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 21.8 m -64.83 -28.95 46.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.182 -0.607 . . . . 2.1299999999999999 110.269 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -59.5 -43.11 93.42 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 120.72 -0.392 . . . . 1.54 110.219 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -52.96 -49.16 66.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.202 -0.908 . . . . 1.27 109.062 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.66 ' CZ ' HG13 ' A' ' 9' ' ' ILE . 39.7 t80 -47.54 -56.9 6.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.065 -0.97 . . . . 2.5800000000000001 110.488 174.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.17 -52.66 11.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.373 -1.285 . . . . 3.23 112.229 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -84.45 -30.52 25.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.84 -0.618 . . . . 2.23 111.762 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.674 ' NE2' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -64.71 -25.02 67.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.54 -0.541 . . . . 2.54 109.54 176.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.784 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.3 tt -48.59 -58.23 5.01 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.246 -1.39 . . . . 2.5499999999999998 107.246 174.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.742 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 64.09 -21.49 0.07 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 126.328 2.268 . . . . 4.8099999999999996 112.874 171.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.68 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 53.98 -173.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 C-N-CA 126.342 1.857 . . . . 4.1900000000000004 114.389 166.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 35' ' ' ILE . 14.7 t70 -157.74 -50.93 0.07 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.848 -1.524 . . . . 4.6200000000000001 107.985 -172.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pt -164.79 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 113.441 -1.709 . . . . 5.3700000000000001 110.863 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.31 -65.04 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 109.675 -1.37 . . . . 4.1299999999999999 109.675 -166.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.869 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 25.1 m-20 -164.31 119.97 1.53 Allowed 'General case' 0 CA--C 1.48 -1.742 0 CA-C-N 112.903 -1.648 . . . . 4.3099999999999996 109.107 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.961 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 4.4 p 59.01 -66.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 126.684 2.49 . . . . 2.96 112.871 171.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.928 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 50.7 m -164.71 -58.52 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.759 0 CA-C-N 112.688 -2.051 . . . . 4.1799999999999997 110.006 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 1.043 ' HG2' ' HD2' ' A' ' 45' ' ' ARG . 23.8 Cg_exo -67.69 4.26 1.47 Allowed 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 120.88 1.054 . . . . 4.3700000000000001 114.44 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 18.0 t70 86.23 -4.85 0.77 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.93 0.872 . . . . 4.2599999999999998 109.578 159.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.518 ' HA2' ' OD2' ' A' ' 39' ' ' ASP . . . 179.06 41.4 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.747 -1.115 . . . . 2.1299999999999999 112.282 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 1.043 ' HD2' ' HG2' ' A' ' 42' ' ' PRO . 2.6 ttt180 -82.74 -7.79 59.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.548 1.166 . . . . 3.7799999999999998 109.167 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.961 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -105.51 -58.98 1.83 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.608 -2.087 . . . . 2.6099999999999999 113.453 -171.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.972 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 73.9 m 30.31 -170.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.588 1.555 . . . . 2.2799999999999998 114.723 -162.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.851 ' HA ' HG23 ' A' ' 9' ' ' ILE . 8.4 tp -166.99 104.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 113.686 0.995 . . . . 3.5600000000000001 113.686 -168.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.806 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.2 m-20 -144.69 130.79 19.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.678 -0.809 . . . . 3.3100000000000001 110.272 160.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t -50.03 -45.24 51.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.972 1.101 . . . . 3.7000000000000002 113.972 160.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.3 -37.86 70.47 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.898 1.814 . . . . 4.7999999999999998 115.898 -157.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' HD2' ' OG ' ' A' ' 10' ' ' SER . 44.9 mtt180 -62.14 -56.87 14.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.229 1.014 . . . . 6.9100000000000001 110.09 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.2 t -64.77 170.7 3.94 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.374 -1.739 . . . . 3.04 109.288 171.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.854 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 12.2 t 75.1 30.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 123.168 1.461 . . . . 4.6799999999999997 108.492 -157.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.5 63.24 0.3 Allowed Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 113.457 -1.701 . . . . 4.1900000000000004 112.886 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.23 56.02 24.42 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 119.507 -1.33 . . . . 4.8499999999999996 115.782 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.9 m -136.35 -30.83 0.91 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.588 1.194 . . . . 3.5600000000000001 109.708 -166.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.51 -26.97 1.57 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.766 2.136 . . . . 3.9100000000000001 116.766 -160.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.83 5.14 5.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.815 1.643 . . . . 5.7000000000000002 112.045 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.67 161.15 35.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 107.876 -1.157 . . . . 3.5800000000000001 107.876 162.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.8 118.69 5.39 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.705 1.287 . . . . 4.3600000000000003 108.998 164.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.76 131.39 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.059 0.392 . . . . 3.0499999999999998 112.059 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.685 HG13 ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -142.05 124.04 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.29 -1.004 . . . . 2.3300000000000001 108.29 158.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.623 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 49.7 ttp -113.2 134.59 54.5 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 118.152 -1.419 . . . . 2.23 111.106 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.922 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.89 119.28 55.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 CA-C-O 119.207 -0.425 . . . . 1.3300000000000001 110.0 174.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.669 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 55.55 31.42 57.37 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.117 -1.039 . . . . 1.1000000000000001 112.008 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.537 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 42.7 mt-10 58.54 12.62 2.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.727 -0.737 . . . . 3.0099999999999998 111.525 -174.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 30.8 mmmt -73.77 -27.49 61.19 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 109.642 -0.503 . . . . 3.0600000000000001 109.642 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 94.6 t 60.51 100.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.047 -0.979 . . . . 2.0699999999999998 112.675 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.847 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.1 m-85 -124.98 -161.45 1.02 Allowed 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.046 0.927 . . . . 1.9399999999999999 112.15 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.685 ' HA2' HG13 ' A' ' 63' ' ' VAL . . . -137.14 18.89 3.48 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.505 -1.225 . . . . 1.49 112.091 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.837 ' HB2' HG23 ' A' ' 81' ' ' ILE . 8.2 t30 -84.62 85.89 7.37 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.083 -0.657 . . . . 1.95 109.813 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.625 HG23 ' HB ' ' A' ' 63' ' ' VAL . 59.9 t -153.36 -56.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.55 0.944 . . . . 3.4399999999999999 113.55 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 25' ' ' VAL . 8.3 p -102.15 149.98 37.08 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.559 -0.291 . . . . 2.9700000000000002 111.586 -164.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.746 ' HD2' ' HA ' ' A' ' 25' ' ' VAL . 1.1 Cg_endo -42.85 112.98 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.21 3.274 . . . . 3.0899999999999999 111.742 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.665 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 119.23 -83.75 0.36 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.216 -1.154 . . . . 1.6399999999999999 110.216 -170.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 1.9 pt20 -64.58 -38.73 92.03 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.766 0.793 . . . . 1.98 109.855 -175.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.674 HG23 ' NE2' ' A' ' 32' ' ' GLN . 9.9 p -50.99 -57.4 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.875 -1.057 . . . . 1.5700000000000001 111.609 -174.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.51 ' N ' ' CG1' ' A' ' 78' ' ' VAL . 16.6 pttp -59.87 -42.4 93.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.604 0.716 . . . . 2.48 110.342 -164.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.665 ' HD2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -89.1 -34.95 16.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.068 -0.969 . . . . 2.8100000000000001 110.489 -172.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.837 HG23 ' HB2' ' A' ' 72' ' ' ASN . 51.1 mm -68.1 -11.54 14.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.87 -0.604 . . . . 1.6399999999999999 109.868 174.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.49 ' HB2' HE22 ' A' ' 32' ' ' GLN . 57.4 tp -60.48 -37.19 80.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.32 -0.862 . . . . 1.3600000000000001 110.47 168.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.54 68.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.724 0.773 . . . . 1.3600000000000001 109.003 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.562 -1.199 . . . . 2.0899999999999999 111.365 174.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.847 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 8.0 m-30 . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 118.283 -0.865 . . . . 1.77 110.95 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 0.854 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.826 0.346 . . . . 14.24 110.727 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t -93.34 119.82 67.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.162 -0.472 . . . . 10.970000000000001 110.876 -174.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 -154.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.869 2.38 . . . . 9.9600000000000009 110.768 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 32.7 mmtp -75.78 -91.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.462 -0.495 . . . . 9.3399999999999999 110.353 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.405 ' C ' ' HD3' ' A' ' 6' ' ' LYS . . . 82.63 175.18 50.68 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 120.275 -0.964 . . . . 4.1799999999999997 110.943 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HD3' ' C ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER 36.77 46.24 0.47 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.856 0.836 . . . . 4.9400000000000004 110.95 -173.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.818 ' HB2' HG11 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -33.96 116.6 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.198 -1.819 . . . . 2.0 113.611 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.642 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 24.2 Cg_exo -66.34 109.54 1.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.024 1.816 . . . . 1.1200000000000001 110.582 166.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -78.52 158.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.166 -0.309 . . . . 1.97 110.166 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.862 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 25.1 m -141.88 111.46 6.58 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.041 -0.527 . . . . 1.8500000000000001 110.354 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.72 120.48 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.971 -0.559 . . . . 2.6800000000000002 110.985 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.713 ' SG ' HG22 ' A' ' 54' ' ' VAL . 35.8 t -70.2 122.98 20.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.673 -0.411 . . . . 2.2400000000000002 110.717 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.75 ' HE1' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -122.84 22.83 9.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.372 -0.377 . . . . 5.4500000000000002 111.019 174.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.611 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -66.43 177.49 16.63 Favored Glycine 0 C--O 1.22 -0.736 0 C-N-CA 120.497 -0.859 . . . . 4.1399999999999997 112.363 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.7 m -66.32 -45.14 81.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.613 0.597 . . . . 6.2599999999999998 112.613 -171.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.63 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.609 0.719 . . . . 4.6399999999999997 110.783 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 91.3 m -63.51 -28.52 70.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.131 -0.94 . . . . 3.1499999999999999 111.568 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 61.4 t80 -56.07 -27.45 53.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.302 0.641 . . . . 4.6500000000000004 110.265 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.45 -20.74 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 4.0099999999999998 110.402 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' NZ ' ' S1 ' ' A' ' 86' ' ' FES . 48.1 mtmt -80.92 10.45 5.05 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.661 0.267 . . . . 5.21 110.671 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.17 28.21 34.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.927 -0.654 . . . . 1.96 112.546 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -73.02 -22.7 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.575 0.226 . . . . 1.9399999999999999 111.454 -171.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.631 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 18.0 t70 -61.43 -46.35 90.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.204 0.526 . . . . 2.4199999999999999 110.29 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.546 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 9.1 mptt -67.18 -33.06 74.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.285 -0.635 . . . . 3.4100000000000001 109.285 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.017 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 99.6 t -56.12 -58.19 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 109.011 -0.737 . . . . 2.75 109.011 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 29' ' ' PHE . 28.9 m -61.58 -34.63 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.706 -0.679 . . . . 2.1299999999999999 111.566 -174.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -63.1 -48.37 78.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 119.112 -1.035 . . . . 1.54 110.189 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.62 81.87 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.846 -1.168 . . . . 1.27 107.846 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.78 ' HZ ' ' HH ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -53.35 -52.56 58.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.488 -1.233 . . . . 2.5800000000000001 110.988 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -51.67 -49.55 62.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.106 -0.952 . . . . 3.23 110.578 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.97 -31.54 34.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.442 -1.254 . . . . 2.23 110.842 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.678 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 5.7 mm100 -64.42 -21.92 66.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.632 -0.713 . . . . 2.54 111.933 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.057 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.4 tt -57.45 -55.0 40.47 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.373 -1.343 . . . . 2.5499999999999998 107.373 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.817 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 62.9 -22.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 126.576 2.422 . . . . 4.8099999999999996 112.997 171.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.21 -175.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.153 -1.385 . . . . 4.1900000000000004 112.667 170.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -156.6 -47.35 0.07 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.687 -1.227 . . . . 4.6200000000000001 107.687 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 pt -167.19 5.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 113.222 -1.808 . . . . 5.3700000000000001 111.089 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 178.65 -54.54 0.09 OUTLIER Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.06 -1.216 . . . . 4.1299999999999999 110.06 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.54 ' HA ' HG22 ' A' ' 35' ' ' ILE . 20.5 t70 -175.24 118.65 0.18 Allowed 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.187 -1.507 . . . . 4.3099999999999996 110.709 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.961 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 9.5 p 56.17 -66.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 O-C-N 127.205 2.816 . . . . 2.96 113.044 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.879 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 41.1 m -154.64 -61.62 0.02 OUTLIER Pre-proline 0 C--N 1.279 -2.495 0 CA-C-N 113.619 -1.628 . . . . 4.1799999999999997 109.99 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.879 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.1 Cg_exo -79.75 8.41 4.02 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 120.908 1.072 . . . . 4.3700000000000001 114.297 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.546 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 22.3 t70 82.77 5.85 0.91 Allowed 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.347 1.07 . . . . 4.2599999999999998 108.356 166.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.482 ' N ' ' HB3' ' A' ' 39' ' ' ASP . . . 175.76 76.2 0.05 OUTLIER Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.177 -1.374 . . . . 2.1299999999999999 112.157 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.607 ' CB ' HG11 ' A' ' 40' ' ' VAL . 5.2 tpt180 -100.45 -60.42 1.53 Allowed 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.463 -0.94 . . . . 3.7799999999999998 108.463 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.057 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.19 115.8 21.68 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 122.508 1.147 . . . . 2.6099999999999999 114.002 -176.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.44 ' C ' HG22 ' A' ' 9' ' ' ILE . 21.2 t -102.27 93.38 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.156 -1.384 . . . . 2.2799999999999998 108.56 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.757 ' HA ' HG22 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -67.52 135.28 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.861 0.689 . . . . 3.5600000000000001 112.861 -168.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.862 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.5 t70 -160.12 138.03 9.93 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.205 1.003 . . . . 3.3100000000000001 112.73 163.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.75 HG22 ' HE1' ' A' ' 13' ' ' MET . 19.3 m -48.47 -49.91 33.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 115.407 1.632 . . . . 3.7000000000000002 115.407 170.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -54.67 -40.65 69.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.915 2.191 . . . . 4.7999999999999998 116.915 -150.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.655 ' HE ' ' HA ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -63.25 -55.37 25.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.896 0.855 . . . . 6.9100000000000001 110.945 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.643 ' H ' ' HB3' ' A' ' 10' ' ' SER . 25.3 t -63.95 166.41 7.5 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.886 -1.506 . . . . 3.04 109.156 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.82 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 14.3 t 72.83 27.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.206 1.479 . . . . 4.6799999999999997 107.586 -153.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.34 65.74 0.32 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 113.292 -1.776 . . . . 4.1900000000000004 113.321 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.16 55.19 25.3 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 119.485 -1.341 . . . . 4.8499999999999996 116.04 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -138.82 -29.89 0.77 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.24 1.02 . . . . 3.5600000000000001 110.183 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.24 -29.51 3.87 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 116.632 2.086 . . . . 3.9100000000000001 116.632 -158.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.9 6.77 4.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.407 1.458 . . . . 5.7000000000000002 111.85 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.39 161.62 30.67 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 3.5800000000000001 108.309 163.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.24 119.13 5.45 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.326 1.152 . . . . 4.3600000000000003 109.307 163.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.09 132.78 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.973 0.731 . . . . 3.0499999999999998 112.973 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.521 HG22 ' CZ ' ' A' ' 29' ' ' PHE . 11.7 p -143.07 121.8 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.86 -0.736 . . . . 2.3300000000000001 109.133 148.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 50.1 ttp -113.44 133.99 54.9 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 119.26 -0.976 . . . . 2.23 108.778 -173.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.818 HG11 ' HB2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -126.04 117.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.222 -0.591 . . . . 1.3300000000000001 109.491 173.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.642 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 49.12 50.79 27.27 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 123.748 0.655 . . . . 1.1000000000000001 113.935 173.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 62.12 -0.67 0.45 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.111 0.412 . . . . 3.0099999999999998 112.111 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.491 ' HZ3' ' HH ' ' A' ' 70' ' ' TYR . 14.4 mmmm -75.8 -38.56 58.1 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.834 -0.432 . . . . 3.0600000000000001 109.834 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 95.3 t 61.43 113.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.042 -0.981 . . . . 2.0699999999999998 112.465 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.595 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 40.0 m-85 -131.53 -172.7 2.92 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.142 0.972 . . . . 1.9399999999999999 112.278 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -132.01 26.32 3.79 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.024 -1.444 . . . . 1.49 110.96 177.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.697 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 2.1 t30 -76.13 111.73 11.84 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.937 -0.764 . . . . 1.95 108.937 177.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.454 HG21 ' H ' ' A' ' 74' ' ' THR . 3.2 m -134.12 -97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 116.34 1.978 . . . . 3.4399999999999999 116.34 -164.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 1.017 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 10.2 t -143.92 -41.41 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 115.66 1.726 . . . . 2.9700000000000002 115.66 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.601 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 5.6 Cg_exo -73.65 57.84 3.76 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 122.133 1.889 . . . . 3.0899999999999999 113.193 -169.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.18 -7.34 10.95 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 116.063 -0.517 . . . . 1.6399999999999999 112.468 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' O ' HG12 ' A' ' 81' ' ' ILE . 13.8 mt-30 -75.84 -30.8 59.09 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 107.227 -1.398 . . . . 1.98 107.227 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.678 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -52.63 -46.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-N 112.554 -2.112 . . . . 1.5700000000000001 112.317 -175.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -54.76 -44.8 73.97 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.517 1.151 . . . . 2.48 108.153 -170.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.569 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -80.63 -46.75 15.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.826 -1.988 . . . . 2.8100000000000001 110.331 -173.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 77' ' ' GLN . 28.9 mm -69.02 -16.24 20.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.893 -1.049 . . . . 1.6399999999999999 110.239 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 78' ' ' VAL . 54.9 tp -61.34 -33.95 74.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.483 -0.76 . . . . 1.3600000000000001 110.107 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 -27.93 69.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.281 0.562 . . . . 1.3600000000000001 109.535 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' OE1' HG22 ' A' ' 81' ' ' ILE . 1.7 mt-10 -71.38 -27.33 63.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.403 -0.817 . . . . 2.0899999999999999 110.191 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.78 ' HH ' ' HZ ' ' A' ' 29' ' ' PHE . 3.3 m-30 . . . . . 0 N--CA 1.422 -1.864 0 CA-C-N 115.628 -0.714 . . . . 1.77 110.555 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 0.82 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HG2' ' HE3' ' A' ' 68' ' ' LYS . 44.6 tpp . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.591 0.234 . . . . 14.24 110.516 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.06 100.9 16.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.039 0.447 . . . . 10.970000000000001 110.167 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 1' ' ' MET . 1.6 Cg_endo -81.4 89.84 1.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.084 2.522 . . . . 9.9600000000000009 111.563 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -79.53 -64.98 1.06 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.284 -0.416 . . . . 9.3399999999999999 110.878 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.58 152.04 5.61 Favored Glycine 0 C--N 1.315 -0.605 0 C-N-CA 120.842 -0.694 . . . . 4.1799999999999997 112.72 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HB3' ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER 39.11 56.84 2.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.969 0.907 . . . . 4.9400000000000004 112.054 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.687 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 15.6 m-85 -46.79 125.98 8.27 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.054 -1.43 . . . . 2.0 112.224 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.682 ' HA ' ' O ' ' A' ' 47' ' ' SER . 61.0 Cg_exo -57.72 94.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.968 2.446 . . . . 1.1200000000000001 112.175 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.826 ' HB ' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -82.02 135.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.32 0.581 . . . . 1.97 111.909 -174.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.675 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.0 m -100.68 124.28 46.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.075 -0.966 . . . . 1.8500000000000001 110.665 -177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 m -116.83 125.01 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.844 0.683 . . . . 2.6800000000000002 112.844 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' CB ' ' A' ' 17' ' ' CYS . 15.1 t -67.71 117.38 9.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.058 0.456 . . . . 2.2400000000000002 112.057 175.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.5 ttt -129.32 23.75 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.901 -0.591 . . . . 5.4500000000000002 109.583 166.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.5 176.46 23.82 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.503 -0.856 . . . . 4.1399999999999997 114.65 -167.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -67.34 -45.33 76.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.979 0.418 . . . . 6.2599999999999998 112.091 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.63 25.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.474 0.654 . . . . 4.6399999999999997 110.1 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 88.5 m -63.76 -33.84 76.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.59 -1.186 . . . . 3.1499999999999999 112.021 -176.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 43.8 t80 -60.45 -32.62 71.55 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.984 0.421 . . . . 4.6500000000000004 111.015 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -72.68 -23.84 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.537 0.684 . . . . 4.0099999999999998 109.886 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 23.9 tptm -83.2 8.1 14.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.419 -0.809 . . . . 5.21 110.001 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.23 28.29 34.13 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.898 -0.668 . . . . 1.96 112.184 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.506 ' HA ' ' CG2' ' A' ' 25' ' ' VAL . . . -71.73 -22.41 61.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 1.9399999999999999 111.15 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.416 ' O ' HG21 ' A' ' 26' ' ' VAL . 10.0 t70 -56.78 -52.86 63.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.409 -0.359 . . . . 2.4199999999999999 110.232 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -66.17 -37.88 86.71 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.44 -0.504 . . . . 3.4100000000000001 110.908 -172.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.02 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.4 m -69.31 -44.56 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 120.583 -0.447 . . . . 2.75 110.72 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 18.9 m -64.52 -31.32 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.919 -0.712 . . . . 2.1299999999999999 109.441 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -59.66 -45.85 90.78 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.932 0.396 . . . . 1.54 110.08 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . -56.1 -43.25 77.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.091 -0.958 . . . . 1.27 108.516 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.725 ' HZ ' ' HE2' ' A' ' 85' ' ' TYR . 1.3 t80 -56.17 -49.18 74.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.062 -0.972 . . . . 2.5800000000000001 110.776 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -50.92 -46.63 60.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.262 -0.881 . . . . 3.23 110.551 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -76.17 -30.18 58.0 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.97 -1.014 . . . . 2.23 110.919 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.737 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 13.5 mm100 -61.66 -27.59 68.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.218 -0.901 . . . . 2.54 111.059 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.65 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -50.86 -58.41 6.03 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.854 -1.165 . . . . 2.5499999999999998 107.854 170.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER 57.45 -2.63 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 O-C-N 125.683 1.865 . . . . 4.8099999999999996 112.61 173.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.65 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 46.05 -166.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.656 -1.611 . . . . 4.1900000000000004 112.935 174.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 6.9 t70 -159.57 -40.25 0.05 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.2 -1.407 . . . . 4.6200000000000001 107.2 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.751 HD13 ' HB2' ' A' ' 43' ' ' ASP . 1.5 pt -164.32 0.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.247 -2.252 . . . . 5.3700000000000001 110.557 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.84 -27.41 0.58 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 119.517 -1.325 . . . . 4.1299999999999999 112.944 -165.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.987 ' HA ' ' HE1' ' A' ' 46' ' ' PHE . 10.6 t70 -138.28 167.86 20.96 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 121.157 0.503 . . . . 4.3099999999999996 111.898 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.682 HG22 ' HB3' ' A' ' 46' ' ' PHE . 5.0 t -25.58 -58.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 126.877 2.611 . . . . 2.96 110.422 174.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.808 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 98.5 m -159.55 -64.69 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 111.627 -2.533 . . . . 4.1799999999999997 111.397 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.808 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.2 Cg_exo -78.62 5.93 5.22 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 121.097 1.198 . . . . 4.3700000000000001 114.561 -172.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.972 ' HA ' ' HB3' ' A' ' 39' ' ' ASP . 36.9 t70 74.27 21.38 2.45 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.252 -1.018 . . . . 4.2599999999999998 108.252 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.05 58.52 0.16 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 118.691 -1.718 . . . . 2.1299999999999999 113.882 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.487 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -122.53 -44.28 2.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.241 0.543 . . . . 3.7799999999999998 110.476 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.987 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -119.55 142.11 48.64 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 113.208 0.818 . . . . 2.6099999999999999 113.208 -170.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.682 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 23.2 t -155.64 97.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.354 -1.721 . . . . 2.2799999999999998 106.354 166.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.488 HG23 ' HD2' ' A' ' 46' ' ' PHE . 36.1 pt -87.97 149.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 114.021 1.119 . . . . 3.5600000000000001 114.021 -159.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.3 p30 -161.02 138.01 8.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.394 -1.275 . . . . 3.3100000000000001 110.333 159.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.5 m -44.06 -45.55 8.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.9 -1.5 . . . . 3.7000000000000002 114.095 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 tp -53.48 -39.5 64.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.711 1.745 . . . . 4.7999999999999998 115.711 -152.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -62.65 -57.76 9.91 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.611 1.196 . . . . 6.9100000000000001 109.62 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.675 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 38.5 t -66.99 166.45 13.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.831 -1.986 . . . . 3.04 111.208 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.219 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 21.4 t 70.65 26.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 123.332 1.539 . . . . 4.6799999999999997 109.238 -169.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.17 63.58 0.3 Allowed Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 113.319 -1.764 . . . . 4.1900000000000004 112.36 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.34 58.84 10.78 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 119.044 -1.55 . . . . 4.8499999999999996 114.498 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.314 0.8 OUTLIER -131.43 -33.76 1.44 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.05 1.425 . . . . 3.5600000000000001 108.982 -157.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.36 2.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 115.311 1.597 . . . . 3.9100000000000001 115.311 -163.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.737 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -72.82 6.39 2.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.984 -1.086 . . . . 5.7000000000000002 111.746 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.1 158.2 46.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 108.027 -1.101 . . . . 3.5800000000000001 108.027 157.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.59 120.07 5.43 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 CA-C-N 120.659 1.271 . . . . 4.3600000000000003 109.507 163.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.61 ' O ' HD12 ' A' ' 62' ' ' ILE . 2.0 pp -111.46 130.31 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.048 0.758 . . . . 3.0499999999999998 113.048 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.895 HG21 ' H ' ' A' ' 73' ' ' VAL . 3.9 t -142.27 116.52 4.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 107.091 -1.448 . . . . 2.3300000000000001 107.091 157.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.606 ' HG3' HG11 ' A' ' 69' ' ' VAL . 20.5 ttt -119.11 136.47 54.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 118.434 -1.306 . . . . 2.23 111.334 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.826 HG12 ' HB ' ' A' ' 9' ' ' ILE . 1.8 m -123.46 115.94 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.533 -1.284 . . . . 1.3300000000000001 107.533 157.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.579 ' HA3' ' HB3' ' A' ' 7' ' ' TYR . . . 50.03 -155.47 2.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.648 -0.787 . . . . 1.1000000000000001 111.223 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.79 37.27 0.41 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.995 -0.603 . . . . 3.0099999999999998 109.93 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.77 ' HB2' HG23 ' A' ' 65' ' ' VAL . 14.5 mmmm -103.09 -22.76 13.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.056 -0.52 . . . . 3.0600000000000001 109.999 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.606 HG11 ' HG3' ' A' ' 64' ' ' MET . 3.5 m 29.06 101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.134 1.531 . . . . 2.0699999999999998 115.134 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.758 ' HD2' ' HE1' ' A' ' 85' ' ' TYR . 62.7 m-85 -118.09 -158.68 0.72 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.99 0.9 . . . . 1.9399999999999999 112.14 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 81' ' ' ILE . . . -147.84 40.8 0.95 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 114.38 -1.282 . . . . 1.49 110.138 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.982 ' HA ' HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -64.37 -4.99 4.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.717 0.77 . . . . 1.95 110.759 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.895 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 48.89 -160.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.91 1.684 . . . . 3.4399999999999999 114.308 169.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 1.02 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 27.1 p -139.66 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.964 1.468 . . . . 2.9700000000000002 114.964 -166.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.823 ' HD2' HE21 ' A' ' 77' ' ' GLN . 3.7 Cg_exo -77.99 76.98 4.1 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.307 2.004 . . . . 3.0899999999999999 113.811 -170.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.2 -20.75 3.03 Favored Glycine 0 N--CA 1.462 0.397 0 C-N-CA 121.405 -0.426 . . . . 1.6399999999999999 112.751 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.823 HE21 ' HD2' ' A' ' 75' ' ' PRO . 18.4 mt-30 -77.99 -18.91 55.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.824 -1.547 . . . . 1.98 106.824 -172.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.737 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -47.15 -51.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 112.069 -2.332 . . . . 1.5700000000000001 110.908 -177.51 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.697 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 44.7 mtmt -54.0 -51.61 63.41 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 122.833 1.301 . . . . 2.48 109.343 -167.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.461 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.23 -35.5 15.29 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.176 -1.829 . . . . 2.8100000000000001 110.675 -169.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.982 HG23 ' HA ' ' A' ' 72' ' ' ASN . 46.5 mm -71.98 -13.6 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.176 -0.92 . . . . 1.6399999999999999 109.126 176.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 85' ' ' TYR . 43.9 tp -56.11 -19.89 15.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.469 -0.332 . . . . 1.3600000000000001 110.343 171.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.7 -22.23 1.98 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.777 0.322 . . . . 1.3600000000000001 111.428 167.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.25 -44.37 95.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.431 0.634 . . . . 2.0899999999999999 110.251 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.758 ' HE1' ' HD2' ' A' ' 70' ' ' TYR . 10.1 m-30 . . . . . 0 N--CA 1.427 -1.586 0 CA-C-N 115.018 -0.992 . . . . 1.77 112.082 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' FES . . . . . 1.219 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.72 ' HG2' ' CE1' ' A' ' 7' ' ' TYR . 25.4 ttpt . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 110.106 -0.331 . . . . 4.58 110.106 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.918 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.0 m-30 -108.5 82.69 1.72 Allowed Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 116.228 -0.442 . . . . 1.64 110.412 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.932 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 87.1 Cg_exo -52.72 94.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.835 2.356 . . . . 1.02 111.972 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.724 ' HB ' ' CG1' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -85.11 127.7 39.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 1.52 112.054 -173.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 14.3 m -100.37 110.99 23.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.286 -0.87 . . . . 1.45 110.627 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -117.21 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.409 . . . . 2.21 110.97 -178.659 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.708 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 24.4 t -67.38 121.24 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.195 -0.602 . . . . 2.24 111.611 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.0 mtm -123.82 23.11 8.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.934 -0.765 . . . . 5.12 108.934 164.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.03 177.38 19.65 Favored Glycine 0 C--O 1.219 -0.807 0 C-N-CA 120.945 -0.645 . . . . 3.86 112.624 -173.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.7 p -64.29 -43.89 93.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.69 0.626 . . . . 5.97 112.69 -168.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.701 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -69.88 -55.63 9.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.43 . . . . 4.41 111.361 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.708 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 86.6 m -66.53 -34.93 79.02 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.408 -0.36 . . . . 2.98 111.757 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 51.3 t80 -62.16 -32.16 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.909 0.484 . . . . 4.18 111.746 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 16' ' ' ALA . 4.2 p -70.91 -18.67 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.147 0.499 . . . . 3.65 110.818 -172.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -80.75 8.43 8.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.501 0.667 . . . . 4.79 109.769 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.78 54.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.561 -0.745 . . . . 1.87 112.048 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.57 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -73.43 -21.08 60.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.421 -0.389 . . . . 1.46 110.673 -172.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 26' ' ' VAL . 13.6 t70 -56.93 -46.55 81.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 2.42 111.309 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -66.88 -36.99 83.57 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.067 -0.653 . . . . 3.03 110.353 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.542 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -72.53 -38.18 58.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.797 -0.638 . . . . 2.26 111.182 177.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.607 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 4.6 m -66.19 -28.43 43.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 119.546 -0.862 . . . . 1.57 109.15 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.48 -40.47 82.82 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.577 -0.527 . . . . 1.35 109.577 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -50.96 -51.26 54.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.863 -1.062 . . . . 0.65 108.904 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.607 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 29.8 t80 -53.65 -48.77 69.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.95 -1.023 . . . . 1.98 112.0 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -46.75 -49.48 19.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.004 -0.998 . . . . 2.85 110.494 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -77.96 -26.79 49.02 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.676 -1.147 . . . . 2.23 110.619 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.651 ' OE1' ' HA ' ' A' ' 79' ' ' LYS . 4.6 mt-30 -60.5 -29.86 69.36 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.536 -0.757 . . . . 2.54 112.393 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.749 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 1.1 tt -48.42 -55.74 10.04 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.373 -1.714 . . . . 2.06 106.373 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.04 -18.81 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 126.513 2.383 . . . . 4.48 112.648 173.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.736 ' HA ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 51.71 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.398 -1.728 . . . . 3.76 113.996 165.287 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -155.51 -55.64 0.09 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.581 -1.645 . . . . 4.62 108.076 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 pt -167.53 9.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 112.728 -2.033 . . . . 5.0 108.486 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.92 -51.81 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.585 0 N-CA-C 108.981 -1.647 . . . . 4.13 108.981 -164.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.581 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -169.72 143.04 2.6 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.546 -0.827 . . . . 4.31 111.772 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.806 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER 18.83 -68.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 O-C-N 127.041 2.713 . . . . 2.96 115.167 161.215 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.624 ' H ' HG13 ' A' ' 40' ' ' VAL . 23.5 m -135.32 94.64 15.42 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 104.793 -2.299 . . . . 3.83 104.793 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -33.06 89.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.965 3.11 . . . . 3.83 113.608 -149.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -144.36 -65.1 0.35 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.919 -1.491 . . . . 4.26 111.37 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' H ' ' HB3' ' A' ' 39' ' ' ASP . . . 113.49 37.41 1.32 Allowed Glycine 0 C--N 1.31 -0.89 0 N-CA-C 110.32 -1.112 . . . . 2.01 110.32 -169.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.621 ' HD3' ' OXT' ' A' ' 85' ' ' TYR . 76.5 mtt180 -61.15 -42.26 98.23 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.876 -1.162 . . . . 3.34 109.845 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.806 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 99.3 m-85 -84.15 136.88 33.81 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.911 -1.041 . . . . 2.07 110.969 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.932 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 19.9 t -145.01 65.25 1.27 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.813 -1.18 . . . . 1.91 107.813 165.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.682 HG22 HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.97 129.17 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.331 -0.85 . . . . 3.19 111.99 -170.09 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -154.93 138.9 16.36 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.281 1.039 . . . . 3.31 110.784 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.7 p -43.86 -45.42 7.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.322 -1.763 . . . . 3.25 115.488 168.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.1 tp -53.16 -41.52 65.24 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.282 1.586 . . . . 4.45 115.282 -149.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -64.43 -57.34 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.931 0.872 . . . . 6.26 111.053 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -66.26 170.51 5.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.835 -1.53 . . . . 3.04 111.026 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG22 ' SG ' ' A' ' 12' ' ' CYS . 5.9 t 73.14 28.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.67 1.224 . . . . 4.32 109.175 -164.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.65 64.2 0.3 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 113.922 -1.49 . . . . 4.19 113.371 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.49 57.49 16.31 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.319 -1.42 . . . . 4.42 115.321 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.252 2.0 m -133.19 -33.32 1.14 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.706 1.253 . . . . 3.52 109.747 -161.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.98 -26.38 2.49 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.397 1.999 . . . . 3.64 116.397 -163.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.72 3.38 6.54 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.316 1.416 . . . . 5.44 111.413 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.94 158.36 50.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.245 -1.391 . . . . 3.22 107.245 154.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.15 118.6 5.03 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-N 121.191 1.461 . . . . 3.83 109.648 164.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.32 131.71 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.89 -0.141 . . . . 2.69 110.867 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.689 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 6.1 t -138.71 125.93 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.891 -1.151 . . . . 1.87 107.891 160.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.74 ' HG3' HG22 ' A' ' 69' ' ' VAL . 49.7 ttm -112.29 136.77 51.32 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 117.703 -1.599 . . . . 1.65 109.815 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.918 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.75 114.71 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 106.649 -1.612 . . . . 0.76 106.649 159.651 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.18 -145.87 1.65 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-O 122.337 0.965 . . . . 1.1 112.596 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.53 25.88 0.31 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.379 -1.411 . . . . 3.01 109.423 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.618 ' HD2' ' CE1' ' A' ' 7' ' ' TYR . 9.1 mmpt? -106.95 -40.82 5.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.298 -0.63 . . . . 2.62 109.298 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.74 HG22 ' HG3' ' A' ' 64' ' ' MET . 80.1 t 46.26 99.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.502 0.927 . . . . 1.51 113.502 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.733 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -117.03 -153.21 0.52 Allowed 'General case' 0 C--O 1.246 0.906 0 CA-C-O 122.07 0.938 . . . . 1.43 113.362 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.594 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -134.51 17.1 4.27 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.202 -1.363 . . . . 1.49 112.796 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.904 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 53.0 t-20 -89.53 98.52 11.81 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.945 -0.761 . . . . 1.83 108.945 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.618 HG13 HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -126.41 -90.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 122.181 0.991 . . . . 3.06 112.652 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.855 HG23 ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -137.77 -66.6 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 113.504 -1.68 . . . . 2.49 111.858 -170.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.855 ' HD3' HG23 ' A' ' 74' ' ' THR . 6.3 Cg_exo -76.84 70.87 6.36 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.648 2.232 . . . . 2.65 114.019 -162.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 80.1 -19.55 6.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.105 -0.569 . . . . 1.4 113.108 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.541 ' O ' HG12 ' A' ' 81' ' ' ILE . 3.8 mt-30 -73.98 -22.86 59.45 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.342 -1.725 . . . . 1.87 106.342 -170.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 79' ' ' LYS . 13.6 m -48.7 -59.18 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 111.826 -2.443 . . . . 0.97 111.386 -175.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.657 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 23.6 pttt -60.17 -39.49 86.62 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.783 0.801 . . . . 2.13 110.741 -165.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.657 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -82.38 -45.27 15.07 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.75 -1.113 . . . . 2.41 109.646 -173.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' A' ' 72' ' ' ASN . 39.5 mm -69.39 -15.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.211 -1.358 . . . . 1.23 110.155 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HA ' HD21 ' A' ' 72' ' ' ASN . 53.6 tp -63.04 -37.81 88.67 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.74 -0.6 . . . . 0.79 110.256 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.7 64.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.013 -0.736 . . . . 0.88 109.013 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 6.6 mt-10 -73.66 -34.49 64.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.871 -1.059 . . . . 2.09 112.748 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 5.1 m-30 . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 118.951 -0.547 . . . . 1.77 112.044 -175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 3.8 tppp? . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 109.422 -0.585 . . . . 4.58 109.422 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 1.071 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 22.5 m-85 -141.71 62.71 15.34 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 114.364 -1.289 . . . . 1.64 110.254 -175.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD2' ' CA ' ' A' ' 66' ' ' GLY . 33.4 Cg_exo -61.48 92.81 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.534 1.489 . . . . 1.02 109.949 172.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.066 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.03 160.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 116.409 -0.36 . . . . 1.52 110.426 -168.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.806 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m -139.86 112.84 8.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 123.644 0.59 . . . . 1.45 111.343 -174.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.7 t -118.17 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.182 -0.917 . . . . 2.21 109.857 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -65.39 120.38 12.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 118.775 0.716 . . . . 2.24 110.958 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ttt -124.3 23.05 8.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.503 -0.771 . . . . 5.12 109.654 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -68.06 177.52 23.73 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.797 . . . . 3.86 112.417 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -67.65 -43.8 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.078 0.399 . . . . 5.97 112.078 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.642 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -71.29 -56.8 5.29 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.549 0.574 . . . . 4.41 112.549 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 98.9 m -63.48 -30.53 71.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.506 -0.316 . . . . 2.98 111.572 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.575 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 56.4 t80 -59.31 -29.53 67.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.286 0.635 . . . . 4.18 112.179 -176.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 16' ' ' ALA . 16.9 m -69.15 -18.65 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 111.91 0.337 . . . . 3.65 111.91 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.02 13.32 2.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.807 0.337 . . . . 4.79 110.591 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.4 28.73 23.99 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.649 -0.58 . . . . 1.87 111.649 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -72.48 -19.63 61.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.253 -0.474 . . . . 1.46 110.97 -172.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . 8.5 p-10 -55.7 -45.0 77.92 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.887 -0.325 . . . . 2.42 110.429 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -62.61 -48.29 80.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.352 -0.539 . . . . 3.03 110.782 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.033 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 6.6 m -65.52 -44.3 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 116.305 -0.407 . . . . 2.26 110.526 -176.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' ASP . 15.0 m -64.17 -36.45 77.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.149 -0.62 . . . . 1.57 110.2 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -60.18 -42.57 95.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.107 -0.637 . . . . 1.35 109.398 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.75 -46.66 81.27 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.42 -1.264 . . . . 0.65 108.629 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.449 ' HZ ' ' CG1' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -44.59 82.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.875 . . . . 1.98 111.425 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -54.63 -51.21 66.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.723 0.773 . . . . 2.85 110.085 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.77 -20.75 38.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.935 -1.03 . . . . 2.23 110.653 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.597 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -62.0 -30.64 71.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.781 -0.645 . . . . 2.54 110.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.098 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.8 tt -54.69 -54.24 44.41 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.259 -1.015 . . . . 2.06 108.259 172.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 65.77 -19.52 0.09 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.357 -2.202 . . . . 4.48 112.493 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.698 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER 54.36 -170.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.501 -1.681 . . . . 3.76 113.12 168.083 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -157.38 -49.56 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.208 -1.405 . . . . 4.62 107.208 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -164.92 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 113.069 -1.878 . . . . 5.0 110.836 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -178.05 -61.98 0.07 OUTLIER Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 109.783 -1.327 . . . . 4.13 109.783 -166.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.584 ' HB2' ' N ' ' A' ' 44' ' ' GLY . 38.2 m-20 -165.52 122.12 1.42 Allowed 'General case' 0 CA--C 1.475 -1.925 0 CA-C-N 113.051 -1.575 . . . . 4.31 108.796 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.986 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 1.4 p 54.99 -71.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 O-C-N 126.775 2.547 . . . . 2.96 113.348 169.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.788 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 84.3 m -151.18 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.275 -2.662 0 CA-C-N 113.262 -1.79 . . . . 3.83 110.256 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.819 ' HD2' HG13 ' A' ' 40' ' ' VAL . 7.1 Cg_exo -73.83 4.42 4.15 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 120.673 0.915 . . . . 3.83 113.946 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 20.2 t70 78.09 14.12 1.56 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.294 -1.373 . . . . 4.26 107.294 169.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.584 ' N ' ' HB2' ' A' ' 39' ' ' ASP . . . 155.07 63.58 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 114.151 -1.386 . . . . 2.01 112.278 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 10.5 ttt180 -94.7 -64.69 1.04 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.814 -1.55 . . . . 3.34 106.814 171.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.098 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -107.23 123.99 49.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.752 -0.658 . . . . 2.07 112.281 171.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.459 ' C ' HG23 ' A' ' 9' ' ' ILE . 4.2 m -105.33 92.15 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.966 . . . . 1.91 109.279 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.005 HG22 HD13 ' A' ' 9' ' ' ILE . 2.3 pp -60.18 123.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.774 -0.648 . . . . 3.19 112.72 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.806 ' O ' ' HA ' ' A' ' 10' ' ' SER . 5.3 t70 -160.85 140.49 10.77 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.241 1.019 . . . . 3.31 113.051 167.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t -47.51 -45.96 26.9 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 115.111 1.522 . . . . 3.25 115.111 169.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.439 ' HG ' ' OD1' ' A' ' 49' ' ' ASP . 51.6 mt -53.49 -38.12 63.38 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.254 2.316 . . . . 4.45 117.254 -152.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.4 mmt180 -61.78 -56.82 15.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.757 1.162 . . . . 6.26 110.18 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.699 ' H ' ' HB3' ' A' ' 10' ' ' SER . 27.4 t -65.07 165.46 11.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.327 -1.76 . . . . 3.04 109.938 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.695 HG22 ' SG ' ' A' ' 12' ' ' CYS . 10.9 t 71.26 25.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 122.93 1.347 . . . . 4.32 108.188 -156.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.51 64.11 0.35 Allowed Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 113.583 -1.644 . . . . 4.19 113.538 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.33 57.71 14.21 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 119.11 -1.519 . . . . 4.42 115.3 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.67 ' HB3' HG21 ' A' ' 62' ' ' ILE 0.267 1.8 m -135.7 -32.65 0.89 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.564 1.182 . . . . 3.52 110.416 -162.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -28.64 5.66 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.477 1.658 . . . . 3.64 115.477 -163.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.57 7.63 2.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.777 1.172 . . . . 5.44 112.053 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.7 160.55 36.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.888 -0.782 . . . . 3.22 108.888 164.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.89 122.18 7.09 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 N-CA-C 108.787 -1.274 . . . . 3.83 108.787 160.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 57' ' ' CYS . 1.9 pp -110.0 133.68 54.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.875 1.065 . . . . 2.69 113.875 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.762 HG21 ' H ' ' A' ' 73' ' ' VAL . 4.0 t -138.03 119.19 17.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.022 -1.844 . . . . 1.87 106.022 154.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.752 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 20.9 ttt -114.36 135.34 54.19 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 120.33 -1.481 . . . . 1.65 111.926 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.071 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -126.57 118.43 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 N-CA-C 107.635 -1.246 . . . . 0.76 107.635 157.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.559 ' CA ' ' HD2' ' A' ' 8' ' ' PRO . . . 60.2 -169.78 7.53 Favored Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.886 -1.15 . . . . 1.1 110.481 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.83 37.96 0.31 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.926 -1.138 . . . . 3.01 107.926 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 54.6 mmtt -107.89 -31.21 8.1 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.892 -1.049 . . . . 2.62 108.646 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.661 ' C ' ' HD1' ' A' ' 70' ' ' TYR . 75.7 t 47.54 113.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 114.472 1.286 . . . . 1.51 114.472 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.678 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -123.53 -170.11 2.06 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 122.615 1.197 . . . . 1.43 112.967 -172.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.71 49.9 0.82 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 113.662 -1.608 . . . . 1.49 110.178 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.919 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -77.92 -0.41 27.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.361 1.077 . . . . 1.83 110.062 175.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.762 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 64.33 -165.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 113.749 -1.569 . . . . 3.06 111.65 168.644 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 1.033 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 64.4 p -138.58 -46.67 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 114.22 1.193 . . . . 2.49 114.22 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.522 ' CD ' ' H ' ' A' ' 74' ' ' THR . 7.0 Cg_endo -88.29 78.58 1.33 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.895 1.73 . . . . 2.65 113.787 -172.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.28 -23.17 2.33 Favored Glycine 0 N--CA 1.461 0.335 0 C-N-CA 121.01 -0.614 . . . . 1.4 113.078 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.466 ' O ' HG12 ' A' ' 81' ' ' ILE . 34.3 mt-30 -75.28 -21.12 58.76 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.413 -1.699 . . . . 1.87 106.413 -174.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.666 HG23 ' H ' ' A' ' 79' ' ' LYS . 4.0 m -45.09 -61.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 111.478 -2.601 . . . . 0.97 112.162 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.666 ' H ' HG23 ' A' ' 78' ' ' VAL . 43.3 mtmt -58.03 -32.03 67.57 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 122.039 0.923 . . . . 2.13 110.657 -166.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -81.28 -50.84 9.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.53 -1.214 . . . . 2.41 108.837 -177.506 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.919 ' CG2' ' HA ' ' A' ' 72' ' ' ASN . 28.8 mm -66.14 -5.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 113.549 -1.66 . . . . 1.23 110.601 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 47.0 tp -54.22 -21.67 9.58 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.508 -0.745 . . . . 0.79 110.143 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.84 -19.66 6.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.687 -0.688 . . . . 0.88 111.352 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 70' ' ' TYR . 6.6 tp10 -69.53 -51.34 36.54 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.44 1.096 . . . . 2.09 110.241 173.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.678 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 11.4 m-30 . . . . . 0 N--CA 1.425 -1.693 0 CA-C-N 113.673 -1.603 . . . . 1.77 112.811 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 24.2 tptp . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 108.817 -0.809 . . . . 4.58 108.817 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 1.092 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -115.89 87.51 18.71 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.711 -1.132 . . . . 1.64 110.916 175.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.34 96.55 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.637 2.225 . . . . 1.02 111.565 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.084 HD13 HG22 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -75.17 117.83 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.799 0.809 . . . . 1.52 110.289 -175.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.694 ' HB3' ' H ' ' A' ' 53' ' ' CYS . 7.3 m -100.14 113.02 25.35 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.139 -1.391 . . . . 1.45 110.528 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.635 HG11 HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -118.48 122.81 70.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.274 -0.875 . . . . 2.21 110.328 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.736 ' SG ' HG22 ' A' ' 54' ' ' VAL . 33.7 t -66.47 122.82 18.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.279 0.561 . . . . 2.24 111.284 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -122.69 23.87 9.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.428 -0.805 . . . . 5.12 109.699 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.95 178.68 20.21 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.792 -0.718 . . . . 3.86 112.778 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -65.36 -44.85 86.38 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.462 0.541 . . . . 5.97 112.462 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 -55.05 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.271 0.558 . . . . 4.41 111.851 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 79.4 m -64.69 -31.08 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.537 -0.756 . . . . 2.98 111.541 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 75.6 t80 -58.35 -27.43 64.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.447 0.699 . . . . 4.18 111.576 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.74 -20.82 26.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.058 -0.519 . . . . 3.65 111.468 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -80.79 11.48 3.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.159 -0.338 . . . . 4.79 111.224 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.38 29.44 27.48 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.725 -0.75 . . . . 1.87 111.954 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -71.93 -20.47 61.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.906 0.335 . . . . 1.46 111.906 -168.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 26' ' ' VAL . 27.1 t70 -57.86 -45.34 86.42 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.845 -0.342 . . . . 2.42 110.881 -176.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -64.92 -42.52 94.64 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.609 . . . . 3.03 111.134 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.9 m -68.91 -39.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.707 0.289 . . . . 2.26 111.228 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.875 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . 10.7 m -65.31 -33.35 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.817 -0.753 . . . . 1.57 110.258 175.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.58 -39.33 87.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.253 0.549 . . . . 1.35 109.551 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 78' ' ' VAL . . . -55.08 -45.84 75.42 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.701 -1.136 . . . . 0.65 109.443 175.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.914 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 23.1 m-85 -52.15 -50.11 62.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 123.46 0.475 . . . . 1.98 111.02 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -49.91 -50.83 44.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.53 0.681 . . . . 2.85 111.312 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.52 -30.22 37.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.296 -0.865 . . . . 2.23 111.39 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.914 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -68.01 -19.29 64.9 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.741 -0.663 . . . . 2.54 110.313 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.04 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -54.52 -56.48 18.42 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 106.153 -1.795 . . . . 2.06 106.153 169.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 70.16 -21.86 0.17 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.775 -2.011 . . . . 4.48 110.909 168.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.717 HG12 HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 56.56 -176.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 112.508 -2.133 . . . . 3.76 113.702 166.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 35' ' ' ILE . 12.9 t70 -158.68 -44.11 0.06 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.075 -1.42 . . . . 4.62 107.748 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.5 pt -168.3 -0.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 113.226 -1.806 . . . . 5.0 111.416 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 176.77 -52.66 0.11 Allowed Glycine 0 CA--C 1.483 -1.923 0 N-CA-C 107.629 -2.188 . . . . 4.13 107.629 -162.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.757 ' CG ' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -171.54 135.54 0.91 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.266 -1.967 . . . . 4.31 109.732 175.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.757 HG12 ' CG ' ' A' ' 39' ' ' ASP . 7.1 p 39.06 -65.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 127.502 3.001 . . . . 2.96 114.955 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.788 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 45.0 m -150.82 -60.11 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.69 -1.595 . . . . 3.83 110.833 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.822 ' HG2' ' HG3' ' A' ' 45' ' ' ARG . 1.1 Cg_endo -88.33 15.51 2.07 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 121.618 1.546 . . . . 3.83 114.937 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 25.8 t70 83.38 -1.75 1.17 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.143 0.973 . . . . 4.26 109.708 160.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.18 53.11 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.774 -1.203 . . . . 2.01 113.566 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.822 ' HG3' ' HG2' ' A' ' 42' ' ' PRO . 20.0 mtt180 -72.26 -53.9 11.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.924 -0.769 . . . . 3.34 108.924 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.04 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -128.08 120.3 27.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.552 1.167 . . . . 2.07 113.768 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.9 p -114.68 106.73 14.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.818 -1.537 . . . . 1.91 108.307 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.084 HG22 HD13 ' A' ' 9' ' ' ILE . 2.0 pp -72.91 121.06 22.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.378 -0.828 . . . . 3.19 112.229 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.49 141.95 15.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 122.744 1.259 . . . . 3.31 112.225 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 21.4 m -43.92 -46.24 8.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.614 2.079 . . . . 3.25 116.614 174.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.44 -41.12 65.76 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.776 2.139 . . . . 4.45 116.776 -147.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 12.7 tpt180 -63.39 -57.72 9.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.271 0.941 . . . . 6.26 110.786 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.694 ' H ' ' HB3' ' A' ' 10' ' ' SER . 33.0 t -65.18 172.72 2.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.591 -1.64 . . . . 3.04 110.727 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.736 HG22 ' SG ' ' A' ' 12' ' ' CYS . 13.5 t 76.2 29.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 122.93 1.348 . . . . 4.32 109.538 -160.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.2 61.65 0.31 Allowed Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 113.849 -1.523 . . . . 4.19 112.555 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.97 54.98 32.38 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 119.892 -1.147 . . . . 4.42 115.709 169.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.257 1.4 m -135.12 -32.49 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.202 1.501 . . . . 3.52 109.704 -161.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.89 -25.27 1.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.921 1.823 . . . . 3.64 115.921 -163.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.63 8.14 1.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.563 1.074 . . . . 5.44 111.791 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.68 161.91 27.97 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.053 -1.092 . . . . 3.22 108.053 162.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.33 119.96 6.27 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 120.704 1.287 . . . . 3.83 109.309 166.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.47 132.74 56.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.429 0.529 . . . . 2.69 112.429 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.721 HG21 ' H ' ' A' ' 73' ' ' VAL . 2.5 t -138.7 119.76 16.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.446 -1.687 . . . . 1.87 106.446 154.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.661 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 20.8 ttt -112.42 136.27 52.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 120.369 -1.457 . . . . 1.65 110.0 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.092 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -125.26 117.15 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.413 -1.329 . . . . 0.76 107.413 159.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 55.09 -162.3 4.72 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.146 -1.026 . . . . 1.1 110.863 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -79.06 34.48 0.24 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.889 -0.782 . . . . 3.01 108.889 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.663 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 70.9 mmtt -108.47 -22.18 12.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.279 -0.873 . . . . 2.62 110.012 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 23.2 m 36.54 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 115.134 1.531 . . . . 1.51 115.134 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.789 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -116.31 -178.33 3.39 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.979 1.371 . . . . 1.43 113.598 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.05 48.67 0.91 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 113.381 -1.736 . . . . 1.49 109.603 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.913 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -78.4 -0.89 30.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.902 0.858 . . . . 1.83 109.191 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.721 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 63.31 -168.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 113.909 -1.496 . . . . 3.06 111.282 171.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.863 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 13.3 p -135.74 -46.36 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 113.946 1.091 . . . . 2.49 113.946 -169.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.534 ' HD3' ' H ' ' A' ' 74' ' ' THR . 4.5 Cg_endo -88.73 85.45 0.58 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.185 1.923 . . . . 2.65 113.224 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.32 -27.77 2.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.17 -0.538 . . . . 1.4 112.774 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.882 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 41.0 mt-30 -77.31 -18.62 57.33 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.064 -1.458 . . . . 1.87 107.064 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.577 HG21 ' HB1' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -46.72 -58.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-N 112.444 -2.162 . . . . 0.97 111.354 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.3 pttt -62.17 -38.06 87.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.426 0.631 . . . . 2.13 111.096 -166.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.882 ' HD2' ' HA ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.85 -34.05 15.42 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.074 0.464 . . . . 2.41 110.873 -176.257 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.913 HG22 ' HA ' ' A' ' 72' ' ' ASN . 47.9 mm -72.45 -10.79 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.909 -0.774 . . . . 1.23 108.909 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.974 HD12 ' HB2' ' A' ' 85' ' ' TYR . 16.7 tp -57.84 -12.97 3.55 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.462 0.705 . . . . 0.79 110.467 171.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -25.58 6.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.08 -0.648 . . . . 0.88 110.076 163.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 5.7 mm-40 -65.49 -49.95 67.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.459 -0.791 . . . . 2.09 110.97 169.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.974 ' HB2' HD12 ' A' ' 82' ' ' LEU . 12.6 m-30 . . . . . 0 N--CA 1.428 -1.556 0 CA-C-N 115.682 -0.69 . . . . 1.77 112.099 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 120.848 0.356 . . . . 4.58 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.821 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.0 m-85 -111.85 98.73 42.82 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 116.094 -0.503 . . . . 1.64 111.915 -172.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.909 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 80.0 Cg_exo -50.69 96.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.882 2.388 . . . . 1.02 112.19 171.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.043 HD13 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.24 115.37 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.79 0.805 . . . . 1.52 110.112 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.718 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 14.0 m -92.61 127.34 38.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.194 -1.366 . . . . 1.45 109.987 -176.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 t -114.25 126.47 71.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 2.21 112.328 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 16.3 t -64.21 115.17 4.75 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.555 0.693 . . . . 2.24 112.138 -175.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.472 ' H ' HG22 ' A' ' 54' ' ' VAL . 84.6 mtp -129.26 24.6 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 5.12 110.737 172.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.812 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . -65.57 176.73 14.11 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.381 -0.914 . . . . 3.86 114.14 -167.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 t -66.17 -45.85 79.45 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.821 0.304 . . . . 5.97 111.821 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 25.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.744 0.783 . . . . 4.41 110.162 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 76.9 m -61.93 -35.73 79.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.312 -1.313 . . . . 2.98 112.237 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 54.0 t80 -61.66 -31.74 71.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.008 0.432 . . . . 4.18 111.024 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.0 t -71.98 -21.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 3.65 110.319 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 27.4 mtpp -82.8 12.92 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.925 -0.579 . . . . 4.79 111.803 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.56 32.06 14.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.151 -1.023 . . . . 1.87 111.906 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.581 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -70.86 -20.97 62.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.635 0.235 . . . . 1.46 111.635 -170.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.585 ' O ' HG22 ' A' ' 26' ' ' VAL . 25.0 t70 -55.82 -49.58 72.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.953 0.406 . . . . 2.42 110.144 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 2.5 mptp? -66.94 -39.62 87.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.561 -0.456 . . . . 3.03 111.59 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.942 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 3.3 m -68.58 -41.09 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 120.888 -0.325 . . . . 2.26 110.843 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 23' ' ' ASP . 8.0 m -64.96 -34.08 68.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.831 -0.748 . . . . 1.57 110.003 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 62.0 t-80 -59.42 -39.4 83.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.26 0.552 . . . . 1.35 109.805 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.673 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -54.71 -50.48 68.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.868 -1.06 . . . . 0.65 108.725 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.858 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.2 m-85 -50.57 -47.27 57.91 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 123.877 0.736 . . . . 1.98 111.68 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 25.1 tptp -49.3 -56.32 9.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 2.85 111.213 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -83.35 -19.67 35.71 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.268 -0.878 . . . . 2.23 111.513 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.858 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.82 -22.1 65.17 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.876 -0.602 . . . . 2.54 110.684 177.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.662 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -50.1 -59.63 3.72 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.55 -1.648 . . . . 2.06 106.55 167.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.581 ' C ' HG13 ' A' ' 35' ' ' ILE . 4.4 pttm 68.09 -27.34 0.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 112.412 -2.177 . . . . 4.48 111.674 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.681 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 55.55 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.24 -1.8 . . . . 3.76 113.379 172.309 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 37' ' ' ILE . 14.9 t70 -155.14 -53.55 0.09 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.214 -1.402 . . . . 4.62 107.214 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.3 pt -174.43 19.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 112.734 -2.03 . . . . 5.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.02 -70.81 0.05 OUTLIER Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 109.278 -1.529 . . . . 4.13 109.278 -168.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.596 ' HA ' HD21 ' A' ' 33' ' ' LEU . 10.5 m-20 -165.27 119.82 1.28 Allowed 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 112.996 -1.602 . . . . 4.31 109.293 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.951 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 7.5 p 56.11 -65.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 126.636 2.46 . . . . 2.96 114.259 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.934 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 64.8 m -164.19 -59.79 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.745 0 CA-C-N 113.236 -1.802 . . . . 3.83 110.06 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.934 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 16.3 Cg_exo -71.3 8.51 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.715 0 N-CA-C 114.493 0.92 . . . . 3.83 114.493 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 11.5 t70 86.56 -15.67 0.44 Allowed 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.613 -0.514 . . . . 4.26 109.613 161.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . -170.23 47.13 0.2 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.068 -1.539 . . . . 2.01 113.819 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -72.86 -32.44 65.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.94 0.876 . . . . 3.34 109.382 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.951 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 49.9 m-85 -96.58 153.29 17.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.194 -1.366 . . . . 2.07 112.386 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.909 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 31.2 t -152.8 66.72 0.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.556 -1.646 . . . . 1.91 106.556 161.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.043 HG22 HD13 ' A' ' 9' ' ' ILE . 2.2 pp -60.09 114.67 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.475 -1.239 . . . . 3.19 112.68 -168.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -161.15 144.53 12.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.746 1.26 . . . . 3.31 112.738 168.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 m -42.76 -43.09 3.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.917 -1.947 . . . . 3.25 115.022 167.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.7 mt -52.21 -41.87 63.06 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 116.058 1.874 . . . . 4.45 116.058 -147.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.54 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 24.1 mmt85 -64.71 -56.97 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.556 1.17 . . . . 6.26 110.261 174.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 35.9 t -66.31 167.05 11.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.714 -2.039 . . . . 3.04 112.617 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' HA2' ' A' ' 14' ' ' GLY . 15.7 t 70.44 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 123.053 1.406 . . . . 4.32 109.411 -168.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.26 64.66 0.31 Allowed Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 113.626 -1.624 . . . . 4.19 113.129 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.08 58.02 13.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 118.719 -1.705 . . . . 4.42 114.941 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.279 1.8 m -132.2 -31.05 1.48 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.618 1.209 . . . . 3.52 109.083 -162.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.7 -27.06 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.554 1.687 . . . . 3.64 115.554 -163.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.24 5.03 3.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.181 1.355 . . . . 5.44 111.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.03 158.65 45.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.078 -1.082 . . . . 3.22 108.078 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -76.61 121.69 6.09 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.494 1.212 . . . . 3.83 109.319 163.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.3 tt -108.34 132.14 56.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.114 -0.635 . . . . 2.69 112.188 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.84 HG21 ' H ' ' A' ' 73' ' ' VAL . 20.9 t -137.88 118.43 16.42 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 105.686 -1.968 . . . . 1.87 105.686 158.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.689 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 17.1 ttt -116.87 137.83 51.94 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.442 -1.411 . . . . 1.65 110.648 -172.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.821 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -124.45 117.09 49.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 107.045 -1.465 . . . . 0.76 107.045 155.4 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . 51.47 -157.52 2.9 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.527 -0.629 . . . . 1.1 111.527 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.14 39.94 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.66 -0.867 . . . . 3.01 108.66 170.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.633 ' HB2' HG23 ' A' ' 65' ' ' VAL . 26.0 mmmt -108.33 -26.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.478 -0.783 . . . . 2.62 109.221 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.629 HG12 ' HG3' ' A' ' 64' ' ' MET . 9.2 m 36.01 109.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 115.138 1.533 . . . . 1.51 115.138 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.713 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.9 m-85 -118.86 -169.88 1.81 Allowed 'General case' 0 C--O 1.248 0.98 0 CA-C-O 122.86 1.314 . . . . 1.43 113.003 -173.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.82 46.45 0.8 Allowed Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 113.55 -1.659 . . . . 1.49 109.955 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.932 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.78 -0.58 21.52 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.981 0.896 . . . . 1.83 110.049 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.84 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 63.22 -165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 114.12 -1.4 . . . . 3.06 112.679 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.942 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.1 p -137.56 -45.13 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 113.604 0.965 . . . . 2.49 113.604 -168.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.579 ' CD ' ' H ' ' A' ' 74' ' ' THR . 83.5 Cg_endo -88.68 77.56 1.34 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 121.845 1.697 . . . . 2.65 113.705 -171.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.92 -24.26 2.87 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.171 -0.538 . . . . 1.4 113.031 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.558 ' O ' HG12 ' A' ' 81' ' ' ILE . 33.7 mt-30 -75.24 -20.9 58.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.565 -1.643 . . . . 1.87 106.565 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.546 HG21 ' HB1' ' A' ' 28' ' ' ALA . 2.7 m -43.58 -56.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 111.559 -2.564 . . . . 0.97 112.025 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.755 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.2 mtmt -56.73 -42.13 78.71 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 122.181 0.991 . . . . 2.13 110.003 -167.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -42.43 13.94 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.34 -1.3 . . . . 2.41 109.812 -172.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.932 HG22 ' HA ' ' A' ' 72' ' ' ASN . 41.3 mm -67.99 -13.78 17.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.694 -1.139 . . . . 1.23 109.29 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.944 HD12 ' HB2' ' A' ' 85' ' ' TYR . 27.2 tp -59.56 -13.42 9.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.657 0.783 . . . . 0.79 110.592 170.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.62 -26.27 8.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.255 -0.578 . . . . 0.88 109.963 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 8.8 mm-40 -62.79 -51.99 64.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.09 109.745 169.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.944 ' HB2' HD12 ' A' ' 82' ' ' LEU . 8.9 m-30 . . . . . 0 N--CA 1.424 -1.735 0 CA-C-N 114.812 -1.086 . . . . 1.77 112.259 -171.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 122.618 1.199 . . . . 4.58 110.739 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.768 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 7.3 m-85 -55.64 113.08 5.02 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.412 -1.722 . . . . 1.64 114.365 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.781 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 72.5 Cg_exo -56.07 90.96 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.1 2.533 . . . . 1.02 111.919 166.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.799 HD13 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.87 119.12 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.675 0.75 . . . . 1.52 110.661 -177.271 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 2.6 m -100.46 114.44 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.606 -1.179 . . . . 1.45 111.291 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.8 t -117.98 122.88 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 2.21 110.85 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 25.1 t -67.61 121.2 15.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.28 -0.568 . . . . 2.24 111.553 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.8 mtp -124.61 23.41 8.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.63 -0.714 . . . . 5.12 109.584 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.67 179.61 12.47 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.178 -0.534 . . . . 3.86 112.998 -174.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -64.25 -45.42 88.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.069 0.396 . . . . 5.97 112.069 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -70.97 -56.41 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.078 0.466 . . . . 4.41 112.178 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.697 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.4 m -66.28 -33.79 76.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.91 -0.587 . . . . 2.98 111.993 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -60.6 -29.86 69.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.575 0.584 . . . . 4.18 112.575 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 16' ' ' ALA . 18.2 m -69.43 -18.95 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.771 0.32 . . . . 3.65 111.526 -171.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -80.57 12.88 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.541 -0.299 . . . . 4.79 110.923 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.25 29.04 26.19 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 121.114 -0.565 . . . . 1.87 111.98 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.1 -20.67 61.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.493 -0.353 . . . . 1.46 110.862 -172.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 26' ' ' VAL . 24.8 t70 -53.99 -50.42 66.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 2.42 110.759 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -66.87 -40.51 87.86 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.304 -0.559 . . . . 3.03 111.152 -172.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.877 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 1.9 m -69.45 -42.71 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.451 -0.34 . . . . 2.26 110.655 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 23' ' ' ASP . 17.6 m -66.15 -29.0 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 119.522 -0.871 . . . . 1.57 109.99 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -58.7 -41.2 85.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.137 0.494 . . . . 1.35 109.747 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -54.84 -46.04 74.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.848 -1.069 . . . . 0.65 109.707 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -49.86 65.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.581 . . . . 1.98 110.411 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -51.9 -50.13 61.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 2.85 111.547 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -79.96 -25.82 40.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.553 -0.749 . . . . 2.23 110.982 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.679 ' NE2' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -61.82 -34.84 76.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.411 -0.589 . . . . 2.54 109.411 175.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.773 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -45.29 -58.74 3.08 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 107.012 -1.477 . . . . 2.06 107.012 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 66.04 -24.77 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.729 -2.032 . . . . 4.48 112.093 171.11 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.719 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.95 -174.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.477 -1.692 . . . . 3.76 113.762 168.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.572 ' O ' HG23 ' A' ' 37' ' ' ILE . 11.0 t70 -156.0 -48.51 0.08 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.077 -1.419 . . . . 4.62 107.497 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 36' ' ' ASP . 1.4 pt -172.09 16.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-N 113.35 -1.75 . . . . 5.0 110.751 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -176.38 -66.94 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.883 -1.287 . . . . 4.13 109.883 -169.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 18.8 m-20 -164.81 117.46 1.25 Allowed 'General case' 0 CA--C 1.484 -1.583 0 CA-C-N 113.268 -1.466 . . . . 4.31 110.296 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.956 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.4 p 57.19 -64.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 126.882 2.613 . . . . 2.96 113.592 171.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.928 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 90.6 m -157.04 -60.45 0.02 OUTLIER Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 113.272 -1.785 . . . . 3.83 110.867 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.928 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 13.8 Cg_exo -70.94 2.18 4.46 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 120.426 0.751 . . . . 3.83 113.449 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 4.4 t70 82.55 4.29 1.08 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-O 123.404 1.574 . . . . 4.26 107.687 167.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 168.47 63.29 0.03 OUTLIER Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 112.539 -2.119 . . . . 2.01 110.225 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.639 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 18.7 tpp85 -93.12 -34.63 13.57 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.296 -1.742 . . . . 3.34 106.296 166.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.956 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 25.1 m-85 -87.9 152.59 21.97 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 110.826 -2.897 . . . . 2.07 110.567 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.781 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 54.1 m -153.55 68.67 0.79 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.618 -1.252 . . . . 1.91 107.618 163.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.799 HG22 HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -69.9 122.62 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.299 -0.864 . . . . 3.19 112.272 -168.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.722 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.0 p30 -156.24 139.11 15.28 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.345 1.069 . . . . 3.31 111.219 164.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 19.9 p -43.61 -46.13 7.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.616 -1.629 . . . . 3.25 115.206 169.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.91 -39.52 65.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.869 1.804 . . . . 4.45 115.869 -151.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.1 -57.27 11.15 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.085 0.945 . . . . 6.26 109.88 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.691 ' O ' HG22 ' A' ' 54' ' ' VAL . 34.3 t -65.6 167.44 8.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 3.04 109.731 173.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 53' ' ' CYS . 1.9 m 72.34 26.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 125.398 1.479 . . . . 4.32 110.129 -159.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.21 65.2 0.26 Allowed Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 113.665 -1.607 . . . . 4.19 112.995 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 57.28 15.49 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 119.492 -1.337 . . . . 4.42 115.235 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.97 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.293 1.8 m -134.48 -32.55 1.02 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.712 1.256 . . . . 3.52 109.943 -162.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.65 2.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.282 1.956 . . . . 3.64 116.282 -160.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 1.2 pp -74.37 5.16 4.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.425 1.466 . . . . 5.44 112.101 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.46 159.46 45.71 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.264 -1.013 . . . . 3.22 108.264 159.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.54 119.66 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 120.372 1.168 . . . . 3.83 109.869 161.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.97 HG13 ' HB3' ' A' ' 57' ' ' CYS . 42.8 mm -110.98 134.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.609 0.226 . . . . 2.69 111.609 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.409 HG12 ' OH ' ' A' ' 85' ' ' TYR . 11.7 t -136.52 123.0 30.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 107.503 -1.295 . . . . 1.87 107.503 163.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 45.5 ttm -114.49 138.0 51.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.002 -1.686 . . . . 1.65 111.313 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -125.01 115.67 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.424 -1.324 . . . . 0.76 107.424 158.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.519 ' CA ' ' HD2' ' A' ' 8' ' ' PRO . . . 46.37 -144.35 4.14 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-O 122.598 1.11 . . . . 1.1 112.67 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -82.8 27.69 0.52 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 113.369 -1.415 . . . . 3.01 109.462 176.084 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.773 ' HB2' HG23 ' A' ' 65' ' ' VAL . 14.3 mmmm -107.26 -24.19 11.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.875 -0.602 . . . . 2.62 110.659 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.9 m 33.95 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.281 0.988 . . . . 1.51 113.484 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.68 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -99.53 -168.83 1.66 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.469 1.604 . . . . 1.43 114.247 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 73' ' ' VAL . . . -134.89 57.27 0.7 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.001 -1.909 . . . . 1.49 110.093 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.624 ' HA ' HG21 ' A' ' 81' ' ' ILE . 44.5 t-20 -86.37 39.64 0.84 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 123.17 1.462 . . . . 1.83 109.053 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.882 HG21 ' HB2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER 47.78 -161.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 112.684 -2.053 . . . . 3.06 113.634 155.02 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.877 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.4 p -134.71 -45.58 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 113.016 0.747 . . . . 2.49 113.016 173.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -75.1 -85.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 121.87 1.714 . . . . 2.65 114.367 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.24 0.15 5.97 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.748 -0.739 . . . . 1.4 112.106 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.882 ' HB2' HG21 ' A' ' 73' ' ' VAL . 67.5 mt-30 -81.26 -13.47 58.45 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 106.382 -1.711 . . . . 1.87 106.382 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.679 ' HB ' ' NE2' ' A' ' 32' ' ' GLN . 2.7 m -51.71 -46.92 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 111.988 -2.369 . . . . 0.97 109.904 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 34.2 mttm -57.28 -44.23 83.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.123 -1.399 . . . . 2.13 109.353 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -77.85 -42.49 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.599 -1.637 . . . . 2.41 109.755 -175.402 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.658 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 33.5 mm -68.4 -17.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.616 -0.72 . . . . 1.23 110.191 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.684 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 9.6 tp -57.92 -38.32 75.66 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.545 -0.722 . . . . 0.79 110.463 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -33.5 69.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.37 0.605 . . . . 0.88 109.483 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 3.3 mm-40 -68.24 -30.84 69.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.964 -1.017 . . . . 2.09 111.857 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.68 ' CE1' ' HD2' ' A' ' 70' ' ' TYR . 2.9 m-30 . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 118.801 -0.619 . . . . 1.77 111.318 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 112.804 0.668 . . . . 4.58 112.804 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.661 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 11.2 m-85 -43.0 107.75 0.58 Allowed Pre-proline 0 N--CA 1.445 -0.713 0 C-N-CA 124.604 1.162 . . . . 1.64 112.807 175.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' SER . 75.1 Cg_exo -56.66 93.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.813 2.342 . . . . 1.02 111.284 171.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.802 ' HB ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -81.3 121.89 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 121.858 0.837 . . . . 1.52 110.405 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.743 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.7 m -105.38 127.11 52.8 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.541 -1.209 . . . . 1.45 111.203 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.1 t -117.91 123.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 2.21 112.016 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.704 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 30.0 t -67.16 124.33 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.22 0.533 . . . . 2.24 111.315 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.9 mmm -120.5 23.1 11.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.545 -0.752 . . . . 5.12 109.278 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.55 177.89 25.03 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.608 -0.724 . . . . 3.86 112.528 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 19' ' ' VAL . 17.3 m -67.45 -45.41 76.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.032 0.382 . . . . 5.97 112.032 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 -56.01 7.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 4.41 112.267 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.704 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 74.6 m -64.59 -32.91 74.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 2.98 111.105 -173.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 68.2 t80 -60.52 -28.63 68.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.961 -0.563 . . . . 4.18 111.774 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 15' ' ' THR . 60.9 t -68.87 -22.11 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.131 0.491 . . . . 3.65 110.921 -173.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -81.94 13.34 3.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.208 -0.451 . . . . 4.79 111.329 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 25' ' ' VAL . . . 87.07 30.29 20.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.366 -0.921 . . . . 1.87 111.766 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -70.68 -21.58 62.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.463 -0.199 . . . . 1.46 110.463 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.03 -54.6 45.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.331 -0.395 . . . . 2.42 110.208 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.562 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 3.03 109.621 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.009 HG13 ' H ' ' A' ' 74' ' ' THR . 54.6 t -59.21 -57.65 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 115.649 -0.705 . . . . 2.26 109.587 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.33 -30.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 120.271 -0.571 . . . . 1.57 109.647 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -59.26 -43.5 92.48 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.128 -0.487 . . . . 1.35 110.253 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.431 ' HB1' HG21 ' A' ' 78' ' ' VAL . . . -54.69 -46.0 74.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.134 -0.939 . . . . 0.65 109.229 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.674 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -55.31 -53.36 57.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.065 -0.97 . . . . 1.98 110.087 175.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -48.83 -47.48 42.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.321 -0.854 . . . . 2.85 110.757 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.41 -34.37 25.53 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.521 -0.763 . . . . 2.23 111.932 -174.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.728 ' NE2' ' HB2' ' A' ' 82' ' ' LEU . 1.9 pt20 -63.17 -25.73 68.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.249 -0.649 . . . . 2.54 109.249 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.73 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -57.72 -60.43 3.7 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.323 -1.362 . . . . 2.06 107.323 173.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.657 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 68.01 -20.83 0.13 Allowed 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 125.503 1.752 . . . . 4.48 110.578 172.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.73 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 58.18 126.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.709 -2.042 . . . . 3.76 113.243 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.616 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 11.1 t70 -86.72 -45.94 10.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 112.284 -2.235 . . . . 4.62 107.741 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' A' ' 43' ' ' ASP . 2.0 pt -168.4 -1.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 112.93 -1.941 . . . . 5.0 110.923 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 173.09 -32.74 0.11 Allowed Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 110.774 -0.93 . . . . 4.13 110.774 -163.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.715 ' OD1' ' HB3' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -145.17 -162.92 1.6 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.095 -1.052 . . . . 4.31 110.883 -169.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.69 HG13 ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -64.61 -30.18 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-O 123.865 1.793 . . . . 2.96 107.531 177.171 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.723 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 65.4 m -168.45 -64.32 0.01 OUTLIER Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 110.026 -3.261 . . . . 3.83 111.182 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 7.1 Cg_exo -73.81 -6.64 18.93 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 121.289 1.326 . . . . 3.83 115.445 -164.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.617 ' H ' ' CB ' ' A' ' 39' ' ' ASP . 26.0 t70 74.59 16.04 3.24 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 122.759 1.266 . . . . 4.26 107.586 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.55 66.91 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.41 -1.723 . . . . 2.01 111.26 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.715 ' HB3' ' OD1' ' A' ' 39' ' ' ASP . 13.7 tpt180 -132.93 -55.72 0.93 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.885 -1.154 . . . . 3.34 107.885 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.715 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.91 146.41 27.39 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.054 -1.43 . . . . 2.07 110.364 176.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.481 ' H ' HG22 ' A' ' 9' ' ' ILE . 52.9 m -154.57 96.85 1.94 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.215 -0.661 . . . . 1.91 109.215 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -87.11 137.3 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.071 0.767 . . . . 3.19 113.071 -167.061 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.01 138.02 12.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.968 -1.014 . . . . 3.31 110.787 158.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.5 m -45.9 -45.34 15.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.11 -1.405 . . . . 3.25 114.323 165.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.69 -39.59 65.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.14 1.534 . . . . 4.45 115.14 -154.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -62.36 -57.13 12.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.476 1.131 . . . . 6.26 109.694 176.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 22.5 t -66.26 167.62 10.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.59 -2.095 . . . . 3.04 111.208 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 53' ' ' CYS . 1.6 m 70.27 25.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 125.883 1.673 . . . . 4.32 109.351 -160.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.29 65.77 0.25 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 113.479 -1.692 . . . . 4.19 112.49 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.88 56.3 17.26 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 119.681 -1.247 . . . . 4.42 115.801 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.616 ' HB2' HG13 ' A' ' 62' ' ' ILE . 1.9 m -136.17 -31.54 0.9 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.46 -0.941 . . . . 3.52 108.46 -170.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.09 -25.94 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.883 1.809 . . . . 3.64 115.883 -163.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.2 7.52 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.81 1.186 . . . . 5.44 111.841 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.45 160.46 37.8 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.229 -1.026 . . . . 3.22 108.229 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.93 119.33 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 120.742 1.301 . . . . 3.83 108.822 165.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.616 HG13 ' HB2' ' A' ' 57' ' ' CYS . 49.2 mm -111.51 130.94 64.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 114.265 1.209 . . . . 2.69 114.265 -172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 72' ' ' ASN . 14.5 p -144.2 122.19 6.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.3 -1.37 . . . . 1.87 107.3 147.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.76 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 65.6 ttp -111.19 137.78 48.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.759 -1.213 . . . . 1.65 109.727 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.802 HG12 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.77 114.23 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 N-CA-C 107.015 -1.476 . . . . 0.76 107.015 167.158 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 48.87 -152.88 2.55 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 122.342 0.968 . . . . 1.1 111.869 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -78.6 37.26 0.28 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.882 -1.159 . . . . 3.01 109.266 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.76 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 29.8 mmmt -113.68 -26.29 8.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.035 -0.529 . . . . 2.62 111.532 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 30.4 m 38.22 108.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 115.205 1.557 . . . . 1.51 115.205 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.76 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 2.8 m-85 -122.42 -170.74 2.13 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.448 1.118 . . . . 1.43 113.352 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.08 21.85 5.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 113.832 -1.531 . . . . 1.49 111.293 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.687 ' HB2' HG22 ' A' ' 81' ' ' ILE . 2.7 t30 -74.22 92.73 2.26 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.862 -0.422 . . . . 1.83 109.862 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -172.37 -167.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 122.882 0.473 . . . . 3.06 111.429 177.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 1.009 ' H ' HG13 ' A' ' 25' ' ' VAL . 41.0 p 50.54 104.08 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 C-N-CA 125.204 1.402 . . . . 2.49 112.266 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.763 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 73.6 Cg_exo -23.47 89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 1 C-N-CA 125.456 4.104 . . . . 2.65 113.28 -174.05 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 80' ' ' LYS . . . 148.11 -61.23 0.44 Allowed Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.974 -1.012 . . . . 1.4 112.572 -171.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.614 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 5.0 mt-30 -76.26 -30.54 57.89 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.193 -1.41 . . . . 1.87 107.193 -166.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.518 HG13 ' CA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -48.24 -52.05 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 112.41 -2.177 . . . . 0.97 111.132 -175.379 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 36.6 mtmt -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.647 1.213 . . . . 2.13 108.523 -166.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -78.89 -42.16 27.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.173 -1.83 . . . . 2.41 110.922 -173.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.687 HG22 ' HB2' ' A' ' 72' ' ' ASN . 33.2 mm -72.57 -15.34 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.157 0.503 . . . . 1.23 109.926 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.728 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 48.0 tp -60.99 -38.58 86.51 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.069 -0.395 . . . . 0.79 110.348 169.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -31.96 67.48 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 121.779 0.799 . . . . 0.88 108.86 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -73.39 -31.62 63.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.753 -1.112 . . . . 2.09 111.354 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.727 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 2.2 m-30 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 119.489 -0.291 . . . . 1.77 111.162 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.52 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 15.7 tppt? . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 109.337 -0.616 . . . . 4.58 109.337 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.653 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 15.1 m-85 -129.59 80.58 71.53 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-O 120.934 0.397 . . . . 1.64 109.974 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 82.0 Cg_exo -50.54 107.25 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.115 2.543 . . . . 1.02 112.09 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.957 HD11 HG22 ' A' ' 48' ' ' ILE . 13.1 pt -81.59 130.55 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 112.092 0.405 . . . . 1.52 112.092 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.5 p -94.32 132.06 39.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.178 -0.675 . . . . 1.45 109.178 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.09 117.85 56.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.167 -0.47 . . . . 2.21 110.63 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 1.042 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -69.96 121.85 18.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 2.24 111.9 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.8 mmm -121.64 20.3 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.968 -1.123 . . . . 5.12 107.968 163.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 179.32 31.15 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.557 -1.201 . . . . 3.86 113.172 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 19' ' ' VAL . 8.1 m -68.93 -44.43 73.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.079 0.4 . . . . 5.97 112.079 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -58.16 4.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.025 0.75 . . . . 4.41 113.025 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 1.042 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 88.8 m -65.31 -33.91 77.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 2.98 111.012 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -60.69 -31.68 70.93 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.904 0.383 . . . . 4.18 111.086 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 15' ' ' THR . 57.5 t -72.54 -25.09 22.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.391 0.615 . . . . 3.65 110.054 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -85.23 9.38 15.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.613 -0.722 . . . . 4.79 110.894 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.04 32.57 17.15 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.021 -1.085 . . . . 1.87 112.466 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.512 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -71.97 -20.81 61.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.849 0.315 . . . . 1.46 111.849 -171.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 26' ' ' VAL . 2.4 p-10 -62.48 -40.84 97.96 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.053 -0.659 . . . . 2.42 109.74 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 11.1 mptt -66.78 -36.51 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.044 -0.724 . . . . 3.03 109.044 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.039 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 76.7 t -55.78 -54.78 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 CA-C-N 115.057 -0.974 . . . . 2.26 109.415 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 23' ' ' ASP . 15.3 m -63.16 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.115 -0.634 . . . . 1.57 110.902 -174.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -60.66 -47.58 85.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.733 -0.787 . . . . 1.35 109.955 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.611 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.59 -46.24 80.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.236 -0.893 . . . . 0.65 108.613 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.872 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.0 t80 -54.49 -48.49 71.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 124.218 0.949 . . . . 1.98 110.146 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -49.11 -54.93 13.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.717 -1.129 . . . . 2.85 111.297 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 -18.87 27.51 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.287 -0.87 . . . . 2.23 111.717 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.872 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -67.98 -21.17 65.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.573 -0.528 . . . . 2.54 109.573 173.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.796 HD22 HG12 ' A' ' 35' ' ' ILE . 1.2 tt -48.6 -59.88 3.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.291 -1.744 . . . . 2.06 106.291 168.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.667 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 65.61 -25.45 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.241 2.213 . . . . 4.48 112.186 171.183 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.796 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 57.78 -174.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 113.073 -1.876 . . . . 3.76 113.74 166.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 37' ' ' ILE . 12.4 t70 -146.89 -53.2 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 106.166 -1.791 . . . . 4.62 106.166 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.648 HG13 ' OD1' ' A' ' 43' ' ' ASP . 1.2 pt -171.63 21.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 113.612 -1.631 . . . . 5.0 109.718 172.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -165.52 -67.07 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 109.464 -1.454 . . . . 4.13 109.464 -174.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.853 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 18.5 m-20 -170.39 116.72 0.51 Allowed 'General case' 0 CA--C 1.485 -1.525 0 CA-C-N 113.602 -1.299 . . . . 4.31 110.156 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.972 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.8 p 58.0 -64.23 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 O-C-N 126.679 2.487 . . . . 2.96 113.057 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.628 ' OG1' ' HD3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -159.33 -56.15 0.02 OUTLIER Pre-proline 0 C--N 1.276 -2.621 0 CA-C-N 113.38 -1.736 . . . . 3.83 111.966 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.698 ' HD2' HG13 ' A' ' 40' ' ' VAL . 13.1 Cg_exo -72.11 -3.63 13.64 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 CA-C-N 119.48 0.85 . . . . 3.83 112.81 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.853 ' HA ' ' H ' ' A' ' 39' ' ' ASP . 73.0 m-20 75.34 19.05 2.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 122.457 1.122 . . . . 4.26 108.96 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' N ' ' HB2' ' A' ' 39' ' ' ASP . . . 171.7 39.15 0.03 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 CA-C-N 112.508 -2.133 . . . . 2.01 110.949 166.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.649 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 22.1 ttt180 -74.4 -34.64 63.33 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.533 -1.654 . . . . 3.34 106.533 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.972 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 29.1 m-85 -88.82 149.75 23.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 112.241 -2.254 . . . . 2.07 110.396 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 15.2 m -168.45 99.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.76 0.424 . . . . 1.91 110.018 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.957 HG22 HD11 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -66.31 136.7 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.919 1.081 . . . . 3.19 113.919 -168.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -160.08 135.75 8.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.626 1.203 . . . . 3.31 113.023 154.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -46.57 -41.53 14.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.026 1.73 . . . . 3.25 114.61 160.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -50.87 -30.24 14.01 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.959 1.466 . . . . 4.45 114.959 -158.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 8.1 mmt180 -54.91 -47.05 74.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.008 0.433 . . . . 6.26 111.108 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.3 t -58.0 160.2 5.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.188 -0.915 . . . . 3.04 113.439 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 14.2 t 67.51 24.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.55 0 CA-C-O 123.139 1.447 . . . . 4.32 108.353 -164.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.88 64.49 0.33 Allowed Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 113.349 -1.75 . . . . 4.19 112.479 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.63 57.99 14.06 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 118.839 -1.648 . . . . 4.42 115.08 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.887 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.253 5.6 m -132.27 -35.28 1.19 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 1.411 . . . . 3.52 113.072 -162.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.72 -30.76 23.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.694 1.739 . . . . 3.64 115.694 -164.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.0 mt -78.37 5.37 10.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.014 1.279 . . . . 5.44 112.793 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 159.94 43.15 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 122.549 0.34 . . . . 3.22 110.479 170.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.9 124.23 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.531 -1.373 . . . . 3.83 108.531 153.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.887 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.5 mm -106.82 129.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.935 -1.106 . . . . 2.69 113.054 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.25 119.37 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.054 -1.462 . . . . 1.87 107.054 158.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.559 ' HG3' HG22 ' A' ' 69' ' ' VAL . 39.0 ttm -114.2 141.61 47.31 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.911 -1.118 . . . . 1.65 111.734 -170.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.927 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.06 112.85 40.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.286 -1.746 . . . . 0.76 106.286 158.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 40.84 -141.82 0.9 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-O 122.507 1.06 . . . . 1.1 113.363 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -79.38 28.57 0.24 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.324 -1.438 . . . . 3.01 109.84 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.927 ' HB2' HG23 ' A' ' 65' ' ' VAL . 10.8 mmmm -100.59 -47.88 4.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.193 -0.669 . . . . 2.62 109.193 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' A' ' 64' ' ' MET . 91.1 t 48.56 116.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 114.225 1.194 . . . . 1.51 114.225 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 62.8 m-85 -138.4 -157.84 0.81 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.099 0.952 . . . . 1.43 113.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -135.07 39.02 1.74 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.151 -1.386 . . . . 1.49 110.0 171.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.826 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 2.0 t30 -58.42 110.5 0.98 Allowed 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.457 -0.942 . . . . 1.83 108.457 173.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.498 ' HB ' ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -100.91 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.247 -1.342 . . . . 3.06 114.532 -157.324 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 1.039 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 2.2 t -143.09 -48.0 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 115.24 1.57 . . . . 2.49 115.24 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD3' ' H ' ' A' ' 74' ' ' THR . 2.3 Cg_endo -80.68 64.0 8.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.939 1.759 . . . . 2.65 113.484 -168.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.544 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 75.8 -12.22 9.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.217 -0.516 . . . . 1.4 112.976 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.646 ' HA ' ' CD ' ' A' ' 80' ' ' LYS . 31.0 mt-30 -75.11 -28.8 60.37 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 106.944 -1.502 . . . . 1.87 106.944 -174.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.531 HG12 ' ND2' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -51.23 -55.08 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 112.04 -2.346 . . . . 0.97 112.561 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 18.8 pttp -60.07 -25.67 65.57 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 121.884 0.85 . . . . 2.13 110.571 -168.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.646 ' CD ' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -80.21 -50.81 9.73 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.936 -1.029 . . . . 2.41 109.082 178.297 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 77' ' ' GLN . 30.0 mm -60.05 -16.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.186 -1.37 . . . . 1.23 109.871 172.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.689 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 63.9 tp -61.36 -40.67 95.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.881 0.372 . . . . 0.79 110.13 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.25 68.68 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.701 0.762 . . . . 0.88 109.336 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 15.4 mt-10 -73.92 -24.4 59.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.479 -1.237 . . . . 2.09 111.959 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.826 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.5 m-30 . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 118.485 -0.769 . . . . 1.77 112.34 -172.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 16.7 tppt? . . . . . 0 N--CA 1.437 -1.11 0 CA-C-O 121.152 0.501 . . . . 4.58 109.75 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.535 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 4.6 m-85 -107.6 93.99 11.16 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.831 -0.622 . . . . 1.64 110.776 172.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 38.5 Cg_exo -63.84 94.45 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.304 2.003 . . . . 1.02 110.717 168.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.966 HG12 ' HA ' ' A' ' 48' ' ' ILE . 1.2 pt -79.08 172.47 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 112.182 0.438 . . . . 1.52 112.182 -168.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.928 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 95.0 p -146.63 117.91 7.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.631 -0.713 . . . . 1.45 111.648 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.33 124.97 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.162 -0.926 . . . . 2.21 110.296 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 31.8 t -66.19 120.37 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.486 0.66 . . . . 2.24 110.954 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.2 mmt -122.57 23.11 9.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.184 -1.043 . . . . 5.12 108.184 170.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.71 179.47 17.16 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.924 -1.035 . . . . 3.86 113.314 -173.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.0 t -65.89 -45.56 81.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.106 0.41 . . . . 5.97 112.106 -175.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.87 -56.98 4.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.454 0.538 . . . . 4.41 112.454 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 71.7 m -65.72 -34.16 77.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.618 -0.719 . . . . 2.98 111.93 -170.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.29 -27.69 68.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.119 0.568 . . . . 4.18 112.076 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 15' ' ' THR . 86.8 t -67.71 -21.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 122.78 0.432 . . . . 3.65 111.711 -168.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -80.99 12.15 3.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.949 -0.47 . . . . 4.79 111.806 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.09 28.48 30.89 Favored Glycine 0 C--O 1.24 0.497 0 C-N-CA 120.986 -0.626 . . . . 1.87 111.552 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.528 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.39 -21.74 61.23 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.105 -0.548 . . . . 1.46 111.548 -168.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.51 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 t70 -55.63 -48.1 75.51 Favored 'General case' 0 C--O 1.211 -0.937 0 C-N-CA 120.393 -0.523 . . . . 2.42 111.057 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -67.35 -36.17 80.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.822 -0.751 . . . . 3.03 111.459 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.637 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.97 -44.84 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 121.118 -0.233 . . . . 2.26 110.647 176.192 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 23' ' ' ASP . 17.9 m -68.59 -19.06 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.975 -0.69 . . . . 1.57 109.965 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.472 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 53.9 t-80 -59.64 -42.54 92.99 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.588 0.709 . . . . 1.35 109.158 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -51.97 -46.35 64.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.085 -1.416 . . . . 0.65 109.541 173.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.854 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 1.4 t80 -57.38 -48.26 79.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.974 -0.557 . . . . 1.98 110.549 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 27' ' ' HIS . 60.8 mttp -47.04 -51.17 18.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.319 -0.855 . . . . 2.85 110.884 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.13 -19.97 24.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.078 -0.964 . . . . 2.23 111.367 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.854 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 1.3 pt20 -67.33 -19.42 65.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.531 -0.544 . . . . 2.54 109.531 176.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.055 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -49.39 -59.52 3.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 106.658 -1.608 . . . . 2.06 106.658 168.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.786 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.19 -19.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 126.42 2.325 . . . . 4.48 113.387 169.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.673 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 50.93 -171.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 126.138 1.775 . . . . 3.76 114.132 166.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 37' ' ' ILE . 13.9 t70 -157.31 -50.52 0.07 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.623 -1.626 . . . . 4.62 107.238 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 36' ' ' ASP . 1.9 pt -168.64 6.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 113.103 -1.862 . . . . 5.0 110.843 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.18 -58.7 0.03 OUTLIER Glycine 0 CA--C 1.482 -1.997 0 N-CA-C 109.653 -1.379 . . . . 4.13 109.653 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.641 ' HA ' HG23 ' A' ' 35' ' ' ILE . 29.9 t70 -178.26 121.01 0.1 Allowed 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 113.244 -1.478 . . . . 4.31 111.664 -177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.092 HG13 ' HD2' ' A' ' 42' ' ' PRO . 7.3 p 55.33 -66.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 127.27 2.856 . . . . 2.96 113.454 173.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.649 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 38.5 m -158.22 -58.54 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.713 0 CA-C-N 113.731 -1.577 . . . . 3.83 110.341 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.092 ' HD2' HG13 ' A' ' 40' ' ' VAL . 59.3 Cg_endo -74.06 7.55 2.44 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 120.418 0.746 . . . . 3.83 113.962 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 13.7 t70 81.55 6.0 1.23 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.817 1.294 . . . . 4.26 108.651 164.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' A' ' 39' ' ' ASP . . . 165.93 67.8 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.639 0 CA-C-N 114.05 -1.432 . . . . 2.01 112.447 172.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.685 ' HD3' ' HG3' ' A' ' 42' ' ' PRO . 16.8 tpt180 -85.09 -64.36 1.17 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.827 -1.175 . . . . 3.34 107.827 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.055 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -114.91 124.2 51.1 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.336 -0.847 . . . . 2.07 112.988 -174.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.567 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 27.4 t -102.86 100.59 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.652 -0.704 . . . . 1.91 109.274 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.966 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.5 pp -65.12 118.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 113.072 0.768 . . . . 3.19 113.072 -171.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' ' HA ' ' A' ' 10' ' ' SER . 9.2 t70 -159.49 140.25 12.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.194 0.997 . . . . 3.31 112.605 162.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -45.61 -46.67 14.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.65 1.722 . . . . 3.25 115.65 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -52.6 -40.73 62.98 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 116.644 2.09 . . . . 4.45 116.644 -148.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.708 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 17.4 mmm180 -63.07 -57.83 9.3 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.096 0.951 . . . . 6.26 110.463 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.928 ' H ' ' HB2' ' A' ' 10' ' ' SER . 33.9 t -65.56 167.11 9.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.41 -1.723 . . . . 3.04 111.12 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG22 ' SG ' ' A' ' 12' ' ' CYS . 11.6 t 71.31 26.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 123.055 1.407 . . . . 4.32 108.501 -161.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.42 64.27 0.34 Allowed Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 113.351 -1.749 . . . . 4.19 113.708 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.89 58.31 12.51 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 118.933 -1.603 . . . . 4.42 115.03 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.286 1.7 m -132.95 -33.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.455 1.128 . . . . 3.52 109.262 -161.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.92 -28.54 6.84 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.685 1.735 . . . . 3.64 115.685 -163.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.97 6.61 3.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.783 1.174 . . . . 5.44 112.161 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.17 160.66 38.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.876 -1.157 . . . . 3.22 107.876 159.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.58 118.23 5.25 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-N 120.849 1.339 . . . . 3.83 108.857 163.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 tp -111.49 129.88 66.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 112.85 0.685 . . . . 2.69 112.85 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.536 HG21 ' N ' ' A' ' 73' ' ' VAL . 86.9 t -141.49 119.53 9.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 107.255 -1.387 . . . . 1.87 107.255 153.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.659 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 38.7 ttm -110.14 135.52 50.8 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 117.779 -1.568 . . . . 1.65 110.217 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.858 HG23 ' HB2' ' A' ' 68' ' ' LYS . 2.5 m -123.91 115.92 46.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.495 -1.669 . . . . 0.76 106.495 168.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 49.07 -153.74 2.37 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-O 122.281 0.934 . . . . 1.1 112.368 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.2 35.62 0.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.343 -0.928 . . . . 3.01 108.583 172.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.858 ' HB2' HG23 ' A' ' 65' ' ' VAL . 28.5 mmmt -105.52 -27.46 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.125 -0.943 . . . . 2.62 109.776 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 64' ' ' MET . 12.3 m 35.61 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 124.459 1.099 . . . . 1.51 113.591 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.761 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 5.0 m-30 -107.89 -163.48 0.9 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-O 122.306 1.051 . . . . 1.43 113.345 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -145.06 50.28 0.65 Allowed Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 114.468 -1.242 . . . . 1.49 110.654 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -71.62 1.58 6.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.803 0.811 . . . . 1.83 109.056 173.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER 46.0 -149.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 113.749 -1.568 . . . . 3.06 113.958 167.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.664 ' H ' ' CD ' ' A' ' 75' ' ' PRO . 12.8 t -148.52 -40.46 0.01 OUTLIER Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.903 -0.59 . . . . 2.49 112.528 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.664 ' CD ' ' H ' ' A' ' 74' ' ' THR . 4.5 Cg_endo -86.04 70.98 4.41 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.881 1.721 . . . . 2.65 113.222 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.14 -38.16 3.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.551 -0.833 . . . . 1.4 113.301 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.556 ' HB2' HG21 ' A' ' 73' ' ' VAL . 29.3 mt-30 -71.05 -10.3 59.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.64 1.21 . . . . 1.87 108.364 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 2.2 t -42.36 -64.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 112.085 -2.325 . . . . 0.97 112.799 174.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.716 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 47.8 mtmt -60.42 -25.55 66.03 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.976 0.893 . . . . 2.13 110.785 -167.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.584 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 2.6 mptp? -77.08 -53.87 7.24 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.596 -1.183 . . . . 2.41 109.921 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.886 ' HB ' ' HA ' ' A' ' 72' ' ' ASN . 18.9 mm -62.73 -14.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.001 -1.0 . . . . 1.23 110.1 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.716 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.6 tp -57.22 -42.81 82.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.969 -0.457 . . . . 0.79 110.257 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.47 -33.55 69.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.588 0.709 . . . . 0.88 109.422 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -73.23 -21.05 60.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.906 -1.043 . . . . 2.09 112.693 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.83 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.9 m-30 . . . . . 0 N--CA 1.433 -1.302 0 CA-C-O 118.111 -0.947 . . . . 1.77 111.854 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.653 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 2.8 tppp? . . . . . 0 N--CA 1.437 -1.103 0 N-CA-C 109.527 -0.546 . . . . 4.58 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 1.068 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.2 m-85 -109.02 85.24 3.1 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.106 -0.497 . . . . 1.64 111.27 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 47' ' ' SER . 87.2 Cg_exo -52.55 97.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.085 2.523 . . . . 1.02 112.327 169.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.682 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -86.77 129.27 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 112.703 0.631 . . . . 1.52 112.703 -172.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.641 ' CB ' ' HB2' ' A' ' 52' ' ' ARG . 59.9 p -91.28 135.44 33.8 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.581 -0.526 . . . . 1.45 109.581 174.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -116.01 121.73 68.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.032 -0.531 . . . . 2.21 110.421 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 22.1 t -67.17 120.01 13.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.066 0.765 . . . . 2.24 113.066 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.1 mmt -123.96 22.56 8.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.462 -1.245 . . . . 5.12 107.858 160.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.28 178.58 22.1 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.892 -1.049 . . . . 3.86 113.744 -171.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -67.95 -44.36 76.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.29 0.478 . . . . 5.97 112.29 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.4 -58.18 3.6 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 112.607 0.595 . . . . 4.41 112.607 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.872 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.7 m -65.29 -35.28 80.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 2.98 111.317 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.85 -30.83 69.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 4.18 112.317 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.83 -25.11 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.033 0.444 . . . . 3.65 110.896 -170.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.43 8.86 17.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.377 -0.374 . . . . 4.79 111.206 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.57 44.8 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.165 -0.774 . . . . 1.87 111.165 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -73.52 -20.61 60.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.353 -0.424 . . . . 1.46 110.946 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 26' ' ' VAL . 8.7 p-10 -62.86 -38.62 91.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 2.42 110.717 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 44.1 mtpt -68.56 -36.37 78.69 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 121.451 -0.78 . . . . 3.03 110.195 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 75' ' ' PRO . 2.5 t -72.3 -28.61 29.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.147 -0.621 . . . . 2.26 111.685 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 23' ' ' ASP . 3.6 m -61.83 -37.49 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.949 -1.13 . . . . 1.57 107.949 172.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 55.5 t-80 -60.09 -41.16 91.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.055 -0.52 . . . . 1.35 109.873 173.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -53.65 -44.87 69.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.295 -0.866 . . . . 0.65 109.295 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.688 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 8.2 t80 -48.82 -61.52 2.0 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 123.75 0.657 . . . . 1.98 109.781 172.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 97.9 mttt -45.43 -45.41 12.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.754 -1.112 . . . . 2.85 111.7 -176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -77.85 -43.28 30.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.717 -0.674 . . . . 2.23 111.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.682 ' HG3' ' O ' ' A' ' 29' ' ' PHE . 1.8 pp0? -63.08 -24.69 68.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.879 -0.415 . . . . 2.54 109.879 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.826 HD21 HG23 ' A' ' 35' ' ' ILE . 10.1 tp -63.24 -55.0 28.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.136 -1.061 . . . . 2.06 108.136 173.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.587 ' HG2' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER 68.73 -14.29 0.29 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.547 1.155 . . . . 4.48 109.465 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.826 HG23 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER 62.38 -10.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 127.066 2.146 . . . . 3.76 113.366 175.247 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.587 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 16.2 t70 68.24 -62.14 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.17 0.988 . . . . 4.62 110.436 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 35' ' ' ILE . 2.4 pt -166.68 4.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.178 -1.374 . . . . 5.0 110.378 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' C ' HG22 ' A' ' 35' ' ' ILE . . . -178.79 -38.75 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.457 -1.354 . . . . 4.13 113.884 -164.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.897 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 14.9 t70 -162.44 179.03 8.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.496 0.554 . . . . 4.31 112.496 -155.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.097 HG23 ' HB3' ' A' ' 46' ' ' PHE . 1.9 t -24.82 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 125.57 1.794 . . . . 2.96 111.868 174.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.547 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 6.8 m -175.42 -55.01 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 111.033 -2.803 . . . . 3.83 108.593 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.625 ' HD3' HG12 ' A' ' 40' ' ' VAL . 5.1 Cg_exo -81.12 -0.08 10.33 Favored 'Trans proline' 0 N--CA 1.433 -2.081 0 N-CA-C 116.381 1.646 . . . . 3.83 116.381 -173.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.696 ' CA ' ' HB3' ' A' ' 39' ' ' ASP . 32.3 t70 77.4 16.78 1.57 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.461 -1.311 . . . . 4.26 107.461 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.54 71.91 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.427 -1.26 . . . . 2.01 112.805 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 12.3 tpt180 -142.18 -60.89 0.45 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.34 -0.93 . . . . 3.34 109.488 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.097 ' HB3' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -102.53 157.75 16.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.551 -1.204 . . . . 2.07 111.684 -173.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.534 ' H ' HG22 ' A' ' 9' ' ' ILE . 53.7 m -165.15 113.44 1.02 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.039 -1.097 . . . . 1.91 108.039 167.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 44.3 pt -92.78 154.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 113.859 1.059 . . . . 3.19 113.859 -162.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.1 p-10 -161.52 137.8 8.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.822 -1.081 . . . . 3.31 111.157 162.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -47.14 -42.29 19.18 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.54 1.311 . . . . 3.25 114.54 163.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' H ' ' A' ' 51' ' ' LEU . 3.0 mm? -51.79 -31.13 25.9 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.102 1.149 . . . . 4.45 114.102 -161.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.641 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 16.8 mmt180 -54.69 -47.51 73.57 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.817 0.341 . . . . 6.26 110.822 176.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.674 ' O ' HG12 ' A' ' 54' ' ' VAL . 50.0 t -58.45 158.1 7.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.561 0.744 . . . . 3.04 112.132 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.674 HG12 ' O ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER 66.43 22.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 123.221 1.486 . . . . 4.32 108.723 -160.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.92 67.87 0.27 Allowed Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 112.606 -2.088 . . . . 4.19 112.165 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.95 57.05 11.55 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.05 -1.548 . . . . 4.42 115.177 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.542 ' HB3' HD13 ' A' ' 62' ' ' ILE . 9.5 m -133.06 -37.73 0.98 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 118.272 1.036 . . . . 3.52 112.816 -171.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.58 -34.57 18.13 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.691 2.108 . . . . 3.64 116.691 -150.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.47 2.43 21.99 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.615 1.552 . . . . 5.44 113.206 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.5 160.39 48.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 C-N-CA 123.373 0.669 . . . . 3.22 109.998 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 Cg_endo -78.97 125.08 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.722 0.948 . . . . 3.83 109.967 156.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.542 HD13 ' HB3' ' A' ' 57' ' ' CYS . 1.5 mp -107.81 134.2 50.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.458 0.54 . . . . 2.69 112.458 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.782 HG13 ' HA2' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -138.27 126.18 29.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.956 0 N-CA-C 107.251 -1.389 . . . . 1.87 107.251 160.21 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.697 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 48.1 ttm -112.31 144.48 41.66 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.742 -1.224 . . . . 1.65 109.618 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.068 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -122.26 117.12 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.526 -1.287 . . . . 0.76 107.526 154.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . 45.98 -147.9 2.28 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-O 122.369 0.983 . . . . 1.1 111.792 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.39 28.38 0.25 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.032 -1.084 . . . . 3.01 108.986 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.771 ' HB2' HG23 ' A' ' 65' ' ' VAL . 42.6 mmtt -107.79 -32.87 7.44 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.512 -0.551 . . . . 2.62 109.512 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.697 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 96.9 t 44.12 110.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 115.271 1.582 . . . . 1.51 115.271 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.747 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.5 m-85 -130.37 -155.08 0.67 Allowed 'General case' 0 C--O 1.249 1.056 0 CA-C-O 122.682 1.23 . . . . 1.43 112.968 -173.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.782 ' HA2' HG13 ' A' ' 63' ' ' VAL . . . -151.95 46.47 0.59 Allowed Glycine 0 C--O 1.218 -0.866 0 CA-C-N 114.279 -1.328 . . . . 1.49 111.878 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.751 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -96.07 1.18 52.35 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.146 0.473 . . . . 1.83 112.237 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.694 HG22 ' HB ' ' A' ' 63' ' ' VAL . 2.6 m -119.37 17.88 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 114.786 1.402 . . . . 3.06 114.786 -166.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.828 ' OG1' ' HD2' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -151.61 175.43 2.89 Favored Pre-proline 0 CA--C 1.563 1.461 0 O-C-N 121.342 -0.849 . . . . 2.49 110.743 -173.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.828 ' HD2' ' OG1' ' A' ' 74' ' ' THR . 65.0 Cg_exo -14.72 94.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.956 1 C-N-CA 126.476 4.784 . . . . 2.65 117.763 -166.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.611 ' H ' HG11 ' A' ' 25' ' ' VAL . . . 74.81 -29.96 1.07 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.871 -0.604 . . . . 1.4 114.237 165.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.825 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 11.7 pt20 -78.38 -15.34 58.79 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.344 -1.354 . . . . 1.87 107.344 -165.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.67 HG23 ' HG3' ' A' ' 79' ' ' LYS . 14.0 m -46.34 -58.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-N 113.135 -1.848 . . . . 0.97 111.248 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.67 ' HG3' HG23 ' A' ' 78' ' ' VAL . 28.7 mtmt -57.85 -42.88 85.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.584 1.183 . . . . 2.13 109.44 -167.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.825 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -78.5 -49.47 13.34 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 112.937 -1.938 . . . . 2.41 109.854 -172.177 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.805 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 47.2 mm -68.64 -10.89 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 113.696 -1.593 . . . . 1.23 109.975 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.66 ' HB2' HE22 ' A' ' 32' ' ' GLN . 52.1 tp -64.17 -36.08 82.89 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.181 -0.949 . . . . 0.79 110.315 167.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.14 67.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.814 -0.81 . . . . 0.88 108.814 171.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.805 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 25.4 mm-40 -69.94 -37.59 75.9 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.926 -1.034 . . . . 2.09 111.066 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.747 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.428 -1.544 0 CA-C-O 119.163 -0.446 . . . . 1.77 111.8 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 114.378 1.251 . . . . 4.58 114.378 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.758 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -50.55 110.94 1.9 Allowed Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 113.83 1.048 . . . . 1.64 113.83 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 88.4 Cg_exo -56.29 99.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.473 0.285 0 C-N-CA 123.191 2.594 . . . . 1.02 111.777 169.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.822 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -85.52 122.56 38.52 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.875 0.695 . . . . 1.52 112.875 -175.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 48.5 m -92.93 129.17 38.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.572 -0.74 . . . . 1.45 110.484 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 128.41 72.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.652 0.982 . . . . 2.21 113.652 -170.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.6 t -63.42 114.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.314 0.578 . . . . 2.24 111.045 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.6 mtm -130.05 22.72 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 5.12 110.449 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.05 175.64 23.63 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.2 -1.0 . . . . 3.86 113.818 -170.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 p -67.51 -46.19 73.61 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.271 0.471 . . . . 5.97 112.271 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.536 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -69.43 -52.88 22.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 4.41 111.083 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -64.09 -39.74 94.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.804 -0.634 . . . . 2.98 111.678 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 25.6 t80 -65.02 -33.42 75.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.628 0.603 . . . . 4.18 112.628 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 16' ' ' ALA . 7.1 p -71.75 -24.04 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.942 0.349 . . . . 3.65 111.942 -166.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 31.2 mmtp -84.2 14.9 3.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.148 0.499 . . . . 4.79 111.57 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.99 29.26 20.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.966 -0.635 . . . . 1.87 112.195 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.76 -19.51 62.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.485 -0.561 . . . . 1.46 109.485 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 14.1 t70 -53.32 -51.76 61.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.396 -0.82 . . . . 2.42 110.605 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -65.83 -38.25 88.4 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.077 -0.649 . . . . 3.03 110.925 -175.176 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.094 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.67 -39.88 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 116.408 -0.36 . . . . 2.26 111.254 -179.073 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.745 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 13.6 p -67.26 -29.82 47.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.595 -0.842 . . . . 1.57 108.92 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.514 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 66.7 t-80 -60.65 -37.85 82.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 1.35 109.897 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -55.28 -46.76 76.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.454 -0.943 . . . . 0.65 108.454 175.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.745 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 36.5 t80 -51.41 -52.67 43.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.183 -0.917 . . . . 1.98 111.186 173.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 16.9 tppt? -45.43 -47.76 13.77 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.71 -1.132 . . . . 2.85 111.171 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.59 -29.58 36.91 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.382 -0.826 . . . . 2.23 111.024 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.739 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 57.9 mm-40 -59.18 -29.39 67.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.278 -0.874 . . . . 2.54 110.988 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.06 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 2.3 tt -53.16 -54.73 31.62 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.377 -0.971 . . . . 2.06 108.377 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.835 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.1 -17.15 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.32 -2.218 . . . . 4.48 113.241 174.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.777 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 52.62 -161.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.215 -1.357 . . . . 3.76 113.307 167.395 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.914 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 17.9 t70 -157.13 -54.99 0.08 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.945 -1.872 . . . . 4.62 105.945 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.0 pt -177.54 21.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 111.808 -2.451 . . . . 5.0 107.443 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -164.97 -70.11 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 108.953 -1.659 . . . . 4.13 108.953 -166.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.561 ' HA ' HD21 ' A' ' 33' ' ' LEU . 17.9 m-20 -178.46 125.45 0.11 Allowed 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.33 -1.435 . . . . 4.31 110.038 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.976 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 2.6 p 57.81 -11.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 115.746 1.758 . . . . 2.96 115.746 165.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.914 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 55.2 m 112.65 -43.09 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.377 1.471 . . . . 3.83 110.742 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 40' ' ' VAL . 87.0 Cg_exo -51.43 -19.57 7.15 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.123 1.215 . . . . 3.83 113.022 163.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 38.2 t70 84.98 12.38 0.26 Allowed 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.98 1.372 . . . . 4.26 107.671 163.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 156.44 76.1 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 112.78 -2.009 . . . . 2.01 110.178 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.712 ' HB3' HG11 ' A' ' 40' ' ' VAL . 3.6 ttt180 -119.54 -53.83 2.2 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 114.724 -0.738 . . . . 3.34 109.091 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.06 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.91 110.54 19.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 113.388 0.884 . . . . 2.07 113.388 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.0 m -117.99 108.22 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.809 -1.087 . . . . 1.91 109.168 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.747 ' HA ' HG23 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.66 145.09 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 113.439 0.903 . . . . 3.19 113.439 -168.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.703 ' O ' ' HA ' ' A' ' 10' ' ' SER . 19.4 t70 -155.05 146.04 22.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.366 -1.288 . . . . 3.31 111.807 175.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -42.36 -44.38 3.91 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 117.009 2.226 . . . . 3.25 117.009 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HG ' ' OD2' ' A' ' 49' ' ' ASP . 55.7 mt -49.26 -38.83 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.783 2.142 . . . . 4.45 116.783 -148.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.687 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 8.5 tpm_? -60.5 -51.69 68.39 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.387 0.994 . . . . 6.26 111.011 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.1 t -62.59 154.92 27.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.54 -1.209 . . . . 3.04 113.547 -168.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 10.5 t 62.93 19.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 114.659 -1.155 . . . . 4.32 109.157 -172.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.8 61.52 0.47 Allowed Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.634 -1.166 . . . . 4.19 113.505 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.25 58.8 12.53 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 118.524 -1.798 . . . . 4.42 114.478 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.565 ' HB3' HG21 ' A' ' 62' ' ' ILE 0.262 2.9 m -129.26 -34.45 1.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.859 1.829 . . . . 3.52 111.157 -154.339 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.45 6.25 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.535 2.05 . . . . 3.64 116.535 -163.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 59' ' ' LEU . 16.2 mt -73.15 4.8 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.591 1.542 . . . . 5.44 112.238 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.74 52.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.581 -0.896 . . . . 3.22 108.581 159.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.8 122.62 6.44 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.018 -1.57 . . . . 3.83 108.018 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.565 HG21 ' HB3' ' A' ' 57' ' ' CYS . 44.7 pt -106.96 127.82 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.862 -1.135 . . . . 2.69 113.085 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.684 HG22 HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -144.08 120.78 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.47 -1.307 . . . . 1.87 107.47 152.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.822 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 25.0 ttt -111.24 135.64 51.48 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.583 -1.266 . . . . 1.65 107.583 -175.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.792 ' CG1' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -119.07 114.39 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.249 0 N-CA-C 107.179 -1.415 . . . . 0.76 107.179 169.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 51.36 -159.14 2.24 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.088 -1.205 . . . . 1.1 110.088 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.36 38.78 0.31 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.29 0.567 . . . . 3.01 109.967 171.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.618 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 51.5 mmtt -105.43 -37.49 6.8 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 115.651 -0.704 . . . . 2.62 110.473 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 85.1 t 53.33 108.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 114.07 1.137 . . . . 1.51 114.07 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.695 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.6 m-30 -126.94 -169.83 2.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.455 1.121 . . . . 1.43 113.222 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -129.05 30.18 3.75 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.061 -1.427 . . . . 1.49 112.598 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.874 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 49.9 t-20 -88.59 89.03 7.82 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.573 -1.269 . . . . 1.83 107.573 172.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -116.66 -93.19 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 122.188 0.994 . . . . 3.06 112.785 -168.239 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 1.094 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 43.7 p -133.83 -61.92 0.02 OUTLIER Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.585 -1.643 . . . . 2.49 113.484 -166.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.75 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 16.4 Cg_endo -87.4 70.07 3.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.271 1.981 . . . . 2.65 113.121 -162.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 77.99 -12.18 18.85 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.919 -0.658 . . . . 1.4 112.689 177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.75 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 20.9 mt-30 -73.52 -25.76 60.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.183 -1.784 . . . . 1.87 106.183 -172.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.739 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 16.0 m -46.8 -61.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 111.566 -2.561 . . . . 0.97 111.651 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.854 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 15.5 pttm -58.45 -39.56 80.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.807 0.813 . . . . 2.13 110.84 -167.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.854 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -81.08 -46.84 14.37 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-N 114.698 -1.137 . . . . 2.41 109.449 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.673 HG22 ' HB2' ' A' ' 72' ' ' ASN . 39.9 mm -70.56 -11.62 15.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.13 -1.395 . . . . 1.23 110.11 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 85' ' ' TYR . 31.0 tp -62.65 -34.17 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.654 -0.654 . . . . 0.79 110.005 168.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.74 -33.03 69.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.854 -0.795 . . . . 0.88 108.854 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -70.09 -41.35 74.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.735 -1.121 . . . . 2.09 111.114 171.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.874 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 7.0 m-30 . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 117.898 -1.049 . . . . 1.77 111.879 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.551 ' HE3' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.516 0 CA-C-O 121.713 0.768 . . . . 4.58 111.718 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.546 ' HB3' ' C ' ' A' ' 65' ' ' VAL . 2.7 m-85 -52.72 109.56 1.51 Allowed Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 113.759 -1.564 . . . . 1.64 113.255 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.919 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 32.1 Cg_exo -61.92 104.42 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.826 1.684 . . . . 1.02 111.029 169.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.078 ' HB ' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -79.43 114.3 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.773 0.797 . . . . 1.52 110.378 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.79 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 8.3 m -93.09 107.11 18.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.526 -1.216 . . . . 1.45 110.41 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -118.17 123.21 71.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.394 -0.821 . . . . 2.21 110.06 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.732 ' SG ' HG22 ' A' ' 54' ' ' VAL . 32.1 t -66.86 119.28 11.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.109 -0.636 . . . . 2.24 110.884 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.7 ttp -122.96 23.29 9.38 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.2 -1.037 . . . . 5.12 108.2 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.78 179.5 17.48 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.18 -0.918 . . . . 3.86 112.616 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 m -62.71 -43.9 97.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.119 0.415 . . . . 5.97 112.119 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -70.18 -56.08 7.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.048 0.452 . . . . 4.41 111.735 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 81.8 m -68.79 -37.75 79.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.202 0.445 . . . . 2.98 112.202 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.767 ' HE1' ' HB2' ' A' ' 23' ' ' ASP . 74.4 t80 -63.99 -31.63 72.88 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.726 0.639 . . . . 4.18 112.726 -176.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 16' ' ' ALA . 8.0 p -68.7 -20.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.917 0.389 . . . . 3.65 111.043 -168.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.51 14.35 3.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.005 -0.543 . . . . 4.79 111.09 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.32 23.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.065 -0.588 . . . . 1.87 111.971 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -72.9 -20.93 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.316 . . . . 1.46 111.462 -172.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.767 ' HB2' ' HE1' ' A' ' 18' ' ' PHE . 17.5 t70 -57.52 -44.44 85.09 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.47 -0.492 . . . . 2.42 110.946 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 1.7 mptp? -64.64 -39.3 93.46 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.885 -0.726 . . . . 3.03 111.528 -171.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.998 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.79 -46.94 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 120.557 -0.457 . . . . 2.26 110.267 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.492 HG23 ' HE3' ' A' ' 30' ' ' LYS . 17.8 m -65.98 -25.3 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.387 -0.525 . . . . 1.57 110.546 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.629 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 66.4 t-80 -60.74 -44.8 96.22 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.214 0.53 . . . . 1.35 109.67 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.42 -40.09 74.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.598 -1.183 . . . . 0.65 109.254 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.649 ' HE2' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -61.49 -46.5 89.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 1.98 110.458 175.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.629 ' HD2' ' HA ' ' A' ' 27' ' ' HIS . 90.5 mttt -53.65 -40.88 66.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.566 -0.743 . . . . 2.85 110.551 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.98 -29.27 29.13 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.396 -0.82 . . . . 2.23 111.448 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -66.27 -21.98 66.3 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.914 -0.584 . . . . 2.54 109.648 177.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.931 ' HG ' HG12 ' A' ' 35' ' ' ILE . 3.6 tp -51.22 -53.94 30.41 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.812 -1.551 . . . . 2.06 106.812 170.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.649 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 63.38 -28.46 0.08 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 125.885 1.991 . . . . 4.48 113.098 168.107 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.931 HG12 ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.25 -173.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 126.152 1.781 . . . . 3.76 114.631 165.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 8.5 t70 -157.69 -41.58 0.07 Allowed 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 113.387 -1.733 . . . . 4.62 107.396 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' ' 43' ' ' ASP . 4.1 pt -163.23 -3.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 113.643 -1.617 . . . . 5.0 112.646 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -174.46 -58.94 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.035 -1.078 . . . . 4.13 110.79 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.994 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 34.1 m-20 -164.5 115.62 1.24 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.821 -0.689 . . . . 4.31 111.798 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.892 HG23 ' CD2' ' A' ' 46' ' ' PHE . 1.3 t 72.56 -62.96 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 O-C-N 125.117 1.51 . . . . 2.96 109.755 175.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.758 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 64.1 m -169.43 -61.21 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 112.215 -2.266 . . . . 3.83 109.635 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.746 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 72.1 Cg_endo -77.11 11.3 2.09 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 120.624 0.882 . . . . 3.83 113.737 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.636 ' HB2' HG13 ' A' ' 37' ' ' ILE . 24.2 t70 82.02 11.03 0.7 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.001 -1.111 . . . . 4.26 108.001 169.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 169.43 77.77 0.04 OUTLIER Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 119.292 -1.432 . . . . 2.01 112.536 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.549 ' HD3' ' OXT' ' A' ' 85' ' ' TYR . 5.1 ttm180 -116.44 1.44 12.98 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.02 -1.844 . . . . 3.34 106.02 165.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.994 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 1.7 m-85 -134.33 169.14 17.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.276 -2.693 . . . . 2.07 111.097 -171.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.919 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 1.4 t 178.26 73.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.493 -1.299 . . . . 1.91 107.493 166.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.044 HG22 HD13 ' A' ' 9' ' ' ILE . 2.1 pp -67.07 116.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.682 -1.145 . . . . 3.19 112.997 -167.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' A' ' 10' ' ' SER . 29.3 t70 -162.27 142.24 9.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.572 1.177 . . . . 3.31 112.711 167.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.4 m -43.76 -45.72 7.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.692 -2.049 . . . . 3.25 116.198 172.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 tp -51.35 -41.74 60.81 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.177 1.918 . . . . 4.45 116.177 -149.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.646 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.0 mmm180 -63.06 -55.93 21.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.156 0.979 . . . . 6.26 110.797 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.693 ' H ' ' HB3' ' A' ' 10' ' ' SER . 34.1 t -63.15 168.72 3.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.343 -1.753 . . . . 3.04 110.252 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.732 HG22 ' SG ' ' A' ' 12' ' ' CYS . 15.7 t 74.52 28.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 123.204 1.478 . . . . 4.32 108.508 -156.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.29 64.35 0.28 Allowed Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 113.425 -1.716 . . . . 4.19 113.025 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 56.89 19.19 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 119.63 -1.271 . . . . 4.42 115.567 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.293 1.1 m -135.79 -33.66 0.85 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.985 1.392 . . . . 3.52 110.213 -162.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.06 -28.98 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 116.221 1.934 . . . . 3.64 116.221 -160.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.03 6.81 3.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.35 1.432 . . . . 5.44 112.244 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.14 39.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 107.807 -1.182 . . . . 3.22 107.807 159.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.45 117.25 4.75 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 N-CA-C 108.431 -1.411 . . . . 3.83 108.431 160.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -113.18 133.68 58.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 119.406 -0.33 . . . . 2.69 111.771 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.649 HG21 ' HE2' ' A' ' 29' ' ' PHE . 99.4 t -139.87 121.54 15.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 108.908 -0.775 . . . . 1.87 108.908 155.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 50.1 ttp -112.45 136.2 52.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.864 -1.135 . . . . 1.65 109.412 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.078 HG13 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.27 114.8 44.05 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 119.877 -0.729 . . . . 0.76 109.485 174.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.702 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 50.76 45.81 48.52 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.808 -0.71 . . . . 1.1 113.433 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 59.55 6.66 0.85 Allowed 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 122.952 0.501 . . . . 3.01 111.4 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.913 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 71.2 mmtt -77.01 -8.76 57.98 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 110.234 -0.284 . . . . 2.62 110.234 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.4 m 35.72 99.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 124.609 1.193 . . . . 1.51 113.889 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.913 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 3.8 m-85 -110.09 165.88 11.39 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-O 122.962 1.363 . . . . 1.43 113.675 -173.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.663 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -109.75 5.96 31.14 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 112.544 -2.116 . . . . 1.49 109.009 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.743 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -65.25 131.57 46.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.49 -1.67 . . . . 1.83 106.49 167.519 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.72 -145.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.466 0.913 . . . . 3.06 113.466 -148.578 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.998 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 76.5 p -131.29 -50.9 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.018 1.118 . . . . 2.49 114.018 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD3' ' OG1' ' A' ' 74' ' ' THR . 91.2 Cg_endo -87.79 73.93 2.45 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.582 1.521 . . . . 2.65 113.474 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.54 4.41 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.75 -0.738 . . . . 1.4 112.782 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.548 ' O ' HG12 ' A' ' 81' ' ' ILE . 23.1 mt-30 -74.38 -19.71 60.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 106.403 -1.702 . . . . 1.87 106.403 -172.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.684 HG23 ' HG3' ' A' ' 79' ' ' LYS . 8.4 m -43.44 -60.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 111.704 -2.498 . . . . 0.97 111.915 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.684 ' HG3' HG23 ' A' ' 78' ' ' VAL . 45.9 mtmt -59.45 -37.59 78.55 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.277 1.037 . . . . 2.13 109.998 -165.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.4 -47.7 12.89 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 114.257 -1.338 . . . . 2.41 109.446 -175.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 42.1 mm -66.57 -10.68 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.291 -1.322 . . . . 1.23 110.013 177.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 85' ' ' TYR . 52.7 tp -58.75 -23.95 60.82 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.521 -0.737 . . . . 0.79 110.127 169.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.44 27.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.448 -0.501 . . . . 0.88 110.305 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.772 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER -67.0 -36.78 82.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.983 -0.553 . . . . 2.09 111.715 174.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.691 ' HB2' HD12 ' A' ' 82' ' ' LEU . 6.7 m-30 . . . . . 0 N--CA 1.432 -1.355 0 CA-C-O 118.523 -0.751 . . . . 1.77 111.547 -174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.531 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 14.3 tppt? . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 108.202 -1.036 . . . . 4.58 108.202 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.598 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 4.7 m-85 -115.44 89.16 21.02 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.837 -1.074 . . . . 1.64 110.541 173.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 51.2 Cg_exo -59.67 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.111 2.541 . . . . 1.02 111.669 171.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.055 HG12 ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -84.48 173.39 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 113.387 0.884 . . . . 1.52 113.387 -167.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.746 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 14.9 p -134.65 134.85 41.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.263 -0.88 . . . . 1.45 109.005 171.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 m -115.46 124.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.785 -0.643 . . . . 2.21 110.962 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.0 t -66.11 112.6 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.299 0.571 . . . . 2.24 110.463 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.3 tpt -131.11 23.85 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.37 -0.832 . . . . 5.12 109.628 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.66 177.26 13.59 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.584 -0.817 . . . . 3.86 113.992 -166.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -66.21 -45.55 80.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 5.97 111.676 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.2 -52.27 20.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.556 0.693 . . . . 4.41 110.339 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.65 -34.19 76.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.626 -1.17 . . . . 2.98 111.734 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 83.6 t80 -60.69 -34.31 74.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.787 0.327 . . . . 4.18 111.346 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.82 -24.33 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.545 0.688 . . . . 3.65 109.862 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -84.44 12.2 7.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.171 -0.922 . . . . 4.79 110.408 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 31.1 17.24 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.537 -0.84 . . . . 1.87 113.145 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -70.74 -19.81 62.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.707 0.289 . . . . 1.46 110.789 -175.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.99 -52.88 62.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 2.42 110.248 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -64.55 -31.36 72.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.887 -0.412 . . . . 3.03 109.887 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.878 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 98.2 t -56.82 -62.51 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 115.557 -0.747 . . . . 2.26 109.426 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -63.98 -27.86 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.729 -0.669 . . . . 1.57 110.793 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -58.5 -47.87 82.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 120.299 -0.56 . . . . 1.35 110.368 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.55 -45.01 81.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.15 -0.932 . . . . 0.65 109.163 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.645 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -53.5 -53.39 52.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.093 -0.958 . . . . 1.98 110.087 177.133 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -51.34 -48.95 62.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.587 -0.733 . . . . 2.85 110.995 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.81 -28.55 28.0 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.123 -0.944 . . . . 2.23 111.446 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -63.97 -26.77 68.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 123.437 0.461 . . . . 2.54 110.328 176.653 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.066 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 tt -50.95 -56.21 13.46 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.612 -1.255 . . . . 2.06 107.612 173.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 63.59 -19.47 0.06 Allowed 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.527 2.392 . . . . 4.48 112.644 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.638 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 56.9 -173.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 113.621 -1.627 . . . . 3.76 112.713 170.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.78 -48.7 0.07 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.944 -1.132 . . . . 4.62 107.944 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 pt -165.58 5.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 112.898 -1.955 . . . . 5.0 110.615 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.555 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 177.16 -54.51 0.1 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 110.103 -1.199 . . . . 4.13 110.103 -166.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.691 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 24.4 t70 -176.53 116.88 0.12 Allowed 'General case' 0 CA--C 1.483 -1.635 0 CA-C-N 113.446 -1.377 . . . . 4.31 111.291 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.027 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 6.5 p 54.9 -65.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 127.301 2.876 . . . . 2.96 113.488 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.82 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 26.2 m -154.0 -58.81 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 113.631 -1.622 . . . . 3.83 110.565 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.82 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 2.8 Cg_exo -77.63 10.06 2.68 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 C-N-CA 120.745 0.963 . . . . 3.83 114.235 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.555 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 6.8 t0 81.43 9.41 0.95 Allowed 'General case' 0 C--N 1.349 0.558 0 N-CA-C 107.644 -1.243 . . . . 4.26 107.644 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.691 ' N ' ' HB3' ' A' ' 39' ' ' ASP . . . 156.92 59.36 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.237 -1.347 . . . . 2.01 112.171 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.64 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 11.6 ttt180 -86.73 -62.0 1.61 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.029 -1.1 . . . . 3.34 108.029 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.066 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -100.95 102.42 13.43 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 122.806 1.289 . . . . 2.07 112.738 173.31 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 22.6 t -92.02 91.98 8.08 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.887 -1.506 . . . . 1.91 109.215 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.055 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.3 pp -56.46 124.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 3.19 112.518 -174.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' SER . 8.5 m-20 -143.21 132.73 23.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.518 1.151 . . . . 3.31 113.464 166.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -48.5 -43.41 35.06 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.171 -1.831 . . . . 3.25 114.581 158.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.16 -35.13 59.44 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.558 1.318 . . . . 4.45 114.558 -160.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.746 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 9.8 mmt85 -60.77 -49.87 75.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.806 0.812 . . . . 6.26 110.176 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.0 t -59.22 158.58 8.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.944 -1.48 . . . . 3.04 112.895 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 54' ' ' VAL . 14.7 t 66.27 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.388 0 CA-C-O 122.83 1.3 . . . . 4.32 108.558 -167.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.77 63.6 0.37 Allowed Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 113.829 -1.532 . . . . 4.19 113.263 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.21 59.08 10.04 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.739 -1.696 . . . . 4.42 114.609 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.727 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.282 2.8 m -130.14 -37.13 1.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.058 1.429 . . . . 3.52 110.765 -159.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.06 -32.65 35.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.916 1.45 . . . . 3.64 114.916 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 59' ' ' LEU . 2.5 pt? -76.83 6.13 6.64 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.117 -0.989 . . . . 5.44 112.334 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.76 160.86 38.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.305 -0.628 . . . . 3.22 109.305 164.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.52 119.19 4.8 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 108.572 -1.357 . . . . 3.83 108.572 155.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.727 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.0 mm -111.58 129.58 66.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.567 0.58 . . . . 2.69 112.567 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 4.7 t -139.57 123.15 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.832 -1.544 . . . . 1.87 106.832 153.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.764 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 22.7 ttt -112.75 136.08 52.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.954 -1.498 . . . . 1.65 110.598 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.748 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -124.81 114.91 42.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 106.545 -1.65 . . . . 0.76 106.545 156.029 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.75 -149.25 1.09 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 122.165 0.87 . . . . 1.1 112.752 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.31 31.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.842 -1.179 . . . . 3.01 108.744 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.748 ' HB2' HG23 ' A' ' 65' ' ' VAL . 13.2 mmmm -106.61 -41.56 5.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.535 -0.757 . . . . 2.62 109.214 -177.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 64' ' ' MET . 87.8 t 46.38 101.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 124.472 1.108 . . . . 1.51 113.523 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.668 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 9.1 m-30 -120.41 -154.77 0.6 Allowed 'General case' 0 C--O 1.248 1.024 0 CA-C-O 121.863 0.839 . . . . 1.43 112.312 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.612 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -142.6 28.21 2.19 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.695 -1.139 . . . . 1.49 112.003 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.865 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 14.2 t-20 -81.76 112.73 19.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.711 -0.477 . . . . 1.83 109.711 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.665 HG23 ' H ' ' A' ' 74' ' ' THR . 6.9 m -137.2 -78.78 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 116.922 2.193 . . . . 3.06 116.922 -171.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.878 ' CB ' ' HA ' ' A' ' 25' ' ' VAL . 13.6 t -153.41 -41.68 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 115.51 1.671 . . . . 2.49 115.51 -172.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.892 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 3.0 Cg_exo -75.31 57.22 4.68 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.09 1.86 . . . . 2.65 112.036 -170.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.447 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 76.3 -7.54 30.23 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.58 -0.737 . . . . 1.4 111.562 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.892 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 26.0 mt-30 -73.62 -35.75 65.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.209 -1.404 . . . . 1.87 107.209 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.762 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -50.67 -55.69 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 112.802 -1.999 . . . . 0.97 110.941 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 48.9 mtmt -54.51 -45.66 73.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.019 0.914 . . . . 2.13 109.508 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.777 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -85.56 -40.94 15.74 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.642 -1.163 . . . . 2.41 110.987 -173.077 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.774 ' CG2' ' HB2' ' A' ' 72' ' ' ASN . 33.3 mm -69.69 -15.11 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.955 -0.566 . . . . 1.23 109.765 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.539 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 54.7 tp -58.93 -41.57 87.65 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.989 -0.445 . . . . 0.79 110.29 171.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.2 -32.74 66.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.544 0.688 . . . . 0.88 109.422 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.55 -31.64 67.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.755 -1.111 . . . . 2.09 112.125 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.865 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 2.1 m-30 . . . . . 0 N--CA 1.432 -1.369 0 CA-C-O 117.418 -1.277 . . . . 1.77 112.004 -170.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.681 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 122.248 1.023 . . . . 4.58 110.915 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.937 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -69.31 112.59 12.35 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.075 -1.42 . . . . 1.64 112.764 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 1.039 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 21.0 Cg_exo -70.8 131.14 19.2 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.903 1.735 . . . . 1.02 111.678 170.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.883 HG22 ' HA ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -77.45 156.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.376 0.608 . . . . 1.52 112.085 -175.074 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.82 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.6 m -141.68 100.81 3.84 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.299 -0.864 . . . . 1.45 109.56 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -117.81 124.64 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.744 -0.662 . . . . 2.21 110.799 -176.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.746 ' SG ' HG22 ' A' ' 54' ' ' VAL . 31.5 t -65.14 120.87 13.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 2.24 110.876 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.4 mtt -122.01 24.8 9.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.15 -0.932 . . . . 5.12 108.714 173.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.09 179.91 13.19 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.132 -0.94 . . . . 3.86 112.836 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 19' ' ' VAL . 19.8 m -65.78 -45.67 81.59 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.993 0.368 . . . . 5.97 111.993 -172.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.641 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -71.62 -56.54 5.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.465 0.543 . . . . 4.41 112.465 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 83.3 m -66.62 -36.55 82.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.535 0.569 . . . . 2.98 112.535 -171.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.78 -30.87 71.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.126 0.787 . . . . 4.18 113.126 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 16' ' ' ALA . 32.6 m -69.74 -18.92 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.948 0.351 . . . . 3.65 111.948 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.95 16.46 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 4.79 111.612 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.85 32.3 10.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.451 -0.881 . . . . 1.87 111.851 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -72.05 -20.82 61.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.436 -0.382 . . . . 1.46 110.617 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.18 -50.86 66.07 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.031 -0.359 . . . . 2.42 110.031 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -65.02 -40.62 95.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.698 -0.401 . . . . 3.03 110.983 -171.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.789 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 6.1 m -67.17 -49.0 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 C-N-CA 120.42 -0.512 . . . . 2.26 110.153 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.675 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 21.8 m -64.83 -28.95 46.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.182 -0.607 . . . . 1.57 110.269 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -59.5 -43.11 93.42 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 120.72 -0.392 . . . . 1.35 110.219 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -52.96 -49.16 66.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.202 -0.908 . . . . 0.65 109.062 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.675 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 39.7 t80 -47.54 -56.9 6.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.065 -0.97 . . . . 1.98 110.488 174.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.17 -52.66 11.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.373 -1.285 . . . . 2.85 112.229 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -84.45 -30.52 25.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.84 -0.618 . . . . 2.23 111.762 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.69 ' NE2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -64.71 -25.02 67.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.54 -0.541 . . . . 2.54 109.54 176.194 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.797 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.3 tt -48.59 -58.23 5.01 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.246 -1.39 . . . . 2.06 107.246 174.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.744 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 64.09 -21.49 0.07 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 126.328 2.268 . . . . 4.48 112.874 171.522 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.701 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 53.98 -173.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 C-N-CA 126.342 1.857 . . . . 3.76 114.389 166.447 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.436 ' H ' HG22 ' A' ' 35' ' ' ILE . 14.7 t70 -157.74 -50.93 0.07 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.848 -1.524 . . . . 4.62 107.985 -172.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pt -164.79 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 113.441 -1.709 . . . . 5.0 110.863 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.31 -65.04 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 109.675 -1.37 . . . . 4.13 109.675 -166.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.895 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 25.1 m-20 -164.31 119.97 1.53 Allowed 'General case' 0 CA--C 1.48 -1.742 0 CA-C-N 112.903 -1.648 . . . . 4.31 109.107 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.992 HG13 ' HD2' ' A' ' 42' ' ' PRO . 4.4 p 59.01 -66.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 126.684 2.49 . . . . 2.96 112.871 171.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.959 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 50.7 m -164.71 -58.52 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.759 0 CA-C-N 112.688 -2.051 . . . . 3.83 110.006 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.072 ' HG2' ' HD2' ' A' ' 45' ' ' ARG . 23.8 Cg_exo -67.69 4.26 1.47 Allowed 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 120.88 1.054 . . . . 3.83 114.44 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 18.0 t70 86.23 -4.85 0.77 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.93 0.872 . . . . 4.26 109.578 159.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.532 ' HA2' ' OD2' ' A' ' 39' ' ' ASP . . . 179.06 41.4 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.747 -1.115 . . . . 2.01 112.282 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 1.072 ' HD2' ' HG2' ' A' ' 42' ' ' PRO . 2.6 ttt180 -82.74 -7.79 59.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.548 1.166 . . . . 3.34 109.167 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.98 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -105.51 -58.98 1.83 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.608 -2.087 . . . . 2.07 113.453 -171.405 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 1.039 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 73.9 m 30.31 -170.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.588 1.555 . . . . 1.91 114.723 -162.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.883 ' HA ' HG22 ' A' ' 9' ' ' ILE . 8.4 tp -166.99 104.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 113.686 0.995 . . . . 3.19 113.686 -168.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.82 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.2 m-20 -144.69 130.79 19.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.678 -0.809 . . . . 3.31 110.272 160.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t -50.03 -45.24 51.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.972 1.101 . . . . 3.25 113.972 160.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.3 -37.86 70.47 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.898 1.814 . . . . 4.45 115.898 -157.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.478 ' HD2' ' OG ' ' A' ' 10' ' ' SER . 44.9 mtt180 -62.14 -56.87 14.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.229 1.014 . . . . 6.26 110.09 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 10' ' ' SER . 34.2 t -64.77 170.7 3.94 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.374 -1.739 . . . . 3.04 109.288 171.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.746 HG22 ' SG ' ' A' ' 12' ' ' CYS . 12.2 t 75.1 30.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 123.168 1.461 . . . . 4.32 108.492 -157.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.5 63.24 0.3 Allowed Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 113.457 -1.701 . . . . 4.19 112.886 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.23 56.02 24.42 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 119.507 -1.33 . . . . 4.42 115.782 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.9 m -136.35 -30.83 0.91 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.588 1.194 . . . . 3.52 109.708 -166.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.51 -26.97 1.57 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.766 2.136 . . . . 3.64 116.766 -160.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.83 5.14 5.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.815 1.643 . . . . 5.44 112.045 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.67 161.15 35.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 107.876 -1.157 . . . . 3.22 107.876 162.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.8 118.69 5.39 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.705 1.287 . . . . 3.83 108.998 164.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.76 131.39 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.059 0.392 . . . . 2.69 112.059 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.691 HG13 ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -142.05 124.04 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.29 -1.004 . . . . 1.87 108.29 158.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.663 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 49.7 ttp -113.2 134.59 54.5 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 118.152 -1.419 . . . . 1.65 111.106 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.937 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.89 119.28 55.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 CA-C-O 119.207 -0.425 . . . . 0.76 110.0 174.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.691 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 55.55 31.42 57.37 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.117 -1.039 . . . . 1.1 112.008 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.543 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 42.7 mt-10 58.54 12.62 2.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.727 -0.737 . . . . 3.01 111.525 -174.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.442 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 30.8 mmmt -73.77 -27.49 61.19 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 109.642 -0.503 . . . . 2.62 109.642 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.663 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 94.6 t 60.51 100.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.047 -0.979 . . . . 1.51 112.675 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.843 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.1 m-85 -124.98 -161.45 1.02 Allowed 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.046 0.927 . . . . 1.43 112.15 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.691 ' HA2' HG13 ' A' ' 63' ' ' VAL . . . -137.14 18.89 3.48 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.505 -1.225 . . . . 1.49 112.091 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.856 ' HB2' HG22 ' A' ' 81' ' ' ILE . 8.2 t30 -84.62 85.89 7.37 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.083 -0.657 . . . . 1.83 109.813 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.655 HG21 ' HB ' ' A' ' 63' ' ' VAL . 59.9 t -153.36 -56.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.55 0.944 . . . . 3.06 113.55 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.68 HG22 ' HB ' ' A' ' 25' ' ' VAL . 8.3 p -102.15 149.98 37.08 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.559 -0.291 . . . . 2.49 111.586 -164.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.789 ' HD2' ' HA ' ' A' ' 25' ' ' VAL . 1.1 Cg_endo -42.85 112.98 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.21 3.274 . . . . 2.65 111.742 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.658 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 119.23 -83.75 0.36 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.216 -1.154 . . . . 1.4 110.216 -170.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 1.9 pt20 -64.58 -38.73 92.03 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.766 0.793 . . . . 1.87 109.855 -175.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.69 HG22 ' NE2' ' A' ' 32' ' ' GLN . 9.9 p -50.99 -57.4 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.875 -1.057 . . . . 0.97 111.609 -174.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.602 ' N ' HG13 ' A' ' 78' ' ' VAL . 16.6 pttp -59.87 -42.4 93.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.604 0.716 . . . . 2.13 110.342 -164.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.658 ' HD2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -89.1 -34.95 16.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.068 -0.969 . . . . 2.41 110.489 -172.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.856 HG22 ' HB2' ' A' ' 72' ' ' ASN . 51.1 mm -68.1 -11.54 14.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.87 -0.604 . . . . 1.23 109.868 174.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.532 ' HB2' HE22 ' A' ' 32' ' ' GLN . 57.4 tp -60.48 -37.19 80.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.32 -0.862 . . . . 0.79 110.47 168.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.54 68.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.724 0.773 . . . . 0.88 109.003 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.562 -1.199 . . . . 2.09 111.365 174.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.843 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 8.0 m-30 . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 118.283 -0.865 . . . . 1.77 110.95 175.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.856 0.836 . . . . 4.58 110.95 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.82 ' HB2' HG12 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -33.96 116.6 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.198 -1.819 . . . . 1.64 113.611 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 24.2 Cg_exo -66.34 109.54 1.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.024 1.816 . . . . 1.02 110.582 166.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.772 HG23 ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -78.52 158.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.166 -0.309 . . . . 1.52 110.166 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.875 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 25.1 m -141.88 111.46 6.58 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.041 -0.527 . . . . 1.45 110.354 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.72 120.48 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.971 -0.559 . . . . 2.21 110.985 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.722 ' SG ' HG22 ' A' ' 54' ' ' VAL . 35.8 t -70.2 122.98 20.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.673 -0.411 . . . . 2.24 110.717 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.84 22.83 9.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.372 -0.377 . . . . 5.12 111.019 174.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.634 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -66.43 177.49 16.63 Favored Glycine 0 C--O 1.22 -0.736 0 C-N-CA 120.497 -0.859 . . . . 3.86 112.363 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.7 m -66.32 -45.14 81.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.613 0.597 . . . . 5.97 112.613 -171.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.63 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.609 0.719 . . . . 4.41 110.783 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 91.3 m -63.51 -28.52 70.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.131 -0.94 . . . . 2.98 111.568 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 61.4 t80 -56.07 -27.45 53.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.302 0.641 . . . . 4.18 110.265 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.45 -20.74 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 3.65 110.402 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -80.92 10.45 5.05 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.661 0.267 . . . . 4.79 110.671 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.17 28.21 34.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.927 -0.654 . . . . 1.87 112.546 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -73.02 -22.7 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.575 0.226 . . . . 1.46 111.454 -171.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.64 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 18.0 t70 -61.43 -46.35 90.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.204 0.526 . . . . 2.42 110.29 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 9.1 mptt -67.18 -33.06 74.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.285 -0.635 . . . . 3.03 109.285 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.979 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 99.6 t -56.12 -58.19 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 109.011 -0.737 . . . . 2.26 109.011 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.532 ' HA ' ' HB2' ' A' ' 29' ' ' PHE . 28.9 m -61.58 -34.63 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.706 -0.679 . . . . 1.57 111.566 -174.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -63.1 -48.37 78.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 119.112 -1.035 . . . . 1.35 110.189 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.62 81.87 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.846 -1.168 . . . . 0.65 107.846 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.678 ' HZ ' ' HH ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -53.35 -52.56 58.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.488 -1.233 . . . . 1.98 110.988 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -51.67 -49.55 62.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.106 -0.952 . . . . 2.85 110.578 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.97 -31.54 34.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.442 -1.254 . . . . 2.23 110.842 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.689 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 33.3 mm-40 -64.42 -21.92 66.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.632 -0.713 . . . . 2.54 111.933 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.092 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.4 tt -57.45 -55.0 40.47 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.373 -1.343 . . . . 2.06 107.373 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.795 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 62.9 -22.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 126.576 2.422 . . . . 4.48 112.997 171.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.638 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.21 -175.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.153 -1.385 . . . . 3.76 112.667 170.673 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -156.6 -47.35 0.07 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.687 -1.227 . . . . 4.62 107.687 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 pt -167.19 5.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 113.222 -1.808 . . . . 5.0 111.089 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.574 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 178.65 -54.54 0.09 OUTLIER Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.06 -1.216 . . . . 4.13 110.06 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.562 ' HA ' HG23 ' A' ' 35' ' ' ILE . 20.5 t70 -175.24 118.65 0.18 Allowed 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.187 -1.507 . . . . 4.31 110.709 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.963 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 9.5 p 56.17 -66.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 O-C-N 127.205 2.816 . . . . 2.96 113.044 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.887 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 41.1 m -154.64 -61.62 0.02 OUTLIER Pre-proline 0 C--N 1.279 -2.495 0 CA-C-N 113.619 -1.628 . . . . 3.83 109.99 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.887 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.1 Cg_exo -79.75 8.41 4.02 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 120.908 1.072 . . . . 3.83 114.297 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.574 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 22.3 t70 82.77 5.85 0.91 Allowed 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.347 1.07 . . . . 4.26 108.356 166.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.504 ' N ' ' HB3' ' A' ' 39' ' ' ASP . . . 175.76 76.2 0.05 OUTLIER Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.177 -1.374 . . . . 2.01 112.157 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.598 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 5.2 tpt180 -100.45 -60.42 1.53 Allowed 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.463 -0.94 . . . . 3.34 108.463 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.092 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.19 115.8 21.68 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 122.508 1.147 . . . . 2.07 114.002 -176.274 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.452 ' C ' HG23 ' A' ' 9' ' ' ILE . 21.2 t -102.27 93.38 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.156 -1.384 . . . . 1.91 108.56 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.772 ' HA ' HG23 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -67.52 135.28 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.861 0.689 . . . . 3.19 112.861 -168.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.875 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.5 t70 -160.12 138.03 9.93 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.205 1.003 . . . . 3.31 112.73 163.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.3 m -48.47 -49.91 33.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 115.407 1.632 . . . . 3.25 115.407 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -54.67 -40.65 69.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.915 2.191 . . . . 4.45 116.915 -150.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.65 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -63.25 -55.37 25.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.896 0.855 . . . . 6.26 110.945 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.72 ' H ' ' HB3' ' A' ' 10' ' ' SER . 25.3 t -63.95 166.41 7.5 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.886 -1.506 . . . . 3.04 109.156 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.722 HG22 ' SG ' ' A' ' 12' ' ' CYS . 14.3 t 72.83 27.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.206 1.479 . . . . 4.32 107.586 -153.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.34 65.74 0.32 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 113.292 -1.776 . . . . 4.19 113.321 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.16 55.19 25.3 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 119.485 -1.341 . . . . 4.42 116.04 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -138.82 -29.89 0.77 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.24 1.02 . . . . 3.52 110.183 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -48.24 -29.51 3.87 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 116.632 2.086 . . . . 3.64 116.632 -158.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.9 6.77 4.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.407 1.458 . . . . 5.44 111.85 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.39 161.62 30.67 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 3.22 108.309 163.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.24 119.13 5.45 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.326 1.152 . . . . 3.83 109.307 163.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.09 132.78 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.973 0.731 . . . . 2.69 112.973 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.529 HG21 ' CZ ' ' A' ' 29' ' ' PHE . 11.7 p -143.07 121.8 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.86 -0.736 . . . . 1.87 109.133 148.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.594 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 50.1 ttp -113.44 133.99 54.9 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 119.26 -0.976 . . . . 1.65 108.778 -173.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -126.04 117.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.222 -0.591 . . . . 0.76 109.491 173.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.654 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 49.12 50.79 27.27 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 123.748 0.655 . . . . 1.1 113.935 173.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 62.12 -0.67 0.45 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.111 0.412 . . . . 3.01 112.111 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -75.8 -38.56 58.1 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.834 -0.432 . . . . 2.62 109.834 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 95.3 t 61.43 113.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.042 -0.981 . . . . 1.51 112.465 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.594 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 40.0 m-85 -131.53 -172.7 2.92 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.142 0.972 . . . . 1.43 112.278 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.01 26.32 3.79 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.024 -1.444 . . . . 1.49 110.96 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 2.1 t30 -76.13 111.73 11.84 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.937 -0.764 . . . . 1.83 108.937 177.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 74' ' ' THR . 3.2 m -134.12 -97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 116.34 1.978 . . . . 3.06 116.34 -164.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.979 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 10.2 t -143.92 -41.41 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 115.66 1.726 . . . . 2.49 115.66 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.605 ' HD3' ' H ' ' A' ' 74' ' ' THR . 5.6 Cg_exo -73.65 57.84 3.76 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 122.133 1.889 . . . . 2.65 113.193 -169.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.18 -7.34 10.95 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 116.063 -0.517 . . . . 1.4 112.468 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.64 ' O ' HG12 ' A' ' 81' ' ' ILE . 10.0 mt-30 -75.84 -30.8 59.09 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 107.227 -1.398 . . . . 1.87 107.227 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.689 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -52.63 -46.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-N 112.554 -2.112 . . . . 0.97 112.317 -175.376 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HG2' HE22 ' A' ' 32' ' ' GLN . 50.1 mtmt -54.76 -44.8 73.97 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.517 1.151 . . . . 2.13 108.153 -170.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -80.63 -46.75 15.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.826 -1.988 . . . . 2.41 110.331 -173.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 77' ' ' GLN . 28.9 mm -69.02 -16.24 20.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.893 -1.049 . . . . 1.23 110.239 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 78' ' ' VAL . 54.9 tp -61.34 -33.95 74.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.483 -0.76 . . . . 0.79 110.107 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 -27.93 69.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.281 0.562 . . . . 0.88 109.535 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.468 ' OE1' HG23 ' A' ' 81' ' ' ILE . 1.7 mt-10 -71.38 -27.33 63.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.403 -0.817 . . . . 2.09 110.191 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 3.3 m-30 . . . . . 0 N--CA 1.422 -1.864 0 CA-C-N 115.628 -0.714 . . . . 1.77 110.555 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 121.729 0.776 . . . . 4.58 112.054 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.726 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 15.6 m-85 -46.79 125.98 8.27 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.054 -1.43 . . . . 1.64 112.224 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 47' ' ' SER . 61.0 Cg_exo -57.72 94.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.968 2.446 . . . . 1.02 112.175 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.778 ' HB ' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -82.02 135.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.32 0.581 . . . . 1.52 111.909 -174.267 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.726 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.0 m -100.68 124.28 46.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.075 -0.966 . . . . 1.45 110.665 -177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 m -116.83 125.01 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.844 0.683 . . . . 2.21 112.844 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' CB ' ' A' ' 17' ' ' CYS . 15.1 t -67.71 117.38 9.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.058 0.456 . . . . 2.24 112.057 175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.5 ttt -129.32 23.75 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.901 -0.591 . . . . 5.12 109.583 166.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.5 176.46 23.82 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.503 -0.856 . . . . 3.86 114.65 -167.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -67.34 -45.33 76.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.979 0.418 . . . . 5.97 112.091 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.63 25.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.474 0.654 . . . . 4.41 110.1 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 88.5 m -63.76 -33.84 76.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.59 -1.186 . . . . 2.98 112.021 -176.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 43.8 t80 -60.45 -32.62 71.55 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.984 0.421 . . . . 4.18 111.015 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -72.68 -23.84 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.537 0.684 . . . . 3.65 109.886 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 23.9 tptm -83.2 8.1 14.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.419 -0.809 . . . . 4.79 110.001 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.23 28.29 34.13 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.898 -0.668 . . . . 1.87 112.184 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 25' ' ' VAL . . . -71.73 -22.41 61.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 1.46 111.15 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 26' ' ' VAL . 10.0 t70 -56.78 -52.86 63.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.409 -0.359 . . . . 2.42 110.232 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.443 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -66.17 -37.88 86.71 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.44 -0.504 . . . . 3.03 110.908 -172.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.979 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.4 m -69.31 -44.56 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 120.583 -0.447 . . . . 2.26 110.72 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 18.9 m -64.52 -31.32 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.919 -0.712 . . . . 1.57 109.441 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -59.66 -45.85 90.78 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.932 0.396 . . . . 1.35 110.08 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . -56.1 -43.25 77.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.091 -0.958 . . . . 0.65 108.516 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.774 ' HZ ' ' HE2' ' A' ' 85' ' ' TYR . 1.3 t80 -56.17 -49.18 74.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.062 -0.972 . . . . 1.98 110.776 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -50.92 -46.63 60.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.262 -0.881 . . . . 2.85 110.551 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -76.17 -30.18 58.0 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.97 -1.014 . . . . 2.23 110.919 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.85 ' NE2' ' HG2' ' A' ' 79' ' ' LYS . 71.6 mm-40 -61.66 -27.59 68.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.218 -0.901 . . . . 2.54 111.059 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -50.86 -58.41 6.03 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.854 -1.165 . . . . 2.06 107.854 170.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER 57.45 -2.63 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 O-C-N 125.683 1.865 . . . . 4.48 112.61 173.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 46.05 -166.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.656 -1.611 . . . . 3.76 112.935 174.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 6.9 t70 -159.57 -40.25 0.05 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.2 -1.407 . . . . 4.62 107.2 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 43' ' ' ASP . 1.5 pt -164.32 0.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.247 -2.252 . . . . 5.0 110.557 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.84 -27.41 0.58 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 119.517 -1.325 . . . . 4.13 112.944 -165.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.996 ' HA ' ' HE1' ' A' ' 46' ' ' PHE . 10.6 t70 -138.28 167.86 20.96 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 121.157 0.503 . . . . 4.31 111.898 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 46' ' ' PHE . 5.0 t -25.58 -58.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 126.877 2.611 . . . . 2.96 110.422 174.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.819 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 98.5 m -159.55 -64.69 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 111.627 -2.533 . . . . 3.83 111.397 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.819 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.2 Cg_exo -78.62 5.93 5.22 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 121.097 1.198 . . . . 3.83 114.561 -172.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.979 ' HA ' ' HB3' ' A' ' 39' ' ' ASP . 36.9 t70 74.27 21.38 2.45 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.252 -1.018 . . . . 4.26 108.252 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.05 58.52 0.16 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 118.691 -1.718 . . . . 2.01 113.882 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.499 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -122.53 -44.28 2.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.241 0.543 . . . . 3.34 110.476 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.996 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -119.55 142.11 48.64 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 113.208 0.818 . . . . 2.07 113.208 -170.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.738 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 23.2 t -155.64 97.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.354 -1.721 . . . . 1.91 106.354 166.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.506 HG23 ' HD2' ' A' ' 46' ' ' PHE . 36.1 pt -87.97 149.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 114.021 1.119 . . . . 3.19 114.021 -159.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.3 p30 -161.02 138.01 8.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.394 -1.275 . . . . 3.31 110.333 159.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.5 m -44.06 -45.55 8.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.9 -1.5 . . . . 3.25 114.095 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 tp -53.48 -39.5 64.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.711 1.745 . . . . 4.45 115.711 -152.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG2' ' H ' ' A' ' 52' ' ' ARG . 2.6 mmt180 -62.65 -57.76 9.91 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.611 1.196 . . . . 6.26 109.62 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.726 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 38.5 t -66.99 166.45 13.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.831 -1.986 . . . . 3.04 111.208 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 54' ' ' VAL . 21.4 t 70.65 26.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 123.332 1.539 . . . . 4.32 109.238 -169.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.17 63.58 0.3 Allowed Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 113.319 -1.764 . . . . 4.19 112.36 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.34 58.84 10.78 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 119.044 -1.55 . . . . 4.42 114.498 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.314 0.8 OUTLIER -131.43 -33.76 1.44 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.05 1.425 . . . . 3.52 108.982 -157.077 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.36 2.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 115.311 1.597 . . . . 3.64 115.311 -163.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -72.82 6.39 2.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.984 -1.086 . . . . 5.44 111.746 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.1 158.2 46.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 108.027 -1.101 . . . . 3.22 108.027 157.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.59 120.07 5.43 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 CA-C-N 120.659 1.271 . . . . 3.83 109.507 163.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.581 ' O ' HD12 ' A' ' 62' ' ' ILE . 2.0 pp -111.46 130.31 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.048 0.758 . . . . 2.69 113.048 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.966 HG21 ' H ' ' A' ' 73' ' ' VAL . 3.9 t -142.27 116.52 4.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 107.091 -1.448 . . . . 1.87 107.091 157.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.576 ' HG3' HG12 ' A' ' 69' ' ' VAL . 20.5 ttt -119.11 136.47 54.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 118.434 -1.306 . . . . 1.65 111.334 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 68' ' ' LYS . 1.8 m -123.46 115.94 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.533 -1.284 . . . . 0.76 107.533 157.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 7' ' ' TYR . . . 50.03 -155.47 2.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.648 -0.787 . . . . 1.1 111.223 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.79 37.27 0.41 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.995 -0.603 . . . . 3.01 109.93 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.797 ' HB2' HG23 ' A' ' 65' ' ' VAL . 14.5 mmmm -103.09 -22.76 13.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.056 -0.52 . . . . 2.62 109.999 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.576 HG12 ' HG3' ' A' ' 64' ' ' MET . 3.5 m 29.06 101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.134 1.531 . . . . 1.51 115.134 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.739 ' HD2' ' HE1' ' A' ' 85' ' ' TYR . 62.7 m-85 -118.09 -158.68 0.72 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.99 0.9 . . . . 1.43 112.14 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 81' ' ' ILE . . . -147.84 40.8 0.95 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 114.38 -1.282 . . . . 1.49 110.138 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 1.006 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -64.37 -4.99 4.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.717 0.77 . . . . 1.83 110.759 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.966 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 48.89 -160.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.91 1.684 . . . . 3.06 114.308 169.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.979 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 27.1 p -139.66 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.964 1.468 . . . . 2.49 114.964 -166.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.583 ' HD3' ' OG1' ' A' ' 74' ' ' THR . 3.7 Cg_exo -77.99 76.98 4.1 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.307 2.004 . . . . 2.65 113.811 -170.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.2 -20.75 3.03 Favored Glycine 0 N--CA 1.462 0.397 0 C-N-CA 121.405 -0.426 . . . . 1.4 112.751 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.49 ' O ' ' HD3' ' A' ' 80' ' ' LYS . 18.7 mt-30 -77.99 -18.91 55.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.824 -1.547 . . . . 1.87 106.824 -172.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.741 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -47.15 -51.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 112.069 -2.332 . . . . 0.97 110.908 -177.51 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.85 ' HG2' ' NE2' ' A' ' 32' ' ' GLN . 44.7 mtmt -54.0 -51.61 63.41 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 122.833 1.301 . . . . 2.13 109.343 -167.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.23 -35.5 15.29 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.176 -1.829 . . . . 2.41 110.675 -169.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.006 HG22 ' HA ' ' A' ' 72' ' ' ASN . 46.5 mm -71.98 -13.6 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.176 -0.92 . . . . 1.23 109.126 176.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 85' ' ' TYR . 43.9 tp -56.11 -19.89 15.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.469 -0.332 . . . . 0.79 110.343 171.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.7 -22.23 1.98 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.777 0.322 . . . . 0.88 111.428 167.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.25 -44.37 95.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.431 0.634 . . . . 2.09 110.251 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.774 ' HE2' ' HZ ' ' A' ' 29' ' ' PHE . 10.1 m-30 . . . . . 0 N--CA 1.427 -1.586 0 CA-C-N 115.018 -0.992 . . . . 1.77 112.082 -173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.275 -0.268 . . . . 13.97 110.275 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.809 ' HB ' ' HD3' ' A' ' 3' ' ' PRO . 60.1 t -64.22 -52.23 56.18 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 108.511 -0.922 . . . . 10.71 108.511 171.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.809 ' HD3' ' HB ' ' A' ' 2' ' ' VAL . 21.1 Cg_exo -67.74 119.93 6.95 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.619 -1.339 . . . . 9.2 108.619 158.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.659 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 13.0 tptm -42.6 -65.82 0.43 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.19 0.931 . . . . 9.04 112.144 -171.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 1.063 ' HA2' ' HB2' ' A' ' 47' ' ' SER . . . 112.37 31.66 2.55 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 114.636 -1.166 . . . . 4.14 111.916 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.72 ' HG2' ' CE1' ' A' ' 7' ' ' TYR . 25.4 ttpt -58.94 -54.01 51.94 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.194 -0.503 . . . . 4.58 110.106 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.918 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.0 m-30 -108.5 82.69 1.72 Allowed Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 116.228 -0.442 . . . . 1.64 110.412 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.932 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 87.1 Cg_exo -52.72 94.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.835 2.356 . . . . 1.02 111.972 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.724 ' HB ' ' CG1' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -85.11 127.7 39.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 1.52 112.054 -173.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 14.3 m -100.37 110.99 23.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.286 -0.87 . . . . 1.45 110.627 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -117.21 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.409 . . . . 2.21 110.97 -178.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.708 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 24.4 t -67.38 121.24 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.195 -0.602 . . . . 2.24 111.611 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.0 mtm -123.82 23.11 8.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.934 -0.765 . . . . 5.12 108.934 164.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.03 177.38 19.65 Favored Glycine 0 C--O 1.219 -0.807 0 C-N-CA 120.945 -0.645 . . . . 3.86 112.624 -173.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.7 p -64.29 -43.89 93.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.69 0.626 . . . . 5.97 112.69 -168.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.701 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -69.88 -55.63 9.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.43 . . . . 4.41 111.361 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.708 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 86.6 m -66.53 -34.93 79.02 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.408 -0.36 . . . . 2.98 111.757 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 51.3 t80 -62.16 -32.16 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.909 0.484 . . . . 4.18 111.746 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 16' ' ' ALA . 4.2 p -70.91 -18.67 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.147 0.499 . . . . 3.65 110.818 -172.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -80.75 8.43 8.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.501 0.667 . . . . 4.79 109.769 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.78 54.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.561 -0.745 . . . . 1.87 112.048 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.57 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -73.43 -21.08 60.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.421 -0.389 . . . . 1.46 110.673 -172.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 26' ' ' VAL . 13.6 t70 -56.93 -46.55 81.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 2.42 111.309 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -66.88 -36.99 83.57 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.067 -0.653 . . . . 3.03 110.353 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.542 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -72.53 -38.18 58.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.797 -0.638 . . . . 2.26 111.182 177.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.607 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 4.6 m -66.19 -28.43 43.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 119.546 -0.862 . . . . 1.57 109.15 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.48 -40.47 82.82 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.577 -0.527 . . . . 1.35 109.577 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -50.96 -51.26 54.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.863 -1.062 . . . . 0.65 108.904 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.607 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 29.8 t80 -53.65 -48.77 69.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.95 -1.023 . . . . 1.98 112.0 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -46.75 -49.48 19.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.004 -0.998 . . . . 2.85 110.494 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -77.96 -26.79 49.02 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.676 -1.147 . . . . 2.23 110.619 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.651 ' OE1' ' HA ' ' A' ' 79' ' ' LYS . 4.6 mt-30 -60.5 -29.86 69.36 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.536 -0.757 . . . . 2.54 112.393 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.749 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 1.1 tt -48.42 -55.74 10.04 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.373 -1.714 . . . . 2.06 106.373 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.04 -18.81 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 126.513 2.383 . . . . 4.48 112.648 173.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.736 ' HA ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 51.71 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.398 -1.728 . . . . 3.76 113.996 165.287 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -155.51 -55.64 0.09 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.581 -1.645 . . . . 4.62 108.076 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 pt -167.53 9.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 112.728 -2.033 . . . . 5.0 108.486 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.92 -51.81 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.585 0 N-CA-C 108.981 -1.647 . . . . 4.13 108.981 -164.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.581 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -169.72 143.04 2.6 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.546 -0.827 . . . . 4.31 111.772 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.806 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER 18.83 -68.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 O-C-N 127.041 2.713 . . . . 2.96 115.167 161.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.624 ' H ' HG13 ' A' ' 40' ' ' VAL . 23.5 m -135.32 94.64 15.42 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 104.793 -2.299 . . . . 3.83 104.793 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -33.06 89.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.965 3.11 . . . . 3.83 113.608 -149.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 4' ' ' LYS . 8.8 t70 -144.36 -65.1 0.35 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.919 -1.491 . . . . 4.26 111.37 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 4' ' ' LYS . . . 113.49 37.41 1.32 Allowed Glycine 0 C--N 1.31 -0.89 0 N-CA-C 110.32 -1.112 . . . . 2.01 110.32 -169.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.621 ' HD3' ' OXT' ' A' ' 85' ' ' TYR . 76.5 mtt180 -61.15 -42.26 98.23 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.876 -1.162 . . . . 3.34 109.845 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.806 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 99.3 m-85 -84.15 136.88 33.81 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.911 -1.041 . . . . 2.07 110.969 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 1.063 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 19.9 t -145.01 65.25 1.27 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.813 -1.18 . . . . 1.91 107.813 165.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.682 HG22 HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.97 129.17 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.331 -0.85 . . . . 3.19 111.99 -170.09 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -154.93 138.9 16.36 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.281 1.039 . . . . 3.31 110.784 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.7 p -43.86 -45.42 7.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.322 -1.763 . . . . 3.25 115.488 168.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.1 tp -53.16 -41.52 65.24 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.282 1.586 . . . . 4.45 115.282 -149.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -64.43 -57.34 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.931 0.872 . . . . 6.26 111.053 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -66.26 170.51 5.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.835 -1.53 . . . . 3.04 111.026 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.903 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 5.9 t 73.14 28.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.67 1.224 . . . . 4.32 109.175 -164.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.65 64.2 0.3 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 113.922 -1.49 . . . . 4.19 113.371 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.49 57.49 16.31 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.319 -1.42 . . . . 4.42 115.321 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.252 2.0 m -133.19 -33.32 1.14 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.706 1.253 . . . . 3.52 109.747 -161.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.98 -26.38 2.49 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.397 1.999 . . . . 3.64 116.397 -163.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.72 3.38 6.54 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.316 1.416 . . . . 5.44 111.413 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.94 158.36 50.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.245 -1.391 . . . . 3.22 107.245 154.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.15 118.6 5.03 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-N 121.191 1.461 . . . . 3.83 109.648 164.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.32 131.71 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.89 -0.141 . . . . 2.69 110.867 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.689 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 6.1 t -138.71 125.93 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.891 -1.151 . . . . 1.87 107.891 160.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.74 ' HG3' HG22 ' A' ' 69' ' ' VAL . 49.7 ttm -112.29 136.77 51.32 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 117.703 -1.599 . . . . 1.65 109.815 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.918 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.75 114.71 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 106.649 -1.612 . . . . 0.76 106.649 159.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.18 -145.87 1.65 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-O 122.337 0.965 . . . . 1.1 112.596 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.53 25.88 0.31 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.379 -1.411 . . . . 3.01 109.423 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.618 ' HD2' ' CE1' ' A' ' 7' ' ' TYR . 9.1 mmpt? -106.95 -40.82 5.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.298 -0.63 . . . . 2.62 109.298 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.74 HG22 ' HG3' ' A' ' 64' ' ' MET . 80.1 t 46.26 99.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.502 0.927 . . . . 1.51 113.502 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.733 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -117.03 -153.21 0.52 Allowed 'General case' 0 C--O 1.246 0.906 0 CA-C-O 122.07 0.938 . . . . 1.43 113.362 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.594 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -134.51 17.1 4.27 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.202 -1.363 . . . . 1.49 112.796 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.904 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 53.0 t-20 -89.53 98.52 11.81 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.945 -0.761 . . . . 1.83 108.945 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.618 HG13 HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -126.41 -90.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 122.181 0.991 . . . . 3.06 112.652 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.855 HG23 ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -137.77 -66.6 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 113.504 -1.68 . . . . 2.49 111.858 -170.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.855 ' HD3' HG23 ' A' ' 74' ' ' THR . 6.3 Cg_exo -76.84 70.87 6.36 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.648 2.232 . . . . 2.65 114.019 -162.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 80.1 -19.55 6.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.105 -0.569 . . . . 1.4 113.108 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.541 ' O ' HG12 ' A' ' 81' ' ' ILE . 3.8 mt-30 -73.98 -22.86 59.45 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.342 -1.725 . . . . 1.87 106.342 -170.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 79' ' ' LYS . 13.6 m -48.7 -59.18 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 111.826 -2.443 . . . . 0.97 111.386 -175.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.657 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 23.6 pttt -60.17 -39.49 86.62 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.783 0.801 . . . . 2.13 110.741 -165.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.657 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -82.38 -45.27 15.07 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.75 -1.113 . . . . 2.41 109.646 -173.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' A' ' 72' ' ' ASN . 39.5 mm -69.39 -15.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.211 -1.358 . . . . 1.23 110.155 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HA ' HD21 ' A' ' 72' ' ' ASN . 53.6 tp -63.04 -37.81 88.67 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.74 -0.6 . . . . 0.79 110.256 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.7 64.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.013 -0.736 . . . . 0.88 109.013 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 6.6 mt-10 -73.66 -34.49 64.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.871 -1.059 . . . . 2.09 112.748 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 5.1 m-30 . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 118.951 -0.547 . . . . 1.77 112.044 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' FES . . . . . 0.903 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mmm . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.881 0.372 . . . . 13.97 110.478 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -125.06 101.1 32.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 10.71 110.232 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.9 100.57 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.498 2.132 . . . . 9.2 111.223 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.844 ' HG3' ' HA3' ' A' ' 44' ' ' GLY . 25.3 mmtp -58.34 -45.22 88.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.428 0.633 . . . . 9.04 111.421 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.92 0.35 58.86 Favored Glycine 0 C--N 1.307 -1.059 0 CA-C-N 115.165 -0.925 . . . . 4.14 114.262 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 3.8 tppp? -64.87 -58.72 5.45 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.422 -0.585 . . . . 4.58 109.422 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 1.071 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 22.5 m-85 -141.71 62.71 15.34 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 114.364 -1.289 . . . . 1.64 110.254 -175.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD2' ' CA ' ' A' ' 66' ' ' GLY . 33.4 Cg_exo -61.48 92.81 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.534 1.489 . . . . 1.02 109.949 172.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.066 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.03 160.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 116.409 -0.36 . . . . 1.52 110.426 -168.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.806 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m -139.86 112.84 8.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 123.644 0.59 . . . . 1.45 111.343 -174.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.7 t -118.17 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.182 -0.917 . . . . 2.21 109.857 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -65.39 120.38 12.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 118.775 0.716 . . . . 2.24 110.958 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ttt -124.3 23.05 8.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.503 -0.771 . . . . 5.12 109.654 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -68.06 177.52 23.73 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.797 . . . . 3.86 112.417 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -67.65 -43.8 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.078 0.399 . . . . 5.97 112.078 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.642 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -71.29 -56.8 5.29 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.549 0.574 . . . . 4.41 112.549 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 98.9 m -63.48 -30.53 71.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.506 -0.316 . . . . 2.98 111.572 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.575 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 56.4 t80 -59.31 -29.53 67.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.286 0.635 . . . . 4.18 112.179 -176.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 16' ' ' ALA . 16.9 m -69.15 -18.65 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 111.91 0.337 . . . . 3.65 111.91 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.02 13.32 2.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.807 0.337 . . . . 4.79 110.591 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.4 28.73 23.99 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.649 -0.58 . . . . 1.87 111.649 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -72.48 -19.63 61.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.253 -0.474 . . . . 1.46 110.97 -172.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . 8.5 p-10 -55.7 -45.0 77.92 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.887 -0.325 . . . . 2.42 110.429 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -62.61 -48.29 80.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.352 -0.539 . . . . 3.03 110.782 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.033 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 6.6 m -65.52 -44.3 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 116.305 -0.407 . . . . 2.26 110.526 -176.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' ASP . 15.0 m -64.17 -36.45 77.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.149 -0.62 . . . . 1.57 110.2 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -60.18 -42.57 95.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.107 -0.637 . . . . 1.35 109.398 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.75 -46.66 81.27 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.42 -1.264 . . . . 0.65 108.629 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' HZ ' ' CG1' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -44.59 82.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.875 . . . . 1.98 111.425 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -54.63 -51.21 66.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.723 0.773 . . . . 2.85 110.085 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.77 -20.75 38.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.935 -1.03 . . . . 2.23 110.653 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.597 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -62.0 -30.64 71.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.781 -0.645 . . . . 2.54 110.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.098 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.8 tt -54.69 -54.24 44.41 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.259 -1.015 . . . . 2.06 108.259 172.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 65.77 -19.52 0.09 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.357 -2.202 . . . . 4.48 112.493 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.698 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER 54.36 -170.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.501 -1.681 . . . . 3.76 113.12 168.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -157.38 -49.56 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.208 -1.405 . . . . 4.62 107.208 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -164.92 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 113.069 -1.878 . . . . 5.0 110.836 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -178.05 -61.98 0.07 OUTLIER Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 109.783 -1.327 . . . . 4.13 109.783 -166.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.584 ' HB2' ' N ' ' A' ' 44' ' ' GLY . 38.2 m-20 -165.52 122.12 1.42 Allowed 'General case' 0 CA--C 1.475 -1.925 0 CA-C-N 113.051 -1.575 . . . . 4.31 108.796 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.986 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 1.4 p 54.99 -71.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 O-C-N 126.775 2.547 . . . . 2.96 113.348 169.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.788 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 84.3 m -151.18 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.275 -2.662 0 CA-C-N 113.262 -1.79 . . . . 3.83 110.256 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.819 ' HD2' HG13 ' A' ' 40' ' ' VAL . 7.1 Cg_exo -73.83 4.42 4.15 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 120.673 0.915 . . . . 3.83 113.946 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 20.2 t70 78.09 14.12 1.56 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.294 -1.373 . . . . 4.26 107.294 169.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.844 ' HA3' ' HG3' ' A' ' 4' ' ' LYS . . . 155.07 63.58 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 114.151 -1.386 . . . . 2.01 112.278 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 10.5 ttt180 -94.7 -64.69 1.04 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.814 -1.55 . . . . 3.34 106.814 171.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.098 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -107.23 123.99 49.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.752 -0.658 . . . . 2.07 112.281 171.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.459 ' C ' HG23 ' A' ' 9' ' ' ILE . 4.2 m -105.33 92.15 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.966 . . . . 1.91 109.279 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.005 HG22 HD13 ' A' ' 9' ' ' ILE . 2.3 pp -60.18 123.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.774 -0.648 . . . . 3.19 112.72 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.806 ' O ' ' HA ' ' A' ' 10' ' ' SER . 5.3 t70 -160.85 140.49 10.77 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.241 1.019 . . . . 3.31 113.051 167.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t -47.51 -45.96 26.9 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 115.111 1.522 . . . . 3.25 115.111 169.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.439 ' HG ' ' OD1' ' A' ' 49' ' ' ASP . 51.6 mt -53.49 -38.12 63.38 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.254 2.316 . . . . 4.45 117.254 -152.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.4 mmt180 -61.78 -56.82 15.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.757 1.162 . . . . 6.26 110.18 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.699 ' H ' ' HB3' ' A' ' 10' ' ' SER . 27.4 t -65.07 165.46 11.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.327 -1.76 . . . . 3.04 109.938 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.012 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 10.9 t 71.26 25.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 122.93 1.347 . . . . 4.32 108.188 -156.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.51 64.11 0.35 Allowed Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 113.583 -1.644 . . . . 4.19 113.538 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.33 57.71 14.21 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 119.11 -1.519 . . . . 4.42 115.3 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.67 ' HB3' HG21 ' A' ' 62' ' ' ILE 0.267 1.8 m -135.7 -32.65 0.89 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.564 1.182 . . . . 3.52 110.416 -162.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -28.64 5.66 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.477 1.658 . . . . 3.64 115.477 -163.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.57 7.63 2.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.777 1.172 . . . . 5.44 112.053 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.7 160.55 36.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.888 -0.782 . . . . 3.22 108.888 164.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.89 122.18 7.09 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 N-CA-C 108.787 -1.274 . . . . 3.83 108.787 160.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 57' ' ' CYS . 1.9 pp -110.0 133.68 54.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.875 1.065 . . . . 2.69 113.875 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.762 HG21 ' H ' ' A' ' 73' ' ' VAL . 4.0 t -138.03 119.19 17.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.022 -1.844 . . . . 1.87 106.022 154.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.752 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 20.9 ttt -114.36 135.34 54.19 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 120.33 -1.481 . . . . 1.65 111.926 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.071 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -126.57 118.43 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 N-CA-C 107.635 -1.246 . . . . 0.76 107.635 157.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.559 ' CA ' ' HD2' ' A' ' 8' ' ' PRO . . . 60.2 -169.78 7.53 Favored Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.886 -1.15 . . . . 1.1 110.481 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.83 37.96 0.31 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.926 -1.138 . . . . 3.01 107.926 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 54.6 mmtt -107.89 -31.21 8.1 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.892 -1.049 . . . . 2.62 108.646 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.661 ' C ' ' HD1' ' A' ' 70' ' ' TYR . 75.7 t 47.54 113.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 114.472 1.286 . . . . 1.51 114.472 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.678 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -123.53 -170.11 2.06 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 122.615 1.197 . . . . 1.43 112.967 -172.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.71 49.9 0.82 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 113.662 -1.608 . . . . 1.49 110.178 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.919 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -77.92 -0.41 27.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.361 1.077 . . . . 1.83 110.062 175.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.762 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 64.33 -165.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 113.749 -1.569 . . . . 3.06 111.65 168.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 1.033 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 64.4 p -138.58 -46.67 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 114.22 1.193 . . . . 2.49 114.22 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.522 ' CD ' ' H ' ' A' ' 74' ' ' THR . 7.0 Cg_endo -88.29 78.58 1.33 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.895 1.73 . . . . 2.65 113.787 -172.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.28 -23.17 2.33 Favored Glycine 0 N--CA 1.461 0.335 0 C-N-CA 121.01 -0.614 . . . . 1.4 113.078 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.466 ' O ' HG12 ' A' ' 81' ' ' ILE . 34.3 mt-30 -75.28 -21.12 58.76 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.413 -1.699 . . . . 1.87 106.413 -174.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.666 HG23 ' H ' ' A' ' 79' ' ' LYS . 4.0 m -45.09 -61.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 111.478 -2.601 . . . . 0.97 112.162 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.666 ' H ' HG23 ' A' ' 78' ' ' VAL . 43.3 mtmt -58.03 -32.03 67.57 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 122.039 0.923 . . . . 2.13 110.657 -166.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -81.28 -50.84 9.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.53 -1.214 . . . . 2.41 108.837 -177.506 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.919 ' CG2' ' HA ' ' A' ' 72' ' ' ASN . 28.8 mm -66.14 -5.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 113.549 -1.66 . . . . 1.23 110.601 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 47.0 tp -54.22 -21.67 9.58 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.508 -0.745 . . . . 0.79 110.143 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.84 -19.66 6.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.687 -0.688 . . . . 0.88 111.352 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 70' ' ' TYR . 6.6 tp10 -69.53 -51.34 36.54 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.44 1.096 . . . . 2.09 110.241 173.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.678 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 11.4 m-30 . . . . . 0 N--CA 1.425 -1.693 0 CA-C-N 113.673 -1.603 . . . . 1.77 112.811 -166.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' FES . . . . . 1.012 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtm . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.757 -0.46 . . . . 13.97 109.757 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.95 113.01 26.79 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.258 -0.645 . . . . 10.71 109.258 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.723 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 17.4 Cg_exo -66.13 147.87 84.49 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.509 2.139 . . . . 9.2 112.353 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.596 ' H ' ' HA3' ' A' ' 44' ' ' GLY . 22.5 ttmm -50.37 -74.38 0.03 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.572 0.701 . . . . 9.04 112.241 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.0 35.67 0.54 Allowed Glycine 0 C--N 1.31 -0.876 0 CA-C-N 114.637 -1.165 . . . . 4.14 112.607 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 24.2 tptp -56.16 -59.44 4.92 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.817 -0.809 . . . . 4.58 108.817 170.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 1.092 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -115.89 87.51 18.71 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.711 -1.132 . . . . 1.64 110.916 175.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.34 96.55 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.637 2.225 . . . . 1.02 111.565 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.084 HD13 HG22 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -75.17 117.83 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.799 0.809 . . . . 1.52 110.289 -175.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.694 ' HB3' ' H ' ' A' ' 53' ' ' CYS . 7.3 m -100.14 113.02 25.35 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.139 -1.391 . . . . 1.45 110.528 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.635 HG11 HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -118.48 122.81 70.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.274 -0.875 . . . . 2.21 110.328 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.736 ' SG ' HG22 ' A' ' 54' ' ' VAL . 33.7 t -66.47 122.82 18.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.279 0.561 . . . . 2.24 111.284 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -122.69 23.87 9.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.428 -0.805 . . . . 5.12 109.699 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.95 178.68 20.21 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.792 -0.718 . . . . 3.86 112.778 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -65.36 -44.85 86.38 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.462 0.541 . . . . 5.97 112.462 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 -55.05 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.271 0.558 . . . . 4.41 111.851 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 79.4 m -64.69 -31.08 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.537 -0.756 . . . . 2.98 111.541 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 75.6 t80 -58.35 -27.43 64.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.447 0.699 . . . . 4.18 111.576 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.74 -20.82 26.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.058 -0.519 . . . . 3.65 111.468 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -80.79 11.48 3.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.159 -0.338 . . . . 4.79 111.224 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.38 29.44 27.48 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.725 -0.75 . . . . 1.87 111.954 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -71.93 -20.47 61.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.906 0.335 . . . . 1.46 111.906 -168.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 26' ' ' VAL . 27.1 t70 -57.86 -45.34 86.42 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.845 -0.342 . . . . 2.42 110.881 -176.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -64.92 -42.52 94.64 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.609 . . . . 3.03 111.134 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.9 m -68.91 -39.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.707 0.289 . . . . 2.26 111.228 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.875 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . 10.7 m -65.31 -33.35 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.817 -0.753 . . . . 1.57 110.258 175.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.58 -39.33 87.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.253 0.549 . . . . 1.35 109.551 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 78' ' ' VAL . . . -55.08 -45.84 75.42 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.701 -1.136 . . . . 0.65 109.443 175.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.914 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 23.1 m-85 -52.15 -50.11 62.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 123.46 0.475 . . . . 1.98 111.02 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -49.91 -50.83 44.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.53 0.681 . . . . 2.85 111.312 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.52 -30.22 37.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.296 -0.865 . . . . 2.23 111.39 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.914 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -68.01 -19.29 64.9 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.741 -0.663 . . . . 2.54 110.313 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.04 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -54.52 -56.48 18.42 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 106.153 -1.795 . . . . 2.06 106.153 169.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 70.16 -21.86 0.17 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.775 -2.011 . . . . 4.48 110.909 168.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.717 HG12 HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 56.56 -176.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 112.508 -2.133 . . . . 3.76 113.702 166.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 35' ' ' ILE . 12.9 t70 -158.68 -44.11 0.06 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.075 -1.42 . . . . 4.62 107.748 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.5 pt -168.3 -0.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 113.226 -1.806 . . . . 5.0 111.416 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 176.77 -52.66 0.11 Allowed Glycine 0 CA--C 1.483 -1.923 0 N-CA-C 107.629 -2.188 . . . . 4.13 107.629 -162.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.757 ' CG ' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -171.54 135.54 0.91 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.266 -1.967 . . . . 4.31 109.732 175.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.757 HG12 ' CG ' ' A' ' 39' ' ' ASP . 7.1 p 39.06 -65.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 127.502 3.001 . . . . 2.96 114.955 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.788 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 45.0 m -150.82 -60.11 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.69 -1.595 . . . . 3.83 110.833 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.822 ' HG2' ' HG3' ' A' ' 45' ' ' ARG . 1.1 Cg_endo -88.33 15.51 2.07 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 121.618 1.546 . . . . 3.83 114.937 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 25.8 t70 83.38 -1.75 1.17 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.143 0.973 . . . . 4.26 109.708 160.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.596 ' HA3' ' H ' ' A' ' 4' ' ' LYS . . . 172.18 53.11 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.774 -1.203 . . . . 2.01 113.566 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.822 ' HG3' ' HG2' ' A' ' 42' ' ' PRO . 20.0 mtt180 -72.26 -53.9 11.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.924 -0.769 . . . . 3.34 108.924 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.04 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -128.08 120.3 27.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.552 1.167 . . . . 2.07 113.768 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.723 ' HB3' ' HB2' ' A' ' 3' ' ' PRO . 41.9 p -114.68 106.73 14.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.818 -1.537 . . . . 1.91 108.307 175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.084 HG22 HD13 ' A' ' 9' ' ' ILE . 2.0 pp -72.91 121.06 22.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.378 -0.828 . . . . 3.19 112.229 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.49 141.95 15.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 122.744 1.259 . . . . 3.31 112.225 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 21.4 m -43.92 -46.24 8.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.614 2.079 . . . . 3.25 116.614 174.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.44 -41.12 65.76 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.776 2.139 . . . . 4.45 116.776 -147.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 12.7 tpt180 -63.39 -57.72 9.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.271 0.941 . . . . 6.26 110.786 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.694 ' H ' ' HB3' ' A' ' 10' ' ' SER . 33.0 t -65.18 172.72 2.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.591 -1.64 . . . . 3.04 110.727 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.997 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 13.5 t 76.2 29.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 122.93 1.348 . . . . 4.32 109.538 -160.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.2 61.65 0.31 Allowed Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 113.849 -1.523 . . . . 4.19 112.555 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.97 54.98 32.38 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 119.892 -1.147 . . . . 4.42 115.709 169.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.257 1.4 m -135.12 -32.49 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.202 1.501 . . . . 3.52 109.704 -161.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.89 -25.27 1.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.921 1.823 . . . . 3.64 115.921 -163.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.63 8.14 1.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.563 1.074 . . . . 5.44 111.791 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.68 161.91 27.97 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.053 -1.092 . . . . 3.22 108.053 162.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.33 119.96 6.27 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 120.704 1.287 . . . . 3.83 109.309 166.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.47 132.74 56.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.429 0.529 . . . . 2.69 112.429 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.721 HG21 ' H ' ' A' ' 73' ' ' VAL . 2.5 t -138.7 119.76 16.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.446 -1.687 . . . . 1.87 106.446 154.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.661 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 20.8 ttt -112.42 136.27 52.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 120.369 -1.457 . . . . 1.65 110.0 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.092 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -125.26 117.15 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.413 -1.329 . . . . 0.76 107.413 159.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 55.09 -162.3 4.72 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.146 -1.026 . . . . 1.1 110.863 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -79.06 34.48 0.24 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.889 -0.782 . . . . 3.01 108.889 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.663 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 70.9 mmtt -108.47 -22.18 12.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.279 -0.873 . . . . 2.62 110.012 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 23.2 m 36.54 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 115.134 1.531 . . . . 1.51 115.134 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.789 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -116.31 -178.33 3.39 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.979 1.371 . . . . 1.43 113.598 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.05 48.67 0.91 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 113.381 -1.736 . . . . 1.49 109.603 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.913 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -78.4 -0.89 30.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.902 0.858 . . . . 1.83 109.191 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.721 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 63.31 -168.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 113.909 -1.496 . . . . 3.06 111.282 171.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.863 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 13.3 p -135.74 -46.36 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 113.946 1.091 . . . . 2.49 113.946 -169.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.534 ' HD3' ' H ' ' A' ' 74' ' ' THR . 4.5 Cg_endo -88.73 85.45 0.58 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.185 1.923 . . . . 2.65 113.224 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.32 -27.77 2.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.17 -0.538 . . . . 1.4 112.774 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.882 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 41.0 mt-30 -77.31 -18.62 57.33 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.064 -1.458 . . . . 1.87 107.064 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.577 HG21 ' HB1' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -46.72 -58.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-N 112.444 -2.162 . . . . 0.97 111.354 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.3 pttt -62.17 -38.06 87.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.426 0.631 . . . . 2.13 111.096 -166.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.882 ' HD2' ' HA ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.85 -34.05 15.42 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.074 0.464 . . . . 2.41 110.873 -176.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.913 HG22 ' HA ' ' A' ' 72' ' ' ASN . 47.9 mm -72.45 -10.79 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.909 -0.774 . . . . 1.23 108.909 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.974 HD12 ' HB2' ' A' ' 85' ' ' TYR . 16.7 tp -57.84 -12.97 3.55 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.462 0.705 . . . . 0.79 110.467 171.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -25.58 6.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.08 -0.648 . . . . 0.88 110.076 163.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 5.7 mm-40 -65.49 -49.95 67.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.459 -0.791 . . . . 2.09 110.97 169.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.974 ' HB2' HD12 ' A' ' 82' ' ' LEU . 12.6 m-30 . . . . . 0 N--CA 1.428 -1.556 0 CA-C-N 115.682 -0.69 . . . . 1.77 112.099 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' FES . . . . . 0.997 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 tpp . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.935 -0.394 . . . . 13.97 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.841 ' HB ' ' HD3' ' A' ' 3' ' ' PRO . 48.9 t -84.59 -56.39 0.41 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.529 -0.305 . . . . 10.71 110.591 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.841 ' HD3' ' HB ' ' A' ' 2' ' ' VAL . 10.4 Cg_exo -73.18 108.61 2.65 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.105 1.87 . . . . 9.2 110.857 172.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 1.06 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 12.3 mptt -65.32 -53.62 41.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.575 -0.739 . . . . 9.04 109.527 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' A' ' 47' ' ' SER . . . -129.64 -137.19 4.2 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.765 -1.107 . . . . 4.14 111.213 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -81.15 -47.51 13.37 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 122.636 0.375 . . . . 4.58 111.928 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.821 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.0 m-85 -111.85 98.73 42.82 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 116.094 -0.503 . . . . 1.64 111.915 -172.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.909 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 80.0 Cg_exo -50.69 96.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.882 2.388 . . . . 1.02 112.19 171.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.043 HD13 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.24 115.37 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.79 0.805 . . . . 1.52 110.112 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.718 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 14.0 m -92.61 127.34 38.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.194 -1.366 . . . . 1.45 109.987 -176.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 t -114.25 126.47 71.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 2.21 112.328 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 16.3 t -64.21 115.17 4.75 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.555 0.693 . . . . 2.24 112.138 -175.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.472 ' H ' HG22 ' A' ' 54' ' ' VAL . 84.6 mtp -129.26 24.6 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 5.12 110.737 172.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.812 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . -65.57 176.73 14.11 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.381 -0.914 . . . . 3.86 114.14 -167.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 t -66.17 -45.85 79.45 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.821 0.304 . . . . 5.97 111.821 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 25.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.744 0.783 . . . . 4.41 110.162 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 76.9 m -61.93 -35.73 79.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.312 -1.313 . . . . 2.98 112.237 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 54.0 t80 -61.66 -31.74 71.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.008 0.432 . . . . 4.18 111.024 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.0 t -71.98 -21.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 3.65 110.319 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 27.4 mtpp -82.8 12.92 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.925 -0.579 . . . . 4.79 111.803 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.56 32.06 14.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.151 -1.023 . . . . 1.87 111.906 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.581 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -70.86 -20.97 62.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.635 0.235 . . . . 1.46 111.635 -170.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.585 ' O ' HG22 ' A' ' 26' ' ' VAL . 25.0 t70 -55.82 -49.58 72.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.953 0.406 . . . . 2.42 110.144 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 2.5 mptp? -66.94 -39.62 87.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.561 -0.456 . . . . 3.03 111.59 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.942 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 3.3 m -68.58 -41.09 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 120.888 -0.325 . . . . 2.26 110.843 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 23' ' ' ASP . 8.0 m -64.96 -34.08 68.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.831 -0.748 . . . . 1.57 110.003 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 62.0 t-80 -59.42 -39.4 83.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.26 0.552 . . . . 1.35 109.805 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.673 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -54.71 -50.48 68.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.868 -1.06 . . . . 0.65 108.725 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.858 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.2 m-85 -50.57 -47.27 57.91 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 123.877 0.736 . . . . 1.98 111.68 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 25.1 tptp -49.3 -56.32 9.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 2.85 111.213 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -83.35 -19.67 35.71 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.268 -0.878 . . . . 2.23 111.513 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.858 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.82 -22.1 65.17 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.876 -0.602 . . . . 2.54 110.684 177.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.662 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -50.1 -59.63 3.72 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.55 -1.648 . . . . 2.06 106.55 167.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.581 ' C ' HG13 ' A' ' 35' ' ' ILE . 4.4 pttm 68.09 -27.34 0.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 112.412 -2.177 . . . . 4.48 111.674 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.681 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 55.55 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.24 -1.8 . . . . 3.76 113.379 172.309 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 37' ' ' ILE . 14.9 t70 -155.14 -53.55 0.09 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.214 -1.402 . . . . 4.62 107.214 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.3 pt -174.43 19.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 112.734 -2.03 . . . . 5.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.02 -70.81 0.05 OUTLIER Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 109.278 -1.529 . . . . 4.13 109.278 -168.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.596 ' HA ' HD21 ' A' ' 33' ' ' LEU . 10.5 m-20 -165.27 119.82 1.28 Allowed 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 112.996 -1.602 . . . . 4.31 109.293 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.951 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 7.5 p 56.11 -65.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 126.636 2.46 . . . . 2.96 114.259 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.934 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 64.8 m -164.19 -59.79 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.745 0 CA-C-N 113.236 -1.802 . . . . 3.83 110.06 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.934 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 16.3 Cg_exo -71.3 8.51 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.715 0 N-CA-C 114.493 0.92 . . . . 3.83 114.493 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 11.5 t70 86.56 -15.67 0.44 Allowed 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.613 -0.514 . . . . 4.26 109.613 161.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . -170.23 47.13 0.2 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.068 -1.539 . . . . 2.01 113.819 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -72.86 -32.44 65.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.94 0.876 . . . . 3.34 109.382 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.951 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 49.9 m-85 -96.58 153.29 17.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.194 -1.366 . . . . 2.07 112.386 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 1.06 ' HA ' ' HB2' ' A' ' 4' ' ' LYS . 31.2 t -152.8 66.72 0.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.556 -1.646 . . . . 1.91 106.556 161.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.043 HG22 HD13 ' A' ' 9' ' ' ILE . 2.2 pp -60.09 114.67 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.475 -1.239 . . . . 3.19 112.68 -168.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -161.15 144.53 12.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.746 1.26 . . . . 3.31 112.738 168.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 m -42.76 -43.09 3.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.917 -1.947 . . . . 3.25 115.022 167.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.7 mt -52.21 -41.87 63.06 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 116.058 1.874 . . . . 4.45 116.058 -147.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.54 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 24.1 mmt85 -64.71 -56.97 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.556 1.17 . . . . 6.26 110.261 174.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 35.9 t -66.31 167.05 11.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.714 -2.039 . . . . 3.04 112.617 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' HA2' ' A' ' 14' ' ' GLY . 15.7 t 70.44 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 123.053 1.406 . . . . 4.32 109.411 -168.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.26 64.66 0.31 Allowed Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 113.626 -1.624 . . . . 4.19 113.129 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.08 58.02 13.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 118.719 -1.705 . . . . 4.42 114.941 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.279 1.8 m -132.2 -31.05 1.48 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.618 1.209 . . . . 3.52 109.083 -162.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.691 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . . . -47.7 -27.06 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.554 1.687 . . . . 3.64 115.554 -163.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.24 5.03 3.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.181 1.355 . . . . 5.44 111.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.03 158.65 45.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.078 -1.082 . . . . 3.22 108.078 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -76.61 121.69 6.09 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.494 1.212 . . . . 3.83 109.319 163.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.437 HG22 ' S1 ' ' A' ' 86' ' ' FES . 13.3 tt -108.34 132.14 56.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.114 -0.635 . . . . 2.69 112.188 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.84 HG21 ' H ' ' A' ' 73' ' ' VAL . 20.9 t -137.88 118.43 16.42 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 105.686 -1.968 . . . . 1.87 105.686 158.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.689 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 17.1 ttt -116.87 137.83 51.94 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.442 -1.411 . . . . 1.65 110.648 -172.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.821 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -124.45 117.09 49.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 107.045 -1.465 . . . . 0.76 107.045 155.4 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . 51.47 -157.52 2.9 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.527 -0.629 . . . . 1.1 111.527 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.14 39.94 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.66 -0.867 . . . . 3.01 108.66 170.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.633 ' HB2' HG23 ' A' ' 65' ' ' VAL . 26.0 mmmt -108.33 -26.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.478 -0.783 . . . . 2.62 109.221 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.629 HG12 ' HG3' ' A' ' 64' ' ' MET . 9.2 m 36.01 109.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 115.138 1.533 . . . . 1.51 115.138 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.713 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.9 m-85 -118.86 -169.88 1.81 Allowed 'General case' 0 C--O 1.248 0.98 0 CA-C-O 122.86 1.314 . . . . 1.43 113.003 -173.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.82 46.45 0.8 Allowed Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 113.55 -1.659 . . . . 1.49 109.955 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.932 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.78 -0.58 21.52 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.981 0.896 . . . . 1.83 110.049 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.84 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 63.22 -165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 114.12 -1.4 . . . . 3.06 112.679 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.942 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.1 p -137.56 -45.13 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 113.604 0.965 . . . . 2.49 113.604 -168.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.579 ' CD ' ' H ' ' A' ' 74' ' ' THR . 83.5 Cg_endo -88.68 77.56 1.34 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 121.845 1.697 . . . . 2.65 113.705 -171.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.92 -24.26 2.87 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.171 -0.538 . . . . 1.4 113.031 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.558 ' O ' HG12 ' A' ' 81' ' ' ILE . 33.7 mt-30 -75.24 -20.9 58.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.565 -1.643 . . . . 1.87 106.565 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.546 HG21 ' HB1' ' A' ' 28' ' ' ALA . 2.7 m -43.58 -56.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 111.559 -2.564 . . . . 0.97 112.025 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.755 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.2 mtmt -56.73 -42.13 78.71 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 122.181 0.991 . . . . 2.13 110.003 -167.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -42.43 13.94 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.34 -1.3 . . . . 2.41 109.812 -172.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.932 HG22 ' HA ' ' A' ' 72' ' ' ASN . 41.3 mm -67.99 -13.78 17.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.694 -1.139 . . . . 1.23 109.29 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.944 HD12 ' HB2' ' A' ' 85' ' ' TYR . 27.2 tp -59.56 -13.42 9.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.657 0.783 . . . . 0.79 110.592 170.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.62 -26.27 8.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.255 -0.578 . . . . 0.88 109.963 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 8.8 mm-40 -62.79 -51.99 64.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.09 109.745 169.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.944 ' HB2' HD12 ' A' ' 82' ' ' LEU . 8.9 m-30 . . . . . 0 N--CA 1.424 -1.735 0 CA-C-N 114.812 -1.086 . . . . 1.77 112.259 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' FES . . . . . 0.691 ' S1 ' ' HA ' ' A' ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.067 -0.345 . . . . 13.97 110.067 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p -70.09 127.18 92.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.334 -0.394 . . . . 10.71 110.112 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.03 111.7 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.882 2.388 . . . . 9.2 112.277 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HB3' ' HE2' ' A' ' 6' ' ' LYS . 90.8 mttt -101.55 -89.43 0.36 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.833 -0.621 . . . . 9.04 109.487 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.734 ' HA2' ' CZ ' ' A' ' 7' ' ' TYR . . . 85.62 36.07 10.98 Favored Glycine 0 CA--C 1.501 -0.826 0 C-N-CA 120.355 -0.926 . . . . 4.14 112.738 172.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -147.68 45.93 1.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.618 1.199 . . . . 4.58 110.739 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.768 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 7.3 m-85 -55.64 113.08 5.02 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.412 -1.722 . . . . 1.64 114.365 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.781 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 72.5 Cg_exo -56.07 90.96 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.1 2.533 . . . . 1.02 111.919 166.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.799 HD13 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.87 119.12 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.675 0.75 . . . . 1.52 110.661 -177.271 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 2.6 m -100.46 114.44 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.606 -1.179 . . . . 1.45 111.291 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.8 t -117.98 122.88 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 2.21 110.85 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 25.1 t -67.61 121.2 15.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.28 -0.568 . . . . 2.24 111.553 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.8 mtp -124.61 23.41 8.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.63 -0.714 . . . . 5.12 109.584 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.67 179.61 12.47 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.178 -0.534 . . . . 3.86 112.998 -174.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -64.25 -45.42 88.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.069 0.396 . . . . 5.97 112.069 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -70.97 -56.41 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.078 0.466 . . . . 4.41 112.178 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.697 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.4 m -66.28 -33.79 76.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.91 -0.587 . . . . 2.98 111.993 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -60.6 -29.86 69.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.575 0.584 . . . . 4.18 112.575 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 16' ' ' ALA . 18.2 m -69.43 -18.95 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.771 0.32 . . . . 3.65 111.526 -171.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -80.57 12.88 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.541 -0.299 . . . . 4.79 110.923 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.25 29.04 26.19 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 121.114 -0.565 . . . . 1.87 111.98 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.1 -20.67 61.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.493 -0.353 . . . . 1.46 110.862 -172.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 26' ' ' VAL . 24.8 t70 -53.99 -50.42 66.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 2.42 110.759 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -66.87 -40.51 87.86 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.304 -0.559 . . . . 3.03 111.152 -172.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.877 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 1.9 m -69.45 -42.71 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.451 -0.34 . . . . 2.26 110.655 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 23' ' ' ASP . 17.6 m -66.15 -29.0 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 119.522 -0.871 . . . . 1.57 109.99 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -58.7 -41.2 85.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.137 0.494 . . . . 1.35 109.747 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -54.84 -46.04 74.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.848 -1.069 . . . . 0.65 109.707 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -49.86 65.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.581 . . . . 1.98 110.411 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -51.9 -50.13 61.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 2.85 111.547 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -79.96 -25.82 40.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.553 -0.749 . . . . 2.23 110.982 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.679 ' NE2' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -61.82 -34.84 76.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.411 -0.589 . . . . 2.54 109.411 175.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.773 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -45.29 -58.74 3.08 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 107.012 -1.477 . . . . 2.06 107.012 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 66.04 -24.77 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.729 -2.032 . . . . 4.48 112.093 171.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.719 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.95 -174.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.477 -1.692 . . . . 3.76 113.762 168.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.572 ' O ' HG23 ' A' ' 37' ' ' ILE . 11.0 t70 -156.0 -48.51 0.08 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.077 -1.419 . . . . 4.62 107.497 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 36' ' ' ASP . 1.4 pt -172.09 16.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-N 113.35 -1.75 . . . . 5.0 110.751 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -176.38 -66.94 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.883 -1.287 . . . . 4.13 109.883 -169.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 18.8 m-20 -164.81 117.46 1.25 Allowed 'General case' 0 CA--C 1.484 -1.583 0 CA-C-N 113.268 -1.466 . . . . 4.31 110.296 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.956 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.4 p 57.19 -64.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 126.882 2.613 . . . . 2.96 113.592 171.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.928 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 90.6 m -157.04 -60.45 0.02 OUTLIER Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 113.272 -1.785 . . . . 3.83 110.867 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.928 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 13.8 Cg_exo -70.94 2.18 4.46 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 120.426 0.751 . . . . 3.83 113.449 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 4.4 t70 82.55 4.29 1.08 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-O 123.404 1.574 . . . . 4.26 107.687 167.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 168.47 63.29 0.03 OUTLIER Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 112.539 -2.119 . . . . 2.01 110.225 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 18.7 tpp85 -93.12 -34.63 13.57 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.296 -1.742 . . . . 3.34 106.296 166.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.956 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 25.1 m-85 -87.9 152.59 21.97 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 110.826 -2.897 . . . . 2.07 110.567 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.781 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 54.1 m -153.55 68.67 0.79 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.618 -1.252 . . . . 1.91 107.618 163.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.799 HG22 HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -69.9 122.62 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.299 -0.864 . . . . 3.19 112.272 -168.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.722 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.0 p30 -156.24 139.11 15.28 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.345 1.069 . . . . 3.31 111.219 164.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 19.9 p -43.61 -46.13 7.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.616 -1.629 . . . . 3.25 115.206 169.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.91 -39.52 65.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.869 1.804 . . . . 4.45 115.869 -151.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.1 -57.27 11.15 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.085 0.945 . . . . 6.26 109.88 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.691 ' O ' HG22 ' A' ' 54' ' ' VAL . 34.3 t -65.6 167.44 8.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 3.04 109.731 173.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.171 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 1.9 m 72.34 26.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 125.398 1.479 . . . . 4.32 110.129 -159.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.21 65.2 0.26 Allowed Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 113.665 -1.607 . . . . 4.19 112.995 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 57.28 15.49 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 119.492 -1.337 . . . . 4.42 115.235 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.97 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.293 1.8 m -134.48 -32.55 1.02 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.712 1.256 . . . . 3.52 109.943 -162.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.65 2.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.282 1.956 . . . . 3.64 116.282 -160.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 1.2 pp -74.37 5.16 4.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.425 1.466 . . . . 5.44 112.101 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.46 159.46 45.71 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.264 -1.013 . . . . 3.22 108.264 159.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.54 119.66 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 120.372 1.168 . . . . 3.83 109.869 161.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.97 HG13 ' HB3' ' A' ' 57' ' ' CYS . 42.8 mm -110.98 134.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.609 0.226 . . . . 2.69 111.609 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.409 HG12 ' OH ' ' A' ' 85' ' ' TYR . 11.7 t -136.52 123.0 30.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 107.503 -1.295 . . . . 1.87 107.503 163.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 45.5 ttm -114.49 138.0 51.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.002 -1.686 . . . . 1.65 111.313 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -125.01 115.67 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.424 -1.324 . . . . 0.76 107.424 158.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' CA ' ' HD2' ' A' ' 8' ' ' PRO . . . 46.37 -144.35 4.14 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-O 122.598 1.11 . . . . 1.1 112.67 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -82.8 27.69 0.52 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 113.369 -1.415 . . . . 3.01 109.462 176.084 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.773 ' HB2' HG23 ' A' ' 65' ' ' VAL . 14.3 mmmm -107.26 -24.19 11.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.875 -0.602 . . . . 2.62 110.659 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.9 m 33.95 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.281 0.988 . . . . 1.51 113.484 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.68 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -99.53 -168.83 1.66 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.469 1.604 . . . . 1.43 114.247 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 73' ' ' VAL . . . -134.89 57.27 0.7 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.001 -1.909 . . . . 1.49 110.093 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.624 ' HA ' HG21 ' A' ' 81' ' ' ILE . 44.5 t-20 -86.37 39.64 0.84 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 123.17 1.462 . . . . 1.83 109.053 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.882 HG21 ' HB2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER 47.78 -161.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 112.684 -2.053 . . . . 3.06 113.634 155.02 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.877 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.4 p -134.71 -45.58 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 113.016 0.747 . . . . 2.49 113.016 173.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -75.1 -85.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 121.87 1.714 . . . . 2.65 114.367 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.24 0.15 5.97 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.748 -0.739 . . . . 1.4 112.106 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.882 ' HB2' HG21 ' A' ' 73' ' ' VAL . 67.5 mt-30 -81.26 -13.47 58.45 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 106.382 -1.711 . . . . 1.87 106.382 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.679 ' HB ' ' NE2' ' A' ' 32' ' ' GLN . 2.7 m -51.71 -46.92 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 111.988 -2.369 . . . . 0.97 109.904 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 34.2 mttm -57.28 -44.23 83.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.123 -1.399 . . . . 2.13 109.353 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -77.85 -42.49 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.599 -1.637 . . . . 2.41 109.755 -175.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.658 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 33.5 mm -68.4 -17.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.616 -0.72 . . . . 1.23 110.191 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.684 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 9.6 tp -57.92 -38.32 75.66 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.545 -0.722 . . . . 0.79 110.463 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -33.5 69.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.37 0.605 . . . . 0.88 109.483 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 3.3 mm-40 -68.24 -30.84 69.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.964 -1.017 . . . . 2.09 111.857 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.68 ' CE1' ' HD2' ' A' ' 70' ' ' TYR . 2.9 m-30 . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 118.801 -0.619 . . . . 1.77 111.318 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' FES . . . . . 1.171 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptp . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 121.604 0.716 . . . . 13.97 110.434 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 6.4 p -111.77 125.84 29.6 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.802 -0.635 . . . . 10.71 110.248 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 23.9 Cg_exo -63.9 97.38 0.23 Allowed 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.991 2.461 . . . . 9.2 112.783 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.76 -95.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.79 -0.641 . . . . 9.04 109.809 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.581 ' C ' ' HD2' ' A' ' 6' ' ' LYS . . . 93.21 167.48 38.61 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.617 -0.72 . . . . 4.14 111.706 176.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.581 ' HD2' ' C ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER 36.14 46.57 0.39 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.98 0.912 . . . . 4.58 112.804 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.661 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 11.2 m-85 -43.0 107.75 0.58 Allowed Pre-proline 0 N--CA 1.445 -0.713 0 C-N-CA 124.604 1.162 . . . . 1.64 112.807 175.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' SER . 75.1 Cg_exo -56.66 93.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.813 2.342 . . . . 1.02 111.284 171.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.802 ' HB ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -81.3 121.89 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 121.858 0.837 . . . . 1.52 110.405 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.743 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.7 m -105.38 127.11 52.8 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.541 -1.209 . . . . 1.45 111.203 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.1 t -117.91 123.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 2.21 112.016 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.704 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 30.0 t -67.16 124.33 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.22 0.533 . . . . 2.24 111.315 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.9 mmm -120.5 23.1 11.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.545 -0.752 . . . . 5.12 109.278 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.55 177.89 25.03 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.608 -0.724 . . . . 3.86 112.528 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 19' ' ' VAL . 17.3 m -67.45 -45.41 76.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.032 0.382 . . . . 5.97 112.032 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 -56.01 7.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 4.41 112.267 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.704 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 74.6 m -64.59 -32.91 74.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 2.98 111.105 -173.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 68.2 t80 -60.52 -28.63 68.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.961 -0.563 . . . . 4.18 111.774 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 15' ' ' THR . 60.9 t -68.87 -22.11 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.131 0.491 . . . . 3.65 110.921 -173.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -81.94 13.34 3.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.208 -0.451 . . . . 4.79 111.329 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 25' ' ' VAL . . . 87.07 30.29 20.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.366 -0.921 . . . . 1.87 111.766 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -70.68 -21.58 62.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.463 -0.199 . . . . 1.46 110.463 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.03 -54.6 45.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.331 -0.395 . . . . 2.42 110.208 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.562 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 3.03 109.621 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.009 HG13 ' H ' ' A' ' 74' ' ' THR . 54.6 t -59.21 -57.65 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 115.649 -0.705 . . . . 2.26 109.587 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.33 -30.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 120.271 -0.571 . . . . 1.57 109.647 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -59.26 -43.5 92.48 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.128 -0.487 . . . . 1.35 110.253 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.431 ' HB1' HG21 ' A' ' 78' ' ' VAL . . . -54.69 -46.0 74.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.134 -0.939 . . . . 0.65 109.229 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.674 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -55.31 -53.36 57.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.065 -0.97 . . . . 1.98 110.087 175.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -48.83 -47.48 42.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.321 -0.854 . . . . 2.85 110.757 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.41 -34.37 25.53 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.521 -0.763 . . . . 2.23 111.932 -174.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.728 ' NE2' ' HB2' ' A' ' 82' ' ' LEU . 1.9 pt20 -63.17 -25.73 68.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.249 -0.649 . . . . 2.54 109.249 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.73 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -57.72 -60.43 3.7 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.323 -1.362 . . . . 2.06 107.323 173.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.657 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 68.01 -20.83 0.13 Allowed 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 125.503 1.752 . . . . 4.48 110.578 172.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.73 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 58.18 126.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.709 -2.042 . . . . 3.76 113.243 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.616 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 11.1 t70 -86.72 -45.94 10.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 112.284 -2.235 . . . . 4.62 107.741 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' A' ' 43' ' ' ASP . 2.0 pt -168.4 -1.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 112.93 -1.941 . . . . 5.0 110.923 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 173.09 -32.74 0.11 Allowed Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 110.774 -0.93 . . . . 4.13 110.774 -163.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.715 ' OD1' ' HB3' ' A' ' 45' ' ' ARG . 1.0 OUTLIER -145.17 -162.92 1.6 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.095 -1.052 . . . . 4.31 110.883 -169.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.69 HG13 ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -64.61 -30.18 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-O 123.865 1.793 . . . . 2.96 107.531 177.171 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.723 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 65.4 m -168.45 -64.32 0.01 OUTLIER Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 110.026 -3.261 . . . . 3.83 111.182 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 7.1 Cg_exo -73.81 -6.64 18.93 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 121.289 1.326 . . . . 3.83 115.445 -164.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.617 ' H ' ' CB ' ' A' ' 39' ' ' ASP . 26.0 t70 74.59 16.04 3.24 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 122.759 1.266 . . . . 4.26 107.586 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.55 66.91 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.41 -1.723 . . . . 2.01 111.26 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.715 ' HB3' ' OD1' ' A' ' 39' ' ' ASP . 13.7 tpt180 -132.93 -55.72 0.93 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.885 -1.154 . . . . 3.34 107.885 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.715 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.91 146.41 27.39 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.054 -1.43 . . . . 2.07 110.364 176.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.481 ' H ' HG22 ' A' ' 9' ' ' ILE . 52.9 m -154.57 96.85 1.94 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.215 -0.661 . . . . 1.91 109.215 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -87.11 137.3 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.071 0.767 . . . . 3.19 113.071 -167.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.01 138.02 12.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.968 -1.014 . . . . 3.31 110.787 158.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.5 m -45.9 -45.34 15.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.11 -1.405 . . . . 3.25 114.323 165.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.69 -39.59 65.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.14 1.534 . . . . 4.45 115.14 -154.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -62.36 -57.13 12.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.476 1.131 . . . . 6.26 109.694 176.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 22.5 t -66.26 167.62 10.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.59 -2.095 . . . . 3.04 111.208 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.744 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 1.6 m 70.27 25.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 125.883 1.673 . . . . 4.32 109.351 -160.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.29 65.77 0.25 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 113.479 -1.692 . . . . 4.19 112.49 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.88 56.3 17.26 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 119.681 -1.247 . . . . 4.42 115.801 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.616 ' HB2' HG13 ' A' ' 62' ' ' ILE . 1.9 m -136.17 -31.54 0.9 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.46 -0.941 . . . . 3.52 108.46 -170.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.429 ' HB2' ' S1 ' ' A' ' 86' ' ' FES . . . -48.09 -25.94 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.883 1.809 . . . . 3.64 115.883 -163.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.2 7.52 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.81 1.186 . . . . 5.44 111.841 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.45 160.46 37.8 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.229 -1.026 . . . . 3.22 108.229 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.93 119.33 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 120.742 1.301 . . . . 3.83 108.822 165.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.616 HG13 ' HB2' ' A' ' 57' ' ' CYS . 49.2 mm -111.51 130.94 64.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 114.265 1.209 . . . . 2.69 114.265 -172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 72' ' ' ASN . 14.5 p -144.2 122.19 6.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.3 -1.37 . . . . 1.87 107.3 147.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.76 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 65.6 ttp -111.19 137.78 48.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.759 -1.213 . . . . 1.65 109.727 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.802 HG12 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.77 114.23 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 N-CA-C 107.015 -1.476 . . . . 0.76 107.015 167.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 48.87 -152.88 2.55 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 122.342 0.968 . . . . 1.1 111.869 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -78.6 37.26 0.28 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.882 -1.159 . . . . 3.01 109.266 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.76 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 29.8 mmmt -113.68 -26.29 8.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.035 -0.529 . . . . 2.62 111.532 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 30.4 m 38.22 108.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 115.205 1.557 . . . . 1.51 115.205 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.76 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 2.8 m-85 -122.42 -170.74 2.13 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.448 1.118 . . . . 1.43 113.352 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.08 21.85 5.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 113.832 -1.531 . . . . 1.49 111.293 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.687 ' HB2' HG22 ' A' ' 81' ' ' ILE . 2.7 t30 -74.22 92.73 2.26 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.862 -0.422 . . . . 1.83 109.862 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -172.37 -167.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 122.882 0.473 . . . . 3.06 111.429 177.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 1.009 ' H ' HG13 ' A' ' 25' ' ' VAL . 41.0 p 50.54 104.08 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 C-N-CA 125.204 1.402 . . . . 2.49 112.266 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.763 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 73.6 Cg_exo -23.47 89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 1 C-N-CA 125.456 4.104 . . . . 2.65 113.28 -174.05 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 80' ' ' LYS . . . 148.11 -61.23 0.44 Allowed Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.974 -1.012 . . . . 1.4 112.572 -171.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.614 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 5.0 mt-30 -76.26 -30.54 57.89 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.193 -1.41 . . . . 1.87 107.193 -166.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.518 HG13 ' CA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -48.24 -52.05 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 112.41 -2.177 . . . . 0.97 111.132 -175.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 36.6 mtmt -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.647 1.213 . . . . 2.13 108.523 -166.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -78.89 -42.16 27.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.173 -1.83 . . . . 2.41 110.922 -173.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.687 HG22 ' HB2' ' A' ' 72' ' ' ASN . 33.2 mm -72.57 -15.34 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.157 0.503 . . . . 1.23 109.926 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.728 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 48.0 tp -60.99 -38.58 86.51 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.069 -0.395 . . . . 0.79 110.348 169.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -31.96 67.48 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 121.779 0.799 . . . . 0.88 108.86 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -73.39 -31.62 63.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.753 -1.112 . . . . 2.09 111.354 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.727 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 2.2 m-30 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 119.489 -0.291 . . . . 1.77 111.162 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' FES . . . . . 0.744 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 110.085 -0.339 . . . . 13.97 110.085 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.9 m -70.28 116.94 49.94 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.359 0.6 . . . . 10.71 112.09 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 1.5 Cg_endo -84.93 68.22 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.16 2.573 . . . . 9.2 111.05 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.74 ' HG3' ' HB3' ' A' ' 47' ' ' SER . 38.2 tptt -50.2 -58.67 5.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.807 0.813 . . . . 9.04 109.543 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.86 -156.97 7.09 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 109.045 -1.622 . . . . 4.14 109.045 170.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.52 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 15.7 tppt? -66.68 -45.54 78.53 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 117.695 0.748 . . . . 4.58 109.337 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.653 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 15.1 m-85 -129.59 80.58 71.53 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-O 120.934 0.397 . . . . 1.64 109.974 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 82.0 Cg_exo -50.54 107.25 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.115 2.543 . . . . 1.02 112.09 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.957 HD11 HG22 ' A' ' 48' ' ' ILE . 13.1 pt -81.59 130.55 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 112.092 0.405 . . . . 1.52 112.092 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.5 p -94.32 132.06 39.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.178 -0.675 . . . . 1.45 109.178 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.09 117.85 56.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.167 -0.47 . . . . 2.21 110.63 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 1.042 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -69.96 121.85 18.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 2.24 111.9 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.8 mmm -121.64 20.3 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.968 -1.123 . . . . 5.12 107.968 163.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 179.32 31.15 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.557 -1.201 . . . . 3.86 113.172 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 19' ' ' VAL . 8.1 m -68.93 -44.43 73.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.079 0.4 . . . . 5.97 112.079 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -58.16 4.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.025 0.75 . . . . 4.41 113.025 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 1.042 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 88.8 m -65.31 -33.91 77.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 2.98 111.012 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -60.69 -31.68 70.93 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.904 0.383 . . . . 4.18 111.086 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 15' ' ' THR . 57.5 t -72.54 -25.09 22.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.391 0.615 . . . . 3.65 110.054 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -85.23 9.38 15.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.613 -0.722 . . . . 4.79 110.894 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.04 32.57 17.15 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.021 -1.085 . . . . 1.87 112.466 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.512 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -71.97 -20.81 61.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.849 0.315 . . . . 1.46 111.849 -171.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 26' ' ' VAL . 2.4 p-10 -62.48 -40.84 97.96 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.053 -0.659 . . . . 2.42 109.74 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.472 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 11.1 mptt -66.78 -36.51 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.044 -0.724 . . . . 3.03 109.044 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.039 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 76.7 t -55.78 -54.78 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 CA-C-N 115.057 -0.974 . . . . 2.26 109.415 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 23' ' ' ASP . 15.3 m -63.16 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.115 -0.634 . . . . 1.57 110.902 -174.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -60.66 -47.58 85.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.733 -0.787 . . . . 1.35 109.955 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.611 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.59 -46.24 80.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.236 -0.893 . . . . 0.65 108.613 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.872 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.0 t80 -54.49 -48.49 71.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 124.218 0.949 . . . . 1.98 110.146 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -49.11 -54.93 13.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.717 -1.129 . . . . 2.85 111.297 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 -18.87 27.51 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.287 -0.87 . . . . 2.23 111.717 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.872 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -67.98 -21.17 65.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.573 -0.528 . . . . 2.54 109.573 173.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.796 HD22 HG12 ' A' ' 35' ' ' ILE . 1.2 tt -48.6 -59.88 3.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.291 -1.744 . . . . 2.06 106.291 168.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.667 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 65.61 -25.45 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.241 2.213 . . . . 4.48 112.186 171.183 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.796 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 57.78 -174.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 113.073 -1.876 . . . . 3.76 113.74 166.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 37' ' ' ILE . 12.4 t70 -146.89 -53.2 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 106.166 -1.791 . . . . 4.62 106.166 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.648 HG13 ' OD1' ' A' ' 43' ' ' ASP . 1.2 pt -171.63 21.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 113.612 -1.631 . . . . 5.0 109.718 172.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -165.52 -67.07 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 109.464 -1.454 . . . . 4.13 109.464 -174.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.853 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 18.5 m-20 -170.39 116.72 0.51 Allowed 'General case' 0 CA--C 1.485 -1.525 0 CA-C-N 113.602 -1.299 . . . . 4.31 110.156 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.972 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.8 p 58.0 -64.23 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 O-C-N 126.679 2.487 . . . . 2.96 113.057 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.628 ' OG1' ' HD3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -159.33 -56.15 0.02 OUTLIER Pre-proline 0 C--N 1.276 -2.621 0 CA-C-N 113.38 -1.736 . . . . 3.83 111.966 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.698 ' HD2' HG13 ' A' ' 40' ' ' VAL . 13.1 Cg_exo -72.11 -3.63 13.64 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 CA-C-N 119.48 0.85 . . . . 3.83 112.81 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.853 ' HA ' ' H ' ' A' ' 39' ' ' ASP . 73.0 m-20 75.34 19.05 2.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 122.457 1.122 . . . . 4.26 108.96 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' N ' ' HB2' ' A' ' 39' ' ' ASP . . . 171.7 39.15 0.03 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 CA-C-N 112.508 -2.133 . . . . 2.01 110.949 166.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.649 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 22.1 ttt180 -74.4 -34.64 63.33 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.533 -1.654 . . . . 3.34 106.533 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.972 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 29.1 m-85 -88.82 149.75 23.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 112.241 -2.254 . . . . 2.07 110.396 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.74 ' HB3' ' HG3' ' A' ' 4' ' ' LYS . 15.2 m -168.45 99.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.76 0.424 . . . . 1.91 110.018 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.957 HG22 HD11 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -66.31 136.7 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.919 1.081 . . . . 3.19 113.919 -168.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -160.08 135.75 8.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.626 1.203 . . . . 3.31 113.023 154.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -46.57 -41.53 14.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.026 1.73 . . . . 3.25 114.61 160.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -50.87 -30.24 14.01 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.959 1.466 . . . . 4.45 114.959 -158.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 8.1 mmt180 -54.91 -47.05 74.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.008 0.433 . . . . 6.26 111.108 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.3 t -58.0 160.2 5.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.188 -0.915 . . . . 3.04 113.439 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 14.2 t 67.51 24.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.55 0 CA-C-O 123.139 1.447 . . . . 4.32 108.353 -164.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.88 64.49 0.33 Allowed Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 113.349 -1.75 . . . . 4.19 112.479 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.63 57.99 14.06 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 118.839 -1.648 . . . . 4.42 115.08 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.887 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.253 5.6 m -132.27 -35.28 1.19 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 1.411 . . . . 3.52 113.072 -162.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.72 -30.76 23.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.694 1.739 . . . . 3.64 115.694 -164.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.0 mt -78.37 5.37 10.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.014 1.279 . . . . 5.44 112.793 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 159.94 43.15 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 122.549 0.34 . . . . 3.22 110.479 170.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.9 124.23 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.531 -1.373 . . . . 3.83 108.531 153.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.887 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.5 mm -106.82 129.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.935 -1.106 . . . . 2.69 113.054 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.25 119.37 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.054 -1.462 . . . . 1.87 107.054 158.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.559 ' HG3' HG22 ' A' ' 69' ' ' VAL . 39.0 ttm -114.2 141.61 47.31 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.911 -1.118 . . . . 1.65 111.734 -170.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.927 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.06 112.85 40.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.286 -1.746 . . . . 0.76 106.286 158.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 40.84 -141.82 0.9 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-O 122.507 1.06 . . . . 1.1 113.363 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -79.38 28.57 0.24 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.324 -1.438 . . . . 3.01 109.84 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.927 ' HB2' HG23 ' A' ' 65' ' ' VAL . 10.8 mmmm -100.59 -47.88 4.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.193 -0.669 . . . . 2.62 109.193 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' A' ' 64' ' ' MET . 91.1 t 48.56 116.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 114.225 1.194 . . . . 1.51 114.225 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 62.8 m-85 -138.4 -157.84 0.81 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.099 0.952 . . . . 1.43 113.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -135.07 39.02 1.74 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.151 -1.386 . . . . 1.49 110.0 171.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.826 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 2.0 t30 -58.42 110.5 0.98 Allowed 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.457 -0.942 . . . . 1.83 108.457 173.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.498 ' HB ' ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -100.91 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.247 -1.342 . . . . 3.06 114.532 -157.324 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 1.039 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 2.2 t -143.09 -48.0 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 115.24 1.57 . . . . 2.49 115.24 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD3' ' H ' ' A' ' 74' ' ' THR . 2.3 Cg_endo -80.68 64.0 8.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.939 1.759 . . . . 2.65 113.484 -168.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.544 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 75.8 -12.22 9.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.217 -0.516 . . . . 1.4 112.976 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.646 ' HA ' ' CD ' ' A' ' 80' ' ' LYS . 31.0 mt-30 -75.11 -28.8 60.37 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 106.944 -1.502 . . . . 1.87 106.944 -174.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.531 HG12 ' ND2' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -51.23 -55.08 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 112.04 -2.346 . . . . 0.97 112.561 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 18.8 pttp -60.07 -25.67 65.57 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 121.884 0.85 . . . . 2.13 110.571 -168.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.646 ' CD ' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -80.21 -50.81 9.73 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.936 -1.029 . . . . 2.41 109.082 178.297 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 77' ' ' GLN . 30.0 mm -60.05 -16.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.186 -1.37 . . . . 1.23 109.871 172.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.689 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 63.9 tp -61.36 -40.67 95.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.881 0.372 . . . . 0.79 110.13 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.25 68.68 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.701 0.762 . . . . 0.88 109.336 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 15.4 mt-10 -73.92 -24.4 59.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.479 -1.237 . . . . 2.09 111.959 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.826 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.5 m-30 . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 118.485 -0.769 . . . . 1.77 112.34 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' FES . . . . . 0.71 ' S2 ' ' HB ' ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 26.0 mmt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.683 0.278 . . . . 13.97 110.253 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.13 79.19 51.93 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.482 -0.327 . . . . 10.71 110.388 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.23 116.75 3.69 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.705 2.27 . . . . 9.2 111.542 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 39.0 mmtm -64.54 -49.48 71.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.635 -0.711 . . . . 9.04 112.629 -175.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.61 ' HA2' ' HB2' ' A' ' 47' ' ' SER . . . 99.62 32.98 5.49 Favored Glycine 0 CA--C 1.496 -1.121 0 C-N-CA 120.197 -1.001 . . . . 4.14 111.883 172.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 16.7 tppt? -52.09 -52.88 48.54 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.947 -0.626 . . . . 4.58 109.75 176.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.535 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 4.6 m-85 -107.6 93.99 11.16 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.831 -0.622 . . . . 1.64 110.776 172.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 38.5 Cg_exo -63.84 94.45 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.304 2.003 . . . . 1.02 110.717 168.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.966 HG12 ' HA ' ' A' ' 48' ' ' ILE . 1.2 pt -79.08 172.47 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 112.182 0.438 . . . . 1.52 112.182 -168.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.928 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 95.0 p -146.63 117.91 7.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.631 -0.713 . . . . 1.45 111.648 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.33 124.97 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.162 -0.926 . . . . 2.21 110.296 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 31.8 t -66.19 120.37 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.486 0.66 . . . . 2.24 110.954 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.2 mmt -122.57 23.11 9.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.184 -1.043 . . . . 5.12 108.184 170.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.71 179.47 17.16 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.924 -1.035 . . . . 3.86 113.314 -173.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.0 t -65.89 -45.56 81.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.106 0.41 . . . . 5.97 112.106 -175.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.87 -56.98 4.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.454 0.538 . . . . 4.41 112.454 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 71.7 m -65.72 -34.16 77.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.618 -0.719 . . . . 2.98 111.93 -170.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.29 -27.69 68.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.119 0.568 . . . . 4.18 112.076 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 15' ' ' THR . 86.8 t -67.71 -21.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 122.78 0.432 . . . . 3.65 111.711 -168.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -80.99 12.15 3.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.949 -0.47 . . . . 4.79 111.806 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.09 28.48 30.89 Favored Glycine 0 C--O 1.24 0.497 0 C-N-CA 120.986 -0.626 . . . . 1.87 111.552 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.39 -21.74 61.23 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.105 -0.548 . . . . 1.46 111.548 -168.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.51 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 t70 -55.63 -48.1 75.51 Favored 'General case' 0 C--O 1.211 -0.937 0 C-N-CA 120.393 -0.523 . . . . 2.42 111.057 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -67.35 -36.17 80.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.822 -0.751 . . . . 3.03 111.459 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.637 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.97 -44.84 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 121.118 -0.233 . . . . 2.26 110.647 176.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 23' ' ' ASP . 17.9 m -68.59 -19.06 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.975 -0.69 . . . . 1.57 109.965 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.472 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 53.9 t-80 -59.64 -42.54 92.99 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.588 0.709 . . . . 1.35 109.158 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -51.97 -46.35 64.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.085 -1.416 . . . . 0.65 109.541 173.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.854 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 1.4 t80 -57.38 -48.26 79.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.974 -0.557 . . . . 1.98 110.549 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 27' ' ' HIS . 60.8 mttp -47.04 -51.17 18.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.319 -0.855 . . . . 2.85 110.884 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.13 -19.97 24.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.078 -0.964 . . . . 2.23 111.367 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.854 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 1.3 pt20 -67.33 -19.42 65.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.531 -0.544 . . . . 2.54 109.531 176.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.055 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -49.39 -59.52 3.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 106.658 -1.608 . . . . 2.06 106.658 168.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.786 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.19 -19.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 126.42 2.325 . . . . 4.48 113.387 169.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.673 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 50.93 -171.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 126.138 1.775 . . . . 3.76 114.132 166.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 37' ' ' ILE . 13.9 t70 -157.31 -50.52 0.07 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.623 -1.626 . . . . 4.62 107.238 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.9 pt -168.64 6.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 113.103 -1.862 . . . . 5.0 110.843 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.18 -58.7 0.03 OUTLIER Glycine 0 CA--C 1.482 -1.997 0 N-CA-C 109.653 -1.379 . . . . 4.13 109.653 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.641 ' HA ' HG23 ' A' ' 35' ' ' ILE . 29.9 t70 -178.26 121.01 0.1 Allowed 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 113.244 -1.478 . . . . 4.31 111.664 -177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.092 HG13 ' HD2' ' A' ' 42' ' ' PRO . 7.3 p 55.33 -66.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 127.27 2.856 . . . . 2.96 113.454 173.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.649 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 38.5 m -158.22 -58.54 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.713 0 CA-C-N 113.731 -1.577 . . . . 3.83 110.341 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.092 ' HD2' HG13 ' A' ' 40' ' ' VAL . 59.3 Cg_endo -74.06 7.55 2.44 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 120.418 0.746 . . . . 3.83 113.962 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 13.7 t70 81.55 6.0 1.23 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.817 1.294 . . . . 4.26 108.651 164.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' A' ' 39' ' ' ASP . . . 165.93 67.8 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.639 0 CA-C-N 114.05 -1.432 . . . . 2.01 112.447 172.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.685 ' HD3' ' HG3' ' A' ' 42' ' ' PRO . 16.8 tpt180 -85.09 -64.36 1.17 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.827 -1.175 . . . . 3.34 107.827 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.055 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -114.91 124.2 51.1 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.336 -0.847 . . . . 2.07 112.988 -174.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.61 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 27.4 t -102.86 100.59 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.652 -0.704 . . . . 1.91 109.274 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.966 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.5 pp -65.12 118.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 113.072 0.768 . . . . 3.19 113.072 -171.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' ' HA ' ' A' ' 10' ' ' SER . 9.2 t70 -159.49 140.25 12.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.194 0.997 . . . . 3.31 112.605 162.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -45.61 -46.67 14.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.65 1.722 . . . . 3.25 115.65 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -52.6 -40.73 62.98 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 116.644 2.09 . . . . 4.45 116.644 -148.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.708 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 17.4 mmm180 -63.07 -57.83 9.3 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.096 0.951 . . . . 6.26 110.463 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.928 ' H ' ' HB2' ' A' ' 10' ' ' SER . 33.9 t -65.56 167.11 9.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.41 -1.723 . . . . 3.04 111.12 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.14 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 11.6 t 71.31 26.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 123.055 1.407 . . . . 4.32 108.501 -161.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.42 64.27 0.34 Allowed Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 113.351 -1.749 . . . . 4.19 113.708 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.89 58.31 12.51 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 118.933 -1.603 . . . . 4.42 115.03 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.286 1.7 m -132.95 -33.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.455 1.128 . . . . 3.52 109.262 -161.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.92 -28.54 6.84 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.685 1.735 . . . . 3.64 115.685 -163.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.97 6.61 3.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.783 1.174 . . . . 5.44 112.161 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.17 160.66 38.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.876 -1.157 . . . . 3.22 107.876 159.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.58 118.23 5.25 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-N 120.849 1.339 . . . . 3.83 108.857 163.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.743 HG21 ' S2 ' ' A' ' 86' ' ' FES . 7.3 tp -111.49 129.88 66.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 112.85 0.685 . . . . 2.69 112.85 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG21 ' N ' ' A' ' 73' ' ' VAL . 86.9 t -141.49 119.53 9.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 107.255 -1.387 . . . . 1.87 107.255 153.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.659 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 38.7 ttm -110.14 135.52 50.8 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 117.779 -1.568 . . . . 1.65 110.217 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.858 HG23 ' HB2' ' A' ' 68' ' ' LYS . 2.5 m -123.91 115.92 46.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.495 -1.669 . . . . 0.76 106.495 168.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 49.07 -153.74 2.37 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-O 122.281 0.934 . . . . 1.1 112.368 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.2 35.62 0.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.343 -0.928 . . . . 3.01 108.583 172.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.858 ' HB2' HG23 ' A' ' 65' ' ' VAL . 28.5 mmmt -105.52 -27.46 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.125 -0.943 . . . . 2.62 109.776 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 64' ' ' MET . 12.3 m 35.61 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 124.459 1.099 . . . . 1.51 113.591 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.761 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 5.0 m-30 -107.89 -163.48 0.9 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-O 122.306 1.051 . . . . 1.43 113.345 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -145.06 50.28 0.65 Allowed Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 114.468 -1.242 . . . . 1.49 110.654 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -71.62 1.58 6.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.803 0.811 . . . . 1.83 109.056 173.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER 46.0 -149.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 113.749 -1.568 . . . . 3.06 113.958 167.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.664 ' H ' ' CD ' ' A' ' 75' ' ' PRO . 12.8 t -148.52 -40.46 0.01 OUTLIER Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.903 -0.59 . . . . 2.49 112.528 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.664 ' CD ' ' H ' ' A' ' 74' ' ' THR . 4.5 Cg_endo -86.04 70.98 4.41 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.881 1.721 . . . . 2.65 113.222 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.14 -38.16 3.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.551 -0.833 . . . . 1.4 113.301 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.556 ' HB2' HG21 ' A' ' 73' ' ' VAL . 29.3 mt-30 -71.05 -10.3 59.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.64 1.21 . . . . 1.87 108.364 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 2.2 t -42.36 -64.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 112.085 -2.325 . . . . 0.97 112.799 174.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.716 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 47.8 mtmt -60.42 -25.55 66.03 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.976 0.893 . . . . 2.13 110.785 -167.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.584 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 2.6 mptp? -77.08 -53.87 7.24 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.596 -1.183 . . . . 2.41 109.921 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.886 ' HB ' ' HA ' ' A' ' 72' ' ' ASN . 18.9 mm -62.73 -14.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.001 -1.0 . . . . 1.23 110.1 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.716 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.6 tp -57.22 -42.81 82.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.969 -0.457 . . . . 0.79 110.257 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.47 -33.55 69.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.588 0.709 . . . . 0.88 109.422 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -73.23 -21.05 60.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.906 -1.043 . . . . 2.09 112.693 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.83 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.9 m-30 . . . . . 0 N--CA 1.433 -1.302 0 CA-C-O 118.111 -0.947 . . . . 1.77 111.854 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' FES . . . . . 1.14 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptp . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.686 0.279 . . . . 13.97 110.806 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 81.8 t -124.35 101.45 34.38 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-O 120.975 0.417 . . . . 10.71 111.27 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -87.43 -168.85 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.067 2.511 . . . . 9.2 111.234 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 15.9 mmtp -84.87 -63.76 1.28 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.32 -0.552 . . . . 9.04 111.556 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.43 35.83 1.7 Allowed Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 120.591 -0.814 . . . . 4.14 113.753 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.653 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 2.8 tppp? -64.67 -49.06 72.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.527 -0.546 . . . . 4.58 109.527 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 1.068 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.2 m-85 -109.02 85.24 3.1 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.106 -0.497 . . . . 1.64 111.27 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 47' ' ' SER . 87.2 Cg_exo -52.55 97.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.085 2.523 . . . . 1.02 112.327 169.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.682 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -86.77 129.27 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 112.703 0.631 . . . . 1.52 112.703 -172.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.641 ' CB ' ' HB2' ' A' ' 52' ' ' ARG . 59.9 p -91.28 135.44 33.8 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.581 -0.526 . . . . 1.45 109.581 174.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -116.01 121.73 68.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.032 -0.531 . . . . 2.21 110.421 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 22.1 t -67.17 120.01 13.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.066 0.765 . . . . 2.24 113.066 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.1 mmt -123.96 22.56 8.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.462 -1.245 . . . . 5.12 107.858 160.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.511 ' HA3' ' S1 ' ' A' ' 86' ' ' FES . . . -68.28 178.58 22.1 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.892 -1.049 . . . . 3.86 113.744 -171.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -67.95 -44.36 76.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.29 0.478 . . . . 5.97 112.29 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.4 -58.18 3.6 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 112.607 0.595 . . . . 4.41 112.607 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.872 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.7 m -65.29 -35.28 80.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 2.98 111.317 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.85 -30.83 69.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 4.18 112.317 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.83 -25.11 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.033 0.444 . . . . 3.65 110.896 -170.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.43 8.86 17.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.377 -0.374 . . . . 4.79 111.206 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.57 44.8 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.165 -0.774 . . . . 1.87 111.165 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -73.52 -20.61 60.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.353 -0.424 . . . . 1.46 110.946 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 26' ' ' VAL . 8.7 p-10 -62.86 -38.62 91.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 2.42 110.717 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 44.1 mtpt -68.56 -36.37 78.69 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 121.451 -0.78 . . . . 3.03 110.195 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 75' ' ' PRO . 2.5 t -72.3 -28.61 29.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.147 -0.621 . . . . 2.26 111.685 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 23' ' ' ASP . 3.6 m -61.83 -37.49 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.949 -1.13 . . . . 1.57 107.949 172.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 55.5 t-80 -60.09 -41.16 91.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.055 -0.52 . . . . 1.35 109.873 173.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -53.65 -44.87 69.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.295 -0.866 . . . . 0.65 109.295 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.688 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 8.2 t80 -48.82 -61.52 2.0 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 123.75 0.657 . . . . 1.98 109.781 172.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 97.9 mttt -45.43 -45.41 12.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.754 -1.112 . . . . 2.85 111.7 -176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -77.85 -43.28 30.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.717 -0.674 . . . . 2.23 111.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.682 ' HG3' ' O ' ' A' ' 29' ' ' PHE . 1.8 pp0? -63.08 -24.69 68.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.879 -0.415 . . . . 2.54 109.879 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.826 HD21 HG23 ' A' ' 35' ' ' ILE . 10.1 tp -63.24 -55.0 28.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.136 -1.061 . . . . 2.06 108.136 173.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.587 ' HG2' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER 68.73 -14.29 0.29 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.547 1.155 . . . . 4.48 109.465 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.826 HG23 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER 62.38 -10.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 127.066 2.146 . . . . 3.76 113.366 175.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.587 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 16.2 t70 68.24 -62.14 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.17 0.988 . . . . 4.62 110.436 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 35' ' ' ILE . 2.4 pt -166.68 4.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.178 -1.374 . . . . 5.0 110.378 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' C ' HG22 ' A' ' 35' ' ' ILE . . . -178.79 -38.75 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.457 -1.354 . . . . 4.13 113.884 -164.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.897 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 14.9 t70 -162.44 179.03 8.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.496 0.554 . . . . 4.31 112.496 -155.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.097 HG23 ' HB3' ' A' ' 46' ' ' PHE . 1.9 t -24.82 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 125.57 1.794 . . . . 2.96 111.868 174.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.547 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 6.8 m -175.42 -55.01 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 111.033 -2.803 . . . . 3.83 108.593 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.625 ' HD3' HG12 ' A' ' 40' ' ' VAL . 5.1 Cg_exo -81.12 -0.08 10.33 Favored 'Trans proline' 0 N--CA 1.433 -2.081 0 N-CA-C 116.381 1.646 . . . . 3.83 116.381 -173.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.696 ' CA ' ' HB3' ' A' ' 39' ' ' ASP . 32.3 t70 77.4 16.78 1.57 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.461 -1.311 . . . . 4.26 107.461 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.54 71.91 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.427 -1.26 . . . . 2.01 112.805 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 12.3 tpt180 -142.18 -60.89 0.45 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.34 -0.93 . . . . 3.34 109.488 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.097 ' HB3' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -102.53 157.75 16.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.551 -1.204 . . . . 2.07 111.684 -173.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.534 ' H ' HG22 ' A' ' 9' ' ' ILE . 53.7 m -165.15 113.44 1.02 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.039 -1.097 . . . . 1.91 108.039 167.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 44.3 pt -92.78 154.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 113.859 1.059 . . . . 3.19 113.859 -162.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.1 p-10 -161.52 137.8 8.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.822 -1.081 . . . . 3.31 111.157 162.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -47.14 -42.29 19.18 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.54 1.311 . . . . 3.25 114.54 163.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' H ' ' A' ' 51' ' ' LEU . 3.0 mm? -51.79 -31.13 25.9 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.102 1.149 . . . . 4.45 114.102 -161.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.641 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 16.8 mmt180 -54.69 -47.51 73.57 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.817 0.341 . . . . 6.26 110.822 176.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.674 ' O ' HG12 ' A' ' 54' ' ' VAL . 50.0 t -58.45 158.1 7.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.561 0.744 . . . . 3.04 112.132 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.674 HG12 ' O ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER 66.43 22.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 123.221 1.486 . . . . 4.32 108.723 -160.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.92 67.87 0.27 Allowed Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 112.606 -2.088 . . . . 4.19 112.165 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.95 57.05 11.55 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.05 -1.548 . . . . 4.42 115.177 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.542 ' HB3' HD13 ' A' ' 62' ' ' ILE . 9.5 m -133.06 -37.73 0.98 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 118.272 1.036 . . . . 3.52 112.816 -171.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.58 -34.57 18.13 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.691 2.108 . . . . 3.64 116.691 -150.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.47 2.43 21.99 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.615 1.552 . . . . 5.44 113.206 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.5 160.39 48.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 C-N-CA 123.373 0.669 . . . . 3.22 109.998 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 Cg_endo -78.97 125.08 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.722 0.948 . . . . 3.83 109.967 156.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.853 ' HB ' ' S2 ' ' A' ' 86' ' ' FES . 1.5 mp -107.81 134.2 50.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.458 0.54 . . . . 2.69 112.458 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.782 HG13 ' HA2' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -138.27 126.18 29.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.956 0 N-CA-C 107.251 -1.389 . . . . 1.87 107.251 160.21 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.697 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 48.1 ttm -112.31 144.48 41.66 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.742 -1.224 . . . . 1.65 109.618 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.068 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -122.26 117.12 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.526 -1.287 . . . . 0.76 107.526 154.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . 45.98 -147.9 2.28 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-O 122.369 0.983 . . . . 1.1 111.792 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.39 28.38 0.25 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.032 -1.084 . . . . 3.01 108.986 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.771 ' HB2' HG23 ' A' ' 65' ' ' VAL . 42.6 mmtt -107.79 -32.87 7.44 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.512 -0.551 . . . . 2.62 109.512 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.697 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 96.9 t 44.12 110.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 115.271 1.582 . . . . 1.51 115.271 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.747 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.5 m-85 -130.37 -155.08 0.67 Allowed 'General case' 0 C--O 1.249 1.056 0 CA-C-O 122.682 1.23 . . . . 1.43 112.968 -173.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.782 ' HA2' HG13 ' A' ' 63' ' ' VAL . . . -151.95 46.47 0.59 Allowed Glycine 0 C--O 1.218 -0.866 0 CA-C-N 114.279 -1.328 . . . . 1.49 111.878 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.751 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -96.07 1.18 52.35 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.146 0.473 . . . . 1.83 112.237 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.694 HG22 ' HB ' ' A' ' 63' ' ' VAL . 2.6 m -119.37 17.88 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 114.786 1.402 . . . . 3.06 114.786 -166.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.828 ' OG1' ' HD2' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -151.61 175.43 2.89 Favored Pre-proline 0 CA--C 1.563 1.461 0 O-C-N 121.342 -0.849 . . . . 2.49 110.743 -173.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.828 ' HD2' ' OG1' ' A' ' 74' ' ' THR . 65.0 Cg_exo -14.72 94.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.956 1 C-N-CA 126.476 4.784 . . . . 2.65 117.763 -166.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.611 ' H ' HG11 ' A' ' 25' ' ' VAL . . . 74.81 -29.96 1.07 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.871 -0.604 . . . . 1.4 114.237 165.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.825 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 11.7 pt20 -78.38 -15.34 58.79 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.344 -1.354 . . . . 1.87 107.344 -165.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.67 HG23 ' HG3' ' A' ' 79' ' ' LYS . 14.0 m -46.34 -58.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-N 113.135 -1.848 . . . . 0.97 111.248 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.67 ' HG3' HG23 ' A' ' 78' ' ' VAL . 28.7 mtmt -57.85 -42.88 85.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.584 1.183 . . . . 2.13 109.44 -167.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.825 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -78.5 -49.47 13.34 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 112.937 -1.938 . . . . 2.41 109.854 -172.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.805 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 47.2 mm -68.64 -10.89 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 113.696 -1.593 . . . . 1.23 109.975 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.66 ' HB2' HE22 ' A' ' 32' ' ' GLN . 52.1 tp -64.17 -36.08 82.89 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.181 -0.949 . . . . 0.79 110.315 167.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.14 67.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.814 -0.81 . . . . 0.88 108.814 171.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.805 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 25.4 mm-40 -69.94 -37.59 75.9 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.926 -1.034 . . . . 2.09 111.066 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.747 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.428 -1.544 0 CA-C-O 119.163 -0.446 . . . . 1.77 111.8 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' FES . . . . . 0.853 ' S2 ' ' HB ' ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.817 -0.438 . . . . 13.97 109.817 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 3.4 p -49.19 120.13 9.56 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 120.995 0.426 . . . . 10.71 111.22 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.7 Cg_exo -74.4 71.76 4.45 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.314 2.676 . . . . 9.2 111.941 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -67.24 -40.09 86.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.21 0.528 . . . . 9.04 111.206 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.838 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . 153.34 -18.58 0.7 Allowed Glycine 0 C--O 1.212 -1.224 0 C-N-CA 119.512 -1.328 . . . . 4.14 115.731 167.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.22 45.73 0.99 Allowed 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 114.378 1.251 . . . . 4.58 114.378 -164.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.758 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -50.55 110.94 1.9 Allowed Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 113.83 1.048 . . . . 1.64 113.83 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 88.4 Cg_exo -56.29 99.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.473 0.285 0 C-N-CA 123.191 2.594 . . . . 1.02 111.777 169.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.822 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -85.52 122.56 38.52 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.875 0.695 . . . . 1.52 112.875 -175.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 48.5 m -92.93 129.17 38.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.572 -0.74 . . . . 1.45 110.484 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 128.41 72.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.652 0.982 . . . . 2.21 113.652 -170.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.6 t -63.42 114.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.314 0.578 . . . . 2.24 111.045 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.6 mtm -130.05 22.72 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 5.12 110.449 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.05 175.64 23.63 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.2 -1.0 . . . . 3.86 113.818 -170.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 p -67.51 -46.19 73.61 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.271 0.471 . . . . 5.97 112.271 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.536 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -69.43 -52.88 22.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 4.41 111.083 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -64.09 -39.74 94.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.804 -0.634 . . . . 2.98 111.678 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 25.6 t80 -65.02 -33.42 75.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.628 0.603 . . . . 4.18 112.628 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 16' ' ' ALA . 7.1 p -71.75 -24.04 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.942 0.349 . . . . 3.65 111.942 -166.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 31.2 mmtp -84.2 14.9 3.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.148 0.499 . . . . 4.79 111.57 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.99 29.26 20.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.966 -0.635 . . . . 1.87 112.195 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.76 -19.51 62.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.485 -0.561 . . . . 1.46 109.485 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 14.1 t70 -53.32 -51.76 61.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.396 -0.82 . . . . 2.42 110.605 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -65.83 -38.25 88.4 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.077 -0.649 . . . . 3.03 110.925 -175.176 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.094 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.67 -39.88 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 116.408 -0.36 . . . . 2.26 111.254 -179.073 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.745 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 13.6 p -67.26 -29.82 47.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.595 -0.842 . . . . 1.57 108.92 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.514 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 66.7 t-80 -60.65 -37.85 82.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 1.35 109.897 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -55.28 -46.76 76.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.454 -0.943 . . . . 0.65 108.454 175.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.745 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 36.5 t80 -51.41 -52.67 43.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.183 -0.917 . . . . 1.98 111.186 173.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 16.9 tppt? -45.43 -47.76 13.77 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.71 -1.132 . . . . 2.85 111.171 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.59 -29.58 36.91 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.382 -0.826 . . . . 2.23 111.024 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.739 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 57.9 mm-40 -59.18 -29.39 67.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.278 -0.874 . . . . 2.54 110.988 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.06 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 2.3 tt -53.16 -54.73 31.62 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.377 -0.971 . . . . 2.06 108.377 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.835 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.1 -17.15 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.32 -2.218 . . . . 4.48 113.241 174.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.777 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 52.62 -161.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.215 -1.357 . . . . 3.76 113.307 167.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.914 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 17.9 t70 -157.13 -54.99 0.08 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.945 -1.872 . . . . 4.62 105.945 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.0 pt -177.54 21.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 111.808 -2.451 . . . . 5.0 107.443 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -164.97 -70.11 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 108.953 -1.659 . . . . 4.13 108.953 -166.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.561 ' HA ' HD21 ' A' ' 33' ' ' LEU . 17.9 m-20 -178.46 125.45 0.11 Allowed 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.33 -1.435 . . . . 4.31 110.038 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.976 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 2.6 p 57.81 -11.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 115.746 1.758 . . . . 2.96 115.746 165.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.914 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 55.2 m 112.65 -43.09 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.377 1.471 . . . . 3.83 110.742 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 40' ' ' VAL . 87.0 Cg_exo -51.43 -19.57 7.15 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.123 1.215 . . . . 3.83 113.022 163.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 38.2 t70 84.98 12.38 0.26 Allowed 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.98 1.372 . . . . 4.26 107.671 163.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 156.44 76.1 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 112.78 -2.009 . . . . 2.01 110.178 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.838 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 3.6 ttt180 -119.54 -53.83 2.2 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 114.724 -0.738 . . . . 3.34 109.091 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.06 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.91 110.54 19.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 113.388 0.884 . . . . 2.07 113.388 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.0 m -117.99 108.22 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.809 -1.087 . . . . 1.91 109.168 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.747 ' HA ' HG23 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.66 145.09 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 113.439 0.903 . . . . 3.19 113.439 -168.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.703 ' O ' ' HA ' ' A' ' 10' ' ' SER . 19.4 t70 -155.05 146.04 22.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.366 -1.288 . . . . 3.31 111.807 175.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -42.36 -44.38 3.91 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 117.009 2.226 . . . . 3.25 117.009 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HG ' ' OD2' ' A' ' 49' ' ' ASP . 55.7 mt -49.26 -38.83 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.783 2.142 . . . . 4.45 116.783 -148.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.687 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 8.5 tpm_? -60.5 -51.69 68.39 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.387 0.994 . . . . 6.26 111.011 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.1 t -62.59 154.92 27.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.54 -1.209 . . . . 3.04 113.547 -168.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 10.5 t 62.93 19.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 114.659 -1.155 . . . . 4.32 109.157 -172.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.8 61.52 0.47 Allowed Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.634 -1.166 . . . . 4.19 113.505 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.25 58.8 12.53 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 118.524 -1.798 . . . . 4.42 114.478 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.565 ' HB3' HG21 ' A' ' 62' ' ' ILE 0.262 2.9 m -129.26 -34.45 1.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.859 1.829 . . . . 3.52 111.157 -154.339 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.45 6.25 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.535 2.05 . . . . 3.64 116.535 -163.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 59' ' ' LEU . 16.2 mt -73.15 4.8 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.591 1.542 . . . . 5.44 112.238 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.74 52.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.581 -0.896 . . . . 3.22 108.581 159.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.8 122.62 6.44 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.018 -1.57 . . . . 3.83 108.018 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.596 HG12 ' S1 ' ' A' ' 86' ' ' FES . 44.7 pt -106.96 127.82 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.862 -1.135 . . . . 2.69 113.085 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.684 HG22 HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -144.08 120.78 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.47 -1.307 . . . . 1.87 107.47 152.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.822 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 25.0 ttt -111.24 135.64 51.48 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.583 -1.266 . . . . 1.65 107.583 -175.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.792 ' CG1' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -119.07 114.39 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.249 0 N-CA-C 107.179 -1.415 . . . . 0.76 107.179 169.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 51.36 -159.14 2.24 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.088 -1.205 . . . . 1.1 110.088 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.36 38.78 0.31 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.29 0.567 . . . . 3.01 109.967 171.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.618 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 51.5 mmtt -105.43 -37.49 6.8 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 115.651 -0.704 . . . . 2.62 110.473 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 85.1 t 53.33 108.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 114.07 1.137 . . . . 1.51 114.07 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.695 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.6 m-30 -126.94 -169.83 2.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.455 1.121 . . . . 1.43 113.222 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -129.05 30.18 3.75 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.061 -1.427 . . . . 1.49 112.598 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.874 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 49.9 t-20 -88.59 89.03 7.82 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.573 -1.269 . . . . 1.83 107.573 172.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -116.66 -93.19 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 122.188 0.994 . . . . 3.06 112.785 -168.239 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 1.094 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 43.7 p -133.83 -61.92 0.02 OUTLIER Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.585 -1.643 . . . . 2.49 113.484 -166.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.75 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 16.4 Cg_endo -87.4 70.07 3.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.271 1.981 . . . . 2.65 113.121 -162.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 77.99 -12.18 18.85 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.919 -0.658 . . . . 1.4 112.689 177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.75 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 20.9 mt-30 -73.52 -25.76 60.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.183 -1.784 . . . . 1.87 106.183 -172.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.739 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 16.0 m -46.8 -61.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 111.566 -2.561 . . . . 0.97 111.651 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.854 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 15.5 pttm -58.45 -39.56 80.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.807 0.813 . . . . 2.13 110.84 -167.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.854 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -81.08 -46.84 14.37 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-N 114.698 -1.137 . . . . 2.41 109.449 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.673 HG22 ' HB2' ' A' ' 72' ' ' ASN . 39.9 mm -70.56 -11.62 15.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.13 -1.395 . . . . 1.23 110.11 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 85' ' ' TYR . 31.0 tp -62.65 -34.17 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.654 -0.654 . . . . 0.79 110.005 168.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.74 -33.03 69.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.854 -0.795 . . . . 0.88 108.854 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -70.09 -41.35 74.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.735 -1.121 . . . . 2.09 111.114 171.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.874 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 7.0 m-30 . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 117.898 -1.049 . . . . 1.77 111.879 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' FES . . . . . 0.596 ' S1 ' HG12 ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.41 -0.219 . . . . 13.97 110.41 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' HB ' ' HD3' ' A' ' 3' ' ' PRO . 93.3 t -81.29 -57.02 0.57 Allowed Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 120.923 -0.311 . . . . 10.71 110.368 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 2' ' ' VAL . 59.4 Cg_endo -75.01 78.64 2.85 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.859 1.706 . . . . 9.2 111.109 172.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.675 ' HB3' ' HD2' ' A' ' 6' ' ' LYS . 88.1 mttt -64.3 -71.82 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.594 -0.73 . . . . 9.04 111.617 -175.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.749 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . 110.94 -21.06 23.43 Favored Glycine 0 C--N 1.314 -0.692 0 C-N-CA 120.709 -0.758 . . . . 4.14 113.374 173.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -101.52 51.87 0.84 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.713 0.768 . . . . 4.58 111.718 -170.073 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.568 ' CZ ' ' HA2' ' A' ' 5' ' ' GLY . 2.7 m-85 -52.72 109.56 1.51 Allowed Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 113.759 -1.564 . . . . 1.64 113.255 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.919 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 32.1 Cg_exo -61.92 104.42 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.826 1.684 . . . . 1.02 111.029 169.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.078 ' HB ' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -79.43 114.3 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.773 0.797 . . . . 1.52 110.378 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.79 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 8.3 m -93.09 107.11 18.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.526 -1.216 . . . . 1.45 110.41 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -118.17 123.21 71.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.394 -0.821 . . . . 2.21 110.06 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.732 ' SG ' HG22 ' A' ' 54' ' ' VAL . 32.1 t -66.86 119.28 11.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.109 -0.636 . . . . 2.24 110.884 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.7 ttp -122.96 23.29 9.38 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.2 -1.037 . . . . 5.12 108.2 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.78 179.5 17.48 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.18 -0.918 . . . . 3.86 112.616 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 m -62.71 -43.9 97.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.119 0.415 . . . . 5.97 112.119 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -70.18 -56.08 7.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.048 0.452 . . . . 4.41 111.735 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 81.8 m -68.79 -37.75 79.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.202 0.445 . . . . 2.98 112.202 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.767 ' HE1' ' HB2' ' A' ' 23' ' ' ASP . 74.4 t80 -63.99 -31.63 72.88 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.726 0.639 . . . . 4.18 112.726 -176.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 16' ' ' ALA . 8.0 p -68.7 -20.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.917 0.389 . . . . 3.65 111.043 -168.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.51 14.35 3.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.005 -0.543 . . . . 4.79 111.09 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.32 23.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.065 -0.588 . . . . 1.87 111.971 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -72.9 -20.93 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.316 . . . . 1.46 111.462 -172.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.767 ' HB2' ' HE1' ' A' ' 18' ' ' PHE . 17.5 t70 -57.52 -44.44 85.09 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.47 -0.492 . . . . 2.42 110.946 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 1.7 mptp? -64.64 -39.3 93.46 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.885 -0.726 . . . . 3.03 111.528 -171.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.998 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.79 -46.94 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 120.557 -0.457 . . . . 2.26 110.267 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.492 HG23 ' HE3' ' A' ' 30' ' ' LYS . 17.8 m -65.98 -25.3 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.387 -0.525 . . . . 1.57 110.546 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.629 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 66.4 t-80 -60.74 -44.8 96.22 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.214 0.53 . . . . 1.35 109.67 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.42 -40.09 74.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.598 -1.183 . . . . 0.65 109.254 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.649 ' HE2' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -61.49 -46.5 89.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 1.98 110.458 175.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.629 ' HD2' ' HA ' ' A' ' 27' ' ' HIS . 90.5 mttt -53.65 -40.88 66.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.566 -0.743 . . . . 2.85 110.551 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.98 -29.27 29.13 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.396 -0.82 . . . . 2.23 111.448 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -66.27 -21.98 66.3 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.914 -0.584 . . . . 2.54 109.648 177.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.931 ' HG ' HG12 ' A' ' 35' ' ' ILE . 3.6 tp -51.22 -53.94 30.41 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.812 -1.551 . . . . 2.06 106.812 170.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.649 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 63.38 -28.46 0.08 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 125.885 1.991 . . . . 4.48 113.098 168.107 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.931 HG12 ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.25 -173.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 126.152 1.781 . . . . 3.76 114.631 165.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 8.5 t70 -157.69 -41.58 0.07 Allowed 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 113.387 -1.733 . . . . 4.62 107.396 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' ' 43' ' ' ASP . 4.1 pt -163.23 -3.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 113.643 -1.617 . . . . 5.0 112.646 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -174.46 -58.94 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.035 -1.078 . . . . 4.13 110.79 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.994 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 34.1 m-20 -164.5 115.62 1.24 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.821 -0.689 . . . . 4.31 111.798 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.892 HG23 ' CD2' ' A' ' 46' ' ' PHE . 1.3 t 72.56 -62.96 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 O-C-N 125.117 1.51 . . . . 2.96 109.755 175.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.758 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 64.1 m -169.43 -61.21 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 112.215 -2.266 . . . . 3.83 109.635 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.746 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 72.1 Cg_endo -77.11 11.3 2.09 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 120.624 0.882 . . . . 3.83 113.737 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.636 ' HB2' HG13 ' A' ' 37' ' ' ILE . 24.2 t70 82.02 11.03 0.7 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.001 -1.111 . . . . 4.26 108.001 169.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 169.43 77.77 0.04 OUTLIER Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 119.292 -1.432 . . . . 2.01 112.536 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.749 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 5.1 ttm180 -116.44 1.44 12.98 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.02 -1.844 . . . . 3.34 106.02 165.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.994 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 1.7 m-85 -134.33 169.14 17.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.276 -2.693 . . . . 2.07 111.097 -171.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.919 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 1.4 t 178.26 73.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.493 -1.299 . . . . 1.91 107.493 166.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.044 HG22 HD13 ' A' ' 9' ' ' ILE . 2.1 pp -67.07 116.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.682 -1.145 . . . . 3.19 112.997 -167.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' A' ' 10' ' ' SER . 29.3 t70 -162.27 142.24 9.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.572 1.177 . . . . 3.31 112.711 167.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.4 m -43.76 -45.72 7.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.692 -2.049 . . . . 3.25 116.198 172.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 tp -51.35 -41.74 60.81 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.177 1.918 . . . . 4.45 116.177 -149.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.646 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.0 mmm180 -63.06 -55.93 21.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.156 0.979 . . . . 6.26 110.797 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.693 ' H ' ' HB3' ' A' ' 10' ' ' SER . 34.1 t -63.15 168.72 3.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.343 -1.753 . . . . 3.04 110.252 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.111 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 15.7 t 74.52 28.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 123.204 1.478 . . . . 4.32 108.508 -156.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.29 64.35 0.28 Allowed Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 113.425 -1.716 . . . . 4.19 113.025 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 56.89 19.19 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 119.63 -1.271 . . . . 4.42 115.567 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.293 1.1 m -135.79 -33.66 0.85 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.985 1.392 . . . . 3.52 110.213 -162.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.06 -28.98 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 116.221 1.934 . . . . 3.64 116.221 -160.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.03 6.81 3.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.35 1.432 . . . . 5.44 112.244 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.14 39.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 107.807 -1.182 . . . . 3.22 107.807 159.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.45 117.25 4.75 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 N-CA-C 108.431 -1.411 . . . . 3.83 108.431 160.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -113.18 133.68 58.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 119.406 -0.33 . . . . 2.69 111.771 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.649 HG21 ' HE2' ' A' ' 29' ' ' PHE . 99.4 t -139.87 121.54 15.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 108.908 -0.775 . . . . 1.87 108.908 155.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 50.1 ttp -112.45 136.2 52.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.864 -1.135 . . . . 1.65 109.412 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.078 HG13 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.27 114.8 44.05 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 119.877 -0.729 . . . . 0.76 109.485 174.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.702 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 50.76 45.81 48.52 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.808 -0.71 . . . . 1.1 113.433 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 59.55 6.66 0.85 Allowed 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 122.952 0.501 . . . . 3.01 111.4 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.913 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 71.2 mmtt -77.01 -8.76 57.98 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 110.234 -0.284 . . . . 2.62 110.234 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.4 m 35.72 99.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 124.609 1.193 . . . . 1.51 113.889 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.913 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 3.8 m-85 -110.09 165.88 11.39 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-O 122.962 1.363 . . . . 1.43 113.675 -173.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.663 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -109.75 5.96 31.14 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 112.544 -2.116 . . . . 1.49 109.009 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.743 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -65.25 131.57 46.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.49 -1.67 . . . . 1.83 106.49 167.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.72 -145.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.466 0.913 . . . . 3.06 113.466 -148.578 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.998 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 76.5 p -131.29 -50.9 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.018 1.118 . . . . 2.49 114.018 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD3' ' OG1' ' A' ' 74' ' ' THR . 91.2 Cg_endo -87.79 73.93 2.45 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.582 1.521 . . . . 2.65 113.474 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.54 4.41 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.75 -0.738 . . . . 1.4 112.782 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.548 ' O ' HG12 ' A' ' 81' ' ' ILE . 23.1 mt-30 -74.38 -19.71 60.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 106.403 -1.702 . . . . 1.87 106.403 -172.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.684 HG23 ' HG3' ' A' ' 79' ' ' LYS . 8.4 m -43.44 -60.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 111.704 -2.498 . . . . 0.97 111.915 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.684 ' HG3' HG23 ' A' ' 78' ' ' VAL . 45.9 mtmt -59.45 -37.59 78.55 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.277 1.037 . . . . 2.13 109.998 -165.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.4 -47.7 12.89 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 114.257 -1.338 . . . . 2.41 109.446 -175.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 42.1 mm -66.57 -10.68 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.291 -1.322 . . . . 1.23 110.013 177.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 85' ' ' TYR . 52.7 tp -58.75 -23.95 60.82 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.521 -0.737 . . . . 0.79 110.127 169.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.44 27.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.448 -0.501 . . . . 0.88 110.305 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.772 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER -67.0 -36.78 82.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.983 -0.553 . . . . 2.09 111.715 174.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.691 ' HB2' HD12 ' A' ' 82' ' ' LEU . 6.7 m-30 . . . . . 0 N--CA 1.432 -1.355 0 CA-C-O 118.523 -0.751 . . . . 1.77 111.547 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' FES . . . . . 1.111 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' HB ' ' A' ' 2' ' ' VAL . 6.5 tmm? . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 109.347 -0.612 . . . . 13.97 109.347 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 1' ' ' MET . 99.5 t 74.17 105.72 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.278 0 O-C-N 123.598 0.561 . . . . 10.71 110.191 -175.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.05 101.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.25 2.633 . . . . 9.2 112.51 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.771 ' H ' ' HA3' ' A' ' 44' ' ' GLY . 26.2 tptp -36.07 -67.49 0.16 Allowed 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 124.682 1.239 . . . . 9.04 112.824 -173.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 47' ' ' SER . . . 122.4 34.49 0.81 Allowed Glycine 0 CA--C 1.495 -1.161 0 CA-C-N 114.815 -1.084 . . . . 4.14 112.269 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.531 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 14.3 tppt? -50.66 -62.02 1.85 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.202 -1.036 . . . . 4.58 108.202 169.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.598 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 4.7 m-85 -115.44 89.16 21.02 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.837 -1.074 . . . . 1.64 110.541 173.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 51.2 Cg_exo -59.67 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.111 2.541 . . . . 1.02 111.669 171.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.055 HG12 ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -84.48 173.39 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 113.387 0.884 . . . . 1.52 113.387 -167.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.746 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 14.9 p -134.65 134.85 41.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.263 -0.88 . . . . 1.45 109.005 171.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 m -115.46 124.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.785 -0.643 . . . . 2.21 110.962 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.0 t -66.11 112.6 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.299 0.571 . . . . 2.24 110.463 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.3 tpt -131.11 23.85 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.37 -0.832 . . . . 5.12 109.628 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.66 177.26 13.59 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.584 -0.817 . . . . 3.86 113.992 -166.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -66.21 -45.55 80.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 5.97 111.676 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.2 -52.27 20.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.556 0.693 . . . . 4.41 110.339 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.65 -34.19 76.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.626 -1.17 . . . . 2.98 111.734 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 83.6 t80 -60.69 -34.31 74.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.787 0.327 . . . . 4.18 111.346 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.82 -24.33 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.545 0.688 . . . . 3.65 109.862 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -84.44 12.2 7.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.171 -0.922 . . . . 4.79 110.408 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 31.1 17.24 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.537 -0.84 . . . . 1.87 113.145 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -70.74 -19.81 62.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.707 0.289 . . . . 1.46 110.789 -175.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.99 -52.88 62.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 2.42 110.248 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -64.55 -31.36 72.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.887 -0.412 . . . . 3.03 109.887 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.878 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 98.2 t -56.82 -62.51 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 115.557 -0.747 . . . . 2.26 109.426 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -63.98 -27.86 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.729 -0.669 . . . . 1.57 110.793 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -58.5 -47.87 82.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 120.299 -0.56 . . . . 1.35 110.368 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.55 -45.01 81.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.15 -0.932 . . . . 0.65 109.163 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.645 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -53.5 -53.39 52.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.093 -0.958 . . . . 1.98 110.087 177.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -51.34 -48.95 62.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.587 -0.733 . . . . 2.85 110.995 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.81 -28.55 28.0 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.123 -0.944 . . . . 2.23 111.446 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -63.97 -26.77 68.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 123.437 0.461 . . . . 2.54 110.328 176.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.066 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 tt -50.95 -56.21 13.46 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.612 -1.255 . . . . 2.06 107.612 173.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 63.59 -19.47 0.06 Allowed 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.527 2.392 . . . . 4.48 112.644 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.638 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 56.9 -173.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 113.621 -1.627 . . . . 3.76 112.713 170.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.78 -48.7 0.07 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.944 -1.132 . . . . 4.62 107.944 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 pt -165.58 5.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 112.898 -1.955 . . . . 5.0 110.615 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.555 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 177.16 -54.51 0.1 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 110.103 -1.199 . . . . 4.13 110.103 -166.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.691 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 24.4 t70 -176.53 116.88 0.12 Allowed 'General case' 0 CA--C 1.483 -1.635 0 CA-C-N 113.446 -1.377 . . . . 4.31 111.291 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.027 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 6.5 p 54.9 -65.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 127.301 2.876 . . . . 2.96 113.488 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.82 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 26.2 m -154.0 -58.81 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 113.631 -1.622 . . . . 3.83 110.565 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.82 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 2.8 Cg_exo -77.63 10.06 2.68 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 C-N-CA 120.745 0.963 . . . . 3.83 114.235 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.555 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 6.8 t0 81.43 9.41 0.95 Allowed 'General case' 0 C--N 1.349 0.558 0 N-CA-C 107.644 -1.243 . . . . 4.26 107.644 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.771 ' HA3' ' H ' ' A' ' 4' ' ' LYS . . . 156.92 59.36 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.237 -1.347 . . . . 2.01 112.171 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.64 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 11.6 ttt180 -86.73 -62.0 1.61 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.029 -1.1 . . . . 3.34 108.029 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.066 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -100.95 102.42 13.43 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 122.806 1.289 . . . . 2.07 112.738 173.31 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.477 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 22.6 t -92.02 91.98 8.08 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.887 -1.506 . . . . 1.91 109.215 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.055 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.3 pp -56.46 124.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 3.19 112.518 -174.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' SER . 8.5 m-20 -143.21 132.73 23.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.518 1.151 . . . . 3.31 113.464 166.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -48.5 -43.41 35.06 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.171 -1.831 . . . . 3.25 114.581 158.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.16 -35.13 59.44 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.558 1.318 . . . . 4.45 114.558 -160.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.746 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 9.8 mmt85 -60.77 -49.87 75.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.806 0.812 . . . . 6.26 110.176 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.0 t -59.22 158.58 8.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.944 -1.48 . . . . 3.04 112.895 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 54' ' ' VAL . 14.7 t 66.27 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.388 0 CA-C-O 122.83 1.3 . . . . 4.32 108.558 -167.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.77 63.6 0.37 Allowed Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 113.829 -1.532 . . . . 4.19 113.263 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.21 59.08 10.04 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.739 -1.696 . . . . 4.42 114.609 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.727 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.282 2.8 m -130.14 -37.13 1.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.058 1.429 . . . . 3.52 110.765 -159.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.06 -32.65 35.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.916 1.45 . . . . 3.64 114.916 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 59' ' ' LEU . 2.5 pt? -76.83 6.13 6.64 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.117 -0.989 . . . . 5.44 112.334 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.76 160.86 38.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.305 -0.628 . . . . 3.22 109.305 164.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.52 119.19 4.8 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 108.572 -1.357 . . . . 3.83 108.572 155.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.727 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.0 mm -111.58 129.58 66.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.567 0.58 . . . . 2.69 112.567 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 4.7 t -139.57 123.15 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.832 -1.544 . . . . 1.87 106.832 153.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.764 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 22.7 ttt -112.75 136.08 52.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.954 -1.498 . . . . 1.65 110.598 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.748 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -124.81 114.91 42.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 106.545 -1.65 . . . . 0.76 106.545 156.029 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.75 -149.25 1.09 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 122.165 0.87 . . . . 1.1 112.752 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.31 31.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.842 -1.179 . . . . 3.01 108.744 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.748 ' HB2' HG23 ' A' ' 65' ' ' VAL . 13.2 mmmm -106.61 -41.56 5.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.535 -0.757 . . . . 2.62 109.214 -177.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 64' ' ' MET . 87.8 t 46.38 101.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 124.472 1.108 . . . . 1.51 113.523 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.668 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 9.1 m-30 -120.41 -154.77 0.6 Allowed 'General case' 0 C--O 1.248 1.024 0 CA-C-O 121.863 0.839 . . . . 1.43 112.312 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.612 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -142.6 28.21 2.19 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.695 -1.139 . . . . 1.49 112.003 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.865 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 14.2 t-20 -81.76 112.73 19.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.711 -0.477 . . . . 1.83 109.711 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.665 HG23 ' H ' ' A' ' 74' ' ' THR . 6.9 m -137.2 -78.78 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 116.922 2.193 . . . . 3.06 116.922 -171.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.878 ' CB ' ' HA ' ' A' ' 25' ' ' VAL . 13.6 t -153.41 -41.68 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 115.51 1.671 . . . . 2.49 115.51 -172.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.892 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 3.0 Cg_exo -75.31 57.22 4.68 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.09 1.86 . . . . 2.65 112.036 -170.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.447 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 76.3 -7.54 30.23 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.58 -0.737 . . . . 1.4 111.562 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.892 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 26.0 mt-30 -73.62 -35.75 65.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.209 -1.404 . . . . 1.87 107.209 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.762 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -50.67 -55.69 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 112.802 -1.999 . . . . 0.97 110.941 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 48.9 mtmt -54.51 -45.66 73.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.019 0.914 . . . . 2.13 109.508 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.777 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -85.56 -40.94 15.74 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.642 -1.163 . . . . 2.41 110.987 -173.077 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.774 ' CG2' ' HB2' ' A' ' 72' ' ' ASN . 33.3 mm -69.69 -15.11 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.955 -0.566 . . . . 1.23 109.765 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.539 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 54.7 tp -58.93 -41.57 87.65 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.989 -0.445 . . . . 0.79 110.29 171.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.2 -32.74 66.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.544 0.688 . . . . 0.88 109.422 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.55 -31.64 67.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.755 -1.111 . . . . 2.09 112.125 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.865 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 2.1 m-30 . . . . . 0 N--CA 1.432 -1.369 0 CA-C-O 117.418 -1.277 . . . . 1.77 112.004 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HG2' HG23 ' A' ' 2' ' ' VAL . 25.8 ttt . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.649 0.261 . . . . 13.97 110.797 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG23 ' HG2' ' A' ' 1' ' ' MET . 68.3 t -120.57 113.51 33.42 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.756 -0.202 . . . . 10.71 110.694 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.2 Cg_exo -76.96 125.13 7.8 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.002 2.468 . . . . 9.2 112.152 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -123.96 -79.06 0.61 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.279 0.561 . . . . 9.04 110.947 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.02 1.52 45.26 Favored Glycine 0 C--N 1.312 -0.754 0 CA-C-N 115.338 -0.846 . . . . 4.14 112.862 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.681 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -140.36 53.27 1.63 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.248 1.023 . . . . 4.58 110.915 -176.617 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.937 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -69.31 112.59 12.35 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.075 -1.42 . . . . 1.64 112.764 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 1.039 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 21.0 Cg_exo -70.8 131.14 19.2 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.903 1.735 . . . . 1.02 111.678 170.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.883 HG22 ' HA ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -77.45 156.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.376 0.608 . . . . 1.52 112.085 -175.074 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.82 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.6 m -141.68 100.81 3.84 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.299 -0.864 . . . . 1.45 109.56 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -117.81 124.64 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.744 -0.662 . . . . 2.21 110.799 -176.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.746 ' SG ' HG22 ' A' ' 54' ' ' VAL . 31.5 t -65.14 120.87 13.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 2.24 110.876 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.4 mtt -122.01 24.8 9.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.15 -0.932 . . . . 5.12 108.714 173.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.09 179.91 13.19 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.132 -0.94 . . . . 3.86 112.836 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 19' ' ' VAL . 19.8 m -65.78 -45.67 81.59 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.993 0.368 . . . . 5.97 111.993 -172.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.641 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -71.62 -56.54 5.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.465 0.543 . . . . 4.41 112.465 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 83.3 m -66.62 -36.55 82.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.535 0.569 . . . . 2.98 112.535 -171.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.78 -30.87 71.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.126 0.787 . . . . 4.18 113.126 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 16' ' ' ALA . 32.6 m -69.74 -18.92 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.948 0.351 . . . . 3.65 111.948 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.95 16.46 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 4.79 111.612 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.85 32.3 10.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.451 -0.881 . . . . 1.87 111.851 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -72.05 -20.82 61.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.436 -0.382 . . . . 1.46 110.617 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.18 -50.86 66.07 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.031 -0.359 . . . . 2.42 110.031 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -65.02 -40.62 95.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.698 -0.401 . . . . 3.03 110.983 -171.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.789 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 6.1 m -67.17 -49.0 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 C-N-CA 120.42 -0.512 . . . . 2.26 110.153 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.675 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 21.8 m -64.83 -28.95 46.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.182 -0.607 . . . . 1.57 110.269 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -59.5 -43.11 93.42 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 120.72 -0.392 . . . . 1.35 110.219 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -52.96 -49.16 66.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.202 -0.908 . . . . 0.65 109.062 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.675 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 39.7 t80 -47.54 -56.9 6.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.065 -0.97 . . . . 1.98 110.488 174.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.17 -52.66 11.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.373 -1.285 . . . . 2.85 112.229 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -84.45 -30.52 25.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.84 -0.618 . . . . 2.23 111.762 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.69 ' NE2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -64.71 -25.02 67.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.54 -0.541 . . . . 2.54 109.54 176.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.797 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.3 tt -48.59 -58.23 5.01 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.246 -1.39 . . . . 2.06 107.246 174.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.744 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 64.09 -21.49 0.07 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 126.328 2.268 . . . . 4.48 112.874 171.522 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.701 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 53.98 -173.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 C-N-CA 126.342 1.857 . . . . 3.76 114.389 166.447 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' H ' HG22 ' A' ' 35' ' ' ILE . 14.7 t70 -157.74 -50.93 0.07 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.848 -1.524 . . . . 4.62 107.985 -172.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pt -164.79 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 113.441 -1.709 . . . . 5.0 110.863 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.31 -65.04 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 109.675 -1.37 . . . . 4.13 109.675 -166.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.895 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 25.1 m-20 -164.31 119.97 1.53 Allowed 'General case' 0 CA--C 1.48 -1.742 0 CA-C-N 112.903 -1.648 . . . . 4.31 109.107 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.992 HG13 ' HD2' ' A' ' 42' ' ' PRO . 4.4 p 59.01 -66.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 126.684 2.49 . . . . 2.96 112.871 171.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.959 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 50.7 m -164.71 -58.52 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.759 0 CA-C-N 112.688 -2.051 . . . . 3.83 110.006 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.072 ' HG2' ' HD2' ' A' ' 45' ' ' ARG . 23.8 Cg_exo -67.69 4.26 1.47 Allowed 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 120.88 1.054 . . . . 3.83 114.44 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 18.0 t70 86.23 -4.85 0.77 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.93 0.872 . . . . 4.26 109.578 159.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.532 ' HA2' ' OD2' ' A' ' 39' ' ' ASP . . . 179.06 41.4 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.747 -1.115 . . . . 2.01 112.282 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 1.072 ' HD2' ' HG2' ' A' ' 42' ' ' PRO . 2.6 ttt180 -82.74 -7.79 59.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.548 1.166 . . . . 3.34 109.167 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.98 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -105.51 -58.98 1.83 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.608 -2.087 . . . . 2.07 113.453 -171.405 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 1.039 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 73.9 m 30.31 -170.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.588 1.555 . . . . 1.91 114.723 -162.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.883 ' HA ' HG22 ' A' ' 9' ' ' ILE . 8.4 tp -166.99 104.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 113.686 0.995 . . . . 3.19 113.686 -168.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.82 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.2 m-20 -144.69 130.79 19.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.678 -0.809 . . . . 3.31 110.272 160.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t -50.03 -45.24 51.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.972 1.101 . . . . 3.25 113.972 160.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.3 -37.86 70.47 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.898 1.814 . . . . 4.45 115.898 -157.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.478 ' HD2' ' OG ' ' A' ' 10' ' ' SER . 44.9 mtt180 -62.14 -56.87 14.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.229 1.014 . . . . 6.26 110.09 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 10' ' ' SER . 34.2 t -64.77 170.7 3.94 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.374 -1.739 . . . . 3.04 109.288 171.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.811 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 12.2 t 75.1 30.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 123.168 1.461 . . . . 4.32 108.492 -157.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.5 63.24 0.3 Allowed Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 113.457 -1.701 . . . . 4.19 112.886 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.23 56.02 24.42 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 119.507 -1.33 . . . . 4.42 115.782 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.9 m -136.35 -30.83 0.91 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.588 1.194 . . . . 3.52 109.708 -166.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.51 -26.97 1.57 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.766 2.136 . . . . 3.64 116.766 -160.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.83 5.14 5.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.815 1.643 . . . . 5.44 112.045 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.67 161.15 35.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 107.876 -1.157 . . . . 3.22 107.876 162.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.8 118.69 5.39 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.705 1.287 . . . . 3.83 108.998 164.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.76 131.39 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.059 0.392 . . . . 2.69 112.059 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.691 HG13 ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -142.05 124.04 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.29 -1.004 . . . . 1.87 108.29 158.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.663 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 49.7 ttp -113.2 134.59 54.5 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 118.152 -1.419 . . . . 1.65 111.106 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.937 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.89 119.28 55.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 CA-C-O 119.207 -0.425 . . . . 0.76 110.0 174.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.691 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 55.55 31.42 57.37 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.117 -1.039 . . . . 1.1 112.008 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.543 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 42.7 mt-10 58.54 12.62 2.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.727 -0.737 . . . . 3.01 111.525 -174.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.442 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 30.8 mmmt -73.77 -27.49 61.19 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 109.642 -0.503 . . . . 2.62 109.642 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.663 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 94.6 t 60.51 100.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.047 -0.979 . . . . 1.51 112.675 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.843 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.1 m-85 -124.98 -161.45 1.02 Allowed 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.046 0.927 . . . . 1.43 112.15 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.691 ' HA2' HG13 ' A' ' 63' ' ' VAL . . . -137.14 18.89 3.48 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.505 -1.225 . . . . 1.49 112.091 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.856 ' HB2' HG22 ' A' ' 81' ' ' ILE . 8.2 t30 -84.62 85.89 7.37 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.083 -0.657 . . . . 1.83 109.813 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.655 HG21 ' HB ' ' A' ' 63' ' ' VAL . 59.9 t -153.36 -56.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.55 0.944 . . . . 3.06 113.55 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.68 HG22 ' HB ' ' A' ' 25' ' ' VAL . 8.3 p -102.15 149.98 37.08 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.559 -0.291 . . . . 2.49 111.586 -164.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.789 ' HD2' ' HA ' ' A' ' 25' ' ' VAL . 1.1 Cg_endo -42.85 112.98 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.21 3.274 . . . . 2.65 111.742 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.658 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 119.23 -83.75 0.36 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.216 -1.154 . . . . 1.4 110.216 -170.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 1.9 pt20 -64.58 -38.73 92.03 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.766 0.793 . . . . 1.87 109.855 -175.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.69 HG22 ' NE2' ' A' ' 32' ' ' GLN . 9.9 p -50.99 -57.4 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.875 -1.057 . . . . 0.97 111.609 -174.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.602 ' N ' HG13 ' A' ' 78' ' ' VAL . 16.6 pttp -59.87 -42.4 93.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.604 0.716 . . . . 2.13 110.342 -164.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.658 ' HD2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -89.1 -34.95 16.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.068 -0.969 . . . . 2.41 110.489 -172.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.856 HG22 ' HB2' ' A' ' 72' ' ' ASN . 51.1 mm -68.1 -11.54 14.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.87 -0.604 . . . . 1.23 109.868 174.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.532 ' HB2' HE22 ' A' ' 32' ' ' GLN . 57.4 tp -60.48 -37.19 80.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.32 -0.862 . . . . 0.79 110.47 168.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.54 68.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.724 0.773 . . . . 0.88 109.003 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.562 -1.199 . . . . 2.09 111.365 174.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.843 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 8.0 m-30 . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 118.283 -0.865 . . . . 1.77 110.95 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' FES . . . . . 0.811 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.826 0.346 . . . . 13.97 110.727 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t -93.34 119.82 67.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.162 -0.472 . . . . 10.71 110.876 -174.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 -154.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.869 2.38 . . . . 9.2 110.768 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 32.7 mmtp -75.78 -91.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.462 -0.495 . . . . 9.04 110.353 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.63 175.18 50.68 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 120.275 -0.964 . . . . 4.14 110.943 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 36.77 46.24 0.47 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.856 0.836 . . . . 4.58 110.95 -173.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.82 ' HB2' HG12 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -33.96 116.6 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.198 -1.819 . . . . 1.64 113.611 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 24.2 Cg_exo -66.34 109.54 1.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.024 1.816 . . . . 1.02 110.582 166.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.772 HG23 ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -78.52 158.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.166 -0.309 . . . . 1.52 110.166 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.875 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 25.1 m -141.88 111.46 6.58 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.041 -0.527 . . . . 1.45 110.354 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.72 120.48 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.971 -0.559 . . . . 2.21 110.985 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.722 ' SG ' HG22 ' A' ' 54' ' ' VAL . 35.8 t -70.2 122.98 20.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.673 -0.411 . . . . 2.24 110.717 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.84 22.83 9.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.372 -0.377 . . . . 5.12 111.019 174.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.634 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -66.43 177.49 16.63 Favored Glycine 0 C--O 1.22 -0.736 0 C-N-CA 120.497 -0.859 . . . . 3.86 112.363 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.7 m -66.32 -45.14 81.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.613 0.597 . . . . 5.97 112.613 -171.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.63 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.609 0.719 . . . . 4.41 110.783 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 91.3 m -63.51 -28.52 70.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.131 -0.94 . . . . 2.98 111.568 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 61.4 t80 -56.07 -27.45 53.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.302 0.641 . . . . 4.18 110.265 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.45 -20.74 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 3.65 110.402 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.489 ' NZ ' ' S1 ' ' A' ' 86' ' ' FES . 48.1 mtmt -80.92 10.45 5.05 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.661 0.267 . . . . 4.79 110.671 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.17 28.21 34.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.927 -0.654 . . . . 1.87 112.546 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -73.02 -22.7 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.575 0.226 . . . . 1.46 111.454 -171.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.64 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 18.0 t70 -61.43 -46.35 90.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.204 0.526 . . . . 2.42 110.29 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 9.1 mptt -67.18 -33.06 74.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.285 -0.635 . . . . 3.03 109.285 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.979 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 99.6 t -56.12 -58.19 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 109.011 -0.737 . . . . 2.26 109.011 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.532 ' HA ' ' HB2' ' A' ' 29' ' ' PHE . 28.9 m -61.58 -34.63 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.706 -0.679 . . . . 1.57 111.566 -174.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -63.1 -48.37 78.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 119.112 -1.035 . . . . 1.35 110.189 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.62 81.87 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.846 -1.168 . . . . 0.65 107.846 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.678 ' HZ ' ' HH ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -53.35 -52.56 58.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.488 -1.233 . . . . 1.98 110.988 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -51.67 -49.55 62.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.106 -0.952 . . . . 2.85 110.578 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.97 -31.54 34.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.442 -1.254 . . . . 2.23 110.842 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.689 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 33.3 mm-40 -64.42 -21.92 66.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.632 -0.713 . . . . 2.54 111.933 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.092 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.4 tt -57.45 -55.0 40.47 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.373 -1.343 . . . . 2.06 107.373 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.795 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 62.9 -22.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 126.576 2.422 . . . . 4.48 112.997 171.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.638 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.21 -175.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.153 -1.385 . . . . 3.76 112.667 170.673 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -156.6 -47.35 0.07 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.687 -1.227 . . . . 4.62 107.687 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 pt -167.19 5.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 113.222 -1.808 . . . . 5.0 111.089 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.574 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 178.65 -54.54 0.09 OUTLIER Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.06 -1.216 . . . . 4.13 110.06 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.562 ' HA ' HG23 ' A' ' 35' ' ' ILE . 20.5 t70 -175.24 118.65 0.18 Allowed 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.187 -1.507 . . . . 4.31 110.709 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.963 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 9.5 p 56.17 -66.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 O-C-N 127.205 2.816 . . . . 2.96 113.044 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.887 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 41.1 m -154.64 -61.62 0.02 OUTLIER Pre-proline 0 C--N 1.279 -2.495 0 CA-C-N 113.619 -1.628 . . . . 3.83 109.99 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.887 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.1 Cg_exo -79.75 8.41 4.02 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 120.908 1.072 . . . . 3.83 114.297 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.574 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 22.3 t70 82.77 5.85 0.91 Allowed 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.347 1.07 . . . . 4.26 108.356 166.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.504 ' N ' ' HB3' ' A' ' 39' ' ' ASP . . . 175.76 76.2 0.05 OUTLIER Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.177 -1.374 . . . . 2.01 112.157 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.598 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 5.2 tpt180 -100.45 -60.42 1.53 Allowed 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.463 -0.94 . . . . 3.34 108.463 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.092 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.19 115.8 21.68 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 122.508 1.147 . . . . 2.07 114.002 -176.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.452 ' C ' HG23 ' A' ' 9' ' ' ILE . 21.2 t -102.27 93.38 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.156 -1.384 . . . . 1.91 108.56 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.772 ' HA ' HG23 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -67.52 135.28 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.861 0.689 . . . . 3.19 112.861 -168.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.875 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.5 t70 -160.12 138.03 9.93 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.205 1.003 . . . . 3.31 112.73 163.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.3 m -48.47 -49.91 33.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 115.407 1.632 . . . . 3.25 115.407 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -54.67 -40.65 69.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.915 2.191 . . . . 4.45 116.915 -150.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.65 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -63.25 -55.37 25.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.896 0.855 . . . . 6.26 110.945 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.72 ' H ' ' HB3' ' A' ' 10' ' ' SER . 25.3 t -63.95 166.41 7.5 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.886 -1.506 . . . . 3.04 109.156 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.772 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 14.3 t 72.83 27.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.206 1.479 . . . . 4.32 107.586 -153.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.34 65.74 0.32 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 113.292 -1.776 . . . . 4.19 113.321 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.16 55.19 25.3 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 119.485 -1.341 . . . . 4.42 116.04 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -138.82 -29.89 0.77 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.24 1.02 . . . . 3.52 110.183 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -48.24 -29.51 3.87 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 116.632 2.086 . . . . 3.64 116.632 -158.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.9 6.77 4.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.407 1.458 . . . . 5.44 111.85 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.39 161.62 30.67 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 3.22 108.309 163.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.24 119.13 5.45 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.326 1.152 . . . . 3.83 109.307 163.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.09 132.78 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.973 0.731 . . . . 2.69 112.973 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.529 HG21 ' CZ ' ' A' ' 29' ' ' PHE . 11.7 p -143.07 121.8 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.86 -0.736 . . . . 1.87 109.133 148.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.594 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 50.1 ttp -113.44 133.99 54.9 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 119.26 -0.976 . . . . 1.65 108.778 -173.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -126.04 117.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.222 -0.591 . . . . 0.76 109.491 173.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.654 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 49.12 50.79 27.27 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 123.748 0.655 . . . . 1.1 113.935 173.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 62.12 -0.67 0.45 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.111 0.412 . . . . 3.01 112.111 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -75.8 -38.56 58.1 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.834 -0.432 . . . . 2.62 109.834 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 95.3 t 61.43 113.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.042 -0.981 . . . . 1.51 112.465 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.594 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 40.0 m-85 -131.53 -172.7 2.92 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.142 0.972 . . . . 1.43 112.278 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.01 26.32 3.79 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.024 -1.444 . . . . 1.49 110.96 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 2.1 t30 -76.13 111.73 11.84 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.937 -0.764 . . . . 1.83 108.937 177.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 74' ' ' THR . 3.2 m -134.12 -97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 116.34 1.978 . . . . 3.06 116.34 -164.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.979 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 10.2 t -143.92 -41.41 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 115.66 1.726 . . . . 2.49 115.66 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.605 ' HD3' ' H ' ' A' ' 74' ' ' THR . 5.6 Cg_exo -73.65 57.84 3.76 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 122.133 1.889 . . . . 2.65 113.193 -169.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.18 -7.34 10.95 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 116.063 -0.517 . . . . 1.4 112.468 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.64 ' O ' HG12 ' A' ' 81' ' ' ILE . 10.0 mt-30 -75.84 -30.8 59.09 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 107.227 -1.398 . . . . 1.87 107.227 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.689 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -52.63 -46.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-N 112.554 -2.112 . . . . 0.97 112.317 -175.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HG2' HE22 ' A' ' 32' ' ' GLN . 50.1 mtmt -54.76 -44.8 73.97 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.517 1.151 . . . . 2.13 108.153 -170.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -80.63 -46.75 15.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.826 -1.988 . . . . 2.41 110.331 -173.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 77' ' ' GLN . 28.9 mm -69.02 -16.24 20.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.893 -1.049 . . . . 1.23 110.239 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 78' ' ' VAL . 54.9 tp -61.34 -33.95 74.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.483 -0.76 . . . . 0.79 110.107 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 -27.93 69.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.281 0.562 . . . . 0.88 109.535 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.468 ' OE1' HG23 ' A' ' 81' ' ' ILE . 1.7 mt-10 -71.38 -27.33 63.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.403 -0.817 . . . . 2.09 110.191 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 3.3 m-30 . . . . . 0 N--CA 1.422 -1.864 0 CA-C-N 115.628 -0.714 . . . . 1.77 110.555 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' FES . . . . . 0.772 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HG2' ' HE3' ' A' ' 68' ' ' LYS . 44.6 tpp . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.591 0.234 . . . . 13.97 110.516 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.06 100.9 16.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.039 0.447 . . . . 10.71 110.167 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 1' ' ' MET . 1.6 Cg_endo -81.4 89.84 1.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.084 2.522 . . . . 9.2 111.563 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -79.53 -64.98 1.06 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.284 -0.416 . . . . 9.04 110.878 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.58 152.04 5.61 Favored Glycine 0 C--N 1.315 -0.605 0 C-N-CA 120.842 -0.694 . . . . 4.14 112.72 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER 39.11 56.84 2.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.969 0.907 . . . . 4.58 112.054 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.726 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 15.6 m-85 -46.79 125.98 8.27 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.054 -1.43 . . . . 1.64 112.224 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 47' ' ' SER . 61.0 Cg_exo -57.72 94.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.968 2.446 . . . . 1.02 112.175 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.778 ' HB ' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -82.02 135.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.32 0.581 . . . . 1.52 111.909 -174.267 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.726 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.0 m -100.68 124.28 46.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.075 -0.966 . . . . 1.45 110.665 -177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 m -116.83 125.01 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.844 0.683 . . . . 2.21 112.844 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' CB ' ' A' ' 17' ' ' CYS . 15.1 t -67.71 117.38 9.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.058 0.456 . . . . 2.24 112.057 175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.5 ttt -129.32 23.75 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.901 -0.591 . . . . 5.12 109.583 166.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.5 176.46 23.82 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.503 -0.856 . . . . 3.86 114.65 -167.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -67.34 -45.33 76.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.979 0.418 . . . . 5.97 112.091 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.63 25.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.474 0.654 . . . . 4.41 110.1 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 88.5 m -63.76 -33.84 76.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.59 -1.186 . . . . 2.98 112.021 -176.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 43.8 t80 -60.45 -32.62 71.55 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.984 0.421 . . . . 4.18 111.015 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -72.68 -23.84 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.537 0.684 . . . . 3.65 109.886 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 23.9 tptm -83.2 8.1 14.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.419 -0.809 . . . . 4.79 110.001 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.23 28.29 34.13 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.898 -0.668 . . . . 1.87 112.184 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 25' ' ' VAL . . . -71.73 -22.41 61.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 1.46 111.15 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 26' ' ' VAL . 10.0 t70 -56.78 -52.86 63.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.409 -0.359 . . . . 2.42 110.232 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -66.17 -37.88 86.71 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.44 -0.504 . . . . 3.03 110.908 -172.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.979 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.4 m -69.31 -44.56 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 120.583 -0.447 . . . . 2.26 110.72 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 18.9 m -64.52 -31.32 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.919 -0.712 . . . . 1.57 109.441 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -59.66 -45.85 90.78 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.932 0.396 . . . . 1.35 110.08 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . -56.1 -43.25 77.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.091 -0.958 . . . . 0.65 108.516 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.774 ' HZ ' ' HE2' ' A' ' 85' ' ' TYR . 1.3 t80 -56.17 -49.18 74.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.062 -0.972 . . . . 1.98 110.776 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -50.92 -46.63 60.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.262 -0.881 . . . . 2.85 110.551 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -76.17 -30.18 58.0 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.97 -1.014 . . . . 2.23 110.919 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.85 ' NE2' ' HG2' ' A' ' 79' ' ' LYS . 71.6 mm-40 -61.66 -27.59 68.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.218 -0.901 . . . . 2.54 111.059 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -50.86 -58.41 6.03 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.854 -1.165 . . . . 2.06 107.854 170.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER 57.45 -2.63 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 O-C-N 125.683 1.865 . . . . 4.48 112.61 173.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 46.05 -166.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.656 -1.611 . . . . 3.76 112.935 174.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 6.9 t70 -159.57 -40.25 0.05 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.2 -1.407 . . . . 4.62 107.2 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 43' ' ' ASP . 1.5 pt -164.32 0.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.247 -2.252 . . . . 5.0 110.557 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.84 -27.41 0.58 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 119.517 -1.325 . . . . 4.13 112.944 -165.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.996 ' HA ' ' HE1' ' A' ' 46' ' ' PHE . 10.6 t70 -138.28 167.86 20.96 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 121.157 0.503 . . . . 4.31 111.898 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 46' ' ' PHE . 5.0 t -25.58 -58.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 126.877 2.611 . . . . 2.96 110.422 174.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.819 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 98.5 m -159.55 -64.69 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 111.627 -2.533 . . . . 3.83 111.397 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.819 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.2 Cg_exo -78.62 5.93 5.22 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 121.097 1.198 . . . . 3.83 114.561 -172.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.979 ' HA ' ' HB3' ' A' ' 39' ' ' ASP . 36.9 t70 74.27 21.38 2.45 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.252 -1.018 . . . . 4.26 108.252 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 6' ' ' LYS . . . -172.05 58.52 0.16 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 118.691 -1.718 . . . . 2.01 113.882 175.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.499 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -122.53 -44.28 2.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.241 0.543 . . . . 3.34 110.476 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.996 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -119.55 142.11 48.64 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 113.208 0.818 . . . . 2.07 113.208 -170.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.738 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 23.2 t -155.64 97.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.354 -1.721 . . . . 1.91 106.354 166.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.506 HG23 ' HD2' ' A' ' 46' ' ' PHE . 36.1 pt -87.97 149.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 114.021 1.119 . . . . 3.19 114.021 -159.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.3 p30 -161.02 138.01 8.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.394 -1.275 . . . . 3.31 110.333 159.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.5 m -44.06 -45.55 8.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.9 -1.5 . . . . 3.25 114.095 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 tp -53.48 -39.5 64.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.711 1.745 . . . . 4.45 115.711 -152.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG2' ' H ' ' A' ' 52' ' ' ARG . 2.6 mmt180 -62.65 -57.76 9.91 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.611 1.196 . . . . 6.26 109.62 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.726 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 38.5 t -66.99 166.45 13.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.831 -1.986 . . . . 3.04 111.208 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.227 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 21.4 t 70.65 26.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 123.332 1.539 . . . . 4.32 109.238 -169.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.17 63.58 0.3 Allowed Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 113.319 -1.764 . . . . 4.19 112.36 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.34 58.84 10.78 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 119.044 -1.55 . . . . 4.42 114.498 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.314 0.8 OUTLIER -131.43 -33.76 1.44 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.05 1.425 . . . . 3.52 108.982 -157.077 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.36 2.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 115.311 1.597 . . . . 3.64 115.311 -163.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -72.82 6.39 2.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.984 -1.086 . . . . 5.44 111.746 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.1 158.2 46.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 108.027 -1.101 . . . . 3.22 108.027 157.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.59 120.07 5.43 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 CA-C-N 120.659 1.271 . . . . 3.83 109.507 163.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.651 HD11 ' S1 ' ' A' ' 86' ' ' FES . 2.0 pp -111.46 130.31 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.048 0.758 . . . . 2.69 113.048 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.966 HG21 ' H ' ' A' ' 73' ' ' VAL . 3.9 t -142.27 116.52 4.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 107.091 -1.448 . . . . 1.87 107.091 157.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.576 ' HG3' HG12 ' A' ' 69' ' ' VAL . 20.5 ttt -119.11 136.47 54.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 118.434 -1.306 . . . . 1.65 111.334 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 68' ' ' LYS . 1.8 m -123.46 115.94 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.533 -1.284 . . . . 0.76 107.533 157.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 7' ' ' TYR . . . 50.03 -155.47 2.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.648 -0.787 . . . . 1.1 111.223 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.79 37.27 0.41 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.995 -0.603 . . . . 3.01 109.93 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.797 ' HB2' HG23 ' A' ' 65' ' ' VAL . 14.5 mmmm -103.09 -22.76 13.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.056 -0.52 . . . . 2.62 109.999 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.576 HG12 ' HG3' ' A' ' 64' ' ' MET . 3.5 m 29.06 101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.134 1.531 . . . . 1.51 115.134 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.739 ' HD2' ' HE1' ' A' ' 85' ' ' TYR . 62.7 m-85 -118.09 -158.68 0.72 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.99 0.9 . . . . 1.43 112.14 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 81' ' ' ILE . . . -147.84 40.8 0.95 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 114.38 -1.282 . . . . 1.49 110.138 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 1.006 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -64.37 -4.99 4.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.717 0.77 . . . . 1.83 110.759 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.966 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 48.89 -160.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.91 1.684 . . . . 3.06 114.308 169.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.979 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 27.1 p -139.66 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.964 1.468 . . . . 2.49 114.964 -166.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.583 ' HD3' ' OG1' ' A' ' 74' ' ' THR . 3.7 Cg_exo -77.99 76.98 4.1 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.307 2.004 . . . . 2.65 113.811 -170.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.2 -20.75 3.03 Favored Glycine 0 N--CA 1.462 0.397 0 C-N-CA 121.405 -0.426 . . . . 1.4 112.751 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.49 ' O ' ' HD3' ' A' ' 80' ' ' LYS . 18.7 mt-30 -77.99 -18.91 55.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.824 -1.547 . . . . 1.87 106.824 -172.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.741 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -47.15 -51.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 112.069 -2.332 . . . . 0.97 110.908 -177.51 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.85 ' HG2' ' NE2' ' A' ' 32' ' ' GLN . 44.7 mtmt -54.0 -51.61 63.41 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 122.833 1.301 . . . . 2.13 109.343 -167.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.23 -35.5 15.29 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.176 -1.829 . . . . 2.41 110.675 -169.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.006 HG22 ' HA ' ' A' ' 72' ' ' ASN . 46.5 mm -71.98 -13.6 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.176 -0.92 . . . . 1.23 109.126 176.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 85' ' ' TYR . 43.9 tp -56.11 -19.89 15.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.469 -0.332 . . . . 0.79 110.343 171.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.7 -22.23 1.98 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.777 0.322 . . . . 0.88 111.428 167.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.25 -44.37 95.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.431 0.634 . . . . 2.09 110.251 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.774 ' HE2' ' HZ ' ' A' ' 29' ' ' PHE . 10.1 m-30 . . . . . 0 N--CA 1.427 -1.586 0 CA-C-N 115.018 -0.992 . . . . 1.77 112.082 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' FES . . . . . 1.227 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.72 ' HG2' ' CE1' ' A' ' 7' ' ' TYR . 25.4 ttpt . . . . . 0 N--CA 1.436 -1.155 0 N-CA-C 110.106 -0.331 . . . . 4.5800000000000001 110.106 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.918 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.0 m-30 -108.5 82.69 1.72 Allowed Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 116.228 -0.442 . . . . 1.6399999999999999 110.412 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.932 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 87.1 Cg_exo -52.72 94.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.835 2.356 . . . . 1.02 111.972 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.724 ' HB ' ' CG1' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -85.11 127.7 39.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 1.52 112.054 -173.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 14.3 m -100.37 110.99 23.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.286 -0.87 . . . . 1.45 110.627 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -117.21 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.409 . . . . 2.21 110.97 -178.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.708 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 24.4 t -67.38 121.24 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.195 -0.602 . . . . 2.2400000000000002 111.611 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.0 mtm -123.82 23.11 8.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.934 -0.765 . . . . 5.1200000000000001 108.934 164.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.03 177.38 19.65 Favored Glycine 0 C--O 1.219 -0.807 0 C-N-CA 120.945 -0.645 . . . . 3.8599999999999999 112.624 -173.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.7 p -64.29 -43.89 93.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.69 0.626 . . . . 5.9699999999999998 112.69 -168.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.701 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -69.88 -55.63 9.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.43 . . . . 4.4100000000000001 111.361 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.708 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 86.6 m -66.53 -34.93 79.02 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.408 -0.36 . . . . 2.98 111.757 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 51.3 t80 -62.16 -32.16 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.909 0.484 . . . . 4.1799999999999997 111.746 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 16' ' ' ALA . 4.2 p -70.91 -18.67 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.147 0.499 . . . . 3.6499999999999999 110.818 -172.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -80.75 8.43 8.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.501 0.667 . . . . 4.79 109.769 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.78 54.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.561 -0.745 . . . . 1.8700000000000001 112.048 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.57 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -73.43 -21.08 60.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.421 -0.389 . . . . 1.46 110.673 -172.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 26' ' ' VAL . 13.6 t70 -56.93 -46.55 81.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 2.4199999999999999 111.309 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -66.88 -36.99 83.57 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.067 -0.653 . . . . 3.0299999999999998 110.353 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.542 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -72.53 -38.18 58.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.797 -0.638 . . . . 2.2599999999999998 111.182 177.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.607 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 4.6 m -66.19 -28.43 43.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 119.546 -0.862 . . . . 1.5700000000000001 109.15 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.48 -40.47 82.82 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.577 -0.527 . . . . 1.3500000000000001 109.577 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -50.96 -51.26 54.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.863 -1.062 . . . . 0.65000000000000002 108.904 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.607 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 29.8 t80 -53.65 -48.77 69.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.95 -1.023 . . . . 1.98 112.0 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -46.75 -49.48 19.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.004 -0.998 . . . . 2.8500000000000001 110.494 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -77.96 -26.79 49.02 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.676 -1.147 . . . . 2.23 110.619 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.651 ' OE1' ' HA ' ' A' ' 79' ' ' LYS . 4.6 mt-30 -60.5 -29.86 69.36 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.536 -0.757 . . . . 2.54 112.393 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.749 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 1.1 tt -48.42 -55.74 10.04 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.373 -1.714 . . . . 2.0600000000000001 106.373 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.04 -18.81 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 126.513 2.383 . . . . 4.4800000000000004 112.648 173.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.736 ' HA ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 51.71 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.398 -1.728 . . . . 3.7599999999999998 113.996 165.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -155.51 -55.64 0.09 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.581 -1.645 . . . . 4.6200000000000001 108.076 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 pt -167.53 9.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 112.728 -2.033 . . . . 5.0 108.486 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.92 -51.81 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.585 0 N-CA-C 108.981 -1.647 . . . . 4.1299999999999999 108.981 -164.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.581 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -169.72 143.04 2.6 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.546 -0.827 . . . . 4.3099999999999996 111.772 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.806 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER 18.83 -68.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 O-C-N 127.041 2.713 . . . . 2.96 115.167 161.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.624 ' H ' HG13 ' A' ' 40' ' ' VAL . 23.5 m -135.32 94.64 15.42 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 104.793 -2.299 . . . . 3.8300000000000001 104.793 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -33.06 89.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.965 3.11 . . . . 3.8300000000000001 113.608 -149.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -144.36 -65.1 0.35 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.919 -1.491 . . . . 4.2599999999999998 111.37 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' H ' ' HB3' ' A' ' 39' ' ' ASP . . . 113.49 37.41 1.32 Allowed Glycine 0 C--N 1.31 -0.89 0 N-CA-C 110.32 -1.112 . . . . 2.0099999999999998 110.32 -169.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.621 ' HD3' ' OXT' ' A' ' 85' ' ' TYR . 76.5 mtt180 -61.15 -42.26 98.23 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.876 -1.162 . . . . 3.3399999999999999 109.845 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.806 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 99.3 m-85 -84.15 136.88 33.81 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.911 -1.041 . . . . 2.0699999999999998 110.969 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.932 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 19.9 t -145.01 65.25 1.27 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.813 -1.18 . . . . 1.9099999999999999 107.813 165.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.682 HG22 HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.97 129.17 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.331 -0.85 . . . . 3.1899999999999999 111.99 -170.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -154.93 138.9 16.36 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.281 1.039 . . . . 3.3100000000000001 110.784 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.7 p -43.86 -45.42 7.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.322 -1.763 . . . . 3.25 115.488 168.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.1 tp -53.16 -41.52 65.24 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.282 1.586 . . . . 4.4500000000000002 115.282 -149.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -64.43 -57.34 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.931 0.872 . . . . 6.2599999999999998 111.053 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -66.26 170.51 5.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.835 -1.53 . . . . 3.04 111.026 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG22 ' SG ' ' A' ' 12' ' ' CYS . 5.9 t 73.14 28.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.67 1.224 . . . . 4.3200000000000003 109.175 -164.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.65 64.2 0.3 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 113.922 -1.49 . . . . 4.1900000000000004 113.371 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.49 57.49 16.31 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.319 -1.42 . . . . 4.4199999999999999 115.321 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.252 2.0 m -133.19 -33.32 1.14 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.706 1.253 . . . . 3.52 109.747 -161.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.98 -26.38 2.49 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.397 1.999 . . . . 3.6400000000000001 116.397 -163.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.72 3.38 6.54 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.316 1.416 . . . . 5.4400000000000004 111.413 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.94 158.36 50.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.245 -1.391 . . . . 3.2200000000000002 107.245 154.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.15 118.6 5.03 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-N 121.191 1.461 . . . . 3.8300000000000001 109.648 164.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.32 131.71 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.89 -0.141 . . . . 2.6899999999999999 110.867 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.689 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 6.1 t -138.71 125.93 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.891 -1.151 . . . . 1.8700000000000001 107.891 160.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.74 ' HG3' HG22 ' A' ' 69' ' ' VAL . 49.7 ttm -112.29 136.77 51.32 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 117.703 -1.599 . . . . 1.6499999999999999 109.815 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.918 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.75 114.71 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 106.649 -1.612 . . . . 0.76000000000000001 106.649 159.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.18 -145.87 1.65 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-O 122.337 0.965 . . . . 1.1000000000000001 112.596 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.53 25.88 0.31 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.379 -1.411 . . . . 3.0099999999999998 109.423 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.618 ' HD2' ' CE1' ' A' ' 7' ' ' TYR . 9.1 mmpt? -106.95 -40.82 5.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.298 -0.63 . . . . 2.6200000000000001 109.298 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.74 HG22 ' HG3' ' A' ' 64' ' ' MET . 80.1 t 46.26 99.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.502 0.927 . . . . 1.51 113.502 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.733 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -117.03 -153.21 0.52 Allowed 'General case' 0 C--O 1.246 0.906 0 CA-C-O 122.07 0.938 . . . . 1.4299999999999999 113.362 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.594 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -134.51 17.1 4.27 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.202 -1.363 . . . . 1.49 112.796 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.904 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -89.53 98.52 11.81 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.945 -0.761 . . . . 1.8300000000000001 108.945 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.618 HG13 HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -126.41 -90.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 122.181 0.991 . . . . 3.0600000000000001 112.652 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.855 HG23 ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -137.77 -66.6 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 113.504 -1.68 . . . . 2.4900000000000002 111.858 -170.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.855 ' HD3' HG23 ' A' ' 74' ' ' THR . 6.3 Cg_exo -76.84 70.87 6.36 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.648 2.232 . . . . 2.6499999999999999 114.019 -162.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 80.1 -19.55 6.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.105 -0.569 . . . . 1.3999999999999999 113.108 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.541 ' O ' HG12 ' A' ' 81' ' ' ILE . 6.2 mt-30 -73.98 -22.86 59.45 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.342 -1.725 . . . . 1.8700000000000001 106.342 -170.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 79' ' ' LYS . 13.6 m -48.7 -59.18 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 111.826 -2.443 . . . . 0.96999999999999997 111.386 -175.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.657 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 23.6 pttt -60.17 -39.49 86.62 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.783 0.801 . . . . 2.1299999999999999 110.741 -165.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.657 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -82.38 -45.27 15.07 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.75 -1.113 . . . . 2.4100000000000001 109.646 -173.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' A' ' 72' ' ' ASN . 39.5 mm -69.39 -15.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.211 -1.358 . . . . 1.23 110.155 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.518 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 53.6 tp -63.04 -37.81 88.67 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.74 -0.6 . . . . 0.79000000000000004 110.256 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.7 64.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.013 -0.736 . . . . 0.88 109.013 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 6.6 mt-10 -73.66 -34.49 64.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.871 -1.059 . . . . 2.0899999999999999 112.748 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 5.1 m-30 . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 118.951 -0.547 . . . . 1.77 112.044 -175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 3.8 tppp? . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 109.422 -0.585 . . . . 4.5800000000000001 109.422 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 1.071 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 22.5 m-85 -141.71 62.71 15.34 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 114.364 -1.289 . . . . 1.6399999999999999 110.254 -175.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD2' ' CA ' ' A' ' 66' ' ' GLY . 33.4 Cg_exo -61.48 92.81 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.534 1.489 . . . . 1.02 109.949 172.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.066 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.03 160.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 116.409 -0.36 . . . . 1.52 110.426 -168.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.806 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m -139.86 112.84 8.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 123.644 0.59 . . . . 1.45 111.343 -174.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.7 t -118.17 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.182 -0.917 . . . . 2.21 109.857 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -65.39 120.38 12.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 118.775 0.716 . . . . 2.2400000000000002 110.958 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ttt -124.3 23.05 8.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.503 -0.771 . . . . 5.1200000000000001 109.654 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -68.06 177.52 23.73 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.797 . . . . 3.8599999999999999 112.417 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -67.65 -43.8 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.078 0.399 . . . . 5.9699999999999998 112.078 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.642 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -71.29 -56.8 5.29 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.549 0.574 . . . . 4.4100000000000001 112.549 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 98.9 m -63.48 -30.53 71.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.506 -0.316 . . . . 2.98 111.572 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.575 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 56.4 t80 -59.31 -29.53 67.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.286 0.635 . . . . 4.1799999999999997 112.179 -176.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 16' ' ' ALA . 16.9 m -69.15 -18.65 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 111.91 0.337 . . . . 3.6499999999999999 111.91 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.02 13.32 2.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.807 0.337 . . . . 4.79 110.591 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.4 28.73 23.99 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.649 -0.58 . . . . 1.8700000000000001 111.649 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -72.48 -19.63 61.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.253 -0.474 . . . . 1.46 110.97 -172.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . 8.5 p-10 -55.7 -45.0 77.92 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.887 -0.325 . . . . 2.4199999999999999 110.429 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -62.61 -48.29 80.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.352 -0.539 . . . . 3.0299999999999998 110.782 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.033 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 6.6 m -65.52 -44.3 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 116.305 -0.407 . . . . 2.2599999999999998 110.526 -176.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' ASP . 15.0 m -64.17 -36.45 77.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.149 -0.62 . . . . 1.5700000000000001 110.2 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -60.18 -42.57 95.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.107 -0.637 . . . . 1.3500000000000001 109.398 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.75 -46.66 81.27 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.42 -1.264 . . . . 0.65000000000000002 108.629 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.449 ' HZ ' ' CG1' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -44.59 82.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.875 . . . . 1.98 111.425 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -54.63 -51.21 66.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.723 0.773 . . . . 2.8500000000000001 110.085 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.77 -20.75 38.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.935 -1.03 . . . . 2.23 110.653 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.597 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -62.0 -30.64 71.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.781 -0.645 . . . . 2.54 110.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.098 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.8 tt -54.69 -54.24 44.41 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.259 -1.015 . . . . 2.0600000000000001 108.259 172.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 65.77 -19.52 0.09 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.357 -2.202 . . . . 4.4800000000000004 112.493 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.698 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER 54.36 -170.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.501 -1.681 . . . . 3.7599999999999998 113.12 168.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -157.38 -49.56 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.208 -1.405 . . . . 4.6200000000000001 107.208 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -164.92 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 113.069 -1.878 . . . . 5.0 110.836 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -178.05 -61.98 0.07 OUTLIER Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 109.783 -1.327 . . . . 4.1299999999999999 109.783 -166.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.584 ' HB2' ' N ' ' A' ' 44' ' ' GLY . 38.2 m-20 -165.52 122.12 1.42 Allowed 'General case' 0 CA--C 1.475 -1.925 0 CA-C-N 113.051 -1.575 . . . . 4.3099999999999996 108.796 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.986 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 1.4 p 54.99 -71.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 O-C-N 126.775 2.547 . . . . 2.96 113.348 169.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.788 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 84.3 m -151.18 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.275 -2.662 0 CA-C-N 113.262 -1.79 . . . . 3.8300000000000001 110.256 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.819 ' HD2' HG13 ' A' ' 40' ' ' VAL . 7.1 Cg_exo -73.83 4.42 4.15 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 120.673 0.915 . . . . 3.8300000000000001 113.946 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 20.2 t70 78.09 14.12 1.56 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.294 -1.373 . . . . 4.2599999999999998 107.294 169.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.584 ' N ' ' HB2' ' A' ' 39' ' ' ASP . . . 155.07 63.58 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 114.151 -1.386 . . . . 2.0099999999999998 112.278 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 10.5 ttt180 -94.7 -64.69 1.04 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.814 -1.55 . . . . 3.3399999999999999 106.814 171.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.098 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -107.23 123.99 49.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.752 -0.658 . . . . 2.0699999999999998 112.281 171.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.459 ' C ' HG23 ' A' ' 9' ' ' ILE . 4.2 m -105.33 92.15 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.966 . . . . 1.9099999999999999 109.279 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.005 HG22 HD13 ' A' ' 9' ' ' ILE . 2.3 pp -60.18 123.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.774 -0.648 . . . . 3.1899999999999999 112.72 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.806 ' O ' ' HA ' ' A' ' 10' ' ' SER . 5.3 t70 -160.85 140.49 10.77 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.241 1.019 . . . . 3.3100000000000001 113.051 167.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t -47.51 -45.96 26.9 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 115.111 1.522 . . . . 3.25 115.111 169.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.439 ' HG ' ' OD1' ' A' ' 49' ' ' ASP . 51.6 mt -53.49 -38.12 63.38 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.254 2.316 . . . . 4.4500000000000002 117.254 -152.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.4 mmt180 -61.78 -56.82 15.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.757 1.162 . . . . 6.2599999999999998 110.18 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.699 ' H ' ' HB3' ' A' ' 10' ' ' SER . 27.4 t -65.07 165.46 11.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.327 -1.76 . . . . 3.04 109.938 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.695 HG22 ' SG ' ' A' ' 12' ' ' CYS . 10.9 t 71.26 25.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 122.93 1.347 . . . . 4.3200000000000003 108.188 -156.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.51 64.11 0.35 Allowed Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 113.583 -1.644 . . . . 4.1900000000000004 113.538 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.33 57.71 14.21 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 119.11 -1.519 . . . . 4.4199999999999999 115.3 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.67 ' HB3' HG21 ' A' ' 62' ' ' ILE 0.267 1.8 m -135.7 -32.65 0.89 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.564 1.182 . . . . 3.52 110.416 -162.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -28.64 5.66 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.477 1.658 . . . . 3.6400000000000001 115.477 -163.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.57 7.63 2.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.777 1.172 . . . . 5.4400000000000004 112.053 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.7 160.55 36.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.888 -0.782 . . . . 3.2200000000000002 108.888 164.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.89 122.18 7.09 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 N-CA-C 108.787 -1.274 . . . . 3.8300000000000001 108.787 160.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 57' ' ' CYS . 1.9 pp -110.0 133.68 54.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.875 1.065 . . . . 2.6899999999999999 113.875 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.762 HG21 ' H ' ' A' ' 73' ' ' VAL . 4.0 t -138.03 119.19 17.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.022 -1.844 . . . . 1.8700000000000001 106.022 154.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.752 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 20.9 ttt -114.36 135.34 54.19 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 120.33 -1.481 . . . . 1.6499999999999999 111.926 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.071 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -126.57 118.43 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 N-CA-C 107.635 -1.246 . . . . 0.76000000000000001 107.635 157.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.559 ' CA ' ' HD2' ' A' ' 8' ' ' PRO . . . 60.2 -169.78 7.53 Favored Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.886 -1.15 . . . . 1.1000000000000001 110.481 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.83 37.96 0.31 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.926 -1.138 . . . . 3.0099999999999998 107.926 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 54.6 mmtt -107.89 -31.21 8.1 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.892 -1.049 . . . . 2.6200000000000001 108.646 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.661 ' C ' ' HD1' ' A' ' 70' ' ' TYR . 75.7 t 47.54 113.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 114.472 1.286 . . . . 1.51 114.472 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.678 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -123.53 -170.11 2.06 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 122.615 1.197 . . . . 1.4299999999999999 112.967 -172.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.71 49.9 0.82 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 113.662 -1.608 . . . . 1.49 110.178 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.919 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -77.92 -0.41 27.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.361 1.077 . . . . 1.8300000000000001 110.062 175.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.762 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 64.33 -165.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 113.749 -1.569 . . . . 3.0600000000000001 111.65 168.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 1.033 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 64.4 p -138.58 -46.67 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 114.22 1.193 . . . . 2.4900000000000002 114.22 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.799 ' HD2' HE21 ' A' ' 77' ' ' GLN . 7.0 Cg_endo -88.29 78.58 1.33 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.895 1.73 . . . . 2.6499999999999999 113.787 -172.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.28 -23.17 2.33 Favored Glycine 0 N--CA 1.461 0.335 0 C-N-CA 121.01 -0.614 . . . . 1.3999999999999999 113.078 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.799 HE21 ' HD2' ' A' ' 75' ' ' PRO . 32.7 mt-30 -75.28 -21.12 58.76 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.413 -1.699 . . . . 1.8700000000000001 106.413 -174.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.666 HG23 ' H ' ' A' ' 79' ' ' LYS . 4.0 m -45.09 -61.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 111.478 -2.601 . . . . 0.96999999999999997 112.162 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.666 ' H ' HG23 ' A' ' 78' ' ' VAL . 43.3 mtmt -58.03 -32.03 67.57 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 122.039 0.923 . . . . 2.1299999999999999 110.657 -166.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -81.28 -50.84 9.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.53 -1.214 . . . . 2.4100000000000001 108.837 -177.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.919 ' CG2' ' HA ' ' A' ' 72' ' ' ASN . 28.8 mm -66.14 -5.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 113.549 -1.66 . . . . 1.23 110.601 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 47.0 tp -54.22 -21.67 9.58 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.508 -0.745 . . . . 0.79000000000000004 110.143 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.84 -19.66 6.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.687 -0.688 . . . . 0.88 111.352 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 70' ' ' TYR . 6.6 tp10 -69.53 -51.34 36.54 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.44 1.096 . . . . 2.0899999999999999 110.241 173.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.678 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 11.4 m-30 . . . . . 0 N--CA 1.425 -1.693 0 CA-C-N 113.673 -1.603 . . . . 1.77 112.811 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 24.2 tptp . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 108.817 -0.809 . . . . 4.5800000000000001 108.817 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 1.092 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -115.89 87.51 18.71 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.711 -1.132 . . . . 1.6399999999999999 110.916 175.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.34 96.55 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.637 2.225 . . . . 1.02 111.565 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.084 HD13 HG22 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -75.17 117.83 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.799 0.809 . . . . 1.52 110.289 -175.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.694 ' HB3' ' H ' ' A' ' 53' ' ' CYS . 7.3 m -100.14 113.02 25.35 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.139 -1.391 . . . . 1.45 110.528 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.635 HG11 HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -118.48 122.81 70.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.274 -0.875 . . . . 2.21 110.328 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.736 ' SG ' HG22 ' A' ' 54' ' ' VAL . 33.7 t -66.47 122.82 18.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.279 0.561 . . . . 2.2400000000000002 111.284 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -122.69 23.87 9.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.428 -0.805 . . . . 5.1200000000000001 109.699 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.95 178.68 20.21 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.792 -0.718 . . . . 3.8599999999999999 112.778 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -65.36 -44.85 86.38 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.462 0.541 . . . . 5.9699999999999998 112.462 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 -55.05 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.271 0.558 . . . . 4.4100000000000001 111.851 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 79.4 m -64.69 -31.08 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.537 -0.756 . . . . 2.98 111.541 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 75.6 t80 -58.35 -27.43 64.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.447 0.699 . . . . 4.1799999999999997 111.576 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.74 -20.82 26.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.058 -0.519 . . . . 3.6499999999999999 111.468 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -80.79 11.48 3.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.159 -0.338 . . . . 4.79 111.224 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.38 29.44 27.48 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.725 -0.75 . . . . 1.8700000000000001 111.954 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -71.93 -20.47 61.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.906 0.335 . . . . 1.46 111.906 -168.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 26' ' ' VAL . 27.1 t70 -57.86 -45.34 86.42 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.845 -0.342 . . . . 2.4199999999999999 110.881 -176.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -64.92 -42.52 94.64 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.609 . . . . 3.0299999999999998 111.134 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.9 m -68.91 -39.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.707 0.289 . . . . 2.2599999999999998 111.228 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.875 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . 10.7 m -65.31 -33.35 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.817 -0.753 . . . . 1.5700000000000001 110.258 175.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.58 -39.33 87.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.253 0.549 . . . . 1.3500000000000001 109.551 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 78' ' ' VAL . . . -55.08 -45.84 75.42 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.701 -1.136 . . . . 0.65000000000000002 109.443 175.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.914 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 23.1 m-85 -52.15 -50.11 62.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 123.46 0.475 . . . . 1.98 111.02 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -49.91 -50.83 44.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.53 0.681 . . . . 2.8500000000000001 111.312 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.52 -30.22 37.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.296 -0.865 . . . . 2.23 111.39 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.914 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -68.01 -19.29 64.9 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.741 -0.663 . . . . 2.54 110.313 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.04 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -54.52 -56.48 18.42 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 106.153 -1.795 . . . . 2.0600000000000001 106.153 169.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 70.16 -21.86 0.17 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.775 -2.011 . . . . 4.4800000000000004 110.909 168.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.717 HG12 HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 56.56 -176.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 112.508 -2.133 . . . . 3.7599999999999998 113.702 166.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 35' ' ' ILE . 12.9 t70 -158.68 -44.11 0.06 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.075 -1.42 . . . . 4.6200000000000001 107.748 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.5 pt -168.3 -0.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 113.226 -1.806 . . . . 5.0 111.416 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 176.77 -52.66 0.11 Allowed Glycine 0 CA--C 1.483 -1.923 0 N-CA-C 107.629 -2.188 . . . . 4.1299999999999999 107.629 -162.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.757 ' CG ' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -171.54 135.54 0.91 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.266 -1.967 . . . . 4.3099999999999996 109.732 175.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.757 HG12 ' CG ' ' A' ' 39' ' ' ASP . 7.1 p 39.06 -65.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 127.502 3.001 . . . . 2.96 114.955 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.788 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 45.0 m -150.82 -60.11 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.69 -1.595 . . . . 3.8300000000000001 110.833 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.822 ' HG2' ' HG3' ' A' ' 45' ' ' ARG . 1.1 Cg_endo -88.33 15.51 2.07 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 121.618 1.546 . . . . 3.8300000000000001 114.937 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 25.8 t70 83.38 -1.75 1.17 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.143 0.973 . . . . 4.2599999999999998 109.708 160.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.18 53.11 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.774 -1.203 . . . . 2.0099999999999998 113.566 172.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.822 ' HG3' ' HG2' ' A' ' 42' ' ' PRO . 20.0 mtt180 -72.26 -53.9 11.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.924 -0.769 . . . . 3.3399999999999999 108.924 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.04 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -128.08 120.3 27.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.552 1.167 . . . . 2.0699999999999998 113.768 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 41.9 p -114.68 106.73 14.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.818 -1.537 . . . . 1.9099999999999999 108.307 175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.084 HG22 HD13 ' A' ' 9' ' ' ILE . 2.0 pp -72.91 121.06 22.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.378 -0.828 . . . . 3.1899999999999999 112.229 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.49 141.95 15.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 122.744 1.259 . . . . 3.3100000000000001 112.225 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 21.4 m -43.92 -46.24 8.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.614 2.079 . . . . 3.25 116.614 174.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.44 -41.12 65.76 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.776 2.139 . . . . 4.4500000000000002 116.776 -147.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 12.7 tpt180 -63.39 -57.72 9.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.271 0.941 . . . . 6.2599999999999998 110.786 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.694 ' H ' ' HB3' ' A' ' 10' ' ' SER . 33.0 t -65.18 172.72 2.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.591 -1.64 . . . . 3.04 110.727 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.736 HG22 ' SG ' ' A' ' 12' ' ' CYS . 13.5 t 76.2 29.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 122.93 1.348 . . . . 4.3200000000000003 109.538 -160.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.2 61.65 0.31 Allowed Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 113.849 -1.523 . . . . 4.1900000000000004 112.555 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.97 54.98 32.38 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 119.892 -1.147 . . . . 4.4199999999999999 115.709 169.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.257 1.4 m -135.12 -32.49 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.202 1.501 . . . . 3.52 109.704 -161.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.89 -25.27 1.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.921 1.823 . . . . 3.6400000000000001 115.921 -163.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.63 8.14 1.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.563 1.074 . . . . 5.4400000000000004 111.791 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.68 161.91 27.97 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.053 -1.092 . . . . 3.2200000000000002 108.053 162.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.33 119.96 6.27 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 120.704 1.287 . . . . 3.8300000000000001 109.309 166.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.47 132.74 56.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.429 0.529 . . . . 2.6899999999999999 112.429 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.721 HG21 ' H ' ' A' ' 73' ' ' VAL . 2.5 t -138.7 119.76 16.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.446 -1.687 . . . . 1.8700000000000001 106.446 154.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.661 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 20.8 ttt -112.42 136.27 52.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 120.369 -1.457 . . . . 1.6499999999999999 110.0 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.092 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -125.26 117.15 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.413 -1.329 . . . . 0.76000000000000001 107.413 159.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 55.09 -162.3 4.72 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.146 -1.026 . . . . 1.1000000000000001 110.863 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -79.06 34.48 0.24 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.889 -0.782 . . . . 3.0099999999999998 108.889 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.663 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 70.9 mmtt -108.47 -22.18 12.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.279 -0.873 . . . . 2.6200000000000001 110.012 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 23.2 m 36.54 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 115.134 1.531 . . . . 1.51 115.134 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.789 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -116.31 -178.33 3.39 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.979 1.371 . . . . 1.4299999999999999 113.598 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.05 48.67 0.91 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 113.381 -1.736 . . . . 1.49 109.603 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.913 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -78.4 -0.89 30.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.902 0.858 . . . . 1.8300000000000001 109.191 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.721 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 63.31 -168.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 113.909 -1.496 . . . . 3.0600000000000001 111.282 171.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.863 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 13.3 p -135.74 -46.36 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 113.946 1.091 . . . . 2.4900000000000002 113.946 -169.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.744 ' HD2' HE21 ' A' ' 77' ' ' GLN . 4.5 Cg_endo -88.73 85.45 0.58 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.185 1.923 . . . . 2.6499999999999999 113.224 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.32 -27.77 2.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.17 -0.538 . . . . 1.3999999999999999 112.774 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.882 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 36.7 mt-30 -77.31 -18.62 57.33 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.064 -1.458 . . . . 1.8700000000000001 107.064 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.577 HG21 ' HB1' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -46.72 -58.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-N 112.444 -2.162 . . . . 0.96999999999999997 111.354 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.3 pttt -62.17 -38.06 87.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.426 0.631 . . . . 2.1299999999999999 111.096 -166.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.882 ' HD2' ' HA ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.85 -34.05 15.42 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.074 0.464 . . . . 2.4100000000000001 110.873 -176.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.913 HG22 ' HA ' ' A' ' 72' ' ' ASN . 47.9 mm -72.45 -10.79 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.909 -0.774 . . . . 1.23 108.909 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.974 HD12 ' HB2' ' A' ' 85' ' ' TYR . 16.7 tp -57.84 -12.97 3.55 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.462 0.705 . . . . 0.79000000000000004 110.467 171.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -25.58 6.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.08 -0.648 . . . . 0.88 110.076 163.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 5.7 mm-40 -65.49 -49.95 67.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.459 -0.791 . . . . 2.0899999999999999 110.97 169.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.974 ' HB2' HD12 ' A' ' 82' ' ' LEU . 12.6 m-30 . . . . . 0 N--CA 1.428 -1.556 0 CA-C-N 115.682 -0.69 . . . . 1.77 112.099 -172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 120.848 0.356 . . . . 4.5800000000000001 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.821 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.0 m-85 -111.85 98.73 42.82 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 116.094 -0.503 . . . . 1.6399999999999999 111.915 -172.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.909 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 80.0 Cg_exo -50.69 96.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.882 2.388 . . . . 1.02 112.19 171.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.043 HD13 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.24 115.37 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.79 0.805 . . . . 1.52 110.112 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.718 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 14.0 m -92.61 127.34 38.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.194 -1.366 . . . . 1.45 109.987 -176.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 t -114.25 126.47 71.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 2.21 112.328 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 16.3 t -64.21 115.17 4.75 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.555 0.693 . . . . 2.2400000000000002 112.138 -175.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.472 ' H ' HG22 ' A' ' 54' ' ' VAL . 84.6 mtp -129.26 24.6 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 5.1200000000000001 110.737 172.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.812 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . -65.57 176.73 14.11 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.381 -0.914 . . . . 3.8599999999999999 114.14 -167.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 t -66.17 -45.85 79.45 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.821 0.304 . . . . 5.9699999999999998 111.821 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 25.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.744 0.783 . . . . 4.4100000000000001 110.162 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 76.9 m -61.93 -35.73 79.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.312 -1.313 . . . . 2.98 112.237 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 54.0 t80 -61.66 -31.74 71.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.008 0.432 . . . . 4.1799999999999997 111.024 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.0 t -71.98 -21.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 3.6499999999999999 110.319 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 27.4 mtpp -82.8 12.92 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.925 -0.579 . . . . 4.79 111.803 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.56 32.06 14.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.151 -1.023 . . . . 1.8700000000000001 111.906 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.581 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -70.86 -20.97 62.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.635 0.235 . . . . 1.46 111.635 -170.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.585 ' O ' HG22 ' A' ' 26' ' ' VAL . 25.0 t70 -55.82 -49.58 72.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.953 0.406 . . . . 2.4199999999999999 110.144 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 2.5 mptp? -66.94 -39.62 87.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.561 -0.456 . . . . 3.0299999999999998 111.59 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.942 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 3.3 m -68.58 -41.09 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 120.888 -0.325 . . . . 2.2599999999999998 110.843 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 23' ' ' ASP . 8.0 m -64.96 -34.08 68.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.831 -0.748 . . . . 1.5700000000000001 110.003 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 62.0 t-80 -59.42 -39.4 83.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.26 0.552 . . . . 1.3500000000000001 109.805 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.673 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -54.71 -50.48 68.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.868 -1.06 . . . . 0.65000000000000002 108.725 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.858 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.2 m-85 -50.57 -47.27 57.91 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 123.877 0.736 . . . . 1.98 111.68 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 25.1 tptp -49.3 -56.32 9.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 2.8500000000000001 111.213 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -83.35 -19.67 35.71 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.268 -0.878 . . . . 2.23 111.513 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.858 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.82 -22.1 65.17 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.876 -0.602 . . . . 2.54 110.684 177.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.662 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -50.1 -59.63 3.72 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.55 -1.648 . . . . 2.0600000000000001 106.55 167.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.581 ' C ' HG13 ' A' ' 35' ' ' ILE . 4.4 pttm 68.09 -27.34 0.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 112.412 -2.177 . . . . 4.4800000000000004 111.674 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.681 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 55.55 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.24 -1.8 . . . . 3.7599999999999998 113.379 172.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 37' ' ' ILE . 14.9 t70 -155.14 -53.55 0.09 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.214 -1.402 . . . . 4.6200000000000001 107.214 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.3 pt -174.43 19.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 112.734 -2.03 . . . . 5.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.02 -70.81 0.05 OUTLIER Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 109.278 -1.529 . . . . 4.1299999999999999 109.278 -168.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.596 ' HA ' HD21 ' A' ' 33' ' ' LEU . 10.5 m-20 -165.27 119.82 1.28 Allowed 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 112.996 -1.602 . . . . 4.3099999999999996 109.293 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.951 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 7.5 p 56.11 -65.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 126.636 2.46 . . . . 2.96 114.259 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.934 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 64.8 m -164.19 -59.79 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.745 0 CA-C-N 113.236 -1.802 . . . . 3.8300000000000001 110.06 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.934 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 16.3 Cg_exo -71.3 8.51 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.715 0 N-CA-C 114.493 0.92 . . . . 3.8300000000000001 114.493 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 11.5 t70 86.56 -15.67 0.44 Allowed 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.613 -0.514 . . . . 4.2599999999999998 109.613 161.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . -170.23 47.13 0.2 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.068 -1.539 . . . . 2.0099999999999998 113.819 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -72.86 -32.44 65.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.94 0.876 . . . . 3.3399999999999999 109.382 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.951 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 49.9 m-85 -96.58 153.29 17.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.194 -1.366 . . . . 2.0699999999999998 112.386 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.909 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 31.2 t -152.8 66.72 0.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.556 -1.646 . . . . 1.9099999999999999 106.556 161.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.043 HG22 HD13 ' A' ' 9' ' ' ILE . 2.2 pp -60.09 114.67 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.475 -1.239 . . . . 3.1899999999999999 112.68 -168.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -161.15 144.53 12.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.746 1.26 . . . . 3.3100000000000001 112.738 168.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 m -42.76 -43.09 3.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.917 -1.947 . . . . 3.25 115.022 167.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.7 mt -52.21 -41.87 63.06 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 116.058 1.874 . . . . 4.4500000000000002 116.058 -147.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.54 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 24.1 mmt85 -64.71 -56.97 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.556 1.17 . . . . 6.2599999999999998 110.261 174.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 35.9 t -66.31 167.05 11.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.714 -2.039 . . . . 3.04 112.617 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' HA2' ' A' ' 14' ' ' GLY . 15.7 t 70.44 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 123.053 1.406 . . . . 4.3200000000000003 109.411 -168.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.26 64.66 0.31 Allowed Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 113.626 -1.624 . . . . 4.1900000000000004 113.129 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.08 58.02 13.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 118.719 -1.705 . . . . 4.4199999999999999 114.941 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.279 1.8 m -132.2 -31.05 1.48 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.618 1.209 . . . . 3.52 109.083 -162.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.7 -27.06 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.554 1.687 . . . . 3.6400000000000001 115.554 -163.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.24 5.03 3.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.181 1.355 . . . . 5.4400000000000004 111.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.03 158.65 45.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.078 -1.082 . . . . 3.2200000000000002 108.078 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -76.61 121.69 6.09 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.494 1.212 . . . . 3.8300000000000001 109.319 163.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.3 tt -108.34 132.14 56.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.114 -0.635 . . . . 2.6899999999999999 112.188 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.84 HG21 ' H ' ' A' ' 73' ' ' VAL . 20.9 t -137.88 118.43 16.42 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 105.686 -1.968 . . . . 1.8700000000000001 105.686 158.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.689 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 17.1 ttt -116.87 137.83 51.94 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.442 -1.411 . . . . 1.6499999999999999 110.648 -172.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.821 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -124.45 117.09 49.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 107.045 -1.465 . . . . 0.76000000000000001 107.045 155.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . 51.47 -157.52 2.9 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.527 -0.629 . . . . 1.1000000000000001 111.527 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.14 39.94 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.66 -0.867 . . . . 3.0099999999999998 108.66 170.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.633 ' HB2' HG23 ' A' ' 65' ' ' VAL . 26.0 mmmt -108.33 -26.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.478 -0.783 . . . . 2.6200000000000001 109.221 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.629 HG12 ' HG3' ' A' ' 64' ' ' MET . 9.2 m 36.01 109.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 115.138 1.533 . . . . 1.51 115.138 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.713 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.9 m-85 -118.86 -169.88 1.81 Allowed 'General case' 0 C--O 1.248 0.98 0 CA-C-O 122.86 1.314 . . . . 1.4299999999999999 113.003 -173.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.82 46.45 0.8 Allowed Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 113.55 -1.659 . . . . 1.49 109.955 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.932 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.78 -0.58 21.52 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.981 0.896 . . . . 1.8300000000000001 110.049 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.84 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 63.22 -165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 114.12 -1.4 . . . . 3.0600000000000001 112.679 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.942 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.1 p -137.56 -45.13 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 113.604 0.965 . . . . 2.4900000000000002 113.604 -168.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.579 ' CD ' ' H ' ' A' ' 74' ' ' THR . 83.5 Cg_endo -88.68 77.56 1.34 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 121.845 1.697 . . . . 2.6499999999999999 113.705 -171.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.92 -24.26 2.87 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.171 -0.538 . . . . 1.3999999999999999 113.031 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.645 ' NE2' HG11 ' A' ' 73' ' ' VAL . 32.8 mt-30 -75.24 -20.9 58.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.565 -1.643 . . . . 1.8700000000000001 106.565 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.726 ' HB ' HE21 ' A' ' 32' ' ' GLN . 2.7 m -43.58 -56.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 111.559 -2.564 . . . . 0.96999999999999997 112.025 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.755 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.2 mtmt -56.73 -42.13 78.71 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 122.181 0.991 . . . . 2.1299999999999999 110.003 -167.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -42.43 13.94 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.34 -1.3 . . . . 2.4100000000000001 109.812 -172.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.932 HG22 ' HA ' ' A' ' 72' ' ' ASN . 41.3 mm -67.99 -13.78 17.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.694 -1.139 . . . . 1.23 109.29 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.944 HD12 ' HB2' ' A' ' 85' ' ' TYR . 27.2 tp -59.56 -13.42 9.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.657 0.783 . . . . 0.79000000000000004 110.592 170.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.62 -26.27 8.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.255 -0.578 . . . . 0.88 109.963 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 8.8 mm-40 -62.79 -51.99 64.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.0899999999999999 109.745 169.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.944 ' HB2' HD12 ' A' ' 82' ' ' LEU . 8.9 m-30 . . . . . 0 N--CA 1.424 -1.735 0 CA-C-N 114.812 -1.086 . . . . 1.77 112.259 -171.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 122.618 1.199 . . . . 4.5800000000000001 110.739 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.768 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 7.3 m-85 -55.64 113.08 5.02 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.412 -1.722 . . . . 1.6399999999999999 114.365 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.781 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 72.5 Cg_exo -56.07 90.96 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.1 2.533 . . . . 1.02 111.919 166.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.799 HD13 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.87 119.12 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.675 0.75 . . . . 1.52 110.661 -177.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 2.6 m -100.46 114.44 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.606 -1.179 . . . . 1.45 111.291 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.8 t -117.98 122.88 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 2.21 110.85 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 25.1 t -67.61 121.2 15.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.28 -0.568 . . . . 2.2400000000000002 111.553 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.8 mtp -124.61 23.41 8.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.63 -0.714 . . . . 5.1200000000000001 109.584 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.67 179.61 12.47 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.178 -0.534 . . . . 3.8599999999999999 112.998 -174.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -64.25 -45.42 88.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.069 0.396 . . . . 5.9699999999999998 112.069 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -70.97 -56.41 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.078 0.466 . . . . 4.4100000000000001 112.178 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.697 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.4 m -66.28 -33.79 76.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.91 -0.587 . . . . 2.98 111.993 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -60.6 -29.86 69.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.575 0.584 . . . . 4.1799999999999997 112.575 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 16' ' ' ALA . 18.2 m -69.43 -18.95 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.771 0.32 . . . . 3.6499999999999999 111.526 -171.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -80.57 12.88 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.541 -0.299 . . . . 4.79 110.923 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.25 29.04 26.19 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 121.114 -0.565 . . . . 1.8700000000000001 111.98 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.1 -20.67 61.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.493 -0.353 . . . . 1.46 110.862 -172.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 26' ' ' VAL . 24.8 t70 -53.99 -50.42 66.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 2.4199999999999999 110.759 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -66.87 -40.51 87.86 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.304 -0.559 . . . . 3.0299999999999998 111.152 -172.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.877 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 1.9 m -69.45 -42.71 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.451 -0.34 . . . . 2.2599999999999998 110.655 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 23' ' ' ASP . 17.6 m -66.15 -29.0 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 119.522 -0.871 . . . . 1.5700000000000001 109.99 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -58.7 -41.2 85.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.137 0.494 . . . . 1.3500000000000001 109.747 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -54.84 -46.04 74.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.848 -1.069 . . . . 0.65000000000000002 109.707 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -49.86 65.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.581 . . . . 1.98 110.411 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -51.9 -50.13 61.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 2.8500000000000001 111.547 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -79.96 -25.82 40.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.553 -0.749 . . . . 2.23 110.982 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.679 ' NE2' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -61.82 -34.84 76.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.411 -0.589 . . . . 2.54 109.411 175.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.773 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -45.29 -58.74 3.08 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 107.012 -1.477 . . . . 2.0600000000000001 107.012 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 66.04 -24.77 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.729 -2.032 . . . . 4.4800000000000004 112.093 171.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.719 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.95 -174.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.477 -1.692 . . . . 3.7599999999999998 113.762 168.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.572 ' O ' HG23 ' A' ' 37' ' ' ILE . 11.0 t70 -156.0 -48.51 0.08 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.077 -1.419 . . . . 4.6200000000000001 107.497 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 36' ' ' ASP . 1.4 pt -172.09 16.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-N 113.35 -1.75 . . . . 5.0 110.751 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -176.38 -66.94 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.883 -1.287 . . . . 4.1299999999999999 109.883 -169.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 18.8 m-20 -164.81 117.46 1.25 Allowed 'General case' 0 CA--C 1.484 -1.583 0 CA-C-N 113.268 -1.466 . . . . 4.3099999999999996 110.296 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.956 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.4 p 57.19 -64.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 126.882 2.613 . . . . 2.96 113.592 171.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.928 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 90.6 m -157.04 -60.45 0.02 OUTLIER Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 113.272 -1.785 . . . . 3.8300000000000001 110.867 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.928 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 13.8 Cg_exo -70.94 2.18 4.46 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 120.426 0.751 . . . . 3.8300000000000001 113.449 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 4.4 t70 82.55 4.29 1.08 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-O 123.404 1.574 . . . . 4.2599999999999998 107.687 167.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 168.47 63.29 0.03 OUTLIER Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 112.539 -2.119 . . . . 2.0099999999999998 110.225 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.639 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 18.7 tpp85 -93.12 -34.63 13.57 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.296 -1.742 . . . . 3.3399999999999999 106.296 166.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.956 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 25.1 m-85 -87.9 152.59 21.97 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 110.826 -2.897 . . . . 2.0699999999999998 110.567 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.781 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 54.1 m -153.55 68.67 0.79 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.618 -1.252 . . . . 1.9099999999999999 107.618 163.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.799 HG22 HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -69.9 122.62 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.299 -0.864 . . . . 3.1899999999999999 112.272 -168.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.722 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.0 p30 -156.24 139.11 15.28 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.345 1.069 . . . . 3.3100000000000001 111.219 164.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 19.9 p -43.61 -46.13 7.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.616 -1.629 . . . . 3.25 115.206 169.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.91 -39.52 65.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.869 1.804 . . . . 4.4500000000000002 115.869 -151.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.1 -57.27 11.15 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.085 0.945 . . . . 6.2599999999999998 109.88 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.691 ' O ' HG22 ' A' ' 54' ' ' VAL . 34.3 t -65.6 167.44 8.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 3.04 109.731 173.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 53' ' ' CYS . 1.9 m 72.34 26.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 125.398 1.479 . . . . 4.3200000000000003 110.129 -159.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.21 65.2 0.26 Allowed Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 113.665 -1.607 . . . . 4.1900000000000004 112.995 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 57.28 15.49 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 119.492 -1.337 . . . . 4.4199999999999999 115.235 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.97 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.293 1.8 m -134.48 -32.55 1.02 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.712 1.256 . . . . 3.52 109.943 -162.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.65 2.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.282 1.956 . . . . 3.6400000000000001 116.282 -160.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 1.2 pp -74.37 5.16 4.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.425 1.466 . . . . 5.4400000000000004 112.101 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.46 159.46 45.71 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.264 -1.013 . . . . 3.2200000000000002 108.264 159.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.54 119.66 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 120.372 1.168 . . . . 3.8300000000000001 109.869 161.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.97 HG13 ' HB3' ' A' ' 57' ' ' CYS . 42.8 mm -110.98 134.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.609 0.226 . . . . 2.6899999999999999 111.609 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.409 HG12 ' OH ' ' A' ' 85' ' ' TYR . 11.7 t -136.52 123.0 30.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 107.503 -1.295 . . . . 1.8700000000000001 107.503 163.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 45.5 ttm -114.49 138.0 51.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.002 -1.686 . . . . 1.6499999999999999 111.313 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -125.01 115.67 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.424 -1.324 . . . . 0.76000000000000001 107.424 158.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.519 ' CA ' ' HD2' ' A' ' 8' ' ' PRO . . . 46.37 -144.35 4.14 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-O 122.598 1.11 . . . . 1.1000000000000001 112.67 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -82.8 27.69 0.52 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 113.369 -1.415 . . . . 3.0099999999999998 109.462 176.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.773 ' HB2' HG23 ' A' ' 65' ' ' VAL . 14.3 mmmm -107.26 -24.19 11.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.875 -0.602 . . . . 2.6200000000000001 110.659 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.9 m 33.95 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.281 0.988 . . . . 1.51 113.484 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.68 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -99.53 -168.83 1.66 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.469 1.604 . . . . 1.4299999999999999 114.247 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 73' ' ' VAL . . . -134.89 57.27 0.7 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.001 -1.909 . . . . 1.49 110.093 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.624 ' HA ' HG21 ' A' ' 81' ' ' ILE . 44.5 t-20 -86.37 39.64 0.84 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 123.17 1.462 . . . . 1.8300000000000001 109.053 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.882 HG21 ' HB2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER 47.78 -161.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 112.684 -2.053 . . . . 3.0600000000000001 113.634 155.02 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.877 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.4 p -134.71 -45.58 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 113.016 0.747 . . . . 2.4900000000000002 113.016 173.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -75.1 -85.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 121.87 1.714 . . . . 2.6499999999999999 114.367 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.24 0.15 5.97 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.748 -0.739 . . . . 1.3999999999999999 112.106 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.882 ' HB2' HG21 ' A' ' 73' ' ' VAL . 9.9 mt-30 -81.26 -13.47 58.45 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 106.382 -1.711 . . . . 1.8700000000000001 106.382 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.679 ' HB ' ' NE2' ' A' ' 32' ' ' GLN . 2.7 m -51.71 -46.92 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 111.988 -2.369 . . . . 0.96999999999999997 109.904 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 34.2 mttm -57.28 -44.23 83.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.123 -1.399 . . . . 2.1299999999999999 109.353 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -77.85 -42.49 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.599 -1.637 . . . . 2.4100000000000001 109.755 -175.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.658 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 33.5 mm -68.4 -17.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.616 -0.72 . . . . 1.23 110.191 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.684 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 9.6 tp -57.92 -38.32 75.66 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.545 -0.722 . . . . 0.79000000000000004 110.463 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -33.5 69.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.37 0.605 . . . . 0.88 109.483 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 3.3 mm-40 -68.24 -30.84 69.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.964 -1.017 . . . . 2.0899999999999999 111.857 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.68 ' CE1' ' HD2' ' A' ' 70' ' ' TYR . 2.9 m-30 . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 118.801 -0.619 . . . . 1.77 111.318 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 112.804 0.668 . . . . 4.5800000000000001 112.804 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.661 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 11.2 m-85 -43.0 107.75 0.58 Allowed Pre-proline 0 N--CA 1.445 -0.713 0 C-N-CA 124.604 1.162 . . . . 1.6399999999999999 112.807 175.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' SER . 75.1 Cg_exo -56.66 93.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.813 2.342 . . . . 1.02 111.284 171.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.802 ' HB ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -81.3 121.89 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 121.858 0.837 . . . . 1.52 110.405 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.743 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.7 m -105.38 127.11 52.8 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.541 -1.209 . . . . 1.45 111.203 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.1 t -117.91 123.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 2.21 112.016 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.704 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 30.0 t -67.16 124.33 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.22 0.533 . . . . 2.2400000000000002 111.315 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.9 mmm -120.5 23.1 11.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.545 -0.752 . . . . 5.1200000000000001 109.278 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.55 177.89 25.03 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.608 -0.724 . . . . 3.8599999999999999 112.528 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 19' ' ' VAL . 17.3 m -67.45 -45.41 76.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.032 0.382 . . . . 5.9699999999999998 112.032 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 -56.01 7.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 4.4100000000000001 112.267 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.704 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 74.6 m -64.59 -32.91 74.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 2.98 111.105 -173.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 68.2 t80 -60.52 -28.63 68.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.961 -0.563 . . . . 4.1799999999999997 111.774 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 15' ' ' THR . 60.9 t -68.87 -22.11 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.131 0.491 . . . . 3.6499999999999999 110.921 -173.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -81.94 13.34 3.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.208 -0.451 . . . . 4.79 111.329 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 25' ' ' VAL . . . 87.07 30.29 20.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.366 -0.921 . . . . 1.8700000000000001 111.766 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -70.68 -21.58 62.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.463 -0.199 . . . . 1.46 110.463 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.03 -54.6 45.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.331 -0.395 . . . . 2.4199999999999999 110.208 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.562 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 3.0299999999999998 109.621 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.009 HG13 ' H ' ' A' ' 74' ' ' THR . 54.6 t -59.21 -57.65 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 115.649 -0.705 . . . . 2.2599999999999998 109.587 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.33 -30.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 120.271 -0.571 . . . . 1.5700000000000001 109.647 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -59.26 -43.5 92.48 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.128 -0.487 . . . . 1.3500000000000001 110.253 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.431 ' HB1' HG21 ' A' ' 78' ' ' VAL . . . -54.69 -46.0 74.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.134 -0.939 . . . . 0.65000000000000002 109.229 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.674 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -55.31 -53.36 57.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.065 -0.97 . . . . 1.98 110.087 175.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -48.83 -47.48 42.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.321 -0.854 . . . . 2.8500000000000001 110.757 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.41 -34.37 25.53 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.521 -0.763 . . . . 2.23 111.932 -174.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.728 ' NE2' ' HB2' ' A' ' 82' ' ' LEU . 1.9 pt20 -63.17 -25.73 68.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.249 -0.649 . . . . 2.54 109.249 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.73 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -57.72 -60.43 3.7 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.323 -1.362 . . . . 2.0600000000000001 107.323 173.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.657 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 68.01 -20.83 0.13 Allowed 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 125.503 1.752 . . . . 4.4800000000000004 110.578 172.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.73 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 58.18 126.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.709 -2.042 . . . . 3.7599999999999998 113.243 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.616 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 11.1 t70 -86.72 -45.94 10.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 112.284 -2.235 . . . . 4.6200000000000001 107.741 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' A' ' 43' ' ' ASP . 2.0 pt -168.4 -1.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 112.93 -1.941 . . . . 5.0 110.923 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 173.09 -32.74 0.11 Allowed Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 110.774 -0.93 . . . . 4.1299999999999999 110.774 -163.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.715 ' HA ' ' HE1' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -145.17 -162.92 1.6 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.095 -1.052 . . . . 4.3099999999999996 110.883 -169.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.69 HG13 ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -64.61 -30.18 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-O 123.865 1.793 . . . . 2.96 107.531 177.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.723 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 65.4 m -168.45 -64.32 0.01 OUTLIER Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 110.026 -3.261 . . . . 3.8300000000000001 111.182 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 7.1 Cg_exo -73.81 -6.64 18.93 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 121.289 1.326 . . . . 3.8300000000000001 115.445 -164.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.617 ' H ' ' CB ' ' A' ' 39' ' ' ASP . 26.0 t70 74.59 16.04 3.24 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 122.759 1.266 . . . . 4.2599999999999998 107.586 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.55 66.91 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.41 -1.723 . . . . 2.0099999999999998 111.26 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.715 ' HB3' ' OD1' ' A' ' 39' ' ' ASP . 13.7 tpt180 -132.93 -55.72 0.93 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.885 -1.154 . . . . 3.3399999999999999 107.885 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.715 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.91 146.41 27.39 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.054 -1.43 . . . . 2.0699999999999998 110.364 176.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.481 ' H ' HG22 ' A' ' 9' ' ' ILE . 52.9 m -154.57 96.85 1.94 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.215 -0.661 . . . . 1.9099999999999999 109.215 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -87.11 137.3 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.071 0.767 . . . . 3.1899999999999999 113.071 -167.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.01 138.02 12.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.968 -1.014 . . . . 3.3100000000000001 110.787 158.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.5 m -45.9 -45.34 15.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.11 -1.405 . . . . 3.25 114.323 165.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.69 -39.59 65.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.14 1.534 . . . . 4.4500000000000002 115.14 -154.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -62.36 -57.13 12.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.476 1.131 . . . . 6.2599999999999998 109.694 176.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 22.5 t -66.26 167.62 10.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.59 -2.095 . . . . 3.04 111.208 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 53' ' ' CYS . 1.6 m 70.27 25.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 125.883 1.673 . . . . 4.3200000000000003 109.351 -160.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.29 65.77 0.25 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 113.479 -1.692 . . . . 4.1900000000000004 112.49 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.88 56.3 17.26 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 119.681 -1.247 . . . . 4.4199999999999999 115.801 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.616 ' HB2' HG13 ' A' ' 62' ' ' ILE . 1.9 m -136.17 -31.54 0.9 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.46 -0.941 . . . . 3.52 108.46 -170.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.09 -25.94 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.883 1.809 . . . . 3.6400000000000001 115.883 -163.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.2 7.52 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.81 1.186 . . . . 5.4400000000000004 111.841 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.45 160.46 37.8 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.229 -1.026 . . . . 3.2200000000000002 108.229 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.93 119.33 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 120.742 1.301 . . . . 3.8300000000000001 108.822 165.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.616 HG13 ' HB2' ' A' ' 57' ' ' CYS . 49.2 mm -111.51 130.94 64.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 114.265 1.209 . . . . 2.6899999999999999 114.265 -172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 72' ' ' ASN . 14.5 p -144.2 122.19 6.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.3 -1.37 . . . . 1.8700000000000001 107.3 147.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.76 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 65.6 ttp -111.19 137.78 48.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.759 -1.213 . . . . 1.6499999999999999 109.727 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.802 HG12 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.77 114.23 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 N-CA-C 107.015 -1.476 . . . . 0.76000000000000001 107.015 167.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 48.87 -152.88 2.55 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 122.342 0.968 . . . . 1.1000000000000001 111.869 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -78.6 37.26 0.28 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.882 -1.159 . . . . 3.0099999999999998 109.266 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.76 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 29.8 mmmt -113.68 -26.29 8.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.035 -0.529 . . . . 2.6200000000000001 111.532 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 30.4 m 38.22 108.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 115.205 1.557 . . . . 1.51 115.205 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.76 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 2.8 m-85 -122.42 -170.74 2.13 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.448 1.118 . . . . 1.4299999999999999 113.352 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.08 21.85 5.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 113.832 -1.531 . . . . 1.49 111.293 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.687 ' HB2' HG22 ' A' ' 81' ' ' ILE . 2.7 t30 -74.22 92.73 2.26 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.862 -0.422 . . . . 1.8300000000000001 109.862 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -172.37 -167.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 122.882 0.473 . . . . 3.0600000000000001 111.429 177.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 1.009 ' H ' HG13 ' A' ' 25' ' ' VAL . 41.0 p 50.54 104.08 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 C-N-CA 125.204 1.402 . . . . 2.4900000000000002 112.266 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.763 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 73.6 Cg_exo -23.47 89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 1 C-N-CA 125.456 4.104 . . . . 2.6499999999999999 113.28 -174.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 80' ' ' LYS . . . 148.11 -61.23 0.44 Allowed Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.974 -1.012 . . . . 1.3999999999999999 112.572 -171.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.614 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 5.0 mt-30 -76.26 -30.54 57.89 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.193 -1.41 . . . . 1.8700000000000001 107.193 -166.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.518 HG13 ' CA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -48.24 -52.05 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 112.41 -2.177 . . . . 0.96999999999999997 111.132 -175.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 36.6 mtmt -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.647 1.213 . . . . 2.1299999999999999 108.523 -166.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -78.89 -42.16 27.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.173 -1.83 . . . . 2.4100000000000001 110.922 -173.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.687 HG22 ' HB2' ' A' ' 72' ' ' ASN . 33.2 mm -72.57 -15.34 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.157 0.503 . . . . 1.23 109.926 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.728 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 48.0 tp -60.99 -38.58 86.51 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.069 -0.395 . . . . 0.79000000000000004 110.348 169.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -31.96 67.48 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 121.779 0.799 . . . . 0.88 108.86 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -73.39 -31.62 63.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.753 -1.112 . . . . 2.0899999999999999 111.354 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.727 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 2.2 m-30 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 119.489 -0.291 . . . . 1.77 111.162 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.52 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 15.7 tppt? . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 109.337 -0.616 . . . . 4.5800000000000001 109.337 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.653 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 15.1 m-85 -129.59 80.58 71.53 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-O 120.934 0.397 . . . . 1.6399999999999999 109.974 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 82.0 Cg_exo -50.54 107.25 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.115 2.543 . . . . 1.02 112.09 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.957 HD11 HG22 ' A' ' 48' ' ' ILE . 13.1 pt -81.59 130.55 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 112.092 0.405 . . . . 1.52 112.092 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.5 p -94.32 132.06 39.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.178 -0.675 . . . . 1.45 109.178 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.09 117.85 56.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.167 -0.47 . . . . 2.21 110.63 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 1.042 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -69.96 121.85 18.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 2.2400000000000002 111.9 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.8 mmm -121.64 20.3 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.968 -1.123 . . . . 5.1200000000000001 107.968 163.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 179.32 31.15 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.557 -1.201 . . . . 3.8599999999999999 113.172 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 19' ' ' VAL . 8.1 m -68.93 -44.43 73.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.079 0.4 . . . . 5.9699999999999998 112.079 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -58.16 4.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.025 0.75 . . . . 4.4100000000000001 113.025 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 1.042 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 88.8 m -65.31 -33.91 77.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 2.98 111.012 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -60.69 -31.68 70.93 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.904 0.383 . . . . 4.1799999999999997 111.086 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 15' ' ' THR . 57.5 t -72.54 -25.09 22.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.391 0.615 . . . . 3.6499999999999999 110.054 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -85.23 9.38 15.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.613 -0.722 . . . . 4.79 110.894 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.04 32.57 17.15 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.021 -1.085 . . . . 1.8700000000000001 112.466 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.512 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -71.97 -20.81 61.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.849 0.315 . . . . 1.46 111.849 -171.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 26' ' ' VAL . 2.4 p-10 -62.48 -40.84 97.96 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.053 -0.659 . . . . 2.4199999999999999 109.74 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 11.1 mptt -66.78 -36.51 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.044 -0.724 . . . . 3.0299999999999998 109.044 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.039 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 76.7 t -55.78 -54.78 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 CA-C-N 115.057 -0.974 . . . . 2.2599999999999998 109.415 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 23' ' ' ASP . 15.3 m -63.16 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.115 -0.634 . . . . 1.5700000000000001 110.902 -174.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -60.66 -47.58 85.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.733 -0.787 . . . . 1.3500000000000001 109.955 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.611 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.59 -46.24 80.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.236 -0.893 . . . . 0.65000000000000002 108.613 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.872 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.0 t80 -54.49 -48.49 71.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 124.218 0.949 . . . . 1.98 110.146 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -49.11 -54.93 13.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.717 -1.129 . . . . 2.8500000000000001 111.297 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 -18.87 27.51 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.287 -0.87 . . . . 2.23 111.717 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.872 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.98 -21.17 65.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.573 -0.528 . . . . 2.54 109.573 173.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.796 HD22 HG12 ' A' ' 35' ' ' ILE . 1.2 tt -48.6 -59.88 3.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.291 -1.744 . . . . 2.0600000000000001 106.291 168.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.667 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 65.61 -25.45 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.241 2.213 . . . . 4.4800000000000004 112.186 171.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.796 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 57.78 -174.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 113.073 -1.876 . . . . 3.7599999999999998 113.74 166.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 37' ' ' ILE . 12.4 t70 -146.89 -53.2 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 106.166 -1.791 . . . . 4.6200000000000001 106.166 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.648 HG13 ' OD1' ' A' ' 43' ' ' ASP . 1.2 pt -171.63 21.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 113.612 -1.631 . . . . 5.0 109.718 172.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -165.52 -67.07 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 109.464 -1.454 . . . . 4.1299999999999999 109.464 -174.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.853 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 18.5 m-20 -170.39 116.72 0.51 Allowed 'General case' 0 CA--C 1.485 -1.525 0 CA-C-N 113.602 -1.299 . . . . 4.3099999999999996 110.156 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.972 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.8 p 58.0 -64.23 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 O-C-N 126.679 2.487 . . . . 2.96 113.057 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.628 ' OG1' ' HD3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -159.33 -56.15 0.02 OUTLIER Pre-proline 0 C--N 1.276 -2.621 0 CA-C-N 113.38 -1.736 . . . . 3.8300000000000001 111.966 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.698 ' HD2' HG13 ' A' ' 40' ' ' VAL . 13.1 Cg_exo -72.11 -3.63 13.64 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 CA-C-N 119.48 0.85 . . . . 3.8300000000000001 112.81 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.853 ' HA ' ' H ' ' A' ' 39' ' ' ASP . 73.0 m-20 75.34 19.05 2.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 122.457 1.122 . . . . 4.2599999999999998 108.96 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' N ' ' HB2' ' A' ' 39' ' ' ASP . . . 171.7 39.15 0.03 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 CA-C-N 112.508 -2.133 . . . . 2.0099999999999998 110.949 166.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.649 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 22.1 ttt180 -74.4 -34.64 63.33 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.533 -1.654 . . . . 3.3399999999999999 106.533 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.972 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 29.1 m-85 -88.82 149.75 23.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 112.241 -2.254 . . . . 2.0699999999999998 110.396 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 15.2 m -168.45 99.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.76 0.424 . . . . 1.9099999999999999 110.018 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.957 HG22 HD11 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -66.31 136.7 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.919 1.081 . . . . 3.1899999999999999 113.919 -168.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -160.08 135.75 8.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.626 1.203 . . . . 3.3100000000000001 113.023 154.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -46.57 -41.53 14.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.026 1.73 . . . . 3.25 114.61 160.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -50.87 -30.24 14.01 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.959 1.466 . . . . 4.4500000000000002 114.959 -158.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 8.1 mmt180 -54.91 -47.05 74.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.008 0.433 . . . . 6.2599999999999998 111.108 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.3 t -58.0 160.2 5.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.188 -0.915 . . . . 3.04 113.439 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 14.2 t 67.51 24.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.55 0 CA-C-O 123.139 1.447 . . . . 4.3200000000000003 108.353 -164.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.88 64.49 0.33 Allowed Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 113.349 -1.75 . . . . 4.1900000000000004 112.479 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.63 57.99 14.06 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 118.839 -1.648 . . . . 4.4199999999999999 115.08 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.887 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.253 5.6 m -132.27 -35.28 1.19 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 1.411 . . . . 3.52 113.072 -162.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.72 -30.76 23.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.694 1.739 . . . . 3.6400000000000001 115.694 -164.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.0 mt -78.37 5.37 10.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.014 1.279 . . . . 5.4400000000000004 112.793 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 159.94 43.15 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 122.549 0.34 . . . . 3.2200000000000002 110.479 170.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.9 124.23 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.531 -1.373 . . . . 3.8300000000000001 108.531 153.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.887 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.5 mm -106.82 129.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.935 -1.106 . . . . 2.6899999999999999 113.054 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.25 119.37 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.054 -1.462 . . . . 1.8700000000000001 107.054 158.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.559 ' HG3' HG22 ' A' ' 69' ' ' VAL . 39.0 ttm -114.2 141.61 47.31 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.911 -1.118 . . . . 1.6499999999999999 111.734 -170.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.927 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.06 112.85 40.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.286 -1.746 . . . . 0.76000000000000001 106.286 158.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 40.84 -141.82 0.9 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-O 122.507 1.06 . . . . 1.1000000000000001 113.363 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -79.38 28.57 0.24 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.324 -1.438 . . . . 3.0099999999999998 109.84 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.927 ' HB2' HG23 ' A' ' 65' ' ' VAL . 10.8 mmmm -100.59 -47.88 4.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.193 -0.669 . . . . 2.6200000000000001 109.193 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' A' ' 64' ' ' MET . 91.1 t 48.56 116.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 114.225 1.194 . . . . 1.51 114.225 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 62.8 m-85 -138.4 -157.84 0.81 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.099 0.952 . . . . 1.4299999999999999 113.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -135.07 39.02 1.74 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.151 -1.386 . . . . 1.49 110.0 171.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.826 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 6.0 t-20 -58.42 110.5 0.98 Allowed 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.457 -0.942 . . . . 1.8300000000000001 108.457 173.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.498 ' HB ' ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -100.91 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.247 -1.342 . . . . 3.0600000000000001 114.532 -157.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 1.039 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 2.2 t -143.09 -48.0 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 115.24 1.57 . . . . 2.4900000000000002 115.24 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD3' ' H ' ' A' ' 74' ' ' THR . 2.3 Cg_endo -80.68 64.0 8.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.939 1.759 . . . . 2.6499999999999999 113.484 -168.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.544 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 75.8 -12.22 9.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.217 -0.516 . . . . 1.3999999999999999 112.976 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.646 ' HA ' ' CD ' ' A' ' 80' ' ' LYS . 30.0 mt-30 -75.11 -28.8 60.37 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 106.944 -1.502 . . . . 1.8700000000000001 106.944 -174.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.65 ' HB ' HE21 ' A' ' 32' ' ' GLN . 0.0 OUTLIER -51.23 -55.08 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 112.04 -2.346 . . . . 0.96999999999999997 112.561 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 18.8 pttp -60.07 -25.67 65.57 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 121.884 0.85 . . . . 2.1299999999999999 110.571 -168.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.646 ' CD ' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -80.21 -50.81 9.73 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.936 -1.029 . . . . 2.4100000000000001 109.082 178.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.806 ' HB ' HD22 ' A' ' 72' ' ' ASN . 30.0 mm -60.05 -16.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.186 -1.37 . . . . 1.23 109.871 172.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.689 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 63.9 tp -61.36 -40.67 95.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.881 0.372 . . . . 0.79000000000000004 110.13 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.25 68.68 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.701 0.762 . . . . 0.88 109.336 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 15.4 mt-10 -73.92 -24.4 59.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.479 -1.237 . . . . 2.0899999999999999 111.959 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.826 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.5 m-30 . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 118.485 -0.769 . . . . 1.77 112.34 -172.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 16.7 tppt? . . . . . 0 N--CA 1.437 -1.11 0 CA-C-O 121.152 0.501 . . . . 4.5800000000000001 109.75 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.535 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 4.6 m-85 -107.6 93.99 11.16 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.831 -0.622 . . . . 1.6399999999999999 110.776 172.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 38.5 Cg_exo -63.84 94.45 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.304 2.003 . . . . 1.02 110.717 168.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.966 HG12 ' HA ' ' A' ' 48' ' ' ILE . 1.2 pt -79.08 172.47 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 112.182 0.438 . . . . 1.52 112.182 -168.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.928 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 95.0 p -146.63 117.91 7.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.631 -0.713 . . . . 1.45 111.648 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.33 124.97 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.162 -0.926 . . . . 2.21 110.296 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 31.8 t -66.19 120.37 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.486 0.66 . . . . 2.2400000000000002 110.954 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.2 mmt -122.57 23.11 9.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.184 -1.043 . . . . 5.1200000000000001 108.184 170.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.71 179.47 17.16 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.924 -1.035 . . . . 3.8599999999999999 113.314 -173.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.0 t -65.89 -45.56 81.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.106 0.41 . . . . 5.9699999999999998 112.106 -175.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.87 -56.98 4.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.454 0.538 . . . . 4.4100000000000001 112.454 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 71.7 m -65.72 -34.16 77.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.618 -0.719 . . . . 2.98 111.93 -170.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.29 -27.69 68.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.119 0.568 . . . . 4.1799999999999997 112.076 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 15' ' ' THR . 86.8 t -67.71 -21.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 122.78 0.432 . . . . 3.6499999999999999 111.711 -168.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -80.99 12.15 3.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.949 -0.47 . . . . 4.79 111.806 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.09 28.48 30.89 Favored Glycine 0 C--O 1.24 0.497 0 C-N-CA 120.986 -0.626 . . . . 1.8700000000000001 111.552 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.528 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.39 -21.74 61.23 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.105 -0.548 . . . . 1.46 111.548 -168.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.51 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 t70 -55.63 -48.1 75.51 Favored 'General case' 0 C--O 1.211 -0.937 0 C-N-CA 120.393 -0.523 . . . . 2.4199999999999999 111.057 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -67.35 -36.17 80.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.822 -0.751 . . . . 3.0299999999999998 111.459 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.637 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.97 -44.84 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 121.118 -0.233 . . . . 2.2599999999999998 110.647 176.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 23' ' ' ASP . 17.9 m -68.59 -19.06 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.975 -0.69 . . . . 1.5700000000000001 109.965 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.472 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 53.9 t-80 -59.64 -42.54 92.99 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.588 0.709 . . . . 1.3500000000000001 109.158 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -51.97 -46.35 64.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.085 -1.416 . . . . 0.65000000000000002 109.541 173.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.854 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 1.4 t80 -57.38 -48.26 79.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.974 -0.557 . . . . 1.98 110.549 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 27' ' ' HIS . 60.8 mttp -47.04 -51.17 18.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.319 -0.855 . . . . 2.8500000000000001 110.884 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.13 -19.97 24.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.078 -0.964 . . . . 2.23 111.367 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.854 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.33 -19.42 65.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.531 -0.544 . . . . 2.54 109.531 176.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.055 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -49.39 -59.52 3.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 106.658 -1.608 . . . . 2.0600000000000001 106.658 168.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.786 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.19 -19.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 126.42 2.325 . . . . 4.4800000000000004 113.387 169.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.673 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 50.93 -171.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 126.138 1.775 . . . . 3.7599999999999998 114.132 166.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 37' ' ' ILE . 13.9 t70 -157.31 -50.52 0.07 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.623 -1.626 . . . . 4.6200000000000001 107.238 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 36' ' ' ASP . 1.9 pt -168.64 6.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 113.103 -1.862 . . . . 5.0 110.843 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.18 -58.7 0.03 OUTLIER Glycine 0 CA--C 1.482 -1.997 0 N-CA-C 109.653 -1.379 . . . . 4.1299999999999999 109.653 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.641 ' HA ' HG23 ' A' ' 35' ' ' ILE . 29.9 t70 -178.26 121.01 0.1 Allowed 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 113.244 -1.478 . . . . 4.3099999999999996 111.664 -177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.092 HG13 ' HD2' ' A' ' 42' ' ' PRO . 7.3 p 55.33 -66.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 127.27 2.856 . . . . 2.96 113.454 173.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.649 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 38.5 m -158.22 -58.54 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.713 0 CA-C-N 113.731 -1.577 . . . . 3.8300000000000001 110.341 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.092 ' HD2' HG13 ' A' ' 40' ' ' VAL . 59.3 Cg_endo -74.06 7.55 2.44 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 120.418 0.746 . . . . 3.8300000000000001 113.962 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 13.7 t70 81.55 6.0 1.23 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.817 1.294 . . . . 4.2599999999999998 108.651 164.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' A' ' 39' ' ' ASP . . . 165.93 67.8 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.639 0 CA-C-N 114.05 -1.432 . . . . 2.0099999999999998 112.447 172.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.685 ' HD3' ' HG3' ' A' ' 42' ' ' PRO . 16.8 tpt180 -85.09 -64.36 1.17 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.827 -1.175 . . . . 3.3399999999999999 107.827 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.055 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -114.91 124.2 51.1 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.336 -0.847 . . . . 2.0699999999999998 112.988 -174.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.567 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 27.4 t -102.86 100.59 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.652 -0.704 . . . . 1.9099999999999999 109.274 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.966 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.5 pp -65.12 118.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 113.072 0.768 . . . . 3.1899999999999999 113.072 -171.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' ' HA ' ' A' ' 10' ' ' SER . 9.2 t70 -159.49 140.25 12.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.194 0.997 . . . . 3.3100000000000001 112.605 162.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -45.61 -46.67 14.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.65 1.722 . . . . 3.25 115.65 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -52.6 -40.73 62.98 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 116.644 2.09 . . . . 4.4500000000000002 116.644 -148.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.708 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 17.4 mmm180 -63.07 -57.83 9.3 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.096 0.951 . . . . 6.2599999999999998 110.463 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.928 ' H ' ' HB2' ' A' ' 10' ' ' SER . 33.9 t -65.56 167.11 9.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.41 -1.723 . . . . 3.04 111.12 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG22 ' SG ' ' A' ' 12' ' ' CYS . 11.6 t 71.31 26.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 123.055 1.407 . . . . 4.3200000000000003 108.501 -161.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.42 64.27 0.34 Allowed Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 113.351 -1.749 . . . . 4.1900000000000004 113.708 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.89 58.31 12.51 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 118.933 -1.603 . . . . 4.4199999999999999 115.03 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.286 1.7 m -132.95 -33.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.455 1.128 . . . . 3.52 109.262 -161.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.92 -28.54 6.84 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.685 1.735 . . . . 3.6400000000000001 115.685 -163.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.97 6.61 3.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.783 1.174 . . . . 5.4400000000000004 112.161 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.17 160.66 38.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.876 -1.157 . . . . 3.2200000000000002 107.876 159.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.58 118.23 5.25 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-N 120.849 1.339 . . . . 3.8300000000000001 108.857 163.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 tp -111.49 129.88 66.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 112.85 0.685 . . . . 2.6899999999999999 112.85 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.536 HG21 ' N ' ' A' ' 73' ' ' VAL . 86.9 t -141.49 119.53 9.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 107.255 -1.387 . . . . 1.8700000000000001 107.255 153.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.659 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 38.7 ttm -110.14 135.52 50.8 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 117.779 -1.568 . . . . 1.6499999999999999 110.217 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.858 HG23 ' HB2' ' A' ' 68' ' ' LYS . 2.5 m -123.91 115.92 46.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.495 -1.669 . . . . 0.76000000000000001 106.495 168.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 49.07 -153.74 2.37 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-O 122.281 0.934 . . . . 1.1000000000000001 112.368 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.2 35.62 0.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.343 -0.928 . . . . 3.0099999999999998 108.583 172.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.858 ' HB2' HG23 ' A' ' 65' ' ' VAL . 28.5 mmmt -105.52 -27.46 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.125 -0.943 . . . . 2.6200000000000001 109.776 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 64' ' ' MET . 12.3 m 35.61 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 124.459 1.099 . . . . 1.51 113.591 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.761 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 5.0 m-30 -107.89 -163.48 0.9 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-O 122.306 1.051 . . . . 1.4299999999999999 113.345 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -145.06 50.28 0.65 Allowed Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 114.468 -1.242 . . . . 1.49 110.654 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -71.62 1.58 6.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.803 0.811 . . . . 1.8300000000000001 109.056 173.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER 46.0 -149.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 113.749 -1.568 . . . . 3.0600000000000001 113.958 167.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.664 ' H ' ' CD ' ' A' ' 75' ' ' PRO . 12.8 t -148.52 -40.46 0.01 OUTLIER Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.903 -0.59 . . . . 2.4900000000000002 112.528 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.664 ' CD ' ' H ' ' A' ' 74' ' ' THR . 4.5 Cg_endo -86.04 70.98 4.41 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.881 1.721 . . . . 2.6499999999999999 113.222 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.14 -38.16 3.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.551 -0.833 . . . . 1.3999999999999999 113.301 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.556 ' HB2' HG21 ' A' ' 73' ' ' VAL . 29.3 mt-30 -71.05 -10.3 59.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.64 1.21 . . . . 1.8700000000000001 108.364 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 2.2 t -42.36 -64.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 112.085 -2.325 . . . . 0.96999999999999997 112.799 174.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.716 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 47.8 mtmt -60.42 -25.55 66.03 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.976 0.893 . . . . 2.1299999999999999 110.785 -167.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.584 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 2.6 mptp? -77.08 -53.87 7.24 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.596 -1.183 . . . . 2.4100000000000001 109.921 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.886 ' HB ' ' HA ' ' A' ' 72' ' ' ASN . 18.9 mm -62.73 -14.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.001 -1.0 . . . . 1.23 110.1 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.716 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.6 tp -57.22 -42.81 82.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.969 -0.457 . . . . 0.79000000000000004 110.257 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.47 -33.55 69.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.588 0.709 . . . . 0.88 109.422 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -73.23 -21.05 60.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.906 -1.043 . . . . 2.0899999999999999 112.693 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.83 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.9 m-30 . . . . . 0 N--CA 1.433 -1.302 0 CA-C-O 118.111 -0.947 . . . . 1.77 111.854 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.653 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 2.8 tppp? . . . . . 0 N--CA 1.437 -1.103 0 N-CA-C 109.527 -0.546 . . . . 4.5800000000000001 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 1.068 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.2 m-85 -109.02 85.24 3.1 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.106 -0.497 . . . . 1.6399999999999999 111.27 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 47' ' ' SER . 87.2 Cg_exo -52.55 97.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.085 2.523 . . . . 1.02 112.327 169.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.682 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -86.77 129.27 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 112.703 0.631 . . . . 1.52 112.703 -172.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.641 ' CB ' ' HB2' ' A' ' 52' ' ' ARG . 59.9 p -91.28 135.44 33.8 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.581 -0.526 . . . . 1.45 109.581 174.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -116.01 121.73 68.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.032 -0.531 . . . . 2.21 110.421 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 22.1 t -67.17 120.01 13.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.066 0.765 . . . . 2.2400000000000002 113.066 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.1 mmt -123.96 22.56 8.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.462 -1.245 . . . . 5.1200000000000001 107.858 160.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.28 178.58 22.1 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.892 -1.049 . . . . 3.8599999999999999 113.744 -171.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -67.95 -44.36 76.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.29 0.478 . . . . 5.9699999999999998 112.29 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.4 -58.18 3.6 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 112.607 0.595 . . . . 4.4100000000000001 112.607 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.872 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.7 m -65.29 -35.28 80.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 2.98 111.317 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.85 -30.83 69.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 4.1799999999999997 112.317 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.83 -25.11 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.033 0.444 . . . . 3.6499999999999999 110.896 -170.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.43 8.86 17.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.377 -0.374 . . . . 4.79 111.206 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.57 44.8 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.165 -0.774 . . . . 1.8700000000000001 111.165 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -73.52 -20.61 60.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.353 -0.424 . . . . 1.46 110.946 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 26' ' ' VAL . 8.7 p-10 -62.86 -38.62 91.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 2.4199999999999999 110.717 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 44.1 mtpt -68.56 -36.37 78.69 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 121.451 -0.78 . . . . 3.0299999999999998 110.195 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 75' ' ' PRO . 2.5 t -72.3 -28.61 29.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.147 -0.621 . . . . 2.2599999999999998 111.685 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 23' ' ' ASP . 3.6 m -61.83 -37.49 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.949 -1.13 . . . . 1.5700000000000001 107.949 172.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 55.5 t-80 -60.09 -41.16 91.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.055 -0.52 . . . . 1.3500000000000001 109.873 173.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -53.65 -44.87 69.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.295 -0.866 . . . . 0.65000000000000002 109.295 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.688 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 8.2 t80 -48.82 -61.52 2.0 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 123.75 0.657 . . . . 1.98 109.781 172.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 97.9 mttt -45.43 -45.41 12.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.754 -1.112 . . . . 2.8500000000000001 111.7 -176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -77.85 -43.28 30.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.717 -0.674 . . . . 2.23 111.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.748 ' NE2' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -63.08 -24.69 68.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.879 -0.415 . . . . 2.54 109.879 177.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.826 HD21 HG23 ' A' ' 35' ' ' ILE . 10.1 tp -63.24 -55.0 28.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.136 -1.061 . . . . 2.0600000000000001 108.136 173.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.587 ' HG2' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER 68.73 -14.29 0.29 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.547 1.155 . . . . 4.4800000000000004 109.465 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.826 HG23 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER 62.38 -10.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 127.066 2.146 . . . . 3.7599999999999998 113.366 175.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.587 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 16.2 t70 68.24 -62.14 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.17 0.988 . . . . 4.6200000000000001 110.436 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 35' ' ' ILE . 2.4 pt -166.68 4.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.178 -1.374 . . . . 5.0 110.378 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' C ' HG22 ' A' ' 35' ' ' ILE . . . -178.79 -38.75 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.457 -1.354 . . . . 4.1299999999999999 113.884 -164.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.897 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 14.9 t70 -162.44 179.03 8.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.496 0.554 . . . . 4.3099999999999996 112.496 -155.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.097 HG23 ' HB3' ' A' ' 46' ' ' PHE . 1.9 t -24.82 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 125.57 1.794 . . . . 2.96 111.868 174.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.547 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 6.8 m -175.42 -55.01 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 111.033 -2.803 . . . . 3.8300000000000001 108.593 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.625 ' HD3' HG12 ' A' ' 40' ' ' VAL . 5.1 Cg_exo -81.12 -0.08 10.33 Favored 'Trans proline' 0 N--CA 1.433 -2.081 0 N-CA-C 116.381 1.646 . . . . 3.8300000000000001 116.381 -173.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.696 ' CA ' ' HB3' ' A' ' 39' ' ' ASP . 32.3 t70 77.4 16.78 1.57 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.461 -1.311 . . . . 4.2599999999999998 107.461 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.54 71.91 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.427 -1.26 . . . . 2.0099999999999998 112.805 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 12.3 tpt180 -142.18 -60.89 0.45 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.34 -0.93 . . . . 3.3399999999999999 109.488 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.097 ' HB3' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -102.53 157.75 16.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.551 -1.204 . . . . 2.0699999999999998 111.684 -173.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.534 ' H ' HG22 ' A' ' 9' ' ' ILE . 53.7 m -165.15 113.44 1.02 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.039 -1.097 . . . . 1.9099999999999999 108.039 167.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 44.3 pt -92.78 154.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 113.859 1.059 . . . . 3.1899999999999999 113.859 -162.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.1 p-10 -161.52 137.8 8.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.822 -1.081 . . . . 3.3100000000000001 111.157 162.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -47.14 -42.29 19.18 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.54 1.311 . . . . 3.25 114.54 163.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' H ' ' A' ' 51' ' ' LEU . 3.0 mm? -51.79 -31.13 25.9 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.102 1.149 . . . . 4.4500000000000002 114.102 -161.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.641 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 16.8 mmt180 -54.69 -47.51 73.57 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.817 0.341 . . . . 6.2599999999999998 110.822 176.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.674 ' O ' HG12 ' A' ' 54' ' ' VAL . 50.0 t -58.45 158.1 7.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.561 0.744 . . . . 3.04 112.132 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.674 HG12 ' O ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER 66.43 22.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 123.221 1.486 . . . . 4.3200000000000003 108.723 -160.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.92 67.87 0.27 Allowed Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 112.606 -2.088 . . . . 4.1900000000000004 112.165 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.95 57.05 11.55 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.05 -1.548 . . . . 4.4199999999999999 115.177 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.542 ' HB3' HD13 ' A' ' 62' ' ' ILE . 9.5 m -133.06 -37.73 0.98 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 118.272 1.036 . . . . 3.52 112.816 -171.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.58 -34.57 18.13 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.691 2.108 . . . . 3.6400000000000001 116.691 -150.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.47 2.43 21.99 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.615 1.552 . . . . 5.4400000000000004 113.206 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.5 160.39 48.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 C-N-CA 123.373 0.669 . . . . 3.2200000000000002 109.998 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 Cg_endo -78.97 125.08 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.722 0.948 . . . . 3.8300000000000001 109.967 156.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.542 HD13 ' HB3' ' A' ' 57' ' ' CYS . 1.5 mp -107.81 134.2 50.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.458 0.54 . . . . 2.6899999999999999 112.458 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.782 HG13 ' HA2' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -138.27 126.18 29.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.956 0 N-CA-C 107.251 -1.389 . . . . 1.8700000000000001 107.251 160.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.697 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 48.1 ttm -112.31 144.48 41.66 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.742 -1.224 . . . . 1.6499999999999999 109.618 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.068 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -122.26 117.12 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.526 -1.287 . . . . 0.76000000000000001 107.526 154.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . 45.98 -147.9 2.28 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-O 122.369 0.983 . . . . 1.1000000000000001 111.792 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.39 28.38 0.25 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.032 -1.084 . . . . 3.0099999999999998 108.986 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.771 ' HB2' HG23 ' A' ' 65' ' ' VAL . 42.6 mmtt -107.79 -32.87 7.44 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.512 -0.551 . . . . 2.6200000000000001 109.512 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.697 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 96.9 t 44.12 110.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 115.271 1.582 . . . . 1.51 115.271 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.747 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.5 m-85 -130.37 -155.08 0.67 Allowed 'General case' 0 C--O 1.249 1.056 0 CA-C-O 122.682 1.23 . . . . 1.4299999999999999 112.968 -173.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.782 ' HA2' HG13 ' A' ' 63' ' ' VAL . . . -151.95 46.47 0.59 Allowed Glycine 0 C--O 1.218 -0.866 0 CA-C-N 114.279 -1.328 . . . . 1.49 111.878 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.751 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -96.07 1.18 52.35 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.146 0.473 . . . . 1.8300000000000001 112.237 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.694 HG22 ' HB ' ' A' ' 63' ' ' VAL . 2.6 m -119.37 17.88 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 114.786 1.402 . . . . 3.0600000000000001 114.786 -166.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.828 ' OG1' ' HD2' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -151.61 175.43 2.89 Favored Pre-proline 0 CA--C 1.563 1.461 0 O-C-N 121.342 -0.849 . . . . 2.4900000000000002 110.743 -173.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.828 ' HD2' ' OG1' ' A' ' 74' ' ' THR . 65.0 Cg_exo -14.72 94.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.956 1 C-N-CA 126.476 4.784 . . . . 2.6499999999999999 117.763 -166.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.611 ' H ' HG11 ' A' ' 25' ' ' VAL . . . 74.81 -29.96 1.07 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.871 -0.604 . . . . 1.3999999999999999 114.237 165.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.825 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 11.7 pt20 -78.38 -15.34 58.79 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.344 -1.354 . . . . 1.8700000000000001 107.344 -165.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.67 HG23 ' HG3' ' A' ' 79' ' ' LYS . 14.0 m -46.34 -58.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-N 113.135 -1.848 . . . . 0.96999999999999997 111.248 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.748 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 28.7 mtmt -57.85 -42.88 85.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.584 1.183 . . . . 2.1299999999999999 109.44 -167.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.825 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -78.5 -49.47 13.34 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 112.937 -1.938 . . . . 2.4100000000000001 109.854 -172.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.805 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 47.2 mm -68.64 -10.89 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 113.696 -1.593 . . . . 1.23 109.975 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 52.1 tp -64.17 -36.08 82.89 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.181 -0.949 . . . . 0.79000000000000004 110.315 167.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.14 67.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.814 -0.81 . . . . 0.88 108.814 171.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.805 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 25.4 mm-40 -69.94 -37.59 75.9 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.926 -1.034 . . . . 2.0899999999999999 111.066 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.747 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.428 -1.544 0 CA-C-O 119.163 -0.446 . . . . 1.77 111.8 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 114.378 1.251 . . . . 4.5800000000000001 114.378 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.758 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -50.55 110.94 1.9 Allowed Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 113.83 1.048 . . . . 1.6399999999999999 113.83 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 88.4 Cg_exo -56.29 99.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.473 0.285 0 C-N-CA 123.191 2.594 . . . . 1.02 111.777 169.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.822 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -85.52 122.56 38.52 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.875 0.695 . . . . 1.52 112.875 -175.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 48.5 m -92.93 129.17 38.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.572 -0.74 . . . . 1.45 110.484 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 128.41 72.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.652 0.982 . . . . 2.21 113.652 -170.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.6 t -63.42 114.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.314 0.578 . . . . 2.2400000000000002 111.045 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.6 mtm -130.05 22.72 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 5.1200000000000001 110.449 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.05 175.64 23.63 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.2 -1.0 . . . . 3.8599999999999999 113.818 -170.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 p -67.51 -46.19 73.61 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.271 0.471 . . . . 5.9699999999999998 112.271 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.536 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -69.43 -52.88 22.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 4.4100000000000001 111.083 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -64.09 -39.74 94.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.804 -0.634 . . . . 2.98 111.678 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 25.6 t80 -65.02 -33.42 75.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.628 0.603 . . . . 4.1799999999999997 112.628 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 16' ' ' ALA . 7.1 p -71.75 -24.04 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.942 0.349 . . . . 3.6499999999999999 111.942 -166.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 31.2 mmtp -84.2 14.9 3.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.148 0.499 . . . . 4.79 111.57 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.99 29.26 20.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.966 -0.635 . . . . 1.8700000000000001 112.195 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.76 -19.51 62.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.485 -0.561 . . . . 1.46 109.485 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 14.1 t70 -53.32 -51.76 61.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.396 -0.82 . . . . 2.4199999999999999 110.605 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -65.83 -38.25 88.4 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.077 -0.649 . . . . 3.0299999999999998 110.925 -175.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.094 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.67 -39.88 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 116.408 -0.36 . . . . 2.2599999999999998 111.254 -179.073 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.745 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 13.6 p -67.26 -29.82 47.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.595 -0.842 . . . . 1.5700000000000001 108.92 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.514 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 66.7 t-80 -60.65 -37.85 82.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 1.3500000000000001 109.897 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -55.28 -46.76 76.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.454 -0.943 . . . . 0.65000000000000002 108.454 175.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.745 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 36.5 t80 -51.41 -52.67 43.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.183 -0.917 . . . . 1.98 111.186 173.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 16.9 tppt? -45.43 -47.76 13.77 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.71 -1.132 . . . . 2.8500000000000001 111.171 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.59 -29.58 36.91 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.382 -0.826 . . . . 2.23 111.024 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.833 ' NE2' ' HA ' ' A' ' 79' ' ' LYS . 8.5 mm100 -59.18 -29.39 67.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.278 -0.874 . . . . 2.54 110.988 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.06 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 2.3 tt -53.16 -54.73 31.62 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.377 -0.971 . . . . 2.0600000000000001 108.377 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.835 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.1 -17.15 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.32 -2.218 . . . . 4.4800000000000004 113.241 174.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.777 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 52.62 -161.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.215 -1.357 . . . . 3.7599999999999998 113.307 167.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.914 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 17.9 t70 -157.13 -54.99 0.08 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.945 -1.872 . . . . 4.6200000000000001 105.945 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.0 pt -177.54 21.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 111.808 -2.451 . . . . 5.0 107.443 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -164.97 -70.11 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 108.953 -1.659 . . . . 4.1299999999999999 108.953 -166.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.561 ' HA ' HD21 ' A' ' 33' ' ' LEU . 17.9 m-20 -178.46 125.45 0.11 Allowed 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.33 -1.435 . . . . 4.3099999999999996 110.038 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.976 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 2.6 p 57.81 -11.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 115.746 1.758 . . . . 2.96 115.746 165.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.914 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 55.2 m 112.65 -43.09 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.377 1.471 . . . . 3.8300000000000001 110.742 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 40' ' ' VAL . 87.0 Cg_exo -51.43 -19.57 7.15 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.123 1.215 . . . . 3.8300000000000001 113.022 163.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 38.2 t70 84.98 12.38 0.26 Allowed 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.98 1.372 . . . . 4.2599999999999998 107.671 163.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 156.44 76.1 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 112.78 -2.009 . . . . 2.0099999999999998 110.178 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.712 ' HB3' HG11 ' A' ' 40' ' ' VAL . 3.6 ttt180 -119.54 -53.83 2.2 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 114.724 -0.738 . . . . 3.3399999999999999 109.091 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.06 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.91 110.54 19.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 113.388 0.884 . . . . 2.0699999999999998 113.388 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.0 m -117.99 108.22 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.809 -1.087 . . . . 1.9099999999999999 109.168 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.747 ' HA ' HG23 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.66 145.09 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 113.439 0.903 . . . . 3.1899999999999999 113.439 -168.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.703 ' O ' ' HA ' ' A' ' 10' ' ' SER . 19.4 t70 -155.05 146.04 22.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.366 -1.288 . . . . 3.3100000000000001 111.807 175.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -42.36 -44.38 3.91 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 117.009 2.226 . . . . 3.25 117.009 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HG ' ' OD2' ' A' ' 49' ' ' ASP . 55.7 mt -49.26 -38.83 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.783 2.142 . . . . 4.4500000000000002 116.783 -148.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.687 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 8.5 tpm_? -60.5 -51.69 68.39 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.387 0.994 . . . . 6.2599999999999998 111.011 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.1 t -62.59 154.92 27.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.54 -1.209 . . . . 3.04 113.547 -168.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 10.5 t 62.93 19.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 114.659 -1.155 . . . . 4.3200000000000003 109.157 -172.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.8 61.52 0.47 Allowed Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.634 -1.166 . . . . 4.1900000000000004 113.505 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.25 58.8 12.53 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 118.524 -1.798 . . . . 4.4199999999999999 114.478 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.565 ' HB3' HG21 ' A' ' 62' ' ' ILE 0.262 2.9 m -129.26 -34.45 1.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.859 1.829 . . . . 3.52 111.157 -154.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.45 6.25 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.535 2.05 . . . . 3.6400000000000001 116.535 -163.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 59' ' ' LEU . 16.2 mt -73.15 4.8 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.591 1.542 . . . . 5.4400000000000004 112.238 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.74 52.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.581 -0.896 . . . . 3.2200000000000002 108.581 159.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.8 122.62 6.44 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.018 -1.57 . . . . 3.8300000000000001 108.018 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.565 HG21 ' HB3' ' A' ' 57' ' ' CYS . 44.7 pt -106.96 127.82 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.862 -1.135 . . . . 2.6899999999999999 113.085 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.684 HG22 HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -144.08 120.78 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.47 -1.307 . . . . 1.8700000000000001 107.47 152.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.822 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 25.0 ttt -111.24 135.64 51.48 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.583 -1.266 . . . . 1.6499999999999999 107.583 -175.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.792 ' CG1' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -119.07 114.39 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.249 0 N-CA-C 107.179 -1.415 . . . . 0.76000000000000001 107.179 169.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 51.36 -159.14 2.24 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.088 -1.205 . . . . 1.1000000000000001 110.088 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.36 38.78 0.31 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.29 0.567 . . . . 3.0099999999999998 109.967 171.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.618 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 51.5 mmtt -105.43 -37.49 6.8 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 115.651 -0.704 . . . . 2.6200000000000001 110.473 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 85.1 t 53.33 108.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 114.07 1.137 . . . . 1.51 114.07 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.695 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.6 m-30 -126.94 -169.83 2.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.455 1.121 . . . . 1.4299999999999999 113.222 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -129.05 30.18 3.75 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.061 -1.427 . . . . 1.49 112.598 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.874 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -88.59 89.03 7.82 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.573 -1.269 . . . . 1.8300000000000001 107.573 172.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -116.66 -93.19 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 122.188 0.994 . . . . 3.0600000000000001 112.785 -168.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 1.094 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 43.7 p -133.83 -61.92 0.02 OUTLIER Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.585 -1.643 . . . . 2.4900000000000002 113.484 -166.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.75 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 16.4 Cg_endo -87.4 70.07 3.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.271 1.981 . . . . 2.6499999999999999 113.121 -162.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 77.99 -12.18 18.85 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.919 -0.658 . . . . 1.3999999999999999 112.689 177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.75 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 25.7 mt-30 -73.52 -25.76 60.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.183 -1.784 . . . . 1.8700000000000001 106.183 -172.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.739 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 16.0 m -46.8 -61.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 111.566 -2.561 . . . . 0.96999999999999997 111.651 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.854 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 15.5 pttm -58.45 -39.56 80.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.807 0.813 . . . . 2.1299999999999999 110.84 -167.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.854 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -81.08 -46.84 14.37 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-N 114.698 -1.137 . . . . 2.4100000000000001 109.449 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.673 HG22 ' HB2' ' A' ' 72' ' ' ASN . 39.9 mm -70.56 -11.62 15.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.13 -1.395 . . . . 1.23 110.11 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 85' ' ' TYR . 31.0 tp -62.65 -34.17 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.654 -0.654 . . . . 0.79000000000000004 110.005 168.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.74 -33.03 69.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.854 -0.795 . . . . 0.88 108.854 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -70.09 -41.35 74.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.735 -1.121 . . . . 2.0899999999999999 111.114 171.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.874 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 7.0 m-30 . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 117.898 -1.049 . . . . 1.77 111.879 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.551 ' O ' ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.516 0 CA-C-O 121.713 0.768 . . . . 4.5800000000000001 111.718 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.546 ' HB3' ' C ' ' A' ' 65' ' ' VAL . 2.7 m-85 -52.72 109.56 1.51 Allowed Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 113.759 -1.564 . . . . 1.6399999999999999 113.255 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.919 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 32.1 Cg_exo -61.92 104.42 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.826 1.684 . . . . 1.02 111.029 169.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.078 ' HB ' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -79.43 114.3 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.773 0.797 . . . . 1.52 110.378 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.79 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 8.3 m -93.09 107.11 18.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.526 -1.216 . . . . 1.45 110.41 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -118.17 123.21 71.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.394 -0.821 . . . . 2.21 110.06 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.732 ' SG ' HG22 ' A' ' 54' ' ' VAL . 32.1 t -66.86 119.28 11.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.109 -0.636 . . . . 2.2400000000000002 110.884 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.7 ttp -122.96 23.29 9.38 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.2 -1.037 . . . . 5.1200000000000001 108.2 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.78 179.5 17.48 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.18 -0.918 . . . . 3.8599999999999999 112.616 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 m -62.71 -43.9 97.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.119 0.415 . . . . 5.9699999999999998 112.119 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -70.18 -56.08 7.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.048 0.452 . . . . 4.4100000000000001 111.735 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 81.8 m -68.79 -37.75 79.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.202 0.445 . . . . 2.98 112.202 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.767 ' HE1' ' HB2' ' A' ' 23' ' ' ASP . 74.4 t80 -63.99 -31.63 72.88 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.726 0.639 . . . . 4.1799999999999997 112.726 -176.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 16' ' ' ALA . 8.0 p -68.7 -20.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.917 0.389 . . . . 3.6499999999999999 111.043 -168.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.51 14.35 3.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.005 -0.543 . . . . 4.79 111.09 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.32 23.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.065 -0.588 . . . . 1.8700000000000001 111.971 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -72.9 -20.93 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.316 . . . . 1.46 111.462 -172.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.767 ' HB2' ' HE1' ' A' ' 18' ' ' PHE . 17.5 t70 -57.52 -44.44 85.09 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.47 -0.492 . . . . 2.4199999999999999 110.946 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 1.7 mptp? -64.64 -39.3 93.46 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.885 -0.726 . . . . 3.0299999999999998 111.528 -171.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.998 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.79 -46.94 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 120.557 -0.457 . . . . 2.2599999999999998 110.267 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.492 HG23 ' HE3' ' A' ' 30' ' ' LYS . 17.8 m -65.98 -25.3 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.387 -0.525 . . . . 1.5700000000000001 110.546 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.629 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 66.4 t-80 -60.74 -44.8 96.22 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.214 0.53 . . . . 1.3500000000000001 109.67 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.42 -40.09 74.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.598 -1.183 . . . . 0.65000000000000002 109.254 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.649 ' HE2' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -61.49 -46.5 89.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 1.98 110.458 175.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.629 ' HD2' ' HA ' ' A' ' 27' ' ' HIS . 90.5 mttt -53.65 -40.88 66.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.566 -0.743 . . . . 2.8500000000000001 110.551 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.98 -29.27 29.13 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.396 -0.82 . . . . 2.23 111.448 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -66.27 -21.98 66.3 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.914 -0.584 . . . . 2.54 109.648 177.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.931 ' HG ' HG12 ' A' ' 35' ' ' ILE . 3.6 tp -51.22 -53.94 30.41 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.812 -1.551 . . . . 2.0600000000000001 106.812 170.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.649 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 63.38 -28.46 0.08 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 125.885 1.991 . . . . 4.4800000000000004 113.098 168.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.931 HG12 ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.25 -173.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 126.152 1.781 . . . . 3.7599999999999998 114.631 165.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 8.5 t70 -157.69 -41.58 0.07 Allowed 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 113.387 -1.733 . . . . 4.6200000000000001 107.396 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' ' 43' ' ' ASP . 4.1 pt -163.23 -3.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 113.643 -1.617 . . . . 5.0 112.646 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -174.46 -58.94 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.035 -1.078 . . . . 4.1299999999999999 110.79 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.994 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 34.1 m-20 -164.5 115.62 1.24 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.821 -0.689 . . . . 4.3099999999999996 111.798 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.892 HG23 ' CD2' ' A' ' 46' ' ' PHE . 1.3 t 72.56 -62.96 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 O-C-N 125.117 1.51 . . . . 2.96 109.755 175.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.758 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 64.1 m -169.43 -61.21 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 112.215 -2.266 . . . . 3.8300000000000001 109.635 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.746 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 72.1 Cg_endo -77.11 11.3 2.09 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 120.624 0.882 . . . . 3.8300000000000001 113.737 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.636 ' HB2' HG13 ' A' ' 37' ' ' ILE . 24.2 t70 82.02 11.03 0.7 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.001 -1.111 . . . . 4.2599999999999998 108.001 169.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 169.43 77.77 0.04 OUTLIER Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 119.292 -1.432 . . . . 2.0099999999999998 112.536 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.549 ' HD3' ' OXT' ' A' ' 85' ' ' TYR . 5.1 ttm180 -116.44 1.44 12.98 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.02 -1.844 . . . . 3.3399999999999999 106.02 165.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.994 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 1.7 m-85 -134.33 169.14 17.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.276 -2.693 . . . . 2.0699999999999998 111.097 -171.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.919 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 1.4 t 178.26 73.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.493 -1.299 . . . . 1.9099999999999999 107.493 166.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.044 HG22 HD13 ' A' ' 9' ' ' ILE . 2.1 pp -67.07 116.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.682 -1.145 . . . . 3.1899999999999999 112.997 -167.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' A' ' 10' ' ' SER . 29.3 t70 -162.27 142.24 9.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.572 1.177 . . . . 3.3100000000000001 112.711 167.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.4 m -43.76 -45.72 7.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.692 -2.049 . . . . 3.25 116.198 172.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 tp -51.35 -41.74 60.81 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.177 1.918 . . . . 4.4500000000000002 116.177 -149.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.646 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.0 mmm180 -63.06 -55.93 21.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.156 0.979 . . . . 6.2599999999999998 110.797 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.693 ' H ' ' HB3' ' A' ' 10' ' ' SER . 34.1 t -63.15 168.72 3.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.343 -1.753 . . . . 3.04 110.252 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.732 HG22 ' SG ' ' A' ' 12' ' ' CYS . 15.7 t 74.52 28.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 123.204 1.478 . . . . 4.3200000000000003 108.508 -156.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.29 64.35 0.28 Allowed Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 113.425 -1.716 . . . . 4.1900000000000004 113.025 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 56.89 19.19 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 119.63 -1.271 . . . . 4.4199999999999999 115.567 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.293 1.1 m -135.79 -33.66 0.85 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.985 1.392 . . . . 3.52 110.213 -162.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.06 -28.98 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 116.221 1.934 . . . . 3.6400000000000001 116.221 -160.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.03 6.81 3.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.35 1.432 . . . . 5.4400000000000004 112.244 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.14 39.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 107.807 -1.182 . . . . 3.2200000000000002 107.807 159.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.45 117.25 4.75 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 N-CA-C 108.431 -1.411 . . . . 3.8300000000000001 108.431 160.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -113.18 133.68 58.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 119.406 -0.33 . . . . 2.6899999999999999 111.771 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.649 HG21 ' HE2' ' A' ' 29' ' ' PHE . 99.4 t -139.87 121.54 15.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 108.908 -0.775 . . . . 1.8700000000000001 108.908 155.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 50.1 ttp -112.45 136.2 52.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.864 -1.135 . . . . 1.6499999999999999 109.412 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.078 HG13 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.27 114.8 44.05 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 119.877 -0.729 . . . . 0.76000000000000001 109.485 174.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.702 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 50.76 45.81 48.52 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.808 -0.71 . . . . 1.1000000000000001 113.433 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 59.55 6.66 0.85 Allowed 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 122.952 0.501 . . . . 3.0099999999999998 111.4 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.913 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 71.2 mmtt -77.01 -8.76 57.98 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 110.234 -0.284 . . . . 2.6200000000000001 110.234 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.4 m 35.72 99.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 124.609 1.193 . . . . 1.51 113.889 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.913 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 3.8 m-85 -110.09 165.88 11.39 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-O 122.962 1.363 . . . . 1.4299999999999999 113.675 -173.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.663 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -109.75 5.96 31.14 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 112.544 -2.116 . . . . 1.49 109.009 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.743 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 26.3 t-20 -65.25 131.57 46.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.49 -1.67 . . . . 1.8300000000000001 106.49 167.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.72 -145.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.466 0.913 . . . . 3.0600000000000001 113.466 -148.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.998 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 76.5 p -131.29 -50.9 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.018 1.118 . . . . 2.4900000000000002 114.018 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD3' ' OG1' ' A' ' 74' ' ' THR . 91.2 Cg_endo -87.79 73.93 2.45 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.582 1.521 . . . . 2.6499999999999999 113.474 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.54 4.41 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.75 -0.738 . . . . 1.3999999999999999 112.782 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.621 HE21 ' HD2' ' A' ' 75' ' ' PRO . 23.6 mt-30 -74.38 -19.71 60.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 106.403 -1.702 . . . . 1.8700000000000001 106.403 -172.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.684 HG23 ' HG3' ' A' ' 79' ' ' LYS . 8.4 m -43.44 -60.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 111.704 -2.498 . . . . 0.96999999999999997 111.915 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.684 ' HG3' HG23 ' A' ' 78' ' ' VAL . 45.9 mtmt -59.45 -37.59 78.55 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.277 1.037 . . . . 2.1299999999999999 109.998 -165.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.4 -47.7 12.89 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 114.257 -1.338 . . . . 2.4100000000000001 109.446 -175.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 42.1 mm -66.57 -10.68 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.291 -1.322 . . . . 1.23 110.013 177.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 85' ' ' TYR . 52.7 tp -58.75 -23.95 60.82 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.521 -0.737 . . . . 0.79000000000000004 110.127 169.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.44 27.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.448 -0.501 . . . . 0.88 110.305 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.772 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER -67.0 -36.78 82.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.983 -0.553 . . . . 2.0899999999999999 111.715 174.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.691 ' HB2' HD12 ' A' ' 82' ' ' LEU . 6.7 m-30 . . . . . 0 N--CA 1.432 -1.355 0 CA-C-O 118.523 -0.751 . . . . 1.77 111.547 -174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.531 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 14.3 tppt? . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 108.202 -1.036 . . . . 4.5800000000000001 108.202 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.598 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 4.7 m-85 -115.44 89.16 21.02 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.837 -1.074 . . . . 1.6399999999999999 110.541 173.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 51.2 Cg_exo -59.67 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.111 2.541 . . . . 1.02 111.669 171.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.055 HG12 ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -84.48 173.39 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 113.387 0.884 . . . . 1.52 113.387 -167.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.746 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 14.9 p -134.65 134.85 41.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.263 -0.88 . . . . 1.45 109.005 171.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 m -115.46 124.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.785 -0.643 . . . . 2.21 110.962 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.0 t -66.11 112.6 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.299 0.571 . . . . 2.2400000000000002 110.463 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.3 tpt -131.11 23.85 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.37 -0.832 . . . . 5.1200000000000001 109.628 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.66 177.26 13.59 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.584 -0.817 . . . . 3.8599999999999999 113.992 -166.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -66.21 -45.55 80.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 5.9699999999999998 111.676 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.2 -52.27 20.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.556 0.693 . . . . 4.4100000000000001 110.339 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.65 -34.19 76.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.626 -1.17 . . . . 2.98 111.734 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 83.6 t80 -60.69 -34.31 74.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.787 0.327 . . . . 4.1799999999999997 111.346 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.82 -24.33 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.545 0.688 . . . . 3.6499999999999999 109.862 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -84.44 12.2 7.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.171 -0.922 . . . . 4.79 110.408 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 31.1 17.24 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.537 -0.84 . . . . 1.8700000000000001 113.145 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -70.74 -19.81 62.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.707 0.289 . . . . 1.46 110.789 -175.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.99 -52.88 62.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 2.4199999999999999 110.248 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -64.55 -31.36 72.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.887 -0.412 . . . . 3.0299999999999998 109.887 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.878 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 98.2 t -56.82 -62.51 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 115.557 -0.747 . . . . 2.2599999999999998 109.426 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -63.98 -27.86 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.729 -0.669 . . . . 1.5700000000000001 110.793 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -58.5 -47.87 82.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 120.299 -0.56 . . . . 1.3500000000000001 110.368 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.55 -45.01 81.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.15 -0.932 . . . . 0.65000000000000002 109.163 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.645 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -53.5 -53.39 52.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.093 -0.958 . . . . 1.98 110.087 177.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -51.34 -48.95 62.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.587 -0.733 . . . . 2.8500000000000001 110.995 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.81 -28.55 28.0 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.123 -0.944 . . . . 2.23 111.446 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -63.97 -26.77 68.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 123.437 0.461 . . . . 2.54 110.328 176.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.066 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 tt -50.95 -56.21 13.46 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.612 -1.255 . . . . 2.0600000000000001 107.612 173.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 63.59 -19.47 0.06 Allowed 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.527 2.392 . . . . 4.4800000000000004 112.644 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.638 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 56.9 -173.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 113.621 -1.627 . . . . 3.7599999999999998 112.713 170.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.78 -48.7 0.07 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.944 -1.132 . . . . 4.6200000000000001 107.944 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 pt -165.58 5.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 112.898 -1.955 . . . . 5.0 110.615 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.555 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 177.16 -54.51 0.1 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 110.103 -1.199 . . . . 4.1299999999999999 110.103 -166.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.691 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 24.4 t70 -176.53 116.88 0.12 Allowed 'General case' 0 CA--C 1.483 -1.635 0 CA-C-N 113.446 -1.377 . . . . 4.3099999999999996 111.291 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.027 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 6.5 p 54.9 -65.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 127.301 2.876 . . . . 2.96 113.488 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.82 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 26.2 m -154.0 -58.81 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 113.631 -1.622 . . . . 3.8300000000000001 110.565 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.82 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 2.8 Cg_exo -77.63 10.06 2.68 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 C-N-CA 120.745 0.963 . . . . 3.8300000000000001 114.235 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.555 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 6.8 t0 81.43 9.41 0.95 Allowed 'General case' 0 C--N 1.349 0.558 0 N-CA-C 107.644 -1.243 . . . . 4.2599999999999998 107.644 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.691 ' N ' ' HB3' ' A' ' 39' ' ' ASP . . . 156.92 59.36 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.237 -1.347 . . . . 2.0099999999999998 112.171 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.64 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 11.6 ttt180 -86.73 -62.0 1.61 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.029 -1.1 . . . . 3.3399999999999999 108.029 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.066 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -100.95 102.42 13.43 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 122.806 1.289 . . . . 2.0699999999999998 112.738 173.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 22.6 t -92.02 91.98 8.08 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.887 -1.506 . . . . 1.9099999999999999 109.215 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.055 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.3 pp -56.46 124.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 3.1899999999999999 112.518 -174.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' SER . 8.5 m-20 -143.21 132.73 23.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.518 1.151 . . . . 3.3100000000000001 113.464 166.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -48.5 -43.41 35.06 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.171 -1.831 . . . . 3.25 114.581 158.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.16 -35.13 59.44 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.558 1.318 . . . . 4.4500000000000002 114.558 -160.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.746 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 9.8 mmt85 -60.77 -49.87 75.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.806 0.812 . . . . 6.2599999999999998 110.176 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.0 t -59.22 158.58 8.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.944 -1.48 . . . . 3.04 112.895 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 54' ' ' VAL . 14.7 t 66.27 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.388 0 CA-C-O 122.83 1.3 . . . . 4.3200000000000003 108.558 -167.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.77 63.6 0.37 Allowed Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 113.829 -1.532 . . . . 4.1900000000000004 113.263 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.21 59.08 10.04 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.739 -1.696 . . . . 4.4199999999999999 114.609 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.727 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.282 2.8 m -130.14 -37.13 1.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.058 1.429 . . . . 3.52 110.765 -159.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.06 -32.65 35.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.916 1.45 . . . . 3.6400000000000001 114.916 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 59' ' ' LEU . 2.5 pt? -76.83 6.13 6.64 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.117 -0.989 . . . . 5.4400000000000004 112.334 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.76 160.86 38.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.305 -0.628 . . . . 3.2200000000000002 109.305 164.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.52 119.19 4.8 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 108.572 -1.357 . . . . 3.8300000000000001 108.572 155.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.727 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.0 mm -111.58 129.58 66.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.567 0.58 . . . . 2.6899999999999999 112.567 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 4.7 t -139.57 123.15 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.832 -1.544 . . . . 1.8700000000000001 106.832 153.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.764 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 22.7 ttt -112.75 136.08 52.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.954 -1.498 . . . . 1.6499999999999999 110.598 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.748 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -124.81 114.91 42.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 106.545 -1.65 . . . . 0.76000000000000001 106.545 156.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.75 -149.25 1.09 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 122.165 0.87 . . . . 1.1000000000000001 112.752 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.31 31.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.842 -1.179 . . . . 3.0099999999999998 108.744 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.748 ' HB2' HG23 ' A' ' 65' ' ' VAL . 13.2 mmmm -106.61 -41.56 5.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.535 -0.757 . . . . 2.6200000000000001 109.214 -177.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 64' ' ' MET . 87.8 t 46.38 101.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 124.472 1.108 . . . . 1.51 113.523 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.668 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 9.1 m-30 -120.41 -154.77 0.6 Allowed 'General case' 0 C--O 1.248 1.024 0 CA-C-O 121.863 0.839 . . . . 1.4299999999999999 112.312 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.612 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -142.6 28.21 2.19 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.695 -1.139 . . . . 1.49 112.003 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.865 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 3.1 t30 -81.76 112.73 19.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.711 -0.477 . . . . 1.8300000000000001 109.711 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.665 HG23 ' H ' ' A' ' 74' ' ' THR . 6.9 m -137.2 -78.78 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 116.922 2.193 . . . . 3.0600000000000001 116.922 -171.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.878 ' CB ' ' HA ' ' A' ' 25' ' ' VAL . 13.6 t -153.41 -41.68 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 115.51 1.671 . . . . 2.4900000000000002 115.51 -172.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.892 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 3.0 Cg_exo -75.31 57.22 4.68 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.09 1.86 . . . . 2.6499999999999999 112.036 -170.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.447 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 76.3 -7.54 30.23 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.58 -0.737 . . . . 1.3999999999999999 111.562 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.892 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 6.8 mt-30 -73.62 -35.75 65.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.209 -1.404 . . . . 1.8700000000000001 107.209 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.621 ' HA ' ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -50.67 -55.69 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 112.802 -1.999 . . . . 0.96999999999999997 110.941 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 48.9 mtmt -54.51 -45.66 73.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.019 0.914 . . . . 2.1299999999999999 109.508 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.777 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -85.56 -40.94 15.74 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.642 -1.163 . . . . 2.4100000000000001 110.987 -173.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.774 ' CG2' ' HB2' ' A' ' 72' ' ' ASN . 33.3 mm -69.69 -15.11 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.955 -0.566 . . . . 1.23 109.765 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.539 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 54.7 tp -58.93 -41.57 87.65 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.989 -0.445 . . . . 0.79000000000000004 110.29 171.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.2 -32.74 66.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.544 0.688 . . . . 0.88 109.422 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.55 -31.64 67.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.755 -1.111 . . . . 2.0899999999999999 112.125 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.865 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 2.1 m-30 . . . . . 0 N--CA 1.432 -1.369 0 CA-C-O 117.418 -1.277 . . . . 1.77 112.004 -170.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.681 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 122.248 1.023 . . . . 4.5800000000000001 110.915 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.937 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -69.31 112.59 12.35 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.075 -1.42 . . . . 1.6399999999999999 112.764 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 1.039 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 21.0 Cg_exo -70.8 131.14 19.2 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.903 1.735 . . . . 1.02 111.678 170.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.883 HG22 ' HA ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -77.45 156.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.376 0.608 . . . . 1.52 112.085 -175.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.82 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.6 m -141.68 100.81 3.84 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.299 -0.864 . . . . 1.45 109.56 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -117.81 124.64 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.744 -0.662 . . . . 2.21 110.799 -176.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.746 ' SG ' HG22 ' A' ' 54' ' ' VAL . 31.5 t -65.14 120.87 13.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 2.2400000000000002 110.876 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.4 mtt -122.01 24.8 9.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.15 -0.932 . . . . 5.1200000000000001 108.714 173.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.09 179.91 13.19 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.132 -0.94 . . . . 3.8599999999999999 112.836 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 19' ' ' VAL . 19.8 m -65.78 -45.67 81.59 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.993 0.368 . . . . 5.9699999999999998 111.993 -172.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.641 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -71.62 -56.54 5.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.465 0.543 . . . . 4.4100000000000001 112.465 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 83.3 m -66.62 -36.55 82.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.535 0.569 . . . . 2.98 112.535 -171.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.78 -30.87 71.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.126 0.787 . . . . 4.1799999999999997 113.126 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 16' ' ' ALA . 32.6 m -69.74 -18.92 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.948 0.351 . . . . 3.6499999999999999 111.948 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.95 16.46 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 4.79 111.612 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.85 32.3 10.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.451 -0.881 . . . . 1.8700000000000001 111.851 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -72.05 -20.82 61.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.436 -0.382 . . . . 1.46 110.617 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.18 -50.86 66.07 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.031 -0.359 . . . . 2.4199999999999999 110.031 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -65.02 -40.62 95.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.698 -0.401 . . . . 3.0299999999999998 110.983 -171.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.789 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 6.1 m -67.17 -49.0 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 C-N-CA 120.42 -0.512 . . . . 2.2599999999999998 110.153 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.675 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 21.8 m -64.83 -28.95 46.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.182 -0.607 . . . . 1.5700000000000001 110.269 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -59.5 -43.11 93.42 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 120.72 -0.392 . . . . 1.3500000000000001 110.219 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -52.96 -49.16 66.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.202 -0.908 . . . . 0.65000000000000002 109.062 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.675 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 39.7 t80 -47.54 -56.9 6.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.065 -0.97 . . . . 1.98 110.488 174.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.17 -52.66 11.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.373 -1.285 . . . . 2.8500000000000001 112.229 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -84.45 -30.52 25.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.84 -0.618 . . . . 2.23 111.762 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.69 ' NE2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -64.71 -25.02 67.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.54 -0.541 . . . . 2.54 109.54 176.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.797 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.3 tt -48.59 -58.23 5.01 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.246 -1.39 . . . . 2.0600000000000001 107.246 174.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.744 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 64.09 -21.49 0.07 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 126.328 2.268 . . . . 4.4800000000000004 112.874 171.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.701 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 53.98 -173.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 C-N-CA 126.342 1.857 . . . . 3.7599999999999998 114.389 166.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.436 ' H ' HG22 ' A' ' 35' ' ' ILE . 14.7 t70 -157.74 -50.93 0.07 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.848 -1.524 . . . . 4.6200000000000001 107.985 -172.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pt -164.79 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 113.441 -1.709 . . . . 5.0 110.863 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.31 -65.04 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 109.675 -1.37 . . . . 4.1299999999999999 109.675 -166.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.895 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 25.1 m-20 -164.31 119.97 1.53 Allowed 'General case' 0 CA--C 1.48 -1.742 0 CA-C-N 112.903 -1.648 . . . . 4.3099999999999996 109.107 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.992 HG13 ' HD2' ' A' ' 42' ' ' PRO . 4.4 p 59.01 -66.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 126.684 2.49 . . . . 2.96 112.871 171.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.959 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 50.7 m -164.71 -58.52 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.759 0 CA-C-N 112.688 -2.051 . . . . 3.8300000000000001 110.006 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.072 ' HG2' ' HD2' ' A' ' 45' ' ' ARG . 23.8 Cg_exo -67.69 4.26 1.47 Allowed 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 120.88 1.054 . . . . 3.8300000000000001 114.44 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 18.0 t70 86.23 -4.85 0.77 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.93 0.872 . . . . 4.2599999999999998 109.578 159.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.532 ' HA2' ' OD2' ' A' ' 39' ' ' ASP . . . 179.06 41.4 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.747 -1.115 . . . . 2.0099999999999998 112.282 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 1.072 ' HD2' ' HG2' ' A' ' 42' ' ' PRO . 2.6 ttt180 -82.74 -7.79 59.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.548 1.166 . . . . 3.3399999999999999 109.167 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.98 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -105.51 -58.98 1.83 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.608 -2.087 . . . . 2.0699999999999998 113.453 -171.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 1.039 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 73.9 m 30.31 -170.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.588 1.555 . . . . 1.9099999999999999 114.723 -162.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.883 ' HA ' HG22 ' A' ' 9' ' ' ILE . 8.4 tp -166.99 104.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 113.686 0.995 . . . . 3.1899999999999999 113.686 -168.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.82 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.2 m-20 -144.69 130.79 19.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.678 -0.809 . . . . 3.3100000000000001 110.272 160.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t -50.03 -45.24 51.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.972 1.101 . . . . 3.25 113.972 160.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.3 -37.86 70.47 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.898 1.814 . . . . 4.4500000000000002 115.898 -157.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.478 ' HD2' ' OG ' ' A' ' 10' ' ' SER . 44.9 mtt180 -62.14 -56.87 14.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.229 1.014 . . . . 6.2599999999999998 110.09 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 10' ' ' SER . 34.2 t -64.77 170.7 3.94 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.374 -1.739 . . . . 3.04 109.288 171.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.746 HG22 ' SG ' ' A' ' 12' ' ' CYS . 12.2 t 75.1 30.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 123.168 1.461 . . . . 4.3200000000000003 108.492 -157.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.5 63.24 0.3 Allowed Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 113.457 -1.701 . . . . 4.1900000000000004 112.886 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.23 56.02 24.42 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 119.507 -1.33 . . . . 4.4199999999999999 115.782 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.9 m -136.35 -30.83 0.91 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.588 1.194 . . . . 3.52 109.708 -166.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.51 -26.97 1.57 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.766 2.136 . . . . 3.6400000000000001 116.766 -160.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.83 5.14 5.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.815 1.643 . . . . 5.4400000000000004 112.045 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.67 161.15 35.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 107.876 -1.157 . . . . 3.2200000000000002 107.876 162.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.8 118.69 5.39 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.705 1.287 . . . . 3.8300000000000001 108.998 164.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.76 131.39 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.059 0.392 . . . . 2.6899999999999999 112.059 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.691 HG13 ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -142.05 124.04 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.29 -1.004 . . . . 1.8700000000000001 108.29 158.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.663 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 49.7 ttp -113.2 134.59 54.5 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 118.152 -1.419 . . . . 1.6499999999999999 111.106 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.937 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.89 119.28 55.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 CA-C-O 119.207 -0.425 . . . . 0.76000000000000001 110.0 174.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.691 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 55.55 31.42 57.37 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.117 -1.039 . . . . 1.1000000000000001 112.008 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.543 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 42.7 mt-10 58.54 12.62 2.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.727 -0.737 . . . . 3.0099999999999998 111.525 -174.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.442 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 30.8 mmmt -73.77 -27.49 61.19 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 109.642 -0.503 . . . . 2.6200000000000001 109.642 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.663 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 94.6 t 60.51 100.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.047 -0.979 . . . . 1.51 112.675 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.843 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.1 m-85 -124.98 -161.45 1.02 Allowed 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.046 0.927 . . . . 1.4299999999999999 112.15 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.691 ' HA2' HG13 ' A' ' 63' ' ' VAL . . . -137.14 18.89 3.48 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.505 -1.225 . . . . 1.49 112.091 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.856 ' HB2' HG22 ' A' ' 81' ' ' ILE . 8.2 t30 -84.62 85.89 7.37 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.083 -0.657 . . . . 1.8300000000000001 109.813 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.655 HG21 ' HB ' ' A' ' 63' ' ' VAL . 59.9 t -153.36 -56.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.55 0.944 . . . . 3.0600000000000001 113.55 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.68 HG22 ' HB ' ' A' ' 25' ' ' VAL . 8.3 p -102.15 149.98 37.08 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.559 -0.291 . . . . 2.4900000000000002 111.586 -164.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.789 ' HD2' ' HA ' ' A' ' 25' ' ' VAL . 1.1 Cg_endo -42.85 112.98 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.21 3.274 . . . . 2.6499999999999999 111.742 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.658 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 119.23 -83.75 0.36 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.216 -1.154 . . . . 1.3999999999999999 110.216 -170.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 1.9 pt20 -64.58 -38.73 92.03 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.766 0.793 . . . . 1.8700000000000001 109.855 -175.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.69 HG22 ' NE2' ' A' ' 32' ' ' GLN . 9.9 p -50.99 -57.4 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.875 -1.057 . . . . 0.96999999999999997 111.609 -174.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.602 ' N ' HG13 ' A' ' 78' ' ' VAL . 16.6 pttp -59.87 -42.4 93.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.604 0.716 . . . . 2.1299999999999999 110.342 -164.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.658 ' HD2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -89.1 -34.95 16.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.068 -0.969 . . . . 2.4100000000000001 110.489 -172.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.856 HG22 ' HB2' ' A' ' 72' ' ' ASN . 51.1 mm -68.1 -11.54 14.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.87 -0.604 . . . . 1.23 109.868 174.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.532 ' HB2' HE22 ' A' ' 32' ' ' GLN . 57.4 tp -60.48 -37.19 80.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.32 -0.862 . . . . 0.79000000000000004 110.47 168.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.54 68.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.724 0.773 . . . . 0.88 109.003 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.562 -1.199 . . . . 2.0899999999999999 111.365 174.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.843 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 8.0 m-30 . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 118.283 -0.865 . . . . 1.77 110.95 175.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.856 0.836 . . . . 4.5800000000000001 110.95 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.82 ' HB2' HG12 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -33.96 116.6 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.198 -1.819 . . . . 1.6399999999999999 113.611 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 24.2 Cg_exo -66.34 109.54 1.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.024 1.816 . . . . 1.02 110.582 166.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.772 HG23 ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -78.52 158.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.166 -0.309 . . . . 1.52 110.166 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.875 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 25.1 m -141.88 111.46 6.58 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.041 -0.527 . . . . 1.45 110.354 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.72 120.48 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.971 -0.559 . . . . 2.21 110.985 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.722 ' SG ' HG22 ' A' ' 54' ' ' VAL . 35.8 t -70.2 122.98 20.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.673 -0.411 . . . . 2.2400000000000002 110.717 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.84 22.83 9.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.372 -0.377 . . . . 5.1200000000000001 111.019 174.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.634 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -66.43 177.49 16.63 Favored Glycine 0 C--O 1.22 -0.736 0 C-N-CA 120.497 -0.859 . . . . 3.8599999999999999 112.363 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.7 m -66.32 -45.14 81.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.613 0.597 . . . . 5.9699999999999998 112.613 -171.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.63 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.609 0.719 . . . . 4.4100000000000001 110.783 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 91.3 m -63.51 -28.52 70.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.131 -0.94 . . . . 2.98 111.568 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 61.4 t80 -56.07 -27.45 53.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.302 0.641 . . . . 4.1799999999999997 110.265 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.45 -20.74 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 3.6499999999999999 110.402 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -80.92 10.45 5.05 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.661 0.267 . . . . 4.79 110.671 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.17 28.21 34.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.927 -0.654 . . . . 1.8700000000000001 112.546 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -73.02 -22.7 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.575 0.226 . . . . 1.46 111.454 -171.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.64 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 18.0 t70 -61.43 -46.35 90.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.204 0.526 . . . . 2.4199999999999999 110.29 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 9.1 mptt -67.18 -33.06 74.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.285 -0.635 . . . . 3.0299999999999998 109.285 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.979 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 99.6 t -56.12 -58.19 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 109.011 -0.737 . . . . 2.2599999999999998 109.011 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.532 ' HA ' ' HB2' ' A' ' 29' ' ' PHE . 28.9 m -61.58 -34.63 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.706 -0.679 . . . . 1.5700000000000001 111.566 -174.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -63.1 -48.37 78.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 119.112 -1.035 . . . . 1.3500000000000001 110.189 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.62 81.87 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.846 -1.168 . . . . 0.65000000000000002 107.846 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.678 ' HZ ' ' HH ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -53.35 -52.56 58.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.488 -1.233 . . . . 1.98 110.988 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -51.67 -49.55 62.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.106 -0.952 . . . . 2.8500000000000001 110.578 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.97 -31.54 34.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.442 -1.254 . . . . 2.23 110.842 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.689 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 5.7 mm100 -64.42 -21.92 66.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.632 -0.713 . . . . 2.54 111.933 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.092 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.4 tt -57.45 -55.0 40.47 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.373 -1.343 . . . . 2.0600000000000001 107.373 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.795 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 62.9 -22.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 126.576 2.422 . . . . 4.4800000000000004 112.997 171.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.638 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.21 -175.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.153 -1.385 . . . . 3.7599999999999998 112.667 170.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -156.6 -47.35 0.07 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.687 -1.227 . . . . 4.6200000000000001 107.687 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 pt -167.19 5.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 113.222 -1.808 . . . . 5.0 111.089 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.574 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 178.65 -54.54 0.09 OUTLIER Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.06 -1.216 . . . . 4.1299999999999999 110.06 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.562 ' HA ' HG23 ' A' ' 35' ' ' ILE . 20.5 t70 -175.24 118.65 0.18 Allowed 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.187 -1.507 . . . . 4.3099999999999996 110.709 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.963 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 9.5 p 56.17 -66.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 O-C-N 127.205 2.816 . . . . 2.96 113.044 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.887 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 41.1 m -154.64 -61.62 0.02 OUTLIER Pre-proline 0 C--N 1.279 -2.495 0 CA-C-N 113.619 -1.628 . . . . 3.8300000000000001 109.99 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.887 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.1 Cg_exo -79.75 8.41 4.02 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 120.908 1.072 . . . . 3.8300000000000001 114.297 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.574 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 22.3 t70 82.77 5.85 0.91 Allowed 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.347 1.07 . . . . 4.2599999999999998 108.356 166.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.504 ' N ' ' HB3' ' A' ' 39' ' ' ASP . . . 175.76 76.2 0.05 OUTLIER Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.177 -1.374 . . . . 2.0099999999999998 112.157 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.598 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 5.2 tpt180 -100.45 -60.42 1.53 Allowed 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.463 -0.94 . . . . 3.3399999999999999 108.463 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.092 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.19 115.8 21.68 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 122.508 1.147 . . . . 2.0699999999999998 114.002 -176.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.452 ' C ' HG23 ' A' ' 9' ' ' ILE . 21.2 t -102.27 93.38 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.156 -1.384 . . . . 1.9099999999999999 108.56 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.772 ' HA ' HG23 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -67.52 135.28 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.861 0.689 . . . . 3.1899999999999999 112.861 -168.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.875 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.5 t70 -160.12 138.03 9.93 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.205 1.003 . . . . 3.3100000000000001 112.73 163.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.3 m -48.47 -49.91 33.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 115.407 1.632 . . . . 3.25 115.407 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -54.67 -40.65 69.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.915 2.191 . . . . 4.4500000000000002 116.915 -150.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.65 ' HE ' ' HA ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -63.25 -55.37 25.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.896 0.855 . . . . 6.2599999999999998 110.945 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.72 ' H ' ' HB3' ' A' ' 10' ' ' SER . 25.3 t -63.95 166.41 7.5 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.886 -1.506 . . . . 3.04 109.156 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.722 HG22 ' SG ' ' A' ' 12' ' ' CYS . 14.3 t 72.83 27.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.206 1.479 . . . . 4.3200000000000003 107.586 -153.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.34 65.74 0.32 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 113.292 -1.776 . . . . 4.1900000000000004 113.321 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.16 55.19 25.3 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 119.485 -1.341 . . . . 4.4199999999999999 116.04 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -138.82 -29.89 0.77 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.24 1.02 . . . . 3.52 110.183 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -48.24 -29.51 3.87 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 116.632 2.086 . . . . 3.6400000000000001 116.632 -158.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.9 6.77 4.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.407 1.458 . . . . 5.4400000000000004 111.85 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.39 161.62 30.67 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 3.2200000000000002 108.309 163.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.24 119.13 5.45 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.326 1.152 . . . . 3.8300000000000001 109.307 163.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.09 132.78 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.973 0.731 . . . . 2.6899999999999999 112.973 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.529 HG21 ' CZ ' ' A' ' 29' ' ' PHE . 11.7 p -143.07 121.8 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.86 -0.736 . . . . 1.8700000000000001 109.133 148.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.594 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 50.1 ttp -113.44 133.99 54.9 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 119.26 -0.976 . . . . 1.6499999999999999 108.778 -173.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -126.04 117.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.222 -0.591 . . . . 0.76000000000000001 109.491 173.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.654 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 49.12 50.79 27.27 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 123.748 0.655 . . . . 1.1000000000000001 113.935 173.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 62.12 -0.67 0.45 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.111 0.412 . . . . 3.0099999999999998 112.111 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -75.8 -38.56 58.1 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.834 -0.432 . . . . 2.6200000000000001 109.834 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 95.3 t 61.43 113.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.042 -0.981 . . . . 1.51 112.465 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.594 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 40.0 m-85 -131.53 -172.7 2.92 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.142 0.972 . . . . 1.4299999999999999 112.278 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.01 26.32 3.79 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.024 -1.444 . . . . 1.49 110.96 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 2.1 t30 -76.13 111.73 11.84 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.937 -0.764 . . . . 1.8300000000000001 108.937 177.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 74' ' ' THR . 3.2 m -134.12 -97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 116.34 1.978 . . . . 3.0600000000000001 116.34 -164.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.979 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 10.2 t -143.92 -41.41 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 115.66 1.726 . . . . 2.4900000000000002 115.66 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.605 ' HD3' ' H ' ' A' ' 74' ' ' THR . 5.6 Cg_exo -73.65 57.84 3.76 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 122.133 1.889 . . . . 2.6499999999999999 113.193 -169.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.18 -7.34 10.95 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 116.063 -0.517 . . . . 1.3999999999999999 112.468 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.64 ' O ' HG12 ' A' ' 81' ' ' ILE . 13.8 mt-30 -75.84 -30.8 59.09 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 107.227 -1.398 . . . . 1.8700000000000001 107.227 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.689 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -52.63 -46.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-N 112.554 -2.112 . . . . 0.96999999999999997 112.317 -175.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 50.1 mtmt -54.76 -44.8 73.97 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.517 1.151 . . . . 2.1299999999999999 108.153 -170.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -80.63 -46.75 15.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.826 -1.988 . . . . 2.4100000000000001 110.331 -173.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 77' ' ' GLN . 28.9 mm -69.02 -16.24 20.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.893 -1.049 . . . . 1.23 110.239 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 78' ' ' VAL . 54.9 tp -61.34 -33.95 74.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.483 -0.76 . . . . 0.79000000000000004 110.107 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 -27.93 69.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.281 0.562 . . . . 0.88 109.535 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.468 ' OE1' HG23 ' A' ' 81' ' ' ILE . 1.7 mt-10 -71.38 -27.33 63.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.403 -0.817 . . . . 2.0899999999999999 110.191 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 3.3 m-30 . . . . . 0 N--CA 1.422 -1.864 0 CA-C-N 115.628 -0.714 . . . . 1.77 110.555 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 121.729 0.776 . . . . 4.5800000000000001 112.054 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.726 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 15.6 m-85 -46.79 125.98 8.27 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.054 -1.43 . . . . 1.6399999999999999 112.224 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 47' ' ' SER . 61.0 Cg_exo -57.72 94.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.968 2.446 . . . . 1.02 112.175 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.778 ' HB ' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -82.02 135.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.32 0.581 . . . . 1.52 111.909 -174.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.726 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.0 m -100.68 124.28 46.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.075 -0.966 . . . . 1.45 110.665 -177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 m -116.83 125.01 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.844 0.683 . . . . 2.21 112.844 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' CB ' ' A' ' 17' ' ' CYS . 15.1 t -67.71 117.38 9.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.058 0.456 . . . . 2.2400000000000002 112.057 175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.5 ttt -129.32 23.75 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.901 -0.591 . . . . 5.1200000000000001 109.583 166.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.5 176.46 23.82 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.503 -0.856 . . . . 3.8599999999999999 114.65 -167.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -67.34 -45.33 76.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.979 0.418 . . . . 5.9699999999999998 112.091 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.63 25.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.474 0.654 . . . . 4.4100000000000001 110.1 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 88.5 m -63.76 -33.84 76.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.59 -1.186 . . . . 2.98 112.021 -176.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 43.8 t80 -60.45 -32.62 71.55 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.984 0.421 . . . . 4.1799999999999997 111.015 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -72.68 -23.84 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.537 0.684 . . . . 3.6499999999999999 109.886 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 23.9 tptm -83.2 8.1 14.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.419 -0.809 . . . . 4.79 110.001 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.23 28.29 34.13 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.898 -0.668 . . . . 1.8700000000000001 112.184 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 25' ' ' VAL . . . -71.73 -22.41 61.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 1.46 111.15 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 26' ' ' VAL . 10.0 t70 -56.78 -52.86 63.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.409 -0.359 . . . . 2.4199999999999999 110.232 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -66.17 -37.88 86.71 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.44 -0.504 . . . . 3.0299999999999998 110.908 -172.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.979 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.4 m -69.31 -44.56 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 120.583 -0.447 . . . . 2.2599999999999998 110.72 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 18.9 m -64.52 -31.32 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.919 -0.712 . . . . 1.5700000000000001 109.441 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -59.66 -45.85 90.78 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.932 0.396 . . . . 1.3500000000000001 110.08 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . -56.1 -43.25 77.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.091 -0.958 . . . . 0.65000000000000002 108.516 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.774 ' HZ ' ' HE2' ' A' ' 85' ' ' TYR . 1.3 t80 -56.17 -49.18 74.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.062 -0.972 . . . . 1.98 110.776 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -50.92 -46.63 60.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.262 -0.881 . . . . 2.8500000000000001 110.551 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -76.17 -30.18 58.0 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.97 -1.014 . . . . 2.23 110.919 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.741 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 13.5 mm100 -61.66 -27.59 68.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.218 -0.901 . . . . 2.54 111.059 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -50.86 -58.41 6.03 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.854 -1.165 . . . . 2.0600000000000001 107.854 170.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER 57.45 -2.63 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 O-C-N 125.683 1.865 . . . . 4.4800000000000004 112.61 173.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 46.05 -166.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.656 -1.611 . . . . 3.7599999999999998 112.935 174.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 6.9 t70 -159.57 -40.25 0.05 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.2 -1.407 . . . . 4.6200000000000001 107.2 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 43' ' ' ASP . 1.5 pt -164.32 0.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.247 -2.252 . . . . 5.0 110.557 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.84 -27.41 0.58 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 119.517 -1.325 . . . . 4.1299999999999999 112.944 -165.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.996 ' HA ' ' HE1' ' A' ' 46' ' ' PHE . 10.6 t70 -138.28 167.86 20.96 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 121.157 0.503 . . . . 4.3099999999999996 111.898 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 46' ' ' PHE . 5.0 t -25.58 -58.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 126.877 2.611 . . . . 2.96 110.422 174.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.819 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 98.5 m -159.55 -64.69 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 111.627 -2.533 . . . . 3.8300000000000001 111.397 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.819 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.2 Cg_exo -78.62 5.93 5.22 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 121.097 1.198 . . . . 3.8300000000000001 114.561 -172.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.979 ' HA ' ' HB3' ' A' ' 39' ' ' ASP . 36.9 t70 74.27 21.38 2.45 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.252 -1.018 . . . . 4.2599999999999998 108.252 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.05 58.52 0.16 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 118.691 -1.718 . . . . 2.0099999999999998 113.882 175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.499 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -122.53 -44.28 2.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.241 0.543 . . . . 3.3399999999999999 110.476 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.996 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -119.55 142.11 48.64 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 113.208 0.818 . . . . 2.0699999999999998 113.208 -170.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.738 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 23.2 t -155.64 97.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.354 -1.721 . . . . 1.9099999999999999 106.354 166.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.506 HG23 ' HD2' ' A' ' 46' ' ' PHE . 36.1 pt -87.97 149.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 114.021 1.119 . . . . 3.1899999999999999 114.021 -159.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.3 p30 -161.02 138.01 8.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.394 -1.275 . . . . 3.3100000000000001 110.333 159.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.5 m -44.06 -45.55 8.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.9 -1.5 . . . . 3.25 114.095 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 tp -53.48 -39.5 64.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.711 1.745 . . . . 4.4500000000000002 115.711 -152.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG2' ' H ' ' A' ' 52' ' ' ARG . 2.6 mmt180 -62.65 -57.76 9.91 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.611 1.196 . . . . 6.2599999999999998 109.62 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.726 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 38.5 t -66.99 166.45 13.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.831 -1.986 . . . . 3.04 111.208 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 54' ' ' VAL . 21.4 t 70.65 26.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 123.332 1.539 . . . . 4.3200000000000003 109.238 -169.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.17 63.58 0.3 Allowed Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 113.319 -1.764 . . . . 4.1900000000000004 112.36 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.34 58.84 10.78 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 119.044 -1.55 . . . . 4.4199999999999999 114.498 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.314 0.8 OUTLIER -131.43 -33.76 1.44 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.05 1.425 . . . . 3.52 108.982 -157.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.36 2.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 115.311 1.597 . . . . 3.6400000000000001 115.311 -163.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -72.82 6.39 2.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.984 -1.086 . . . . 5.4400000000000004 111.746 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.1 158.2 46.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 108.027 -1.101 . . . . 3.2200000000000002 108.027 157.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.59 120.07 5.43 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 CA-C-N 120.659 1.271 . . . . 3.8300000000000001 109.507 163.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.581 ' O ' HD12 ' A' ' 62' ' ' ILE . 2.0 pp -111.46 130.31 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.048 0.758 . . . . 2.6899999999999999 113.048 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.966 HG21 ' H ' ' A' ' 73' ' ' VAL . 3.9 t -142.27 116.52 4.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 107.091 -1.448 . . . . 1.8700000000000001 107.091 157.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.576 ' HG3' HG12 ' A' ' 69' ' ' VAL . 20.5 ttt -119.11 136.47 54.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 118.434 -1.306 . . . . 1.6499999999999999 111.334 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 68' ' ' LYS . 1.8 m -123.46 115.94 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.533 -1.284 . . . . 0.76000000000000001 107.533 157.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 7' ' ' TYR . . . 50.03 -155.47 2.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.648 -0.787 . . . . 1.1000000000000001 111.223 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.79 37.27 0.41 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.995 -0.603 . . . . 3.0099999999999998 109.93 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.797 ' HB2' HG23 ' A' ' 65' ' ' VAL . 14.5 mmmm -103.09 -22.76 13.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.056 -0.52 . . . . 2.6200000000000001 109.999 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.576 HG12 ' HG3' ' A' ' 64' ' ' MET . 3.5 m 29.06 101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.134 1.531 . . . . 1.51 115.134 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.739 ' HD2' ' HE1' ' A' ' 85' ' ' TYR . 62.7 m-85 -118.09 -158.68 0.72 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.99 0.9 . . . . 1.4299999999999999 112.14 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 81' ' ' ILE . . . -147.84 40.8 0.95 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 114.38 -1.282 . . . . 1.49 110.138 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 1.006 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -64.37 -4.99 4.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.717 0.77 . . . . 1.8300000000000001 110.759 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.966 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 48.89 -160.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.91 1.684 . . . . 3.0600000000000001 114.308 169.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.979 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 27.1 p -139.66 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.964 1.468 . . . . 2.4900000000000002 114.964 -166.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.889 ' HD2' HE21 ' A' ' 77' ' ' GLN . 3.7 Cg_exo -77.99 76.98 4.1 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.307 2.004 . . . . 2.6499999999999999 113.811 -170.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.2 -20.75 3.03 Favored Glycine 0 N--CA 1.462 0.397 0 C-N-CA 121.405 -0.426 . . . . 1.3999999999999999 112.751 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.889 HE21 ' HD2' ' A' ' 75' ' ' PRO . 18.4 mt-30 -77.99 -18.91 55.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.824 -1.547 . . . . 1.8700000000000001 106.824 -172.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.741 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -47.15 -51.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 112.069 -2.332 . . . . 0.96999999999999997 110.908 -177.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.707 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 44.7 mtmt -54.0 -51.61 63.41 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 122.833 1.301 . . . . 2.1299999999999999 109.343 -167.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.23 -35.5 15.29 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.176 -1.829 . . . . 2.4100000000000001 110.675 -169.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.006 HG22 ' HA ' ' A' ' 72' ' ' ASN . 46.5 mm -71.98 -13.6 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.176 -0.92 . . . . 1.23 109.126 176.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 85' ' ' TYR . 43.9 tp -56.11 -19.89 15.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.469 -0.332 . . . . 0.79000000000000004 110.343 171.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.7 -22.23 1.98 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.777 0.322 . . . . 0.88 111.428 167.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.25 -44.37 95.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.431 0.634 . . . . 2.0899999999999999 110.251 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.774 ' HE2' ' HZ ' ' A' ' 29' ' ' PHE . 10.1 m-30 . . . . . 0 N--CA 1.427 -1.586 0 CA-C-N 115.018 -0.992 . . . . 1.77 112.082 -173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.275 -0.268 . . . . 13.970000000000001 110.275 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.809 ' HB ' ' HD3' ' A' ' 3' ' ' PRO . 60.1 t -64.22 -52.23 56.18 Favored Pre-proline 0 C--N 1.332 -0.166 0 N-CA-C 108.511 -0.922 . . . . 10.710000000000001 108.511 171.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.809 ' HD3' ' HB ' ' A' ' 2' ' ' VAL . 21.1 Cg_exo -67.74 119.93 6.95 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.619 -1.339 . . . . 9.1999999999999993 108.619 158.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.659 ' CB ' ' HA3' ' A' ' 44' ' ' GLY . 13.0 tptm -42.6 -65.82 0.43 Allowed 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 124.19 0.931 . . . . 9.0399999999999991 112.144 -171.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 1.063 ' HA2' ' HB2' ' A' ' 47' ' ' SER . . . 112.37 31.66 2.55 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 114.636 -1.166 . . . . 4.1399999999999997 111.916 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.72 ' HG2' ' CE1' ' A' ' 7' ' ' TYR . 25.4 ttpt -58.94 -54.01 51.94 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.194 -0.503 . . . . 4.5800000000000001 110.106 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.918 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.0 m-30 -108.5 82.69 1.72 Allowed Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 116.228 -0.442 . . . . 1.6399999999999999 110.412 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.932 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 87.1 Cg_exo -52.72 94.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.835 2.356 . . . . 1.02 111.972 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.724 ' HB ' ' CG1' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -85.11 127.7 39.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 1.52 112.054 -173.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 14.3 m -100.37 110.99 23.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.286 -0.87 . . . . 1.45 110.627 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -117.21 124.12 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.299 -0.409 . . . . 2.21 110.97 -178.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.708 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 24.4 t -67.38 121.24 15.32 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.195 -0.602 . . . . 2.2400000000000002 111.611 174.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.0 mtm -123.82 23.11 8.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.934 -0.765 . . . . 5.1200000000000001 108.934 164.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.03 177.38 19.65 Favored Glycine 0 C--O 1.219 -0.807 0 C-N-CA 120.945 -0.645 . . . . 3.8599999999999999 112.624 -173.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.7 p -64.29 -43.89 93.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.69 0.626 . . . . 5.9699999999999998 112.69 -168.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.701 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -69.88 -55.63 9.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.002 0.43 . . . . 4.4100000000000001 111.361 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.708 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 86.6 m -66.53 -34.93 79.02 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.408 -0.36 . . . . 2.98 111.757 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 51.3 t80 -62.16 -32.16 72.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.909 0.484 . . . . 4.1799999999999997 111.746 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 16' ' ' ALA . 4.2 p -70.91 -18.67 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.147 0.499 . . . . 3.6499999999999999 110.818 -172.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -80.75 8.43 8.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.501 0.667 . . . . 4.79 109.769 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.01 23.78 54.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.561 -0.745 . . . . 1.8700000000000001 112.048 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.57 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -73.43 -21.08 60.56 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.421 -0.389 . . . . 1.46 110.673 -172.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 26' ' ' VAL . 13.6 t70 -56.93 -46.55 81.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.625 -0.716 . . . . 2.4199999999999999 111.309 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -66.88 -36.99 83.57 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.067 -0.653 . . . . 3.0299999999999998 110.353 -175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.542 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -72.53 -38.18 58.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.797 -0.638 . . . . 2.2599999999999998 111.182 177.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.607 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 4.6 m -66.19 -28.43 43.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 119.546 -0.862 . . . . 1.5700000000000001 109.15 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -58.48 -40.47 82.82 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.577 -0.527 . . . . 1.3500000000000001 109.577 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 32' ' ' GLN . . . -50.96 -51.26 54.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.863 -1.062 . . . . 0.65000000000000002 108.904 174.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.607 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 29.8 t80 -53.65 -48.77 69.1 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.95 -1.023 . . . . 1.98 112.0 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -46.75 -49.48 19.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.004 -0.998 . . . . 2.8500000000000001 110.494 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -77.96 -26.79 49.02 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.676 -1.147 . . . . 2.23 110.619 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.651 ' OE1' ' HA ' ' A' ' 79' ' ' LYS . 4.6 mt-30 -60.5 -29.86 69.36 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.536 -0.757 . . . . 2.54 112.393 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.749 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 1.1 tt -48.42 -55.74 10.04 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.373 -1.714 . . . . 2.0600000000000001 106.373 171.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.04 -18.81 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 O-C-N 126.513 2.383 . . . . 4.4800000000000004 112.648 173.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.736 ' HA ' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 51.71 -164.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 113.398 -1.728 . . . . 3.7599999999999998 113.996 165.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -155.51 -55.64 0.09 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.581 -1.645 . . . . 4.6200000000000001 108.076 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 pt -167.53 9.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 112.728 -2.033 . . . . 5.0 108.486 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.92 -51.81 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.585 0 N-CA-C 108.981 -1.647 . . . . 4.1299999999999999 108.981 -164.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.581 ' HA ' HG23 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -169.72 143.04 2.6 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.546 -0.827 . . . . 4.3099999999999996 111.772 178.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.806 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER 18.83 -68.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 O-C-N 127.041 2.713 . . . . 2.96 115.167 161.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.624 ' H ' HG13 ' A' ' 40' ' ' VAL . 23.5 m -135.32 94.64 15.42 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 104.793 -2.299 . . . . 3.8300000000000001 104.793 -176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -33.06 89.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 123.965 3.11 . . . . 3.8300000000000001 113.608 -149.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 4' ' ' LYS . 8.8 t70 -144.36 -65.1 0.35 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.919 -1.491 . . . . 4.2599999999999998 111.37 -175.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 4' ' ' LYS . . . 113.49 37.41 1.32 Allowed Glycine 0 C--N 1.31 -0.89 0 N-CA-C 110.32 -1.112 . . . . 2.0099999999999998 110.32 -169.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.621 ' HD3' ' OXT' ' A' ' 85' ' ' TYR . 76.5 mtt180 -61.15 -42.26 98.23 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.876 -1.162 . . . . 3.3399999999999999 109.845 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.806 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 99.3 m-85 -84.15 136.88 33.81 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.911 -1.041 . . . . 2.0699999999999998 110.969 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 1.063 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 19.9 t -145.01 65.25 1.27 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.813 -1.18 . . . . 1.9099999999999999 107.813 165.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.682 HG22 HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.97 129.17 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.331 -0.85 . . . . 3.1899999999999999 111.99 -170.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -154.93 138.9 16.36 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 122.281 1.039 . . . . 3.3100000000000001 110.784 163.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.7 p -43.86 -45.42 7.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.322 -1.763 . . . . 3.25 115.488 168.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 45.1 tp -53.16 -41.52 65.24 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 115.282 1.586 . . . . 4.4500000000000002 115.282 -149.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -64.43 -57.34 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.931 0.872 . . . . 6.2599999999999998 111.053 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -66.26 170.51 5.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.835 -1.53 . . . . 3.04 111.026 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.903 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 5.9 t 73.14 28.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.67 1.224 . . . . 4.3200000000000003 109.175 -164.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.65 64.2 0.3 Allowed Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 113.922 -1.49 . . . . 4.1900000000000004 113.371 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.49 57.49 16.31 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 119.319 -1.42 . . . . 4.4199999999999999 115.321 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.252 2.0 m -133.19 -33.32 1.14 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.706 1.253 . . . . 3.52 109.747 -161.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.98 -26.38 2.49 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.397 1.999 . . . . 3.6400000000000001 116.397 -163.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.72 3.38 6.54 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.316 1.416 . . . . 5.4400000000000004 111.413 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.94 158.36 50.28 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.245 -1.391 . . . . 3.2200000000000002 107.245 154.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.15 118.6 5.03 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-N 121.191 1.461 . . . . 3.8300000000000001 109.648 164.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 mp -110.32 131.71 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.89 -0.141 . . . . 2.6899999999999999 110.867 173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.689 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 6.1 t -138.71 125.93 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 107.891 -1.151 . . . . 1.8700000000000001 107.891 160.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.74 ' HG3' HG22 ' A' ' 69' ' ' VAL . 49.7 ttm -112.29 136.77 51.32 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 117.703 -1.599 . . . . 1.6499999999999999 109.815 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.918 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.75 114.71 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 106.649 -1.612 . . . . 0.76000000000000001 106.649 159.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.18 -145.87 1.65 Allowed Glycine 0 N--CA 1.438 -1.2 0 CA-C-O 122.337 0.965 . . . . 1.1000000000000001 112.596 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.53 25.88 0.31 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.379 -1.411 . . . . 3.0099999999999998 109.423 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.618 ' HD2' ' CE1' ' A' ' 7' ' ' TYR . 9.1 mmpt? -106.95 -40.82 5.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.298 -0.63 . . . . 2.6200000000000001 109.298 -174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.74 HG22 ' HG3' ' A' ' 64' ' ' MET . 80.1 t 46.26 99.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 113.502 0.927 . . . . 1.51 113.502 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.733 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -117.03 -153.21 0.52 Allowed 'General case' 0 C--O 1.246 0.906 0 CA-C-O 122.07 0.938 . . . . 1.4299999999999999 113.362 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.594 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -134.51 17.1 4.27 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 114.202 -1.363 . . . . 1.49 112.796 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.904 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -89.53 98.52 11.81 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.945 -0.761 . . . . 1.8300000000000001 108.945 179.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.618 HG13 HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -126.41 -90.31 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 CA-C-O 122.181 0.991 . . . . 3.0600000000000001 112.652 -173.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.855 HG23 ' HD3' ' A' ' 75' ' ' PRO . 0.5 OUTLIER -137.77 -66.6 0.02 OUTLIER Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 113.504 -1.68 . . . . 2.4900000000000002 111.858 -170.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.855 ' HD3' HG23 ' A' ' 74' ' ' THR . 6.3 Cg_exo -76.84 70.87 6.36 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.648 2.232 . . . . 2.6499999999999999 114.019 -162.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.469 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 80.1 -19.55 6.53 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.105 -0.569 . . . . 1.3999999999999999 113.108 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.541 ' O ' HG12 ' A' ' 81' ' ' ILE . 6.2 mt-30 -73.98 -22.86 59.45 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 106.342 -1.725 . . . . 1.8700000000000001 106.342 -170.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 79' ' ' LYS . 13.6 m -48.7 -59.18 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 111.826 -2.443 . . . . 0.96999999999999997 111.386 -175.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.657 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 23.6 pttt -60.17 -39.49 86.62 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 121.783 0.801 . . . . 2.1299999999999999 110.741 -165.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.657 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -82.38 -45.27 15.07 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.75 -1.113 . . . . 2.4100000000000001 109.646 -173.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' A' ' 72' ' ' ASN . 39.5 mm -69.39 -15.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.211 -1.358 . . . . 1.23 110.155 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.518 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 53.6 tp -63.04 -37.81 88.67 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.74 -0.6 . . . . 0.79000000000000004 110.256 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.41 -29.7 64.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.013 -0.736 . . . . 0.88 109.013 172.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 6.6 mt-10 -73.66 -34.49 64.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.871 -1.059 . . . . 2.0899999999999999 112.748 174.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.904 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 5.1 m-30 . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 118.951 -0.547 . . . . 1.77 112.044 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 0.903 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mmm . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.881 0.372 . . . . 13.970000000000001 110.478 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 48.6 t -125.06 101.1 32.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 10.710000000000001 110.232 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.9 100.57 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.498 2.132 . . . . 9.1999999999999993 111.223 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.844 ' HG3' ' HA3' ' A' ' 44' ' ' GLY . 25.3 mmtp -58.34 -45.22 88.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.428 0.633 . . . . 9.0399999999999991 111.421 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.92 0.35 58.86 Favored Glycine 0 C--N 1.307 -1.059 0 CA-C-N 115.165 -0.925 . . . . 4.1399999999999997 114.262 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 3.8 tppp? -64.87 -58.72 5.45 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 109.422 -0.585 . . . . 4.5800000000000001 109.422 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 1.071 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 22.5 m-85 -141.71 62.71 15.34 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 114.364 -1.289 . . . . 1.6399999999999999 110.254 -175.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD2' ' CA ' ' A' ' 66' ' ' GLY . 33.4 Cg_exo -61.48 92.81 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.534 1.489 . . . . 1.02 109.949 172.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.066 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.03 160.37 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-N 116.409 -0.36 . . . . 1.52 110.426 -168.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.806 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 3.1 m -139.86 112.84 8.13 Favored 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 123.644 0.59 . . . . 1.45 111.343 -174.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.7 t -118.17 125.37 74.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.182 -0.917 . . . . 2.21 109.857 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -65.39 120.38 12.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 118.775 0.716 . . . . 2.2400000000000002 110.958 177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.8 ttt -124.3 23.05 8.42 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.503 -0.771 . . . . 5.1200000000000001 109.654 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.575 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -68.06 177.52 23.73 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.625 -0.797 . . . . 3.8599999999999999 112.417 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -67.65 -43.8 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.078 0.399 . . . . 5.9699999999999998 112.078 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.642 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -71.29 -56.8 5.29 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.549 0.574 . . . . 4.4100000000000001 112.549 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 98.9 m -63.48 -30.53 71.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.506 -0.316 . . . . 2.98 111.572 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.575 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 56.4 t80 -59.31 -29.53 67.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.286 0.635 . . . . 4.1799999999999997 112.179 -176.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 16' ' ' ALA . 16.9 m -69.15 -18.65 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 111.91 0.337 . . . . 3.6499999999999999 111.91 -171.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -81.02 13.32 2.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.807 0.337 . . . . 4.79 110.591 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.4 28.73 23.99 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.649 -0.58 . . . . 1.8700000000000001 111.649 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -72.48 -19.63 61.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.253 -0.474 . . . . 1.46 110.97 -172.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 18' ' ' PHE . 8.5 p-10 -55.7 -45.0 77.92 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.887 -0.325 . . . . 2.4199999999999999 110.429 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -62.61 -48.29 80.06 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.352 -0.539 . . . . 3.0299999999999998 110.782 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.033 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 6.6 m -65.52 -44.3 94.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 116.305 -0.407 . . . . 2.2599999999999998 110.526 -176.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' ASP . 15.0 m -64.17 -36.45 77.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.149 -0.62 . . . . 1.5700000000000001 110.2 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -60.18 -42.57 95.3 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.107 -0.637 . . . . 1.3500000000000001 109.398 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.597 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.75 -46.66 81.27 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.42 -1.264 . . . . 0.65000000000000002 108.629 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' HZ ' ' CG1' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -44.59 82.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.274 -0.875 . . . . 1.98 111.425 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -54.63 -51.21 66.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.723 0.773 . . . . 2.8500000000000001 110.085 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.77 -20.75 38.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.935 -1.03 . . . . 2.23 110.653 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.597 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -62.0 -30.64 71.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.781 -0.645 . . . . 2.54 110.341 178.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.098 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.8 tt -54.69 -54.24 44.41 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.259 -1.015 . . . . 2.0600000000000001 108.259 172.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 65.77 -19.52 0.09 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 112.357 -2.202 . . . . 4.4800000000000004 112.493 172.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.698 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER 54.36 -170.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 113.501 -1.681 . . . . 3.7599999999999998 113.12 168.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -157.38 -49.56 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.208 -1.405 . . . . 4.6200000000000001 107.208 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -164.92 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 113.069 -1.878 . . . . 5.0 110.836 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -178.05 -61.98 0.07 OUTLIER Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 109.783 -1.327 . . . . 4.1299999999999999 109.783 -166.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.584 ' HB2' ' N ' ' A' ' 44' ' ' GLY . 38.2 m-20 -165.52 122.12 1.42 Allowed 'General case' 0 CA--C 1.475 -1.925 0 CA-C-N 113.051 -1.575 . . . . 4.3099999999999996 108.796 178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.986 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 1.4 p 54.99 -71.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 O-C-N 126.775 2.547 . . . . 2.96 113.348 169.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.788 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 84.3 m -151.18 -57.72 0.02 OUTLIER Pre-proline 0 C--N 1.275 -2.662 0 CA-C-N 113.262 -1.79 . . . . 3.8300000000000001 110.256 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.819 ' HD2' HG13 ' A' ' 40' ' ' VAL . 7.1 Cg_exo -73.83 4.42 4.15 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 120.673 0.915 . . . . 3.8300000000000001 113.946 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 20.2 t70 78.09 14.12 1.56 Allowed 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.294 -1.373 . . . . 4.2599999999999998 107.294 169.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.844 ' HA3' ' HG3' ' A' ' 4' ' ' LYS . . . 155.07 63.58 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 114.151 -1.386 . . . . 2.0099999999999998 112.278 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 10.5 ttt180 -94.7 -64.69 1.04 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.814 -1.55 . . . . 3.3399999999999999 106.814 171.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.098 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -107.23 123.99 49.1 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.752 -0.658 . . . . 2.0699999999999998 112.281 171.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.459 ' C ' HG23 ' A' ' 9' ' ' ILE . 4.2 m -105.33 92.15 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.076 -0.966 . . . . 1.9099999999999999 109.279 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.005 HG22 HD13 ' A' ' 9' ' ' ILE . 2.3 pp -60.18 123.34 12.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.774 -0.648 . . . . 3.1899999999999999 112.72 -172.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.806 ' O ' ' HA ' ' A' ' 10' ' ' SER . 5.3 t70 -160.85 140.49 10.77 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 122.241 1.019 . . . . 3.3100000000000001 113.051 167.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 8.8 t -47.51 -45.96 26.9 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 115.111 1.522 . . . . 3.25 115.111 169.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.439 ' HG ' ' OD1' ' A' ' 49' ' ' ASP . 51.6 mt -53.49 -38.12 63.38 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.254 2.316 . . . . 4.4500000000000002 117.254 -152.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.577 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.4 mmt180 -61.78 -56.82 15.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.757 1.162 . . . . 6.2599999999999998 110.18 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.699 ' H ' ' HB3' ' A' ' 10' ' ' SER . 27.4 t -65.07 165.46 11.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.327 -1.76 . . . . 3.04 109.938 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.012 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 10.9 t 71.26 25.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 122.93 1.347 . . . . 4.3200000000000003 108.188 -156.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.51 64.11 0.35 Allowed Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 113.583 -1.644 . . . . 4.1900000000000004 113.538 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.33 57.71 14.21 Favored Glycine 0 C--N 1.342 0.892 0 C-N-CA 119.11 -1.519 . . . . 4.4199999999999999 115.3 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.67 ' HB3' HG21 ' A' ' 62' ' ' ILE 0.267 1.8 m -135.7 -32.65 0.89 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.564 1.182 . . . . 3.52 110.416 -162.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.51 -28.64 5.66 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.477 1.658 . . . . 3.6400000000000001 115.477 -163.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.57 7.63 2.85 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.777 1.172 . . . . 5.4400000000000004 112.053 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.7 160.55 36.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.888 -0.782 . . . . 3.2200000000000002 108.888 164.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.89 122.18 7.09 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 N-CA-C 108.787 -1.274 . . . . 3.8300000000000001 108.787 160.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 57' ' ' CYS . 1.9 pp -110.0 133.68 54.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.875 1.065 . . . . 2.6899999999999999 113.875 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.762 HG21 ' H ' ' A' ' 73' ' ' VAL . 4.0 t -138.03 119.19 17.07 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.95 0 N-CA-C 106.022 -1.844 . . . . 1.8700000000000001 106.022 154.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.752 ' HB3' ' HB2' ' A' ' 10' ' ' SER . 20.9 ttt -114.36 135.34 54.19 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 120.33 -1.481 . . . . 1.6499999999999999 111.926 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.071 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.7 OUTLIER -126.57 118.43 50.96 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 N-CA-C 107.635 -1.246 . . . . 0.76000000000000001 107.635 157.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.559 ' CA ' ' HD2' ' A' ' 8' ' ' PRO . . . 60.2 -169.78 7.53 Favored Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 119.886 -1.15 . . . . 1.1000000000000001 110.481 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -78.83 37.96 0.31 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.926 -1.138 . . . . 3.0099999999999998 107.926 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.638 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 54.6 mmtt -107.89 -31.21 8.1 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.892 -1.049 . . . . 2.6200000000000001 108.646 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.661 ' C ' ' HD1' ' A' ' 70' ' ' TYR . 75.7 t 47.54 113.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 114.472 1.286 . . . . 1.51 114.472 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.678 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -123.53 -170.11 2.06 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 122.615 1.197 . . . . 1.4299999999999999 112.967 -172.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -138.71 49.9 0.82 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 113.662 -1.608 . . . . 1.49 110.178 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.919 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -77.92 -0.41 27.45 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.361 1.077 . . . . 1.8300000000000001 110.062 175.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.762 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 64.33 -165.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 113.749 -1.569 . . . . 3.0600000000000001 111.65 168.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 1.033 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 64.4 p -138.58 -46.67 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.078 0 N-CA-C 114.22 1.193 . . . . 2.4900000000000002 114.22 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.799 ' HD2' HE21 ' A' ' 77' ' ' GLN . 7.0 Cg_endo -88.29 78.58 1.33 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.895 1.73 . . . . 2.6499999999999999 113.787 -172.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.28 -23.17 2.33 Favored Glycine 0 N--CA 1.461 0.335 0 C-N-CA 121.01 -0.614 . . . . 1.3999999999999999 113.078 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.799 HE21 ' HD2' ' A' ' 75' ' ' PRO . 32.7 mt-30 -75.28 -21.12 58.76 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.413 -1.699 . . . . 1.8700000000000001 106.413 -174.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.666 HG23 ' H ' ' A' ' 79' ' ' LYS . 4.0 m -45.09 -61.32 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 111.478 -2.601 . . . . 0.96999999999999997 112.162 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.666 ' H ' HG23 ' A' ' 78' ' ' VAL . 43.3 mtmt -58.03 -32.03 67.57 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 122.039 0.923 . . . . 2.1299999999999999 110.657 -166.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -81.28 -50.84 9.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.53 -1.214 . . . . 2.4100000000000001 108.837 -177.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.919 ' CG2' ' HA ' ' A' ' 72' ' ' ASN . 28.8 mm -66.14 -5.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 113.549 -1.66 . . . . 1.23 110.601 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 47.0 tp -54.22 -21.67 9.58 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.508 -0.745 . . . . 0.79000000000000004 110.143 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.84 -19.66 6.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.687 -0.688 . . . . 0.88 111.352 169.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 70' ' ' TYR . 6.6 tp10 -69.53 -51.34 36.54 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.44 1.096 . . . . 2.0899999999999999 110.241 173.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.678 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 11.4 m-30 . . . . . 0 N--CA 1.425 -1.693 0 CA-C-N 113.673 -1.603 . . . . 1.77 112.811 -166.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 1.012 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 mtm . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.757 -0.46 . . . . 13.970000000000001 109.757 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.95 113.01 26.79 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.258 -0.645 . . . . 10.710000000000001 109.258 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.723 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 17.4 Cg_exo -66.13 147.87 84.49 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.509 2.139 . . . . 9.1999999999999993 112.353 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.596 ' H ' ' HA3' ' A' ' 44' ' ' GLY . 22.5 ttmm -50.37 -74.38 0.03 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.572 0.701 . . . . 9.0399999999999991 112.241 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.0 35.67 0.54 Allowed Glycine 0 C--N 1.31 -0.876 0 CA-C-N 114.637 -1.165 . . . . 4.1399999999999997 112.607 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 24.2 tptp -56.16 -59.44 4.92 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.817 -0.809 . . . . 4.5800000000000001 108.817 170.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 1.092 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -115.89 87.51 18.71 Favored Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-N 114.711 -1.132 . . . . 1.6399999999999999 110.916 175.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -53.34 96.55 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.637 2.225 . . . . 1.02 111.565 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.084 HD13 HG22 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -75.17 117.83 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.799 0.809 . . . . 1.52 110.289 -175.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.694 ' HB3' ' H ' ' A' ' 53' ' ' CYS . 7.3 m -100.14 113.02 25.35 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.139 -1.391 . . . . 1.45 110.528 -171.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.635 HG11 HG12 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -118.48 122.81 70.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.274 -0.875 . . . . 2.21 110.328 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.736 ' SG ' HG22 ' A' ' 54' ' ' VAL . 33.7 t -66.47 122.82 18.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.279 0.561 . . . . 2.2400000000000002 111.284 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.0 mtt -122.69 23.87 9.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.428 -0.805 . . . . 5.1200000000000001 109.699 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.95 178.68 20.21 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.792 -0.718 . . . . 3.8599999999999999 112.778 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 t -65.36 -44.85 86.38 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.462 0.541 . . . . 5.9699999999999998 112.462 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.23 -55.05 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.271 0.558 . . . . 4.4100000000000001 111.851 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 79.4 m -64.69 -31.08 72.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.537 -0.756 . . . . 2.98 111.541 -173.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 75.6 t80 -58.35 -27.43 64.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.447 0.699 . . . . 4.1799999999999997 111.576 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.5 t -67.74 -20.82 26.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.058 -0.519 . . . . 3.6499999999999999 111.468 -171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -80.79 11.48 3.87 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.159 -0.338 . . . . 4.79 111.224 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.38 29.44 27.48 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.725 -0.75 . . . . 1.8700000000000001 111.954 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -71.93 -20.47 61.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.906 0.335 . . . . 1.46 111.906 -168.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 26' ' ' VAL . 27.1 t70 -57.86 -45.34 86.42 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.845 -0.342 . . . . 2.4199999999999999 110.881 -176.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -64.92 -42.52 94.64 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.176 -0.609 . . . . 3.0299999999999998 111.134 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.9 m -68.91 -39.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.707 0.289 . . . . 2.2599999999999998 111.228 -178.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.875 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . 10.7 m -65.31 -33.35 63.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.817 -0.753 . . . . 1.5700000000000001 110.258 175.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.58 -39.33 87.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 121.253 0.549 . . . . 1.3500000000000001 109.551 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 78' ' ' VAL . . . -55.08 -45.84 75.42 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.701 -1.136 . . . . 0.65000000000000002 109.443 175.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.914 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 23.1 m-85 -52.15 -50.11 62.43 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 123.46 0.475 . . . . 1.98 111.02 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -49.91 -50.83 44.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.53 0.681 . . . . 2.8500000000000001 111.312 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.52 -30.22 37.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.296 -0.865 . . . . 2.23 111.39 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.914 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -68.01 -19.29 64.9 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.741 -0.663 . . . . 2.54 110.313 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.04 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -54.52 -56.48 18.42 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 106.153 -1.795 . . . . 2.0600000000000001 106.153 169.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 70.16 -21.86 0.17 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.775 -2.011 . . . . 4.4800000000000004 110.909 168.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.717 HG12 HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 56.56 -176.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 112.508 -2.133 . . . . 3.7599999999999998 113.702 166.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' H ' HG22 ' A' ' 35' ' ' ILE . 12.9 t70 -158.68 -44.11 0.06 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.075 -1.42 . . . . 4.6200000000000001 107.748 -172.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.5 pt -168.3 -0.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 113.226 -1.806 . . . . 5.0 111.416 -173.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 176.77 -52.66 0.11 Allowed Glycine 0 CA--C 1.483 -1.923 0 N-CA-C 107.629 -2.188 . . . . 4.1299999999999999 107.629 -162.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.757 ' CG ' HG12 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -171.54 135.54 0.91 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 112.266 -1.967 . . . . 4.3099999999999996 109.732 175.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.757 HG12 ' CG ' ' A' ' 39' ' ' ASP . 7.1 p 39.06 -65.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 O-C-N 127.502 3.001 . . . . 2.96 114.955 167.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.788 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 45.0 m -150.82 -60.11 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.69 -1.595 . . . . 3.8300000000000001 110.833 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.822 ' HG2' ' HG3' ' A' ' 45' ' ' ARG . 1.1 Cg_endo -88.33 15.51 2.07 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 121.618 1.546 . . . . 3.8300000000000001 114.937 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 25.8 t70 83.38 -1.75 1.17 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 122.143 0.973 . . . . 4.2599999999999998 109.708 160.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.596 ' HA3' ' H ' ' A' ' 4' ' ' LYS . . . 172.18 53.11 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 119.774 -1.203 . . . . 2.0099999999999998 113.566 172.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.822 ' HG3' ' HG2' ' A' ' 42' ' ' PRO . 20.0 mtt180 -72.26 -53.9 11.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.924 -0.769 . . . . 3.3399999999999999 108.924 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.04 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -128.08 120.3 27.15 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 122.552 1.167 . . . . 2.0699999999999998 113.768 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.723 ' HB3' ' HB2' ' A' ' 3' ' ' PRO . 41.9 p -114.68 106.73 14.57 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.818 -1.537 . . . . 1.9099999999999999 108.307 175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.084 HG22 HD13 ' A' ' 9' ' ' ILE . 2.0 pp -72.91 121.06 22.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.378 -0.828 . . . . 3.1899999999999999 112.229 -170.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.49 141.95 15.11 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 122.744 1.259 . . . . 3.3100000000000001 112.225 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 21.4 m -43.92 -46.24 8.0 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.614 2.079 . . . . 3.25 116.614 174.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.3 mt -53.44 -41.12 65.76 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.776 2.139 . . . . 4.4500000000000002 116.776 -147.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.556 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 12.7 tpt180 -63.39 -57.72 9.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.271 0.941 . . . . 6.2599999999999998 110.786 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.694 ' H ' ' HB3' ' A' ' 10' ' ' SER . 33.0 t -65.18 172.72 2.87 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.591 -1.64 . . . . 3.04 110.727 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.997 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 13.5 t 76.2 29.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 122.93 1.348 . . . . 4.3200000000000003 109.538 -160.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.2 61.65 0.31 Allowed Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 113.849 -1.523 . . . . 4.1900000000000004 112.555 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.97 54.98 32.38 Favored Glycine 0 C--N 1.345 1.034 0 C-N-CA 119.892 -1.147 . . . . 4.4199999999999999 115.709 169.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.257 1.4 m -135.12 -32.49 0.95 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.202 1.501 . . . . 3.52 109.704 -161.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.89 -25.27 1.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.921 1.823 . . . . 3.6400000000000001 115.921 -163.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -72.63 8.14 1.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.563 1.074 . . . . 5.4400000000000004 111.791 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.68 161.91 27.97 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 108.053 -1.092 . . . . 3.2200000000000002 108.053 162.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.33 119.96 6.27 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 CA-C-N 120.704 1.287 . . . . 3.8300000000000001 109.309 166.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.47 132.74 56.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.429 0.529 . . . . 2.6899999999999999 112.429 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.721 HG21 ' H ' ' A' ' 73' ' ' VAL . 2.5 t -138.7 119.76 16.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.446 -1.687 . . . . 1.8700000000000001 106.446 154.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.661 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 20.8 ttt -112.42 136.27 52.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 O-C-N 120.369 -1.457 . . . . 1.6499999999999999 110.0 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.092 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -125.26 117.15 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.413 -1.329 . . . . 0.76000000000000001 107.413 159.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 55.09 -162.3 4.72 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.146 -1.026 . . . . 1.1000000000000001 110.863 -176.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -79.06 34.48 0.24 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.889 -0.782 . . . . 3.0099999999999998 108.889 171.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.663 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 70.9 mmtt -108.47 -22.18 12.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.279 -0.873 . . . . 2.6200000000000001 110.012 -173.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 23.2 m 36.54 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 115.134 1.531 . . . . 1.51 115.134 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.789 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.2 m-30 -116.31 -178.33 3.39 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.979 1.371 . . . . 1.4299999999999999 113.598 -173.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -136.05 48.67 0.91 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 113.381 -1.736 . . . . 1.49 109.603 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.913 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -78.4 -0.89 30.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.902 0.858 . . . . 1.8300000000000001 109.191 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.721 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER 63.31 -168.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 113.909 -1.496 . . . . 3.0600000000000001 111.282 171.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.863 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 13.3 p -135.74 -46.36 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.059 0 N-CA-C 113.946 1.091 . . . . 2.4900000000000002 113.946 -169.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.744 ' HD2' HE21 ' A' ' 77' ' ' GLN . 4.5 Cg_endo -88.73 85.45 0.58 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.185 1.923 . . . . 2.6499999999999999 113.224 -172.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.32 -27.77 2.07 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.17 -0.538 . . . . 1.3999999999999999 112.774 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.882 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 36.7 mt-30 -77.31 -18.62 57.33 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 107.064 -1.458 . . . . 1.8700000000000001 107.064 -173.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.577 HG21 ' HB1' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -46.72 -58.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-N 112.444 -2.162 . . . . 0.96999999999999997 111.354 179.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.3 pttt -62.17 -38.06 87.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.426 0.631 . . . . 2.1299999999999999 111.096 -166.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.882 ' HD2' ' HA ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.85 -34.05 15.42 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.074 0.464 . . . . 2.4100000000000001 110.873 -176.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.913 HG22 ' HA ' ' A' ' 72' ' ' ASN . 47.9 mm -72.45 -10.79 14.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 108.909 -0.774 . . . . 1.23 108.909 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.974 HD12 ' HB2' ' A' ' 85' ' ' TYR . 16.7 tp -57.84 -12.97 3.55 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.462 0.705 . . . . 0.79000000000000004 110.467 171.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.3 -25.58 6.05 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 120.08 -0.648 . . . . 0.88 110.076 163.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 5.7 mm-40 -65.49 -49.95 67.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.459 -0.791 . . . . 2.0899999999999999 110.97 169.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.974 ' HB2' HD12 ' A' ' 82' ' ' LEU . 12.6 m-30 . . . . . 0 N--CA 1.428 -1.556 0 CA-C-N 115.682 -0.69 . . . . 1.77 112.099 -172.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 0.997 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 tpp . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 109.935 -0.394 . . . . 13.970000000000001 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.841 ' HB ' ' HD3' ' A' ' 3' ' ' PRO . 48.9 t -84.59 -56.39 0.41 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.529 -0.305 . . . . 10.710000000000001 110.591 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.841 ' HD3' ' HB ' ' A' ' 2' ' ' VAL . 10.4 Cg_exo -73.18 108.61 2.65 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.105 1.87 . . . . 9.1999999999999993 110.857 172.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 1.06 ' HB2' ' HA ' ' A' ' 47' ' ' SER . 12.3 mptt -65.32 -53.62 41.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.575 -0.739 . . . . 9.0399999999999991 109.527 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.599 ' H ' ' HB2' ' A' ' 47' ' ' SER . . . -129.64 -137.19 4.2 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.765 -1.107 . . . . 4.1399999999999997 111.213 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -81.15 -47.51 13.37 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 122.636 0.375 . . . . 4.5800000000000001 111.928 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.821 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.0 m-85 -111.85 98.73 42.82 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 116.094 -0.503 . . . . 1.6399999999999999 111.915 -172.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.909 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 80.0 Cg_exo -50.69 96.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.882 2.388 . . . . 1.02 112.19 171.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.043 HD13 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.24 115.37 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 121.79 0.805 . . . . 1.52 110.112 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.718 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 14.0 m -92.61 127.34 38.07 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.194 -1.366 . . . . 1.45 109.987 -176.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 t -114.25 126.47 71.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 2.21 112.328 -170.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 16.3 t -64.21 115.17 4.75 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.555 0.693 . . . . 2.2400000000000002 112.138 -175.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.472 ' H ' HG22 ' A' ' 54' ' ' VAL . 84.6 mtp -129.26 24.6 5.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.11 -0.95 . . . . 5.1200000000000001 110.737 172.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.812 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . -65.57 176.73 14.11 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.381 -0.914 . . . . 3.8599999999999999 114.14 -167.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.9 t -66.17 -45.85 79.45 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 111.821 0.304 . . . . 5.9699999999999998 111.821 -173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.48 25.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.744 0.783 . . . . 4.4100000000000001 110.162 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 76.9 m -61.93 -35.73 79.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.312 -1.313 . . . . 2.98 112.237 -171.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.581 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 54.0 t80 -61.66 -31.74 71.88 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.008 0.432 . . . . 4.1799999999999997 111.024 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.0 t -71.98 -21.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 3.6499999999999999 110.319 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 27.4 mtpp -82.8 12.92 4.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.925 -0.579 . . . . 4.79 111.803 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.56 32.06 14.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.151 -1.023 . . . . 1.8700000000000001 111.906 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.581 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -70.86 -20.97 62.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.635 0.235 . . . . 1.46 111.635 -170.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.585 ' O ' HG22 ' A' ' 26' ' ' VAL . 25.0 t70 -55.82 -49.58 72.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.953 0.406 . . . . 2.4199999999999999 110.144 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 2.5 mptp? -66.94 -39.62 87.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.561 -0.456 . . . . 3.0299999999999998 111.59 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.942 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 3.3 m -68.58 -41.09 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 120.888 -0.325 . . . . 2.2599999999999998 110.843 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 23' ' ' ASP . 8.0 m -64.96 -34.08 68.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.831 -0.748 . . . . 1.5700000000000001 110.003 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 62.0 t-80 -59.42 -39.4 83.37 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.26 0.552 . . . . 1.3500000000000001 109.805 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.673 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -54.71 -50.48 68.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.868 -1.06 . . . . 0.65000000000000002 108.725 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.858 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.2 m-85 -50.57 -47.27 57.91 Favored 'General case' 0 C--N 1.339 0.123 0 O-C-N 123.877 0.736 . . . . 1.98 111.68 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 25.1 tptp -49.3 -56.32 9.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 2.8500000000000001 111.213 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -83.35 -19.67 35.71 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.268 -0.878 . . . . 2.23 111.513 -176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.858 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.82 -22.1 65.17 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.876 -0.602 . . . . 2.54 110.684 177.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.662 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -50.1 -59.63 3.72 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 106.55 -1.648 . . . . 2.0600000000000001 106.55 167.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.581 ' C ' HG13 ' A' ' 35' ' ' ILE . 4.4 pttm 68.09 -27.34 0.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 112.412 -2.177 . . . . 4.4800000000000004 111.674 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.681 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 55.55 -173.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 113.24 -1.8 . . . . 3.7599999999999998 113.379 172.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 37' ' ' ILE . 14.9 t70 -155.14 -53.55 0.09 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.214 -1.402 . . . . 4.6200000000000001 107.214 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.3 pt -174.43 19.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 112.734 -2.03 . . . . 5.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.02 -70.81 0.05 OUTLIER Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 109.278 -1.529 . . . . 4.1299999999999999 109.278 -168.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.596 ' HA ' HD21 ' A' ' 33' ' ' LEU . 10.5 m-20 -165.27 119.82 1.28 Allowed 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 112.996 -1.602 . . . . 4.3099999999999996 109.293 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.951 ' HB ' ' HE2' ' A' ' 46' ' ' PHE . 7.5 p 56.11 -65.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 126.636 2.46 . . . . 2.96 114.259 172.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.934 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 64.8 m -164.19 -59.79 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.745 0 CA-C-N 113.236 -1.802 . . . . 3.8300000000000001 110.06 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.934 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 16.3 Cg_exo -71.3 8.51 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.715 0 N-CA-C 114.493 0.92 . . . . 3.8300000000000001 114.493 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 11.5 t70 86.56 -15.67 0.44 Allowed 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.613 -0.514 . . . . 4.2599999999999998 109.613 161.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . -170.23 47.13 0.2 Allowed Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 119.068 -1.539 . . . . 2.0099999999999998 113.819 173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 0.4 OUTLIER -72.86 -32.44 65.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.94 0.876 . . . . 3.3399999999999999 109.382 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.951 ' HE2' ' HB ' ' A' ' 40' ' ' VAL . 49.9 m-85 -96.58 153.29 17.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.194 -1.366 . . . . 2.0699999999999998 112.386 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 1.06 ' HA ' ' HB2' ' A' ' 4' ' ' LYS . 31.2 t -152.8 66.72 0.8 Allowed 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.556 -1.646 . . . . 1.9099999999999999 106.556 161.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.043 HG22 HD13 ' A' ' 9' ' ' ILE . 2.2 pp -60.09 114.67 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.475 -1.239 . . . . 3.1899999999999999 112.68 -168.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -161.15 144.53 12.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 122.746 1.26 . . . . 3.3100000000000001 112.738 168.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.7 m -42.76 -43.09 3.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.917 -1.947 . . . . 3.25 115.022 167.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.7 mt -52.21 -41.87 63.06 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 116.058 1.874 . . . . 4.4500000000000002 116.058 -147.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.54 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 24.1 mmt85 -64.71 -56.97 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.556 1.17 . . . . 6.2599999999999998 110.261 174.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.718 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 35.9 t -66.31 167.05 11.03 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 112.714 -2.039 . . . . 3.04 112.617 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' HA2' ' A' ' 14' ' ' GLY . 15.7 t 70.44 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 123.053 1.406 . . . . 4.3200000000000003 109.411 -168.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.26 64.66 0.31 Allowed Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 113.626 -1.624 . . . . 4.1900000000000004 113.129 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.08 58.02 13.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 118.719 -1.705 . . . . 4.4199999999999999 114.941 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.279 1.8 m -132.2 -31.05 1.48 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.618 1.209 . . . . 3.52 109.083 -162.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.691 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . . . -47.7 -27.06 1.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 115.554 1.687 . . . . 3.6400000000000001 115.554 -163.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.24 5.03 3.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.181 1.355 . . . . 5.4400000000000004 111.774 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.03 158.65 45.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.078 -1.082 . . . . 3.2200000000000002 108.078 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -76.61 121.69 6.09 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 CA-C-N 120.494 1.212 . . . . 3.8300000000000001 109.319 163.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.437 HG22 ' S1 ' ' A' ' 86' ' ' FES . 13.3 tt -108.34 132.14 56.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.114 -0.635 . . . . 2.6899999999999999 112.188 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.84 HG21 ' H ' ' A' ' 73' ' ' VAL . 20.9 t -137.88 118.43 16.42 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 105.686 -1.968 . . . . 1.8700000000000001 105.686 158.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.689 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 17.1 ttt -116.87 137.83 51.94 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 120.442 -1.411 . . . . 1.6499999999999999 110.648 -172.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.821 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -124.45 117.09 49.53 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.798 0 N-CA-C 107.045 -1.465 . . . . 0.76000000000000001 107.045 155.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . 51.47 -157.52 2.9 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.527 -0.629 . . . . 1.1000000000000001 111.527 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.14 39.94 0.46 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.66 -0.867 . . . . 3.0099999999999998 108.66 170.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.633 ' HB2' HG23 ' A' ' 65' ' ' VAL . 26.0 mmmt -108.33 -26.95 10.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.478 -0.783 . . . . 2.6200000000000001 109.221 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.629 HG12 ' HG3' ' A' ' 64' ' ' MET . 9.2 m 36.01 109.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 115.138 1.533 . . . . 1.51 115.138 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.713 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.9 m-85 -118.86 -169.88 1.81 Allowed 'General case' 0 C--O 1.248 0.98 0 CA-C-O 122.86 1.314 . . . . 1.4299999999999999 113.003 -173.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.82 46.45 0.8 Allowed Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 113.55 -1.659 . . . . 1.49 109.955 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.932 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.78 -0.58 21.52 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.981 0.896 . . . . 1.8300000000000001 110.049 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.84 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 63.22 -165.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 114.12 -1.4 . . . . 3.0600000000000001 112.679 169.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.942 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.1 p -137.56 -45.13 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 113.604 0.965 . . . . 2.4900000000000002 113.604 -168.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.579 ' CD ' ' H ' ' A' ' 74' ' ' THR . 83.5 Cg_endo -88.68 77.56 1.34 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 121.845 1.697 . . . . 2.6499999999999999 113.705 -171.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.92 -24.26 2.87 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.171 -0.538 . . . . 1.3999999999999999 113.031 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.645 ' NE2' HG11 ' A' ' 73' ' ' VAL . 32.8 mt-30 -75.24 -20.9 58.97 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.565 -1.643 . . . . 1.8700000000000001 106.565 -173.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.726 ' HB ' HE21 ' A' ' 32' ' ' GLN . 2.7 m -43.58 -56.75 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.011 0 CA-C-N 111.559 -2.564 . . . . 0.96999999999999997 112.025 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.755 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 42.2 mtmt -56.73 -42.13 78.71 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 122.181 0.991 . . . . 2.1299999999999999 110.003 -167.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -42.43 13.94 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.34 -1.3 . . . . 2.4100000000000001 109.812 -172.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.932 HG22 ' HA ' ' A' ' 72' ' ' ASN . 41.3 mm -67.99 -13.78 17.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 114.694 -1.139 . . . . 1.23 109.29 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.944 HD12 ' HB2' ' A' ' 85' ' ' TYR . 27.2 tp -59.56 -13.42 9.18 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.657 0.783 . . . . 0.79000000000000004 110.592 170.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.62 -26.27 8.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.255 -0.578 . . . . 0.88 109.963 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 8.8 mm-40 -62.79 -51.99 64.94 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.0899999999999999 109.745 169.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.944 ' HB2' HD12 ' A' ' 82' ' ' LEU . 8.9 m-30 . . . . . 0 N--CA 1.424 -1.735 0 CA-C-N 114.812 -1.086 . . . . 1.77 112.259 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 0.691 ' S1 ' ' HA ' ' A' ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.067 -0.345 . . . . 13.970000000000001 110.067 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p -70.09 127.18 92.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.334 -0.394 . . . . 10.710000000000001 110.112 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.03 111.7 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.882 2.388 . . . . 9.1999999999999993 112.277 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HB3' ' HE2' ' A' ' 6' ' ' LYS . 90.8 mttt -101.55 -89.43 0.36 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.833 -0.621 . . . . 9.0399999999999991 109.487 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.734 ' HA2' ' CZ ' ' A' ' 7' ' ' TYR . . . 85.62 36.07 10.98 Favored Glycine 0 CA--C 1.501 -0.826 0 C-N-CA 120.355 -0.926 . . . . 4.1399999999999997 112.738 172.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -147.68 45.93 1.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.618 1.199 . . . . 4.5800000000000001 110.739 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.768 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 7.3 m-85 -55.64 113.08 5.02 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.412 -1.722 . . . . 1.6399999999999999 114.365 -173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.781 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 72.5 Cg_exo -56.07 90.96 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.1 2.533 . . . . 1.02 111.919 166.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.799 HD13 HG22 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -77.87 119.12 26.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.675 0.75 . . . . 1.52 110.661 -177.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 2.6 m -100.46 114.44 28.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.606 -1.179 . . . . 1.45 111.291 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 50' ' ' THR . 1.8 t -117.98 122.88 70.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 2.21 110.85 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 25.1 t -67.61 121.2 15.37 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.28 -0.568 . . . . 2.2400000000000002 111.553 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.8 mtp -124.61 23.41 8.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.63 -0.714 . . . . 5.1200000000000001 109.584 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.67 179.61 12.47 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.178 -0.534 . . . . 3.8599999999999999 112.998 -174.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -64.25 -45.42 88.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.069 0.396 . . . . 5.9699999999999998 112.069 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -70.97 -56.41 6.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.078 0.466 . . . . 4.4100000000000001 112.178 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.697 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.4 m -66.28 -33.79 76.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.91 -0.587 . . . . 2.98 111.993 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -60.6 -29.86 69.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.575 0.584 . . . . 4.1799999999999997 112.575 -174.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 16' ' ' ALA . 18.2 m -69.43 -18.95 22.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.771 0.32 . . . . 3.6499999999999999 111.526 -171.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -80.57 12.88 2.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.541 -0.299 . . . . 4.79 110.923 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.25 29.04 26.19 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 121.114 -0.565 . . . . 1.8700000000000001 111.98 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.1 -20.67 61.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.493 -0.353 . . . . 1.46 110.862 -172.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 26' ' ' VAL . 24.8 t70 -53.99 -50.42 66.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.493 -0.321 . . . . 2.4199999999999999 110.759 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -66.87 -40.51 87.86 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.304 -0.559 . . . . 3.0299999999999998 111.152 -172.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.877 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 1.9 m -69.45 -42.71 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 116.451 -0.34 . . . . 2.2599999999999998 110.655 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 23' ' ' ASP . 17.6 m -66.15 -29.0 45.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 119.522 -0.871 . . . . 1.5700000000000001 109.99 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -58.7 -41.2 85.74 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.137 0.494 . . . . 1.3500000000000001 109.747 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -54.84 -46.04 74.57 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.848 -1.069 . . . . 0.65000000000000002 109.707 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -49.86 65.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.923 -0.581 . . . . 1.98 110.411 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -51.9 -50.13 61.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.308 -0.86 . . . . 2.8500000000000001 111.547 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -79.96 -25.82 40.26 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.553 -0.749 . . . . 2.23 110.982 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.679 ' NE2' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -61.82 -34.84 76.66 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.411 -0.589 . . . . 2.54 109.411 175.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.773 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 1.1 tt -45.29 -58.74 3.08 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 107.012 -1.477 . . . . 2.0600000000000001 107.012 173.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 66.04 -24.77 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 112.729 -2.032 . . . . 4.4800000000000004 112.093 171.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.719 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.95 -174.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.477 -1.692 . . . . 3.7599999999999998 113.762 168.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.572 ' O ' HG23 ' A' ' 37' ' ' ILE . 11.0 t70 -156.0 -48.51 0.08 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.077 -1.419 . . . . 4.6200000000000001 107.497 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 36' ' ' ASP . 1.4 pt -172.09 16.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-N 113.35 -1.75 . . . . 5.0 110.751 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -176.38 -66.94 0.06 OUTLIER Glycine 0 CA--C 1.486 -1.743 0 N-CA-C 109.883 -1.287 . . . . 4.1299999999999999 109.883 -169.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 18.8 m-20 -164.81 117.46 1.25 Allowed 'General case' 0 CA--C 1.484 -1.583 0 CA-C-N 113.268 -1.466 . . . . 4.3099999999999996 110.296 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.956 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.4 p 57.19 -64.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 O-C-N 126.882 2.613 . . . . 2.96 113.592 171.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.928 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 90.6 m -157.04 -60.45 0.02 OUTLIER Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 113.272 -1.785 . . . . 3.8300000000000001 110.867 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.928 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 13.8 Cg_exo -70.94 2.18 4.46 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 120.426 0.751 . . . . 3.8300000000000001 113.449 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 4.4 t70 82.55 4.29 1.08 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-O 123.404 1.574 . . . . 4.2599999999999998 107.687 167.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 168.47 63.29 0.03 OUTLIER Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 112.539 -2.119 . . . . 2.0099999999999998 110.225 174.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 18.7 tpp85 -93.12 -34.63 13.57 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.296 -1.742 . . . . 3.3399999999999999 106.296 166.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.956 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 25.1 m-85 -87.9 152.59 21.97 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 110.826 -2.897 . . . . 2.0699999999999998 110.567 175.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.781 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 54.1 m -153.55 68.67 0.79 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.618 -1.252 . . . . 1.9099999999999999 107.618 163.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.799 HG22 HD13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -69.9 122.62 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.299 -0.864 . . . . 3.1899999999999999 112.272 -168.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.722 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.0 p30 -156.24 139.11 15.28 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.345 1.069 . . . . 3.3100000000000001 111.219 164.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 19.9 p -43.61 -46.13 7.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.616 -1.629 . . . . 3.25 115.206 169.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.91 -39.52 65.89 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.869 1.804 . . . . 4.4500000000000002 115.869 -151.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -63.1 -57.27 11.15 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.085 0.945 . . . . 6.2599999999999998 109.88 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.691 ' O ' HG22 ' A' ' 54' ' ' VAL . 34.3 t -65.6 167.44 8.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.668 -1.605 . . . . 3.04 109.731 173.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.171 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 1.9 m 72.34 26.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 125.398 1.479 . . . . 4.3200000000000003 110.129 -159.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.21 65.2 0.26 Allowed Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 113.665 -1.607 . . . . 4.1900000000000004 112.995 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.46 57.28 15.49 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 119.492 -1.337 . . . . 4.4199999999999999 115.235 172.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.97 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.293 1.8 m -134.48 -32.55 1.02 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.712 1.256 . . . . 3.52 109.943 -162.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.34 -27.65 2.68 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 116.282 1.956 . . . . 3.6400000000000001 116.282 -160.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 1.2 pp -74.37 5.16 4.86 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.425 1.466 . . . . 5.4400000000000004 112.101 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.46 159.46 45.71 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.264 -1.013 . . . . 3.2200000000000002 108.264 159.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -77.54 119.66 4.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 CA-C-N 120.372 1.168 . . . . 3.8300000000000001 109.869 161.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.97 HG13 ' HB3' ' A' ' 57' ' ' CYS . 42.8 mm -110.98 134.15 54.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 111.609 0.226 . . . . 2.6899999999999999 111.609 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.409 HG12 ' OH ' ' A' ' 85' ' ' TYR . 11.7 t -136.52 123.0 30.34 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 N-CA-C 107.503 -1.295 . . . . 1.8700000000000001 107.503 163.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 45.5 ttm -114.49 138.0 51.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.002 -1.686 . . . . 1.6499999999999999 111.313 -176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -125.01 115.67 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.424 -1.324 . . . . 0.76000000000000001 107.424 158.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.519 ' CA ' ' HD2' ' A' ' 8' ' ' PRO . . . 46.37 -144.35 4.14 Favored Glycine 0 N--CA 1.435 -1.392 0 CA-C-O 122.598 1.11 . . . . 1.1000000000000001 112.67 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 0.6 OUTLIER -82.8 27.69 0.52 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 113.369 -1.415 . . . . 3.0099999999999998 109.462 176.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.773 ' HB2' HG23 ' A' ' 65' ' ' VAL . 14.3 mmmm -107.26 -24.19 11.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.875 -0.602 . . . . 2.6200000000000001 110.659 -176.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.9 m 33.95 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 124.281 0.988 . . . . 1.51 113.484 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.68 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 7.2 m-30 -99.53 -168.83 1.66 Allowed 'General case' 0 C--O 1.246 0.897 0 CA-C-O 123.469 1.604 . . . . 1.4299999999999999 114.247 -172.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 73' ' ' VAL . . . -134.89 57.27 0.7 Allowed Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 113.001 -1.909 . . . . 1.49 110.093 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.624 ' HA ' HG21 ' A' ' 81' ' ' ILE . 44.5 t-20 -86.37 39.64 0.84 Allowed 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 123.17 1.462 . . . . 1.8300000000000001 109.053 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.882 HG21 ' HB2' ' A' ' 77' ' ' GLN . 0.6 OUTLIER 47.78 -161.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 112.684 -2.053 . . . . 3.0600000000000001 113.634 155.02 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.877 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 18.4 p -134.71 -45.58 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 113.016 0.747 . . . . 2.4900000000000002 113.016 173.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.658 ' HA ' HG12 ' A' ' 25' ' ' VAL . 2.7 Cg_exo -75.1 -85.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.412 0 C-N-CA 121.87 1.714 . . . . 2.6499999999999999 114.367 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.24 0.15 5.97 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.748 -0.739 . . . . 1.3999999999999999 112.106 -176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.882 ' HB2' HG21 ' A' ' 73' ' ' VAL . 9.9 mt-30 -81.26 -13.47 58.45 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 106.382 -1.711 . . . . 1.8700000000000001 106.382 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.679 ' HB ' ' NE2' ' A' ' 32' ' ' GLN . 2.7 m -51.71 -46.92 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 111.988 -2.369 . . . . 0.96999999999999997 109.904 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 34.2 mttm -57.28 -44.23 83.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.123 -1.399 . . . . 2.1299999999999999 109.353 -167.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -77.85 -42.49 33.41 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 113.599 -1.637 . . . . 2.4100000000000001 109.755 -175.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.658 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 33.5 mm -68.4 -17.24 21.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.616 -0.72 . . . . 1.23 110.191 176.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.684 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 9.6 tp -57.92 -38.32 75.66 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.545 -0.722 . . . . 0.79000000000000004 110.463 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -33.5 69.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.37 0.605 . . . . 0.88 109.483 172.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 3.3 mm-40 -68.24 -30.84 69.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.964 -1.017 . . . . 2.0899999999999999 111.857 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.68 ' CE1' ' HD2' ' A' ' 70' ' ' TYR . 2.9 m-30 . . . . . 0 N--CA 1.433 -1.291 0 CA-C-O 118.801 -0.619 . . . . 1.77 111.318 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 1.171 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptp . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 121.604 0.716 . . . . 13.970000000000001 110.434 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 6.4 p -111.77 125.84 29.6 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.802 -0.635 . . . . 10.710000000000001 110.248 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 23.9 Cg_exo -63.9 97.38 0.23 Allowed 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.991 2.461 . . . . 9.1999999999999993 112.783 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -101.76 -95.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.79 -0.641 . . . . 9.0399999999999991 109.809 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.581 ' C ' ' HD2' ' A' ' 6' ' ' LYS . . . 93.21 167.48 38.61 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.617 -0.72 . . . . 4.1399999999999997 111.706 176.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.581 ' HD2' ' C ' ' A' ' 5' ' ' GLY . 0.0 OUTLIER 36.14 46.57 0.39 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.98 0.912 . . . . 4.5800000000000001 112.804 179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.661 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 11.2 m-85 -43.0 107.75 0.58 Allowed Pre-proline 0 N--CA 1.445 -0.713 0 C-N-CA 124.604 1.162 . . . . 1.6399999999999999 112.807 175.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' SER . 75.1 Cg_exo -56.66 93.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.813 2.342 . . . . 1.02 111.284 171.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.802 ' HB ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -81.3 121.89 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-O 121.858 0.837 . . . . 1.52 110.405 -178.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.743 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.7 m -105.38 127.11 52.8 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.541 -1.209 . . . . 1.45 111.203 -172.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.1 t -117.91 123.59 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 2.21 112.016 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.704 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 30.0 t -67.16 124.33 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.22 0.533 . . . . 2.2400000000000002 111.315 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 89.9 mmm -120.5 23.1 11.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.545 -0.752 . . . . 5.1200000000000001 109.278 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.55 177.89 25.03 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.608 -0.724 . . . . 3.8599999999999999 112.528 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 19' ' ' VAL . 17.3 m -67.45 -45.41 76.1 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.032 0.382 . . . . 5.9699999999999998 112.032 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.08 -56.01 7.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 4.4100000000000001 112.267 -172.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.704 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 74.6 m -64.59 -32.91 74.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.757 -0.656 . . . . 2.98 111.105 -173.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 68.2 t80 -60.52 -28.63 68.55 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.961 -0.563 . . . . 4.1799999999999997 111.774 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 15' ' ' THR . 60.9 t -68.87 -22.11 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.131 0.491 . . . . 3.6499999999999999 110.921 -173.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -81.94 13.34 3.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.208 -0.451 . . . . 4.79 111.329 -175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 25' ' ' VAL . . . 87.07 30.29 20.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.366 -0.921 . . . . 1.8700000000000001 111.766 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -70.68 -21.58 62.57 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.463 -0.199 . . . . 1.46 110.463 -171.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -59.03 -54.6 45.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.331 -0.395 . . . . 2.4199999999999999 110.208 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.562 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 3.0299999999999998 109.621 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.009 HG13 ' H ' ' A' ' 74' ' ' THR . 54.6 t -59.21 -57.65 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 CA-C-N 115.649 -0.705 . . . . 2.2599999999999998 109.587 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.33 -30.57 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 120.271 -0.571 . . . . 1.5700000000000001 109.647 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -59.26 -43.5 92.48 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 116.128 -0.487 . . . . 1.3500000000000001 110.253 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.431 ' HB1' HG21 ' A' ' 78' ' ' VAL . . . -54.69 -46.0 74.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.134 -0.939 . . . . 0.65000000000000002 109.229 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.674 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -55.31 -53.36 57.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.065 -0.97 . . . . 1.98 110.087 175.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -48.83 -47.48 42.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.321 -0.854 . . . . 2.8500000000000001 110.757 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.41 -34.37 25.53 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.521 -0.763 . . . . 2.23 111.932 -174.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.728 ' NE2' ' HB2' ' A' ' 82' ' ' LEU . 1.9 pt20 -63.17 -25.73 68.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.249 -0.649 . . . . 2.54 109.249 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.73 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER -57.72 -60.43 3.7 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 107.323 -1.362 . . . . 2.0600000000000001 107.323 173.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.657 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 68.01 -20.83 0.13 Allowed 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 125.503 1.752 . . . . 4.4800000000000004 110.578 172.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.73 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 58.18 126.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.709 -2.042 . . . . 3.7599999999999998 113.243 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.616 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 11.1 t70 -86.72 -45.94 10.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 112.284 -2.235 . . . . 4.6200000000000001 107.741 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' A' ' 43' ' ' ASP . 2.0 pt -168.4 -1.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 112.93 -1.941 . . . . 5.0 110.923 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 173.09 -32.74 0.11 Allowed Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 110.774 -0.93 . . . . 4.1299999999999999 110.774 -163.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.715 ' HA ' ' HE1' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -145.17 -162.92 1.6 Allowed 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 114.095 -1.052 . . . . 4.3099999999999996 110.883 -169.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.69 HG13 ' OD1' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -64.61 -30.18 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-O 123.865 1.793 . . . . 2.96 107.531 177.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.723 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 65.4 m -168.45 -64.32 0.01 OUTLIER Pre-proline 0 C--N 1.29 -1.999 0 CA-C-N 110.026 -3.261 . . . . 3.8300000000000001 111.182 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 7.1 Cg_exo -73.81 -6.64 18.93 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 121.289 1.326 . . . . 3.8300000000000001 115.445 -164.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.617 ' H ' ' CB ' ' A' ' 39' ' ' ASP . 26.0 t70 74.59 16.04 3.24 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 122.759 1.266 . . . . 4.2599999999999998 107.586 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 176.55 66.91 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.847 0 CA-C-N 113.41 -1.723 . . . . 2.0099999999999998 111.26 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.715 ' HB3' ' OD1' ' A' ' 39' ' ' ASP . 13.7 tpt180 -132.93 -55.72 0.93 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.885 -1.154 . . . . 3.3399999999999999 107.885 -176.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.715 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -100.91 146.41 27.39 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.054 -1.43 . . . . 2.0699999999999998 110.364 176.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.481 ' H ' HG22 ' A' ' 9' ' ' ILE . 52.9 m -154.57 96.85 1.94 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.215 -0.661 . . . . 1.9099999999999999 109.215 172.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.644 HG22 HG23 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -87.11 137.3 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.071 0.767 . . . . 3.1899999999999999 113.071 -167.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.1 p30 -158.01 138.02 12.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.968 -1.014 . . . . 3.3100000000000001 110.787 158.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.5 m -45.9 -45.34 15.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.11 -1.405 . . . . 3.25 114.323 165.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.69 -39.59 65.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.14 1.534 . . . . 4.4500000000000002 115.14 -154.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -62.36 -57.13 12.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 122.476 1.131 . . . . 6.2599999999999998 109.694 176.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 22.5 t -66.26 167.62 10.01 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.59 -2.095 . . . . 3.04 111.208 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.744 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 1.6 m 70.27 25.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 125.883 1.673 . . . . 4.3200000000000003 109.351 -160.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -112.29 65.77 0.25 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 113.479 -1.692 . . . . 4.1900000000000004 112.49 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.88 56.3 17.26 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 119.681 -1.247 . . . . 4.4199999999999999 115.801 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.616 ' HB2' HG13 ' A' ' 62' ' ' ILE . 1.9 m -136.17 -31.54 0.9 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.46 -0.941 . . . . 3.52 108.46 -170.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.429 ' HB2' ' S1 ' ' A' ' 86' ' ' FES . . . -48.09 -25.94 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.883 1.809 . . . . 3.6400000000000001 115.883 -163.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.2 mp -73.2 7.52 2.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.81 1.186 . . . . 5.4400000000000004 111.841 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.45 160.46 37.8 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 108.229 -1.026 . . . . 3.2200000000000002 108.229 160.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.93 119.33 5.82 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 120.742 1.301 . . . . 3.8300000000000001 108.822 165.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.616 HG13 ' HB2' ' A' ' 57' ' ' CYS . 49.2 mm -111.51 130.94 64.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 114.265 1.209 . . . . 2.6899999999999999 114.265 -172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 72' ' ' ASN . 14.5 p -144.2 122.19 6.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 N-CA-C 107.3 -1.37 . . . . 1.8700000000000001 107.3 147.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.76 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 65.6 ttp -111.19 137.78 48.46 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.759 -1.213 . . . . 1.6499999999999999 109.727 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.802 HG12 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -118.77 114.23 44.2 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 N-CA-C 107.015 -1.476 . . . . 0.76000000000000001 107.015 167.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 68' ' ' LYS . . . 48.87 -152.88 2.55 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 122.342 0.968 . . . . 1.1000000000000001 111.869 -176.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -78.6 37.26 0.28 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 113.882 -1.159 . . . . 3.0099999999999998 109.266 172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.76 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 29.8 mmmt -113.68 -26.29 8.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.035 -0.529 . . . . 2.6200000000000001 111.532 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 30.4 m 38.22 108.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 115.205 1.557 . . . . 1.51 115.205 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.76 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 2.8 m-85 -122.42 -170.74 2.13 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 122.448 1.118 . . . . 1.4299999999999999 113.352 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -127.08 21.85 5.76 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 113.832 -1.531 . . . . 1.49 111.293 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.687 ' HB2' HG22 ' A' ' 81' ' ' ILE . 2.7 t30 -74.22 92.73 2.26 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.862 -0.422 . . . . 1.8300000000000001 109.862 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -172.37 -167.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 122.882 0.473 . . . . 3.0600000000000001 111.429 177.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 1.009 ' H ' HG13 ' A' ' 25' ' ' VAL . 41.0 p 50.54 104.08 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.403 0 C-N-CA 125.204 1.402 . . . . 2.4900000000000002 112.266 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.763 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 73.6 Cg_exo -23.47 89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.296 1 C-N-CA 125.456 4.104 . . . . 2.6499999999999999 113.28 -174.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 80' ' ' LYS . . . 148.11 -61.23 0.44 Allowed Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 114.974 -1.012 . . . . 1.3999999999999999 112.572 -171.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.614 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 5.0 mt-30 -76.26 -30.54 57.89 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 107.193 -1.41 . . . . 1.8700000000000001 107.193 -166.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.518 HG13 ' CA ' ' A' ' 73' ' ' VAL . 0.7 OUTLIER -48.24 -52.05 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 CA-C-N 112.41 -2.177 . . . . 0.96999999999999997 111.132 -175.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 36.6 mtmt -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 122.647 1.213 . . . . 2.1299999999999999 108.523 -166.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -78.89 -42.16 27.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.173 -1.83 . . . . 2.4100000000000001 110.922 -173.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.687 HG22 ' HB2' ' A' ' 72' ' ' ASN . 33.2 mm -72.57 -15.34 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.157 0.503 . . . . 1.23 109.926 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.728 ' HB2' ' NE2' ' A' ' 32' ' ' GLN . 48.0 tp -60.99 -38.58 86.51 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.069 -0.395 . . . . 0.79000000000000004 110.348 169.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.02 -31.96 67.48 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 121.779 0.799 . . . . 0.88 108.86 172.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -73.39 -31.62 63.99 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.753 -1.112 . . . . 2.0899999999999999 111.354 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.727 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 2.2 m-30 . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 119.489 -0.291 . . . . 1.77 111.162 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 0.744 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 110.085 -0.339 . . . . 13.970000000000001 110.085 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 7.9 m -70.28 116.94 49.94 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.359 0.6 . . . . 10.710000000000001 112.09 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 1.5 Cg_endo -84.93 68.22 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.16 2.573 . . . . 9.1999999999999993 111.05 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.74 ' HG3' ' HB3' ' A' ' 47' ' ' SER . 38.2 tptt -50.2 -58.67 5.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.807 0.813 . . . . 9.0399999999999991 109.543 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -145.86 -156.97 7.09 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 109.045 -1.622 . . . . 4.1399999999999997 109.045 170.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.52 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 15.7 tppt? -66.68 -45.54 78.53 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 117.695 0.748 . . . . 4.5800000000000001 109.337 174.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.653 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 15.1 m-85 -129.59 80.58 71.53 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-O 120.934 0.397 . . . . 1.6399999999999999 109.974 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' SER . 82.0 Cg_exo -50.54 107.25 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.115 2.543 . . . . 1.02 112.09 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.957 HD11 HG22 ' A' ' 48' ' ' ILE . 13.1 pt -81.59 130.55 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 112.092 0.405 . . . . 1.52 112.092 -173.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.5 p -94.32 132.06 39.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.178 -0.675 . . . . 1.45 109.178 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.09 117.85 56.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 116.167 -0.47 . . . . 2.21 110.63 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 1.042 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 28.3 t -69.96 121.85 18.18 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.867 -0.606 . . . . 2.2400000000000002 111.9 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.8 mmm -121.64 20.3 11.05 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.968 -1.123 . . . . 5.1200000000000001 107.968 163.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.83 179.32 31.15 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.557 -1.201 . . . . 3.8599999999999999 113.172 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 19' ' ' VAL . 8.1 m -68.93 -44.43 73.09 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.079 0.4 . . . . 5.9699999999999998 112.079 177.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.45 -58.16 4.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.025 0.75 . . . . 4.4100000000000001 113.025 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 1.042 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 88.8 m -65.31 -33.91 77.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 2.98 111.012 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -60.69 -31.68 70.93 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.904 0.383 . . . . 4.1799999999999997 111.086 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 15' ' ' THR . 57.5 t -72.54 -25.09 22.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.391 0.615 . . . . 3.6499999999999999 110.054 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -85.23 9.38 15.33 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.613 -0.722 . . . . 4.79 110.894 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.04 32.57 17.15 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.021 -1.085 . . . . 1.8700000000000001 112.466 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.512 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -71.97 -20.81 61.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.849 0.315 . . . . 1.46 111.849 -171.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 26' ' ' VAL . 2.4 p-10 -62.48 -40.84 97.96 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.053 -0.659 . . . . 2.4199999999999999 109.74 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 24' ' ' LYS . 11.1 mptt -66.78 -36.51 82.57 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.044 -0.724 . . . . 3.0299999999999998 109.044 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.039 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 76.7 t -55.78 -54.78 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.674 0 CA-C-N 115.057 -0.974 . . . . 2.2599999999999998 109.415 177.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 23' ' ' ASP . 15.3 m -63.16 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.115 -0.634 . . . . 1.5700000000000001 110.902 -174.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -60.66 -47.58 85.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.733 -0.787 . . . . 1.3500000000000001 109.955 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.611 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.59 -46.24 80.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.236 -0.893 . . . . 0.65000000000000002 108.613 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.872 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 2.0 t80 -54.49 -48.49 71.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 124.218 0.949 . . . . 1.98 110.146 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -49.11 -54.93 13.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.717 -1.129 . . . . 2.8500000000000001 111.297 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -88.36 -18.87 27.51 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.287 -0.87 . . . . 2.23 111.717 -174.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.872 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.98 -21.17 65.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.573 -0.528 . . . . 2.54 109.573 173.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.796 HD22 HG12 ' A' ' 35' ' ' ILE . 1.2 tt -48.6 -59.88 3.15 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 106.291 -1.744 . . . . 2.0600000000000001 106.291 168.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.667 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 65.61 -25.45 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 O-C-N 126.241 2.213 . . . . 4.4800000000000004 112.186 171.183 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.796 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 57.78 -174.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 113.073 -1.876 . . . . 3.7599999999999998 113.74 166.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 37' ' ' ILE . 12.4 t70 -146.89 -53.2 0.22 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 106.166 -1.791 . . . . 4.6200000000000001 106.166 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.648 HG13 ' OD1' ' A' ' 43' ' ' ASP . 1.2 pt -171.63 21.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 113.612 -1.631 . . . . 5.0 109.718 172.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -165.52 -67.07 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 109.464 -1.454 . . . . 4.1299999999999999 109.464 -174.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.853 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 18.5 m-20 -170.39 116.72 0.51 Allowed 'General case' 0 CA--C 1.485 -1.525 0 CA-C-N 113.602 -1.299 . . . . 4.3099999999999996 110.156 -177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.972 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 6.8 p 58.0 -64.23 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 O-C-N 126.679 2.487 . . . . 2.96 113.057 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.628 ' OG1' ' HD3' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -159.33 -56.15 0.02 OUTLIER Pre-proline 0 C--N 1.276 -2.621 0 CA-C-N 113.38 -1.736 . . . . 3.8300000000000001 111.966 -177.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.698 ' HD2' HG13 ' A' ' 40' ' ' VAL . 13.1 Cg_exo -72.11 -3.63 13.64 Favored 'Trans proline' 0 N--CA 1.435 -1.955 0 CA-C-N 119.48 0.85 . . . . 3.8300000000000001 112.81 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.853 ' HA ' ' H ' ' A' ' 39' ' ' ASP . 73.0 m-20 75.34 19.05 2.26 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 122.457 1.122 . . . . 4.2599999999999998 108.96 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' N ' ' HB2' ' A' ' 39' ' ' ASP . . . 171.7 39.15 0.03 OUTLIER Glycine 0 N--CA 1.423 -2.215 0 CA-C-N 112.508 -2.133 . . . . 2.0099999999999998 110.949 166.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.649 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 22.1 ttt180 -74.4 -34.64 63.33 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.533 -1.654 . . . . 3.3399999999999999 106.533 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.972 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 29.1 m-85 -88.82 149.75 23.25 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 112.241 -2.254 . . . . 2.0699999999999998 110.396 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.74 ' HB3' ' HG3' ' A' ' 4' ' ' LYS . 15.2 m -168.45 99.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.76 0.424 . . . . 1.9099999999999999 110.018 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.957 HG22 HD11 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -66.31 136.7 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 113.919 1.081 . . . . 3.1899999999999999 113.919 -168.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' SER . 2.2 p30 -160.08 135.75 8.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 122.626 1.203 . . . . 3.3100000000000001 113.023 154.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -46.57 -41.53 14.55 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.026 1.73 . . . . 3.25 114.61 160.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -50.87 -30.24 14.01 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.959 1.466 . . . . 4.4500000000000002 114.959 -158.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 8.1 mmt180 -54.91 -47.05 74.85 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.008 0.433 . . . . 6.2599999999999998 111.108 177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.3 t -58.0 160.2 5.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.188 -0.915 . . . . 3.04 113.439 -171.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 14.2 t 67.51 24.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.55 0 CA-C-O 123.139 1.447 . . . . 4.3200000000000003 108.353 -164.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.88 64.49 0.33 Allowed Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 113.349 -1.75 . . . . 4.1900000000000004 112.479 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.63 57.99 14.06 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 118.839 -1.648 . . . . 4.4199999999999999 115.08 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.887 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.253 5.6 m -132.27 -35.28 1.19 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 119.021 1.411 . . . . 3.52 113.072 -162.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.72 -30.76 23.56 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.694 1.739 . . . . 3.6400000000000001 115.694 -164.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.0 mt -78.37 5.37 10.7 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.014 1.279 . . . . 5.4400000000000004 112.793 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.15 159.94 43.15 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 122.549 0.34 . . . . 3.2200000000000002 110.479 170.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.9 124.23 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.531 -1.373 . . . . 3.8300000000000001 108.531 153.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.887 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.5 mm -106.82 129.05 61.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.935 -1.106 . . . . 2.6899999999999999 113.054 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.25 119.37 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.054 -1.462 . . . . 1.8700000000000001 107.054 158.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.559 ' HG3' HG22 ' A' ' 69' ' ' VAL . 39.0 ttm -114.2 141.61 47.31 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 120.911 -1.118 . . . . 1.6499999999999999 111.734 -170.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.927 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -118.06 112.85 40.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 N-CA-C 106.286 -1.746 . . . . 0.76000000000000001 106.286 158.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 40.84 -141.82 0.9 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-O 122.507 1.06 . . . . 1.1000000000000001 113.363 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -79.38 28.57 0.24 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 113.324 -1.438 . . . . 3.0099999999999998 109.84 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.927 ' HB2' HG23 ' A' ' 65' ' ' VAL . 10.8 mmmm -100.59 -47.88 4.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.193 -0.669 . . . . 2.6200000000000001 109.193 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' A' ' 64' ' ' MET . 91.1 t 48.56 116.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 114.225 1.194 . . . . 1.51 114.225 -177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 62.8 m-85 -138.4 -157.84 0.81 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.099 0.952 . . . . 1.4299999999999999 113.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -135.07 39.02 1.74 Allowed Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 114.151 -1.386 . . . . 1.49 110.0 171.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.826 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 6.0 t-20 -58.42 110.5 0.98 Allowed 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.457 -0.942 . . . . 1.8300000000000001 108.457 173.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.498 ' HB ' ' H ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -100.91 -114.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.247 -1.342 . . . . 3.0600000000000001 114.532 -157.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 1.039 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 2.2 t -143.09 -48.0 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 115.24 1.57 . . . . 2.4900000000000002 115.24 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD3' ' H ' ' A' ' 74' ' ' THR . 2.3 Cg_endo -80.68 64.0 8.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.939 1.759 . . . . 2.6499999999999999 113.484 -168.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.544 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 75.8 -12.22 9.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.217 -0.516 . . . . 1.3999999999999999 112.976 176.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.646 ' HA ' ' CD ' ' A' ' 80' ' ' LYS . 30.0 mt-30 -75.11 -28.8 60.37 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 106.944 -1.502 . . . . 1.8700000000000001 106.944 -174.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.65 ' HB ' HE21 ' A' ' 32' ' ' GLN . 0.0 OUTLIER -51.23 -55.08 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 112.04 -2.346 . . . . 0.96999999999999997 112.561 177.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 18.8 pttp -60.07 -25.67 65.57 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 121.884 0.85 . . . . 2.1299999999999999 110.571 -168.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.646 ' CD ' ' HA ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -80.21 -50.81 9.73 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.936 -1.029 . . . . 2.4100000000000001 109.082 178.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.806 ' HB ' HD22 ' A' ' 72' ' ' ASN . 30.0 mm -60.05 -16.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.186 -1.37 . . . . 1.23 109.871 172.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.689 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 63.9 tp -61.36 -40.67 95.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.881 0.372 . . . . 0.79000000000000004 110.13 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.98 -33.25 68.68 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.701 0.762 . . . . 0.88 109.336 172.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 15.4 mt-10 -73.92 -24.4 59.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.479 -1.237 . . . . 2.0899999999999999 111.959 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.826 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.5 m-30 . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 118.485 -0.769 . . . . 1.77 112.34 -172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 0.71 ' S2 ' ' HB ' ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 26.0 mmt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 120.683 0.278 . . . . 13.970000000000001 110.253 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.13 79.19 51.93 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.482 -0.327 . . . . 10.710000000000001 110.388 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.23 116.75 3.69 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.705 2.27 . . . . 9.1999999999999993 111.542 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 39.0 mmtm -64.54 -49.48 71.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.635 -0.711 . . . . 9.0399999999999991 112.629 -175.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.61 ' HA2' ' HB2' ' A' ' 47' ' ' SER . . . 99.62 32.98 5.49 Favored Glycine 0 CA--C 1.496 -1.121 0 C-N-CA 120.197 -1.001 . . . . 4.1399999999999997 111.883 172.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 16.7 tppt? -52.09 -52.88 48.54 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.947 -0.626 . . . . 4.5800000000000001 109.75 176.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.535 ' CD1' ' HG3' ' A' ' 68' ' ' LYS . 4.6 m-85 -107.6 93.99 11.16 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 115.831 -0.622 . . . . 1.6399999999999999 110.776 172.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 38.5 Cg_exo -63.84 94.45 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.304 2.003 . . . . 1.02 110.717 168.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.966 HG12 ' HA ' ' A' ' 48' ' ' ILE . 1.2 pt -79.08 172.47 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 112.182 0.438 . . . . 1.52 112.182 -168.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.928 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 95.0 p -146.63 117.91 7.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.631 -0.713 . . . . 1.45 111.648 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.33 124.97 73.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.162 -0.926 . . . . 2.21 110.296 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 31.8 t -66.19 120.37 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.486 0.66 . . . . 2.2400000000000002 110.954 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.2 mmt -122.57 23.11 9.71 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.184 -1.043 . . . . 5.1200000000000001 108.184 170.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.71 179.47 17.16 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.924 -1.035 . . . . 3.8599999999999999 113.314 -173.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.0 t -65.89 -45.56 81.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.106 0.41 . . . . 5.9699999999999998 112.106 -175.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.87 -56.98 4.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.454 0.538 . . . . 4.4100000000000001 112.454 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.715 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 71.7 m -65.72 -34.16 77.55 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.618 -0.719 . . . . 2.98 111.93 -170.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -61.29 -27.69 68.66 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.119 0.568 . . . . 4.1799999999999997 112.076 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 15' ' ' THR . 86.8 t -67.71 -21.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 122.78 0.432 . . . . 3.6499999999999999 111.711 -168.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -80.99 12.15 3.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.949 -0.47 . . . . 4.79 111.806 -174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.09 28.48 30.89 Favored Glycine 0 C--O 1.24 0.497 0 C-N-CA 120.986 -0.626 . . . . 1.8700000000000001 111.552 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.39 -21.74 61.23 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.105 -0.548 . . . . 1.46 111.548 -168.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.51 ' HA ' HG22 ' A' ' 26' ' ' VAL . 11.8 t70 -55.63 -48.1 75.51 Favored 'General case' 0 C--O 1.211 -0.937 0 C-N-CA 120.393 -0.523 . . . . 2.4199999999999999 111.057 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -67.35 -36.17 80.85 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.822 -0.751 . . . . 3.0299999999999998 111.459 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.637 ' HB ' ' OG1' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.97 -44.84 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 121.118 -0.233 . . . . 2.2599999999999998 110.647 176.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 23' ' ' ASP . 17.9 m -68.59 -19.06 23.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 119.975 -0.69 . . . . 1.5700000000000001 109.965 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.472 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 53.9 t-80 -59.64 -42.54 92.99 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.588 0.709 . . . . 1.3500000000000001 109.158 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.572 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -51.97 -46.35 64.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.085 -1.416 . . . . 0.65000000000000002 109.541 173.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.854 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 1.4 t80 -57.38 -48.26 79.51 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.974 -0.557 . . . . 1.98 110.549 175.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 27' ' ' HIS . 60.8 mttp -47.04 -51.17 18.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.319 -0.855 . . . . 2.8500000000000001 110.884 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.13 -19.97 24.86 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.078 -0.964 . . . . 2.23 111.367 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.854 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -67.33 -19.42 65.45 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.531 -0.544 . . . . 2.54 109.531 176.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.055 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -49.39 -59.52 3.64 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 106.658 -1.608 . . . . 2.0600000000000001 106.658 168.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.786 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.19 -19.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 126.42 2.325 . . . . 4.4800000000000004 113.387 169.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.673 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 50.93 -171.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 C-N-CA 126.138 1.775 . . . . 3.7599999999999998 114.132 166.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 37' ' ' ILE . 13.9 t70 -157.31 -50.52 0.07 Allowed 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.623 -1.626 . . . . 4.6200000000000001 107.238 -176.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 1.9 pt -168.64 6.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 113.103 -1.862 . . . . 5.0 110.843 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.18 -58.7 0.03 OUTLIER Glycine 0 CA--C 1.482 -1.997 0 N-CA-C 109.653 -1.379 . . . . 4.1299999999999999 109.653 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.641 ' HA ' HG23 ' A' ' 35' ' ' ILE . 29.9 t70 -178.26 121.01 0.1 Allowed 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 113.244 -1.478 . . . . 4.3099999999999996 111.664 -177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.092 HG13 ' HD2' ' A' ' 42' ' ' PRO . 7.3 p 55.33 -66.36 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 127.27 2.856 . . . . 2.96 113.454 173.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.649 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 38.5 m -158.22 -58.54 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.713 0 CA-C-N 113.731 -1.577 . . . . 3.8300000000000001 110.341 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.092 ' HD2' HG13 ' A' ' 40' ' ' VAL . 59.3 Cg_endo -74.06 7.55 2.44 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 120.418 0.746 . . . . 3.8300000000000001 113.962 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 13.7 t70 81.55 6.0 1.23 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.817 1.294 . . . . 4.2599999999999998 108.651 164.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' A' ' 39' ' ' ASP . . . 165.93 67.8 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.639 0 CA-C-N 114.05 -1.432 . . . . 2.0099999999999998 112.447 172.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.685 ' HD3' ' HG3' ' A' ' 42' ' ' PRO . 16.8 tpt180 -85.09 -64.36 1.17 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.827 -1.175 . . . . 3.3399999999999999 107.827 174.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.055 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -114.91 124.2 51.1 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.336 -0.847 . . . . 2.0699999999999998 112.988 -174.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.61 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 27.4 t -102.86 100.59 10.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.652 -0.704 . . . . 1.9099999999999999 109.274 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.966 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.5 pp -65.12 118.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 113.072 0.768 . . . . 3.1899999999999999 113.072 -171.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.905 ' O ' ' HA ' ' A' ' 10' ' ' SER . 9.2 t70 -159.49 140.25 12.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.194 0.997 . . . . 3.3100000000000001 112.605 162.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -45.61 -46.67 14.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 115.65 1.722 . . . . 3.25 115.65 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -52.6 -40.73 62.98 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 116.644 2.09 . . . . 4.4500000000000002 116.644 -148.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.708 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 17.4 mmm180 -63.07 -57.83 9.3 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 122.096 0.951 . . . . 6.2599999999999998 110.463 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.928 ' H ' ' HB2' ' A' ' 10' ' ' SER . 33.9 t -65.56 167.11 9.4 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.41 -1.723 . . . . 3.04 111.12 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.14 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 11.6 t 71.31 26.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 123.055 1.407 . . . . 4.3200000000000003 108.501 -161.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.42 64.27 0.34 Allowed Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 113.351 -1.749 . . . . 4.1900000000000004 113.708 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.89 58.31 12.51 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 118.933 -1.603 . . . . 4.4199999999999999 115.03 172.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.286 1.7 m -132.95 -33.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.455 1.128 . . . . 3.52 109.262 -161.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.92 -28.54 6.84 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 115.685 1.735 . . . . 3.6400000000000001 115.685 -163.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.97 6.61 3.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.783 1.174 . . . . 5.4400000000000004 112.161 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.17 160.66 38.39 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.876 -1.157 . . . . 3.2200000000000002 107.876 159.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -74.58 118.23 5.25 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-N 120.849 1.339 . . . . 3.8300000000000001 108.857 163.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.743 HG21 ' S2 ' ' A' ' 86' ' ' FES . 7.3 tp -111.49 129.88 66.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 112.85 0.685 . . . . 2.6899999999999999 112.85 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG21 ' N ' ' A' ' 73' ' ' VAL . 86.9 t -141.49 119.53 9.06 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 107.255 -1.387 . . . . 1.8700000000000001 107.255 153.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.659 ' HB3' ' OG ' ' A' ' 10' ' ' SER . 38.7 ttm -110.14 135.52 50.8 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 117.779 -1.568 . . . . 1.6499999999999999 110.217 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.858 HG23 ' HB2' ' A' ' 68' ' ' LYS . 2.5 m -123.91 115.92 46.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 106.495 -1.669 . . . . 0.76000000000000001 106.495 168.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 49.07 -153.74 2.37 Favored Glycine 0 N--CA 1.439 -1.122 0 CA-C-O 122.281 0.934 . . . . 1.1000000000000001 112.368 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -82.2 35.62 0.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.343 -0.928 . . . . 3.0099999999999998 108.583 172.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.858 ' HB2' HG23 ' A' ' 65' ' ' VAL . 28.5 mmmt -105.52 -27.46 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.125 -0.943 . . . . 2.6200000000000001 109.776 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 64' ' ' MET . 12.3 m 35.61 89.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 124.459 1.099 . . . . 1.51 113.591 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.761 ' HD2' ' CE1' ' A' ' 85' ' ' TYR . 5.0 m-30 -107.89 -163.48 0.9 Allowed 'General case' 0 C--O 1.243 0.712 0 CA-C-O 122.306 1.051 . . . . 1.4299999999999999 113.345 -173.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -145.06 50.28 0.65 Allowed Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 114.468 -1.242 . . . . 1.49 110.654 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.886 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -71.62 1.58 6.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.803 0.811 . . . . 1.8300000000000001 109.056 173.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 77' ' ' GLN . 0.0 OUTLIER 46.0 -149.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 113.749 -1.568 . . . . 3.0600000000000001 113.958 167.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.664 ' H ' ' CD ' ' A' ' 75' ' ' PRO . 12.8 t -148.52 -40.46 0.01 OUTLIER Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.903 -0.59 . . . . 2.4900000000000002 112.528 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.664 ' CD ' ' H ' ' A' ' 74' ' ' THR . 4.5 Cg_endo -86.04 70.98 4.41 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.881 1.721 . . . . 2.6499999999999999 113.222 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.14 -38.16 3.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.551 -0.833 . . . . 1.3999999999999999 113.301 172.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.556 ' HB2' HG21 ' A' ' 73' ' ' VAL . 29.3 mt-30 -71.05 -10.3 59.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.64 1.21 . . . . 1.8700000000000001 108.364 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 2.2 t -42.36 -64.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 112.085 -2.325 . . . . 0.96999999999999997 112.799 174.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.716 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 47.8 mtmt -60.42 -25.55 66.03 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.976 0.893 . . . . 2.1299999999999999 110.785 -167.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.584 ' HD2' ' N ' ' A' ' 80' ' ' LYS . 2.6 mptp? -77.08 -53.87 7.24 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.596 -1.183 . . . . 2.4100000000000001 109.921 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.886 ' HB ' ' HA ' ' A' ' 72' ' ' ASN . 18.9 mm -62.73 -14.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.001 -1.0 . . . . 1.23 110.1 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.716 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 26.6 tp -57.22 -42.81 82.07 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.969 -0.457 . . . . 0.79000000000000004 110.257 169.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.47 -33.55 69.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.588 0.709 . . . . 0.88 109.422 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -73.23 -21.05 60.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.906 -1.043 . . . . 2.0899999999999999 112.693 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.83 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 1.9 m-30 . . . . . 0 N--CA 1.433 -1.302 0 CA-C-O 118.111 -0.947 . . . . 1.77 111.854 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 1.14 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptp . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.686 0.279 . . . . 13.970000000000001 110.806 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 81.8 t -124.35 101.45 34.38 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-O 120.975 0.417 . . . . 10.710000000000001 111.27 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -87.43 -168.85 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.067 2.511 . . . . 9.1999999999999993 111.234 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 15.9 mmtp -84.87 -63.76 1.28 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.32 -0.552 . . . . 9.0399999999999991 111.556 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 112.43 35.83 1.7 Allowed Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 120.591 -0.814 . . . . 4.1399999999999997 113.753 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.653 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 2.8 tppp? -64.67 -49.06 72.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.527 -0.546 . . . . 4.5800000000000001 109.527 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 1.068 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 3.2 m-85 -109.02 85.24 3.1 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 116.106 -0.497 . . . . 1.6399999999999999 111.27 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 47' ' ' SER . 87.2 Cg_exo -52.55 97.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.085 2.523 . . . . 1.02 112.327 169.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.682 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.1 OUTLIER -86.77 129.27 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 112.703 0.631 . . . . 1.52 112.703 -172.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.641 ' CB ' ' HB2' ' A' ' 52' ' ' ARG . 59.9 p -91.28 135.44 33.8 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 109.581 -0.526 . . . . 1.45 109.581 174.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -116.01 121.73 68.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.032 -0.531 . . . . 2.21 110.421 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.872 ' SG ' ' HB2' ' A' ' 17' ' ' CYS . 22.1 t -67.17 120.01 13.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.066 0.765 . . . . 2.2400000000000002 113.066 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.1 mmt -123.96 22.56 8.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.462 -1.245 . . . . 5.1200000000000001 107.858 160.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.511 ' HA3' ' S1 ' ' A' ' 86' ' ' FES . . . -68.28 178.58 22.1 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.892 -1.049 . . . . 3.8599999999999999 113.744 -171.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.8 t -67.95 -44.36 76.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.29 0.478 . . . . 5.9699999999999998 112.29 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.4 -58.18 3.6 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 112.607 0.595 . . . . 4.4100000000000001 112.607 -171.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.872 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 72.7 m -65.29 -35.28 80.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 2.98 111.317 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -59.85 -30.83 69.24 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.65 -0.705 . . . . 4.1799999999999997 112.317 -170.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -69.83 -25.11 27.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.033 0.444 . . . . 3.6499999999999999 110.896 -170.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -85.43 8.86 17.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.377 -0.374 . . . . 4.79 111.206 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.89 26.57 44.8 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.165 -0.774 . . . . 1.8700000000000001 111.165 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -73.52 -20.61 60.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.353 -0.424 . . . . 1.46 110.946 -172.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.821 ' O ' HG22 ' A' ' 26' ' ' VAL . 8.7 p-10 -62.86 -38.62 91.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.871 -0.604 . . . . 2.4199999999999999 110.717 -176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 27' ' ' HIS . 44.1 mtpt -68.56 -36.37 78.69 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 121.451 -0.78 . . . . 3.0299999999999998 110.195 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.66 HG11 ' HA ' ' A' ' 75' ' ' PRO . 2.5 t -72.3 -28.61 29.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.147 -0.621 . . . . 2.2599999999999998 111.685 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 23' ' ' ASP . 3.6 m -61.83 -37.49 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.949 -1.13 . . . . 1.5700000000000001 107.949 172.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 55.5 t-80 -60.09 -41.16 91.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.055 -0.52 . . . . 1.3500000000000001 109.873 173.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -53.65 -44.87 69.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.295 -0.866 . . . . 0.65000000000000002 109.295 176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.688 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 8.2 t80 -48.82 -61.52 2.0 Favored 'General case' 0 CA--C 1.502 -0.894 0 O-C-N 123.75 0.657 . . . . 1.98 109.781 172.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 33' ' ' LEU . 97.9 mttt -45.43 -45.41 12.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.754 -1.112 . . . . 2.8500000000000001 111.7 -176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -77.85 -43.28 30.79 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.717 -0.674 . . . . 2.23 111.717 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.748 ' NE2' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -63.08 -24.69 68.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.879 -0.415 . . . . 2.54 109.879 177.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.826 HD21 HG23 ' A' ' 35' ' ' ILE . 10.1 tp -63.24 -55.0 28.56 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.136 -1.061 . . . . 2.0600000000000001 108.136 173.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.587 ' HG2' ' H ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER 68.73 -14.29 0.29 Allowed 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.547 1.155 . . . . 4.4800000000000004 109.465 -179.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.826 HG23 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER 62.38 -10.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 127.066 2.146 . . . . 3.7599999999999998 113.366 175.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.587 ' H ' ' HG2' ' A' ' 34' ' ' LYS . 16.2 t70 68.24 -62.14 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.17 0.988 . . . . 4.6200000000000001 110.436 173.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 35' ' ' ILE . 2.4 pt -166.68 4.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.178 -1.374 . . . . 5.0 110.378 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' C ' HG22 ' A' ' 35' ' ' ILE . . . -178.79 -38.75 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.457 -1.354 . . . . 4.1299999999999999 113.884 -164.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.897 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 14.9 t70 -162.44 179.03 8.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.496 0.554 . . . . 4.3099999999999996 112.496 -155.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.097 HG23 ' HB3' ' A' ' 46' ' ' PHE . 1.9 t -24.82 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 O-C-N 125.57 1.794 . . . . 2.96 111.868 174.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.547 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 6.8 m -175.42 -55.01 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 111.033 -2.803 . . . . 3.8300000000000001 108.593 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.625 ' HD3' HG12 ' A' ' 40' ' ' VAL . 5.1 Cg_exo -81.12 -0.08 10.33 Favored 'Trans proline' 0 N--CA 1.433 -2.081 0 N-CA-C 116.381 1.646 . . . . 3.8300000000000001 116.381 -173.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.696 ' CA ' ' HB3' ' A' ' 39' ' ' ASP . 32.3 t70 77.4 16.78 1.57 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.461 -1.311 . . . . 4.2599999999999998 107.461 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -176.54 71.91 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 114.427 -1.26 . . . . 2.0099999999999998 112.805 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.526 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . 12.3 tpt180 -142.18 -60.89 0.45 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 114.34 -0.93 . . . . 3.3399999999999999 109.488 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.097 ' HB3' HG23 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -102.53 157.75 16.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.551 -1.204 . . . . 2.0699999999999998 111.684 -173.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.534 ' H ' HG22 ' A' ' 9' ' ' ILE . 53.7 m -165.15 113.44 1.02 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.039 -1.097 . . . . 1.9099999999999999 108.039 167.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 44.3 pt -92.78 154.64 3.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 113.859 1.059 . . . . 3.1899999999999999 113.859 -162.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 10' ' ' SER . 4.1 p-10 -161.52 137.8 8.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.822 -1.081 . . . . 3.3100000000000001 111.157 162.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -47.14 -42.29 19.18 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.54 1.311 . . . . 3.25 114.54 163.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.611 HD22 ' H ' ' A' ' 51' ' ' LEU . 3.0 mm? -51.79 -31.13 25.9 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.102 1.149 . . . . 4.4500000000000002 114.102 -161.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.641 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 16.8 mmt180 -54.69 -47.51 73.57 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.817 0.341 . . . . 6.2599999999999998 110.822 176.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.674 ' O ' HG12 ' A' ' 54' ' ' VAL . 50.0 t -58.45 158.1 7.97 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.561 0.744 . . . . 3.04 112.132 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.674 HG12 ' O ' ' A' ' 53' ' ' CYS . 0.8 OUTLIER 66.43 22.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 123.221 1.486 . . . . 4.3200000000000003 108.723 -160.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.92 67.87 0.27 Allowed Glycine 0 N--CA 1.432 -1.573 0 CA-C-N 112.606 -2.088 . . . . 4.1900000000000004 112.165 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.95 57.05 11.55 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 119.05 -1.548 . . . . 4.4199999999999999 115.177 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.542 ' HB3' HD13 ' A' ' 62' ' ' ILE . 9.5 m -133.06 -37.73 0.98 Allowed 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 118.272 1.036 . . . . 3.52 112.816 -171.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.58 -34.57 18.13 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 116.691 2.108 . . . . 3.6400000000000001 116.691 -150.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.47 2.43 21.99 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 120.615 1.552 . . . . 5.4400000000000004 113.206 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.5 160.39 48.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 C-N-CA 123.373 0.669 . . . . 3.2200000000000002 109.998 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 59.4 Cg_endo -78.97 125.08 6.39 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.722 0.948 . . . . 3.8300000000000001 109.967 156.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.853 ' HB ' ' S2 ' ' A' ' 86' ' ' FES . 1.5 mp -107.81 134.2 50.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.458 0.54 . . . . 2.6899999999999999 112.458 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.782 HG13 ' HA2' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -138.27 126.18 29.56 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.956 0 N-CA-C 107.251 -1.389 . . . . 1.8700000000000001 107.251 160.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.697 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 48.1 ttm -112.31 144.48 41.66 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.742 -1.224 . . . . 1.6499999999999999 109.618 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.068 ' HB ' ' HB3' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -122.26 117.12 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.526 -1.287 . . . . 0.76000000000000001 107.526 154.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 8' ' ' PRO . . . 45.98 -147.9 2.28 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-O 122.369 0.983 . . . . 1.1000000000000001 111.792 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -79.39 28.38 0.25 Allowed 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.032 -1.084 . . . . 3.0099999999999998 108.986 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.771 ' HB2' HG23 ' A' ' 65' ' ' VAL . 42.6 mmtt -107.79 -32.87 7.44 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 109.512 -0.551 . . . . 2.6200000000000001 109.512 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.697 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 96.9 t 44.12 110.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 115.271 1.582 . . . . 1.51 115.271 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.747 ' CG ' ' HE1' ' A' ' 85' ' ' TYR . 2.5 m-85 -130.37 -155.08 0.67 Allowed 'General case' 0 C--O 1.249 1.056 0 CA-C-O 122.682 1.23 . . . . 1.4299999999999999 112.968 -173.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.782 ' HA2' HG13 ' A' ' 63' ' ' VAL . . . -151.95 46.47 0.59 Allowed Glycine 0 C--O 1.218 -0.866 0 CA-C-N 114.279 -1.328 . . . . 1.49 111.878 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.751 ' HA ' ' HB ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -96.07 1.18 52.35 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.146 0.473 . . . . 1.8300000000000001 112.237 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.694 HG22 ' HB ' ' A' ' 63' ' ' VAL . 2.6 m -119.37 17.88 6.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 114.786 1.402 . . . . 3.0600000000000001 114.786 -166.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.828 ' OG1' ' HD2' ' A' ' 75' ' ' PRO . 0.8 OUTLIER -151.61 175.43 2.89 Favored Pre-proline 0 CA--C 1.563 1.461 0 O-C-N 121.342 -0.849 . . . . 2.4900000000000002 110.743 -173.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.828 ' HD2' ' OG1' ' A' ' 74' ' ' THR . 65.0 Cg_exo -14.72 94.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.956 1 C-N-CA 126.476 4.784 . . . . 2.6499999999999999 117.763 -166.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.611 ' H ' HG11 ' A' ' 25' ' ' VAL . . . 74.81 -29.96 1.07 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.871 -0.604 . . . . 1.3999999999999999 114.237 165.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.825 ' HA ' ' HD3' ' A' ' 80' ' ' LYS . 11.7 pt20 -78.38 -15.34 58.79 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.344 -1.354 . . . . 1.8700000000000001 107.344 -165.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.67 HG23 ' HG3' ' A' ' 79' ' ' LYS . 14.0 m -46.34 -58.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.884 0 CA-C-N 113.135 -1.848 . . . . 0.96999999999999997 111.248 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.748 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 28.7 mtmt -57.85 -42.88 85.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 122.584 1.183 . . . . 2.1299999999999999 109.44 -167.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.825 ' HD3' ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -78.5 -49.47 13.34 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 112.937 -1.938 . . . . 2.4100000000000001 109.854 -172.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.805 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 47.2 mm -68.64 -10.89 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 113.696 -1.593 . . . . 1.23 109.975 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 52.1 tp -64.17 -36.08 82.89 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.181 -0.949 . . . . 0.79000000000000004 110.315 167.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.74 -28.14 67.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.814 -0.81 . . . . 0.88 108.814 171.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.805 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 25.4 mm-40 -69.94 -37.59 75.9 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 114.926 -1.034 . . . . 2.0899999999999999 111.066 173.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.747 ' HE1' ' CG ' ' A' ' 70' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.428 -1.544 0 CA-C-O 119.163 -0.446 . . . . 1.77 111.8 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 0.853 ' S2 ' ' HB ' ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.817 -0.438 . . . . 13.970000000000001 109.817 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 3.4 p -49.19 120.13 9.56 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 120.995 0.426 . . . . 10.710000000000001 111.22 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.7 Cg_exo -74.4 71.76 4.45 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.314 2.676 . . . . 9.1999999999999993 111.941 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -67.24 -40.09 86.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.21 0.528 . . . . 9.0399999999999991 111.206 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.838 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . 153.34 -18.58 0.7 Allowed Glycine 0 C--O 1.212 -1.224 0 C-N-CA 119.512 -1.328 . . . . 4.1399999999999997 115.731 167.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.22 45.73 0.99 Allowed 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 114.378 1.251 . . . . 4.5800000000000001 114.378 -164.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.758 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 4.8 m-85 -50.55 110.94 1.9 Allowed Pre-proline 0 C--N 1.309 -1.178 0 N-CA-C 113.83 1.048 . . . . 1.6399999999999999 113.83 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 88.4 Cg_exo -56.29 99.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.473 0.285 0 C-N-CA 123.191 2.594 . . . . 1.02 111.777 169.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.822 ' HA ' ' O ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -85.52 122.56 38.52 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.896 0 N-CA-C 112.875 0.695 . . . . 1.52 112.875 -175.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 48.5 m -92.93 129.17 38.93 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.572 -0.74 . . . . 1.45 110.484 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.38 128.41 72.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.652 0.982 . . . . 2.21 113.652 -170.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 13.6 t -63.42 114.57 3.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.314 0.578 . . . . 2.2400000000000002 111.045 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.6 mtm -130.05 22.72 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.574 -0.739 . . . . 5.1200000000000001 110.449 171.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.05 175.64 23.63 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.2 -1.0 . . . . 3.8599999999999999 113.818 -170.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.7 p -67.51 -46.19 73.61 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.271 0.471 . . . . 5.9699999999999998 112.271 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.536 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -69.43 -52.88 22.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 4.4100000000000001 111.083 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -64.09 -39.74 94.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.804 -0.634 . . . . 2.98 111.678 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 25.6 t80 -65.02 -33.42 75.99 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.628 0.603 . . . . 4.1799999999999997 112.628 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 16' ' ' ALA . 7.1 p -71.75 -24.04 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 111.942 0.349 . . . . 3.6499999999999999 111.942 -166.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 31.2 mmtp -84.2 14.9 3.87 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.148 0.499 . . . . 4.79 111.57 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.99 29.26 20.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.966 -0.635 . . . . 1.8700000000000001 112.195 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.76 -19.51 62.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.485 -0.561 . . . . 1.46 109.485 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . 14.1 t70 -53.32 -51.76 61.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.396 -0.82 . . . . 2.4199999999999999 110.605 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -65.83 -38.25 88.4 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.077 -0.649 . . . . 3.0299999999999998 110.925 -175.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.094 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -71.67 -39.88 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 116.408 -0.36 . . . . 2.2599999999999998 111.254 -179.073 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.745 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 13.6 p -67.26 -29.82 47.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 119.595 -0.842 . . . . 1.5700000000000001 108.92 172.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.514 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 66.7 t-80 -60.65 -37.85 82.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 1.3500000000000001 109.897 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' VAL . . . -55.28 -46.76 76.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.454 -0.943 . . . . 0.65000000000000002 108.454 175.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.745 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 36.5 t80 -51.41 -52.67 43.96 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.183 -0.917 . . . . 1.98 111.186 173.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 27' ' ' HIS . 16.9 tppt? -45.43 -47.76 13.77 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.71 -1.132 . . . . 2.8500000000000001 111.171 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -80.59 -29.58 36.91 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.382 -0.826 . . . . 2.23 111.024 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.833 ' NE2' ' HA ' ' A' ' 79' ' ' LYS . 8.5 mm100 -59.18 -29.39 67.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.278 -0.874 . . . . 2.54 110.988 172.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.06 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 2.3 tt -53.16 -54.73 31.62 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 108.377 -0.971 . . . . 2.0600000000000001 108.377 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.835 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 61.1 -17.15 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 112.32 -2.218 . . . . 4.4800000000000004 113.241 174.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.777 ' HA ' ' H ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 52.62 -161.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.215 -1.357 . . . . 3.7599999999999998 113.307 167.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.914 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 17.9 t70 -157.13 -54.99 0.08 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 105.945 -1.872 . . . . 4.6200000000000001 105.945 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 36' ' ' ASP . 2.0 pt -177.54 21.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 111.808 -2.451 . . . . 5.0 107.443 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -164.97 -70.11 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 108.953 -1.659 . . . . 4.1299999999999999 108.953 -166.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.561 ' HA ' HD21 ' A' ' 33' ' ' LEU . 17.9 m-20 -178.46 125.45 0.11 Allowed 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 113.33 -1.435 . . . . 4.3099999999999996 110.038 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.976 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 2.6 p 57.81 -11.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 115.746 1.758 . . . . 2.96 115.746 165.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.914 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 55.2 m 112.65 -43.09 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.377 1.471 . . . . 3.8300000000000001 110.742 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 40' ' ' VAL . 87.0 Cg_exo -51.43 -19.57 7.15 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.123 1.215 . . . . 3.8300000000000001 113.022 163.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 38.2 t70 84.98 12.38 0.26 Allowed 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.98 1.372 . . . . 4.2599999999999998 107.671 163.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 156.44 76.1 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 112.78 -2.009 . . . . 2.0099999999999998 110.178 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.838 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 3.6 ttt180 -119.54 -53.83 2.2 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 114.724 -0.738 . . . . 3.3399999999999999 109.091 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.06 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -115.91 110.54 19.14 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 113.388 0.884 . . . . 2.0699999999999998 113.388 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.0 m -117.99 108.22 15.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.809 -1.087 . . . . 1.9099999999999999 109.168 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.747 ' HA ' HG23 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -70.66 145.09 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 113.439 0.903 . . . . 3.1899999999999999 113.439 -168.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.703 ' O ' ' HA ' ' A' ' 10' ' ' SER . 19.4 t70 -155.05 146.04 22.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.366 -1.288 . . . . 3.3100000000000001 111.807 175.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.3 m -42.36 -44.38 3.91 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 117.009 2.226 . . . . 3.25 117.009 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HG ' ' OD2' ' A' ' 49' ' ' ASP . 55.7 mt -49.26 -38.83 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.783 2.142 . . . . 4.4500000000000002 116.783 -148.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.687 ' HB3' ' HB3' ' A' ' 10' ' ' SER . 8.5 tpm_? -60.5 -51.69 68.39 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.387 0.994 . . . . 6.2599999999999998 111.011 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' A' ' 54' ' ' VAL . 42.1 t -62.59 154.92 27.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.54 -1.209 . . . . 3.04 113.547 -168.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 10.5 t 62.93 19.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 114.659 -1.155 . . . . 4.3200000000000003 109.157 -172.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.8 61.52 0.47 Allowed Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.634 -1.166 . . . . 4.1900000000000004 113.505 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.25 58.8 12.53 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 118.524 -1.798 . . . . 4.4199999999999999 114.478 168.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.565 ' HB3' HG21 ' A' ' 62' ' ' ILE 0.262 2.9 m -129.26 -34.45 1.86 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.859 1.829 . . . . 3.52 111.157 -154.339 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.45 6.25 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 116.535 2.05 . . . . 3.6400000000000001 116.535 -163.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 59' ' ' LEU . 16.2 mt -73.15 4.8 4.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.591 1.542 . . . . 5.4400000000000004 112.238 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.74 52.5 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.581 -0.896 . . . . 3.2200000000000002 108.581 159.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.8 122.62 6.44 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.018 -1.57 . . . . 3.8300000000000001 108.018 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.596 HG12 ' S1 ' ' A' ' 86' ' ' FES . 44.7 pt -106.96 127.82 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 118.862 -1.135 . . . . 2.6899999999999999 113.085 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.684 HG22 HG13 ' A' ' 73' ' ' VAL . 0.0 OUTLIER -144.08 120.78 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.054 0 N-CA-C 107.47 -1.307 . . . . 1.8700000000000001 107.47 152.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.822 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 25.0 ttt -111.24 135.64 51.48 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.583 -1.266 . . . . 1.6499999999999999 107.583 -175.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.792 ' CG1' ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -119.07 114.39 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.249 0 N-CA-C 107.179 -1.415 . . . . 0.76000000000000001 107.179 169.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 51.36 -159.14 2.24 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.088 -1.205 . . . . 1.1000000000000001 110.088 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.36 38.78 0.31 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-O 121.29 0.567 . . . . 3.0099999999999998 109.967 171.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.618 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 51.5 mmtt -105.43 -37.49 6.8 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 115.651 -0.704 . . . . 2.6200000000000001 110.473 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.736 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 85.1 t 53.33 108.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 114.07 1.137 . . . . 1.51 114.07 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.695 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.6 m-30 -126.94 -169.83 2.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 122.455 1.121 . . . . 1.4299999999999999 113.222 -173.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 70' ' ' TYR . . . -129.05 30.18 3.75 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.061 -1.427 . . . . 1.49 112.598 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.874 ' HB3' ' CE2' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -88.59 89.03 7.82 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 107.573 -1.269 . . . . 1.8300000000000001 107.573 172.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -116.66 -93.19 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.856 0 CA-C-O 122.188 0.994 . . . . 3.0600000000000001 112.785 -168.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 1.094 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 43.7 p -133.83 -61.92 0.02 OUTLIER Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.585 -1.643 . . . . 2.4900000000000002 113.484 -166.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.75 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 16.4 Cg_endo -87.4 70.07 3.52 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.271 1.981 . . . . 2.6499999999999999 113.121 -162.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 77.99 -12.18 18.85 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.919 -0.658 . . . . 1.3999999999999999 112.689 177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.75 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 25.7 mt-30 -73.52 -25.76 60.56 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 106.183 -1.784 . . . . 1.8700000000000001 106.183 -172.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.739 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 16.0 m -46.8 -61.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.076 0 CA-C-N 111.566 -2.561 . . . . 0.96999999999999997 111.651 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.854 ' HG3' ' HG3' ' A' ' 80' ' ' LYS . 15.5 pttm -58.45 -39.56 80.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.807 0.813 . . . . 2.1299999999999999 110.84 -167.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.854 ' HG3' ' HG3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -81.08 -46.84 14.37 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-N 114.698 -1.137 . . . . 2.4100000000000001 109.449 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.673 HG22 ' HB2' ' A' ' 72' ' ' ASN . 39.9 mm -70.56 -11.62 15.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.13 -1.395 . . . . 1.23 110.11 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 85' ' ' TYR . 31.0 tp -62.65 -34.17 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.654 -0.654 . . . . 0.79000000000000004 110.005 168.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.74 -33.03 69.79 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 108.854 -0.795 . . . . 0.88 108.854 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -70.09 -41.35 74.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.735 -1.121 . . . . 2.0899999999999999 111.114 171.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.874 ' CE2' ' HB3' ' A' ' 72' ' ' ASN . 7.0 m-30 . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 117.898 -1.049 . . . . 1.77 111.879 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 0.596 ' S1 ' HG12 ' A' ' 62' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.41 -0.219 . . . . 13.970000000000001 110.41 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.594 ' HB ' ' HD3' ' A' ' 3' ' ' PRO . 93.3 t -81.29 -57.02 0.57 Allowed Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 120.923 -0.311 . . . . 10.710000000000001 110.368 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 2' ' ' VAL . 59.4 Cg_endo -75.01 78.64 2.85 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.859 1.706 . . . . 9.1999999999999993 111.109 172.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.675 ' HB3' ' HD2' ' A' ' 6' ' ' LYS . 88.1 mttt -64.3 -71.82 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.594 -0.73 . . . . 9.0399999999999991 111.617 -175.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.749 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . 110.94 -21.06 23.43 Favored Glycine 0 C--N 1.314 -0.692 0 C-N-CA 120.709 -0.758 . . . . 4.1399999999999997 113.374 173.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -101.52 51.87 0.84 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.713 0.768 . . . . 4.5800000000000001 111.718 -170.073 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.568 ' CZ ' ' HA2' ' A' ' 5' ' ' GLY . 2.7 m-85 -52.72 109.56 1.51 Allowed Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 113.759 -1.564 . . . . 1.6399999999999999 113.255 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.919 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 32.1 Cg_exo -61.92 104.42 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.826 1.684 . . . . 1.02 111.029 169.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.078 ' HB ' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -79.43 114.3 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.773 0.797 . . . . 1.52 110.378 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.79 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 8.3 m -93.09 107.11 18.97 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.526 -1.216 . . . . 1.45 110.41 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -118.17 123.21 71.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.394 -0.821 . . . . 2.21 110.06 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.732 ' SG ' HG22 ' A' ' 54' ' ' VAL . 32.1 t -66.86 119.28 11.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.109 -0.636 . . . . 2.2400000000000002 110.884 178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.7 ttp -122.96 23.29 9.38 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.2 -1.037 . . . . 5.1200000000000001 108.2 170.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.78 179.5 17.48 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 115.18 -0.918 . . . . 3.8599999999999999 112.616 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.3 m -62.71 -43.9 97.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.119 0.415 . . . . 5.9699999999999998 112.119 -170.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -70.18 -56.08 7.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.048 0.452 . . . . 4.4100000000000001 111.735 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.622 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 81.8 m -68.79 -37.75 79.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.202 0.445 . . . . 2.98 112.202 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.767 ' HE1' ' HB2' ' A' ' 23' ' ' ASP . 74.4 t80 -63.99 -31.63 72.88 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.726 0.639 . . . . 4.1799999999999997 112.726 -176.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 16' ' ' ALA . 8.0 p -68.7 -20.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.917 0.389 . . . . 3.6499999999999999 111.043 -168.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -82.51 14.35 3.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.005 -0.543 . . . . 4.79 111.09 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.32 23.35 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.065 -0.588 . . . . 1.8700000000000001 111.971 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 18' ' ' PHE . . . -72.9 -20.93 60.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.316 . . . . 1.46 111.462 -172.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.767 ' HB2' ' HE1' ' A' ' 18' ' ' PHE . 17.5 t70 -57.52 -44.44 85.09 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 120.47 -0.492 . . . . 2.4199999999999999 110.946 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 1.7 mptp? -64.64 -39.3 93.46 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.885 -0.726 . . . . 3.0299999999999998 111.528 -171.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.998 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 0.4 OUTLIER -68.79 -46.94 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 120.557 -0.457 . . . . 2.2599999999999998 110.267 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.492 HG23 ' HE3' ' A' ' 30' ' ' LYS . 17.8 m -65.98 -25.3 35.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.387 -0.525 . . . . 1.5700000000000001 110.546 177.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.629 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 66.4 t-80 -60.74 -44.8 96.22 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.214 0.53 . . . . 1.3500000000000001 109.67 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.42 -40.09 74.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.598 -1.183 . . . . 0.65000000000000002 109.254 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.649 ' HE2' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -61.49 -46.5 89.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 1.98 110.458 175.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.629 ' HD2' ' HA ' ' A' ' 27' ' ' HIS . 90.5 mttt -53.65 -40.88 66.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.566 -0.743 . . . . 2.8500000000000001 110.551 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -82.98 -29.27 29.13 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.396 -0.82 . . . . 2.23 111.448 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.627 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -66.27 -21.98 66.3 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.914 -0.584 . . . . 2.54 109.648 177.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.931 ' HG ' HG12 ' A' ' 35' ' ' ILE . 3.6 tp -51.22 -53.94 30.41 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 106.812 -1.551 . . . . 2.0600000000000001 106.812 170.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.649 ' C ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER 63.38 -28.46 0.08 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 125.885 1.991 . . . . 4.4800000000000004 113.098 168.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.931 HG12 ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.25 -173.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 126.152 1.781 . . . . 3.7599999999999998 114.631 165.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 8.5 t70 -157.69 -41.58 0.07 Allowed 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 113.387 -1.733 . . . . 4.6200000000000001 107.396 -176.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' ' 43' ' ' ASP . 4.1 pt -163.23 -3.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 113.643 -1.617 . . . . 5.0 112.646 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -174.46 -58.94 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.285 0 C-N-CA 120.035 -1.078 . . . . 4.1299999999999999 110.79 -170.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.994 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 34.1 m-20 -164.5 115.62 1.24 Allowed 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.821 -0.689 . . . . 4.3099999999999996 111.798 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.892 HG23 ' CD2' ' A' ' 46' ' ' PHE . 1.3 t 72.56 -62.96 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 O-C-N 125.117 1.51 . . . . 2.96 109.755 175.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.758 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 64.1 m -169.43 -61.21 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 112.215 -2.266 . . . . 3.8300000000000001 109.635 -173.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.746 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 72.1 Cg_endo -77.11 11.3 2.09 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 120.624 0.882 . . . . 3.8300000000000001 113.737 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.636 ' HB2' HG13 ' A' ' 37' ' ' ILE . 24.2 t70 82.02 11.03 0.7 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.001 -1.111 . . . . 4.2599999999999998 108.001 169.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.586 ' HA2' ' HB2' ' A' ' 39' ' ' ASP . . . 169.43 77.77 0.04 OUTLIER Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 119.292 -1.432 . . . . 2.0099999999999998 112.536 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.749 ' HA ' ' O ' ' A' ' 5' ' ' GLY . 5.1 ttm180 -116.44 1.44 12.98 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.02 -1.844 . . . . 3.3399999999999999 106.02 165.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.994 ' HB2' ' HB3' ' A' ' 39' ' ' ASP . 1.7 m-85 -134.33 169.14 17.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.276 -2.693 . . . . 2.0699999999999998 111.097 -171.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.919 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 1.4 t 178.26 73.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.493 -1.299 . . . . 1.9099999999999999 107.493 166.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.044 HG22 HD13 ' A' ' 9' ' ' ILE . 2.1 pp -67.07 116.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.682 -1.145 . . . . 3.1899999999999999 112.997 -167.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' A' ' 10' ' ' SER . 29.3 t70 -162.27 142.24 9.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.572 1.177 . . . . 3.3100000000000001 112.711 167.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 23.4 m -43.76 -45.72 7.31 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.692 -2.049 . . . . 3.25 116.198 172.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 tp -51.35 -41.74 60.81 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.177 1.918 . . . . 4.4500000000000002 116.177 -149.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.646 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 11.0 mmm180 -63.06 -55.93 21.32 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.156 0.979 . . . . 6.2599999999999998 110.797 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.693 ' H ' ' HB3' ' A' ' 10' ' ' SER . 34.1 t -63.15 168.72 3.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.343 -1.753 . . . . 3.04 110.252 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.111 ' HA ' ' S1 ' ' A' ' 86' ' ' FES . 15.7 t 74.52 28.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 123.204 1.478 . . . . 4.3200000000000003 108.508 -156.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.29 64.35 0.28 Allowed Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 113.425 -1.716 . . . . 4.1900000000000004 113.025 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.4 56.89 19.19 Favored Glycine 0 C--N 1.345 1.079 0 C-N-CA 119.63 -1.271 . . . . 4.4199999999999999 115.567 171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.293 1.1 m -135.79 -33.66 0.85 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.985 1.392 . . . . 3.52 110.213 -162.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.06 -28.98 11.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 116.221 1.934 . . . . 3.6400000000000001 116.221 -160.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.03 6.81 3.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.35 1.432 . . . . 5.4400000000000004 112.244 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.51 160.14 39.17 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 107.807 -1.182 . . . . 3.2200000000000002 107.807 159.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.45 117.25 4.75 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 N-CA-C 108.431 -1.411 . . . . 3.8300000000000001 108.431 160.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.1 tp -113.18 133.68 58.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 119.406 -0.33 . . . . 2.6899999999999999 111.771 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.649 HG21 ' HE2' ' A' ' 29' ' ' PHE . 99.4 t -139.87 121.54 15.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 108.908 -0.775 . . . . 1.8700000000000001 108.908 155.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 50.1 ttp -112.45 136.2 52.23 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.864 -1.135 . . . . 1.6499999999999999 109.412 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.078 HG13 ' HB ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -122.27 114.8 44.05 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 119.877 -0.729 . . . . 0.76000000000000001 109.485 174.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.702 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 50.76 45.81 48.52 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.808 -0.71 . . . . 1.1000000000000001 113.433 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 59.55 6.66 0.85 Allowed 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 122.952 0.501 . . . . 3.0099999999999998 111.4 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.913 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 71.2 mmtt -77.01 -8.76 57.98 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 110.234 -0.284 . . . . 2.6200000000000001 110.234 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.4 m 35.72 99.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 124.609 1.193 . . . . 1.51 113.889 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.913 ' HE1' ' HB3' ' A' ' 68' ' ' LYS . 3.8 m-85 -110.09 165.88 11.39 Favored 'General case' 0 C--O 1.254 1.312 0 CA-C-O 122.962 1.363 . . . . 1.4299999999999999 113.675 -173.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.663 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -109.75 5.96 31.14 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 112.544 -2.116 . . . . 1.49 109.009 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.743 ' HA ' ' CG2' ' A' ' 81' ' ' ILE . 26.3 t-20 -65.25 131.57 46.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.49 -1.67 . . . . 1.8300000000000001 106.49 167.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -120.72 -145.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 113.466 0.913 . . . . 3.0600000000000001 113.466 -148.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.998 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 76.5 p -131.29 -50.9 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.018 1.118 . . . . 2.4900000000000002 114.018 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD3' ' OG1' ' A' ' 74' ' ' THR . 91.2 Cg_endo -87.79 73.93 2.45 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.582 1.521 . . . . 2.6499999999999999 113.474 -170.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.02 -23.54 4.41 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.75 -0.738 . . . . 1.3999999999999999 112.782 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.621 HE21 ' HD2' ' A' ' 75' ' ' PRO . 23.6 mt-30 -74.38 -19.71 60.34 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 106.403 -1.702 . . . . 1.8700000000000001 106.403 -172.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.684 HG23 ' HG3' ' A' ' 79' ' ' LYS . 8.4 m -43.44 -60.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 111.704 -2.498 . . . . 0.96999999999999997 111.915 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.684 ' HG3' HG23 ' A' ' 78' ' ' VAL . 45.9 mtmt -59.45 -37.59 78.55 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 122.277 1.037 . . . . 2.1299999999999999 109.998 -165.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.4 -47.7 12.89 Favored 'General case' 0 CA--C 1.487 -1.478 0 CA-C-N 114.257 -1.338 . . . . 2.4100000000000001 109.446 -175.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.772 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 42.1 mm -66.57 -10.68 11.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.291 -1.322 . . . . 1.23 110.013 177.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.691 HD12 ' HB2' ' A' ' 85' ' ' TYR . 52.7 tp -58.75 -23.95 60.82 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.521 -0.737 . . . . 0.79000000000000004 110.127 169.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.44 27.34 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.448 -0.501 . . . . 0.88 110.305 168.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.772 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER -67.0 -36.78 82.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.983 -0.553 . . . . 2.0899999999999999 111.715 174.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.691 ' HB2' HD12 ' A' ' 82' ' ' LEU . 6.7 m-30 . . . . . 0 N--CA 1.432 -1.355 0 CA-C-O 118.523 -0.751 . . . . 1.77 111.547 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 1.111 ' S1 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' HB ' ' A' ' 2' ' ' VAL . 6.5 tmm? . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 109.347 -0.612 . . . . 13.970000000000001 109.347 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 1' ' ' MET . 99.5 t 74.17 105.72 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.278 0 O-C-N 123.598 0.561 . . . . 10.710000000000001 110.191 -175.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.05 101.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.25 2.633 . . . . 9.1999999999999993 112.51 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.771 ' H ' ' HA3' ' A' ' 44' ' ' GLY . 26.2 tptp -36.07 -67.49 0.16 Allowed 'General case' 0 CA--C 1.511 -0.555 0 O-C-N 124.682 1.239 . . . . 9.0399999999999991 112.824 -173.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 47' ' ' SER . . . 122.4 34.49 0.81 Allowed Glycine 0 CA--C 1.495 -1.161 0 CA-C-N 114.815 -1.084 . . . . 4.1399999999999997 112.269 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.531 ' HG3' ' CE1' ' A' ' 7' ' ' TYR . 14.3 tppt? -50.66 -62.02 1.85 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.202 -1.036 . . . . 4.5800000000000001 108.202 169.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.598 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 4.7 m-85 -115.44 89.16 21.02 Favored Pre-proline 0 N--CA 1.434 -1.257 0 CA-C-N 114.837 -1.074 . . . . 1.6399999999999999 110.541 173.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 51.2 Cg_exo -59.67 102.28 0.16 Allowed 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.111 2.541 . . . . 1.02 111.669 171.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.055 HG12 ' HA ' ' A' ' 48' ' ' ILE . 0.5 OUTLIER -84.48 173.39 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 113.387 0.884 . . . . 1.52 113.387 -167.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.746 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 14.9 p -134.65 134.85 41.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.263 -0.88 . . . . 1.45 109.005 171.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 m -115.46 124.47 72.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.785 -0.643 . . . . 2.21 110.962 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.0 t -66.11 112.6 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.299 0.571 . . . . 2.2400000000000002 110.463 -177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.3 tpt -131.11 23.85 4.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.37 -0.832 . . . . 5.1200000000000001 109.628 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.66 177.26 13.59 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.584 -0.817 . . . . 3.8599999999999999 113.992 -166.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.0 t -66.21 -45.55 80.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 5.9699999999999998 111.676 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.2 -52.27 20.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.556 0.693 . . . . 4.4100000000000001 110.339 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.2 m -62.65 -34.19 76.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.626 -1.17 . . . . 2.98 111.734 -172.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 83.6 t80 -60.69 -34.31 74.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.787 0.327 . . . . 4.1799999999999997 111.346 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.82 -24.33 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.545 0.688 . . . . 3.6499999999999999 109.862 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -84.44 12.2 7.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.171 -0.922 . . . . 4.79 110.408 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 31.1 17.24 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.537 -0.84 . . . . 1.8700000000000001 113.145 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -70.74 -19.81 62.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.707 0.289 . . . . 1.46 110.789 -175.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.99 -52.88 62.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.15 -0.477 . . . . 2.4199999999999999 110.248 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -64.55 -31.36 72.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.887 -0.412 . . . . 3.0299999999999998 109.887 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.878 ' HA ' ' CB ' ' A' ' 74' ' ' THR . 98.2 t -56.82 -62.51 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 CA-C-N 115.557 -0.747 . . . . 2.2599999999999998 109.426 176.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -63.98 -27.86 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 115.729 -0.669 . . . . 1.5700000000000001 110.793 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -58.5 -47.87 82.68 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 120.299 -0.56 . . . . 1.3500000000000001 110.368 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -56.55 -45.01 81.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.15 -0.932 . . . . 0.65000000000000002 109.163 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.645 ' HA ' ' HG2' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -53.5 -53.39 52.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.093 -0.958 . . . . 1.98 110.087 177.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -51.34 -48.95 62.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.587 -0.733 . . . . 2.8500000000000001 110.995 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.81 -28.55 28.0 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.123 -0.944 . . . . 2.23 111.446 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -63.97 -26.77 68.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 123.437 0.461 . . . . 2.54 110.328 176.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.066 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 tt -50.95 -56.21 13.46 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.612 -1.255 . . . . 2.0600000000000001 107.612 173.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 63.59 -19.47 0.06 Allowed 'General case' 0 C--N 1.321 -0.67 0 O-C-N 126.527 2.392 . . . . 4.4800000000000004 112.644 170.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.638 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER 56.9 -173.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 113.621 -1.627 . . . . 3.7599999999999998 112.713 170.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.78 -48.7 0.07 Allowed 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.944 -1.132 . . . . 4.6200000000000001 107.944 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 pt -165.58 5.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 112.898 -1.955 . . . . 5.0 110.615 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.555 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 177.16 -54.51 0.1 Allowed Glycine 0 CA--C 1.487 -1.713 0 N-CA-C 110.103 -1.199 . . . . 4.1299999999999999 110.103 -166.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.691 ' HB3' ' N ' ' A' ' 44' ' ' GLY . 24.4 t70 -176.53 116.88 0.12 Allowed 'General case' 0 CA--C 1.483 -1.635 0 CA-C-N 113.446 -1.377 . . . . 4.3099999999999996 111.291 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.027 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 6.5 p 54.9 -65.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 127.301 2.876 . . . . 2.96 113.488 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.82 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 26.2 m -154.0 -58.81 0.02 OUTLIER Pre-proline 0 C--N 1.274 -2.689 0 CA-C-N 113.631 -1.622 . . . . 3.8300000000000001 110.565 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.82 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 2.8 Cg_exo -77.63 10.06 2.68 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 C-N-CA 120.745 0.963 . . . . 3.8300000000000001 114.235 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.555 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 6.8 t0 81.43 9.41 0.95 Allowed 'General case' 0 C--N 1.349 0.558 0 N-CA-C 107.644 -1.243 . . . . 4.2599999999999998 107.644 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.771 ' HA3' ' H ' ' A' ' 4' ' ' LYS . . . 156.92 59.36 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.237 -1.347 . . . . 2.0099999999999998 112.171 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.64 ' HB2' ' HG2' ' A' ' 42' ' ' PRO . 11.6 ttt180 -86.73 -62.0 1.61 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 108.029 -1.1 . . . . 3.3399999999999999 108.029 177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.066 ' HZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -100.95 102.42 13.43 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 122.806 1.289 . . . . 2.0699999999999998 112.738 173.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.477 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 22.6 t -92.02 91.98 8.08 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.887 -1.506 . . . . 1.9099999999999999 109.215 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.055 ' HA ' HG12 ' A' ' 9' ' ' ILE . 2.3 pp -56.46 124.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.928 -1.033 . . . . 3.1899999999999999 112.518 -174.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 10' ' ' SER . 8.5 m-20 -143.21 132.73 23.58 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.518 1.151 . . . . 3.3100000000000001 113.464 166.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.0 t -48.5 -43.41 35.06 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.171 -1.831 . . . . 3.25 114.581 158.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.0 mt -53.16 -35.13 59.44 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.558 1.318 . . . . 4.4500000000000002 114.558 -160.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.746 ' HB2' ' HB2' ' A' ' 10' ' ' SER . 9.8 mmt85 -60.77 -49.87 75.75 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.806 0.812 . . . . 6.2599999999999998 110.176 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.0 t -59.22 158.58 8.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.944 -1.48 . . . . 3.04 112.895 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 54' ' ' VAL . 14.7 t 66.27 24.27 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.388 0 CA-C-O 122.83 1.3 . . . . 4.3200000000000003 108.558 -167.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.77 63.6 0.37 Allowed Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 113.829 -1.532 . . . . 4.1900000000000004 113.263 -178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.21 59.08 10.04 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 118.739 -1.696 . . . . 4.4199999999999999 114.609 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.727 ' HB3' HG13 ' A' ' 62' ' ' ILE 0.282 2.8 m -130.14 -37.13 1.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.058 1.429 . . . . 3.52 110.765 -159.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.06 -32.65 35.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.916 1.45 . . . . 3.6400000000000001 114.916 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 59' ' ' LEU . 2.5 pt? -76.83 6.13 6.64 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.117 -0.989 . . . . 5.4400000000000004 112.334 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.76 160.86 38.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.305 -0.628 . . . . 3.2200000000000002 109.305 164.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.52 119.19 4.8 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 108.572 -1.357 . . . . 3.8300000000000001 108.572 155.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.727 HG13 ' HB3' ' A' ' 57' ' ' CYS . 47.0 mm -111.58 129.58 66.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 112.567 0.58 . . . . 2.6899999999999999 112.567 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 4.7 t -139.57 123.15 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.832 -1.544 . . . . 1.8700000000000001 106.832 153.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.764 ' O ' ' HB ' ' A' ' 9' ' ' ILE . 22.7 ttt -112.75 136.08 52.76 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.954 -1.498 . . . . 1.6499999999999999 110.598 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.748 HG23 ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -124.81 114.91 42.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 106.545 -1.65 . . . . 0.76000000000000001 106.545 156.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 7' ' ' TYR . . . 44.75 -149.25 1.09 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 122.165 0.87 . . . . 1.1000000000000001 112.752 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.31 31.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.842 -1.179 . . . . 3.0099999999999998 108.744 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.748 ' HB2' HG23 ' A' ' 65' ' ' VAL . 13.2 mmmm -106.61 -41.56 5.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.535 -0.757 . . . . 2.6200000000000001 109.214 -177.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 64' ' ' MET . 87.8 t 46.38 101.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 124.472 1.108 . . . . 1.51 113.523 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.668 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 9.1 m-30 -120.41 -154.77 0.6 Allowed 'General case' 0 C--O 1.248 1.024 0 CA-C-O 121.863 0.839 . . . . 1.4299999999999999 112.312 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.612 ' HA2' ' CG2' ' A' ' 63' ' ' VAL . . . -142.6 28.21 2.19 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 114.695 -1.139 . . . . 1.49 112.003 -178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.865 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 3.1 t30 -81.76 112.73 19.19 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.711 -0.477 . . . . 1.8300000000000001 109.711 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.665 HG23 ' H ' ' A' ' 74' ' ' THR . 6.9 m -137.2 -78.78 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 116.922 2.193 . . . . 3.0600000000000001 116.922 -171.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.878 ' CB ' ' HA ' ' A' ' 25' ' ' VAL . 13.6 t -153.41 -41.68 0.0 OUTLIER Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 115.51 1.671 . . . . 2.4900000000000002 115.51 -172.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.892 ' HD2' ' HG3' ' A' ' 77' ' ' GLN . 3.0 Cg_exo -75.31 57.22 4.68 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.09 1.86 . . . . 2.6499999999999999 112.036 -170.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.447 ' HA2' ' HE2' ' A' ' 79' ' ' LYS . . . 76.3 -7.54 30.23 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.58 -0.737 . . . . 1.3999999999999999 111.562 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.892 ' HG3' ' HD2' ' A' ' 75' ' ' PRO . 6.8 mt-30 -73.62 -35.75 65.38 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.209 -1.404 . . . . 1.8700000000000001 107.209 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.621 ' HA ' ' OD1' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -50.67 -55.69 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 112.802 -1.999 . . . . 0.96999999999999997 110.941 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 48.9 mtmt -54.51 -45.66 73.35 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.019 0.914 . . . . 2.1299999999999999 109.508 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.777 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -85.56 -40.94 15.74 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.642 -1.163 . . . . 2.4100000000000001 110.987 -173.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.774 ' CG2' ' HB2' ' A' ' 72' ' ' ASN . 33.3 mm -69.69 -15.11 19.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.955 -0.566 . . . . 1.23 109.765 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.539 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 54.7 tp -58.93 -41.57 87.65 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.989 -0.445 . . . . 0.79000000000000004 110.29 171.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.2 -32.74 66.79 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.544 0.688 . . . . 0.88 109.422 173.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.55 -31.64 67.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.755 -1.111 . . . . 2.0899999999999999 112.125 175.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.865 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 2.1 m-30 . . . . . 0 N--CA 1.432 -1.369 0 CA-C-O 117.418 -1.277 . . . . 1.77 112.004 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HG2' HG23 ' A' ' 2' ' ' VAL . 25.8 ttt . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.649 0.261 . . . . 13.970000000000001 110.797 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG23 ' HG2' ' A' ' 1' ' ' MET . 68.3 t -120.57 113.51 33.42 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.756 -0.202 . . . . 10.710000000000001 110.694 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.2 Cg_exo -76.96 125.13 7.8 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.002 2.468 . . . . 9.1999999999999993 112.152 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -123.96 -79.06 0.61 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.279 0.561 . . . . 9.0399999999999991 110.947 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.02 1.52 45.26 Favored Glycine 0 C--N 1.312 -0.754 0 CA-C-N 115.338 -0.846 . . . . 4.1399999999999997 112.862 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.681 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -140.36 53.27 1.63 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.248 1.023 . . . . 4.5800000000000001 110.915 -176.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.937 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -69.31 112.59 12.35 Favored Pre-proline 0 C--N 1.309 -1.167 0 CA-C-N 114.075 -1.42 . . . . 1.6399999999999999 112.764 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 1.039 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 21.0 Cg_exo -70.8 131.14 19.2 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.903 1.735 . . . . 1.02 111.678 170.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.883 HG22 ' HA ' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -77.45 156.02 5.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.376 0.608 . . . . 1.52 112.085 -175.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.82 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 10.6 m -141.68 100.81 3.84 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.299 -0.864 . . . . 1.45 109.56 178.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 50' ' ' THR . 0.2 OUTLIER -117.81 124.64 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.744 -0.662 . . . . 2.21 110.799 -176.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.746 ' SG ' HG22 ' A' ' 54' ' ' VAL . 31.5 t -65.14 120.87 13.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.527 0.679 . . . . 2.2400000000000002 110.876 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.4 mtt -122.01 24.8 9.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.15 -0.932 . . . . 5.1200000000000001 108.714 173.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.09 179.91 13.19 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.132 -0.94 . . . . 3.8599999999999999 112.836 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 19' ' ' VAL . 19.8 m -65.78 -45.67 81.59 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.993 0.368 . . . . 5.9699999999999998 111.993 -172.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.641 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -71.62 -56.54 5.65 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.465 0.543 . . . . 4.4100000000000001 112.465 -178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 83.3 m -66.62 -36.55 82.87 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.535 0.569 . . . . 2.98 112.535 -171.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -63.78 -30.87 71.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.126 0.787 . . . . 4.1799999999999997 113.126 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 16' ' ' ALA . 32.6 m -69.74 -18.92 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.948 0.351 . . . . 3.6499999999999999 111.948 -170.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.95 16.46 0.9 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.396 -0.366 . . . . 4.79 111.612 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.85 32.3 10.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.451 -0.881 . . . . 1.8700000000000001 111.851 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' HG22 ' A' ' 25' ' ' VAL . . . -72.05 -20.82 61.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.436 -0.382 . . . . 1.46 110.617 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -54.18 -50.86 66.07 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.031 -0.359 . . . . 2.4199999999999999 110.031 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -65.02 -40.62 95.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.698 -0.401 . . . . 3.0299999999999998 110.983 -171.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.789 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 6.1 m -67.17 -49.0 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 C-N-CA 120.42 -0.512 . . . . 2.2599999999999998 110.153 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.675 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 21.8 m -64.83 -28.95 46.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.182 -0.607 . . . . 1.5700000000000001 110.269 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -59.5 -43.11 93.42 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 120.72 -0.392 . . . . 1.3500000000000001 110.219 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 32' ' ' GLN . . . -52.96 -49.16 66.64 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.202 -0.908 . . . . 0.65000000000000002 109.062 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.675 ' HB3' ' O ' ' A' ' 26' ' ' VAL . 39.7 t80 -47.54 -56.9 6.14 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.065 -0.97 . . . . 1.98 110.488 174.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.17 -52.66 11.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.373 -1.285 . . . . 2.8500000000000001 112.229 -176.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -84.45 -30.52 25.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.84 -0.618 . . . . 2.23 111.762 -173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.69 ' NE2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -64.71 -25.02 67.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 109.54 -0.541 . . . . 2.54 109.54 176.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.797 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.3 tt -48.59 -58.23 5.01 Favored 'General case' 0 CA--C 1.488 -1.42 0 N-CA-C 107.246 -1.39 . . . . 2.0600000000000001 107.246 174.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.744 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 64.09 -21.49 0.07 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 126.328 2.268 . . . . 4.4800000000000004 112.874 171.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.701 HG12 HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 53.98 -173.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 C-N-CA 126.342 1.857 . . . . 3.7599999999999998 114.389 166.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' H ' HG22 ' A' ' 35' ' ' ILE . 14.7 t70 -157.74 -50.93 0.07 Allowed 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 113.848 -1.524 . . . . 4.6200000000000001 107.985 -172.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pt -164.79 5.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 113.441 -1.709 . . . . 5.0 110.863 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.31 -65.04 0.06 OUTLIER Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 109.675 -1.37 . . . . 4.1299999999999999 109.675 -166.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.895 ' HB3' ' HB2' ' A' ' 46' ' ' PHE . 25.1 m-20 -164.31 119.97 1.53 Allowed 'General case' 0 CA--C 1.48 -1.742 0 CA-C-N 112.903 -1.648 . . . . 4.3099999999999996 109.107 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.992 HG13 ' HD2' ' A' ' 42' ' ' PRO . 4.4 p 59.01 -66.26 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 O-C-N 126.684 2.49 . . . . 2.96 112.871 171.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.959 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 50.7 m -164.71 -58.52 0.01 OUTLIER Pre-proline 0 C--N 1.273 -2.759 0 CA-C-N 112.688 -2.051 . . . . 3.8300000000000001 110.006 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.072 ' HG2' ' HD2' ' A' ' 45' ' ' ARG . 23.8 Cg_exo -67.69 4.26 1.47 Allowed 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 120.88 1.054 . . . . 3.8300000000000001 114.44 178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 42' ' ' PRO . 18.0 t70 86.23 -4.85 0.77 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.93 0.872 . . . . 4.2599999999999998 109.578 159.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.532 ' HA2' ' OD2' ' A' ' 39' ' ' ASP . . . 179.06 41.4 0.07 OUTLIER Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 114.747 -1.115 . . . . 2.0099999999999998 112.282 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 1.072 ' HD2' ' HG2' ' A' ' 42' ' ' PRO . 2.6 ttt180 -82.74 -7.79 59.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 122.548 1.166 . . . . 3.3399999999999999 109.167 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.98 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -105.51 -58.98 1.83 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 112.608 -2.087 . . . . 2.0699999999999998 113.453 -171.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 1.039 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 73.9 m 30.31 -170.81 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.588 1.555 . . . . 1.9099999999999999 114.723 -162.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.883 ' HA ' HG22 ' A' ' 9' ' ' ILE . 8.4 tp -166.99 104.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 113.686 0.995 . . . . 3.1899999999999999 113.686 -168.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.82 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.2 m-20 -144.69 130.79 19.45 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.678 -0.809 . . . . 3.3100000000000001 110.272 160.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t -50.03 -45.24 51.85 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 113.972 1.101 . . . . 3.25 113.972 160.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.0 mt -56.3 -37.86 70.47 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.898 1.814 . . . . 4.4500000000000002 115.898 -157.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.478 ' HD2' ' OG ' ' A' ' 10' ' ' SER . 44.9 mtt180 -62.14 -56.87 14.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.229 1.014 . . . . 6.2599999999999998 110.09 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 10' ' ' SER . 34.2 t -64.77 170.7 3.94 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 113.374 -1.739 . . . . 3.04 109.288 171.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.811 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 12.2 t 75.1 30.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 123.168 1.461 . . . . 4.3200000000000003 108.492 -157.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.5 63.24 0.3 Allowed Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 113.457 -1.701 . . . . 4.1900000000000004 112.886 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.23 56.02 24.42 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 119.507 -1.33 . . . . 4.4199999999999999 115.782 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.9 m -136.35 -30.83 0.91 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.588 1.194 . . . . 3.52 109.708 -166.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -47.51 -26.97 1.57 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.766 2.136 . . . . 3.6400000000000001 116.766 -160.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.83 5.14 5.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.815 1.643 . . . . 5.4400000000000004 112.045 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.67 161.15 35.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 107.876 -1.157 . . . . 3.2200000000000002 107.876 162.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.8 118.69 5.39 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 CA-C-N 120.705 1.287 . . . . 3.8300000000000001 108.998 164.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.6 tp -110.76 131.39 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.059 0.392 . . . . 2.6899999999999999 112.059 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.691 HG13 ' HA2' ' A' ' 71' ' ' GLY . 1.2 m -142.05 124.04 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.29 -1.004 . . . . 1.8700000000000001 108.29 158.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.663 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 49.7 ttp -113.2 134.59 54.5 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 118.152 -1.419 . . . . 1.6499999999999999 111.106 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.937 ' HB ' ' CB ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.89 119.28 55.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 CA-C-O 119.207 -0.425 . . . . 0.76000000000000001 110.0 174.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.691 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 55.55 31.42 57.37 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.117 -1.039 . . . . 1.1000000000000001 112.008 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.543 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 42.7 mt-10 58.54 12.62 2.18 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.727 -0.737 . . . . 3.0099999999999998 111.525 -174.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.442 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 30.8 mmmt -73.77 -27.49 61.19 Favored 'General case' 0 C--O 1.227 -0.11 0 N-CA-C 109.642 -0.503 . . . . 2.6200000000000001 109.642 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.663 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 94.6 t 60.51 100.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 115.047 -0.979 . . . . 1.51 112.675 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.843 ' CD2' ' HE1' ' A' ' 85' ' ' TYR . 3.1 m-85 -124.98 -161.45 1.02 Allowed 'General case' 0 C--O 1.248 0.998 0 CA-C-O 122.046 0.927 . . . . 1.4299999999999999 112.15 -177.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.691 ' HA2' HG13 ' A' ' 63' ' ' VAL . . . -137.14 18.89 3.48 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 114.505 -1.225 . . . . 1.49 112.091 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.856 ' HB2' HG22 ' A' ' 81' ' ' ILE . 8.2 t30 -84.62 85.89 7.37 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.083 -0.657 . . . . 1.8300000000000001 109.813 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.655 HG21 ' HB ' ' A' ' 63' ' ' VAL . 59.9 t -153.36 -56.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.55 0.944 . . . . 3.0600000000000001 113.55 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.68 HG22 ' HB ' ' A' ' 25' ' ' VAL . 8.3 p -102.15 149.98 37.08 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.559 -0.291 . . . . 2.4900000000000002 111.586 -164.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.789 ' HD2' ' HA ' ' A' ' 25' ' ' VAL . 1.1 Cg_endo -42.85 112.98 0.31 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.21 3.274 . . . . 2.6499999999999999 111.742 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.658 ' O ' ' HD2' ' A' ' 80' ' ' LYS . . . 119.23 -83.75 0.36 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.216 -1.154 . . . . 1.3999999999999999 110.216 -170.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 1.9 pt20 -64.58 -38.73 92.03 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.766 0.793 . . . . 1.8700000000000001 109.855 -175.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.69 HG22 ' NE2' ' A' ' 32' ' ' GLN . 9.9 p -50.99 -57.4 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 CA-C-N 114.875 -1.057 . . . . 0.96999999999999997 111.609 -174.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.602 ' N ' HG13 ' A' ' 78' ' ' VAL . 16.6 pttp -59.87 -42.4 93.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.604 0.716 . . . . 2.1299999999999999 110.342 -164.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.658 ' HD2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -89.1 -34.95 16.56 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.068 -0.969 . . . . 2.4100000000000001 110.489 -172.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.856 HG22 ' HB2' ' A' ' 72' ' ' ASN . 51.1 mm -68.1 -11.54 14.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.87 -0.604 . . . . 1.23 109.868 174.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.532 ' HB2' HE22 ' A' ' 32' ' ' GLN . 57.4 tp -60.48 -37.19 80.25 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.32 -0.862 . . . . 0.79000000000000004 110.47 168.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.98 -30.54 68.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.724 0.773 . . . . 0.88 109.003 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER -71.77 -32.68 67.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.562 -1.199 . . . . 2.0899999999999999 111.365 174.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.843 ' HE1' ' CD2' ' A' ' 70' ' ' TYR . 8.0 m-30 . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 118.283 -0.865 . . . . 1.77 110.95 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 0.811 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.826 0.346 . . . . 13.970000000000001 110.727 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t -93.34 119.82 67.11 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.162 -0.472 . . . . 10.710000000000001 110.876 -174.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.58 -154.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.869 2.38 . . . . 9.1999999999999993 110.768 174.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 4' ' ' LYS . 32.7 mmtp -75.78 -91.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.462 -0.495 . . . . 9.0399999999999991 110.353 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.63 175.18 50.68 Favored Glycine 0 C--N 1.311 -0.819 0 C-N-CA 120.275 -0.964 . . . . 4.1399999999999997 110.943 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 36.77 46.24 0.47 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.856 0.836 . . . . 4.5800000000000001 110.95 -173.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.82 ' HB2' HG12 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -33.96 116.6 0.48 Allowed Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.198 -1.819 . . . . 1.6399999999999999 113.611 179.318 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.654 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 24.2 Cg_exo -66.34 109.54 1.6 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.024 1.816 . . . . 1.02 110.582 166.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.772 HG23 ' HA ' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -78.52 158.87 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 110.166 -0.309 . . . . 1.52 110.166 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.875 ' HA ' ' O ' ' A' ' 49' ' ' ASP . 25.1 m -141.88 111.46 6.58 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.041 -0.527 . . . . 1.45 110.354 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -117.72 120.48 64.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.971 -0.559 . . . . 2.21 110.985 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.722 ' SG ' HG22 ' A' ' 54' ' ' VAL . 35.8 t -70.2 122.98 20.52 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.673 -0.411 . . . . 2.2400000000000002 110.717 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.84 22.83 9.61 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.372 -0.377 . . . . 5.1200000000000001 111.019 174.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.634 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -66.43 177.49 16.63 Favored Glycine 0 C--O 1.22 -0.736 0 C-N-CA 120.497 -0.859 . . . . 3.8599999999999999 112.363 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.7 m -66.32 -45.14 81.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.613 0.597 . . . . 5.9699999999999998 112.613 -171.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.63 16.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.609 0.719 . . . . 4.4100000000000001 110.783 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 91.3 m -63.51 -28.52 70.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.131 -0.94 . . . . 2.98 111.568 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CE1' ' HB2' ' A' ' 23' ' ' ASP . 61.4 t80 -56.07 -27.45 53.51 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.302 0.641 . . . . 4.1799999999999997 110.265 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.45 -20.74 25.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.573 -0.74 . . . . 3.6499999999999999 110.402 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.489 ' NZ ' ' S1 ' ' A' ' 86' ' ' FES . 48.1 mtmt -80.92 10.45 5.05 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.661 0.267 . . . . 4.79 110.671 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.17 28.21 34.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.927 -0.654 . . . . 1.8700000000000001 112.546 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . -73.02 -22.7 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.575 0.226 . . . . 1.46 111.454 -171.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.64 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 18.0 t70 -61.43 -46.35 90.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.204 0.526 . . . . 2.4199999999999999 110.29 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 9.1 mptt -67.18 -33.06 74.59 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.285 -0.635 . . . . 3.0299999999999998 109.285 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.979 ' HA ' ' HB ' ' A' ' 74' ' ' THR . 99.6 t -56.12 -58.19 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 N-CA-C 109.011 -0.737 . . . . 2.2599999999999998 109.011 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.532 ' HA ' ' HB2' ' A' ' 29' ' ' PHE . 28.9 m -61.58 -34.63 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 115.706 -0.679 . . . . 1.5700000000000001 111.566 -174.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -63.1 -48.37 78.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 C-N-CA 119.112 -1.035 . . . . 1.3500000000000001 110.189 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.98 -43.62 81.87 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.846 -1.168 . . . . 0.65000000000000002 107.846 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.678 ' HZ ' ' HH ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -53.35 -52.56 58.85 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.488 -1.233 . . . . 1.98 110.988 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -51.67 -49.55 62.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.106 -0.952 . . . . 2.8500000000000001 110.578 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.97 -31.54 34.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.442 -1.254 . . . . 2.23 110.842 -175.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.689 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 5.7 mm100 -64.42 -21.92 66.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.632 -0.713 . . . . 2.54 111.933 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.092 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.4 tt -57.45 -55.0 40.47 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.373 -1.343 . . . . 2.0600000000000001 107.373 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.795 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 62.9 -22.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 126.576 2.422 . . . . 4.4800000000000004 112.997 171.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.638 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 54.21 -175.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.153 -1.385 . . . . 3.7599999999999998 112.667 170.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -156.6 -47.35 0.07 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.687 -1.227 . . . . 4.6200000000000001 107.687 -174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 pt -167.19 5.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 113.222 -1.808 . . . . 5.0 111.089 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.574 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . 178.65 -54.54 0.09 OUTLIER Glycine 0 CA--C 1.486 -1.727 0 N-CA-C 110.06 -1.216 . . . . 4.1299999999999999 110.06 -165.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.562 ' HA ' HG23 ' A' ' 35' ' ' ILE . 20.5 t70 -175.24 118.65 0.18 Allowed 'General case' 0 CA--C 1.481 -1.681 0 CA-C-N 113.187 -1.507 . . . . 4.3099999999999996 110.709 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.963 ' HB ' ' HE1' ' A' ' 46' ' ' PHE . 9.5 p 56.17 -66.23 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 O-C-N 127.205 2.816 . . . . 2.96 113.044 173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.887 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 41.1 m -154.64 -61.62 0.02 OUTLIER Pre-proline 0 C--N 1.279 -2.495 0 CA-C-N 113.619 -1.628 . . . . 3.8300000000000001 109.99 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.887 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.1 Cg_exo -79.75 8.41 4.02 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 120.908 1.072 . . . . 3.8300000000000001 114.297 -177.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.574 ' OD1' ' HA3' ' A' ' 38' ' ' GLY . 22.3 t70 82.77 5.85 0.91 Allowed 'General case' 0 C--N 1.353 0.747 0 CA-C-O 122.347 1.07 . . . . 4.2599999999999998 108.356 166.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.504 ' N ' ' HB3' ' A' ' 39' ' ' ASP . . . 175.76 76.2 0.05 OUTLIER Glycine 0 N--CA 1.428 -1.846 0 CA-C-N 114.177 -1.374 . . . . 2.0099999999999998 112.157 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.598 ' HB2' ' CG1' ' A' ' 40' ' ' VAL . 5.2 tpt180 -100.45 -60.42 1.53 Allowed 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.463 -0.94 . . . . 3.3399999999999999 108.463 173.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.092 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.19 115.8 21.68 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 122.508 1.147 . . . . 2.0699999999999998 114.002 -176.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.452 ' C ' HG23 ' A' ' 9' ' ' ILE . 21.2 t -102.27 93.38 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.156 -1.384 . . . . 1.9099999999999999 108.56 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.772 ' HA ' HG23 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -67.52 135.28 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.861 0.689 . . . . 3.1899999999999999 112.861 -168.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.875 ' O ' ' HA ' ' A' ' 10' ' ' SER . 6.5 t70 -160.12 138.03 9.93 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.205 1.003 . . . . 3.3100000000000001 112.73 163.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.3 m -48.47 -49.91 33.64 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 115.407 1.632 . . . . 3.25 115.407 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.4 mt -54.67 -40.65 69.29 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.915 2.191 . . . . 4.4500000000000002 116.915 -150.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.65 ' HE ' ' HA ' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -63.25 -55.37 25.46 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.896 0.855 . . . . 6.2599999999999998 110.945 -179.235 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.72 ' H ' ' HB3' ' A' ' 10' ' ' SER . 25.3 t -63.95 166.41 7.5 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.886 -1.506 . . . . 3.04 109.156 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.772 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 14.3 t 72.83 27.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 123.206 1.479 . . . . 4.3200000000000003 107.586 -153.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.34 65.74 0.32 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 113.292 -1.776 . . . . 4.1900000000000004 113.321 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.16 55.19 25.3 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 119.485 -1.341 . . . . 4.4199999999999999 116.04 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 2.7 m -138.82 -29.89 0.77 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.24 1.02 . . . . 3.52 110.183 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -48.24 -29.51 3.87 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 116.632 2.086 . . . . 3.6400000000000001 116.632 -158.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -75.9 6.77 4.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.407 1.458 . . . . 5.4400000000000004 111.85 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.39 161.62 30.67 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.309 -0.997 . . . . 3.2200000000000002 108.309 163.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -75.24 119.13 5.45 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.326 1.152 . . . . 3.8300000000000001 109.307 163.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 tp -113.09 132.78 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.973 0.731 . . . . 2.6899999999999999 112.973 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.529 HG21 ' CZ ' ' A' ' 29' ' ' PHE . 11.7 p -143.07 121.8 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.86 -0.736 . . . . 1.8700000000000001 109.133 148.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.594 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 50.1 ttp -113.44 133.99 54.9 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 119.26 -0.976 . . . . 1.6499999999999999 108.778 -173.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.82 HG12 ' HB2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -126.04 117.05 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 C-N-CA 120.222 -0.591 . . . . 0.76000000000000001 109.491 173.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.654 ' HA2' ' HD2' ' A' ' 8' ' ' PRO . . . 49.12 50.79 27.27 Favored Glycine 0 CA--C 1.5 -0.898 0 O-C-N 123.748 0.655 . . . . 1.1000000000000001 113.935 173.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 62.12 -0.67 0.45 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 112.111 0.412 . . . . 3.0099999999999998 112.111 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -75.8 -38.56 58.1 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.834 -0.432 . . . . 2.6200000000000001 109.834 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 95.3 t 61.43 113.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.042 -0.981 . . . . 1.51 112.465 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.594 ' CD2' ' CE1' ' A' ' 85' ' ' TYR . 40.0 m-85 -131.53 -172.7 2.92 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-O 122.142 0.972 . . . . 1.4299999999999999 112.278 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -132.01 26.32 3.79 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.024 -1.444 . . . . 1.49 110.96 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 85' ' ' TYR . 2.1 t30 -76.13 111.73 11.84 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.937 -0.764 . . . . 1.8300000000000001 108.937 177.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 74' ' ' THR . 3.2 m -134.12 -97.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 116.34 1.978 . . . . 3.0600000000000001 116.34 -164.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.979 ' HB ' ' HA ' ' A' ' 25' ' ' VAL . 10.2 t -143.92 -41.41 0.01 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 115.66 1.726 . . . . 2.4900000000000002 115.66 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.605 ' HD3' ' H ' ' A' ' 74' ' ' THR . 5.6 Cg_exo -73.65 57.84 3.76 Favored 'Trans proline' 0 C--N 1.365 1.401 0 C-N-CA 122.133 1.889 . . . . 2.6499999999999999 113.193 -169.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.18 -7.34 10.95 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 116.063 -0.517 . . . . 1.3999999999999999 112.468 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.64 ' O ' HG12 ' A' ' 81' ' ' ILE . 13.8 mt-30 -75.84 -30.8 59.09 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 107.227 -1.398 . . . . 1.8700000000000001 107.227 -169.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.689 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -52.63 -46.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-N 112.554 -2.112 . . . . 0.96999999999999997 112.317 -175.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 82' ' ' LEU . 50.1 mtmt -54.76 -44.8 73.97 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.517 1.151 . . . . 2.1299999999999999 108.153 -170.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -80.63 -46.75 15.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.826 -1.988 . . . . 2.4100000000000001 110.331 -173.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 77' ' ' GLN . 28.9 mm -69.02 -16.24 20.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.893 -1.049 . . . . 1.23 110.239 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 78' ' ' VAL . 54.9 tp -61.34 -33.95 74.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.483 -0.76 . . . . 0.79000000000000004 110.107 167.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.83 -27.93 69.12 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.281 0.562 . . . . 0.88 109.535 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.468 ' OE1' HG23 ' A' ' 81' ' ' ILE . 1.7 mt-10 -71.38 -27.33 63.26 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.403 -0.817 . . . . 2.0899999999999999 110.191 173.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 72' ' ' ASN . 3.3 m-30 . . . . . 0 N--CA 1.422 -1.864 0 CA-C-N 115.628 -0.714 . . . . 1.77 110.555 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 0.772 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HG2' ' HE3' ' A' ' 68' ' ' LYS . 44.6 tpp . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.591 0.234 . . . . 13.970000000000001 110.516 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.06 100.9 16.33 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.039 0.447 . . . . 10.710000000000001 110.167 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 1' ' ' MET . 1.6 Cg_endo -81.4 89.84 1.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.084 2.522 . . . . 9.1999999999999993 111.563 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -79.53 -64.98 1.06 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.284 -0.416 . . . . 9.0399999999999991 110.878 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.58 152.04 5.61 Favored Glycine 0 C--N 1.315 -0.605 0 C-N-CA 120.842 -0.694 . . . . 4.1399999999999997 112.72 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER 39.11 56.84 2.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.969 0.907 . . . . 4.5800000000000001 112.054 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.726 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 15.6 m-85 -46.79 125.98 8.27 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.054 -1.43 . . . . 1.6399999999999999 112.224 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.738 ' HA ' ' O ' ' A' ' 47' ' ' SER . 61.0 Cg_exo -57.72 94.23 0.06 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.968 2.446 . . . . 1.02 112.175 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.778 ' HB ' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -82.02 135.52 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 121.32 0.581 . . . . 1.52 111.909 -174.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.726 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 13.0 m -100.68 124.28 46.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.075 -0.966 . . . . 1.45 110.665 -177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.7 m -116.83 125.01 73.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 112.844 0.683 . . . . 2.21 112.844 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.463 ' SG ' ' CB ' ' A' ' 17' ' ' CYS . 15.1 t -67.71 117.38 9.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.058 0.456 . . . . 2.2400000000000002 112.057 175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.5 ttt -129.32 23.75 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.901 -0.591 . . . . 5.1200000000000001 109.583 166.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -67.5 176.46 23.82 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.503 -0.856 . . . . 3.8599999999999999 114.65 -167.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.3 t -67.34 -45.33 76.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.979 0.418 . . . . 5.9699999999999998 112.091 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.29 -52.63 25.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.474 0.654 . . . . 4.4100000000000001 110.1 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' SG ' ' A' ' 12' ' ' CYS . 88.5 m -63.76 -33.84 76.56 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.59 -1.186 . . . . 2.98 112.021 -176.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 43.8 t80 -60.45 -32.62 71.55 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.984 0.421 . . . . 4.1799999999999997 111.015 -178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -72.68 -23.84 21.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.537 0.684 . . . . 3.6499999999999999 109.886 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 23.9 tptm -83.2 8.1 14.23 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.419 -0.809 . . . . 4.79 110.001 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.23 28.29 34.13 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.898 -0.668 . . . . 1.8700000000000001 112.184 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.52 ' HA ' ' CG2' ' A' ' 25' ' ' VAL . . . -71.73 -22.41 61.62 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 120.725 0.298 . . . . 1.46 111.15 -171.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 26' ' ' VAL . 10.0 t70 -56.78 -52.86 63.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.409 -0.359 . . . . 2.4199999999999999 110.232 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -66.17 -37.88 86.71 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.44 -0.504 . . . . 3.0299999999999998 110.908 -172.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.979 ' HB ' ' HB ' ' A' ' 74' ' ' THR . 2.4 m -69.31 -44.56 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 C-N-CA 120.583 -0.447 . . . . 2.2599999999999998 110.72 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 18.9 m -64.52 -31.32 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.919 -0.712 . . . . 1.5700000000000001 109.441 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -59.66 -45.85 90.78 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 120.932 0.396 . . . . 1.3500000000000001 110.08 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' O ' ' HG2' ' A' ' 32' ' ' GLN . . . -56.1 -43.25 77.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.091 -0.958 . . . . 0.65000000000000002 108.516 177.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.774 ' HZ ' ' HE2' ' A' ' 85' ' ' TYR . 1.3 t80 -56.17 -49.18 74.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.062 -0.972 . . . . 1.98 110.776 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -50.92 -46.63 60.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.262 -0.881 . . . . 2.8500000000000001 110.551 178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -76.17 -30.18 58.0 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.97 -1.014 . . . . 2.23 110.919 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.741 ' HG3' ' HB ' ' A' ' 78' ' ' VAL . 13.5 mm100 -61.66 -27.59 68.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.218 -0.901 . . . . 2.54 111.059 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -50.86 -58.41 6.03 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.854 -1.165 . . . . 2.0600000000000001 107.854 170.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER 57.45 -2.63 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 O-C-N 125.683 1.865 . . . . 4.4800000000000004 112.61 173.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER 46.05 -166.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.373 0 CA-C-N 113.656 -1.611 . . . . 3.7599999999999998 112.935 174.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 41' ' ' THR . 6.9 t70 -159.57 -40.25 0.05 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.2 -1.407 . . . . 4.6200000000000001 107.2 -175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.773 HD11 ' HB2' ' A' ' 43' ' ' ASP . 1.5 pt -164.32 0.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 112.247 -2.252 . . . . 5.0 110.557 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 155.84 -27.41 0.58 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 119.517 -1.325 . . . . 4.1299999999999999 112.944 -165.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.996 ' HA ' ' HE1' ' A' ' 46' ' ' PHE . 10.6 t70 -138.28 167.86 20.96 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 121.157 0.503 . . . . 4.3099999999999996 111.898 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 46' ' ' PHE . 5.0 t -25.58 -58.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 126.877 2.611 . . . . 2.96 110.422 174.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.819 ' HB ' ' HD3' ' A' ' 42' ' ' PRO . 98.5 m -159.55 -64.69 0.02 OUTLIER Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 111.627 -2.533 . . . . 3.8300000000000001 111.397 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.819 ' HD3' ' HB ' ' A' ' 41' ' ' THR . 6.2 Cg_exo -78.62 5.93 5.22 Favored 'Trans proline' 0 N--CA 1.437 -1.808 0 C-N-CA 121.097 1.198 . . . . 3.8300000000000001 114.561 -172.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.979 ' HA ' ' HB3' ' A' ' 39' ' ' ASP . 36.9 t70 74.27 21.38 2.45 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.252 -1.018 . . . . 4.2599999999999998 108.252 176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 6' ' ' LYS . . . -172.05 58.52 0.16 Allowed Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 118.691 -1.718 . . . . 2.0099999999999998 113.882 175.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.499 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 0.5 OUTLIER -122.53 -44.28 2.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.241 0.543 . . . . 3.3399999999999999 110.476 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.996 ' HE1' ' HA ' ' A' ' 39' ' ' ASP . 0.8 OUTLIER -119.55 142.11 48.64 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 113.208 0.818 . . . . 2.0699999999999998 113.208 -170.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.738 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 23.2 t -155.64 97.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.354 -1.721 . . . . 1.9099999999999999 106.354 166.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.506 HG23 ' HD2' ' A' ' 46' ' ' PHE . 36.1 pt -87.97 149.7 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 114.021 1.119 . . . . 3.1899999999999999 114.021 -159.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 10' ' ' SER . 3.3 p30 -161.02 138.01 8.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.394 -1.275 . . . . 3.3100000000000001 110.333 159.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.5 m -44.06 -45.55 8.09 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 113.9 -1.5 . . . . 3.25 114.095 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 tp -53.48 -39.5 64.58 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.711 1.745 . . . . 4.4500000000000002 115.711 -152.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG2' ' H ' ' A' ' 52' ' ' ARG . 2.6 mmt180 -62.65 -57.76 9.91 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.611 1.196 . . . . 6.2599999999999998 109.62 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.726 ' HB2' ' HB3' ' A' ' 10' ' ' SER . 38.5 t -66.99 166.45 13.61 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 112.831 -1.986 . . . . 3.04 111.208 175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.227 ' HA ' ' S2 ' ' A' ' 86' ' ' FES . 21.4 t 70.65 26.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 123.332 1.539 . . . . 4.3200000000000003 109.238 -169.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.17 63.58 0.3 Allowed Glycine 0 N--CA 1.431 -1.644 0 CA-C-N 113.319 -1.764 . . . . 4.1900000000000004 112.36 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.34 58.84 10.78 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 119.044 -1.55 . . . . 4.4199999999999999 114.498 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . 0.314 0.8 OUTLIER -131.43 -33.76 1.44 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.05 1.425 . . . . 3.52 108.982 -157.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.78 -26.36 2.33 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 115.311 1.597 . . . . 3.6400000000000001 115.311 -163.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -72.82 6.39 2.59 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 118.984 -1.086 . . . . 5.4400000000000004 111.746 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.1 158.2 46.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 108.027 -1.101 . . . . 3.2200000000000002 108.027 157.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.59 120.07 5.43 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 CA-C-N 120.659 1.271 . . . . 3.8300000000000001 109.507 163.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.651 HD11 ' S1 ' ' A' ' 86' ' ' FES . 2.0 pp -111.46 130.31 65.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 113.048 0.758 . . . . 2.6899999999999999 113.048 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.966 HG21 ' H ' ' A' ' 73' ' ' VAL . 3.9 t -142.27 116.52 4.66 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 107.091 -1.448 . . . . 1.8700000000000001 107.091 157.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.576 ' HG3' HG12 ' A' ' 69' ' ' VAL . 20.5 ttt -119.11 136.47 54.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 118.434 -1.306 . . . . 1.6499999999999999 111.334 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.797 HG23 ' HB2' ' A' ' 68' ' ' LYS . 1.8 m -123.46 115.94 46.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 107.533 -1.284 . . . . 0.76000000000000001 107.533 157.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 7' ' ' TYR . . . 50.03 -155.47 2.49 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.648 -0.787 . . . . 1.1000000000000001 111.223 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.79 37.27 0.41 Allowed 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.995 -0.603 . . . . 3.0099999999999998 109.93 172.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.797 ' HB2' HG23 ' A' ' 65' ' ' VAL . 14.5 mmmm -103.09 -22.76 13.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.056 -0.52 . . . . 2.6200000000000001 109.999 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.576 HG12 ' HG3' ' A' ' 64' ' ' MET . 3.5 m 29.06 101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 115.134 1.531 . . . . 1.51 115.134 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.739 ' HD2' ' HE1' ' A' ' 85' ' ' TYR . 62.7 m-85 -118.09 -158.68 0.72 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.99 0.9 . . . . 1.4299999999999999 112.14 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 81' ' ' ILE . . . -147.84 40.8 0.95 Allowed Glycine 0 N--CA 1.433 -1.53 0 CA-C-N 114.38 -1.282 . . . . 1.49 110.138 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 1.006 ' HA ' HG22 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -64.37 -4.99 4.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.717 0.77 . . . . 1.8300000000000001 110.759 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.966 ' H ' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER 48.89 -160.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.91 1.684 . . . . 3.0600000000000001 114.308 169.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.979 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 27.1 p -139.66 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 114.964 1.468 . . . . 2.4900000000000002 114.964 -166.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.889 ' HD2' HE21 ' A' ' 77' ' ' GLN . 3.7 Cg_exo -77.99 76.98 4.1 Favored 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 122.307 2.004 . . . . 2.6499999999999999 113.811 -170.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.2 -20.75 3.03 Favored Glycine 0 N--CA 1.462 0.397 0 C-N-CA 121.405 -0.426 . . . . 1.3999999999999999 112.751 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.889 HE21 ' HD2' ' A' ' 75' ' ' PRO . 18.4 mt-30 -77.99 -18.91 55.38 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 106.824 -1.547 . . . . 1.8700000000000001 106.824 -172.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.741 ' HB ' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -47.15 -51.09 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 112.069 -2.332 . . . . 0.96999999999999997 110.908 -177.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.707 ' HA ' ' NE2' ' A' ' 32' ' ' GLN . 44.7 mtmt -54.0 -51.61 63.41 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-O 122.833 1.301 . . . . 2.1299999999999999 109.343 -167.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -90.23 -35.5 15.29 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.176 -1.829 . . . . 2.4100000000000001 110.675 -169.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.006 HG22 ' HA ' ' A' ' 72' ' ' ASN . 46.5 mm -71.98 -13.6 16.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.176 -0.92 . . . . 1.23 109.126 176.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 85' ' ' TYR . 43.9 tp -56.11 -19.89 15.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.469 -0.332 . . . . 0.79000000000000004 110.343 171.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.7 -22.23 1.98 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.777 0.322 . . . . 0.88 111.428 167.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.25 -44.37 95.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.431 0.634 . . . . 2.0899999999999999 110.251 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.774 ' HE2' ' HZ ' ' A' ' 29' ' ' PHE . 10.1 m-30 . . . . . 0 N--CA 1.427 -1.586 0 CA-C-N 115.018 -0.992 . . . . 1.77 112.082 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' FES . . . . . 1.227 ' S2 ' ' HA ' ' A' ' 54' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_